Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168915498-169031324 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 80.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 41.7;Alveolar cells type 2: 44.1;Club cells: 19.3;Early spermatids: 16.5;granulocytes: 24.0;Hepatocytes: 20.4" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.6;RT4: 1.6;TIME: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 62: Liver - Hemostasis" "Cluster 24: NB-4 - Immune response" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.5 0.0 0.3 0.1 0.3 0.0 0.6 0.3 0.5 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 80.8 0.0 0.1 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.4 0.1 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.0 6.2 0.2 0.0 0.0 0.0 0.1 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.4 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.2 0.2 1.0 0.6 0.5 0.3 0.2 0.3 0.0 41.7 44.1 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 19.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 16.5 0.1 0.0 1.8 0.0 2.7 0.8 0.0 0.0 6.6 0.0 0.0 24.0 0.0 0.0 20.4 0.0 0.0 0.3 0.0 0.0 0.3 0.0 9.1 0.0 3.8 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.0 8.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.6 0.2 0.0 0.6 AC004556.3 ENSG00000276345 "39S ribosomal protein L23, mitochondrial" Unmapped 2585-11802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 24.0" "Group enriched" "Detected in some" 6 "Extravillous trophoblasts: 35.6;Hofbauer cells: 23.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 94.7;K-562: 75.5;MOLT-4: 85.4;NB-4: 160.6;PC-3: 141.1;WM-115: 113.7" HPA050406 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" Mitochondria "Nucleoli fibrillar center" "HPA050406: AB_2681116" 3.8 0.0 2.5 4.0 3.0 0.0 19.4 2.8 3.2 0.0 2.6 10.3 0.1 5.0 14.3 0.0 4.9 5.9 24.0 2.4 2.7 6.7 8.5 1.6 0.0 3.1 3.7 6.3 6.8 0.0 2.1 3.4 5.0 0.0 1.2 7.5 0.3 14.5 5.1 9.9 0.5 2.4 4.1 5.0 2.4 2.8 9.9 2.6 0.0 0.1 4.5 2.8 0.2 0.0 0.1 0.1 0.0 0.0 42.0 27.8 43.4 46.5 33.2 94.7 0.8 0.1 0.1 0.0 0.0 0.6 0.7 0.3 18.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 51.1 0.0 31.4 48.3 75.5 42.5 0.4 0.4 85.4 160.6 0.0 0.2 141.1 0.5 22.8 0.2 44.0 27.1 0.2 0.6 0.0 0.2 0.1 0.0 70.4 0.0 0.0 0.0 0.1 0.3 0.4 0.5 0.3 0.1 0.8 0.3 113.7 12.3 3.4 2.2 1.7 6.2 1.4 1.7 2.5 3.5 3.0 2.0 2.6 2.9 1.0 2.1 2.8 2.8 4.0 2.1 2.5 3.0 2.8 3.2 2.4 2.7 3.1 3.7 3.4 2.4 2.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 35.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 AC008982.1 ENSG00000268083 "Novel protein" 19 38817471-38840178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 2.1" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "NB-4: 26.4" "HPA002907, HPA051748" Uncertain Uncertain Mitochondria NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Mitochondria "HPA002907: AB_1847964, HPA051748: AB_2681588" "unprognostic (1.36e-2)" 0.6 0.2 0.4 0.1 0.4 1.0 0.2 0.4 2.1 0.2 0.4 0.7 0.5 0.3 0.0 0.2 0.1 0.0 0.4 0.4 0.4 0.3 0.2 0.5 0.3 0.4 0.4 0.2 0.3 0.0 0.1 0.2 0.4 0.2 0.0 0.1 0.2 0.1 1.4 0.3 0.3 0.0 0.4 0.2 0.2 0.3 0.4 0.0 0.2 0.4 0.0 0.1 0.2 0.4 1.5 0.0 0.2 0.3 0.1 0.1 1.8 0.5 0.0 0.6 0.1 0.8 0.1 0.2 1.2 0.1 0.1 0.8 0.0 0.0 0.2 1.5 0.5 1.0 0.0 0.0 0.1 0.5 1.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.6 0.5 0.0 0.9 1.3 26.4 1.9 0.0 0.0 1.6 0.8 0.7 0.3 0.3 0.7 2.9 0.0 0.0 6.0 0.0 0.5 3.0 0.0 0.1 2.7 1.6 2.1 1.3 1.0 2.2 0.1 0.8 0.1 0.5 0.7 0.7 0.6 0.5 1.0 0.4 0.7 0.7 0.6 0.5 0.6 0.8 0.0 0.8 0.3 1.5 0.9 0.7 0.4 0.4 0.4 2.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011043.2 ENSG00000278198 Unmapped 173872-179372 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.7;NB-4: 2.3" NA NA "Cluster 24: NB-4 - Immune response" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.7 0.1 0.7 0.8 0.2 0.0 0.6 0.3 0.2 0.2 0.4 1.0 0.2 0.0 0.1 0.0 0.5 0.8 0.6 0.2 0.7 0.6 0.7 0.5 0.7 0.9 0.0 1.0 1.0 0.0 0.3 0.1 0.4 0.4 0.1 0.7 0.1 0.8 0.2 0.1 0.2 2.3 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.3 0.0 0.5 0.0 0.4 0.2 0.2 0.5 0.2 0.2 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.2 0.1 0.2 0.3 0.3 0.3 0.4 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011841.1 ENSG00000273496 Unmapped 99351-104855 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Melanocytes: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.7;NB-4: 2.3" NA NA "Cluster 24: NB-4 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.7 0.1 0.7 0.8 0.2 0.0 0.6 0.3 0.2 0.2 0.4 1.0 0.2 0.0 0.1 0.0 0.5 0.8 0.6 0.2 0.7 0.6 0.7 0.5 0.7 0.9 0.0 1.0 1.0 0.0 0.3 0.1 0.4 0.4 0.1 0.7 0.1 0.8 0.2 0.1 0.2 2.3 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.3 0.0 0.5 0.0 0.4 0.2 0.2 0.5 0.2 0.2 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.2 0.1 0.2 0.3 0.3 0.3 0.4 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC099850.2 ENSG00000265303 "Novel protein" 17 59197566-59215226 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NB-4: 11.0;SK-MEL-30: 2.4;THP-1: 5.9" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 11: Alveolar cells - Smell perception" 1.4 3.1 6.2 0.0 6.3 0.7 1.2 6.4 9.4 1.4 6.2 1.5 0.0 1.2 0.0 2.5 1.1 0.0 3.5 6.3 6.2 2.1 5.9 1.0 0.5 6.3 6.2 1.4 3.2 0.0 2.5 0.1 6.3 1.6 0.2 0.4 1.2 0.1 1.2 2.2 1.8 0.0 6.2 3.8 2.4 2.9 6.3 0.3 1.0 0.2 0.6 1.2 1.2 6.4 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.3 0.0 0.6 0.0 1.5 0.7 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.3 0.3 1.1 0.0 0.0 0.7 0.0 0.6 11.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.3 0.0 2.4 0.3 0.3 5.9 0.0 0.0 0.7 0.2 0.1 0.2 0.4 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.6 0.0 0.2 0.1 0.0 6.2 6.3 6.4 9.4 6.3 6.2 6.3 6.2 6.3 6.2 6.3 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135050.2 ENSG00000255439 "Novel protein, VKORC1 and PRSS53 readthrough" 16 31083439-31094956 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skin 1: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 5.2;NB-4: 6.8;RPMI-8226: 8.7;U-266/70: 5.7" HPA042720 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 24: NB-4 - Immune response" "Cluster 11: Alveolar cells - Smell perception" "Endoplasmic reticulum" "HPA042720: AB_10961864" "unprognostic (2.74e-1)" "unprognostic (9.61e-2)" "unprognostic (6.94e-2)" "unprognostic (2.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.68e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "unprognostic (3.57e-1)" "unprognostic (2.79e-2)" "unprognostic (4.48e-3)" "unprognostic (8.49e-2)" "unprognostic (2.84e-8)" "unprognostic (4.96e-6)" "unprognostic (1.39e-1)" "unprognostic (4.81e-1)" "unprognostic (2.29e-4)" 0.4 0.1 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.7 0.1 0.3 0.1 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.7 0.2 0.2 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 1.1 0.4 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.1 0.9 0.4 0.0 0.4 1.0 1.2 0.3 5.2 0.3 0.0 0.2 0.2 0.3 3.4 1.8 0.1 0.0 0.2 0.0 0.1 0.0 1.3 2.7 0.8 0.3 0.2 0.0 0.5 1.1 0.3 0.2 0.2 0.0 0.2 0.0 0.6 0.0 0.7 0.1 0.4 0.8 6.8 0.1 0.0 1.5 3.4 0.3 8.7 0.0 0.3 2.1 2.6 1.2 0.4 1.0 0.0 0.0 0.2 1.3 0.5 0.0 1.6 0.5 5.7 0.7 0.6 1.2 0.9 0.2 0.6 0.7 2.5 2.0 0.8 2.7 2.1 2.1 2.8 0.9 1.6 1.3 1.9 0.9 0.9 1.8 1.6 2.8 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ACAP1 "CENTB1, KIAA0050" ENSG00000072818 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 1" Q15027 17 7336529-7351477 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0" "Cell type enriched" "Detected in many" 6 "Late spermatids: 3430.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 23.3;HDLM-2: 31.0;JURKAT: 42.4;Karpas-707: 29.4;NB-4: 37.9;U-937: 24.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075570 Approved Approved "Golgi apparatus" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA075570: AB_2732295" "unprognostic (1.20e-2)" "prognostic favorable (3.66e-4)" "unprognostic (2.49e-1)" "prognostic favorable (2.97e-5)" "unprognostic (4.43e-4)" "prognostic favorable (4.17e-5)" "unprognostic (5.66e-3)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (2.48e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.65e-10)" "unprognostic (1.14e-1)" "unprognostic (5.58e-2)" "unprognostic (2.90e-1)" "unprognostic (8.61e-3)" 5.6 1.1 0.4 18.9 0.5 41.0 2.1 0.5 0.8 2.3 0.5 7.4 4.1 1.5 0.3 4.2 4.0 3.6 2.1 0.3 0.4 4.6 5.2 16.1 39.5 0.6 0.5 0.9 1.2 0.1 1.3 0.5 0.6 3.8 2.1 0.2 3.6 0.4 0.9 2.5 43.3 0.9 0.5 96.0 5.0 0.8 0.8 25.8 5.2 0.8 22.6 4.3 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 23.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 8.8 0.1 0.0 0.1 11.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 42.4 0.0 29.4 0.0 0.0 14.5 37.9 0.4 0.0 0.0 15.1 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.9 0.0 0.0 0.1 0.0 0.0 9.1 8.2 10.9 0.1 24.9 0.0 28.8 7.9 30.8 29.6 2.4 33.3 20.2 31.5 32.1 13.7 21.3 26.7 27.5 22.6 32.5 0.4 17.3 39.0 22.3 0.4 0.5 0.5 0.8 0.3 0.4 0.6 0.5 0.6 0.5 0.8 0.6 3.8 9.6 5.5 1.6 150.9 8.3 7.6 25.1 2.8 15.8 7.0 8.1 32.9 7.2 12.3 5.5 18.8 3.9 160.7 2.0 7.9 3.9 498.1 8.3 5.4 5.0 3.6 22.9 0.3 3.7 3.2 8.0 5.6 3.4 40.5 1.8 7.1 5.3 7.5 0.0 1.9 2.7 8.2 26.2 39.5 3430.7 20.2 27.9 24.9 2.8 38.3 11.7 332.7 0.5 1.0 5.5 0.0 15.4 68.0 4.6 1.3 3.8 44.6 20.4 19.7 7.5 8.1 15.6 10.5 1.5 7.4 4.4 268.3 0.9 1.6 3.5 ACBD6 MGC2404 ENSG00000230124 "Acyl-CoA binding domain containing 6" Q9BR61 1 180269653-180502954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028179, HPA028457" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 24: NB-4 - Immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Cytosol "HPA028179: AB_10601788, HPA028457: " "unprognostic (3.12e-1)" "unprognostic (4.38e-2)" "unprognostic (1.66e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (1.75e-2)" "unprognostic (2.03e-2)" "unprognostic (2.73e-2)" "unprognostic (7.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (4.02e-7)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.51e-1)" 19.5 19.0 11.5 15.0 11.3 25.9 18.4 14.9 13.8 20.5 10.7 21.1 15.2 21.5 15.1 15.1 17.7 17.7 22.3 10.6 12.3 17.7 15.5 15.2 19.0 10.7 10.5 24.7 19.5 25.0 14.4 28.2 10.7 16.4 13.6 7.2 17.3 17.4 24.0 20.7 13.8 18.5 10.3 17.8 15.4 33.0 11.1 20.5 20.0 20.6 18.1 19.5 17.3 13.5 69.4 56.4 47.6 33.2 33.9 57.4 91.1 31.3 69.7 57.6 52.0 80.1 52.8 60.0 62.2 35.3 27.5 47.0 36.2 62.7 38.3 44.5 56.8 48.3 51.9 48.2 82.2 85.5 41.2 51.1 89.5 35.9 59.0 52.4 66.2 49.9 74.5 48.9 48.4 70.7 68.1 84.1 47.8 53.2 20.3 67.3 38.0 119.4 51.4 40.8 68.0 86.0 44.4 74.6 44.9 48.6 75.6 65.4 50.4 40.8 45.3 49.5 71.0 88.1 55.7 137.4 43.4 50.7 47.7 3.1 13.1 4.4 13.6 20.0 15.4 18.1 11.6 11.8 22.0 11.6 13.9 16.3 0.9 27.3 16.3 17.7 11.7 12.2 11.5 11.3 14.9 13.8 10.6 12.3 10.7 10.5 10.7 10.3 11.1 13.5 31.5 32.1 33.0 60.4 32.7 21.3 29.9 38.7 42.7 64.2 23.6 33.3 42.3 21.5 35.4 16.5 39.6 165.0 38.7 3.8 41.1 43.7 106.9 22.2 38.0 31.9 19.4 25.0 124.9 41.6 41.7 35.6 19.9 23.3 20.2 52.2 23.9 13.4 44.6 52.2 118.1 15.7 34.6 17.8 18.6 59.2 51.3 25.0 37.4 60.9 30.0 37.8 26.8 98.0 109.3 36.2 12.9 50.8 48.4 27.2 19.6 51.2 27.4 6.6 59.2 38.4 53.4 143.6 64.6 40.5 22.4 84.4 29.4 63.2 19.2 24.8 ADAM7 "EAPI, GP-83" ENSG00000069206 "ADAM metallopeptidase domain 7" Q9H2U9 8 24440930-24526970 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 237 "epididymis: 3726.4" "Cell type enriched" "Detected in some" 7 "Early spermatids: 128.3" "Group enriched" "Detected in some" 16 "prostate cancer: 1.0;renal cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "BEWO: 2.4;NB-4: 6.1;RPMI-8226: 1.7;SH-SY5Y: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA008879 Enhanced "Intracellular and membrane" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA008879: AB_10601789" "unprognostic (1.03e-3)" "unprognostic (3.96e-4)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3726.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.8 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.3 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 16.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS10 ADAM-TS10 ENSG00000142303 "ADAM metallopeptidase with thrombospondin type 1 motif 10" Q9H324 19 8580240-8610735 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 18.3;Excitatory neurons: 21.4;Inhibitory neurons: 19.9;Microglial cells: 30.9;Skeletal myocytes: 15.9;Smooth muscle cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 7.2;hTERT-RPE1: 7.5;NB-4: 37.0;REH: 9.8" "Region enriched" "Detected in many" 5 "cerebellum: 8.8" "Low region specificity" "Detected in all" HPA040223 Uncertain "Secreted to extracellular matrix" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" "HPA040223: AB_10795376" "unprognostic (2.60e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (1.14e-1)" "unprognostic (8.16e-2)" "unprognostic (1.91e-4)" "unprognostic (4.98e-3)" "unprognostic (4.06e-2)" "unprognostic (2.24e-2)" "unprognostic (6.52e-2)" "unprognostic (2.47e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (6.86e-3)" "unprognostic (1.71e-1)" "unprognostic (2.33e-1)" "unprognostic (4.12e-2)" 15.9 8.2 7.1 2.3 7.3 1.8 9.5 5.0 11.9 13.0 5.8 7.3 0.8 12.7 0.7 4.1 10.2 1.9 8.5 7.6 8.7 6.9 6.3 8.2 3.2 7.1 6.8 8.3 7.8 0.8 4.1 1.7 6.7 8.4 0.5 0.4 4.1 1.5 2.8 8.8 6.3 1.5 6.0 5.4 3.8 2.4 8.1 1.4 6.2 0.8 1.3 5.7 8.7 6.5 0.0 4.6 2.5 0.0 0.4 0.3 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 2.2 1.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 7.2 0.0 0.3 0.0 0.1 1.8 0.0 0.0 0.0 7.5 0.1 0.3 0.1 0.0 0.0 0.0 0.3 37.0 1.5 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 1.2 0.1 0.4 2.0 3.1 4.4 2.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 7.3 5.0 11.9 7.6 8.7 7.1 6.8 6.7 6.0 8.1 6.5 5.6 0.0 0.0 18.3 0.3 1.7 0.6 0.1 0.0 1.5 1.2 1.5 1.3 5.7 0.1 0.0 0.0 0.1 6.9 0.0 0.0 8.8 5.1 0.4 7.4 5.8 0.0 1.3 21.4 0.5 0.0 6.4 1.1 0.4 0.0 1.8 6.8 2.0 0.9 0.0 19.9 0.3 0.0 2.7 6.0 2.4 7.5 3.3 0.0 30.9 0.6 0.8 11.3 9.5 1.2 0.9 0.0 6.0 1.3 0.2 0.0 0.1 0.0 0.2 6.6 15.9 15.0 0.1 0.4 0.1 0.9 0.4 3.2 0.6 0.1 0.3 ADGRG3 "GPR97, Pb99, PGR26" ENSG00000182885 "Adhesion G protein-coupled receptor G3" Q86Y34 16 57668277-57689378 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 147.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.4;dendritic cells: 2.9;Endothelial cells: 2.8;Erythroid cells: 5.3;T-cells: 4.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebral cortex: 10.6" "Immune cell enhanced" "Detected in some" "eosinophil: 142.3;neutrophil: 169.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 169.8" "Group enriched" "Detected in some" 6 "NB-4: 5.0;SK-MEL-30: 2.1;U-937: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA040469 Uncertain NA NA 1200000 "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA040469: AB_10794032" "unprognostic (4.41e-3)" "unprognostic (3.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" "unprognostic (8.84e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-4)" "unprognostic (5.25e-3)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (1.93e-1)" "unprognostic (1.53e-1)" "unprognostic (2.67e-3)" "unprognostic (4.75e-2)" "unprognostic (3.77e-1)" "unprognostic (1.00e-1)" "unprognostic (2.90e-1)" 8.5 0.3 0.1 14.6 0.2 147.0 1.7 0.1 10.6 1.1 0.3 1.6 2.2 1.0 0.0 1.0 4.3 2.3 1.2 0.1 0.1 0.8 2.3 12.0 0.3 0.2 0.2 0.4 0.7 0.0 0.2 1.7 2.0 0.6 1.4 0.0 0.4 0.1 0.3 0.7 3.4 2.6 0.1 29.4 1.3 0.3 0.4 0.6 3.2 2.8 0.4 3.8 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 75.5 0.0 142.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.8 36.4 0.1 0.0 0.0 0.9 0.1 0.2 0.1 10.6 0.1 0.1 0.2 0.2 2.0 0.1 0.4 0.1 1.0 9.6 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 1.8 0.0 0.0 0.3 2.9 0.0 0.0 0.1 0.6 0.5 0.2 2.8 0.0 5.3 0.1 0.0 0.1 0.9 0.0 0.4 2.5 0.2 2.2 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.2 1.5 0.0 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.1 4.2 0.0 0.0 0.1 ADM5 "AM5, C19orf76" ENSG00000224420 "Adrenomedullin 5 (putative)" C9JUS6 19 49688664-49690575 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Adipocytes: 29.3;Endothelial cells: 47.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 18.0" "Secreted to blood" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "unprognostic (2.34e-2)" "unprognostic (2.56e-1)" "unprognostic (3.08e-3)" "unprognostic (5.62e-2)" "unprognostic (2.18e-2)" "unprognostic (2.64e-2)" "unprognostic (1.28e-1)" "unprognostic (2.39e-2)" "unprognostic (9.82e-2)" "unprognostic (2.92e-1)" "unprognostic (1.47e-2)" "unprognostic (8.94e-2)" "unprognostic (4.21e-11)" "unprognostic (2.39e-2)" "unprognostic (9.25e-2)" "unprognostic (9.92e-3)" "prognostic favorable (6.74e-4)" 7.8 0.8 1.9 0.7 1.9 1.3 6.0 4.5 2.9 3.7 1.5 2.4 0.8 4.3 0.3 3.3 5.0 0.6 1.8 2.0 1.9 3.5 1.8 4.3 1.0 1.9 1.9 2.0 1.8 0.1 2.7 0.7 2.2 3.9 0.2 1.5 2.6 0.4 3.9 5.0 2.9 0.8 1.8 6.7 2.3 3.0 2.2 0.7 2.6 0.4 0.7 3.6 3.6 1.9 3.4 5.7 3.3 2.3 0.1 0.0 3.9 0.3 0.3 1.1 0.6 6.6 3.1 5.1 1.2 0.2 0.3 1.0 5.9 1.9 0.4 6.0 11.3 5.8 1.6 4.3 0.1 1.7 3.8 0.6 4.2 0.7 0.5 0.8 1.1 5.4 4.2 3.7 0.2 5.4 2.6 18.0 4.4 0.6 1.6 7.4 2.5 5.3 0.5 5.9 2.0 0.9 0.8 1.6 1.6 0.8 3.6 2.5 0.9 1.8 6.6 0.9 1.4 12.6 10.7 5.9 1.2 10.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 4.5 2.9 2.0 1.9 1.9 1.9 2.2 1.8 2.2 1.9 29.3 0.0 1.5 1.3 1.4 6.1 1.4 1.4 6.2 4.3 5.4 6.1 0.1 1.5 1.5 0.0 0.0 0.5 1.0 1.8 0.0 0.5 8.1 3.0 1.9 47.3 1.2 0.0 0.3 1.1 0.5 2.2 1.5 6.0 0.0 0.7 5.0 0.3 0.3 0.0 0.4 1.5 0.0 1.0 4.9 4.3 0.6 1.3 5.4 0.0 0.2 0.9 0.0 0.0 0.9 0.6 0.4 0.7 0.2 1.9 0.3 0.0 1.6 2.4 0.0 2.9 1.5 1.1 1.2 6.2 6.3 0.1 1.3 0.3 1.6 1.1 AGAP3 CENTG3 ENSG00000133612 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 3" Q96P47 7 151085831-151144436 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012883 Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 62: Horizontal cells - Visual perception" "HPA012883: AB_1846533" "unprognostic (3.63e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (4.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (6.21e-4)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (7.30e-2)" "unprognostic (2.89e-2)" "unprognostic (3.15e-3)" "prognostic unfavorable (8.58e-5)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (1.55e-2)" "unprognostic (9.50e-3)" 46.7 42.9 104.5 14.7 112.6 7.1 47.2 60.6 186.6 79.5 38.1 54.8 17.7 57.6 11.1 64.6 55.2 15.4 50.5 120.6 72.0 34.9 53.7 72.5 13.0 90.8 74.1 71.9 56.7 24.2 100.5 19.0 86.5 64.8 7.9 12.4 45.5 18.3 46.1 69.9 38.6 14.7 56.0 37.8 41.9 20.0 82.7 5.4 47.5 13.8 8.4 54.8 66.0 111.2 44.1 34.8 30.7 67.6 28.5 22.7 47.2 33.9 31.9 26.0 22.8 34.1 44.9 0.9 42.7 19.8 31.8 60.8 21.8 47.7 8.3 51.4 67.6 39.4 38.0 46.8 40.0 26.7 15.5 22.9 58.2 21.1 22.1 41.3 39.0 16.7 71.8 31.0 15.4 115.6 11.2 123.6 57.5 34.9 38.4 27.6 21.2 62.4 32.7 106.4 91.5 76.4 26.0 8.1 83.9 21.5 22.5 40.3 37.8 35.1 11.7 43.3 42.3 39.5 19.0 0.6 69.3 45.1 44.8 0.0 2.7 0.2 0.9 1.8 0.7 1.9 1.3 1.6 1.2 0.2 0.9 0.5 0.2 2.0 0.5 0.0 0.2 1.5 104.5 112.6 60.6 186.6 120.6 72.0 90.8 74.1 86.5 56.0 82.7 111.2 24.3 28.9 25.3 24.2 2.4 21.3 14.1 17.7 22.8 53.7 14.7 23.4 21.5 10.0 16.8 3.7 8.4 8.8 6.4 16.2 0.0 5.8 0.4 13.5 19.4 21.9 7.2 1.3 45.4 10.5 1.6 16.0 7.7 15.6 17.2 34.6 13.9 19.0 19.5 57.2 38.0 11.1 8.2 17.9 47.5 2.8 11.8 24.1 12.4 26.2 8.9 13.2 1.0 16.6 38.5 21.6 3.2 11.7 5.5 14.8 17.8 6.5 11.8 15.1 13.1 12.3 9.8 0.7 13.6 22.6 18.6 3.1 6.6 20.2 11.8 11.7 AGAP4 "AGAP8, CTGLF1, CTGLF5, Em:AC012044.1, MRIP2" ENSG00000188234 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 4" Q96P64 10 45825613-45853875 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 141.3;Late spermatids: 52.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 21.6" HPA042490 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA042490: AB_2678022" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.05e-1)" "unprognostic (7.50e-2)" "unprognostic (2.50e-2)" "unprognostic (4.10e-4)" "unprognostic (4.13e-3)" "unprognostic (5.72e-2)" "unprognostic (3.68e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (2.81e-3)" "unprognostic (3.76e-5)" "unprognostic (7.49e-2)" "unprognostic (3.19e-1)" "unprognostic (8.58e-2)" "unprognostic (5.28e-4)" 5.0 6.8 11.9 5.1 12.2 5.9 5.3 14.6 13.7 7.5 11.2 6.0 7.5 5.0 5.8 4.9 6.1 3.0 6.0 12.0 11.8 8.9 9.3 5.1 7.1 11.5 11.0 7.3 7.4 2.5 9.0 3.6 11.7 9.1 3.7 9.8 4.6 4.2 7.2 9.6 6.8 2.7 10.4 10.2 5.8 7.1 12.1 5.3 6.3 2.8 3.5 5.8 5.9 12.9 2.8 3.2 9.3 5.6 3.8 4.5 7.0 3.2 3.0 3.4 3.5 7.3 7.3 4.1 4.7 2.6 1.9 7.8 1.8 4.5 2.4 5.2 5.8 0.3 8.1 9.2 3.7 4.8 3.1 3.0 3.9 3.9 4.1 2.6 1.8 8.5 6.1 4.8 1.9 4.5 4.0 21.6 4.3 2.7 1.2 5.7 3.1 4.5 3.3 3.5 6.5 5.3 1.5 5.7 5.5 4.8 5.1 5.8 5.3 1.5 4.4 3.3 6.8 8.5 5.0 3.6 3.1 6.9 1.7 2.0 0.2 0.7 0.4 0.2 0.3 0.1 0.1 0.4 0.3 0.5 0.2 0.2 1.0 0.4 0.1 0.3 0.1 0.1 11.9 12.2 14.6 13.7 12.0 11.8 11.5 11.0 11.7 10.4 12.1 12.9 5.4 19.2 8.2 6.2 2.4 0.4 1.6 0.1 0.0 4.2 4.3 4.7 5.2 5.7 5.1 1.8 10.4 4.6 4.3 4.7 0.0 2.0 141.3 4.2 2.7 4.4 1.2 2.1 15.1 1.8 1.4 2.9 10.2 3.0 12.7 6.5 5.7 2.5 2.3 0.0 14.3 4.9 2.0 4.1 0.6 52.9 2.1 2.6 0.0 2.8 4.4 1.8 3.1 8.0 9.9 1.5 1.0 5.3 2.9 2.8 5.5 1.0 6.4 5.5 6.6 3.3 4.8 6.6 5.3 2.1 0.1 1.9 3.4 3.9 5.6 2.1 AGAP5 "CTGLF2, Em:AC073389.1" ENSG00000172650 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 5" A6NIR3 10 73674287-73697881 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 79.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA042490 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA042490: AB_2678022" "unprognostic (1.84e-1)" "unprognostic (3.59e-2)" "unprognostic (1.27e-2)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (4.45e-3)" "unprognostic (1.40e-1)" "unprognostic (4.52e-1)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (4.04e-3)" "unprognostic (4.33e-3)" "unprognostic (5.83e-5)" "unprognostic (3.33e-2)" "unprognostic (2.87e-1)" "unprognostic (7.29e-2)" "unprognostic (1.17e-2)" 3.2 5.1 2.7 3.8 3.1 3.2 4.3 4.2 3.7 3.9 4.4 3.5 3.5 3.3 4.2 3.2 3.3 2.6 5.5 2.7 3.2 4.4 6.9 3.6 4.4 3.0 2.8 4.8 9.9 1.9 4.7 2.6 3.2 4.7 3.1 5.3 6.3 2.5 8.7 6.5 4.0 2.2 2.1 5.0 4.3 8.4 3.4 3.1 4.0 2.1 2.8 3.3 3.5 4.6 2.4 2.9 3.8 4.2 3.0 2.3 5.7 2.9 2.1 2.0 1.7 3.9 3.3 2.9 2.4 2.3 0.8 5.9 2.8 2.4 1.3 3.4 3.3 2.3 6.7 4.5 2.5 5.9 3.7 2.4 2.6 2.3 6.2 5.2 1.6 4.2 3.0 5.8 1.8 2.3 2.3 7.7 1.1 2.6 7.9 3.1 1.6 2.2 2.0 2.3 1.7 1.5 1.7 6.2 3.5 2.7 3.5 4.7 2.9 2.5 3.4 2.5 3.8 6.9 3.7 1.7 2.6 6.7 1.1 0.6 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 2.7 3.1 4.2 3.7 2.7 3.2 3.0 2.8 3.2 2.1 3.4 4.6 2.1 0.0 9.0 4.2 1.5 1.9 0.3 0.8 0.0 2.4 2.4 1.7 0.0 1.5 3.7 3.7 6.2 1.7 2.1 1.0 0.0 1.6 79.9 2.6 2.3 2.1 0.0 2.7 6.4 2.2 0.7 1.7 4.6 1.5 3.8 2.5 3.9 3.5 1.5 3.3 6.3 2.0 0.0 1.3 2.2 18.9 1.2 1.9 1.8 1.9 2.4 1.7 2.1 4.5 8.4 2.7 0.5 3.8 1.6 1.1 3.2 0.6 6.6 2.7 0.0 0.9 0.9 4.2 2.4 0.9 1.3 0.7 1.8 1.3 2.1 0.7 AGAP6 "bA324H6.1, CTGLF3" ENSG00000204149 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 6" Q5VW22 10 49982190-50011654 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 84.8;Late spermatids: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 9.0" HPA042490 Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA042490: AB_2678022" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (3.07e-3)" "unprognostic (2.96e-1)" "unprognostic (1.71e-1)" "unprognostic (7.60e-3)" "unprognostic (1.34e-2)" "unprognostic (7.48e-2)" "unprognostic (5.51e-2)" "unprognostic (1.91e-2)" "prognostic favorable (2.66e-4)" "unprognostic (9.93e-3)" "prognostic unfavorable (9.70e-10)" "unprognostic (8.04e-2)" "unprognostic (2.12e-1)" "unprognostic (1.85e-2)" "prognostic favorable (1.83e-7)" 20.3 21.7 1.9 1.1 2.0 0.4 20.2 2.3 2.7 23.6 2.7 23.8 1.4 18.6 0.2 16.0 20.7 0.3 17.4 1.8 1.7 28.8 38.7 22.6 2.3 1.8 1.7 22.6 31.4 0.4 38.6 0.8 1.8 28.4 1.0 0.7 18.5 1.3 20.1 18.9 24.0 1.1 1.5 35.0 20.8 29.3 1.9 3.2 29.0 0.6 0.7 19.2 19.5 2.1 1.0 1.4 0.8 2.1 2.7 1.5 1.8 3.0 0.5 1.0 1.6 2.9 1.1 2.3 1.0 0.6 0.6 1.5 1.0 1.0 1.4 1.4 4.3 3.8 3.0 1.2 1.2 3.1 4.6 1.8 3.4 1.2 3.7 1.6 1.2 2.3 3.9 3.1 1.8 1.4 3.5 9.0 0.6 0.8 3.6 2.6 0.9 1.2 2.0 2.3 2.1 2.6 0.7 2.3 1.1 0.7 1.8 1.6 3.1 1.4 1.4 0.4 2.4 4.9 2.1 1.5 0.3 3.3 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.9 2.0 2.3 2.7 1.8 1.7 1.8 1.7 1.8 1.5 1.9 2.1 6.0 19.2 10.9 19.2 2.9 3.3 1.8 1.3 1.2 6.2 5.6 7.4 8.3 2.8 7.8 0.0 4.2 2.6 6.0 4.5 0.0 2.4 84.8 4.3 5.0 5.8 7.3 2.5 22.6 2.5 1.5 3.9 6.6 5.1 7.6 5.1 5.0 5.4 2.2 3.3 17.8 6.4 0.0 5.0 1.5 44.0 5.6 4.5 0.0 10.3 5.1 2.8 3.1 14.6 17.4 2.6 3.3 4.5 6.2 3.2 4.0 0.7 7.5 7.0 0.0 4.3 4.8 10.7 7.8 1.3 5.3 1.4 5.9 3.8 8.4 2.0 AGAP9 "bA301J7.2, CTGLF6, FLJ00312" ENSG00000204172 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 9" Q5VTM2 10 47501854-47523638 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA042490 Uncertain NA NA "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA042490: AB_2678022" "unprognostic (6.26e-2)" "unprognostic (5.74e-2)" "prognostic unfavorable (9.98e-5)" "unprognostic (1.85e-1)" "unprognostic (6.80e-2)" "unprognostic (9.89e-4)" "unprognostic (1.13e-2)" "unprognostic (3.71e-2)" "unprognostic (1.13e-1)" "unprognostic (5.85e-2)" "unprognostic (4.51e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.02e-5)" "unprognostic (9.44e-2)" "unprognostic (3.42e-2)" "unprognostic (2.70e-3)" "prognostic favorable (7.04e-4)" 12.7 14.5 7.8 5.2 8.6 8.5 14.4 9.7 9.4 17.9 9.4 14.1 15.6 12.2 6.7 13.5 14.9 5.6 13.0 7.7 8.1 22.1 39.8 12.2 5.4 8.7 8.4 18.6 32.1 3.0 26.1 2.3 9.0 18.0 3.4 11.9 14.2 4.7 9.9 19.7 19.2 3.5 7.1 14.6 18.4 27.3 9.0 4.9 19.8 2.3 3.2 12.3 14.8 10.0 4.4 6.6 5.7 5.8 5.1 4.2 6.8 4.2 1.9 2.0 1.5 7.9 6.9 0.9 5.2 2.9 1.2 12.9 2.3 3.0 1.5 8.5 12.4 2.5 2.6 9.4 4.5 9.3 7.4 2.9 5.8 5.1 14.2 2.2 1.0 0.5 4.0 3.5 1.3 7.3 1.6 11.9 3.1 3.2 1.3 3.4 3.2 2.8 4.1 5.0 0.7 4.1 3.4 7.0 0.9 5.4 9.3 5.1 5.3 4.3 7.1 5.0 7.8 4.8 3.7 4.3 4.3 9.7 1.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 7.8 8.6 9.7 9.4 7.7 8.1 8.7 8.4 9.0 7.1 9.0 10.0 3.8 3.2 9.9 0.0 1.6 0.0 1.6 0.0 2.8 6.6 5.3 5.0 1.6 7.2 3.1 11.0 18.8 3.1 3.0 0.2 1.9 1.8 109.7 12.3 4.7 2.7 1.2 2.7 0.0 2.2 0.7 3.6 20.4 4.1 7.6 7.1 2.2 7.2 2.1 11.8 0.0 1.5 0.0 3.0 0.0 21.5 3.4 3.3 0.0 0.0 1.7 4.3 1.0 0.0 0.0 6.0 0.8 6.0 2.1 2.6 6.7 1.0 6.6 8.7 0.0 3.2 2.9 12.4 4.8 1.8 0.0 1.0 2.3 4.0 2.0 1.8 AHRR "AHH, AHHR, bHLHe77, KIAA1234" ENSG00000063438 "Aryl-hydrocarbon receptor repressor" A9YTQ3 5 321759-438291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 46.4" "Group enriched" "Detected in some" 10 "Early spermatids: 299.1;Late spermatids: 168.8;Spermatocytes: 123.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 59.6;HMC-1: 76.8;NB-4: 91.1;WM-115: 53.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA021483 Supported Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 83: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA021483: AB_1855110" "unprognostic (2.06e-4)" "unprognostic (3.48e-2)" "unprognostic (8.71e-3)" "unprognostic (2.23e-1)" "unprognostic (1.09e-1)" "unprognostic (9.33e-4)" "unprognostic (4.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.02e-5)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.65e-6)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.55e-2)" 1.4 0.7 2.2 0.6 1.8 0.4 0.8 0.0 6.0 3.8 1.1 2.1 0.7 1.6 0.5 2.2 0.7 1.2 0.5 5.0 1.7 1.6 0.7 2.2 0.4 0.4 0.7 2.6 0.6 0.1 1.5 2.0 0.0 1.0 1.1 0.1 0.7 0.1 0.5 5.9 1.9 0.3 0.0 5.7 1.1 46.4 2.6 0.2 1.4 0.0 0.4 3.4 2.2 0.0 0.4 5.8 1.4 1.0 6.1 11.9 11.0 22.5 30.0 10.7 18.4 0.6 6.7 0.6 10.1 38.6 2.2 0.5 0.9 0.5 5.1 1.2 2.8 8.6 59.6 0.9 3.5 1.6 76.8 1.4 0.8 7.3 1.3 17.3 3.4 0.8 1.0 0.6 11.8 0.7 0.3 91.1 0.5 2.6 8.9 1.3 0.5 0.4 0.5 0.2 10.0 0.4 27.6 3.7 14.7 0.1 0.5 36.4 6.1 20.5 1.6 21.5 0.4 2.6 3.6 0.8 8.3 0.8 53.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 1.8 0.0 6.0 5.0 1.7 0.4 0.7 0.0 0.0 2.6 0.0 0.6 0.0 0.0 2.0 0.2 2.2 0.0 0.1 0.0 0.4 0.2 0.3 1.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.2 299.1 0.3 0.8 3.6 0.0 0.0 11.1 0.2 5.8 2.7 0.5 0.7 0.0 0.3 0.0 0.0 0.8 0.0 9.5 0.1 0.0 0.0 9.7 168.8 3.4 1.5 19.6 3.7 5.7 0.2 0.0 3.5 2.9 0.2 0.0 1.2 0.1 0.3 0.1 0.1 0.2 0.2 6.6 0.0 3.0 123.7 6.9 0.1 1.4 0.8 1.2 0.7 0.1 0.2 ALDOB ENSG00000136872 "Aldolase, fructose-bisphosphate B" P05062 9 101420560-101449664 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 27 "intestine: 5736.6;kidney: 7181.0;liver: 11160.8" "Group enriched" "Detected in some" 4 "Proximal enterocytes: 20078.3;Proximal tubular cells: 7956.0" "Cancer enriched" "Detected in many" 31 "liver cancer: 1414.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 21.4;NB-4: 21.0;RPMI-8226: 28.6;SH-SY5Y: 20.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA002198, CAB020827" Enhanced NA NA 560000000 "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 24: NB-4 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "CAB020827: , HPA002198: AB_1078129" "unprognostic (6.58e-3)" "unprognostic (2.83e-1)" "unprognostic (1.43e-3)" "unprognostic (1.03e-1)" "unprognostic (8.10e-2)" "unprognostic (1.96e-2)" "unprognostic (1.44e-3)" "unprognostic (4.34e-2)" "unprognostic (4.57e-2)" "unprognostic (2.66e-1)" "unprognostic (5.79e-2)" "unprognostic (7.48e-2)" "unprognostic (1.66e-2)" "unprognostic (2.02e-1)" "unprognostic (2.58e-1)" "unprognostic (5.19e-2)" "unprognostic (1.96e-2)" 3.3 1.4 0.4 17.0 0.7 0.0 0.7 1.0 2.3 0.2 0.0 30.1 4073.8 2.8 1.0 0.7 0.4 176.9 1.0 2.4 0.0 7181.0 11160.8 0.5 4.9 0.0 0.0 0.5 292.7 0.0 5.6 0.4 0.0 2.1 5.6 0.3 0.3 0.0 0.4 0.5 5736.6 7.0 0.0 2.0 34.3 1.1 0.0 0.7 0.3 0.0 0.8 0.1 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.5 0.0 4.5 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 2.2 0.0 1.0 0.0 6.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 0.3 21.0 0.4 0.5 0.0 0.3 4.6 28.6 0.0 0.0 4.3 20.6 2.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 1.0 7.1 0.3 0.5 0.7 2.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.0 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 39.4 0.0 0.0 0.3 0.0 1.1 0.0 0.0 1.1 308.8 0.8 150.8 0.0 0.0 0.0 13.5 620.3 4.9 0.0 0.0 0.4 3.6 0.0 50.8 0.5 253.3 0.1 0.0 0.0 0.3 0.0 0.0 49.2 3225.4 0.2 3.3 0.2 464.9 0.0 66.2 0.0 0.0 0.0 38.1 0.0 0.0 3.6 0.3 0.0 0.0 0.3 182.1 997.4 0.0 0.1 0.0 20078.3 7956.0 0.2 0.6 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.3 20.6 0.2 412.7 0.0 ALYREF "ALY, ALY/REF, BEF, REF, THOC4" ENSG00000183684 "Aly/REF export factor" 17 81887835-81891586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 148.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016281, HPA019799, HPA061282" Supported Enhanced "Nuclear speckles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: AB_2684464" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (4.89e-3)" "unprognostic (5.35e-2)" "unprognostic (3.43e-1)" "unprognostic (2.13e-2)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.77e-2)" "unprognostic (2.26e-1)" "unprognostic (2.55e-3)" "unprognostic (6.58e-2)" "unprognostic (8.07e-2)" "unprognostic (1.74e-3)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" 39.0 30.0 19.2 50.2 19.6 148.9 34.9 20.2 22.9 33.1 17.7 37.4 32.9 35.1 17.1 57.6 31.3 19.6 37.8 19.8 20.0 37.7 29.6 36.0 62.4 19.6 20.7 32.4 26.9 21.3 28.9 32.1 20.9 30.0 24.3 9.4 30.3 15.9 61.5 45.7 34.5 21.1 20.9 44.7 31.6 72.7 19.8 65.7 30.6 21.2 48.8 35.7 36.4 22.1 263.7 237.8 165.5 164.6 34.4 44.8 213.8 130.0 68.0 257.0 161.0 269.4 173.7 291.4 100.8 104.9 155.6 150.5 241.9 137.5 111.7 111.8 425.9 210.8 151.2 295.1 68.6 341.4 183.0 46.1 61.8 155.3 62.0 37.8 155.5 204.6 275.9 175.2 97.2 279.8 721.2 587.2 231.3 152.0 254.2 472.3 206.1 155.1 54.1 152.1 229.8 299.0 123.9 304.8 110.4 89.9 222.1 343.3 103.9 275.1 270.9 130.0 443.2 201.8 107.3 377.6 143.7 217.0 238.2 0.3 1.1 0.1 1.5 1.2 1.0 1.0 1.1 1.0 1.2 1.2 0.3 0.8 0.2 0.9 1.1 2.2 0.6 0.6 19.2 19.6 20.2 22.9 19.8 20.0 19.6 20.7 20.9 20.9 19.8 22.1 68.4 0.0 16.0 1.3 22.9 34.9 22.9 7.5 9.1 11.0 24.7 32.5 13.0 11.5 8.4 20.2 0.0 9.8 59.0 16.1 1.9 5.2 2.3 52.9 49.0 23.4 12.6 43.3 1.7 8.4 23.1 24.9 17.3 53.7 15.2 39.1 8.9 14.8 17.9 5.0 1.7 24.3 6.1 13.9 33.8 3.2 3.4 31.3 14.2 3.7 12.7 21.5 8.2 2.5 5.0 10.5 10.1 4.1 46.4 33.1 7.4 4.3 8.4 7.6 0.0 27.9 30.6 16.5 8.8 22.6 43.0 16.6 27.6 38.2 21.9 31.6 ANAPC10 "APC10, DKFZP564L0562, DOC1" ENSG00000164162 "Anaphase promoting complex subunit 10" Q9UM13 4 144831908-145098541 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044547 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 23: Testis - Cell cycle regulation" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Golgi apparatus" "HPA044547: AB_2678979" "unprognostic (2.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.04e-1)" "unprognostic (5.88e-2)" "unprognostic (2.66e-3)" "unprognostic (1.02e-2)" "unprognostic (6.69e-2)" "prognostic unfavorable (8.22e-4)" "unprognostic (2.80e-2)" "unprognostic (1.46e-1)" "unprognostic (4.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (7.81e-2)" "unprognostic (1.70e-1)" "unprognostic (5.55e-2)" 11.4 9.4 7.7 6.1 8.2 10.1 14.3 9.6 11.2 11.0 7.9 9.1 4.4 11.6 13.3 7.7 10.7 7.7 13.9 7.9 8.5 12.9 13.6 9.8 10.3 8.3 8.9 11.9 7.5 9.0 7.5 12.3 8.3 8.9 9.8 9.2 8.1 9.2 14.9 8.2 6.6 11.8 8.5 8.4 7.4 19.0 8.4 13.8 11.8 15.1 10.7 11.0 9.0 9.1 14.3 7.8 20.0 7.8 19.5 21.2 13.0 17.1 16.9 21.6 15.7 18.9 18.6 19.6 11.1 11.8 15.6 8.4 17.6 22.6 23.1 19.0 14.0 12.1 6.0 15.6 24.5 23.9 13.7 17.2 15.9 17.7 28.8 18.0 17.1 23.0 32.2 28.2 22.8 10.3 40.5 29.1 14.1 17.0 15.7 20.5 15.5 11.8 24.1 9.0 14.0 10.4 11.1 10.4 23.1 18.6 9.4 19.7 15.6 14.7 8.9 13.7 21.7 22.3 25.2 31.3 19.2 30.2 18.7 25.5 7.8 9.7 13.0 10.3 13.4 15.1 13.5 13.2 11.5 12.4 13.4 13.7 2.2 16.4 9.6 15.6 18.1 7.4 7.7 8.2 9.6 11.2 7.9 8.5 8.3 8.9 8.3 8.5 8.4 9.1 30.7 12.8 17.0 31.3 16.7 16.3 22.0 61.6 10.8 9.9 16.9 26.0 14.8 4.3 34.3 14.7 0.0 38.9 20.2 7.6 46.9 25.8 83.3 26.4 21.0 22.2 3.0 8.6 61.2 26.1 35.8 20.7 9.2 15.6 26.0 15.3 19.6 15.6 35.1 5.0 58.0 13.0 40.7 12.7 18.2 22.8 33.8 17.6 10.6 36.5 27.8 19.0 22.6 55.8 62.3 27.3 15.5 27.1 10.5 26.9 14.3 49.8 27.6 9.8 32.9 21.0 36.2 126.8 41.5 14.2 19.9 29.6 19.5 26.1 13.7 29.4 ANKRD13D ENSG00000172932 "Ankyrin repeat domain 13D" Q6ZTN6 11 67289300-67302485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 63.9;SK-MEL-30: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039950 Approved Approved Nucleoplasm,Mitochondria No No "Cluster 10: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Mitochondria "HPA039950: AB_10796337" "unprognostic (1.10e-1)" "unprognostic (1.18e-3)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (9.83e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-3)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (5.06e-3)" "unprognostic (3.71e-2)" "prognostic unfavorable (5.73e-10)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" "unprognostic (4.01e-2)" "unprognostic (6.74e-2)" 12.0 14.7 13.3 6.8 14.3 0.3 11.4 10.9 20.7 19.5 10.8 13.8 3.1 12.5 2.9 24.4 15.3 7.9 12.0 16.5 12.9 16.2 8.9 13.8 15.0 13.8 11.7 14.1 9.5 6.0 28.9 5.2 15.1 23.8 2.3 2.0 14.4 7.3 3.7 15.0 13.8 6.5 10.2 39.2 12.8 12.1 15.8 10.0 11.2 3.8 5.7 17.5 20.5 19.6 9.7 7.2 5.8 12.3 10.9 10.1 3.8 7.0 8.4 7.2 5.6 6.4 10.1 11.6 12.4 5.6 10.7 12.4 4.5 8.6 1.0 19.9 5.3 11.6 11.3 4.3 16.8 14.0 27.8 10.4 11.8 6.2 6.8 14.1 9.5 9.2 6.3 12.4 8.0 14.1 18.0 63.9 2.5 19.8 10.1 28.5 4.9 9.9 13.6 6.0 6.0 9.8 7.0 16.7 57.0 4.5 14.3 33.1 7.7 7.1 6.1 7.9 8.2 9.8 9.4 5.6 17.4 21.4 8.2 6.6 0.6 5.7 2.0 2.1 1.3 0.8 1.5 2.8 1.2 0.5 0.5 3.2 1.9 3.1 1.4 1.8 1.6 1.2 13.3 14.3 10.9 20.7 16.5 12.9 13.8 11.7 15.1 10.2 15.8 19.6 23.2 0.0 18.8 18.9 22.2 14.1 11.7 15.4 17.6 61.1 21.5 20.8 7.0 8.6 14.5 16.5 75.0 8.3 73.6 7.5 1.9 8.3 18.0 27.7 19.7 17.9 10.8 8.2 29.8 6.9 9.0 15.7 20.4 18.0 25.3 25.7 22.1 3.0 20.0 42.1 29.7 7.9 18.3 52.0 21.4 6.0 22.1 45.8 12.4 18.7 49.7 20.8 49.4 17.6 18.4 9.9 4.6 17.0 30.7 19.9 2.3 2.6 30.4 51.7 13.1 13.6 18.5 3.1 8.1 19.3 25.1 7.5 49.9 28.9 8.4 19.8 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 34.5;choroid plexus: 10.6" "Cell type enhanced" "Detected in many" "Early spermatids: 34.4;Excitatory neurons: 13.8;Muller glia cells: 22.3;Spermatocytes: 41.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 27.5" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Uncertain "Nucleoli,Nucleoli rim,Cytosol" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 0.4 0.2 16.8 0.0 17.5 0.1 0.1 34.5 30.1 0.2 10.6 0.0 0.0 0.1 0.1 1.9 0.2 0.4 0.0 18.2 13.6 0.0 0.0 0.1 0.1 22.3 15.7 0.0 0.0 0.0 0.4 0.2 21.4 1.2 0.0 1.9 0.1 0.0 0.7 2.2 0.0 0.0 12.7 0.3 0.0 3.9 14.5 0.0 0.2 0.1 0.1 0.7 0.9 17.0 10.0 8.8 0.6 0.1 0.2 1.5 0.9 2.1 2.1 2.7 2.9 2.1 0.2 0.2 0.4 0.3 2.9 2.2 5.9 2.1 3.6 0.1 5.2 10.2 13.1 1.5 0.0 3.5 0.6 0.8 3.6 3.7 9.3 0.7 5.0 0.0 5.5 0.5 3.0 1.7 0.0 27.5 9.1 0.2 4.8 0.0 13.0 2.0 1.6 2.4 0.3 8.5 4.2 0.3 0.4 5.5 7.5 13.4 4.6 1.5 5.8 4.4 3.9 1.5 0.8 0.0 0.8 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 17.5 34.5 30.1 18.2 13.6 22.3 15.7 21.4 12.7 14.5 17.0 0.0 0.0 0.0 0.7 0.0 2.0 5.4 2.9 1.2 8.5 0.5 0.9 3.1 4.3 2.8 1.8 0.0 0.0 0.0 0.6 0.0 0.8 34.4 12.1 0.2 0.3 0.0 0.0 13.8 0.5 0.4 0.1 0.0 4.0 0.0 12.1 0.4 0.1 0.2 0.0 9.0 2.0 4.1 0.0 0.3 3.7 0.6 0.2 0.0 1.9 0.0 22.3 0.0 4.0 0.8 0.4 1.7 0.7 0.0 2.5 0.3 0.1 9.8 5.5 0.0 0.5 0.5 41.4 2.1 6.2 3.3 0.0 0.2 0.0 1.3 3.9 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493979-94499578 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: AB_2680279" "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavorable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favorable (6.16e-4)" 7.8 6.8 8.3 12.7 8.9 25.2 13.1 11.1 11.4 9.7 8.2 10.8 11.4 10.4 18.3 9.5 8.5 8.4 5.3 8.3 8.4 7.8 8.6 7.5 20.8 8.2 7.7 12.6 13.4 9.3 8.9 12.1 8.0 10.9 13.6 11.8 10.7 10.8 5.8 10.2 16.2 8.8 7.8 15.6 12.7 5.4 9.3 17.1 14.2 7.3 20.8 7.9 8.5 9.5 8.9 4.4 11.0 9.4 10.2 12.0 13.5 13.3 12.0 14.9 17.1 20.7 18.4 23.4 20.9 8.5 12.5 20.5 14.0 9.8 12.2 17.9 12.1 18.9 16.8 7.8 11.1 17.8 15.8 9.1 23.1 10.7 14.9 10.4 11.3 20.9 18.4 14.4 9.4 6.1 19.8 32.8 6.3 17.5 9.8 14.9 11.3 12.0 12.9 9.2 10.5 10.9 10.2 9.8 8.7 18.4 18.0 12.9 7.5 13.0 9.3 13.8 7.2 7.6 20.0 24.6 4.4 21.8 7.4 77.8 23.1 23.9 21.9 19.5 23.7 34.1 23.4 19.4 18.4 28.8 28.4 25.9 42.7 27.2 15.8 30.5 31.4 17.8 8.3 8.9 11.1 11.4 8.3 8.4 8.2 7.7 8.0 7.8 9.3 9.5 20.5 12.8 9.3 11.1 43.2 5.6 10.0 15.1 14.2 16.3 14.0 11.3 9.1 24.3 15.4 25.8 14.6 31.1 36.1 27.8 21.5 20.3 10.1 11.9 18.1 15.4 13.3 40.0 11.1 23.0 13.8 16.5 27.0 15.1 21.5 18.7 16.4 18.8 14.3 11.8 9.5 23.6 8.2 28.5 8.4 3.7 35.8 18.5 10.6 8.4 28.1 21.8 57.7 5.5 12.7 22.8 35.2 23.7 28.0 11.3 45.3 19.3 8.1 14.4 26.3 11.3 18.4 21.0 19.9 11.6 6.8 28.0 36.5 9.8 22.0 5.8 AOAH ENSG00000136250 "Acyloxyacyl hydrolase" P28039 7 36512941-36724549 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;lymphoid tissue: 64.9" "Cell type enhanced" "Detected in many" "dendritic cells: 77.9;Kupffer cells: 119.7;Macrophages: 77.1;Microglial cells: 233.3;monocytes: 67.5;NK-cells: 90.6;T-cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 298.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "GAMG: 4.8;NB-4: 26.5;THP-1: 20.2;U-937: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA021666, HPA026716" Approved Uncertain Vesicles "Secreted to blood" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA021666: AB_2670799, HPA026716: AB_2671960" "unprognostic (3.55e-2)" "unprognostic (4.03e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-1)" "unprognostic (6.06e-2)" "unprognostic (4.78e-2)" "unprognostic (2.40e-1)" "unprognostic (3.14e-3)" "unprognostic (5.42e-2)" "unprognostic (6.02e-2)" "unprognostic (3.36e-2)" "unprognostic (1.05e-1)" "unprognostic (1.46e-3)" "unprognostic (1.75e-1)" "unprognostic (1.92e-3)" "unprognostic (2.38e-1)" "unprognostic (1.35e-1)" 7.5 5.1 2.4 33.7 2.2 43.3 3.8 2.1 3.1 5.7 4.7 10.4 9.5 2.8 1.5 3.3 3.5 15.6 2.0 2.1 3.6 1.9 13.2 12.7 35.1 6.6 5.1 2.6 1.5 1.5 0.9 11.2 5.7 2.5 13.3 0.8 3.7 2.8 0.5 0.8 12.1 9.3 4.0 64.9 7.0 1.3 5.1 13.9 1.8 0.9 15.1 13.9 1.3 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.6 0.0 0.0 0.0 3.8 0.0 0.3 0.1 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.6 26.5 0.1 0.0 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 8.9 0.0 1.8 298.5 97.8 43.6 251.9 9.0 2.6 2.2 30.7 183.1 0.3 4.8 37.3 97.9 106.8 113.2 2.7 0.7 207.3 2.4 2.2 2.1 3.1 2.1 3.6 6.6 5.1 5.7 4.0 5.1 8.6 1.3 0.0 9.6 1.3 3.6 0.8 0.1 0.0 0.0 1.1 0.6 1.7 0.5 1.5 2.5 0.0 0.0 0.2 77.9 9.2 1.9 0.3 0.6 0.4 0.3 1.4 15.5 16.0 12.4 0.0 0.2 3.1 2.6 0.4 5.1 0.7 2.5 0.9 32.8 0.0 8.1 0.3 0.0 119.7 20.3 1.2 0.0 77.1 0.0 233.3 67.5 2.8 90.6 12.1 38.6 0.0 3.8 0.4 13.6 0.1 0.3 0.5 0.7 0.3 0.0 0.3 0.5 0.0 0.1 0.4 0.3 0.1 54.1 0.6 0.9 0.2 AP2S1 "CLAPS2, FBH3, FBHOk, HHC3" ENSG00000042753 "Adaptor related protein complex 2 subunit sigma 1" P53680 19 46838136-46850846 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 991.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" "unprognostic (1.34e-1)" "unprognostic (5.93e-2)" "unprognostic (9.89e-2)" "unprognostic (1.97e-1)" "unprognostic (1.30e-1)" "unprognostic (6.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.11e-2)" "unprognostic (9.54e-2)" "unprognostic (2.19e-1)" "unprognostic (5.25e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (5.79e-2)" "unprognostic (3.56e-1)" "unprognostic (3.07e-1)" "unprognostic (6.05e-2)" 120.2 136.5 110.7 80.6 119.9 126.5 95.9 104.9 138.5 83.0 99.6 91.5 67.3 62.1 41.0 188.9 58.6 46.1 107.5 122.1 117.7 106.8 148.9 90.2 62.4 108.0 103.9 52.3 77.2 51.9 72.4 79.1 111.9 90.8 57.4 27.6 99.8 48.8 101.6 125.8 79.8 60.1 106.0 124.6 85.1 69.2 111.3 67.2 61.5 63.7 67.6 82.9 103.4 112.5 380.3 363.2 181.6 198.7 227.1 248.7 122.2 311.0 383.2 349.2 411.0 277.1 189.3 121.1 168.6 476.2 153.6 178.8 144.9 450.6 263.9 115.1 418.6 210.4 220.6 204.0 306.7 142.1 150.0 317.9 259.0 337.9 281.1 259.0 471.1 199.5 186.1 180.4 331.1 403.2 181.1 1060.2 295.7 341.8 268.8 142.8 167.0 170.8 269.2 299.9 177.2 258.8 239.1 298.4 377.0 113.9 248.6 336.4 343.2 246.0 293.8 135.3 375.7 130.8 302.0 134.8 439.0 292.3 437.6 278.6 640.3 406.6 174.3 708.8 145.2 211.5 167.3 174.5 716.8 198.4 153.1 156.3 204.6 188.5 544.6 431.5 233.8 673.1 110.7 119.9 104.9 138.5 122.1 117.7 108.0 103.9 111.9 106.0 111.3 112.5 129.0 38.5 57.2 10.4 85.9 171.6 103.9 341.6 73.4 39.5 179.0 227.8 79.4 137.2 163.9 95.6 16.7 415.2 100.9 397.7 348.3 215.6 80.7 67.8 106.7 190.6 163.7 250.7 14.6 247.2 257.4 130.2 95.8 82.5 92.7 176.1 396.9 308.4 991.6 45.4 13.3 259.6 164.8 515.0 389.5 232.8 92.6 389.5 200.9 4.7 661.1 109.4 160.6 4.5 14.8 249.8 333.9 95.5 94.8 157.6 442.9 432.4 89.0 42.5 98.6 59.1 173.9 78.9 52.5 252.2 253.3 440.5 87.9 230.6 282.1 164.3 AP5Z1 "KIAA0415, SPG48, zeta" ENSG00000242802 "Adaptor related protein complex 5 subunit zeta 1" O43299 7 4775615-4794397 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035693 Supported Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear speckles" Nucleoplasm "HPA035693: AB_10960687" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (3.01e-3)" "unprognostic (4.24e-2)" "unprognostic (2.43e-3)" "unprognostic (5.19e-1)" "prognostic unfavorable (1.35e-5)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-3)" "unprognostic (1.26e-2)" "unprognostic (5.32e-3)" "unprognostic (8.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.95e-2)" "unprognostic (2.22e-1)" 14.8 18.5 7.0 0.7 7.1 1.5 11.8 7.3 10.0 12.4 5.8 13.2 1.1 13.4 1.0 11.0 11.0 0.8 7.7 6.9 5.7 9.2 9.2 12.9 1.8 8.3 6.5 11.8 9.9 0.7 9.8 1.1 7.4 11.7 0.4 0.6 12.4 0.7 8.5 21.8 15.5 0.4 5.9 22.9 12.0 8.6 7.4 0.9 11.2 0.2 0.6 13.4 10.9 7.3 2.8 4.2 0.7 2.4 1.0 0.9 4.3 1.3 1.9 2.0 1.7 5.2 3.5 1.6 1.8 0.9 5.1 5.4 0.7 0.5 0.6 1.8 3.5 2.4 4.5 4.6 3.0 2.5 5.1 2.2 1.6 1.8 1.3 0.7 0.5 2.2 3.4 1.1 1.2 7.7 0.3 15.0 5.9 0.3 4.3 2.9 2.6 4.8 1.0 4.4 1.7 3.0 1.8 8.7 6.4 0.5 6.4 8.9 3.8 2.3 4.4 6.5 1.7 8.5 7.4 2.3 1.7 5.6 3.6 1.9 2.3 2.9 2.4 2.8 1.4 1.9 1.8 2.4 1.2 1.8 2.5 2.2 2.2 2.4 2.5 2.4 1.8 1.3 7.0 7.1 7.3 10.0 6.9 5.7 8.3 6.5 7.4 5.9 7.4 7.3 12.4 9.6 15.0 7.5 18.2 6.9 2.9 8.8 8.0 10.5 5.7 5.8 4.3 15.7 6.6 11.0 4.2 11.5 20.3 20.1 0.0 14.1 2.2 9.9 10.1 11.6 12.0 5.0 12.4 13.6 7.7 9.9 21.4 16.4 17.1 14.3 12.5 8.1 28.7 18.5 10.7 15.1 10.2 12.3 10.7 1.5 13.4 16.3 14.2 13.1 23.4 8.2 21.6 10.6 12.6 20.6 15.9 10.9 19.8 4.9 14.7 6.8 8.3 9.4 0.0 5.8 9.5 8.1 10.8 7.6 11.1 16.6 15.6 12.6 14.1 3.8 APOA4 ENSG00000110244 "Apolipoprotein A4" P06727 11 116820700-116823304 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 3112.4" "Cell type enriched" "Detected in some" 44 "Proximal enterocytes: 10311.5" "Cancer enriched" "Detected in some" 29 "liver cancer: 291.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.7;CACO-2: 8.0;Hep G2: 7.7;NB-4: 7.3;RPMI-8226: 12.5;SH-SY5Y: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001352, HPA002549, CAB068250, CAB068251, CAB068252" Enhanced Approved Vesicles "Secreted to blood" NA NA 61200000000 74000000000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" Vesicles "CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177" "unprognostic (8.81e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (7.91e-2)" 0.3 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.9 2204.9 1.8 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 257.2 0.0 2.4 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 3112.4 3.0 0.0 0.1 4.6 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 3.1 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 77.5 0.0 0.0 0.0 234.3 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 221.5 0.0 0.0 0.0 10311.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 87.7 0.0 ARMC5 FLJ13063 ENSG00000140691 "Armadillo repeat containing 5" Q96C12 16 31458080-31467166 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cushing syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatocytes: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041524, HPA063706" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Intracellular and membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA041524: AB_10796676, HPA063706: AB_2685098" "unprognostic (1.37e-1)" "unprognostic (1.68e-3)" "unprognostic (8.22e-3)" "unprognostic (9.96e-2)" "unprognostic (2.59e-1)" "unprognostic (2.94e-3)" "unprognostic (4.09e-2)" "unprognostic (6.14e-3)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favorable (1.97e-6)" "unprognostic (4.70e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 6.3 7.9 9.0 3.4 9.2 21.4 4.3 8.9 11.7 6.0 7.0 5.8 4.6 6.9 0.9 9.9 5.6 2.0 6.5 9.2 8.1 8.7 24.6 4.6 3.2 12.3 9.4 6.8 6.4 3.0 9.0 2.1 12.4 7.7 0.9 2.4 5.3 2.2 16.0 8.5 7.0 1.7 9.1 8.8 6.8 6.8 9.2 2.9 9.7 3.9 1.3 5.6 6.6 10.5 5.0 7.6 3.3 4.8 2.0 1.5 8.4 6.5 2.8 3.6 3.0 7.2 5.0 4.9 13.3 3.5 3.6 7.5 3.9 5.7 0.7 6.8 9.9 2.2 12.4 16.7 4.0 14.9 14.3 3.7 6.3 3.6 1.0 4.2 5.5 8.0 11.2 11.5 2.5 12.2 5.6 59.5 5.3 2.2 5.0 10.0 4.7 18.2 2.9 5.6 10.7 9.4 5.9 7.8 4.6 2.0 5.1 17.6 10.9 7.8 5.7 3.2 5.4 10.4 9.8 3.0 5.1 12.2 5.7 2.9 2.3 0.7 3.2 1.1 2.7 2.7 2.5 2.6 3.0 2.2 2.2 2.6 1.3 7.1 1.3 7.2 3.2 2.6 9.0 9.2 8.9 11.7 9.2 8.1 12.3 9.4 12.4 9.1 9.2 10.5 8.7 6.4 14.3 4.2 6.2 6.5 9.2 8.7 9.1 6.0 6.3 5.0 5.8 11.5 8.2 0.0 6.2 7.5 7.6 11.1 3.9 5.0 1.2 5.2 8.6 10.8 7.8 8.2 4.3 4.4 5.4 6.1 6.6 7.6 9.5 6.7 8.9 28.7 6.1 13.5 4.0 8.7 6.1 3.7 4.0 0.6 4.4 6.7 1.8 2.8 3.9 7.2 6.2 2.0 4.6 4.4 3.8 5.7 8.0 6.9 9.2 4.6 3.4 5.9 0.0 8.7 6.6 5.5 8.0 9.6 6.3 11.5 7.6 6.1 7.7 6.1 ARPC3 "ARC21, p21-Arc" ENSG00000111229 "Actin related protein 2/3 complex subunit 3" O15145 12 110434823-110450422 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006550 Approved Uncertain Nucleoplasm NA NA 3800000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA006550: AB_1854869" "unprognostic (1.83e-1)" "unprognostic (4.21e-3)" "unprognostic (4.15e-1)" "unprognostic (4.26e-3)" "unprognostic (2.89e-1)" "unprognostic (1.11e-3)" "unprognostic (1.10e-2)" "unprognostic (6.71e-2)" "unprognostic (2.89e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (9.96e-2)" "prognostic unfavorable (2.22e-11)" "unprognostic (3.00e-1)" "unprognostic (5.83e-2)" "unprognostic (2.05e-2)" "unprognostic (1.79e-3)" 196.5 205.3 160.2 365.7 167.7 774.3 213.5 160.2 228.2 205.5 165.9 324.0 259.5 151.6 298.3 367.1 162.2 253.1 153.0 167.3 171.5 241.6 262.4 264.7 578.8 172.9 166.9 107.2 171.6 174.8 163.6 276.6 170.8 166.9 344.1 60.4 205.0 152.1 106.7 156.5 258.2 206.6 169.4 366.3 263.3 106.9 165.1 343.3 184.2 102.5 573.7 355.8 206.5 180.5 452.0 360.8 307.0 196.4 318.3 600.2 411.5 476.0 550.1 594.6 578.6 392.9 350.1 654.7 359.3 559.7 354.4 340.1 343.9 520.7 647.7 377.7 415.6 562.1 146.6 385.1 519.7 565.6 842.4 422.6 555.3 375.3 347.8 736.2 756.3 434.5 366.2 170.3 746.3 365.6 661.6 1390.3 302.7 525.8 428.6 510.9 181.5 559.4 1050.5 581.0 346.6 342.2 334.0 464.7 427.1 453.8 757.8 933.8 630.0 350.5 195.7 312.9 349.9 332.7 507.0 914.8 458.0 568.1 425.1 1313.6 1022.6 1660.3 352.4 1182.3 322.2 692.3 361.1 398.7 987.2 604.5 267.0 349.5 1607.5 418.3 1417.4 632.7 619.8 1547.5 160.2 167.7 160.2 228.2 167.3 171.5 172.9 166.9 170.8 169.4 165.1 180.5 316.2 189.1 239.5 16.6 619.4 159.5 315.8 810.1 145.1 36.1 222.3 252.2 52.2 208.8 555.8 268.5 12.5 538.2 582.4 473.2 579.2 636.3 131.2 373.6 241.1 269.0 274.1 244.0 32.4 535.1 824.0 199.0 190.6 459.6 491.8 245.8 227.7 165.5 1432.0 53.8 25.1 538.9 537.1 918.9 781.2 45.3 172.4 935.9 240.1 45.9 1221.8 184.1 545.8 23.6 41.6 630.2 665.2 157.6 352.5 313.5 422.2 777.0 407.3 35.6 249.8 108.4 329.6 209.8 200.1 365.5 171.9 721.6 462.6 323.3 401.1 629.3 ASB3 ASB-3 ENSG00000115239 "Ankyrin repeat and SOCS box containing 3" Q9Y575 2 53532672-53860160 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003940 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 6: Brain - Smell perception" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" "HPA003940: AB_1845067" "unprognostic (8.32e-2)" "unprognostic (3.42e-2)" "unprognostic (2.25e-1)" "unprognostic (2.91e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (1.64e-4)" "unprognostic (5.45e-5)" "unprognostic (6.73e-2)" "unprognostic (2.57e-1)" "unprognostic (2.07e-1)" "unprognostic (4.82e-1)" "unprognostic (1.43e-5)" "unprognostic (3.87e-2)" "unprognostic (1.21e-1)" "unprognostic (2.05e-2)" "unprognostic (1.82e-1)" 8.4 11.5 28.1 8.3 29.9 15.0 10.3 32.0 32.8 10.4 14.3 7.6 6.7 11.4 14.0 8.4 9.5 7.8 9.6 29.1 23.8 9.0 10.8 10.0 11.0 18.9 25.9 12.2 7.4 10.3 14.5 11.5 18.4 13.0 8.0 23.4 8.8 10.2 7.2 9.6 8.6 8.2 17.5 12.7 7.1 11.5 24.7 17.2 11.6 7.7 12.2 7.9 9.8 27.9 15.4 12.5 26.8 10.6 17.6 14.7 23.0 16.3 11.5 12.2 15.2 10.8 10.9 14.5 26.1 11.6 22.6 9.4 19.6 12.1 18.0 29.0 17.6 16.0 16.2 21.2 13.7 20.7 12.2 12.3 8.0 11.4 22.4 21.1 15.1 18.9 17.6 17.9 18.1 9.9 23.4 27.3 20.7 14.3 10.8 21.5 20.2 11.9 13.9 12.8 19.1 15.0 18.8 17.4 15.3 23.2 6.8 11.4 13.9 19.0 11.3 15.1 18.8 26.4 13.3 8.1 16.3 15.5 16.3 16.6 6.9 12.9 9.0 6.6 12.7 12.2 10.4 10.2 7.5 10.4 11.1 11.1 5.0 11.2 7.5 6.2 11.6 6.8 28.1 29.9 32.0 32.8 29.1 23.8 18.9 25.9 18.4 17.5 24.7 27.9 5.9 25.6 23.2 16.3 14.4 0.0 6.3 0.0 12.5 16.1 5.1 6.1 0.0 5.7 14.9 1.8 4.2 11.6 6.4 1.5 0.0 4.8 5.0 6.6 7.2 6.0 1.2 9.0 3.6 2.7 10.0 9.1 7.1 3.1 16.4 5.5 4.6 4.4 4.6 3.3 3.1 3.6 0.0 5.7 0.0 2.5 9.6 5.9 0.0 3.7 4.0 10.1 9.2 26.7 3.5 4.4 1.5 9.8 18.9 3.2 3.3 3.9 12.4 10.3 6.6 6.5 5.7 16.8 14.5 8.9 0.0 7.7 11.3 6.5 3.0 3.4 ATG4D "APG4-D, APG4D, AUTL4" ENSG00000130734 "Autophagy related 4D cysteine peptidase" Q86TL0 19 10543895-10553418 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 103.9;Proximal enterocytes: 109.3;Spermatocytes: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 57.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067683 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Mitochondria" "HPA067683: AB_2685886" "unprognostic (2.85e-1)" "prognostic favorable (3.18e-5)" "unprognostic (2.73e-1)" "unprognostic (3.67e-1)" "unprognostic (2.18e-1)" "unprognostic (1.15e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (4.28e-2)" "unprognostic (7.30e-2)" "prognostic favorable (9.95e-4)" "unprognostic (1.52e-1)" "prognostic favorable (2.39e-7)" "prognostic favorable (5.03e-4)" "unprognostic (3.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.18e-3)" 7.3 15.6 4.2 7.3 4.7 33.2 7.4 8.3 8.6 9.4 8.2 22.3 21.8 8.1 1.6 27.3 7.6 3.9 23.2 4.5 4.0 20.8 13.2 10.6 8.3 5.2 4.7 9.5 16.3 10.7 16.6 4.9 5.3 14.0 5.2 2.5 16.6 4.4 36.9 24.6 23.2 2.1 3.1 17.0 13.7 24.5 5.4 12.0 13.4 10.8 4.6 9.7 15.0 6.1 13.8 8.7 11.7 16.5 2.1 1.8 9.9 9.2 7.8 11.1 12.2 14.9 4.3 9.2 16.2 0.9 8.6 20.8 7.3 6.8 1.4 10.4 23.5 23.1 22.3 8.2 7.4 9.4 22.1 1.8 14.2 9.8 3.4 2.8 3.3 18.1 17.8 19.8 3.6 21.9 27.6 57.8 18.9 6.1 29.0 20.0 8.2 15.1 6.4 17.8 45.3 17.8 12.6 22.6 11.3 2.1 14.0 21.6 6.4 16.8 11.0 34.7 20.4 19.2 15.4 10.8 14.4 18.0 19.5 1.6 0.8 3.7 1.1 1.0 1.5 1.0 1.3 1.2 0.6 0.4 1.2 1.7 0.2 1.3 0.4 4.2 2.2 0.8 4.2 4.7 8.3 8.6 4.5 4.0 5.2 4.7 5.3 3.1 5.4 6.1 6.3 9.6 6.6 9.1 14.4 30.5 19.8 14.9 24.5 14.9 14.1 10.2 0.5 14.3 8.1 1.8 14.6 27.9 38.7 103.9 13.7 16.1 83.6 9.6 5.5 5.3 22.2 43.6 8.4 16.5 6.7 8.2 26.5 10.1 7.0 10.9 6.1 11.9 13.4 28.6 9.1 38.5 20.3 15.0 12.1 16.3 8.7 10.0 12.4 4.7 15.7 11.8 22.6 4.5 8.4 20.5 72.4 4.5 17.6 21.6 109.3 25.4 5.2 20.1 13.1 9.1 14.2 100.7 21.2 33.4 31.3 36.5 19.6 10.6 33.2 36.4 ATP5MC2 ATP5G2 ENSG00000135390 "ATP synthase membrane subunit c locus 2" Q06055 12 53632726-53677408 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 1335.2;Breast myoepithelial cells: 1873.6;Distal tubular cells: 1762.9;Hofbauer cells: 1076.1;Proximal tubular cells: 2061.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051469 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA051469: AB_2681496" "unprognostic (1.48e-1)" "unprognostic (1.06e-1)" "unprognostic (3.01e-1)" "unprognostic (3.37e-3)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (2.97e-3)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (3.78e-2)" "unprognostic (5.71e-2)" "unprognostic (3.32e-3)" "unprognostic (3.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.42e-1)" "unprognostic (7.09e-2)" 250.6 297.8 487.0 240.0 510.5 445.5 485.5 498.2 574.6 338.4 492.0 444.0 383.6 279.1 463.7 340.5 533.7 296.1 759.6 475.9 499.0 437.4 469.4 243.6 406.4 509.5 488.1 487.2 499.1 503.0 18.9 265.3 507.8 322.2 551.7 275.9 483.0 284.9 1405.5 345.5 322.5 361.1 504.7 295.8 312.1 126.9 500.7 453.9 314.0 1447.2 540.2 365.6 15.2 519.7 325.4 684.8 701.3 640.3 478.0 1162.4 330.7 278.3 630.3 824.5 561.2 236.2 745.1 392.9 668.3 554.8 263.9 304.7 914.6 652.8 729.3 660.9 1096.7 1068.7 515.2 495.7 1034.1 819.7 508.5 1297.4 956.8 797.0 1315.9 1313.7 1078.7 468.0 776.8 1116.6 852.6 857.0 842.8 1996.5 603.6 681.5 756.7 838.3 665.2 981.9 1019.4 407.0 365.8 669.0 376.5 431.6 974.2 610.1 1403.7 1473.7 512.5 396.4 542.2 307.5 441.4 577.6 537.6 288.1 589.9 863.0 620.2 367.7 977.3 281.8 645.6 924.4 710.5 1119.6 826.1 693.6 1324.3 974.6 896.6 755.0 214.2 769.1 849.6 1023.6 955.8 1565.2 487.0 510.5 498.2 574.6 475.9 499.0 509.5 488.1 507.8 504.7 500.7 519.7 412.1 182.7 266.7 0.0 167.8 0.0 0.0 0.0 0.0 0.0 1335.2 1873.6 0.0 0.0 177.0 527.8 0.0 732.4 297.0 0.0 1762.9 470.7 0.0 529.1 446.9 190.2 0.0 0.0 0.0 676.5 777.5 222.2 0.0 454.1 224.5 715.4 0.0 0.0 1076.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 358.0 0.0 0.0 380.9 0.0 0.0 0.0 0.0 392.7 0.0 0.0 52.8 0.0 0.0 2061.3 215.7 0.0 0.0 0.0 248.9 0.0 0.0 0.0 0.0 507.7 182.6 802.8 0.0 0.0 AVP "ADH, ARVP" ENSG00000101200 "Arginine vasopressin" P01185 20 3082556-3084724 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Hormone, Vasoactive, Vasoconstrictor" "Diabetes insipidus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1308 "brain: 7951.2" "Group enriched" "Detected in some" 6 "Late spermatids: 26.2;Proximal tubular cells: 46.6" "Not detected" "Not detected" "Region enriched" "Detected in many" 131 "hypothalamus: 7951.2" "Immune cell enriched" "Detected in single" 6 "eosinophil: 2.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.7" "Cell line enriched" "Detected in single" 13 "NB-4: 2.3" "Region enriched" "Detected in many" 10 "hypothalamus: 232.9" "Group enriched" "Detected in many" 337 "basal ganglia: 815.6;hypothalamus: 743.3" "CAB025318, HPA071892" Enhanced Supported "Secreted to blood" NA NA 19300 "Cluster 49: Eosinophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 24: NB-4 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "CAB025318: , HPA071892: AB_2732190" "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" 0.3 0.3 24.5 0.0 7.0 0.8 0.2 1.2 60.5 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.6 7951.2 1.5 0.3 0.1 0.0 0.2 0.7 0.1 0.1 0.0 6.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 1.7 0.1 0.0 1.0 0.0 0.0 1.4 10.8 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 24.5 7.0 1.2 60.5 1.6 7951.2 0.2 0.7 0.3 1.0 10.8 0.5 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 5.7 0.0 0.2 0.0 0.0 4.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.0 0.2 0.0 0.0 0.0 0.3 26.2 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 46.6 0.0 0.1 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 BAHCC1 "BAHD2, KIAA1447" ENSG00000266074 "BAH domain and coiled-coil containing 1" Q9P281 17 81395457-81466332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 47.3;Cone photoreceptor cells: 22.9;Horizontal cells: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 25.5;MOLT-4: 31.7;NB-4: 108.4;REH: 33.0" "Low region specificity" "Detected in all" "HPA023386, HPA076910" Approved Approved Nucleoli NA NA "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 62: Horizontal cells - Visual perception" Nucleoli "HPA023386: AB_1859537, HPA076910: AB_2732325" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "unprognostic (1.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.08e-1)" "unprognostic (1.16e-2)" "unprognostic (5.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.05e-2)" "prognostic favorable (7.38e-4)" "unprognostic (1.43e-1)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.18e-1)" "unprognostic (2.18e-1)" "unprognostic (3.78e-2)" 5.9 5.4 4.0 1.8 5.2 4.9 5.0 7.9 6.4 5.8 0.0 4.9 3.3 6.6 1.0 2.9 6.7 3.1 4.0 3.2 2.6 5.6 3.2 4.4 0.7 4.3 3.6 7.7 5.2 2.1 5.2 0.9 3.3 5.6 0.9 2.1 3.7 1.9 3.8 3.8 4.3 1.5 1.1 3.7 5.7 4.0 6.0 4.0 8.3 0.9 0.4 5.9 4.0 7.6 4.1 6.9 4.9 16.3 1.7 2.6 2.3 3.0 2.6 1.6 0.9 1.3 1.8 0.1 4.3 3.4 2.3 4.1 2.4 1.9 0.3 0.0 7.5 5.6 1.8 2.1 1.5 25.5 5.2 4.4 0.7 1.4 1.4 2.5 1.8 6.2 4.0 0.0 0.7 2.4 31.7 108.4 0.3 2.5 4.6 33.0 3.4 0.0 2.0 0.3 22.5 3.5 3.8 0.0 13.3 0.5 0.8 20.3 2.2 8.8 1.2 4.8 1.5 0.0 0.0 0.0 0.0 11.6 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 5.2 7.9 6.4 3.2 2.6 4.3 3.6 3.3 1.1 6.0 7.6 6.7 6.4 13.1 11.4 0.0 0.0 1.5 0.0 3.4 47.3 4.8 4.3 10.0 8.6 3.7 3.7 22.9 0.1 4.4 2.4 1.9 3.3 0.7 1.4 2.0 6.7 8.4 1.7 15.5 4.0 0.2 7.5 4.1 1.7 0.0 7.3 6.1 3.7 0.6 33.7 18.9 4.7 0.0 2.8 0.0 0.4 7.5 2.8 0.0 2.8 2.5 8.6 0.0 12.5 15.1 2.0 1.7 5.7 0.0 1.8 4.6 1.2 2.2 17.8 0.0 7.6 9.8 1.8 10.0 3.1 0.0 0.0 0.2 4.9 5.4 0.9 BBC3 "JFY1, PUMA" ENSG00000105327 "BCL2 binding component 3" "Q96PG8, Q9BXH1" 19 47220822-47232766 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 117.4;Basal squamous epithelial cells: 111.5;Prostatic glandular cells: 132.9;Suprabasal keratinocytes: 143.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 4.5;neutrophil: 3.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.5" "Cell line enhanced" "Detected in many" "HHSteC: 28.4;NB-4: 34.9" "CAB007752, HPA070403" Approved Approved Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB007752: AB_562336, HPA070403: " "unprognostic (4.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.31e-4)" "unprognostic (2.95e-2)" "unprognostic (4.74e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (1.93e-1)" "unprognostic (8.38e-3)" "unprognostic (7.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-2)" "unprognostic (4.66e-3)" "unprognostic (5.06e-2)" "unprognostic (3.57e-1)" "prognostic favorable (2.62e-5)" 3.1 4.4 3.1 2.1 2.8 4.8 4.0 4.3 4.7 3.2 1.8 6.4 2.4 3.4 0.6 1.9 3.6 2.0 3.9 3.3 2.4 5.1 5.6 7.7 2.7 2.8 3.7 3.2 7.7 2.0 2.1 1.9 2.9 4.1 1.8 0.2 7.5 1.2 10.4 8.2 5.0 0.7 2.3 6.1 5.0 2.6 2.8 4.0 3.1 1.1 0.8 4.9 3.4 2.5 3.8 8.3 9.0 1.9 2.1 4.1 22.1 5.9 7.9 1.4 3.5 2.5 6.3 14.7 2.5 1.5 2.5 1.2 1.3 5.3 0.2 9.3 15.9 4.2 2.8 16.4 28.4 0.7 13.4 9.8 8.4 3.0 2.8 3.7 10.3 4.4 10.9 9.0 1.0 8.6 1.6 34.9 5.6 6.5 1.1 4.1 1.3 17.7 0.4 1.3 1.5 13.5 2.7 5.6 18.7 7.1 1.9 11.7 6.9 1.7 11.1 0.2 1.9 14.4 3.4 9.5 2.6 2.2 6.2 4.5 0.4 0.2 0.4 0.5 0.4 0.1 0.1 0.3 0.2 0.0 0.5 0.3 3.4 0.6 0.4 0.1 0.3 0.2 3.1 2.8 4.3 4.7 3.3 2.4 2.8 3.7 2.9 2.3 2.8 2.5 16.2 9.6 7.4 1.6 21.7 117.4 78.8 40.3 111.5 6.5 46.4 29.1 5.6 10.0 21.8 7.3 0.0 4.7 28.3 51.9 0.0 52.4 14.6 65.2 14.0 15.8 21.4 16.8 3.2 39.8 5.5 12.1 23.4 66.2 12.7 8.4 3.9 3.5 7.1 0.0 3.9 40.6 30.5 10.3 31.9 3.3 6.2 17.1 64.0 2.8 15.7 3.7 32.0 1.0 0.5 55.2 49.3 4.1 19.3 132.9 16.2 4.1 22.9 4.4 6.6 12.4 34.9 0.5 1.7 59.4 143.3 20.5 28.5 10.2 27.4 66.2 BCL2L10 "BCL-B, Boo, Diva" ENSG00000137875 "BCL2 like 10" Q9HD36 15 52109263-52112775 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 9.6;skin 1: 6.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 13.7;Proximal enterocytes: 11.4;Proximal tubular cells: 9.8;Squamous epithelial cells: 7.9;Suprabasal keratinocytes: 8.7" "Cancer enhanced" "Detected in many" "liver cancer: 6.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "NB-4: 34.1" "Not detected" "Not detected" HPA042222 Approved NA NA "Cluster 10: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 44: Endometrium - Transcription" "HPA042222: AB_10794271" "unprognostic (5.33e-4)" "unprognostic (1.26e-1)" "unprognostic (1.58e-1)" "unprognostic (3.22e-4)" "unprognostic (1.19e-2)" "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "unprognostic (4.80e-3)" "unprognostic (8.86e-2)" "unprognostic (3.47e-2)" "unprognostic (9.52e-2)" "unprognostic (3.83e-1)" "unprognostic (2.18e-9)" "unprognostic (9.59e-2)" "unprognostic (1.86e-1)" "unprognostic (1.92e-1)" "unprognostic (3.20e-2)" 0.2 2.6 1.2 0.3 1.6 0.1 1.0 0.8 1.1 2.3 0.5 1.0 1.9 0.8 0.0 3.5 0.6 0.9 0.0 0.9 1.7 3.1 9.6 0.0 0.2 0.6 0.6 0.4 0.6 0.2 1.2 0.0 0.8 0.5 0.8 0.4 0.8 0.1 0.1 6.9 2.1 0.2 0.5 0.6 0.9 0.2 1.8 0.1 0.3 0.0 0.2 1.2 3.6 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.7 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.1 4.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 1.6 0.8 1.1 0.9 1.7 0.6 0.6 0.8 0.5 1.8 0.7 0.1 0.0 0.0 0.0 0.6 6.1 5.3 2.5 4.6 1.0 1.7 2.5 0.3 4.3 0.7 0.0 0.0 0.1 0.2 2.8 13.7 2.2 0.0 1.4 1.4 0.3 0.0 0.8 0.4 1.5 0.2 0.3 0.0 5.2 0.0 0.1 0.0 4.5 0.1 0.0 0.2 2.1 6.1 0.0 0.7 0.1 0.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.7 0.4 1.1 2.0 11.4 9.8 0.4 0.2 0.0 0.2 0.3 0.0 0.1 7.9 8.7 0.1 0.2 0.1 3.1 5.4 BICRA GLTSCR1 ENSG00000063169 "BRD4 interacting chromatin remodeling complex associated protein" Q9NZM4 19 47608196-47703277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.5;Breast myoepithelial cells: 6.1;Collecting duct cells: 7.3;Endometrial stromal cells: 6.4;Glandular and luminal cells: 6.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056211 Approved Supported Nucleoplasm NA NA "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA056211: AB_2683068" "unprognostic (2.36e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-2)" "unprognostic (9.58e-2)" "unprognostic (7.75e-2)" "prognostic favorable (1.34e-4)" "unprognostic (8.38e-2)" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-2)" "unprognostic (1.56e-3)" "unprognostic (2.21e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (9.72e-2)" "unprognostic (7.98e-2)" "unprognostic (1.61e-1)" "prognostic favorable (9.34e-4)" 6.7 5.0 1.6 5.0 2.1 5.3 6.9 4.3 3.6 9.6 0.9 9.1 6.5 10.6 1.6 6.9 9.1 2.4 6.2 3.6 1.1 3.9 4.9 7.0 3.9 1.9 0.5 8.6 4.4 4.0 5.6 4.8 1.0 8.2 3.6 4.2 7.0 4.1 13.7 9.9 7.3 5.3 0.0 6.1 6.3 3.0 2.2 5.6 7.5 5.5 3.5 8.6 8.3 5.5 6.8 6.6 12.3 9.5 6.0 6.1 7.0 5.8 4.9 6.4 4.3 7.3 3.5 7.3 3.0 6.7 5.4 6.9 7.7 4.1 6.4 7.5 6.5 4.3 5.3 3.1 7.7 5.1 7.5 5.2 5.6 7.0 6.3 5.3 6.5 6.2 6.7 8.4 3.9 4.8 9.1 16.3 8.6 8.7 5.4 9.7 4.2 2.1 2.5 4.6 7.4 9.6 14.4 8.3 3.7 10.0 3.4 4.0 8.1 5.3 10.8 4.4 7.9 6.8 11.8 7.1 1.2 3.6 8.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.6 2.1 4.3 3.6 3.6 1.1 1.9 0.5 1.0 0.0 2.2 5.5 5.1 9.6 6.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.2 6.1 0.0 0.0 0.6 7.3 0.0 4.3 3.8 0.0 0.0 3.2 0.0 4.9 6.4 2.0 0.0 0.0 0.0 3.8 3.9 1.6 0.0 6.0 1.3 4.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 5.5 2.0 3.3 0.0 0.0 BLOC1S4 "BCAS4L, CNO, FLJ11230" ENSG00000186222 "Biogenesis of lysosomal organelles complex 1 subunit 4" Q9NUP1 4 6716174-6717664 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043840 Approved Approved Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles Cytosol "HPA043840: AB_10965701" "unprognostic (3.09e-1)" "unprognostic (8.40e-2)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (1.80e-1)" "unprognostic (3.53e-1)" "unprognostic (1.76e-1)" "unprognostic (9.24e-3)" "unprognostic (5.62e-3)" 8.6 11.7 8.0 7.9 8.2 9.8 8.9 8.3 8.7 9.4 9.1 8.9 9.2 9.9 7.1 11.1 9.3 6.5 8.0 8.3 7.7 10.0 11.3 6.3 12.1 8.1 8.2 12.0 7.9 5.6 7.2 7.7 8.3 9.4 5.7 4.3 8.2 6.4 10.8 8.6 11.4 5.1 8.4 13.1 8.8 6.3 8.3 8.9 7.6 5.7 8.6 9.6 8.6 8.6 15.3 10.3 15.2 15.6 11.7 15.0 30.5 12.0 13.2 11.0 9.7 9.2 16.0 14.4 12.6 10.9 15.5 10.1 8.6 14.0 8.4 11.7 14.1 22.0 10.3 23.2 14.3 10.8 19.7 14.2 13.6 8.7 7.5 10.8 10.3 12.3 29.3 12.6 11.6 15.1 17.6 37.5 19.7 11.2 20.0 17.9 16.8 13.0 15.3 13.3 13.1 17.5 9.9 7.1 22.7 11.6 22.4 20.8 11.6 10.0 8.9 11.8 15.4 18.8 19.8 19.4 11.2 19.6 16.3 2.5 2.7 14.0 4.4 4.6 4.5 6.3 5.4 4.8 3.6 5.2 8.4 4.5 1.4 2.5 3.1 3.4 5.1 1.7 8.0 8.2 8.3 8.7 8.3 7.7 8.1 8.2 8.3 8.4 8.3 8.6 18.7 6.4 5.9 3.9 40.8 23.6 35.2 4.9 26.7 29.1 25.2 27.8 5.3 21.5 5.7 23.9 6.2 65.1 49.5 21.7 25.4 9.7 2.5 28.6 28.0 20.2 11.4 26.5 6.8 7.0 93.1 27.8 21.9 25.3 3.8 18.7 32.5 23.6 35.8 30.3 6.6 22.8 4.1 24.0 22.2 1.6 32.3 16.6 30.2 5.6 18.1 38.4 60.8 4.5 8.3 9.9 33.9 22.6 19.7 40.3 33.9 51.3 4.6 24.7 6.6 26.6 20.0 16.0 14.3 23.1 24.9 63.3 47.7 39.1 24.2 34.8 BSPH1 "BSP1, ELSPBP2" ENSG00000188334 "Binder of sperm protein homolog 1" Q075Z2 19 47968046-47992170 "Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "epididymis: 383.0" "Cell type enhanced" "Detected in single" "Bipolar cells: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048335 Enhanced "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 56: Bipolar cells - Visual perception" "HPA048335: AB_2732546" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 383.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1D "LRP1, Rrp47, SUN-CoR, SUNCOR" ENSG00000197223 "C1D nuclear receptor corepressor" Q13901 2 68041130-68110948 "Predicted intracellular proteins" "Apoptosis, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037413, HPA037588" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 34: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA037413: AB_2675463, HPA037588: AB_10672907" "unprognostic (1.84e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.03e-1)" "unprognostic (1.49e-2)" "unprognostic (4.01e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.98e-1)" "unprognostic (3.90e-2)" "unprognostic (1.29e-2)" "unprognostic (4.24e-3)" "unprognostic (6.18e-2)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.01e-1)" 21.7 25.3 11.6 17.0 11.8 48.1 21.4 11.9 19.0 19.9 12.8 19.1 16.6 20.0 17.0 19.3 18.3 14.7 22.2 12.0 12.8 31.5 33.4 19.0 21.4 11.3 11.8 19.3 15.8 24.0 15.3 17.5 11.6 19.5 14.7 16.6 18.7 15.5 46.9 17.5 18.5 13.7 12.0 21.7 21.4 14.8 12.0 17.5 19.6 31.9 16.5 17.4 28.2 13.9 36.6 20.3 22.0 21.0 22.2 27.0 29.6 48.7 28.1 29.3 22.4 40.8 45.0 45.2 27.2 28.9 28.1 18.0 24.7 20.4 43.1 43.0 36.6 43.5 17.6 46.3 22.3 68.1 54.4 25.0 32.4 22.1 20.9 36.3 22.0 41.4 44.8 41.1 26.6 22.2 51.3 69.6 25.4 29.8 24.4 29.6 28.3 39.9 28.2 29.2 20.5 25.4 15.1 30.0 51.6 26.7 22.2 41.2 30.9 27.9 34.5 34.0 38.9 38.0 40.8 58.6 38.9 41.3 34.2 45.3 17.6 43.7 19.0 23.3 22.5 24.2 22.0 16.6 20.6 21.3 23.4 24.3 34.9 30.3 25.2 19.2 25.3 15.2 11.6 11.8 11.9 19.0 12.0 12.8 11.3 11.8 11.6 12.0 12.0 13.9 65.2 76.9 47.9 13.1 70.7 85.0 83.2 132.8 33.6 34.3 52.9 58.4 36.5 64.3 86.3 64.4 22.9 98.9 76.2 48.1 234.8 83.4 52.4 53.7 47.2 42.9 51.6 121.2 17.7 59.4 82.7 60.2 44.9 46.6 44.3 32.8 43.5 81.7 87.5 35.3 15.9 42.6 109.9 61.9 46.1 21.7 55.6 66.9 56.9 8.4 80.1 57.4 88.6 14.1 21.9 65.6 63.3 59.0 58.5 78.1 57.0 251.4 95.4 36.8 98.6 54.2 65.3 164.5 100.3 44.5 86.2 107.8 62.9 52.2 32.8 109.0 C20orf96 dJ1103G7.2 ENSG00000196476 "Chromosome 20 open reading frame 96" Q9NUD7 20 270863-290778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 109.6;Endometrial ciliated cells: 89.2;Respiratory ciliated cells: 106.2;Spermatocytes: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048649, HPA056227" Approved Approved "Centriolar satellite" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Centriolar satellite" "HPA048649: AB_2680476, HPA056227: " "unprognostic (1.59e-2)" "unprognostic (4.15e-2)" "unprognostic (1.26e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-1)" "unprognostic (8.21e-2)" "prognostic unfavorable (6.12e-5)" "unprognostic (4.62e-2)" "unprognostic (5.12e-1)" "unprognostic (3.24e-1)" "prognostic favorable (4.12e-5)" "unprognostic (2.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "prognostic favorable (1.05e-4)" 6.6 10.5 13.5 5.3 13.1 8.1 10.2 12.6 13.7 16.8 20.5 11.0 9.6 16.6 20.7 4.4 33.5 8.8 8.3 13.6 13.6 15.1 6.2 10.2 5.4 17.2 20.8 20.3 9.2 8.4 17.3 3.8 17.3 13.9 8.3 11.2 9.8 7.8 3.5 3.6 9.2 10.3 16.6 9.6 9.8 30.1 14.3 6.7 17.1 2.3 4.6 8.9 8.1 13.4 7.5 23.3 23.9 21.1 6.2 6.0 10.6 5.3 6.8 7.7 10.3 4.5 14.3 18.7 3.4 6.4 13.4 6.4 8.9 4.1 8.9 4.7 13.9 12.5 0.2 25.6 17.2 10.3 5.2 8.3 3.5 13.2 1.6 19.4 15.6 23.6 25.9 9.1 6.7 3.7 12.2 39.9 7.9 7.4 10.1 36.9 4.2 15.4 12.1 11.5 2.5 21.3 6.3 9.0 15.3 11.0 15.6 22.7 10.5 7.6 13.1 6.8 4.4 20.7 22.5 12.8 4.2 31.9 7.2 0.0 1.3 0.0 0.6 1.0 0.4 1.6 0.4 0.5 3.0 1.7 0.9 1.2 0.0 1.3 0.7 1.4 0.6 0.8 13.5 13.1 12.6 13.7 13.6 13.6 17.2 20.8 17.3 16.6 14.3 13.4 7.2 3.2 3.6 13.4 4.1 3.7 5.5 9.9 9.1 3.8 21.8 19.2 0.8 11.5 12.5 18.4 6.2 5.1 2.8 5.0 39.2 11.4 109.6 89.2 11.0 10.4 8.4 9.7 5.1 6.9 3.1 9.1 15.8 7.1 14.7 18.6 9.7 3.4 9.1 6.7 4.0 8.1 26.4 3.8 3.3 35.8 10.8 7.7 3.6 4.7 3.7 7.7 4.1 2.0 4.6 8.5 1.9 18.0 10.7 4.9 4.6 23.1 106.2 9.8 6.6 6.5 8.7 60.8 45.1 4.3 1.6 2.7 4.1 9.8 9.3 4.2 C6orf52 ENSG00000137434 "Chromosome 6 open reading frame 52" Q5T4I8 6 10671418-10694797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 13.7" "Cell type enhanced" "Detected in many" "Early spermatids: 46.4;Endometrial ciliated cells: 44.9;Late spermatids: 27.3;Respiratory ciliated cells: 37.7;Spermatocytes: 36.1;Spermatogonia: 20.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 6.1;U-266/84: 6.4" "Not detected" "Not detected" HPA051142 Uncertain Approved "Nuclear speckles,Intermediate filaments" No No "Cluster 35: T-regs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" "Intermediate filaments" "HPA051142: AB_2681359" "unprognostic (1.14e-2)" "unprognostic (2.21e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.50e-5)" "unprognostic (9.12e-2)" "unprognostic (2.96e-1)" "unprognostic (1.11e-3)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-2)" "unprognostic (3.92e-2)" "unprognostic (9.31e-3)" "unprognostic (7.65e-2)" 1.0 1.8 2.2 0.5 2.2 0.3 1.1 2.3 4.0 0.7 3.1 0.8 3.3 0.5 3.5 0.6 3.3 0.2 0.6 2.2 2.5 4.4 0.7 1.0 0.4 2.6 2.7 1.1 2.2 0.3 2.0 0.2 2.6 2.0 0.3 0.8 0.8 0.5 0.5 1.3 0.7 0.3 2.4 0.7 1.6 13.7 2.3 0.5 0.8 0.2 0.6 0.6 0.5 2.8 1.0 2.0 1.8 1.7 0.6 0.0 3.3 0.3 0.0 0.2 0.4 2.7 1.6 0.2 2.9 0.0 2.8 0.2 1.8 0.0 0.6 1.2 4.5 0.8 0.5 0.5 0.0 1.2 0.5 0.3 2.6 0.7 1.0 0.4 0.0 1.9 3.6 0.3 0.7 6.1 1.5 6.1 1.9 1.4 2.3 1.3 0.4 0.9 0.8 0.5 3.8 2.1 0.8 0.5 3.9 2.3 0.2 1.0 0.7 1.4 0.5 1.0 1.4 2.6 6.4 1.4 2.3 0.9 1.6 0.0 0.2 2.4 0.6 0.5 0.2 0.2 0.7 0.6 0.5 0.3 0.3 0.3 0.3 0.7 0.3 0.4 3.1 0.3 2.2 2.2 2.3 4.0 2.2 2.5 2.6 2.7 2.6 2.4 2.3 2.8 0.7 0.0 2.7 3.3 1.2 1.5 2.0 4.2 0.0 1.6 3.2 3.7 1.3 1.5 2.6 3.7 2.1 2.9 0.2 1.6 5.9 4.1 46.4 44.9 0.9 1.9 3.0 0.0 0.9 6.1 2.3 1.1 2.0 2.5 0.0 0.6 1.4 1.9 1.2 1.7 1.0 1.2 0.0 0.3 1.0 27.3 2.1 0.6 3.6 0.0 1.6 3.3 1.0 0.0 3.5 2.8 2.7 0.0 2.5 2.0 1.3 9.6 37.7 0.9 0.0 1.1 2.1 36.1 20.4 0.6 1.4 1.4 0.4 0.4 1.7 1.0 CBWD1 ENSG00000172785 "COBW domain containing 1" Q9BRT8 9 121038-179147 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 185.1" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (3.75e-2)" "unprognostic (3.47e-2)" "unprognostic (5.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.39e-1)" "unprognostic (2.67e-2)" "unprognostic (3.91e-2)" "unprognostic (3.72e-1)" "unprognostic (4.15e-2)" "unprognostic (2.07e-3)" "unprognostic (1.82e-1)" "unprognostic (4.68e-2)" "unprognostic (5.80e-7)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (8.94e-2)" "unprognostic (4.98e-3)" 18.6 34.4 8.7 15.3 9.2 13.0 19.9 10.6 11.1 14.3 13.0 16.9 13.3 13.7 20.8 26.8 14.6 10.6 20.7 9.0 10.2 40.1 26.8 16.1 13.4 9.0 9.0 15.4 30.0 38.3 19.4 22.2 9.2 19.9 15.2 27.5 23.7 12.2 21.8 22.3 14.1 12.2 9.0 16.9 19.1 16.4 9.1 13.2 25.4 17.6 20.1 23.4 17.1 9.9 43.3 16.1 22.7 12.2 29.1 26.2 50.3 22.2 14.6 30.4 23.0 23.4 16.1 39.4 28.3 8.2 18.4 7.3 11.3 21.1 32.4 67.8 38.9 0.4 39.1 72.6 31.5 115.1 17.2 23.5 9.9 7.3 59.0 19.5 32.9 19.7 13.6 84.3 25.2 52.1 25.1 185.1 22.9 37.6 34.6 47.7 34.6 75.8 39.4 120.7 40.8 24.8 45.8 16.8 17.8 55.5 35.6 109.2 34.4 16.0 22.9 20.8 19.7 10.1 14.6 44.6 39.6 60.6 19.2 3.6 65.7 19.3 10.3 75.6 16.9 21.1 18.6 16.8 74.1 15.7 16.2 17.7 10.2 12.8 60.8 19.6 18.1 48.3 8.7 9.2 10.6 11.1 9.0 10.2 9.0 9.0 9.2 9.0 9.1 9.9 19.5 54.5 50.1 8.1 41.2 47.7 29.9 47.6 97.9 50.8 49.4 37.6 51.8 30.0 49.8 35.0 108.4 96.3 17.7 20.4 35.2 79.9 51.7 14.9 10.1 23.0 31.2 44.6 17.0 118.5 41.2 23.0 34.7 11.9 32.8 26.7 20.7 19.0 32.0 38.7 17.1 39.0 50.8 25.1 38.0 16.4 18.0 37.9 32.0 18.7 81.5 32.2 18.6 5.5 16.7 66.9 38.2 13.2 90.0 32.0 49.5 73.6 31.0 63.5 32.9 20.2 27.8 48.6 28.1 83.8 50.6 124.8 23.5 24.1 62.3 24.9 CCDC146 "KIAA1505, MBO2" ENSG00000135205 "Coiled-coil domain containing 146" Q8IYE0 7 77122434-77329533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 34.0" "Cell type enhanced" "Detected in many" "Early spermatids: 308.3;Endometrial ciliated cells: 460.8;Oligodendrocyte precursor cells: 151.3;Respiratory ciliated cells: 417.9;Spermatocytes: 149.4" "Group enriched" "Detected in all" 4 "endometrial cancer: 8.8;ovarian cancer: 13.6;renal cancer: 15.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 14.3;neutrophil: 15.4" "Group enriched" "Detected in many" 4 "granulocytes: 15.4;NK-cells: 5.3;T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA020082, HPA020105" Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA020082: AB_1852410, HPA020105: AB_2072056" "unprognostic (3.07e-3)" "unprognostic (9.94e-3)" "unprognostic (1.56e-1)" "unprognostic (2.54e-3)" "unprognostic (1.85e-1)" "prognostic favorable (7.37e-4)" "unprognostic (1.95e-3)" "unprognostic (8.02e-3)" "unprognostic (4.05e-4)" "unprognostic (1.73e-1)" "unprognostic (4.63e-1)" "unprognostic (4.09e-2)" "unprognostic (7.38e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-1)" "unprognostic (2.70e-3)" "unprognostic (5.58e-3)" 2.2 1.1 4.0 2.5 3.7 1.7 2.4 2.0 2.5 4.5 18.3 3.8 2.4 4.6 2.5 3.6 34.0 3.1 1.8 2.7 4.4 4.2 1.8 5.2 3.0 11.5 11.4 3.3 2.5 3.9 3.8 1.9 7.4 3.7 2.7 14.5 4.1 2.3 1.1 9.4 2.8 3.0 7.8 3.7 3.3 21.5 3.9 3.1 7.7 1.6 2.7 3.1 3.9 6.3 0.6 0.9 2.7 1.4 1.7 1.7 0.3 0.7 0.6 0.7 1.1 0.0 4.6 1.4 0.1 0.2 2.6 0.9 0.4 0.8 1.1 1.9 0.3 1.8 1.5 0.8 0.5 1.8 1.3 0.8 1.3 1.2 0.2 2.2 0.6 1.4 0.0 1.4 0.1 0.2 1.5 2.9 0.3 0.6 0.6 4.0 0.4 0.2 2.8 0.5 2.0 1.3 1.0 0.9 0.6 0.8 0.8 0.6 0.9 1.0 0.4 1.4 0.4 2.7 4.5 1.2 2.3 2.7 2.3 0.9 0.6 14.3 4.4 0.9 3.0 1.2 1.9 3.1 0.8 0.2 1.2 2.0 15.4 5.3 0.4 2.0 1.6 0.8 4.0 3.7 2.0 2.5 2.7 4.4 11.5 11.4 7.4 7.8 3.9 6.3 6.9 3.2 9.7 34.0 3.6 7.1 2.6 16.9 6.2 8.6 2.7 4.6 32.0 2.8 56.9 5.5 62.6 1.2 9.3 2.8 21.5 3.2 308.3 460.8 11.1 4.8 1.8 0.4 49.0 1.6 0.7 15.4 6.1 106.0 6.3 6.1 23.6 0.8 1.6 5.0 48.8 1.4 24.4 3.5 7.1 52.4 12.2 4.5 5.4 50.6 2.0 12.1 20.6 151.3 62.8 1.7 5.2 6.4 3.7 5.8 2.9 30.1 417.9 55.1 6.6 15.6 11.6 149.4 10.8 5.5 3.4 2.5 8.6 7.2 4.0 5.4 CCDC28A "C6orf80, CCRL1AP, DKFZp586D0623" ENSG00000024862 "Coiled-coil domain containing 28A" 6 138773769-138793319 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 146.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055125 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Plasma membrane" Nucleoplasm "HPA055125: AB_2682705" "unprognostic (1.51e-1)" "unprognostic (6.88e-3)" "unprognostic (2.70e-1)" "unprognostic (6.67e-2)" "unprognostic (7.96e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (2.58e-3)" "unprognostic (3.80e-1)" "unprognostic (8.34e-3)" "unprognostic (4.29e-3)" "unprognostic (1.02e-1)" "prognostic favorable (1.11e-5)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (2.28e-2)" "unprognostic (2.37e-2)" 21.8 48.4 41.8 19.6 42.5 40.1 28.1 38.4 48.7 23.8 47.1 23.8 30.4 16.7 38.1 16.4 35.8 23.8 19.1 43.8 43.2 59.9 67.8 26.2 35.4 38.5 38.8 21.8 35.5 53.0 29.5 32.1 39.3 25.0 24.3 25.6 52.3 20.2 15.7 18.0 30.7 15.9 37.8 29.8 29.3 23.8 41.1 46.5 54.2 21.3 33.6 26.2 17.2 39.0 7.2 12.9 9.5 17.4 17.5 24.4 19.4 11.7 20.3 15.2 24.6 11.1 14.1 31.1 22.3 11.8 21.3 12.3 15.6 16.2 24.4 35.9 35.7 25.3 16.3 22.1 27.6 43.8 25.6 15.7 20.2 10.9 32.0 31.0 25.1 43.1 25.8 42.2 17.1 15.9 36.3 58.0 8.9 28.9 13.2 21.7 9.5 29.2 18.3 10.6 11.8 18.4 15.6 13.8 34.9 18.6 6.7 47.6 19.5 11.9 13.5 22.3 18.0 55.8 53.0 23.1 12.7 27.1 10.6 137.8 91.6 120.6 84.5 96.5 76.4 107.1 88.4 92.8 102.1 106.6 101.5 93.3 249.6 115.8 85.0 90.0 159.8 93.6 41.8 42.5 38.4 48.7 43.8 43.2 38.5 38.8 39.3 37.8 41.1 39.0 24.5 32.1 35.4 12.7 36.5 13.4 25.0 36.9 29.0 16.0 24.6 25.1 11.0 24.3 31.6 36.8 18.8 82.7 42.7 31.7 123.3 19.3 146.8 83.5 11.4 20.7 24.7 39.2 25.6 31.6 49.2 23.2 16.3 15.6 43.1 25.3 29.3 50.8 38.0 10.1 22.3 30.6 38.7 41.5 31.5 99.9 16.8 36.1 32.0 3.7 39.5 24.6 42.2 5.5 17.9 16.8 35.9 15.1 29.7 31.2 81.0 130.9 89.0 14.2 13.1 14.0 15.8 48.6 27.2 15.5 14.9 108.9 35.4 18.1 23.1 36.2 CCDC61 ENSG00000104983 "Coiled-coil domain containing 61" Q9Y6R9 19 45995461-46021318 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 6.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.5" "Cell line enhanced" "Detected in all" "NB-4: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040325, HPA061548" Uncertain Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA040325: AB_10672970, HPA061548: AB_2684559" "unprognostic (1.30e-1)" "unprognostic (1.51e-3)" "unprognostic (2.56e-1)" "unprognostic (6.23e-3)" "unprognostic (7.27e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (2.81e-1)" "unprognostic (1.58e-1)" "unprognostic (2.93e-2)" "unprognostic (2.73e-2)" "unprognostic (1.34e-1)" "unprognostic (2.13e-3)" "unprognostic (2.58e-1)" "unprognostic (2.09e-1)" "unprognostic (1.40e-2)" "unprognostic (1.09e-1)" 9.3 11.2 6.9 8.0 8.1 5.9 9.3 13.7 11.2 11.6 4.8 11.1 7.9 10.0 7.2 10.4 16.2 5.0 8.4 7.8 5.4 12.2 12.5 8.6 11.0 6.6 5.1 12.5 10.3 9.9 13.3 5.9 5.4 11.2 4.9 1.6 9.0 8.0 5.6 12.7 10.3 5.1 4.0 13.9 11.0 24.9 5.3 9.7 12.4 4.1 6.9 11.2 10.0 7.8 13.9 10.0 5.2 9.0 9.6 7.0 7.9 9.8 5.0 5.8 9.7 6.1 12.0 8.7 4.7 6.9 8.0 11.6 5.7 13.1 4.3 16.6 5.4 9.3 8.6 10.1 10.6 8.9 12.2 7.6 17.9 5.0 10.4 9.9 11.7 16.3 10.5 17.5 7.5 4.4 20.4 57.2 1.9 14.9 4.3 13.7 1.7 14.1 9.5 11.4 5.6 5.1 9.7 12.5 7.6 5.1 5.3 12.7 10.0 4.2 1.7 2.0 11.2 10.6 5.5 8.9 9.4 9.8 7.1 6.5 0.4 0.4 0.9 0.4 0.5 0.8 0.5 0.5 0.2 1.2 0.6 0.5 1.3 0.3 0.5 0.3 0.5 0.2 6.9 8.1 13.7 11.2 7.8 5.4 6.6 5.1 5.4 4.0 5.3 7.8 8.8 0.0 4.4 4.6 7.0 6.2 7.1 1.1 4.6 4.3 4.3 5.3 6.0 4.3 3.0 11.0 0.0 11.2 5.1 11.9 9.8 1.6 3.4 9.0 5.7 5.3 3.6 2.1 4.0 2.0 8.5 6.4 12.8 5.6 0.0 11.8 4.2 4.4 8.0 3.3 4.1 8.6 0.0 5.3 2.7 1.6 5.3 5.5 3.6 1.9 2.3 3.3 2.1 1.5 2.6 1.8 5.8 5.7 6.1 4.3 6.6 8.4 3.5 1.9 6.6 4.6 6.0 13.9 6.2 6.4 5.3 7.8 7.3 9.8 10.9 4.3 CCDC9 DKFZP586M1019 ENSG00000105321 "Coiled-coil domain containing 9" Q9Y3X0 19 47255980-47273701 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 50.6;Late spermatids: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 116.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045624, HPA072007" Enhanced Approved Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA045624: AB_10961402, HPA072007: AB_2686482" "unprognostic (4.53e-3)" "unprognostic (1.75e-1)" "unprognostic (3.70e-3)" "unprognostic (8.22e-2)" "unprognostic (7.47e-2)" "unprognostic (1.15e-2)" "unprognostic (8.35e-3)" "unprognostic (1.45e-1)" "unprognostic (4.99e-1)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (9.78e-2)" "unprognostic (2.58e-1)" "unprognostic (2.45e-2)" "unprognostic (1.02e-1)" "unprognostic (7.46e-3)" "unprognostic (4.02e-1)" 22.7 21.1 11.7 16.1 12.2 40.7 22.2 10.5 16.1 27.8 17.3 24.8 13.7 24.7 8.8 18.1 24.8 10.3 21.8 12.7 10.0 25.9 22.7 26.6 10.6 15.9 12.0 30.7 49.0 14.0 16.6 13.6 11.3 25.8 8.5 12.6 20.0 12.3 26.2 34.9 18.9 9.8 9.5 23.1 24.8 35.8 12.6 9.3 23.0 11.7 7.7 23.8 23.9 12.3 27.5 27.7 21.2 23.7 6.6 17.9 24.1 37.2 16.4 22.4 24.5 29.5 21.1 12.5 10.0 24.8 18.6 25.5 19.7 16.0 12.1 33.3 12.3 32.3 27.3 22.7 21.1 13.2 31.9 19.2 23.0 21.4 20.0 19.0 15.1 15.6 45.0 61.8 15.0 32.8 15.4 116.9 23.7 45.3 10.8 26.9 20.2 14.4 10.2 19.7 8.3 21.1 50.5 36.4 20.3 17.3 30.2 26.7 20.9 25.8 23.0 15.6 32.2 20.5 38.5 19.0 24.2 17.8 20.3 0.4 1.1 2.0 1.3 1.4 0.7 0.6 1.0 1.0 0.9 0.9 1.0 0.7 3.6 1.1 0.8 1.4 1.9 0.4 11.7 12.2 10.5 16.1 12.7 10.0 15.9 12.0 11.3 9.5 12.6 12.3 13.6 6.4 1.7 1.3 16.4 14.0 15.7 1.8 12.0 3.1 8.9 5.2 3.0 2.8 1.9 1.8 4.2 5.4 9.3 13.1 5.9 7.5 50.6 13.0 10.3 9.7 3.6 8.2 1.4 11.2 9.1 7.6 14.3 16.8 8.2 4.3 3.3 3.6 5.8 0.0 1.0 12.0 2.0 7.8 14.4 79.3 4.4 9.8 7.2 1.9 10.4 1.8 7.2 0.5 0.9 11.1 11.5 3.8 15.2 8.9 7.8 6.7 2.1 7.6 6.6 8.7 10.5 2.8 7.5 12.7 17.8 15.3 12.2 5.3 8.4 13.5 CCL25 "Ckb15, SCYA25, TECK" ENSG00000131142 "C-C motif chemokine ligand 25" O15444 19 8052318-8062660 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 1030 "intestine: 581.5;lymphoid tissue: 771.3" "Cell type enhanced" "Detected in some" "Intestinal goblet cells: 149.1;Proximal enterocytes: 774.7;Undifferentiated cells: 399.3" "Group enriched" "Detected in many" 4 "liver cancer: 25.4;stomach cancer: 33.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "NK-cell: 3.5" "Lineage enriched" "Detected in single" 5 "NK-cells: 3.5" "Cell line enhanced" "Detected in some" "BEWO: 2.0;HEL: 2.1;NB-4: 2.6;REH: 6.1;RPMI-8226: 1.8;SH-SY5Y: 1.9" HPA055883 Approved "Secreted to blood" NA NA 183000000 "Cluster 48: NK-cells - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" "HPA055883: AB_2682955" "unprognostic (9.22e-3)" "unprognostic (3.13e-4)" "unprognostic (1.12e-1)" "unprognostic (1.29e-1)" "unprognostic (2.87e-1)" "unprognostic (9.30e-3)" "unprognostic (2.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (8.85e-3)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.27e-4)" "unprognostic (6.43e-2)" "unprognostic (3.86e-1)" "unprognostic (6.57e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.2 0.5 0.0 0.1 1.3 512.4 0.3 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.0 1.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 581.5 0.0 0.1 0.5 0.5 0.6 0.3 771.3 0.2 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 2.6 0.1 0.0 0.3 6.1 0.0 1.8 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.2 0.2 1.6 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 149.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 57.6 0.0 1.5 0.0 774.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 399.3 0.0 CCL5 "D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228" ENSG00000271503 "C-C motif chemokine ligand 5" P13501 17 35871491-35880793 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 122.1;lymphoid tissue: 135.2" "Group enriched" "Detected in many" 8 "dendritic cells: 2049.9;NK-cells: 2344.0;T-cells: 1947.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 6788.6;memory CD8 T-cell: 7164.3" "Group enriched" "Detected in all" 7 "NK-cells: 2041.1;T-cells: 7164.3" "Cell line enhanced" "Detected in some" "HL-60: 94.1;NB-4: 539.9;THP-1: 139.9;U-937: 120.1" CAB078447 Enhanced "Secreted to blood" NA NA 20100000 2900000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB078447: AB_223462" "unprognostic (3.91e-3)" "unprognostic (1.50e-3)" "unprognostic (8.63e-2)" "prognostic favorable (1.34e-5)" "unprognostic (1.36e-3)" "unprognostic (6.37e-3)" "unprognostic (8.70e-2)" "unprognostic (2.64e-2)" "prognostic favorable (2.42e-4)" "unprognostic (3.26e-3)" "unprognostic (1.64e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (1.70e-2)" "unprognostic (7.55e-2)" "unprognostic (8.56e-3)" "unprognostic (3.73e-2)" 17.2 17.1 3.9 36.3 4.0 122.1 19.5 3.8 6.5 15.5 5.4 27.7 48.7 15.7 14.4 15.8 14.0 42.9 8.9 3.9 3.7 7.5 28.4 57.4 135.2 7.3 4.3 16.9 7.0 3.0 3.8 6.3 6.4 10.4 25.6 0.3 33.5 7.9 4.8 4.0 84.5 10.5 5.8 123.9 47.9 4.6 4.7 29.5 11.5 2.7 33.4 31.4 9.5 6.1 0.7 0.5 0.2 0.0 0.5 0.4 0.8 0.3 4.0 17.8 20.8 0.4 1.7 0.3 1.6 0.9 1.3 0.9 0.0 0.0 2.3 6.5 0.3 0.0 1.5 0.6 0.5 94.1 0.8 0.1 0.2 5.5 0.3 0.0 0.2 0.1 0.1 12.5 0.2 0.6 0.1 539.9 0.5 0.0 0.0 0.6 0.2 14.0 0.2 0.5 0.1 0.5 0.2 1.2 13.4 0.5 0.2 139.9 0.3 0.6 0.3 0.6 0.4 14.2 6.6 0.8 0.4 120.1 1.3 657.8 30.0 35.8 6788.6 21.3 4221.0 61.3 1394.5 7164.3 49.8 41.6 332.4 4032.4 189.9 2041.1 26.1 46.5 25.9 6664.4 3.9 4.0 3.8 6.5 3.9 3.7 7.3 4.3 6.4 5.8 4.7 6.1 22.4 99.3 244.4 0.3 55.2 7.4 1.3 6.0 4.6 1.3 19.9 18.2 5.4 21.5 41.7 1.8 0.0 1.8 2049.9 3.1 1.9 6.3 1.2 5.5 5.4 24.2 1.8 106.3 0.5 0.2 7.1 26.0 46.9 6.7 80.8 0.2 45.0 7.0 33.8 0.0 0.3 3.5 0.0 48.0 25.0 0.1 0.3 256.3 12.4 2.8 38.5 0.4 2344.0 0.0 0.4 1.6 6.9 0.4 179.5 1.7 2.4 6.7 29.2 1.1 0.0 6.5 28.2 1.1 1.2 5.5 6.3 16.0 1947.0 0.1 3.5 1.9 CCM2 "C7orf22, MGC4607, OSM" ENSG00000136280 "CCM2 scaffold protein" Q9BSQ5 7 44999475-45076469 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 140.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020273, HPA021669, HPA065815" Supported Enhanced Mitochondria NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 3: Monocytes - Immune response regulation" Mitochondria "HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: AB_2685562" "unprognostic (4.30e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (3.17e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (4.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.37e-3)" "unprognostic (3.92e-1)" "unprognostic (2.65e-1)" "prognostic favorable (1.16e-4)" "unprognostic (3.03e-1)" "prognostic unfavorable (5.06e-7)" "unprognostic (2.45e-1)" "unprognostic (1.79e-1)" "unprognostic (2.81e-2)" "unprognostic (2.48e-1)" 32.7 40.7 62.5 25.1 74.5 15.5 26.6 58.7 89.1 19.1 48.4 30.2 13.2 20.3 6.4 22.4 18.9 11.5 37.1 63.0 62.4 24.2 86.0 29.2 43.6 67.6 62.8 16.1 26.6 21.4 30.4 14.5 69.2 23.8 10.8 9.4 18.8 14.5 48.2 21.1 27.6 16.9 60.0 54.6 24.0 30.3 71.5 45.4 18.7 36.9 29.6 27.2 20.0 68.6 38.7 41.8 24.4 49.2 45.5 39.8 17.7 45.9 37.3 32.0 43.3 30.6 39.3 53.7 34.5 58.5 101.8 49.5 15.3 58.9 21.4 61.0 29.7 23.3 34.0 22.1 39.9 9.9 61.5 44.7 38.0 56.3 24.0 30.0 59.2 76.8 27.5 42.1 64.7 58.2 47.9 131.6 28.4 32.3 46.1 25.7 14.2 43.9 33.1 36.8 46.9 36.8 37.5 29.2 20.9 31.7 33.3 45.7 45.1 43.4 36.4 44.2 44.8 75.9 64.0 109.2 42.3 35.7 53.4 108.1 33.5 105.8 52.2 40.2 35.2 42.0 62.3 57.4 23.6 43.6 58.9 44.1 103.9 60.9 47.7 23.8 167.1 40.2 62.5 74.5 58.7 89.1 63.0 62.4 67.6 62.8 69.2 60.0 71.5 68.6 28.7 19.2 19.4 26.1 57.5 46.8 22.6 27.6 54.7 19.0 13.5 24.6 13.0 20.0 18.8 14.7 4.2 28.3 53.7 30.5 25.4 30.2 6.9 6.0 14.3 26.7 15.6 13.7 33.3 38.5 35.8 25.0 11.2 7.4 36.1 23.8 30.4 56.5 49.3 82.4 24.9 15.2 12.2 47.9 51.1 12.8 21.1 47.7 33.8 56.2 140.0 34.1 122.6 20.1 51.7 45.3 11.4 20.3 69.1 40.4 13.6 22.9 8.0 14.4 19.7 16.2 29.6 15.3 37.8 16.8 23.0 10.4 55.7 36.9 15.2 19.7 CD300LB "CLM7, TREM5" ENSG00000178789 "CD300 molecule like family member b" A8K4G0 17 74521174-74531475 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 7.8;brain: 16.3;lymphoid tissue: 8.2" "Group enriched" "Detected in some" 4 "dendritic cells: 7.1;Hofbauer cells: 6.2;Kupffer cells: 8.7;Langerhans cells: 6.5;Macrophages: 16.6;monocytes: 13.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 5 "cerebral cortex: 16.3" "Immune cell enhanced" "Detected in many" "eosinophil: 75.9" "Group enriched" "Detected in many" 53 "dendritic cells: 25.0;granulocytes: 75.9;monocytes: 31.7" "Group enriched" "Detected in some" 6 "HL-60: 1.7;NB-4: 2.4;THP-1: 1.9;U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060449 Approved "Plasma membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" "HPA060449: " "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.37e-1)" "unprognostic (4.39e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (7.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.95e-2)" "unprognostic (6.24e-2)" "unprognostic (3.32e-1)" "unprognostic (2.49e-4)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (7.08e-2)" "unprognostic (4.01e-2)" 1.7 0.4 0.1 8.2 0.2 7.8 0.7 0.1 16.3 0.4 0.6 0.7 0.7 0.3 0.0 0.3 0.3 2.1 0.2 0.1 0.2 0.2 0.8 1.7 0.8 0.3 0.3 0.1 0.9 0.1 0.2 0.9 3.1 0.4 0.9 0.0 0.3 0.1 0.3 0.1 1.6 1.8 0.2 3.7 0.6 0.3 1.3 0.6 0.2 0.1 0.9 2.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 1.1 0.0 1.5 31.7 75.9 0.1 13.6 0.3 0.0 0.0 0.0 25.0 0.0 0.0 0.2 33.3 0.8 1.9 15.6 0.0 11.8 0.1 0.2 0.1 16.3 0.1 0.2 0.3 0.3 3.1 0.2 1.3 0.4 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.6 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.4 0.2 6.2 0.0 0.0 0.0 0.0 8.7 6.5 0.2 0.0 16.6 0.0 0.0 13.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 CD320 "8D6, 8D6A" ENSG00000167775 "CD320 molecule" Q9NPF0 19 8302127-8308358 "CD markers, Disease related genes, Predicted membrane proteins" "Growth factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 419.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 418.4;RPMI-8226: 381.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014500, HPA073489" Approved Approved Cytosol NA NA 61000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "HPA014500: AB_1846295, HPA073489: AB_2686609" "unprognostic (9.97e-2)" "unprognostic (2.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.54e-3)" "unprognostic (2.17e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (4.19e-2)" "unprognostic (7.13e-2)" "unprognostic (1.31e-1)" "unprognostic (9.35e-3)" "unprognostic (1.25e-1)" "unprognostic (2.03e-1)" "unprognostic (1.07e-1)" "unprognostic (8.92e-2)" "unprognostic (3.14e-1)" "unprognostic (9.90e-2)" 61.8 44.7 39.3 15.8 36.7 8.1 57.5 41.1 42.8 26.2 46.7 52.9 18.8 34.2 63.4 15.7 28.4 16.5 48.4 34.1 40.0 31.2 24.1 25.9 15.3 42.8 40.9 27.7 45.3 15.5 25.7 11.4 46.7 35.2 15.5 4.7 21.3 12.8 34.2 15.8 43.8 13.0 40.9 57.1 45.5 38.3 44.1 10.5 44.4 16.7 7.1 32.5 21.3 36.0 71.7 71.5 15.5 201.1 49.2 25.6 36.6 36.6 48.5 71.2 54.3 77.0 41.7 63.7 111.4 26.8 53.3 44.7 0.1 57.7 13.8 90.0 216.7 30.8 58.4 111.5 33.1 58.8 74.6 24.4 13.6 41.7 34.4 31.7 70.3 42.3 95.4 214.4 28.4 67.6 63.1 418.4 109.3 62.1 293.6 76.6 21.5 381.7 53.9 1.7 143.4 62.3 75.5 32.1 94.5 11.5 2.6 26.2 40.5 82.0 60.6 122.9 117.0 200.5 136.3 71.0 58.4 214.3 90.2 0.5 2.7 0.1 219.9 3.0 125.9 48.4 140.0 117.7 5.1 49.4 94.1 107.1 3.3 91.0 2.2 113.8 102.4 69.4 39.3 36.7 41.1 42.8 34.1 40.0 42.8 40.9 46.7 40.9 44.1 36.0 419.5 12.8 18.8 6.2 34.4 18.5 29.8 39.3 25.6 53.7 42.6 47.6 34.6 14.3 13.0 18.4 33.3 42.7 53.4 126.2 13.7 46.5 25.2 14.6 28.2 146.8 50.9 22.5 6.1 18.5 54.0 53.3 23.0 22.5 11.4 65.6 143.5 20.0 29.5 21.9 10.2 69.6 26.4 7.5 20.2 57.9 21.8 6.4 39.2 34.7 6.2 21.6 33.0 9.0 5.5 18.6 54.7 17.0 121.2 60.8 3.3 48.0 8.8 46.2 13.1 32.0 26.3 122.1 30.2 10.4 14.1 35.4 43.3 119.3 128.6 21.1 CDC37 P50CDC37 ENSG00000105401 "Cell division cycle 37, HSP90 cochaperone" Q16543 19 10391133-10420121 "Cancer-related genes, Predicted intracellular proteins, Transporters" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003928, CAB004214" Supported Supported Cytosol NA NA 610000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB004214: AB_627232, HPA003928: AB_1846373" "unprognostic (2.40e-1)" "unprognostic (1.06e-1)" "unprognostic (1.27e-1)" "unprognostic (2.33e-2)" "unprognostic (2.46e-3)" "unprognostic (6.21e-2)" "unprognostic (1.37e-1)" "unprognostic (7.90e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-3)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.84e-2)" "prognostic favorable (2.33e-4)" "unprognostic (5.80e-2)" "unprognostic (1.23e-1)" "unprognostic (3.02e-2)" 149.9 93.6 82.2 81.3 84.6 89.5 130.6 75.0 104.2 111.4 72.1 109.9 58.1 110.0 34.2 125.7 98.5 39.8 186.0 86.3 85.8 123.2 102.2 129.9 66.5 85.9 85.8 105.9 100.3 59.3 74.6 62.7 88.1 105.0 48.2 34.6 96.6 52.2 313.2 100.9 96.3 50.2 75.7 137.5 102.8 77.5 82.5 69.3 100.8 222.6 52.4 110.3 103.0 87.8 279.2 181.2 95.5 137.5 128.8 111.8 122.9 322.8 144.6 198.3 168.8 209.1 106.7 165.3 254.7 198.3 117.2 169.9 130.6 208.7 136.4 133.6 387.2 313.9 147.2 300.9 202.5 183.9 137.9 136.9 112.5 231.8 104.0 113.5 258.1 142.2 248.2 193.8 156.1 265.3 184.3 450.2 234.6 175.5 317.8 181.0 128.3 190.3 185.1 178.2 111.5 161.9 151.5 158.1 143.1 72.7 108.4 195.7 290.0 230.8 133.9 319.9 262.2 261.3 276.5 204.4 181.4 294.1 191.2 77.2 110.8 97.1 114.4 107.9 103.1 73.2 91.8 103.5 105.2 62.9 70.0 81.8 60.2 101.1 112.6 89.4 106.8 145.6 82.2 84.6 75.0 104.2 86.3 85.8 85.9 85.8 88.1 75.7 82.5 87.8 420.1 54.5 95.5 51.6 163.7 148.6 119.3 149.0 127.5 78.0 85.0 75.8 71.3 75.8 114.8 64.4 39.6 188.9 166.1 192.3 101.8 199.8 119.0 88.2 120.5 267.5 81.3 89.8 35.0 199.0 430.2 108.3 226.8 126.4 134.3 90.8 172.1 45.3 210.2 89.2 24.6 181.3 105.8 83.9 313.8 253.8 106.2 165.6 138.7 29.0 165.1 75.8 135.9 21.1 32.5 297.6 183.5 103.4 170.5 120.1 117.9 89.7 78.2 84.4 78.9 94.4 138.6 72.4 73.5 138.1 133.7 242.4 164.2 123.0 186.1 156.1 CDK3 ENSG00000250506 "Cyclin dependent kinase 3" Q00526 17 76000906-76005999 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 5.3;Breast myoepithelial cells: 5.0;Glandular and luminal cells: 5.2;Granulosa cells: 6.3;Ionocytes: 10.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA007420 Uncertain Approved Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA007420: AB_1078490" "unprognostic (6.77e-2)" "unprognostic (1.26e-1)" "unprognostic (3.69e-2)" "unprognostic (1.87e-3)" "unprognostic (6.41e-2)" "unprognostic (1.10e-3)" "unprognostic (1.61e-2)" "unprognostic (1.56e-1)" "unprognostic (8.12e-3)" "unprognostic (1.34e-1)" "unprognostic (9.80e-5)" "unprognostic (1.19e-2)" "unprognostic (6.75e-7)" "unprognostic (4.25e-2)" "unprognostic (1.63e-2)" "unprognostic (4.68e-1)" "unprognostic (4.47e-4)" 12.7 11.0 11.4 7.7 11.8 10.6 12.2 11.5 13.8 15.7 12.0 14.9 10.4 11.5 10.7 11.1 13.7 10.3 8.4 11.3 12.2 18.4 34.8 14.2 10.5 12.0 11.7 15.9 15.1 4.8 19.7 8.9 12.2 25.7 10.1 6.9 13.6 8.4 3.6 24.7 14.7 7.6 11.5 21.9 12.2 15.6 11.8 5.8 19.5 3.3 10.5 10.8 13.3 13.6 5.5 7.5 13.5 6.5 7.3 9.0 26.1 4.6 4.6 8.0 7.4 7.0 11.0 6.5 4.5 5.7 4.6 11.6 10.2 4.1 5.6 3.3 14.1 12.7 17.8 7.3 6.7 5.9 14.9 8.7 10.8 7.3 5.1 13.0 6.9 4.1 5.6 4.5 4.3 12.1 6.3 21.8 6.3 3.8 8.4 10.4 5.2 7.2 6.9 15.8 8.4 22.0 3.8 12.0 3.2 14.2 17.4 10.9 5.5 16.4 9.6 5.4 6.7 9.9 7.2 6.2 5.4 5.5 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 11.4 11.8 11.5 13.8 11.3 12.2 12.0 11.7 12.2 11.5 11.8 13.6 4.3 0.0 0.0 0.0 0.5 2.7 0.0 4.0 0.0 0.0 5.3 5.0 0.3 0.0 2.2 0.0 0.0 0.0 3.1 0.0 1.9 2.0 0.0 2.9 3.9 1.4 0.0 0.0 0.0 2.3 0.0 1.3 0.0 5.2 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 4.4 0.0 0.0 1.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.5 0.0 0.0 1.2 2.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.7 0.0 1.0 2.8 0.0 0.0 CDT1 "DUP, RIS2" ENSG00000167513 "Chromatin licensing and DNA replication factor 1" Q9H211 16 88803789-88809258 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Disease variant, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 38.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 51.4;Erythroid cells: 71.3;Extravillous trophoblasts: 92.0;Spermatogonia: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 149.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA017224 Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA017224: AB_1846468" "unprognostic (1.33e-1)" "unprognostic (2.04e-2)" "unprognostic (7.32e-2)" "unprognostic (2.67e-1)" "unprognostic (4.34e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.12e-6)" "unprognostic (3.44e-3)" "unprognostic (2.81e-2)" "unprognostic (4.59e-2)" "unprognostic (1.21e-1)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.69e-6)" "unprognostic (7.72e-3)" "unprognostic (5.79e-2)" "unprognostic (2.80e-2)" "unprognostic (8.54e-2)" 0.7 0.8 0.8 3.8 1.2 38.5 0.7 2.5 1.3 1.7 0.0 3.3 4.1 0.5 0.2 6.7 0.5 0.2 0.5 0.8 2.3 0.7 1.0 1.3 4.8 2.2 1.1 0.4 0.6 1.3 2.1 2.8 1.9 0.7 1.6 0.4 1.1 0.2 0.1 3.6 3.9 0.6 0.7 3.1 2.4 3.5 1.1 8.7 0.6 0.0 3.3 0.5 2.3 1.0 33.6 34.5 16.5 25.3 0.7 3.4 64.2 24.1 6.6 19.4 12.0 79.3 33.8 51.4 24.2 5.5 12.7 46.0 21.6 17.7 6.2 18.2 92.1 51.8 28.8 59.9 0.3 28.8 21.5 1.8 1.4 19.8 4.4 1.6 5.9 60.9 80.8 18.4 7.6 90.6 109.3 149.4 41.8 12.2 31.6 120.3 22.9 42.4 4.3 23.8 36.6 26.2 44.4 13.1 16.9 7.4 39.0 55.9 5.9 24.6 42.6 37.2 35.4 61.4 55.7 73.6 19.3 71.9 31.6 0.2 0.1 0.9 0.3 0.0 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.7 0.4 0.1 0.1 0.7 0.2 0.8 1.2 2.5 1.3 0.8 2.3 2.2 1.1 1.9 0.7 1.1 1.0 0.4 0.0 1.1 0.7 4.9 11.2 4.3 1.4 7.4 0.7 5.4 7.5 2.2 1.5 1.7 1.8 0.0 51.4 2.2 12.7 1.9 1.1 0.4 1.4 1.4 2.2 2.4 71.3 0.2 0.0 92.0 5.2 9.2 2.2 0.0 29.0 0.4 1.0 19.5 0.0 0.8 16.1 4.1 5.6 5.5 1.2 0.3 2.8 1.8 0.0 1.9 1.5 4.1 0.0 0.6 0.6 2.3 0.4 23.1 2.2 2.0 1.6 2.1 1.9 0.0 2.1 3.4 6.6 37.1 10.8 7.1 24.8 5.4 5.7 30.1 4.4 CEBPD "C/EBP-delta, CELF, CRP3, NF-IL6-beta" ENSG00000221869 "CCAAT enhancer binding protein delta" P49716 8 47736913-47738164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1541.7;Basal prostatic cells: 1435.6;Basal squamous epithelial cells: 2487.0;Prostatic glandular cells: 1668.5;Skeletal myocytes: 1386.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 54.9" "Group enriched" "Detected in many" 5 "granulocytes: 54.9;monocytes: 19.9" "Cell line enhanced" "Detected in many" "BEWO: 51.9;HHSteC: 66.8;HSkMC: 66.7;NB-4: 148.7;SiHa: 58.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA067581 Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "HPA067581: AB_2685865" "prognostic favorable (2.28e-5)" "unprognostic (1.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.74e-2)" "unprognostic (2.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.52e-2)" "unprognostic (2.12e-1)" "unprognostic (6.81e-2)" "unprognostic (5.16e-2)" "unprognostic (5.47e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (4.62e-2)" "unprognostic (3.40e-2)" 251.6 72.0 33.4 62.1 35.2 34.3 168.0 37.2 42.0 99.7 43.9 143.5 26.7 82.8 2.7 85.4 192.0 14.7 136.9 35.8 63.6 106.9 207.8 157.5 8.7 81.5 49.3 265.3 81.9 7.6 117.4 50.0 49.5 151.1 12.1 16.9 89.3 19.4 133.0 106.9 79.6 21.6 46.5 109.7 116.3 14.3 47.4 18.5 103.5 21.6 6.6 168.1 139.9 44.6 9.5 7.4 0.3 0.1 41.5 43.2 51.9 24.1 18.7 6.8 14.4 14.8 14.8 0.1 17.3 6.6 5.8 9.9 1.7 12.9 2.1 0.1 3.9 0.5 6.0 6.3 66.8 4.1 0.0 66.7 33.7 1.6 16.0 4.3 1.4 0.4 4.1 7.3 2.5 2.9 0.1 148.7 2.8 6.2 2.5 0.1 5.1 0.5 20.6 7.8 2.8 1.0 58.7 7.7 6.3 2.6 6.4 33.5 6.2 1.5 3.9 15.6 1.5 0.1 0.1 0.1 7.9 0.1 0.3 2.3 19.9 10.6 2.1 8.4 6.2 0.1 0.3 1.2 7.4 0.6 0.0 0.0 54.9 3.7 3.2 0.2 0.3 2.8 33.4 35.2 37.2 42.0 35.8 63.6 81.5 49.3 49.5 46.5 47.4 44.6 1541.7 102.5 196.3 31.3 14.9 663.5 1435.6 98.7 2487.0 6.0 551.3 617.1 79.2 185.8 76.5 224.3 6.2 189.8 152.8 59.2 217.2 50.7 3.5 287.0 418.9 547.9 23.4 30.3 12.5 77.2 457.9 1377.3 387.3 621.0 5.1 96.4 269.5 157.7 220.3 1.7 2.5 44.3 42.7 520.1 502.0 21.5 435.5 912.6 268.6 29.0 163.5 321.9 150.4 6.0 0.5 53.2 58.4 144.8 34.9 1668.5 127.1 353.4 54.9 17.3 466.8 1386.3 1290.5 3.7 13.9 940.2 817.5 351.9 122.7 85.9 73.2 814.5 CEBPE CRP1 ENSG00000092067 "CCAAT enhancer binding protein epsilon" Q15744 14 23117306-23119255 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 51.8" "Cell type enhanced" "Detected in some" "Hofbauer cells: 6.6;Kupffer cells: 1.4;Macrophages: 2.3;monocytes: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 218 "eosinophil: 750.4" "Lineage enriched" "Detected in many" 250 "granulocytes: 750.4" "Group enriched" "Detected in some" 4 "HL-60: 233.8;NB-4: 122.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002928, CAB005113" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "Plasma membrane, Cytosol" "CAB005113: AB_631240, HPA002928: AB_1078494" "unprognostic (1.33e-2)" "unprognostic (4.76e-2)" "unprognostic (4.19e-2)" "unprognostic (2.04e-1)" "unprognostic (5.01e-2)" "unprognostic (1.66e-3)" "unprognostic (2.84e-1)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (5.69e-2)" "unprognostic (9.03e-2)" "unprognostic (2.22e-1)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.57e-2)" "unprognostic (8.19e-2)" 0.1 0.0 0.1 1.6 0.1 51.8 0.0 0.0 0.2 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.1 3.2 0.3 0.1 3.4 0.8 0.0 0.3 0.5 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 233.8 39.6 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.9 122.5 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 26.3 0.0 0.5 3.0 750.4 0.0 0.6 0.1 0.5 1.0 0.4 1.5 0.5 1.8 1.5 3.4 0.0 0.3 1.5 0.0 1.8 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 6.6 0.0 0.0 0.0 0.0 1.4 0.6 0.1 0.0 2.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.0 0.0 CEP57 "KIAA0092, Translokin, TSP57" ENSG00000166037 "Centrosomal protein 57" Q86XR8 11 95789965-95832693 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 462.9;Late spermatids: 372.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA018315 Approved Approved Microtubules,Cytosol "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" Microtubules Cytosol "HPA018315: AB_1846537" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (1.45e-2)" "unprognostic (2.66e-1)" "prognostic favorable (7.24e-4)" "unprognostic (1.69e-1)" "unprognostic (2.25e-2)" "unprognostic (8.10e-2)" "unprognostic (9.04e-3)" "unprognostic (7.93e-2)" "unprognostic (2.38e-3)" "unprognostic (7.81e-2)" "unprognostic (1.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.35e-1)" "unprognostic (6.69e-3)" "unprognostic (3.25e-1)" 16.6 14.0 10.6 19.2 11.4 29.0 21.6 15.0 13.3 19.0 12.6 17.7 32.4 21.8 19.8 15.0 17.7 27.3 15.6 10.4 11.2 15.7 44.6 16.9 30.1 12.2 11.2 31.2 22.8 12.2 14.9 16.1 10.8 16.2 18.6 25.9 14.1 17.3 12.8 17.8 21.9 15.5 10.9 20.5 17.8 27.9 11.7 34.2 22.7 14.3 30.6 14.0 15.1 12.4 26.7 13.1 42.0 32.7 19.4 38.6 34.4 29.8 48.6 41.4 46.1 47.5 55.1 47.1 39.6 22.4 24.2 43.8 34.7 29.5 43.8 38.1 21.8 66.4 36.9 38.4 33.9 67.0 37.2 25.9 42.5 43.2 80.4 39.3 33.4 49.6 43.8 25.3 33.8 13.1 74.7 89.1 23.3 30.2 29.2 43.8 53.2 40.7 34.8 27.8 21.5 28.9 36.1 34.4 38.3 29.7 35.1 44.0 17.2 35.2 28.3 52.0 28.2 16.9 38.1 51.7 14.6 74.4 31.0 19.0 11.8 24.3 19.5 14.4 25.9 23.6 25.7 22.7 15.6 21.7 24.8 23.5 11.6 26.0 13.2 21.1 33.7 17.5 10.6 11.4 15.0 13.3 10.4 11.2 12.2 11.2 10.8 10.9 11.7 12.4 43.7 54.5 51.1 35.9 58.5 36.3 30.6 35.7 51.2 72.3 30.6 42.7 41.3 85.8 41.7 29.5 35.5 44.1 42.8 16.2 54.8 34.2 462.9 52.2 33.0 38.2 28.8 88.1 68.0 25.7 50.8 41.1 18.3 33.0 27.3 58.4 30.7 71.5 33.1 57.2 78.3 34.0 16.2 35.0 37.3 372.7 33.8 33.2 17.8 27.2 37.6 29.6 44.3 57.8 60.9 26.2 23.9 35.7 57.8 28.8 45.2 40.2 52.6 59.0 65.7 34.4 37.8 75.8 46.1 42.0 32.0 38.4 59.1 53.0 47.2 27.6 CEP83 "CCDC41, NPHP18, NY-REN-58" ENSG00000173588 "Centrosomal protein 83" Q9Y592 12 94306449-94459988 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 109.1;Oligodendrocyte precursor cells: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038161 Approved NA NA "Cluster 35: T-regs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA038161: AB_10674547" "unprognostic (4.98e-2)" "unprognostic (1.64e-2)" "unprognostic (7.22e-2)" "unprognostic (1.75e-2)" "unprognostic (4.76e-3)" "unprognostic (3.59e-2)" "unprognostic (5.44e-3)" "unprognostic (1.70e-1)" "unprognostic (2.24e-2)" "unprognostic (1.92e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (4.98e-4)" "prognostic unfavorable (5.00e-10)" "unprognostic (1.29e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "unprognostic (1.95e-2)" 5.5 7.9 4.7 5.3 4.7 6.9 6.8 5.3 5.3 6.0 7.3 5.4 3.9 6.2 6.0 5.1 11.5 3.9 15.2 5.1 4.4 6.1 5.1 5.4 6.0 5.5 6.5 7.8 9.7 5.5 5.1 4.5 5.5 5.2 7.1 5.3 4.1 2.8 5.1 4.9 4.3 4.5 5.6 5.3 5.1 18.6 4.7 5.3 7.1 3.3 5.9 4.6 5.4 6.1 8.2 9.1 15.1 14.2 6.5 8.7 12.9 14.2 4.5 10.1 10.3 11.3 6.7 21.3 3.0 4.3 6.4 11.4 18.3 10.9 15.5 12.5 13.3 12.7 9.2 11.5 6.5 20.9 8.3 5.7 8.9 8.4 25.6 5.9 9.6 17.1 16.6 8.5 10.6 8.3 14.3 34.5 17.2 14.0 16.6 19.4 14.2 21.6 9.1 10.2 15.6 6.5 11.9 13.9 9.9 13.3 9.5 13.0 5.7 11.8 7.3 5.9 11.3 11.1 13.3 19.3 4.9 21.8 11.4 0.6 2.5 1.5 3.8 2.5 3.6 4.7 3.9 3.1 5.7 4.8 4.0 3.6 1.0 4.6 1.2 6.1 5.2 1.5 4.7 4.7 5.3 5.3 5.1 4.4 5.5 6.5 5.5 5.6 4.7 6.1 10.3 16.0 10.7 37.5 17.9 0.0 15.3 0.0 23.9 12.9 12.7 11.7 39.0 1.5 11.8 3.7 14.6 6.8 9.4 8.9 1.9 4.7 55.4 109.1 26.3 8.0 14.9 14.9 51.7 3.5 9.6 13.3 17.3 17.0 26.6 17.8 2.9 5.2 5.7 5.0 45.6 11.9 0.0 4.6 0.0 16.6 10.8 11.6 0.0 46.9 15.1 4.9 11.3 74.4 55.0 3.5 5.2 6.4 17.4 15.0 1.9 5.5 48.1 12.0 0.0 24.9 7.8 45.4 24.0 18.4 0.0 3.3 10.5 15.2 12.5 13.2 CERS4 "FLJ12089, LASS4, Trh1" ENSG00000090661 "Ceramide synthase 4" Q9HA82 19 8206736-8262421 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 71.3;Muller glia cells: 150.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 55.1;NB-4: 99.8;U-937: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033734, HPA054729" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 5: Muller glia cells - Visual perception" "Nucleoplasm, Vesicles" "CAB033734: AB_2132977, HPA054729: " "unprognostic (5.96e-2)" "prognostic favorable (2.71e-4)" "unprognostic (2.46e-2)" "unprognostic (2.82e-2)" "unprognostic (1.30e-1)" "prognostic favorable (7.83e-4)" "unprognostic (1.74e-1)" "prognostic favorable (3.45e-5)" "unprognostic (1.48e-2)" "unprognostic (3.32e-1)" "prognostic favorable (8.05e-4)" "unprognostic (1.77e-1)" "prognostic favorable (9.63e-5)" "unprognostic (6.08e-3)" "unprognostic (2.69e-2)" "unprognostic (2.91e-2)" "unprognostic (8.08e-3)" 13.6 13.0 31.8 10.0 38.9 3.4 31.1 26.6 37.1 35.9 18.7 17.7 6.3 21.5 61.5 64.3 21.3 11.2 14.8 35.3 25.2 27.8 57.7 19.4 19.9 36.9 30.5 22.0 89.1 29.0 22.2 1.9 30.8 32.9 3.9 36.9 55.0 17.6 3.1 47.7 15.2 12.0 26.8 17.7 26.8 11.5 30.7 13.1 51.9 5.3 20.4 18.4 32.7 44.0 0.4 2.1 2.1 25.0 0.8 0.2 1.7 3.1 8.4 3.7 1.7 19.5 1.7 40.0 27.4 0.0 9.6 13.6 16.4 0.4 1.7 35.5 12.4 7.6 0.1 55.1 31.6 0.0 21.3 12.3 20.7 8.8 18.9 10.5 0.3 17.7 5.9 1.2 0.0 0.8 2.6 99.8 25.4 0.2 8.7 49.1 0.8 3.0 6.3 0.0 9.3 12.2 4.3 0.7 14.5 16.7 18.8 8.8 0.2 2.9 7.8 18.6 0.1 24.5 21.1 32.0 0.1 61.9 2.8 12.3 7.1 27.4 7.5 3.9 5.7 19.8 4.3 4.6 4.1 17.7 3.9 3.8 22.4 22.4 2.4 3.9 5.5 5.8 31.8 38.9 26.6 37.1 35.3 25.2 36.9 30.5 30.8 26.8 30.7 44.0 3.2 6.4 10.7 27.1 31.2 18.0 13.2 12.0 15.4 24.5 47.0 28.8 4.1 22.8 22.2 1.8 18.8 3.4 17.2 0.2 7.9 20.0 1.7 7.9 11.2 8.6 23.9 4.0 38.3 30.5 0.9 15.7 3.1 7.6 12.7 14.4 8.2 71.3 16.4 11.8 24.4 1.3 8.2 7.1 7.2 7.3 14.3 6.7 26.6 16.9 19.6 150.3 27.8 47.7 48.1 9.4 2.5 16.1 12.4 40.6 0.4 44.6 27.8 29.5 6.6 6.9 13.8 1.0 1.6 20.6 25.9 2.9 15.7 2.7 2.5 11.9 CHAT ENSG00000070748 "Choline O-acetyltransferase" P28329 10 49609095-49667942 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Acyltransferase, Transferase" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 13.0;placenta: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "NB-4: 20.9" "Region enhanced" "Detected in many" "basal ganglia: 20.6" "Group enriched" "Detected in some" 7 "basal ganglia: 6.5;pons: 7.0;spinal cord: 12.0" "CAB002313, HPA048547, CAB079053" Supported Supported NA NA "Cluster 65: Brain - Ion transport" "Cluster 24: NB-4 - Immune response" "Cluster 33: Fibroblasts - ECM organization" "CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437" "unprognostic (2.34e-2)" "unprognostic (6.10e-2)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (2.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.6 0.2 2.8 0.0 0.0 0.3 13.0 0.0 0.3 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 7.9 5.1 0.0 0.3 0.0 0.0 5.5 9.4 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.8 20.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 2.8 0.3 13.0 0.1 3.1 7.9 5.1 9.4 1.3 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHCHD2 "C7orf17, MIX17B, MNRR1" ENSG00000106153 "Coiled-coil-helix-coiled-coil-helix domain containing 2" Q9Y6H1 7 56101573-56106476 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transcription Activator "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 3195.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027407, HPA052510" Approved Supported Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA027407: AB_10959659, HPA052510: AB_2681856" "unprognostic (8.68e-3)" "unprognostic (2.79e-1)" "unprognostic (8.48e-2)" "unprognostic (2.32e-1)" "unprognostic (3.90e-2)" "prognostic unfavorable (1.90e-5)" "prognostic unfavorable (9.41e-5)" "unprognostic (4.38e-2)" "unprognostic (3.61e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (2.60e-2)" "unprognostic (4.01e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (2.40e-2)" 250.6 665.5 321.4 167.4 331.8 426.3 253.9 361.8 358.5 220.7 351.0 257.6 252.0 219.0 252.4 269.6 210.6 132.1 412.4 325.3 352.7 349.4 316.7 213.8 205.0 340.1 341.5 246.3 315.9 322.9 272.3 151.8 343.2 237.2 191.7 226.2 281.2 196.7 791.4 233.3 243.9 150.5 354.6 223.3 287.6 120.7 352.2 267.7 208.2 591.3 200.2 217.8 214.2 367.9 3195.8 553.5 351.8 732.5 275.9 379.3 261.7 456.7 436.2 584.6 561.3 513.0 517.4 932.1 589.1 285.1 741.3 527.6 456.5 507.4 469.6 609.1 831.5 549.2 422.0 738.9 510.5 745.9 844.8 339.1 571.9 438.0 532.4 312.3 444.1 800.3 1182.9 546.7 486.4 449.9 1007.2 2306.5 760.6 867.3 872.6 668.3 343.3 1539.3 532.5 417.0 671.5 834.3 360.6 874.7 597.1 239.4 1002.5 1046.8 354.2 354.2 823.5 1473.9 683.6 497.1 785.4 1698.9 555.3 802.0 448.0 354.1 509.1 400.6 362.1 458.7 377.4 461.2 387.4 387.2 575.8 435.0 344.9 354.9 268.0 400.9 467.1 785.2 550.9 1066.7 321.4 331.8 361.8 358.5 325.3 352.7 340.1 341.5 343.2 354.6 352.2 367.9 465.1 256.4 284.0 44.4 521.9 717.5 956.6 1072.0 387.0 348.7 758.3 929.8 160.8 513.3 612.1 413.8 62.6 955.1 577.6 807.9 1860.7 1034.0 167.2 593.3 396.0 446.5 541.2 666.1 26.7 1325.1 1259.9 514.7 393.0 622.8 394.3 458.8 377.0 727.2 969.6 492.9 35.6 973.0 752.7 483.5 701.2 213.4 614.2 496.2 763.1 28.1 806.5 769.6 593.2 19.6 43.2 1190.3 974.5 505.9 803.3 1321.7 1138.5 1558.4 559.1 353.7 427.3 620.2 583.8 520.4 574.2 680.8 719.3 1228.8 492.5 633.1 929.0 1464.2 CHMP5 "C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60" ENSG00000086065 "Charged multivesicular body protein 5" Q9NZZ3 9 33264879-33282070 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033874, HPA042883, HPA056437" Enhanced Supported Microtubules,Midbody,Cytosol Yes No 22000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Microtubules, Cytosol" Midbody "CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (9.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.32e-1)" "unprognostic (4.56e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-2)" "unprognostic (4.71e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.66e-1)" "prognostic favorable (2.87e-7)" "unprognostic (2.22e-1)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (7.31e-2)" 54.6 54.6 48.3 36.7 49.2 30.5 49.6 50.4 63.8 56.4 50.0 55.7 55.2 41.3 48.1 64.6 43.8 42.1 50.8 49.0 50.3 77.8 56.3 53.5 41.6 50.4 49.7 42.9 32.7 63.9 49.7 63.8 50.7 54.8 55.9 53.8 43.7 39.4 48.2 47.0 59.2 33.9 52.7 43.5 54.6 36.2 49.4 44.9 55.8 44.3 38.1 49.7 56.5 56.9 92.2 66.5 67.0 43.5 99.0 89.0 61.9 90.1 99.7 138.3 152.6 50.9 56.9 49.0 96.3 84.3 95.9 39.2 70.5 72.8 111.1 102.5 49.3 41.5 129.7 55.8 85.9 53.4 78.8 95.6 131.3 93.6 86.4 114.5 73.3 68.3 44.9 63.6 110.5 41.3 56.1 164.1 61.8 70.1 80.6 34.0 59.2 32.9 115.2 48.7 32.7 83.6 91.0 53.4 87.2 77.8 54.2 82.7 74.4 69.5 73.0 60.2 80.8 42.3 87.6 57.0 100.5 36.0 45.6 98.6 50.3 106.3 25.3 56.5 27.6 31.0 33.7 33.8 46.5 26.4 30.6 29.4 129.4 47.4 67.3 71.2 43.4 51.3 48.3 49.2 50.4 63.8 49.0 50.3 50.4 49.7 50.7 52.7 49.4 56.9 182.7 89.8 59.0 14.0 52.9 188.1 156.2 372.5 71.7 63.7 85.2 75.1 64.7 94.4 228.6 110.3 27.1 172.0 77.4 241.0 285.7 141.7 245.2 228.0 90.6 133.8 80.2 90.1 19.6 86.1 186.1 104.4 56.1 167.0 58.4 66.5 97.5 70.5 154.9 26.9 19.0 137.9 246.2 100.9 103.2 35.9 93.2 95.3 117.4 15.0 166.3 156.2 38.1 14.6 26.8 151.9 247.9 104.6 45.2 182.4 226.3 355.2 328.9 68.2 85.5 97.0 130.0 99.5 68.7 70.1 236.3 259.0 68.5 71.4 78.5 246.0 CHP2 ENSG00000166869 "Calcineurin like EF-hand protein 2" O43745 16 23755026-23758935 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 16 "intestine: 305.0;skin 1: 149.7" "Group enriched" "Detected in some" 5 "Distal enterocytes: 345.0;Paneth cells: 274.0;Proximal enterocytes: 654.2;Undifferentiated cells: 205.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.3;hTERT-RPE1: 10.2;NB-4: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055198, CAB072806" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Nucleoli, Cytosol" "CAB072806: , HPA055198: " "unprognostic (4.82e-1)" "unprognostic (3.40e-1)" "unprognostic (4.93e-2)" "unprognostic (1.01e-2)" "unprognostic (8.85e-2)" "unprognostic (3.54e-1)" "unprognostic (4.54e-2)" "unprognostic (1.47e-1)" "unprognostic (1.38e-1)" "unprognostic (5.31e-2)" "unprognostic (4.70e-2)" "unprognostic (1.44e-5)" "unprognostic (2.21e-1)" "unprognostic (5.97e-2)" "unprognostic (7.84e-2)" "unprognostic (9.01e-2)" 0.4 0.2 1.1 3.8 1.1 2.2 4.3 3.6 1.3 14.0 0.0 146.7 305.0 0.9 1.1 0.6 0.9 0.4 0.4 0.7 1.6 4.1 0.7 0.6 0.8 0.5 0.1 0.4 0.5 0.1 0.0 1.4 0.9 3.8 147.4 1.3 0.8 4.5 1.2 149.7 250.5 6.5 0.1 0.3 1.1 7.3 0.9 0.5 0.6 0.2 0.4 9.0 4.2 2.9 1.0 2.2 0.5 0.6 1.2 1.3 1.2 2.9 1.1 0.3 1.0 0.5 2.3 0.4 0.9 2.5 1.2 1.4 0.4 2.9 0.6 0.7 0.2 0.5 4.1 1.6 1.7 0.3 0.7 0.9 0.8 2.5 7.3 10.2 1.1 0.3 1.2 1.0 1.2 0.1 0.1 8.7 0.3 0.5 2.1 0.2 0.1 1.4 1.1 0.7 0.6 0.7 0.8 0.2 0.0 0.6 0.2 0.2 1.3 0.5 0.6 0.7 0.1 0.4 0.1 0.2 0.0 0.5 0.5 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.0 1.1 1.1 3.6 1.3 0.7 1.6 0.5 0.1 0.9 0.1 0.9 2.9 0.0 0.0 0.0 0.0 0.0 10.3 8.7 6.1 0.0 0.0 0.0 0.1 0.1 0.0 24.4 1.8 0.0 0.9 0.0 345.0 0.0 0.0 0.6 1.3 0.5 0.2 9.1 0.0 0.0 0.0 4.1 0.2 0.0 3.6 4.5 0.7 0.0 0.0 0.1 0.0 0.0 70.0 12.2 0.0 1.6 0.5 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 274.0 0.0 0.0 2.5 654.2 12.9 4.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 67.5 0.7 0.2 0.2 205.4 29.9 CHST11 "C4ST, C4St-1, C4ST1, HSA269537" ENSG00000171310 "Carbohydrate sulfotransferase 11" Q9NPF2 12 104455295-104762014 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.0;choroid plexus: 59.1" "Group enriched" "Detected in many" 4 "Microglial cells: 281.1;Oligodendrocyte precursor cells: 1012.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 12.7;eosinophil: 11.2;neutrophil: 15.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 15.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052828 Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA 55000 "Cluster 5: Granulocytes - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" "HPA052828: AB_2681966" "unprognostic (6.35e-2)" "unprognostic (2.68e-3)" "unprognostic (2.28e-2)" "unprognostic (7.53e-2)" "unprognostic (3.45e-2)" "unprognostic (2.64e-2)" "unprognostic (1.64e-3)" "unprognostic (9.21e-3)" "unprognostic (3.12e-1)" "unprognostic (9.02e-2)" "unprognostic (1.22e-2)" "unprognostic (5.44e-2)" "prognostic unfavorable (7.59e-11)" "unprognostic (1.64e-2)" "unprognostic (5.60e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (8.42e-4)" 5.0 10.2 14.5 20.1 13.9 39.0 3.5 11.1 14.1 5.6 59.1 4.2 3.0 11.9 13.3 3.4 3.7 9.4 4.5 15.0 16.0 3.6 3.0 12.2 15.2 17.9 16.4 6.2 4.6 1.3 4.5 15.5 17.1 3.9 4.0 2.2 2.2 8.0 1.1 1.7 6.2 10.9 13.1 12.8 6.3 2.3 17.3 19.5 3.3 1.0 11.7 8.3 3.8 17.5 38.8 18.2 8.2 5.3 20.5 10.0 27.8 3.1 1.2 1.8 1.5 0.0 51.2 0.2 5.6 5.4 42.3 9.9 4.9 20.8 2.2 0.4 7.1 53.2 4.8 0.2 3.1 62.4 60.6 3.7 2.9 32.9 5.4 30.7 13.2 74.4 82.8 13.2 3.5 9.7 47.8 73.1 6.6 0.4 7.0 54.0 27.3 12.9 17.0 0.4 13.6 21.9 2.1 26.3 48.3 7.2 7.7 62.7 29.2 5.7 6.2 29.4 32.3 67.2 75.9 10.6 26.3 43.5 57.7 12.7 1.4 11.2 3.0 1.4 1.7 1.0 1.5 2.2 0.8 2.8 0.7 1.9 15.6 1.6 1.3 2.9 3.2 0.8 14.5 13.9 11.1 14.1 15.0 16.0 17.9 16.4 17.1 13.1 17.3 17.5 8.4 16.0 13.1 142.4 33.8 2.8 18.2 2.6 4.0 3.1 0.5 1.1 5.7 1.5 6.4 5.5 0.0 41.6 45.6 0.1 0.0 4.9 0.9 1.3 24.7 12.9 0.0 36.2 43.8 61.4 12.0 9.5 2.6 0.9 41.3 1.4 18.2 0.5 42.6 10.1 114.4 0.0 0.0 26.8 42.9 2.0 7.5 56.5 3.6 281.1 65.6 2.3 30.9 1012.8 3.5 28.6 0.0 17.0 64.0 3.9 0.0 6.0 8.1 0.6 6.6 1.8 12.8 0.6 2.5 0.9 2.8 26.5 49.0 15.5 0.3 3.7 CHST12 "C4S-2, C4ST2" ENSG00000136213 "Carbohydrate sulfotransferase 12" Q9NRB3 7 2403588-2448484 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "dendritic cells: 158.7;Hepatic stellate cells: 152.8;NK-cells: 368.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 60.1;NB-4: 57.4;U-266/70: 88.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041680 Approved Approved "Golgi apparatus" NA NA 960000 "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA041680: AB_10959789" "unprognostic (4.12e-2)" "unprognostic (3.56e-1)" "unprognostic (3.04e-3)" "unprognostic (1.59e-1)" "unprognostic (2.05e-3)" "unprognostic (7.15e-2)" "unprognostic (2.01e-3)" "unprognostic (1.34e-1)" "unprognostic (3.20e-2)" "unprognostic (4.88e-2)" "prognostic favorable (1.32e-5)" "unprognostic (9.61e-2)" "unprognostic (1.66e-3)" "unprognostic (4.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" 16.1 13.3 4.5 5.1 3.5 6.1 15.0 7.3 5.0 15.4 0.2 13.7 5.4 17.8 0.6 7.9 15.8 1.2 15.5 9.0 2.6 11.3 7.1 14.5 2.9 9.4 4.7 11.6 11.7 1.4 17.6 2.8 4.6 13.6 0.6 1.2 10.3 2.8 8.3 15.6 10.6 1.4 3.8 24.5 11.1 9.1 5.9 1.4 14.1 0.9 1.0 13.1 13.1 4.3 9.5 9.1 2.7 10.0 3.8 2.3 29.5 17.2 4.2 4.2 5.7 9.0 3.2 8.5 31.6 2.7 10.3 7.1 1.6 2.2 0.8 11.2 17.7 5.9 7.0 9.9 2.6 19.4 60.1 4.8 0.9 3.8 0.5 3.3 4.2 11.5 15.1 25.0 1.2 6.8 19.8 57.4 19.1 1.3 14.4 7.1 7.6 42.1 1.2 3.8 6.8 28.7 8.4 4.5 4.0 2.0 6.6 22.3 13.0 9.6 26.5 20.0 15.2 88.9 37.1 3.9 7.8 8.8 17.9 59.1 10.4 53.2 87.6 9.1 54.4 14.7 30.0 71.4 20.4 18.3 12.6 37.8 3.1 121.6 3.9 64.9 33.0 22.9 4.5 3.5 7.3 5.0 9.0 2.6 9.4 4.7 4.6 3.8 5.9 4.3 36.8 16.0 50.5 9.1 32.8 18.1 35.5 24.3 18.8 45.6 18.0 13.0 8.3 15.7 30.5 18.4 66.7 104.5 158.7 6.2 1.9 22.4 6.7 4.7 21.1 59.4 12.7 37.0 11.0 15.3 15.0 37.0 6.1 6.4 38.0 13.4 152.8 7.2 24.8 47.1 12.3 9.1 24.4 26.4 22.9 5.8 95.7 21.2 21.4 10.3 21.3 15.1 368.7 14.1 9.5 13.3 6.7 67.7 107.8 18.4 16.2 9.5 15.2 50.5 19.7 25.6 17.9 37.8 30.6 9.2 15.3 133.5 93.2 18.4 12.2 13.1 CLCA1 "CaCC, CLCRG1" ENSG00000016490 "Chloride channel accessory 1" A8K7I4 1 86468368-86500259 "Predicted secreted proteins, Transporters" "Calcium transport, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "intestine: 1399.9" "Cell type enriched" "Detected in some" 16 "Intestinal goblet cells: 3524.6" "Group enriched" "Detected in some" 9 "colorectal cancer: 86.8;pancreatic cancer: 27.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;NB-4: 2.5;RPMI-8226: 2.9;SH-SY5Y: 1.8;U-2197: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052787, HPA059301" Enhanced "Secreted to digestive system" NA NA 77000 "Cluster 9: Intestine - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA052787: AB_2681947, HPA059301: AB_2683971" "prognostic favorable (2.98e-4)" "unprognostic (3.42e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-1)" 1.1 0.0 0.0 109.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 739.9 909.7 1.2 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1061.8 0.0 0.0 0.5 0.0 0.0 1399.9 15.4 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 3524.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 54.8 0.0 0.0 0.0 213.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 68.3 0.1 CLDN15 ENSG00000106404 "Claudin 15" P56746 7 101232092-101238820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "adipose tissue: 65.4;intestine: 259.8" "Cell type enriched" "Detected in many" 4 "Proximal enterocytes: 594.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" "unprognostic (8.85e-2)" "unprognostic (1.48e-1)" "unprognostic (4.93e-2)" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (6.81e-2)" "unprognostic (1.58e-2)" "unprognostic (1.03e-1)" "unprognostic (6.56e-2)" "unprognostic (1.79e-1)" "prognostic favorable (2.56e-4)" "unprognostic (2.02e-2)" "prognostic unfavorable (5.31e-5)" "unprognostic (9.98e-2)" "unprognostic (2.89e-2)" "unprognostic (9.64e-2)" "prognostic favorable (3.30e-4)" 65.4 3.9 8.8 7.3 10.4 13.6 20.2 9.4 11.0 14.9 6.3 22.3 259.8 11.1 2.2 7.2 16.3 7.3 8.6 8.6 9.1 23.9 22.2 10.7 9.8 11.4 9.8 18.5 7.8 2.0 6.8 5.9 11.3 11.4 7.9 8.8 6.5 2.6 3.6 11.2 183.9 4.4 8.4 22.6 10.0 8.3 10.1 8.7 9.3 1.3 7.0 9.8 11.6 18.2 3.3 10.1 5.3 8.4 8.1 6.5 3.6 3.2 4.0 3.9 5.6 7.3 3.8 11.0 5.6 2.1 6.4 6.1 8.8 1.8 3.8 13.8 18.5 5.1 6.9 9.0 7.1 5.7 10.6 6.2 8.8 5.1 6.7 8.3 3.3 10.9 24.3 17.4 3.0 11.7 9.1 32.6 4.1 4.9 6.9 12.3 4.5 9.3 2.3 4.1 5.1 18.1 2.9 5.5 16.4 7.2 5.1 11.4 4.7 12.8 11.0 19.5 3.9 18.3 24.9 11.7 3.6 14.9 7.5 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.3 0.1 0.2 8.8 10.4 9.4 11.0 8.6 9.1 11.4 9.8 11.3 8.4 10.1 18.2 27.3 3.2 1.1 4.9 5.2 6.8 5.4 12.9 5.2 20.4 7.5 6.1 1.2 18.6 8.2 22.0 31.3 5.1 6.3 18.9 13.7 5.6 17.1 8.6 3.8 22.4 12.1 16.8 1.5 6.5 3.8 17.2 9.2 7.1 0.0 5.2 7.5 10.6 2.7 15.2 1.4 55.7 16.2 4.6 7.5 4.1 15.2 4.0 7.2 4.7 5.1 4.4 10.3 0.5 10.5 6.6 93.1 2.2 1.2 6.1 594.4 3.5 10.1 20.2 6.6 6.4 5.1 5.8 7.2 3.4 5.3 5.1 5.5 3.2 120.6 3.9 CLEC11A "CLECSF3, LSLCL, P47, SCGF" ENSG00000105472 "C-type lectin domain containing 11A" Q9Y240 19 50723364-50725718 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 132.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 119.3;Fibroblasts: 107.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 24.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "HEL: 363.0;HMC-1: 637.3;NB-4: 901.1;THP-1: 694.7;U-937: 358.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042690 Approved Approved Centrosome "Secreted in other tissues" NA NA 1300000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Centrosome "HPA042690: AB_10795511" "unprognostic (9.33e-2)" "unprognostic (6.66e-2)" "unprognostic (2.40e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.33e-1)" "unprognostic (8.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.29e-2)" "unprognostic (5.26e-2)" "unprognostic (4.99e-2)" "unprognostic (2.79e-2)" "unprognostic (8.30e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (6.09e-2)" "unprognostic (8.66e-3)" "unprognostic (4.00e-2)" "unprognostic (1.57e-2)" 17.5 17.5 5.0 7.0 5.6 132.6 14.1 7.9 9.1 44.4 2.9 12.0 4.8 31.9 1.6 8.4 37.5 6.2 16.3 4.4 7.2 21.1 12.1 15.0 2.7 10.2 7.9 31.5 7.5 2.4 22.3 5.5 8.1 22.5 1.9 0.7 6.9 4.8 4.4 16.8 9.7 8.1 7.2 14.0 8.0 9.1 6.2 2.6 12.8 1.0 0.8 19.2 28.2 6.0 2.6 3.5 0.0 2.9 33.7 45.3 79.2 139.3 37.9 15.6 15.7 0.1 0.0 0.4 1.7 70.2 0.8 1.6 0.4 0.2 10.7 0.6 22.9 363.0 0.1 0.0 21.3 0.2 637.3 33.7 0.2 1.9 2.3 0.1 17.9 16.1 4.1 2.2 29.0 2.6 3.1 901.1 1.6 0.3 4.6 30.7 0.2 0.2 0.8 0.4 0.0 3.8 4.2 0.0 58.1 0.0 0.9 694.7 100.3 1.1 41.6 0.7 0.7 2.1 2.2 0.5 47.3 358.7 44.2 1.4 24.3 0.4 0.9 11.5 0.1 0.6 0.3 0.2 17.7 0.4 2.0 4.5 1.6 5.7 5.6 4.8 0.2 8.2 5.0 5.6 7.9 9.1 4.4 7.2 10.2 7.9 8.1 7.2 6.2 6.0 12.4 3.2 5.4 10.4 3.9 32.0 32.2 2.9 27.3 20.5 30.8 31.9 3.4 8.6 4.0 29.5 10.4 8.6 5.0 1.7 119.3 11.0 6.5 17.0 70.7 16.9 26.5 36.4 9.0 3.1 72.4 107.2 4.1 14.1 5.7 18.9 51.4 6.3 49.4 21.9 8.3 4.5 10.2 21.5 73.3 19.9 70.8 29.6 78.2 9.4 11.2 70.4 14.4 8.0 12.9 3.1 1.7 67.4 0.9 21.4 0.5 13.7 5.0 20.7 65.7 20.2 59.2 17.2 21.7 26.3 45.9 18.3 5.8 56.7 3.5 17.8 COMMD1 "C2orf5, MGC27155, MURR1" ENSG00000173163 "Copper metabolism domain containing 1" Q8N668 2 61888724-62147247 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034633, HPA049223" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA034633: AB_10601800, HPA049223: AB_2680680" "unprognostic (6.08e-2)" "unprognostic (2.34e-2)" "unprognostic (2.83e-1)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.22e-2)" "unprognostic (5.58e-2)" "unprognostic (1.07e-1)" "unprognostic (4.93e-1)" "unprognostic (3.41e-2)" "unprognostic (2.26e-1)" "unprognostic (2.07e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (1.27e-1)" "unprognostic (5.51e-2)" "unprognostic (2.77e-1)" 20.8 26.4 22.2 21.9 23.4 20.4 27.0 25.2 33.0 23.0 22.9 18.6 22.6 20.0 30.1 24.8 20.9 20.2 54.7 23.5 22.9 31.2 35.9 18.7 23.5 22.1 22.1 21.3 24.1 24.4 14.8 26.5 22.6 22.2 22.6 20.1 33.5 20.2 35.2 22.2 14.9 29.9 22.4 20.6 19.2 24.4 22.2 20.7 28.1 38.1 25.5 23.9 19.8 24.1 23.2 29.1 32.0 25.4 41.2 41.2 27.4 27.2 45.6 53.7 37.9 50.1 20.4 40.4 22.3 50.8 45.8 17.6 18.0 33.1 55.8 43.9 21.1 31.5 16.3 56.0 35.1 49.6 23.8 34.6 37.7 26.1 30.8 39.2 54.6 23.2 19.6 64.3 56.7 43.6 38.6 87.4 27.9 19.0 39.0 27.1 42.4 46.7 49.3 25.0 19.5 21.7 30.7 50.9 28.6 31.8 32.4 21.4 25.9 48.1 41.5 30.2 42.4 26.6 22.9 48.6 26.5 42.8 42.8 62.4 96.2 48.4 63.0 86.5 63.4 91.8 71.5 72.0 117.3 84.7 68.1 73.8 8.1 91.1 78.4 109.5 88.8 110.8 22.2 23.4 25.2 33.0 23.5 22.9 22.1 22.1 22.6 22.4 22.2 24.1 53.0 35.3 33.8 56.8 38.2 54.4 73.8 98.7 47.8 35.4 47.0 72.4 176.7 41.5 57.3 35.0 10.4 127.3 37.3 27.4 129.1 71.5 195.6 50.6 52.1 53.2 21.6 43.1 91.9 65.1 75.5 67.6 32.1 47.2 57.7 60.4 52.5 72.4 101.7 28.6 78.4 29.8 63.1 36.0 81.3 163.5 41.3 46.3 83.6 71.2 118.6 45.3 30.9 89.5 109.7 57.1 37.1 49.7 71.5 48.9 49.0 192.3 49.1 33.2 32.9 57.6 97.2 124.5 58.7 49.6 61.7 147.2 38.6 81.6 30.1 64.0 COQ10A FLJ32452 ENSG00000135469 "Coenzyme Q10A" Q96MF6 12 56266890-56270966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "heart muscle: 166.3;skeletal muscle: 280.7;tongue: 387.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 120.5;Distal tubular cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068931 Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 24: NB-4 - Immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol "Endoplasmic reticulum, Golgi apparatus" "HPA068931: AB_2686061" "unprognostic (4.55e-2)" "unprognostic (4.88e-3)" "prognostic unfavorable (5.46e-4)" "unprognostic (8.99e-3)" "unprognostic (2.77e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-1)" "unprognostic (2.86e-3)" "unprognostic (6.09e-2)" "unprognostic (8.57e-2)" "prognostic favorable (2.06e-4)" "unprognostic (5.03e-2)" "prognostic favorable (3.44e-4)" "unprognostic (1.67e-1)" "unprognostic (8.07e-2)" "unprognostic (7.20e-2)" "unprognostic (1.15e-1)" 7.0 33.3 16.3 3.5 16.9 4.6 7.2 17.7 19.7 9.1 21.1 9.5 3.2 10.0 16.2 9.0 10.8 6.3 166.3 16.2 17.6 17.1 37.0 6.7 7.8 16.5 18.3 10.2 18.0 15.7 25.4 2.7 17.2 11.9 5.0 26.0 12.6 9.8 280.7 5.0 9.7 7.2 16.4 12.2 8.8 6.8 18.6 7.9 10.3 387.5 8.9 8.5 6.8 15.8 3.7 15.2 14.4 9.4 8.1 8.0 6.0 5.2 12.5 18.3 18.2 11.9 5.6 21.5 11.3 13.3 5.1 3.5 16.8 3.0 10.9 3.2 17.0 10.2 14.1 12.4 11.0 8.1 5.9 8.4 4.9 13.6 5.3 11.4 9.8 14.9 6.8 8.8 17.1 5.1 11.7 29.1 12.0 2.7 8.7 24.2 15.6 14.5 10.1 2.2 20.5 22.0 18.1 3.8 5.8 10.6 5.8 8.9 6.9 3.4 10.0 9.5 5.3 18.1 20.4 10.8 10.2 7.6 2.6 14.1 1.1 1.1 7.4 1.0 7.4 12.7 7.0 7.8 1.7 6.8 8.3 8.1 0.4 5.8 0.9 6.9 5.1 3.9 16.3 16.9 17.7 19.7 16.2 17.6 16.5 18.3 17.2 16.4 18.6 15.8 8.1 3.2 7.2 12.4 20.8 13.4 13.0 2.3 15.4 17.9 8.4 12.7 120.5 7.2 3.2 11.0 16.7 5.8 32.0 2.0 52.8 2.8 0.2 13.7 6.3 9.6 16.2 4.2 3.9 4.6 6.8 10.9 6.6 5.1 4.5 8.2 3.6 15.2 5.2 32.0 6.2 3.4 4.1 2.5 12.1 1.7 8.4 4.5 12.4 3.7 2.5 26.5 13.4 4.5 2.3 2.7 2.5 17.0 18.6 4.4 3.1 18.1 11.0 32.3 39.5 22.1 14.0 4.0 22.2 4.9 10.5 3.0 19.5 10.4 4.4 5.9 CPO ENSG00000144410 "Carboxypeptidase O" Q8IVL8 2 206939518-206969474 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 111.8" "Cell type enriched" "Detected in some" 8 "Proximal enterocytes: 349.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 30 "basophil: 12.0" "Lineage enriched" "Detected in single" 84 "granulocytes: 12.0" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" "Intracellular and membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" "unprognostic (9.39e-2)" "unprognostic (2.64e-1)" "unprognostic (2.95e-2)" "unprognostic (5.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.27e-2)" "unprognostic (1.16e-1)" "unprognostic (9.06e-2)" "unprognostic (4.03e-1)" "unprognostic (1.33e-1)" "unprognostic (3.75e-3)" "unprognostic (1.22e-1)" "unprognostic (3.60e-2)" "unprognostic (2.52e-1)" "unprognostic (6.56e-2)" "unprognostic (4.03e-2)" "unprognostic (4.89e-2)" 0.7 1.0 2.4 0.1 2.4 0.0 0.8 1.3 3.1 0.5 1.2 1.2 0.5 0.3 7.5 0.2 0.7 0.4 0.4 2.2 2.3 1.3 0.7 0.3 0.1 2.0 2.1 0.4 0.5 1.0 1.2 0.2 2.3 0.9 0.4 0.6 0.8 0.8 0.7 0.5 111.8 0.7 2.1 0.2 0.5 0.8 2.4 0.1 1.0 0.5 0.1 0.5 0.3 3.3 0.0 0.0 0.0 0.0 0.7 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 12.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.4 1.3 3.1 2.2 2.3 2.0 2.1 2.3 2.1 2.4 3.3 0.1 0.0 0.0 9.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.2 0.0 0.0 0.0 43.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 35.9 6.3 0.0 0.0 0.0 0.7 0.3 0.0 0.0 6.5 0.0 0.0 0.0 2.0 14.6 0.0 3.8 0.0 0.0 0.0 349.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 CRISP1 "AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP" ENSG00000124812 "Cysteine rich secretory protein 1" P54107 6 49834257-49877096 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "epididymis: 1573.9" "Group enriched" "Detected in some" 29 "Early spermatids: 45.5;Late spermatids: 71.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.0;NB-4: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028445, HPA030534" Enhanced "Secreted in male reproductive system" NA NA 35000 "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA028445: AB_10670428, HPA030534: AB_2732459" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1573.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 71.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CTBP1 BARS ENSG00000159692 "C-terminal binding protein 1" Q13363 4 1211445-1249953 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004217, HPA018987, HPA044971" Approved Enhanced Nucleoplasm NA NA 16000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161" "unprognostic (6.19e-2)" "unprognostic (4.78e-2)" "unprognostic (9.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (3.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.52e-2)" "unprognostic (1.04e-2)" "unprognostic (9.65e-2)" "unprognostic (2.24e-2)" "unprognostic (6.35e-3)" "unprognostic (3.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.46e-2)" "unprognostic (3.00e-1)" "unprognostic (3.22e-2)" "prognostic favorable (8.94e-4)" 76.1 88.1 92.3 86.1 91.2 71.5 72.7 96.6 104.3 94.7 73.6 94.6 91.0 98.4 47.5 85.0 89.2 61.4 100.0 92.7 98.1 88.4 109.2 82.6 108.7 99.2 94.1 93.5 141.1 58.8 140.0 45.7 94.6 94.8 41.9 38.8 90.9 50.8 170.1 74.3 97.1 48.1 77.1 118.7 79.5 47.3 90.0 98.1 86.2 91.5 62.4 87.5 79.8 89.8 108.5 156.8 118.4 146.6 81.5 58.6 101.7 83.4 76.8 101.8 102.8 135.0 255.1 131.0 93.8 97.5 156.6 84.1 72.3 109.9 30.4 101.0 86.6 119.1 185.6 177.1 135.7 108.4 163.3 101.3 82.5 86.5 49.8 97.8 76.8 147.1 138.1 219.6 56.9 178.1 351.4 338.3 140.5 87.8 148.4 244.4 71.4 173.2 65.8 135.9 222.0 138.1 79.6 85.2 114.5 70.9 187.2 164.5 99.7 168.5 94.2 97.8 182.1 157.7 164.3 155.2 133.4 166.4 135.6 12.6 15.6 17.4 31.8 23.1 24.0 20.1 22.3 27.4 20.6 19.3 17.1 25.1 12.7 23.9 23.9 34.6 20.9 16.1 92.3 91.2 96.6 104.3 92.7 98.1 99.2 94.1 94.6 77.1 90.0 89.8 33.3 41.7 39.0 17.9 36.8 34.2 21.1 22.1 13.1 32.1 52.0 39.5 54.9 37.1 19.2 36.8 4.2 25.4 72.4 57.2 11.7 29.4 4.0 34.0 46.4 35.7 46.1 42.3 19.4 40.6 32.0 37.5 37.8 41.6 24.1 31.2 45.0 85.0 43.0 40.4 21.2 49.7 20.3 72.9 31.8 5.5 45.1 37.7 46.2 21.5 45.9 46.8 82.4 19.6 17.7 45.0 35.7 35.7 42.0 36.9 42.8 37.4 25.7 17.8 6.6 31.2 32.9 10.8 13.4 30.3 37.8 19.8 41.1 32.0 57.5 27.9 CTDP1 FCP1 ENSG00000060069 "CTD phosphatase subunit 1" Q9Y5B0 18 79679803-79754510 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cataract, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 113.1;Late spermatids: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032641, HPA040394, HPA070389" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Vesicles "CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155" "unprognostic (1.71e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" "prognostic favorable (6.43e-4)" "unprognostic (2.64e-2)" "unprognostic (7.99e-2)" "unprognostic (3.47e-3)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (1.15e-1)" "unprognostic (5.21e-3)" "unprognostic (1.99e-2)" "prognostic favorable (5.51e-5)" "unprognostic (5.16e-2)" "unprognostic (8.58e-2)" "unprognostic (2.85e-2)" "unprognostic (4.74e-2)" 9.3 7.4 3.8 7.2 3.9 13.7 8.9 3.3 4.2 7.8 4.1 11.1 7.2 10.4 1.4 10.7 8.1 4.0 7.2 3.3 3.3 7.9 9.5 9.3 8.7 5.3 4.2 5.0 9.0 3.3 6.9 4.2 4.0 8.2 3.1 1.5 9.5 3.9 11.9 20.5 10.9 3.1 3.3 13.5 9.9 22.2 4.0 6.5 8.0 3.1 3.7 9.6 8.6 4.4 13.4 14.0 7.7 11.0 6.0 5.0 25.9 9.6 6.1 7.6 7.5 9.4 8.0 17.2 4.2 5.6 9.1 16.4 6.6 8.8 3.1 16.9 12.4 8.5 6.6 12.9 8.7 37.6 20.5 8.4 8.3 8.1 3.8 4.6 9.2 12.2 11.2 8.1 3.0 11.5 25.4 29.5 12.7 4.2 19.1 20.7 10.1 20.0 5.6 13.1 12.0 12.4 10.2 9.8 13.9 5.8 8.0 21.7 12.9 12.9 19.4 5.3 9.7 7.4 27.6 16.1 11.0 18.8 9.3 0.0 0.4 3.2 0.5 0.4 0.4 0.2 0.4 0.8 0.6 0.1 0.5 0.3 1.0 1.1 0.4 0.1 0.1 0.2 3.8 3.9 3.3 4.2 3.3 3.3 5.3 4.2 4.0 3.3 4.0 4.4 7.4 0.0 4.1 3.6 9.2 8.5 5.0 4.0 11.4 9.5 7.7 6.5 3.8 4.3 4.5 3.7 14.6 8.8 24.2 20.0 1.9 5.4 113.1 18.6 8.0 7.5 6.0 13.5 7.7 7.2 8.0 4.8 19.9 24.0 7.0 7.8 6.4 5.7 8.8 23.5 6.6 16.6 6.1 7.5 9.5 123.2 7.8 13.8 7.2 6.5 6.5 6.5 19.6 3.0 8.9 10.2 14.9 10.5 15.2 11.8 10.0 6.8 9.6 14.8 0.0 5.9 7.4 18.0 10.5 10.5 10.1 19.0 18.3 8.0 11.7 12.6 CTSW ENSG00000172543 "Cathepsin W" P56202 11 65879809-65883741 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 116.3;lymphoid tissue: 42.4" "Group enriched" "Detected in many" 9 "dendritic cells: 717.8;NK-cells: 867.2;T-cells: 352.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 8 "gdT-cell: 1376.3;MAIT T-cell: 869.4;memory CD8 T-cell: 892.8;naive CD8 T-cell: 636.3;NK-cell: 2276.1" "Group enriched" "Detected in all" 39 "NK-cells: 2276.1;T-cells: 1376.3" "Group enriched" "Detected in some" 22 "HEL: 156.7;NB-4: 363.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB016345, HPA066903" Enhanced "Intracellular and membrane" NA NA 270000 "Cluster 48: NK-cells - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB016345: AB_626813, HPA066903: " "prognostic favorable (3.06e-4)" "unprognostic (2.06e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.36e-6)" "unprognostic (1.21e-1)" "prognostic favorable (9.89e-4)" "unprognostic (5.69e-2)" "unprognostic (1.09e-2)" "unprognostic (1.25e-3)" "unprognostic (5.14e-3)" "unprognostic (2.83e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (8.84e-6)" "unprognostic (3.86e-2)" "unprognostic (3.78e-1)" "unprognostic (1.26e-1)" "unprognostic (4.01e-3)" 5.1 2.9 0.8 12.9 0.9 116.3 3.7 1.8 1.6 2.6 0.6 5.6 6.1 6.7 2.8 3.1 4.0 6.2 2.9 0.8 0.9 2.1 6.5 24.0 29.5 1.6 0.7 2.4 1.8 0.5 1.1 3.3 1.2 2.1 6.3 0.0 9.1 3.9 1.3 2.7 6.1 2.7 1.2 42.4 8.3 1.2 1.1 7.8 3.2 0.4 13.9 8.6 2.5 1.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 156.7 0.3 0.0 0.0 11.8 0.4 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.0 9.1 0.2 0.2 1.9 363.4 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.0 0.0 5.6 0.1 0.0 0.1 0.4 0.1 0.3 0.5 0.0 0.2 9.9 0.3 46.4 3.4 4.8 1376.3 4.0 869.4 5.1 145.3 892.8 37.6 3.7 86.0 636.3 25.7 2276.1 5.4 23.3 23.7 809.3 0.8 0.9 1.8 1.6 0.8 0.9 1.6 0.7 1.2 1.2 1.1 1.1 5.1 0.0 4.2 0.0 9.7 4.6 0.4 0.0 1.8 0.0 2.3 2.2 0.4 2.8 1.4 0.0 0.0 0.4 717.8 0.3 0.0 0.3 2.0 0.9 0.9 1.9 0.0 44.1 0.0 0.0 0.2 4.0 12.8 1.1 71.7 0.1 5.7 1.6 1.9 0.0 0.0 0.2 0.0 5.6 34.1 11.1 0.0 9.9 17.8 0.0 6.1 0.0 867.2 0.0 0.2 0.0 0.0 0.0 57.7 0.3 0.0 1.1 0.8 0.0 0.0 1.6 1.9 0.3 1.2 0.8 6.3 0.3 352.6 0.1 0.3 0.3 CWC25 "CCDC49, FLJ20291" ENSG00000273559 "CWC25 spliceosome associated protein homolog" Q9NXE8 17 38800441-38825355 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 28.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014874, HPA062997" Supported Enhanced "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB014874: , HPA062997: AB_2684917" "unprognostic (2.21e-1)" "unprognostic (4.30e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (4.75e-2)" "unprognostic (3.69e-2)" "unprognostic (1.01e-2)" "unprognostic (3.24e-2)" "unprognostic (3.43e-3)" "unprognostic (8.79e-3)" "unprognostic (4.17e-3)" "unprognostic (4.98e-2)" "unprognostic (1.32e-1)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (8.68e-3)" 13.3 12.6 7.9 9.9 8.9 62.2 12.3 8.5 9.7 11.6 8.8 11.1 10.3 10.3 5.4 12.5 11.9 7.6 9.0 8.2 8.5 11.6 16.2 13.0 12.6 8.7 8.5 11.2 12.6 7.2 11.0 6.7 8.5 11.7 6.1 8.6 10.9 4.5 12.7 17.4 13.1 6.8 8.0 16.8 11.6 18.4 8.5 14.2 11.3 7.1 9.0 10.9 11.5 9.4 11.2 13.1 8.2 14.1 10.9 7.1 8.3 11.5 7.9 12.0 11.0 8.4 11.7 12.7 7.8 9.2 9.2 25.3 8.2 7.7 14.5 12.0 8.7 9.9 14.9 10.4 10.8 25.2 15.6 8.4 12.3 11.8 9.7 12.7 9.8 13.5 15.5 15.0 10.2 6.2 26.4 25.6 8.5 8.2 6.4 20.0 12.1 11.4 12.0 10.7 9.3 8.2 10.7 7.6 13.8 12.2 12.0 19.8 10.2 10.8 9.9 14.3 17.9 11.9 9.3 18.8 11.4 12.1 10.9 18.0 4.1 10.6 4.6 3.9 4.0 4.5 4.3 4.8 3.5 6.0 4.9 3.7 28.7 5.9 8.1 1.7 2.9 3.0 7.9 8.9 8.5 9.7 8.2 8.5 8.7 8.5 8.5 8.0 8.5 9.4 50.7 57.7 69.5 10.4 54.2 63.9 61.2 45.9 39.9 37.2 40.8 31.2 18.3 21.5 46.3 23.9 83.4 35.1 60.6 56.6 29.4 27.5 118.4 63.8 51.7 45.3 41.8 34.5 10.0 23.6 35.2 43.8 52.0 100.2 58.9 23.8 37.9 27.2 28.6 26.9 7.9 51.9 26.4 27.0 37.9 31.9 37.3 38.2 26.6 5.6 38.7 30.1 41.2 5.5 8.1 29.3 70.9 34.6 43.2 51.4 61.5 27.2 41.9 43.4 39.5 57.0 45.7 93.9 33.6 30.5 76.7 79.1 54.6 28.8 32.6 72.4 CYP2E1 CYP2E ENSG00000130649 "Cytochrome P450 family 2 subfamily E member 1" P05181 10 133520406-133561220 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 309 "liver: 10379.8" "Cell type enriched" "Detected in many" 58 "Hepatocytes: 6272.7" "Cancer enriched" "Detected in some" 278 "liver cancer: 265.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.5;myeloid DC: 6.2" "Group enriched" "Detected in many" 16 "dendritic cells: 6.2;T-cells: 2.5" "Cell line enhanced" "Detected in many" "HaCaT: 11.0;HL-60: 8.9;HMC-1: 8.9;NB-4: 24.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA009128, HPA029564" Enhanced Approved "Endoplasmic reticulum,Mitochondria" "Intracellular and membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 24: NB-4 - Immune response" "Cluster 2: Hepatocytes - Metabolism" "Endoplasmic reticulum, Mitochondria" "HPA009128: AB_1078613, HPA029564: AB_10602213" "unprognostic (6.32e-2)" "unprognostic (1.51e-2)" "unprognostic (3.83e-5)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.92e-3)" "unprognostic (6.36e-3)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.70e-4)" "unprognostic (1.72e-1)" "unprognostic (8.36e-2)" "unprognostic (3.78e-1)" "unprognostic (9.59e-2)" 2.8 2.9 5.4 0.6 5.4 0.8 3.0 9.1 7.5 4.9 3.0 5.0 1.4 4.5 8.3 16.7 5.5 2.5 2.1 5.5 5.5 9.1 10379.8 2.6 2.0 6.1 5.5 4.1 12.4 0.6 4.1 1.4 6.7 5.3 1.2 11.5 3.6 6.1 2.8 13.8 2.2 2.2 5.0 7.2 6.7 3.7 6.3 1.7 4.0 0.9 33.6 3.5 3.2 7.5 0.1 0.0 0.3 1.0 3.5 1.9 0.7 1.6 4.5 0.0 0.3 0.0 2.7 1.4 0.2 0.5 0.0 11.0 0.0 0.2 0.4 0.3 1.5 1.8 0.2 1.3 0.6 8.9 8.9 1.0 0.2 0.0 0.7 1.9 0.0 3.1 0.6 0.4 1.0 0.7 0.6 24.0 6.4 4.3 0.4 0.4 6.1 0.0 2.0 0.0 0.0 0.0 4.2 0.0 0.6 0.2 0.3 0.9 0.0 1.4 0.4 2.3 1.0 2.2 1.0 3.0 1.5 7.4 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.1 0.6 6.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 5.4 5.4 9.1 7.5 5.5 5.5 6.1 5.5 6.7 5.0 6.3 7.5 0.8 0.0 1.1 5.5 9.2 2.3 0.2 0.7 0.6 5.7 0.6 0.5 2.8 48.6 1.9 0.0 2.1 0.0 0.4 0.1 0.0 1.6 2.1 0.6 0.8 4.6 0.0 67.6 6.7 1.3 0.1 1.1 1.5 0.5 1.3 0.7 67.1 6272.7 0.0 8.4 5.3 0.0 0.0 108.0 2.8 2.1 1.5 0.3 0.0 1.9 0.4 0.7 0.0 2.0 2.2 3.2 0.0 2.6 0.3 0.6 0.0 0.6 2.2 5.8 0.0 0.2 0.6 4.1 4.2 2.0 7.5 0.1 5.7 0.2 0.0 0.0 CYP3A4 CYP3A3 ENSG00000160868 "Cytochrome P450 family 3 subfamily A member 4" P08684 7 99756960-99784248 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 3796.2" "Group enriched" "Detected in some" 40 "Hepatocytes: 2612.9;Proximal enterocytes: 1685.2" "Cancer enriched" "Detected in some" 240 "liver cancer: 351.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0" "Low region specificity" "Detected in all" "CAB033671, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 85: Liver - Metabolism" "Cluster 24: NB-4 - Immune response" "Cluster 2: Hepatocytes - Metabolism" Cytosol Vesicles "CAB033671: AB_782375, HPA072245: , HPA075539: " "unprognostic (4.55e-2)" "unprognostic (8.95e-2)" "unprognostic (8.08e-2)" "unprognostic (1.63e-1)" "unprognostic (5.89e-2)" "unprognostic (5.37e-2)" "unprognostic (7.07e-3)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" "unprognostic (4.92e-2)" "unprognostic (3.78e-2)" "unprognostic (6.42e-2)" "unprognostic (1.89e-8)" "unprognostic (2.59e-1)" "unprognostic (1.75e-2)" "unprognostic (9.79e-2)" "unprognostic (6.82e-2)" 0.3 3.8 0.1 1.1 0.3 0.0 0.3 0.0 0.8 0.1 0.0 4.6 797.6 0.6 0.2 0.4 0.1 0.6 0.1 0.1 0.0 4.9 3796.2 0.1 0.9 0.0 0.0 0.1 43.4 0.0 1.0 0.0 0.0 0.2 2.2 0.4 0.3 0.0 2.4 1.9 853.0 0.0 0.0 0.1 1.1 1.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.8 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 2.2 0.2 0.0 0.0 0.0 0.8 3.4 0.0 0.1 1.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.3 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 2.2 0.4 0.8 0.2 0.0 0.0 0.0 0.0 0.4 32.9 0.0 0.0 0.0 0.3 0.0 5.6 0.0 0.1 0.4 0.0 0.0 1.4 0.0 26.7 0.6 0.9 0.0 0.0 0.0 0.1 0.0 0.0 30.0 2612.9 0.0 0.0 0.6 29.6 2.0 52.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.1 38.9 0.0 0.0 0.6 1685.2 3.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.9 0.1 2.3 0.5 16.1 1.1 CYTL1 "C17, C4orf4" ENSG00000170891 "Cytokine like 1" Q9NRR1 4 5014586-5019458 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 46.0" "Cell type enhanced" "Detected in some" "Adipocytes: 14.1;Endothelial cells: 32.0;Erythroid cells: 86.6;Fibroblasts: 16.8;Hofbauer cells: 15.5;Microglial cells: 23.4" "Group enriched" "Detected in many" 5 "glioma: 21.0;melanoma: 20.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "NK-cell: 27.0" "Lineage enriched" "Detected in many" 11 "NK-cells: 27.0" "Cell line enhanced" "Detected in some" "HEL: 194.1;HUVEC TERT2: 152.3;NB-4: 382.2;WM-115: 89.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067201 Supported "Nuclear membrane,Endoplasmic reticulum" "Secreted in other tissues" NA NA 270000 "Cluster 40: NK-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear membrane, Endoplasmic reticulum" "HPA067201: AB_2732760" "unprognostic (2.35e-2)" "unprognostic (9.01e-3)" "unprognostic (3.56e-1)" "unprognostic (3.76e-2)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (1.44e-1)" "unprognostic (7.10e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (4.78e-2)" "prognostic unfavorable (7.43e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.18e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.25e-4)" 5.8 1.9 2.1 1.8 2.5 13.9 6.9 2.8 3.9 12.9 3.1 5.5 0.6 9.5 1.3 4.8 7.9 4.6 1.5 2.6 2.7 1.0 0.3 4.9 4.5 4.2 3.0 1.7 1.2 1.2 1.6 46.0 3.9 10.8 1.4 0.2 4.3 14.4 0.5 3.2 2.4 4.0 3.3 1.2 4.7 0.3 3.4 4.5 5.8 0.2 4.9 12.0 7.3 4.8 0.1 0.0 0.1 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 194.1 0.1 0.0 0.9 0.0 0.0 5.0 0.0 2.7 0.0 0.0 152.3 0.0 0.0 7.5 0.0 0.0 0.0 382.2 0.7 0.0 0.0 5.7 7.7 0.2 0.0 0.0 0.1 8.8 0.3 0.0 24.5 0.2 0.0 0.0 52.7 0.0 34.6 0.1 0.0 1.0 0.2 0.4 0.0 4.8 89.6 2.5 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.7 0.1 27.0 0.0 0.4 0.0 0.9 2.1 2.5 2.8 3.9 2.6 2.7 4.2 3.0 3.9 3.3 3.4 4.8 14.1 0.0 0.5 0.0 1.2 2.8 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.2 0.4 0.3 0.3 32.0 0.0 86.6 0.0 0.0 0.4 16.8 0.0 0.3 8.9 0.2 0.7 0.0 15.5 0.0 0.0 0.0 0.0 0.8 2.9 0.0 0.0 4.7 8.8 23.4 0.6 0.0 3.1 0.5 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 2.3 0.8 0.1 0.0 0.3 1.6 0.5 0.5 8.6 0.0 0.6 DBP DABP ENSG00000105516 "D-box binding PAR bZIP transcription factor" Q10586 19 48630030-48637379 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 318.3;Horizontal cells: 215.4;Muller glia cells: 194.2;Rod photoreceptor cells: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 61.7;NB-4: 235.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (1.49e-1)" "unprognostic (3.68e-3)" "unprognostic (2.16e-3)" "unprognostic (1.40e-1)" "unprognostic (4.67e-2)" "prognostic favorable (5.49e-4)" "unprognostic (2.00e-1)" "prognostic favorable (1.16e-5)" "unprognostic (3.32e-2)" "unprognostic (2.39e-1)" "unprognostic (4.24e-3)" "unprognostic (4.75e-2)" "prognostic favorable (2.41e-5)" "unprognostic (2.23e-1)" "unprognostic (2.52e-1)" "unprognostic (1.46e-2)" "unprognostic (3.61e-2)" 12.4 53.0 22.5 6.6 34.6 7.5 12.6 35.7 32.9 12.9 9.7 18.7 19.2 13.2 7.2 21.1 11.6 6.0 18.3 21.9 23.4 17.9 24.7 9.8 14.6 21.3 24.5 33.5 14.0 15.6 34.9 2.8 18.6 16.8 3.8 32.6 42.2 13.8 57.1 58.1 15.5 4.5 23.5 19.1 16.4 16.4 29.0 13.6 34.4 7.7 8.4 8.8 16.3 20.5 4.3 7.3 3.6 17.6 2.6 3.4 3.8 1.0 9.8 3.0 7.4 4.6 39.7 8.5 4.8 4.8 3.6 9.8 12.6 2.5 2.5 8.9 6.0 17.2 6.1 2.4 12.9 10.6 12.5 12.1 2.3 0.5 2.0 21.1 0.6 17.9 1.3 61.7 2.7 5.9 32.8 235.3 2.5 11.3 4.9 15.8 2.9 22.2 1.5 1.3 11.7 14.7 5.5 26.5 15.6 1.6 4.8 10.5 1.1 6.5 17.8 3.4 1.9 28.4 50.7 15.6 3.1 15.0 3.9 3.3 3.0 4.9 1.9 3.5 3.9 2.7 3.2 1.6 4.1 1.7 2.5 3.1 0.1 0.7 1.9 3.5 3.7 1.1 22.5 34.6 35.7 32.9 21.9 23.4 21.3 24.5 18.6 23.5 29.0 20.5 14.1 12.8 6.2 9.4 21.7 21.9 15.3 3.1 52.3 318.3 17.2 23.5 4.7 12.8 3.2 7.3 87.6 5.2 15.9 8.0 45.0 5.8 1.4 9.0 25.4 10.8 1.8 6.9 4.2 5.6 1.9 25.5 7.1 13.1 0.0 17.6 10.4 10.0 10.9 215.4 5.7 8.1 6.1 15.1 9.6 3.3 16.8 19.4 17.8 1.9 12.9 194.2 32.0 1.5 4.8 3.0 11.3 25.6 6.8 7.8 63.7 26.6 1.3 108.4 0.0 22.8 13.6 1.3 8.4 32.2 22.6 1.6 20.8 85.8 7.5 18.3 DCAF16 "C4orf30, FLJ20280" ENSG00000163257 "DDB1 and CUL4 associated factor 16" Q9NXF7 4 17800655-17810758 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042487 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane, Cytosol" "HPA042487: AB_10795505" "unprognostic (2.23e-3)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" "unprognostic (3.97e-1)" "unprognostic (8.02e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (6.40e-4)" "prognostic favorable (5.78e-4)" "unprognostic (5.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" "unprognostic (3.19e-2)" "unprognostic (1.78e-1)" "unprognostic (8.72e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-3)" "prognostic favorable (7.67e-4)" 9.6 8.2 4.5 8.0 7.0 18.1 13.0 6.4 6.7 12.8 2.9 10.4 7.9 13.8 10.2 7.9 11.9 6.6 8.4 4.2 7.4 9.2 4.8 9.1 11.9 6.1 5.8 19.4 11.3 12.3 13.3 9.8 5.7 10.6 9.5 13.3 10.9 7.9 8.2 15.0 10.2 8.9 4.5 8.9 8.8 10.9 7.8 12.0 10.1 4.4 11.4 10.0 10.2 9.4 21.7 4.6 24.3 25.5 6.8 11.9 13.2 13.9 16.3 16.2 19.1 13.1 17.2 24.2 10.8 12.9 13.1 10.7 14.4 14.7 23.9 8.3 13.2 34.2 16.0 21.5 16.3 30.4 13.4 15.5 11.8 20.6 20.3 10.8 11.3 23.6 37.4 39.3 9.4 8.2 33.4 29.0 20.0 6.3 13.1 35.0 27.8 15.7 7.1 16.9 36.0 28.9 14.8 3.9 16.9 12.2 14.3 8.1 14.5 18.7 14.7 20.8 17.8 17.3 7.4 29.4 15.4 20.6 12.8 7.8 1.4 2.1 2.5 1.6 3.3 2.0 2.7 2.8 0.9 2.9 3.4 3.2 1.0 2.1 1.1 1.8 2.1 1.3 4.5 7.0 6.4 6.7 4.2 7.4 6.1 5.8 5.7 4.5 7.8 9.4 11.6 19.2 24.8 13.1 17.6 25.4 24.3 9.4 25.6 12.2 16.3 16.9 21.9 12.8 14.4 9.2 6.2 17.6 27.0 8.6 13.7 9.9 19.6 12.9 18.4 13.0 17.5 21.7 20.2 7.7 10.0 15.9 14.3 13.3 17.1 24.8 11.4 6.4 7.7 15.2 20.2 12.5 14.2 11.9 11.3 11.5 21.1 9.4 10.6 15.0 10.2 27.5 7.2 29.1 36.7 11.8 7.6 22.2 27.6 14.6 9.2 5.1 17.1 14.6 13.1 21.7 16.2 28.8 17.3 19.5 21.2 12.3 20.3 19.0 13.9 19.2 DCAF4L1 WDR21B ENSG00000182308 "DDB1 and CUL4 associated factor 4 like 1" Q3SXM0 4 41981756-41986465 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 24.7" "Group enriched" "Detected in some" 9 "Early spermatids: 35.4;Spermatocytes: 89.6;Spermatogonia: 128.4" "Cancer enriched" "Detected in single" 49 "testis cancer: 8.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "REH: 1.1" CAB073535 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "CAB073535: " "unprognostic (6.24e-2)" "unprognostic (7.52e-3)" "unprognostic (8.11e-3)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (9.63e-3)" "unprognostic (4.64e-4)" "unprognostic (1.62e-1)" "unprognostic (1.42e-2)" "unprognostic (3.11e-2)" "unprognostic (2.83e-2)" "unprognostic (4.03e-1)" "unprognostic (3.76e-3)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.49e-2)" "unprognostic (1.36e-4)" 0.2 0.2 0.5 0.2 0.5 0.1 0.1 0.7 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.4 0.3 0.4 0.4 0.3 0.1 0.4 0.3 0.1 0.1 0.0 0.8 0.0 0.5 0.2 0.0 0.7 0.2 0.0 1.1 0.3 0.2 0.0 0.3 0.6 0.1 24.7 0.5 0.0 0.2 0.0 0.1 0.2 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.2 0.6 0.7 0.1 0.0 0.7 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.1 0.2 1.1 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.6 0.2 0.6 0.2 0.9 0.1 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.7 0.7 0.4 0.3 0.4 0.3 0.5 0.3 0.5 0.6 0.8 0.0 0.0 0.7 0.5 0.4 0.3 0.2 0.0 1.2 0.9 0.5 1.2 1.5 0.3 0.0 0.0 0.2 0.6 0.3 0.0 0.3 35.4 0.9 0.9 0.9 0.0 0.4 1.4 0.6 0.3 0.5 0.0 1.2 0.0 0.1 0.0 0.6 0.3 0.0 0.8 0.4 2.0 2.2 0.3 8.6 1.2 0.8 3.6 0.0 0.7 0.7 2.1 0.5 0.6 0.9 0.1 0.4 0.9 1.2 0.2 0.1 0.5 1.6 0.0 2.9 0.7 89.6 128.4 0.6 0.9 0.5 0.6 0.2 0.7 0.6 DCTN3 DCTN-22 ENSG00000137100 "Dynactin subunit 3" O75935 9 34613545-34620523 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044905 Approved Approved Nucleoli,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" Cytosol Nucleoli "HPA044905: AB_10960996" "unprognostic (3.38e-1)" "unprognostic (4.13e-2)" "unprognostic (3.47e-1)" "unprognostic (6.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.92e-3)" "unprognostic (9.88e-2)" "unprognostic (4.41e-2)" "prognostic favorable (2.10e-5)" "unprognostic (1.26e-3)" "unprognostic (4.24e-3)" "prognostic favorable (5.76e-11)" "unprognostic (3.06e-1)" "unprognostic (2.25e-1)" "unprognostic (3.22e-1)" "unprognostic (4.43e-2)" 72.9 87.9 98.3 33.7 104.6 107.3 72.2 97.0 123.5 80.6 92.9 81.1 42.0 72.9 46.8 98.5 66.4 38.7 127.1 106.0 103.3 88.6 67.0 60.8 48.0 97.1 97.2 78.7 76.5 94.4 108.4 40.7 102.4 68.2 39.0 57.0 69.2 51.4 152.5 111.1 51.1 53.6 94.1 58.7 75.6 36.3 100.3 81.3 71.5 114.4 59.0 69.5 79.2 95.6 147.1 120.7 110.1 115.6 95.1 132.3 45.1 122.7 112.8 166.4 130.2 77.7 53.8 67.0 74.6 161.8 58.4 57.4 101.0 128.3 105.6 211.9 126.5 44.9 202.9 68.5 102.6 118.8 131.3 117.5 109.4 115.6 75.0 81.4 111.1 123.6 54.2 135.3 147.4 120.9 151.4 320.0 33.4 61.0 192.7 75.2 59.7 93.4 81.5 51.2 36.5 93.3 90.9 82.7 48.0 32.2 110.6 134.5 102.7 104.6 84.1 120.1 121.0 90.6 126.0 45.5 164.1 68.6 217.4 235.2 131.1 187.4 99.9 139.4 92.1 88.4 106.0 106.8 133.8 94.7 83.6 98.9 114.4 102.2 150.3 136.1 179.1 152.5 98.3 104.6 97.0 123.5 106.0 103.3 97.1 97.2 102.4 94.1 100.3 95.6 103.7 32.1 38.3 13.1 61.3 101.6 111.8 180.7 82.0 83.2 97.3 146.9 86.1 77.2 91.8 80.9 25.0 128.8 105.6 74.1 207.4 127.5 14.3 78.6 98.8 79.2 74.7 115.7 16.8 154.6 111.9 97.9 56.6 67.1 87.5 82.4 88.5 84.9 133.8 74.0 16.2 64.9 91.6 88.8 99.0 21.1 103.5 76.8 149.4 5.6 94.9 212.9 125.7 7.5 16.8 126.7 84.5 122.6 89.1 54.7 89.0 240.2 95.0 96.7 59.2 82.0 150.5 82.2 72.9 109.9 142.6 99.7 95.7 143.2 61.6 96.6 DDX55 KIAA1595 ENSG00000111364 "DEAD-box helicase 55" Q8NHQ9 12 123602077-123620943 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 74.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039962, HPA044101" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli" Cytosol "HPA039962: AB_2676774, HPA044101: AB_2678810" "unprognostic (1.14e-1)" "unprognostic (2.30e-2)" "unprognostic (2.29e-1)" "unprognostic (3.71e-3)" "unprognostic (1.92e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.11e-9)" "unprognostic (1.60e-1)" "unprognostic (4.49e-2)" "unprognostic (7.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-3)" "prognostic unfavorable (8.97e-12)" "unprognostic (9.15e-3)" "unprognostic (2.94e-1)" "unprognostic (3.47e-2)" "unprognostic (1.23e-3)" 11.0 10.3 11.1 10.4 11.1 20.3 11.1 13.2 19.5 12.1 11.2 9.7 7.6 9.6 7.7 11.1 12.2 5.6 6.9 10.7 11.4 12.3 14.7 8.4 13.8 11.5 10.8 13.1 15.4 6.5 11.3 7.7 11.6 11.4 8.8 12.6 9.5 6.3 6.4 13.6 10.8 7.1 9.9 14.9 9.7 9.6 11.3 10.3 9.1 3.4 10.7 10.7 11.1 12.9 20.5 28.4 21.4 21.7 18.0 14.2 32.2 24.8 9.1 21.6 14.8 32.5 14.6 30.2 19.3 10.9 19.5 24.4 32.8 18.4 25.1 22.8 29.7 40.8 34.0 24.3 13.7 50.7 30.7 12.0 19.2 25.7 29.5 16.7 15.8 23.9 42.3 15.5 15.5 21.1 50.0 68.2 33.3 23.6 27.9 37.1 22.7 19.7 15.2 34.8 25.3 21.0 20.2 25.9 35.0 17.7 46.2 32.4 16.3 18.6 24.5 30.6 31.2 28.4 37.4 54.2 17.7 35.8 32.4 3.4 9.1 7.8 11.4 10.6 12.4 13.9 11.1 12.3 7.7 10.7 14.9 13.9 5.2 13.3 6.4 13.2 9.9 8.6 11.1 11.1 13.2 19.5 10.7 11.4 11.5 10.8 11.6 9.9 11.3 12.9 13.3 22.4 13.9 15.7 14.2 11.0 13.4 13.9 9.6 20.2 9.6 14.9 2.5 8.6 11.7 7.3 22.9 13.8 26.3 5.9 7.9 12.2 45.1 9.0 18.4 12.0 7.2 19.6 13.4 12.0 17.4 12.0 11.2 7.2 25.3 16.4 7.1 9.4 14.3 15.2 16.5 15.9 10.2 7.1 7.4 74.8 17.1 9.0 7.2 12.2 9.9 16.1 15.5 6.6 14.3 13.3 7.6 14.7 13.8 13.3 5.9 6.3 12.3 28.1 6.6 10.5 14.1 21.9 18.6 12.5 16.9 7.7 14.2 14.0 10.2 11.0 DEFA1 "DEF1, DEFA2, HNP-1, MRS" ENSG00000206047 "Defensin alpha 1" P59665 8 6977649-6980080 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "bone marrow: 18020.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "NB-4: 2.1" "CAB032548, HPA052517" Enhanced "Secreted to blood" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "CAB032548: AB_2277258, HPA052517: AB_2681860" 31.6 4.3 0.7 0.6 0.8 18020.9 16.8 0.5 3.0 4.0 0.6 4.1 0.0 11.3 0.0 3.2 2.2 1.3 62.5 0.5 0.6 15.0 91.6 560.5 3.5 0.7 0.7 4.1 5.5 0.1 20.6 11.4 0.7 2.7 0.0 0.3 14.5 0.0 16.8 40.3 2.3 0.0 0.8 1803.8 6.4 3.1 0.8 37.0 15.8 0.0 0.8 3.4 5.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.5 3.0 0.5 0.6 0.7 0.7 0.7 0.8 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DEFA3 "DEF3, HNP-3" ENSG00000239839 "Defensin alpha 3" P59666 8 7015869-7018297 "Cancer-related genes, Predicted secreted proteins" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 64 "bone marrow: 37615.2" "Cell type enhanced" "Detected in some" "B-cells: 17.9;Erythroid cells: 10.1;Hepatocytes: 17.0;Macrophages: 5.7;Plasma cells: 4.0;T-cells: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in many" 19 "neutrophil: 854.3" "Lineage enriched" "Detected in many" 19 "granulocytes: 854.3" "Cell line enriched" "Detected in single" 8 "NB-4: 1.5" HPA052517 Supported "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "HPA052517: AB_2681860" "unprognostic (8.21e-2)" 8.8 1.2 0.5 1.0 0.3 37615.2 5.0 0.2 1.2 2.0 0.3 1.3 0.0 5.6 0.0 1.0 0.7 0.2 16.1 0.2 0.3 4.4 26.1 180.2 5.3 0.4 0.6 1.3 1.6 0.0 7.6 18.8 0.5 0.8 0.0 0.2 24.2 0.0 5.0 42.1 0.7 0.0 0.5 589.4 1.8 0.6 0.6 147.9 4.5 1.1 1.3 1.1 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 24.4 3.6 44.3 1.2 1.6 2.3 1.0 0.8 1.0 1.1 6.9 0.3 854.3 0.4 2.6 1.4 0.3 6033.6 0.5 0.3 0.2 1.2 0.2 0.3 0.4 0.6 0.5 0.5 0.6 0.2 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.8 17.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.7 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 DEFA5 "DEF5, HD-5" ENSG00000164816 "Defensin alpha 5" Q01523 8 7055304-7056739 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 768 "intestine: 9759.8" "Group enriched" "Detected in some" 4 "Proximal enterocytes: 1740.2;Undifferentiated cells: 1753.0" "Cancer enhanced" "Detected in many" "cervical cancer: 181.1;colorectal cancer: 147.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 28.3;NB-4: 24.2;RPMI-8226: 26.6;SH-SY5Y: 19.6;U-2197: 8.5" "HPA015309, HPA015775, CAB069919" Enhanced Approved Vesicles,Midbody "Secreted to digestive system" Yes NA 110000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" Vesicles Midbody "CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594" "prognostic favorable (9.44e-5)" "unprognostic (3.91e-2)" 0.3 0.4 0.1 12.7 0.1 0.2 0.5 0.1 0.5 0.0 0.1 56.6 5185.1 3.9 0.1 0.8 0.0 0.0 0.4 0.1 0.2 0.2 1.1 0.4 6.0 0.1 0.2 0.4 0.8 0.0 1.1 0.0 0.2 0.7 0.2 0.1 0.7 0.0 0.3 0.3 9759.8 0.1 0.1 0.4 0.9 0.8 0.2 0.4 0.3 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 2.5 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.1 325.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 399.9 0.0 0.0 0.0 1740.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.4 0.0 1753.0 0.0 DEFA6 "DEF6, HD-6" ENSG00000164822 "Defensin alpha 6" Q01524 8 6924697-6926076 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 863 "intestine: 4819.9" "Group enriched" "Detected in some" 6 "Proximal enterocytes: 448.9;Undifferentiated cells: 904.1" "Group enriched" "Detected in many" 5 "cervical cancer: 21.2;colorectal cancer: 75.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BEWO: 14.7;NB-4: 15.9;RPMI-8226: 19.7;SH-SY5Y: 12.2;U-2197: 5.7" HPA019462 Enhanced "Secreted to digestive system" NA NA 260000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA019462: AB_1847595" "unprognostic (7.48e-3)" "unprognostic (1.63e-1)" "unprognostic (1.34e-1)" 0.1 0.2 0.0 5.5 0.0 0.3 0.2 0.0 0.0 0.0 0.0 25.7 2862.9 2.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.2 3.4 0.0 0.0 0.2 0.4 0.0 0.5 0.0 0.1 0.3 3.3 0.0 0.3 0.0 0.2 0.6 4819.9 0.0 0.0 0.2 0.4 0.6 0.0 2.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 1.1 12.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.6 0.0 0.0 0.0 0.5 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.4 0.0 0.0 0.0 448.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 904.1 0.0 DEFB105B ENSG00000186599 "Defensin beta 105B" Q8NG35 8 7487679-7489593 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12966 "epididymis: 2383.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NB-4: 4.2" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2383.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB106A "DEFB-6, DEFB106" ENSG00000186579 "Defensin beta 106A" Q8N104 8 7825139-7829053 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16935 "epididymis: 3003.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "NB-4: 2.2" HPA045592 Supported "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "HPA045592: AB_2679378" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3003.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB110 "DEFB-10, DEFB-11, DEFB111" ENSG00000203970 "Defensin beta 110" Q30KQ9 6 50009138-50021994 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4674 "epididymis: 871.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NB-4: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 871.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB118 "C20orf63, DEFB-18, dJ1018D12.3, ESC42" ENSG00000131068 "Defensin beta 118" Q96PH6 20 31368601-31373923 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9912 "epididymis: 991.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" HPA042634 Enhanced "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 56: Bipolar cells - Visual perception" "HPA042634: AB_10797505" "unprognostic (3.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 991.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB119 "DEFB-19, DEFB-20, DEFB120" ENSG00000180483 "Defensin beta 119" Q8N690 20 31377164-31390590 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "epididymis: 1925.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 42.6;Cone photoreceptor cells: 39.6;Early spermatids: 61.9;Late spermatids: 99.8;Rod photoreceptor cells: 150.2" "Cancer enriched" "Detected in single" 67 "testis cancer: 3.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.5" HPA043059 Supported "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA043059: AB_10797025" "unprognostic (2.03e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.1 1925.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 155.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 331.5 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.0 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.1 0.0 0.0 0.0 0.0 99.8 12.5 0.8 0.0 0.0 0.0 22.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 150.2 13.1 0.0 0.0 17.4 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB121 DEFB-21 ENSG00000204548 "Defensin beta 121" Q5J5C9 20 31404845-31412838 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11866 "epididymis: 2605.3" "Group enriched" "Detected in some" 22 "Early spermatids: 14.5;Late spermatids: 5.4;Spermatocytes: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "NB-4: 3.1" "Not detected" "Not detected" HPA079460 Enhanced "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA079460: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2605.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB129 "bA530N10.3, C20orf87, DEFB-29" ENSG00000125903 "Defensin beta 129" Q9H1M3 20 227258-229886 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 585 "epididymis: 1943.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.6;SH-SY5Y: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA014581 Enhanced "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "HPA014581: AB_2732410" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1943.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DGKQ "DAGK, DAGK4, DAGK7" ENSG00000145214 "Diacylglycerol kinase theta" P52824 4 958887-986895 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 33.5;Intestinal goblet cells: 21.6;Paneth cells: 33.1;Proximal enterocytes: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026797, CAB033835" Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "CAB033835: AB_2091307, HPA026797: AB_10600902" "unprognostic (7.39e-2)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.64e-2)" "unprognostic (1.14e-1)" "unprognostic (5.08e-2)" "unprognostic (3.37e-1)" "unprognostic (6.39e-2)" "unprognostic (2.90e-2)" "unprognostic (1.06e-1)" "unprognostic (6.45e-2)" "unprognostic (1.06e-2)" "unprognostic (9.77e-2)" "unprognostic (3.08e-3)" "unprognostic (4.38e-2)" "unprognostic (2.65e-2)" "unprognostic (1.65e-3)" 6.5 8.2 11.7 9.2 11.4 9.8 6.7 15.4 15.8 9.0 3.6 20.0 22.2 7.9 2.6 10.8 7.6 5.1 6.0 14.0 10.9 8.3 8.1 9.5 11.0 14.3 8.6 6.5 9.9 3.7 10.5 3.2 10.1 9.3 6.5 1.0 9.4 4.0 3.6 13.2 23.6 2.7 6.1 15.4 8.4 9.0 11.8 7.5 8.7 1.3 4.4 8.4 9.7 7.0 5.7 9.1 3.9 13.2 4.7 3.8 14.5 10.7 6.0 6.0 5.9 6.5 11.1 7.6 8.8 6.8 12.2 6.5 2.2 7.5 1.4 6.0 6.9 11.8 10.3 11.6 8.0 5.1 15.2 7.2 12.5 4.9 2.3 5.1 7.3 15.6 9.1 0.9 4.7 8.6 10.7 29.6 6.9 15.9 15.3 17.0 1.1 0.9 6.5 7.9 2.4 6.6 3.7 4.1 11.3 3.0 9.9 12.3 10.8 10.3 4.8 11.7 7.2 20.2 9.4 6.0 8.9 10.9 9.5 2.9 0.5 1.3 2.0 0.5 0.9 0.5 0.7 1.7 0.4 0.4 0.7 1.3 0.3 2.4 0.4 0.8 0.5 0.8 11.7 11.4 15.4 15.8 14.0 10.9 14.3 8.6 10.1 6.1 11.8 7.0 4.3 3.2 3.1 8.5 3.6 2.8 1.3 2.9 1.2 3.6 3.5 3.9 3.0 4.3 2.9 3.7 4.2 0.5 15.1 33.5 0.0 3.0 0.6 2.6 3.3 3.3 7.7 5.7 12.4 4.9 2.1 2.9 3.1 4.1 0.0 6.2 2.5 5.8 2.5 3.3 11.8 21.6 0.0 4.1 2.3 1.3 4.1 4.6 3.6 5.6 4.5 3.0 10.3 3.0 3.2 5.7 33.1 2.6 4.6 3.1 29.1 0.9 4.4 1.0 0.0 2.6 2.8 3.2 4.3 2.9 3.8 0.7 6.7 3.6 14.5 3.8 EDDM3B "FAM12B, HE3-BETA" ENSG00000181552 "Epididymal protein 3B" P56851 14 20768404-20770948 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 279 "epididymis: 2563.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;NB-4: 2.6" "Not detected" "Not detected" HPA001323 Enhanced "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" "HPA001323: AB_1848377" "unprognostic (2.40e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2563.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EIF3F "eIF3-epsilon, eIF3-p47, EIF3S5" ENSG00000175390 "Eukaryotic translation initiation factor 3 subunit F" O00303 11 7970251-8001862 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis, Ubl conjugation pathway" "Hydrolase, Initiation factor, Protease, Thiol protease" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049250 Approved NA NA 83000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" "HPA049250: AB_2680692" "unprognostic (1.11e-2)" "unprognostic (1.42e-1)" "unprognostic (8.46e-2)" "unprognostic (1.15e-2)" "unprognostic (8.50e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.16e-1)" "unprognostic (1.97e-1)" "unprognostic (1.74e-1)" "unprognostic (3.11e-1)" "unprognostic (2.04e-1)" "unprognostic (1.57e-1)" "unprognostic (5.66e-2)" "unprognostic (2.61e-1)" "unprognostic (8.36e-2)" "unprognostic (8.78e-2)" 225.1 160.8 7.8 10.2 7.4 21.7 216.8 8.6 7.6 249.1 5.1 248.9 10.5 206.8 10.1 227.3 213.3 16.7 186.2 7.6 6.6 165.8 160.3 157.0 24.7 7.9 6.8 353.9 361.3 8.0 126.6 11.7 7.7 170.0 12.6 15.5 175.5 12.9 374.0 333.1 188.6 21.2 6.7 201.6 238.9 132.7 7.3 11.8 153.7 12.8 25.4 218.7 212.9 8.2 23.6 9.3 12.7 11.3 23.5 52.6 39.9 16.1 28.1 20.3 19.4 9.6 23.0 70.4 6.7 15.7 9.1 12.5 9.9 27.7 20.4 23.1 32.4 24.8 9.5 11.1 38.7 26.9 10.0 32.2 32.7 7.9 18.7 18.6 20.7 12.6 21.5 16.1 22.2 9.6 15.8 25.5 13.1 9.5 22.6 17.7 17.3 22.4 11.0 15.8 29.2 50.6 15.2 6.7 19.3 7.7 11.9 18.6 19.3 9.5 11.0 6.9 11.7 11.8 21.1 29.0 6.4 16.8 12.6 37.5 92.4 41.7 81.5 99.7 112.1 174.6 130.5 96.4 130.9 161.6 155.4 114.5 11.7 95.8 93.6 87.7 177.6 246.5 7.8 7.4 8.6 7.6 7.6 6.6 7.9 6.8 7.7 6.7 7.3 8.2 179.9 109.0 145.4 11.1 355.2 349.1 364.1 411.0 266.9 72.2 271.6 285.6 96.8 264.5 197.2 79.1 52.1 631.3 283.7 121.1 293.5 277.0 424.5 113.8 204.9 218.3 210.2 221.7 11.5 442.8 670.6 216.3 139.7 112.1 164.8 335.7 256.6 170.6 344.2 45.4 10.9 262.0 140.4 423.1 398.1 913.3 246.0 263.4 247.3 8.4 471.1 141.5 362.5 7.5 18.8 322.2 242.2 196.7 237.6 247.4 312.9 286.9 115.1 87.1 98.6 222.4 374.3 197.0 124.8 358.3 440.4 563.4 319.3 264.8 392.2 426.0 EIF3G "eIF3-delta, eIF3-p44, EIF3S4" ENSG00000130811 "Eukaryotic translation initiation factor 3 subunit G" O75821 19 10115014-10119918 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1509.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 1471.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041997 Approved Enhanced Cytosol NA NA 64000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" Cytosol "HPA041997: AB_10804123" "unprognostic (1.80e-2)" "unprognostic (2.16e-2)" "unprognostic (9.00e-2)" "unprognostic (3.33e-2)" "unprognostic (2.22e-2)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.49e-1)" "unprognostic (1.73e-1)" "prognostic favorable (3.94e-4)" "unprognostic (4.90e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-1)" "unprognostic (2.40e-2)" "unprognostic (7.63e-2)" "unprognostic (1.91e-1)" "unprognostic (2.43e-1)" 193.6 153.1 91.9 97.0 98.6 127.9 188.0 97.9 110.3 211.3 91.2 219.0 94.9 190.6 61.3 144.2 189.7 68.1 212.6 88.1 93.5 152.7 134.3 135.4 125.4 100.6 94.6 280.0 324.5 116.2 119.6 90.8 99.9 172.0 54.3 24.8 182.2 102.2 529.8 212.4 148.0 73.8 98.4 168.9 207.6 176.3 96.8 124.9 139.2 221.1 98.8 183.5 171.9 103.1 211.5 175.5 130.1 174.9 170.8 216.6 169.2 175.6 242.3 269.0 247.7 289.2 111.1 214.9 245.1 210.8 121.9 158.4 159.7 265.0 111.1 196.0 491.8 379.8 179.0 293.2 283.7 303.8 192.7 262.7 191.0 191.6 181.0 172.2 195.7 263.1 349.2 249.6 164.3 282.3 333.2 1471.2 323.1 131.9 372.0 265.3 129.2 287.2 173.4 181.8 170.0 328.9 117.6 152.0 287.9 73.2 133.4 264.4 196.1 233.0 132.6 256.1 339.1 726.8 567.8 240.2 175.6 328.5 227.9 199.9 319.1 139.5 267.6 238.7 348.0 244.5 287.0 291.8 303.2 255.3 287.5 262.4 60.3 458.6 200.3 240.7 351.5 457.0 91.9 98.6 97.9 110.3 88.1 93.5 100.6 94.6 99.9 98.4 96.8 103.1 183.9 44.8 94.5 7.2 219.3 228.2 271.7 185.8 191.2 41.5 276.0 342.9 43.3 164.5 118.1 108.5 18.8 470.9 273.6 146.4 187.9 182.7 438.1 99.7 141.5 160.6 129.9 131.1 4.2 309.1 328.2 159.1 122.3 108.9 129.3 197.3 167.4 98.9 225.1 21.9 4.1 231.1 81.4 288.5 268.9 1509.3 237.9 198.9 145.9 4.7 351.7 85.5 557.1 6.6 10.8 205.3 198.8 177.1 192.6 241.0 277.0 320.1 100.6 56.6 164.3 189.9 243.8 221.1 142.4 152.9 238.7 527.2 261.5 209.6 235.4 263.2 EMID1 "EMI5, EMU1, hEmu1" ENSG00000186998 "EMI domain containing 1" Q96A84 22 29205896-29259597 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5;lymphoid tissue: 54.8" "Cell type enhanced" "Detected in many" "Astrocytes: 92.1;Granulosa cells: 32.7;Oligodendrocyte precursor cells: 51.8;Theca cells: 151.0" "Group enriched" "Detected in all" 4 "endometrial cancer: 23.1;glioma: 7.8;ovarian cancer: 10.9;thyroid cancer: 7.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HEL: 28.8;NB-4: 102.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000592 Uncertain "Secreted in other tissues" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "HPA000592: AB_1078737" "unprognostic (2.20e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-2)" "unprognostic (7.80e-3)" "unprognostic (2.40e-2)" "unprognostic (1.42e-1)" "unprognostic (3.46e-1)" "unprognostic (6.25e-3)" "unprognostic (3.75e-2)" "unprognostic (2.33e-1)" "unprognostic (5.24e-3)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.59e-1)" "unprognostic (1.76e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-1)" 2.6 29.0 34.5 4.2 35.0 14.8 2.5 27.7 49.5 6.5 24.4 5.7 5.1 10.0 1.7 1.3 10.4 4.8 2.3 36.8 29.4 15.0 3.3 13.0 7.5 30.1 30.4 7.0 14.0 12.4 2.0 4.9 28.3 6.1 3.4 0.3 3.6 3.9 0.8 6.3 8.3 2.3 27.0 54.8 7.7 2.3 27.8 4.8 13.2 0.3 2.3 4.9 2.2 32.4 0.0 0.2 4.9 10.5 0.0 0.0 0.7 0.0 0.0 0.4 0.3 5.7 0.7 0.0 4.7 0.1 0.0 0.0 2.5 0.1 0.0 11.5 8.6 28.8 0.1 1.1 0.7 4.1 2.2 0.3 0.2 0.2 0.0 0.0 0.0 6.4 2.5 0.0 0.0 8.0 0.2 102.0 1.1 0.1 0.4 0.0 0.2 11.3 0.0 0.1 13.2 6.3 0.4 0.1 0.2 0.8 4.2 5.4 0.0 0.0 8.0 0.0 0.1 0.5 0.0 0.0 0.0 14.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 34.5 35.0 27.7 49.5 36.8 29.4 30.1 30.4 28.3 27.0 27.8 32.4 0.4 0.0 2.5 92.1 0.1 2.8 1.0 0.1 0.0 1.7 5.3 3.9 0.7 4.3 0.6 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.2 10.8 22.6 6.2 0.0 18.5 5.6 1.3 0.1 11.8 0.5 20.0 11.4 32.7 11.4 2.1 0.3 0.0 6.2 0.4 0.0 0.3 5.2 0.5 3.1 0.6 0.0 10.3 0.6 1.1 0.0 51.8 1.0 0.4 0.0 1.9 1.0 1.9 0.1 1.9 0.0 0.4 0.0 17.5 4.0 0.1 1.5 0.0 2.0 0.3 1.1 151.0 0.3 0.4 EMP3 YMP ENSG00000142227 "Epithelial membrane protein 3" P54852 19 48321509-48330553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 2037.4;Macrophages: 699.2;Melanocytes: 1117.1" "Cancer enhanced" "Detected in all" "melanoma: 195.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 1472.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062030 Approved "Vesicles,Plasma membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" "Vesicles, Plasma membrane" "HPA062030: " "unprognostic (5.06e-3)" "unprognostic (4.41e-1)" "unprognostic (1.83e-1)" "unprognostic (9.28e-3)" "unprognostic (1.33e-2)" "unprognostic (4.83e-3)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (9.31e-2)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.31e-7)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.16e-1)" "unprognostic (2.41e-1)" "unprognostic (2.90e-3)" 107.7 85.6 37.6 115.8 37.4 325.1 68.8 37.9 41.0 149.6 36.9 166.7 36.9 143.9 60.7 37.1 96.2 72.5 100.9 38.6 53.8 51.8 29.1 141.0 86.1 52.1 43.9 110.8 18.4 17.1 21.4 67.1 46.9 61.3 65.5 9.2 41.8 90.1 21.7 61.6 81.6 202.9 44.2 91.8 65.3 33.5 43.7 45.2 43.2 43.7 94.7 132.8 106.9 48.4 73.8 739.3 44.9 127.1 691.3 1081.5 1.2 490.7 898.0 627.6 560.7 73.5 265.0 6.9 107.5 1101.0 296.4 12.1 45.5 54.6 390.4 241.3 20.5 335.0 192.0 43.3 572.4 160.2 338.9 586.1 12.2 635.3 436.3 455.5 277.9 66.1 237.4 616.1 1019.5 10.1 25.1 1472.4 55.4 12.1 196.9 22.1 150.1 355.7 554.6 0.4 1.8 2.0 225.2 1.2 131.2 77.2 2.7 253.1 456.6 574.7 236.5 435.8 388.1 287.6 426.6 20.1 339.2 232.5 402.5 2401.3 980.4 1402.3 1324.0 1173.0 1117.1 570.1 1425.3 1327.0 688.7 467.9 818.8 948.4 1094.0 854.5 1148.4 516.9 1631.4 1971.4 37.6 37.4 37.9 41.0 38.6 53.8 52.1 43.9 46.9 44.2 43.7 48.4 66.5 0.0 4.5 5.5 338.0 278.0 75.4 161.0 48.3 2.3 14.7 22.9 5.4 21.5 21.8 33.1 0.0 14.9 375.9 1.5 5.9 72.0 6.5 18.9 255.1 118.6 6.0 94.8 0.2 11.2 26.0 371.3 23.0 15.1 257.0 8.5 128.2 7.2 589.0 0.0 0.3 4.1 42.7 458.8 2037.4 21.3 335.5 699.2 1117.1 6.5 444.5 64.6 565.4 0.0 0.7 114.3 28.2 217.0 334.9 285.5 1.7 9.3 14.6 5.0 105.2 193.0 278.7 16.2 6.7 10.6 189.9 20.2 441.4 29.1 4.9 44.4 ENDOG ENSG00000167136 "Endonuclease G" Q14249 9 128818500-128822676 "Plasma proteins, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 135.2" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 111.4;Late spermatids: 147.4;Respiratory ciliated cells: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021335, HPA021830" Approved "Intracellular and membrane" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA021335: AB_1848151, HPA021830: AB_1848152" "unprognostic (1.35e-1)" "unprognostic (3.41e-1)" "unprognostic (4.86e-2)" "prognostic favorable (5.12e-4)" "unprognostic (2.51e-1)" "unprognostic (3.95e-1)" "unprognostic (6.56e-2)" "unprognostic (2.64e-2)" "unprognostic (4.90e-1)" "unprognostic (6.97e-2)" "unprognostic (8.35e-3)" "unprognostic (1.03e-1)" "prognostic favorable (1.06e-7)" "unprognostic (1.69e-2)" "unprognostic (1.81e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" 11.2 18.8 19.7 2.9 20.0 4.4 11.9 23.7 25.1 9.3 27.0 16.8 12.5 9.3 1.8 17.5 12.6 1.7 52.2 20.1 22.5 24.3 52.9 9.9 3.3 23.4 20.8 8.1 22.5 12.0 13.7 3.6 19.5 14.9 5.7 2.0 14.9 7.0 135.2 13.6 11.5 3.0 20.3 9.2 18.4 20.6 22.6 3.8 11.9 59.1 3.1 11.8 11.0 22.9 14.2 15.3 3.9 20.7 10.0 8.5 17.5 13.4 6.9 12.4 8.6 9.3 11.2 4.6 11.9 8.8 7.7 39.6 12.5 11.8 2.2 9.0 22.4 8.0 14.6 16.7 4.5 24.8 29.3 8.9 14.1 7.5 5.1 7.6 9.6 15.2 25.4 7.1 7.9 20.9 19.4 51.1 9.7 24.6 56.4 22.9 4.5 48.2 18.8 5.1 34.0 33.8 30.0 27.2 7.4 2.6 26.1 12.2 9.8 8.7 5.2 12.5 10.2 22.2 3.3 8.9 17.5 17.6 9.1 0.0 1.1 0.7 1.3 2.0 1.2 1.5 1.3 0.6 1.8 2.8 1.2 1.4 0.0 1.3 0.9 3.6 0.6 0.6 19.7 20.0 23.7 25.1 20.1 22.5 23.4 20.8 19.5 20.3 22.6 22.9 19.0 9.6 5.5 13.1 11.4 8.8 26.9 12.8 6.2 14.0 28.7 21.7 0.6 20.0 16.8 23.9 4.2 31.9 26.9 55.1 101.8 6.0 97.1 111.4 15.1 9.3 14.4 16.8 4.6 7.9 34.4 14.9 21.4 30.1 1.3 93.0 10.0 80.3 20.0 11.8 8.3 27.2 18.3 17.7 7.7 147.4 18.6 15.6 10.6 4.7 6.4 37.2 10.3 3.0 7.8 7.8 24.1 18.8 11.0 18.4 52.0 108.2 115.1 13.1 6.6 23.7 19.0 74.9 6.6 19.1 14.5 10.1 14.5 44.5 36.6 23.3 ENKD1 "C16orf48, DKFZP434A1319, FBB11" ENSG00000124074 "Enkurin domain containing 1" Q9H0I2 16 67662945-67667265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 34.2;Endometrial ciliated cells: 38.3;Respiratory ciliated cells: 42.5;Spermatocytes: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041163, HPA041478" Approved Approved "Plasma membrane,Centrosome,Cytosol" Yes No "Cluster 8: Neutrophils - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Centrosome" Cytosol "HPA041163: AB_10794986, HPA041478: AB_10794668" "unprognostic (6.02e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-3)" "prognostic favorable (1.68e-4)" "unprognostic (4.41e-1)" "unprognostic (1.06e-1)" "unprognostic (3.78e-3)" "unprognostic (1.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (5.69e-2)" "unprognostic (6.58e-2)" "unprognostic (1.67e-1)" "unprognostic (2.44e-1)" "unprognostic (3.31e-2)" "unprognostic (2.23e-1)" "unprognostic (9.60e-2)" 12.8 12.8 8.4 4.6 8.3 3.5 14.9 22.0 11.5 23.2 13.6 28.6 3.9 21.2 5.6 8.6 30.7 3.6 13.2 8.2 8.6 26.6 11.6 14.7 2.2 9.9 10.9 21.2 67.2 16.0 25.6 3.3 8.4 20.6 2.7 8.5 13.7 9.2 9.5 12.1 11.1 4.4 10.0 11.9 15.9 41.1 9.1 4.7 22.3 1.6 2.5 21.5 14.2 8.5 11.1 7.5 17.2 8.0 5.6 5.8 8.5 8.5 5.1 6.7 8.1 5.5 16.5 4.1 14.3 5.3 0.0 12.7 4.5 10.2 8.2 6.5 10.2 4.1 25.7 13.1 9.1 7.4 5.4 5.1 7.3 9.1 8.2 15.4 5.5 13.3 6.9 2.5 3.5 5.7 8.2 30.9 8.2 11.5 3.0 28.5 1.8 31.3 7.2 1.1 17.4 18.9 18.2 1.8 9.7 3.9 15.8 10.5 14.3 8.1 11.4 15.2 0.1 19.1 9.2 4.5 12.3 10.8 2.5 0.0 0.4 0.0 0.1 0.1 0.4 0.2 0.3 0.2 0.1 0.0 0.2 0.3 0.9 0.2 0.2 1.3 0.0 0.1 8.4 8.3 22.0 11.5 8.2 8.6 9.9 10.9 8.4 10.0 9.1 8.5 8.8 22.4 14.4 8.8 1.7 6.9 5.9 6.2 4.0 3.6 10.4 11.2 5.5 10.0 4.0 9.2 4.2 3.1 1.5 4.4 1.9 13.1 34.2 38.3 10.5 8.6 13.2 2.1 2.1 10.7 2.4 7.5 1.5 9.5 1.3 7.4 10.4 26.4 4.7 3.3 2.2 6.0 2.0 3.2 4.3 20.6 13.1 2.6 5.4 0.0 3.0 8.8 0.0 2.5 1.7 9.5 1.4 14.3 2.6 6.0 1.8 7.3 42.5 10.5 6.6 9.1 8.0 37.0 7.9 1.2 5.3 3.4 1.9 11.6 4.9 4.4 EPX "EPO, EPP, EPX-PEN" ENSG00000121053 "Eosinophil peroxidase" P11678 17 58192726-58205174 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "bone marrow: 33.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.5;Inhibitory neurons: 1.2;Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 23 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.2" "Cell line enriched" "Detected in some" 68 "NB-4: 248.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA076792 Enhanced NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA076792: " "unprognostic (5.67e-2)" "unprognostic (1.73e-2)" "unprognostic (3.36e-2)" "unprognostic (3.30e-1)" "unprognostic (2.18e-1)" "unprognostic (1.34e-3)" "unprognostic (4.83e-1)" "unprognostic (3.16e-2)" "unprognostic (1.41e-1)" "unprognostic (1.52e-2)" "unprognostic (1.71e-4)" "unprognostic (7.38e-2)" "unprognostic (1.64e-1)" "unprognostic (2.02e-1)" "unprognostic (5.43e-2)" "unprognostic (1.02e-2)" "unprognostic (1.73e-1)" 0.0 0.1 0.0 0.2 0.2 33.7 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.5 0.1 0.0 0.0 1.3 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.2 248.2 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ERP29 "C12orf8, ERp28, ERp31, PDI-DB, PDIA9" ENSG00000089248 "Endoplasmic reticulum protein 29" P30040 12 112013348-112023449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039363, HPA039456" Enhanced Uncertain Nucleoplasm,Microtubules "Intracellular and membrane" NA NA 900000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Microtubules Nucleoplasm "HPA039363: AB_10673422, HPA039456: AB_10672963" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.43e-5)" "unprognostic (1.13e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (1.21e-1)" "unprognostic (5.10e-3)" "unprognostic (2.58e-1)" "unprognostic (3.21e-1)" "unprognostic (2.74e-3)" "unprognostic (3.34e-1)" "unprognostic (1.76e-1)" "unprognostic (6.26e-2)" 62.7 100.9 56.9 77.9 58.0 202.3 84.0 65.1 62.0 78.4 91.1 94.5 100.7 60.5 109.8 91.5 74.8 64.1 59.0 56.0 68.7 93.0 179.9 78.8 123.8 61.1 62.6 78.9 174.6 123.6 99.1 73.0 64.2 93.4 91.3 68.3 122.7 87.4 34.3 113.3 96.1 47.1 57.8 118.3 131.4 57.6 60.8 107.6 90.4 34.3 111.2 75.9 71.0 61.6 145.4 137.2 98.8 194.2 367.4 143.7 211.3 139.2 163.7 108.5 139.3 215.2 164.4 152.7 106.4 244.5 117.8 175.4 187.8 181.2 89.3 133.7 104.2 174.3 150.1 239.2 246.8 432.1 164.0 207.5 227.6 178.4 201.6 287.4 156.1 157.9 203.2 277.3 84.7 166.6 140.9 765.7 161.5 513.1 102.5 114.2 120.9 501.2 229.8 213.5 88.6 119.8 173.6 140.1 426.1 187.4 177.1 575.7 116.5 92.6 142.7 88.8 103.3 303.4 379.8 128.0 157.8 268.5 73.2 96.2 241.4 346.2 131.6 178.8 140.4 259.1 170.7 164.1 229.7 264.1 186.5 154.9 47.5 86.5 170.9 455.8 179.6 307.4 56.9 58.0 65.1 62.0 56.0 68.7 61.1 62.6 64.2 57.8 60.8 61.6 102.6 83.3 183.4 13.7 324.8 141.4 205.5 249.3 132.6 125.3 207.8 199.9 91.6 198.8 178.0 185.8 110.5 497.7 396.6 210.1 93.9 239.5 7.7 142.1 84.9 114.9 197.9 134.4 14.4 211.8 405.3 118.3 131.5 149.9 88.8 164.4 146.3 346.6 373.1 80.8 20.6 280.6 343.8 306.9 192.6 16.6 128.9 230.4 168.9 12.2 269.0 152.8 160.6 11.6 22.8 128.7 288.0 106.8 350.1 195.4 355.5 274.6 187.0 164.9 52.6 79.2 112.2 100.3 195.3 143.1 161.0 441.6 221.7 252.4 285.2 219.8 EVA1B "C1orf78, FAM176B, FLJ10647" ENSG00000142694 "Eva-1 homolog B" Q9NVM1 1 36322031-36324154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 143.9;Extravillous trophoblasts: 250.3;Syncytiotrophoblasts: 161.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.3;BJ: 29.0;BJ hTERT+: 22.4;HSkMC: 20.4;NB-4: 41.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041928, HPA043537" Approved Approved Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "HPA041928: AB_2677752, HPA043537: AB_2678538" "prognostic favorable (4.58e-4)" "unprognostic (5.66e-3)" "unprognostic (1.04e-3)" "unprognostic (3.20e-2)" "unprognostic (1.22e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (4.82e-4)" "unprognostic (1.45e-1)" "unprognostic (8.33e-2)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.79e-5)" "unprognostic (1.87e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" 26.8 19.4 5.5 3.4 5.4 2.0 35.8 5.5 6.4 41.8 7.5 19.8 2.5 34.0 0.6 12.2 21.9 1.3 19.9 5.0 5.9 39.2 8.5 26.1 1.9 6.8 6.4 30.2 7.8 1.9 9.4 9.0 6.0 29.0 0.4 0.0 28.7 2.9 5.7 24.0 15.8 1.6 7.0 37.6 14.2 7.5 6.6 0.5 33.9 1.0 0.5 22.0 30.1 5.7 0.7 2.7 1.6 3.0 7.9 23.3 6.8 29.0 22.4 5.4 6.3 0.2 2.1 0.0 8.5 9.2 1.0 0.2 0.2 1.1 1.1 3.3 6.0 3.6 0.6 1.3 17.4 0.1 0.6 20.4 0.0 6.9 0.3 0.9 8.7 0.1 1.4 1.0 3.6 0.2 0.1 41.7 1.7 0.0 10.4 1.5 0.3 7.1 4.6 0.0 0.1 3.9 2.8 1.1 13.3 1.1 0.0 2.7 12.7 7.9 0.0 10.5 2.7 0.3 0.0 0.1 2.9 1.8 7.1 4.0 0.9 0.0 0.2 0.3 0.6 0.0 0.3 0.5 0.5 0.0 0.0 0.0 1.7 1.6 0.1 0.0 1.2 0.1 5.5 5.4 5.5 6.4 5.0 5.9 6.8 6.4 6.0 7.0 6.6 5.7 82.8 0.0 0.0 2.3 6.2 16.2 19.3 7.3 0.0 0.0 143.9 90.6 2.2 1.5 5.1 7.3 0.0 54.7 8.4 0.3 1.9 20.2 7.1 9.4 88.4 53.9 0.0 0.8 0.0 15.2 250.3 56.6 0.0 15.2 4.5 15.7 84.9 0.9 48.7 0.0 0.0 0.1 6.1 41.3 28.8 24.8 50.7 30.4 12.4 5.6 10.2 14.1 4.1 0.0 0.1 28.9 1.1 48.5 7.9 56.6 0.4 7.7 5.6 0.9 26.3 7.8 98.4 8.4 3.3 0.7 12.4 161.3 9.7 58.2 0.5 30.3 EXOSC1 "CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p" ENSG00000171311 "Exosome component 1" Q9Y3B2 10 97435909-97446017 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038370 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 22: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" Nucleoplasm "HPA038370: AB_10672515" "unprognostic (1.77e-2)" "unprognostic (1.08e-2)" "unprognostic (1.32e-2)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (1.10e-2)" "unprognostic (3.27e-3)" "unprognostic (2.33e-2)" "unprognostic (1.62e-2)" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.88e-9)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (4.41e-2)" 21.9 25.4 31.4 23.5 34.3 28.7 22.4 50.4 39.9 25.5 27.7 25.6 24.3 24.0 42.6 28.4 22.2 17.0 23.5 29.7 33.6 25.3 26.9 20.5 32.3 33.3 32.2 23.6 38.8 21.1 24.2 17.6 32.6 24.5 23.5 21.2 26.6 17.3 29.0 23.5 22.3 22.1 32.6 30.3 31.2 15.2 32.8 32.5 21.6 14.8 31.9 25.3 22.9 36.3 62.9 49.6 34.8 61.7 42.1 44.3 47.0 52.2 73.9 57.2 64.4 86.5 62.1 60.4 59.0 50.2 44.1 64.0 52.5 58.9 56.6 77.3 61.3 39.5 48.0 68.9 74.5 94.2 46.1 45.8 77.9 69.6 101.3 70.2 66.3 90.5 45.6 108.0 43.2 70.3 88.0 153.3 58.1 64.7 43.2 65.8 43.4 106.4 39.4 32.8 20.4 38.3 38.6 30.0 87.6 44.1 71.2 113.2 43.6 31.9 40.1 50.4 117.6 72.5 103.1 119.5 54.3 113.2 26.3 79.0 91.0 93.5 75.5 132.8 96.5 109.6 93.1 87.9 96.4 94.7 89.4 78.1 35.7 57.9 121.7 82.9 144.0 86.4 31.4 34.3 50.4 39.9 29.7 33.6 33.3 32.2 32.6 32.6 32.8 36.3 22.5 25.6 24.6 15.0 42.4 19.1 35.7 59.3 18.2 31.0 22.5 27.3 20.5 27.1 35.8 44.1 27.1 48.6 41.2 15.4 39.2 36.0 17.4 22.6 24.1 27.7 14.3 23.8 24.7 41.8 58.1 27.0 21.9 16.7 25.3 31.0 34.6 25.3 50.9 30.3 22.2 28.1 36.7 31.4 20.7 17.0 32.6 28.7 30.2 17.8 61.0 29.1 61.8 12.1 25.5 35.9 20.0 24.0 43.6 24.9 30.1 53.8 47.1 48.1 26.3 20.7 35.2 35.8 39.1 27.6 24.4 41.2 44.3 26.4 25.7 31.7 EXOSC7 "EAP1, hRrp42p, KIAA0116, p8, RRP42, Rrp42p" ENSG00000075914 "Exosome component 7" Q15024 3 44975241-45036066 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036182, HPA057980" Approved Supported "Nuclear speckles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" "HPA036182: AB_10673346, HPA057980: AB_2683571" "unprognostic (1.69e-2)" "unprognostic (3.92e-3)" "unprognostic (1.84e-3)" "unprognostic (4.97e-2)" "unprognostic (3.00e-3)" "unprognostic (2.16e-1)" "unprognostic (2.34e-3)" "unprognostic (2.21e-2)" "unprognostic (2.96e-1)" "unprognostic (7.85e-2)" "unprognostic (1.20e-1)" "unprognostic (7.67e-3)" "prognostic favorable (2.69e-4)" "unprognostic (4.33e-1)" "unprognostic (7.30e-2)" "unprognostic (2.94e-1)" "unprognostic (1.20e-1)" 17.5 44.1 9.5 12.5 9.5 17.2 18.4 10.0 10.4 23.5 10.7 15.3 11.6 20.4 7.0 27.2 17.0 9.1 27.0 9.5 10.9 22.2 18.1 15.0 19.6 10.4 9.8 19.0 18.6 20.1 17.3 15.4 10.1 15.9 10.8 5.9 17.5 15.9 43.8 44.6 13.2 11.2 9.7 15.3 20.0 23.2 10.5 20.2 19.9 36.4 16.8 22.7 22.2 9.8 61.5 55.7 44.9 37.3 45.9 50.0 40.5 26.2 42.2 56.0 57.7 93.3 47.8 77.4 40.3 45.6 42.6 33.9 55.9 72.2 46.0 52.3 49.2 67.5 64.5 91.5 88.7 95.3 26.5 44.1 45.6 61.2 123.6 36.5 54.8 84.9 107.4 37.8 40.3 63.2 68.6 167.9 54.3 55.2 78.4 33.8 41.7 117.7 51.0 85.5 20.9 31.4 37.0 31.6 39.7 38.4 46.7 77.9 39.3 28.8 43.0 48.3 71.7 47.1 47.5 92.6 42.4 131.6 26.2 6.8 41.3 7.6 38.8 41.5 43.6 71.3 44.6 40.2 66.0 59.7 51.8 41.4 2.1 58.3 31.5 40.2 47.7 45.4 9.5 9.5 10.0 10.4 9.5 10.9 10.4 9.8 10.1 9.7 10.5 9.8 25.0 35.3 30.1 16.0 23.2 61.8 68.8 97.2 47.3 29.5 23.9 43.2 39.0 21.5 46.5 35.0 18.8 67.8 22.1 8.6 135.0 51.7 3.9 23.7 34.8 24.0 13.1 19.6 19.9 46.7 62.4 32.7 23.0 21.7 15.2 33.0 18.2 28.6 46.5 20.2 22.5 19.3 79.3 14.2 22.6 8.3 47.8 17.4 26.6 8.4 20.6 37.6 33.0 10.6 14.0 41.7 10.3 41.0 19.4 74.8 17.7 47.4 34.3 23.4 13.1 25.7 53.9 53.7 66.3 35.5 74.2 63.1 26.2 52.2 24.3 56.3 FAAP100 "C17orf70, FLJ22175" ENSG00000185504 "FA core complex associated protein 100" Q0VG06 17 81539885-81553961 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023954, HPA024626, HPA026532" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.91e-1)" "unprognostic (1.85e-2)" "unprognostic (4.87e-3)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (3.49e-2)" "unprognostic (1.05e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (9.85e-2)" "unprognostic (4.24e-1)" 14.7 16.8 6.7 13.8 7.0 10.1 15.9 14.7 9.5 18.6 6.8 15.8 12.0 17.3 3.1 16.2 18.8 9.5 16.3 6.7 6.4 21.2 22.7 16.0 15.9 8.1 6.5 19.5 26.6 7.8 22.4 7.2 6.3 20.7 4.9 3.7 14.6 7.8 13.2 16.1 18.8 6.9 5.1 38.1 15.5 13.3 7.3 8.8 24.1 6.0 7.3 17.9 15.5 8.8 11.7 21.3 9.4 26.8 11.0 11.5 14.6 11.2 5.9 14.3 8.9 14.5 14.0 21.0 8.6 15.5 13.8 15.0 4.9 14.5 3.3 6.1 13.9 13.5 23.3 20.0 11.6 15.4 16.0 14.0 10.7 10.4 11.7 17.6 27.0 22.0 20.7 16.5 7.0 23.0 24.4 25.8 11.3 13.6 7.7 22.1 9.4 19.3 10.4 21.1 20.5 17.1 8.5 24.4 10.4 9.7 26.2 20.7 22.8 30.6 18.8 8.3 18.9 18.3 1.5 10.7 8.0 9.9 14.3 0.0 3.0 1.2 2.4 2.8 1.9 3.0 1.6 1.6 2.9 2.0 1.5 1.2 0.4 2.4 1.4 3.2 1.6 2.2 6.7 7.0 14.7 9.5 6.7 6.4 8.1 6.5 6.3 5.1 7.3 8.8 11.4 3.2 7.5 0.0 7.5 0.0 3.5 0.0 4.6 10.3 9.8 10.9 8.9 10.0 2.5 14.7 4.2 6.1 8.5 7.1 3.9 8.2 1.9 4.5 7.3 7.5 7.3 11.8 0.0 6.9 4.8 8.3 15.8 6.8 0.0 14.9 6.8 11.7 8.4 6.7 0.0 6.2 0.0 14.1 0.0 3.0 5.0 7.0 0.0 0.0 8.9 6.2 4.1 0.0 0.0 8.9 4.4 5.3 6.6 5.3 12.7 6.8 1.5 4.9 0.0 7.4 6.4 7.3 7.5 9.5 0.0 3.1 6.2 10.7 7.3 3.6 FABP2 I-FABP ENSG00000145384 "Fatty acid binding protein 2" P12104 4 119317250-119322138 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 173 "intestine: 550.0" "Cell type enriched" "Detected in some" 10 "Proximal enterocytes: 5965.8" "Group enriched" "Detected in some" 9 "colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basophil: 1.6;neutrophil: 4.2" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.2" "Cell line enhanced" "Detected in some" "NB-4: 1.2;RPMI-8226: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA034607, CAB047325, CAB047326" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 61000 "Cluster 1: Neutrophils - Mixed function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" "Actin filaments, Cytosol" "Plasma membrane" "CAB047325: , CAB047326: , HPA034607: AB_10601317" "unprognostic (3.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (4.58e-1)" "unprognostic (1.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.69e-4)" "unprognostic (1.93e-1)" "unprognostic (1.02e-1)" 0.2 0.1 0.1 3.1 0.1 0.9 0.0 0.6 0.2 0.0 0.4 28.2 291.0 0.3 0.1 0.1 0.2 0.1 0.6 0.2 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 35.2 0.3 0.0 0.0 0.1 0.4 550.0 1.9 0.0 0.1 0.7 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.3 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.2 0.0 0.2 0.1 0.0 0.0 1.6 0.4 0.4 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.2 4.2 0.4 0.1 0.3 0.3 0.0 0.1 0.1 0.6 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 1.8 0.0 0.0 0.0 242.0 0.0 0.0 0.0 1.4 0.1 0.1 1.2 0.0 0.0 0.2 0.1 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 570.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 383.1 0.0 0.0 0.0 5965.8 17.3 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 222.5 0.0 FAM193A "C4orf8, RES4-22" ENSG00000125386 "Family with sequence similarity 193 member A" P78312 4 2536647-2732573 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043116 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA043116: AB_10795767" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (1.17e-3)" "unprognostic (1.97e-1)" "unprognostic (3.66e-3)" "unprognostic (6.34e-3)" "unprognostic (1.02e-1)" "unprognostic (7.16e-2)" "unprognostic (4.84e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.38e-2)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (3.47e-2)" "unprognostic (5.55e-2)" "unprognostic (4.96e-3)" 14.3 11.7 9.7 7.6 9.3 13.0 13.2 15.1 11.5 14.8 9.6 13.4 7.9 13.8 6.8 9.6 12.9 6.0 9.7 9.5 9.7 11.9 11.6 10.1 9.6 9.8 9.0 15.0 11.1 9.2 15.5 7.6 9.3 12.1 6.0 8.9 10.1 7.0 15.1 13.2 12.3 8.0 6.9 12.0 10.5 21.1 10.5 12.4 12.2 8.7 6.7 11.5 11.2 11.8 8.7 10.7 20.0 11.3 12.0 12.2 10.5 13.1 11.3 12.7 10.8 10.9 13.9 17.1 7.7 14.7 15.7 7.4 14.0 9.4 10.8 10.3 8.9 25.7 14.3 11.5 14.4 15.8 17.2 13.3 9.8 12.7 13.0 11.6 12.8 10.0 18.2 18.5 10.8 9.4 25.5 25.6 15.9 8.9 11.8 24.7 10.3 8.4 8.7 11.1 17.1 14.6 11.2 7.8 11.3 10.9 14.3 15.9 17.4 19.2 11.3 10.5 17.5 18.0 14.5 16.1 10.7 12.8 13.8 3.3 0.9 0.8 0.8 0.6 0.6 0.6 0.7 1.2 0.6 0.9 0.7 1.1 1.8 1.3 3.1 1.7 0.6 0.5 9.7 9.3 15.1 11.5 9.5 9.7 9.8 9.0 9.3 6.9 10.5 11.8 21.8 12.8 18.2 62.7 11.2 9.4 6.7 6.5 9.1 25.7 10.5 9.0 14.7 4.3 15.6 1.8 47.9 7.3 20.0 12.9 1.9 9.4 8.9 19.8 21.8 19.4 14.4 17.9 62.4 7.5 7.1 13.2 15.8 27.1 8.8 30.2 11.0 6.3 8.7 15.2 70.8 11.1 8.2 7.6 11.6 13.4 17.1 15.9 14.2 51.5 11.1 15.8 11.3 45.8 58.3 10.1 11.0 14.7 12.4 11.3 11.4 2.8 5.6 26.2 6.6 20.5 17.5 36.2 32.4 9.6 9.9 5.6 14.4 13.6 9.6 9.2 FARSA "CML33, FARSL, FARSLA" ENSG00000179115 "Phenylalanyl-tRNA synthetase subunit alpha" Q9Y285 19 12922479-12934037 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001911 Enhanced Approved Cytosol NA NA 55000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA001911: AB_1848427" "unprognostic (1.52e-1)" "prognostic favorable (8.23e-4)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.22e-4)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (4.93e-3)" "unprognostic (5.76e-2)" "unprognostic (2.86e-1)" "unprognostic (1.24e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-2)" "unprognostic (1.45e-3)" "prognostic favorable (8.32e-4)" "unprognostic (2.59e-1)" "unprognostic (8.25e-2)" "unprognostic (1.84e-2)" 26.4 32.5 30.1 29.4 32.2 31.6 25.0 28.1 40.0 21.8 19.4 29.1 26.2 24.3 12.1 39.2 24.0 16.4 37.4 33.4 32.7 29.1 40.6 20.7 36.0 32.6 31.8 23.1 36.3 30.4 32.1 22.5 33.4 25.5 17.1 14.7 30.4 21.7 57.0 33.3 26.5 17.7 24.3 32.0 30.6 22.6 30.6 33.0 25.5 30.6 25.4 30.6 25.6 31.1 135.7 125.6 49.3 106.9 33.4 31.4 88.9 93.6 60.8 133.0 103.9 154.2 56.1 148.7 147.1 54.1 53.9 101.9 121.0 108.4 48.1 87.9 183.7 117.0 106.8 124.2 108.4 227.7 147.8 43.4 78.7 102.8 82.1 43.8 73.1 148.7 179.6 30.6 56.7 181.5 273.4 283.5 154.2 83.4 210.6 139.5 51.2 191.4 70.5 78.7 153.8 141.4 64.2 109.2 69.0 23.0 85.9 137.5 71.3 108.0 47.8 165.6 180.6 199.6 186.5 156.8 97.7 203.4 114.1 66.6 111.0 86.3 87.1 119.0 108.2 88.2 85.1 81.4 120.4 94.5 85.4 82.3 7.0 118.0 92.8 97.0 87.6 130.2 30.1 32.2 28.1 40.0 33.4 32.7 32.6 31.8 33.4 24.3 30.6 31.1 15.0 9.6 21.4 9.1 24.7 25.4 28.0 63.4 20.5 25.1 18.8 18.5 25.7 14.3 35.4 23.9 10.4 87.5 17.5 26.7 58.7 55.4 5.8 16.0 18.6 20.0 22.8 61.8 12.1 46.4 78.7 18.4 27.5 15.8 23.5 26.3 21.0 25.8 62.9 18.5 12.8 32.6 69.2 23.5 21.2 9.4 19.0 19.7 33.8 1.9 45.5 23.6 25.7 8.5 7.5 47.0 26.3 13.2 40.9 32.6 30.4 55.7 22.3 17.1 6.6 16.5 24.3 20.2 41.9 26.3 29.5 96.7 22.5 28.9 44.7 26.8 FBRSL1 KIAA1545 ENSG00000112787 "Fibrosin like 1" Q9HCM7 12 132489551-132585188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 90.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049880 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA049880: AB_2680930" "unprognostic (2.02e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-2)" "unprognostic (7.75e-2)" "unprognostic (3.21e-1)" "unprognostic (2.59e-2)" "unprognostic (1.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-3)" "prognostic unfavorable (9.82e-4)" "prognostic favorable (1.17e-4)" "unprognostic (1.13e-1)" "unprognostic (3.39e-1)" "unprognostic (1.09e-2)" "prognostic favorable (7.21e-4)" 12.3 19.2 16.3 8.7 13.1 10.1 13.2 20.7 21.2 17.8 7.2 20.5 11.2 18.6 7.7 15.6 18.7 4.1 31.1 16.2 6.7 19.3 26.8 16.2 8.5 10.0 7.7 22.3 39.2 7.3 28.7 5.7 8.0 22.0 3.6 5.9 14.7 7.2 31.9 19.4 23.3 4.1 4.7 28.3 21.4 29.1 9.6 6.2 15.7 9.4 4.7 17.8 15.7 10.2 11.7 18.5 8.7 14.8 3.7 4.5 64.4 10.9 3.1 7.1 4.3 32.7 6.9 19.0 18.4 3.6 6.1 22.6 9.3 6.1 2.3 14.7 47.6 23.2 11.0 25.0 8.0 24.7 23.4 4.1 10.7 6.6 4.8 6.5 7.0 15.9 49.9 3.8 3.1 29.8 33.7 90.0 22.7 8.4 33.4 50.9 9.3 13.2 6.2 11.2 33.4 28.0 10.2 15.8 14.1 3.6 18.6 23.7 11.1 7.6 18.5 13.7 13.9 24.6 13.0 12.0 8.8 23.8 9.4 1.2 0.4 1.2 0.3 0.3 0.3 0.8 0.3 0.3 0.3 0.6 0.3 0.4 0.5 0.2 0.7 1.0 0.6 0.3 16.3 13.1 20.7 21.2 16.2 6.7 10.0 7.7 8.0 4.7 9.6 10.2 14.9 3.2 5.2 24.2 12.8 9.2 7.1 3.3 11.4 28.9 20.7 18.5 13.7 4.3 4.0 11.0 41.7 6.9 19.8 24.0 7.9 6.2 1.4 16.8 17.9 8.8 31.0 12.0 17.0 7.6 5.8 11.8 15.3 22.0 1.3 22.6 7.5 22.2 6.9 11.8 17.1 21.7 0.0 11.6 11.1 2.0 16.1 16.4 5.4 15.0 7.7 9.3 6.2 12.5 16.8 9.0 15.0 15.4 11.9 16.0 13.3 6.4 6.4 22.7 6.6 12.7 11.5 5.7 8.0 10.8 10.4 11.5 10.9 12.7 18.7 10.4 FBXL12 "Fbl12, FLJ20188" ENSG00000127452 "F-box and leucine rich repeat protein 12" Q9NXK8 19 9810267-9827816 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002843 Approved Approved Mitochondria NA NA "Cluster 44: Non-specific - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 33: Fibroblasts - ECM organization" Mitochondria "HPA002843: AB_2666679" "unprognostic (7.65e-2)" "unprognostic (5.88e-2)" "unprognostic (7.72e-2)" "unprognostic (3.82e-2)" "unprognostic (8.21e-2)" "prognostic favorable (3.21e-4)" "prognostic unfavorable (1.41e-4)" "unprognostic (6.45e-2)" "prognostic unfavorable (4.96e-4)" "unprognostic (1.38e-3)" "unprognostic (1.49e-2)" "unprognostic (4.07e-3)" "unprognostic (9.28e-3)" "unprognostic (1.41e-1)" "unprognostic (1.36e-1)" "unprognostic (2.61e-1)" "unprognostic (4.77e-3)" 20.0 15.0 8.9 10.4 9.6 27.1 19.1 12.0 10.4 21.5 9.5 22.5 14.9 23.5 10.8 17.2 22.6 9.0 17.0 8.7 9.0 19.4 22.4 17.3 12.8 10.5 8.8 23.9 14.6 7.1 17.5 15.1 10.2 19.5 10.5 6.4 13.5 10.7 19.0 16.6 21.0 11.1 8.0 18.2 17.3 13.2 9.9 44.0 17.6 9.4 8.9 23.6 18.2 10.9 18.8 9.3 21.1 20.6 23.5 20.8 24.1 19.9 20.1 21.2 24.9 28.9 12.1 17.5 31.2 20.1 16.4 17.7 16.0 17.6 16.8 17.7 30.9 33.9 21.1 28.8 30.2 24.8 20.1 29.9 11.5 20.4 18.0 15.6 15.1 44.6 26.2 35.6 11.2 14.9 36.3 76.3 24.3 11.4 17.2 21.5 15.7 31.7 15.3 25.2 13.1 17.9 14.7 10.8 23.4 19.5 15.0 29.1 18.1 29.1 14.1 39.3 20.0 47.7 20.1 27.6 12.3 22.2 14.1 33.5 18.4 36.3 19.0 15.9 21.6 16.7 18.4 21.7 20.6 24.1 21.4 17.0 14.3 31.1 15.3 21.8 22.0 15.2 8.9 9.6 12.0 10.4 8.7 9.0 10.5 8.8 10.2 8.0 9.9 10.9 18.5 6.4 9.2 12.7 15.5 7.4 15.8 16.5 18.8 7.3 14.3 15.9 26.8 15.7 10.8 12.9 4.2 42.1 15.4 26.8 5.9 11.7 2.2 9.6 16.4 15.6 12.6 7.8 15.3 9.9 30.3 24.1 15.3 9.9 3.8 14.2 16.4 7.3 17.2 8.4 14.2 17.0 12.2 9.0 10.0 2.8 26.4 11.0 10.6 8.4 17.7 8.4 13.4 12.5 13.0 9.3 23.4 21.8 8.4 13.5 36.8 10.0 9.3 11.9 13.1 13.7 23.0 24.8 20.8 15.3 11.1 63.3 13.3 18.1 19.7 19.3 FDX2 "FDX1L, MGC19604" ENSG00000267673 "Ferredoxin 2" Q6P4F2 19 10310045-10316015 "Disease related genes, Predicted intracellular proteins" "Electron transport, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Ductal cells: 38.5;Exocrine glandular cells: 30.3;Hofbauer cells: 37.0;monocytes: 31.6;Pancreatic endocrine cells: 30.2;Proximal tubular cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 266.8" HPA043986 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA043986: AB_10960282" "unprognostic (1.48e-2)" "unprognostic (3.76e-2)" "unprognostic (7.61e-3)" "unprognostic (3.83e-2)" "unprognostic (1.48e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-3)" "unprognostic (9.70e-3)" "unprognostic (2.29e-1)" "unprognostic (1.42e-3)" "unprognostic (4.92e-2)" "unprognostic (3.73e-2)" "unprognostic (3.93e-2)" "unprognostic (3.14e-1)" "unprognostic (4.74e-2)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" 16.1 27.2 58.1 9.1 59.5 4.9 15.1 53.8 79.8 15.4 55.1 20.5 7.7 16.3 13.2 14.4 13.6 9.8 23.3 60.7 60.6 32.1 28.2 14.1 11.2 54.9 57.9 15.3 20.0 29.9 28.8 9.3 58.7 20.2 6.8 4.4 14.0 16.0 24.6 12.6 11.5 13.3 52.3 15.2 17.4 12.1 57.8 8.7 24.4 22.1 7.9 19.5 13.9 61.9 34.9 28.4 19.4 33.4 40.2 31.7 20.2 32.2 51.0 53.6 44.5 41.4 24.5 26.2 59.2 45.9 37.7 26.5 32.3 61.1 20.7 28.6 46.0 38.3 30.0 30.5 58.4 18.7 12.3 28.9 42.6 45.2 44.4 25.9 32.9 30.0 47.2 20.4 61.2 56.2 35.1 266.8 33.8 32.7 52.2 26.3 16.0 39.0 62.1 36.4 42.5 25.7 40.0 46.7 36.6 13.1 39.3 13.7 23.2 73.9 18.6 76.7 48.2 44.9 73.2 42.1 68.6 41.2 39.3 0.0 9.1 0.0 10.8 19.6 14.7 19.7 10.9 14.0 20.9 14.1 13.6 15.6 1.7 24.4 19.0 15.4 15.5 7.7 58.1 59.5 53.8 79.8 60.7 60.6 54.9 57.9 58.7 52.3 57.8 61.9 11.3 9.6 10.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 18.9 18.7 0.0 0.0 4.3 11.0 0.0 14.1 3.5 0.0 29.4 38.5 0.0 5.7 5.1 4.9 0.0 0.0 0.0 30.3 19.5 5.7 0.0 4.3 2.5 5.5 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 31.6 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.9 0.0 0.0 69.9 5.8 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 7.9 2.1 5.7 0.0 0.0 FGFR1OP2 DKFZp564O1863 ENSG00000111790 "FGFR1 oncogene partner 2" Q9NVK5 12 26938470-26966650 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 249.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038308, HPA038696" Supported Approved Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 6: Erythroid cells - Oxygen transport" Mitochondria "HPA038308: AB_10672524, HPA038696: AB_10675948" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (1.95e-1)" "unprognostic (2.34e-1)" "unprognostic (4.01e-2)" "unprognostic (1.19e-1)" "unprognostic (4.37e-3)" "unprognostic (1.72e-1)" "unprognostic (8.17e-2)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (3.41e-2)" "unprognostic (1.55e-2)" "unprognostic (6.82e-2)" "unprognostic (1.40e-1)" "unprognostic (5.33e-2)" "unprognostic (1.36e-2)" 29.4 41.6 29.0 30.6 32.6 61.6 26.3 28.6 48.3 24.9 21.0 23.1 23.1 31.6 29.0 23.1 23.7 28.7 28.5 34.2 28.1 30.9 27.8 25.7 42.4 29.2 28.6 59.5 15.1 19.3 17.8 27.1 29.3 19.9 20.0 30.7 18.2 18.6 23.3 23.5 22.9 26.6 29.8 33.2 20.5 23.0 27.5 36.2 24.1 32.8 30.9 25.2 21.1 44.3 30.3 36.9 30.5 41.1 51.9 37.4 44.2 51.6 60.1 39.1 42.5 57.3 34.4 44.3 24.8 45.9 37.4 31.4 21.3 38.8 55.5 33.6 31.1 75.0 39.4 38.4 61.3 43.5 54.9 27.3 24.8 47.7 61.6 53.3 56.8 39.6 45.3 33.0 46.2 36.3 58.0 103.3 50.4 39.1 59.9 34.6 84.2 37.1 34.8 36.5 9.3 18.5 58.9 21.5 52.1 69.9 38.5 65.3 61.7 51.6 52.0 95.9 48.5 23.1 25.2 93.4 43.2 50.2 42.7 81.1 31.5 40.6 31.6 31.4 28.3 22.3 33.0 30.7 25.2 19.7 29.8 33.3 32.0 25.9 31.3 20.6 61.3 23.7 29.0 32.6 28.6 48.3 34.2 28.1 29.2 28.6 29.3 29.8 27.5 44.3 70.8 38.5 37.2 39.2 97.1 140.3 62.3 30.6 86.0 52.7 45.4 39.6 45.4 24.3 41.2 27.6 77.2 41.5 114.1 19.9 72.4 28.9 17.9 28.9 47.8 70.1 26.9 249.0 79.4 23.1 37.8 86.5 23.0 30.8 59.5 77.9 70.6 30.7 60.6 58.9 30.6 22.0 26.4 64.7 96.2 18.8 105.3 74.6 88.9 47.8 49.6 64.3 83.4 63.8 128.5 29.7 29.0 170.8 138.2 56.7 27.2 70.0 20.8 48.0 46.0 69.6 81.4 32.9 70.1 57.4 119.8 59.5 141.2 42.9 20.0 63.5 FRG1 "FRG1A, FSG1" ENSG00000109536 "FSHD region gene 1" Q14331 4 189940870-189963202 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Myogenesis, Ribosome biogenesis, rRNA processing" "Actin-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA075683 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" "HPA075683: " "unprognostic (1.67e-1)" "unprognostic (1.04e-2)" "unprognostic (1.24e-1)" "unprognostic (1.52e-1)" "unprognostic (5.56e-2)" "unprognostic (7.14e-2)" "unprognostic (5.62e-2)" "unprognostic (9.60e-2)" "unprognostic (6.45e-3)" "unprognostic (2.83e-3)" "unprognostic (2.55e-1)" "unprognostic (2.42e-1)" "unprognostic (3.84e-3)" "prognostic favorable (9.65e-4)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.01e-1)" 36.8 25.7 6.0 6.4 6.0 16.6 33.9 6.1 13.0 29.5 6.1 35.0 6.6 32.9 9.6 30.7 27.6 5.9 31.9 6.0 6.1 29.2 24.8 23.5 7.9 6.0 6.0 32.0 30.6 13.1 18.5 5.9 6.0 21.7 7.7 3.6 24.9 7.5 31.1 28.6 26.7 8.6 6.0 29.0 30.0 19.8 6.0 13.0 23.4 9.4 8.4 28.8 28.3 6.1 12.2 8.5 21.5 19.0 11.0 16.4 14.6 18.0 13.4 23.3 15.6 6.1 20.1 21.9 8.5 13.5 8.8 7.3 20.3 13.8 24.6 13.3 9.6 39.4 9.3 4.3 18.8 28.9 14.9 12.1 15.5 12.9 4.2 15.8 15.5 19.1 25.4 42.4 19.0 6.9 38.6 42.7 4.4 5.4 12.8 27.2 4.9 14.4 16.3 6.9 15.8 15.7 11.4 13.0 21.1 11.8 6.7 20.3 15.4 8.8 11.6 6.5 13.4 15.4 12.8 17.6 15.7 18.7 13.1 30.7 13.4 19.7 13.6 18.0 13.8 16.9 16.0 15.1 12.1 15.4 13.6 14.8 13.3 16.9 19.1 13.4 20.1 13.6 6.0 6.0 6.1 13.0 6.0 6.1 6.0 6.0 6.0 6.0 6.0 6.1 69.3 80.1 52.9 6.5 61.9 33.4 42.5 62.9 18.2 43.1 47.6 56.9 70.6 64.3 52.9 33.1 16.7 77.0 82.2 45.6 131.0 106.0 50.4 42.4 51.4 61.1 44.9 94.1 12.5 121.9 65.2 50.9 18.8 40.9 84.2 34.8 83.6 133.8 68.1 32.0 11.6 53.9 50.8 92.6 46.7 20.4 76.1 57.4 21.4 4.7 107.6 61.1 124.6 12.5 17.0 88.4 48.9 72.6 41.9 20.7 60.8 126.2 51.7 52.0 52.6 50.7 84.6 75.9 70.6 27.5 28.1 53.5 64.6 42.8 52.9 32.4 FSCN1 "FLJ38511, p55, SNL" ENSG00000075618 "Fascin actin-bundling protein 1" Q16658 7 5592816-5606655 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 256.5;Hofbauer cells: 274.2;monocytes: 1028.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 600.3;Hep G2: 464.9;K-562: 533.6;NB-4: 600.9;PC-3: 508.2;SH-SY5Y: 482.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000121, HPA005723, CAB035991, HPA050654" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 4300000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 3: Monocytes - Immune response regulation" Cytosol "Plasma membrane" "CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203" "unprognostic (1.91e-1)" "unprognostic (2.03e-2)" "unprognostic (3.12e-2)" "unprognostic (5.00e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (2.28e-4)" "unprognostic (6.31e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.15e-7)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (1.05e-2)" "unprognostic (6.93e-3)" 27.5 39.7 41.5 31.1 62.2 8.3 24.9 26.3 57.2 33.7 10.7 12.1 4.4 19.7 0.7 69.4 15.6 7.6 15.8 39.4 28.2 17.3 8.3 27.6 14.5 49.4 42.7 47.7 5.5 2.3 20.2 27.9 22.8 10.3 1.7 3.4 23.8 2.4 7.3 56.3 12.6 5.7 20.9 55.6 9.3 42.5 79.0 9.0 25.6 2.1 8.3 20.4 41.6 77.1 62.3 139.3 91.2 326.3 34.8 65.4 600.3 144.2 62.4 24.2 26.1 98.5 15.6 1.3 172.0 63.5 24.3 231.3 52.2 229.9 2.1 70.6 28.7 4.8 142.0 464.9 18.0 0.2 13.9 40.8 66.6 46.1 37.2 40.4 118.3 0.7 533.6 0.9 31.6 6.9 2.0 600.9 238.4 4.2 508.2 140.0 22.3 2.3 34.9 5.9 73.1 482.4 121.0 2.6 5.3 58.5 3.9 38.4 246.4 167.4 289.3 99.1 151.0 0.9 0.8 0.7 107.8 0.6 317.2 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 41.5 62.2 26.3 57.2 39.4 28.2 49.4 42.7 22.8 20.9 79.0 77.1 90.0 3.2 4.1 1.6 8.3 181.2 26.7 75.1 189.5 9.4 32.3 44.3 10.4 1.5 13.4 1.8 0.0 6.7 10.8 3.9 0.0 12.8 14.3 8.0 37.8 120.6 42.1 28.0 12.1 5.1 110.8 48.9 10.7 10.1 16.5 256.5 84.6 0.8 274.2 0.0 10.9 5.4 8.2 28.0 136.1 12.3 25.4 27.4 51.6 23.4 1028.2 73.5 0.0 4.5 43.2 15.5 1.1 9.1 4.2 7.5 0.4 0.4 2.9 2.6 0.0 29.7 46.3 5.7 8.0 121.2 147.2 14.6 12.2 8.3 2.6 28.0 GAK DNAJC26 ENSG00000178950 "Cyclin G associated kinase" O14976 4 849276-932373 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 134.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027405, HPA027459, HPA027463" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.24e-3)" "unprognostic (1.07e-1)" "unprognostic (3.50e-3)" "unprognostic (1.68e-1)" "unprognostic (7.07e-2)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (3.33e-3)" "prognostic favorable (1.70e-6)" "unprognostic (1.09e-3)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "prognostic favorable (7.41e-4)" 31.9 40.7 21.1 25.9 22.5 35.5 34.0 20.1 29.7 42.7 20.1 56.3 51.2 41.9 8.0 49.7 43.0 17.7 25.4 21.5 17.8 55.0 47.7 46.0 25.6 28.7 19.8 40.5 53.1 22.7 37.1 15.6 22.1 41.8 14.8 9.4 71.0 13.3 31.4 40.4 57.4 9.8 17.7 61.5 54.2 45.8 20.6 21.6 38.5 6.6 12.9 38.7 39.3 20.5 36.0 28.3 16.9 29.0 16.6 14.2 43.6 33.0 19.7 22.3 18.5 35.9 49.8 30.4 20.9 20.1 40.3 29.7 17.7 27.4 10.5 30.7 27.9 35.3 29.5 27.5 31.1 36.2 53.0 20.5 23.2 22.7 11.0 14.2 24.7 35.3 38.4 37.4 15.2 34.7 61.6 92.1 30.4 38.2 46.3 50.2 19.4 27.4 18.2 28.8 29.0 31.3 19.3 24.2 23.3 14.1 39.2 30.7 40.8 30.9 18.0 31.8 45.1 59.5 41.3 33.8 34.9 43.7 29.0 3.0 10.3 12.8 8.8 9.8 7.6 4.9 5.8 6.1 6.5 3.9 3.3 4.8 7.4 4.8 24.6 7.6 5.6 9.4 21.1 22.5 20.1 29.7 21.5 17.8 28.7 19.8 22.1 17.7 20.6 20.5 24.7 25.6 33.2 34.0 33.9 17.0 15.3 17.9 14.8 27.2 25.3 17.7 12.2 18.6 28.2 25.8 64.6 19.0 46.2 131.3 9.8 18.8 99.1 32.2 21.6 26.7 29.4 26.1 25.7 28.0 17.5 19.5 93.8 52.5 18.3 31.2 18.5 31.6 36.6 11.8 23.5 66.5 26.4 35.9 18.4 134.7 25.1 35.5 16.0 59.0 28.8 16.3 35.0 9.0 24.4 37.6 71.1 18.8 26.1 28.4 65.8 31.0 33.8 26.9 19.7 17.9 18.0 32.9 27.4 19.9 22.3 31.1 34.6 41.6 65.0 44.6 GAL "GAL-GMAP, GALN, GLNN, GMAP" ENSG00000069482 "Galanin and GMAP prepropeptide" P22466 11 68683779-68691175 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hormone, Neuropeptide" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "brain: 645.9;pituitary gland: 885.8" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3" "Cancer enhanced" "Detected in many" "testis cancer: 22.2" "Region enriched" "Detected in many" 13 "hypothalamus: 645.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6" "Region enhanced" "Detected in many" "hypothalamus: 82.6" "Low region specificity" "Detected in all" "HPA049864, CAB079779" Enhanced Supported Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 60000 200000 "Cluster 7: Monocytes - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 24: NB-4 - Immune response" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" Vesicles "CAB079779: , HPA049864: AB_2680922" "unprognostic (8.56e-2)" "unprognostic (1.45e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (8.07e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.98e-2)" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (7.42e-2)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.38e-2)" "unprognostic (3.24e-2)" 3.2 0.9 2.8 14.9 2.1 0.7 4.4 1.1 5.2 1.0 0.8 17.6 1.8 0.2 0.0 0.8 1.0 0.2 1.0 2.2 645.9 1.5 0.3 0.5 0.1 48.5 5.1 0.2 2.1 0.1 885.8 0.3 13.8 4.4 4.0 0.0 0.9 0.2 0.4 33.3 4.1 9.9 0.6 0.3 9.7 1.0 19.5 0.7 0.4 0.0 0.0 0.7 2.9 2.6 0.0 11.0 1.1 0.3 0.0 0.0 24.0 36.7 0.0 0.7 0.0 267.2 9.9 0.0 12.7 1.3 0.4 0.1 0.0 0.2 0.0 0.0 119.3 6.4 74.6 0.0 1.3 3.7 0.0 1.7 4.0 0.0 0.1 0.0 6.3 0.0 139.5 0.0 0.2 77.2 0.0 493.5 60.3 2.9 23.7 0.0 0.1 51.1 0.6 0.0 49.8 189.6 25.8 1.5 0.0 26.8 1.5 57.6 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.1 1.1 5.2 2.2 645.9 48.5 5.1 13.8 0.6 19.5 2.6 0.6 0.0 0.0 0.0 0.2 2.0 22.2 0.1 0.0 0.0 3.2 5.8 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.7 0.0 38.9 0.1 64.2 50.8 3.4 1.8 4.2 2.1 52.1 48.7 6.6 2.0 26.4 4.5 0.4 0.0 0.0 2.0 0.0 0.2 1.1 4.1 0.0 1.2 0.2 0.0 0.7 1.8 0.0 0.6 0.0 0.0 0.0 0.3 39.5 0.1 0.0 1.0 82.5 0.0 0.4 0.0 0.0 0.0 1.6 6.7 2.2 10.9 1.1 3.4 1.9 0.8 0.0 1.3 24.3 GIGYF1 "GYF1, PERQ1" ENSG00000146830 "GRB10 interacting GYF protein 1" O75420 7 100679507-100694250 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 100.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020999, HPA023995" Enhanced Approved Vesicles,Microtubules NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Vesicles Microtubules "HPA020999: AB_2111744, HPA023995: AB_1855221" "unprognostic (3.82e-3)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (2.67e-2)" "unprognostic (7.46e-2)" "prognostic favorable (7.42e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.43e-2)" "unprognostic (8.06e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.35e-5)" "unprognostic (3.66e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (1.89e-1)" "unprognostic (2.79e-1)" "unprognostic (2.67e-3)" 25.7 25.9 21.1 15.6 21.1 30.5 26.9 27.7 24.1 36.1 21.3 26.5 15.8 34.9 11.0 19.1 30.2 10.4 22.4 19.5 17.3 27.3 23.1 22.6 18.9 20.9 18.8 43.4 36.1 13.5 41.9 11.4 18.7 28.5 8.0 8.8 29.6 13.7 26.5 33.5 30.7 11.2 16.2 39.1 25.1 32.2 21.4 17.2 32.8 16.7 11.3 23.5 23.6 24.0 16.5 16.8 26.1 38.2 12.3 9.6 46.6 15.3 12.4 9.4 10.8 9.8 27.6 22.9 19.2 11.1 19.0 19.4 12.9 15.3 5.8 24.4 26.4 15.9 48.5 14.3 12.2 18.1 26.1 15.1 12.2 12.0 17.0 15.3 9.5 26.4 44.8 21.9 8.7 37.5 32.1 100.1 32.0 6.5 20.1 51.2 13.9 23.1 6.9 14.8 23.3 36.7 19.8 31.2 18.2 17.6 14.2 30.2 14.7 26.8 32.9 44.7 14.2 17.8 8.4 12.3 15.6 35.9 16.2 2.2 1.3 1.2 2.4 1.2 1.8 1.3 1.6 1.5 0.5 1.9 1.4 1.5 4.5 1.3 1.3 2.0 0.9 0.5 21.1 21.1 27.7 24.1 19.5 17.3 20.9 18.8 18.7 16.2 21.4 24.0 26.5 3.2 7.8 19.9 18.1 31.7 11.0 5.8 8.0 25.5 25.5 20.6 8.3 32.9 5.8 18.4 18.8 12.0 31.2 19.5 15.6 11.5 1.0 12.2 24.3 17.5 18.6 9.9 18.1 9.4 10.7 17.8 18.8 17.5 5.7 26.5 22.5 19.0 11.4 52.2 17.7 22.8 6.1 25.5 19.8 3.8 24.5 15.6 17.8 29.0 12.5 15.3 20.6 14.6 22.6 11.8 18.0 18.0 10.5 16.7 20.4 9.9 5.0 28.0 32.9 33.2 19.6 16.4 36.0 6.8 22.4 16.3 20.5 12.9 16.1 10.2 GIT2 "KIAA0148, PKL" ENSG00000139436 "GIT ArfGAP 2" Q14161 12 109929802-109996389 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004681 Approved Approved Microtubules NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Microtubules "CAB004681: AB_425820" "unprognostic (1.07e-1)" "unprognostic (2.61e-1)" "unprognostic (3.67e-3)" "unprognostic (3.44e-2)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (3.87e-2)" "unprognostic (1.50e-1)" "unprognostic (1.87e-1)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "unprognostic (8.71e-2)" "unprognostic (2.41e-2)" 16.6 18.0 12.1 25.5 18.1 60.2 13.0 20.3 17.0 14.0 9.8 15.0 11.2 14.1 10.8 11.5 12.1 15.4 17.4 16.4 12.1 11.7 11.8 16.9 33.1 16.2 13.9 17.8 17.2 14.1 13.8 22.9 16.5 12.8 13.8 9.1 13.5 12.8 14.7 13.1 19.0 19.8 12.1 36.0 10.7 13.9 15.3 37.0 16.4 15.6 32.1 16.3 12.8 16.2 20.6 24.6 16.6 18.4 28.6 26.3 11.9 42.1 41.3 37.0 23.2 12.5 10.8 49.8 16.3 51.7 14.6 14.9 14.5 18.8 38.1 42.1 14.3 32.7 15.0 14.6 18.1 47.7 49.6 22.0 17.4 34.9 18.7 34.0 39.5 28.5 17.2 12.4 46.0 13.1 42.0 66.4 11.7 11.7 17.7 34.5 41.7 27.9 18.2 17.1 10.1 14.9 27.1 12.5 16.6 17.0 17.9 39.3 37.3 25.0 12.6 20.0 22.0 25.0 22.8 49.3 21.5 34.9 21.2 85.6 76.4 172.9 42.7 72.0 41.6 42.4 42.3 43.9 74.7 49.4 36.0 32.2 165.1 49.3 71.3 30.6 46.5 63.7 12.1 18.1 20.3 17.0 16.4 12.1 16.2 13.9 16.5 12.1 15.3 16.2 26.3 19.2 15.3 24.8 44.8 9.6 6.4 11.3 11.4 24.7 10.8 10.0 7.8 14.3 12.2 27.6 8.4 13.1 37.7 9.9 3.9 16.0 6.5 7.6 16.9 24.0 7.8 19.4 73.2 14.0 11.3 15.3 14.8 11.1 14.5 36.1 24.7 13.7 35.1 33.7 82.2 6.7 8.2 65.5 32.0 5.2 18.6 45.1 14.2 66.5 64.5 9.3 61.8 28.6 39.8 18.4 8.6 19.9 26.1 4.3 22.8 7.2 12.4 18.7 13.1 29.4 14.5 36.1 20.1 11.8 11.4 6.2 36.5 19.1 9.9 7.4 GOLGA8F DKFZp434P162 ENSG00000153684 "Golgin A8 family member F" Q08AF8 15 28378621-28392018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 180 "testis: 20.1" "Cell type enhanced" "Detected in some" "Early spermatids: 1.7;Spermatocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NB-4: 2.1" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (4.96e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPN3 "ATPBD1C, MGC14560" ENSG00000111231 "GPN-loop GTPase 3" Q9UHW5 12 110452486-110469268 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039764, HPA047793" Uncertain Approved "Nuclear speckles,Cytosol" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" Cytosol "HPA039764: AB_2676669, HPA047793: AB_2680157" "unprognostic (1.68e-3)" "unprognostic (1.11e-2)" "unprognostic (9.82e-2)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.27e-3)" "prognostic unfavorable (3.98e-5)" "unprognostic (5.50e-2)" "unprognostic (4.45e-2)" "unprognostic (2.70e-1)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" "prognostic favorable (2.65e-6)" "unprognostic (5.81e-2)" "unprognostic (2.85e-1)" "unprognostic (1.62e-1)" "unprognostic (2.27e-1)" 25.6 18.9 10.4 16.3 11.7 15.4 24.4 12.9 12.9 15.7 11.6 15.6 8.1 17.8 15.2 16.3 18.5 13.8 34.2 10.0 11.0 31.4 32.1 16.9 22.9 12.2 11.2 23.3 19.9 29.2 11.1 21.3 12.8 22.2 13.1 23.4 24.2 18.0 47.9 11.1 10.6 19.5 13.0 16.2 15.6 41.3 10.9 18.1 21.2 51.1 18.1 17.6 13.8 14.9 42.3 65.8 43.2 42.8 47.5 30.1 57.6 57.1 34.1 62.2 50.3 59.7 24.6 81.5 38.5 31.0 46.0 37.9 54.2 50.5 83.9 46.9 50.6 47.7 33.8 50.5 33.2 75.2 42.2 32.2 31.4 61.1 39.5 34.9 45.6 67.0 82.1 17.9 44.3 28.2 69.8 142.8 53.4 58.6 64.8 23.5 59.9 62.2 39.3 37.8 34.7 34.8 57.7 39.0 49.9 55.0 66.7 87.7 25.4 51.6 38.0 51.3 66.6 24.7 68.0 85.1 38.2 68.5 60.3 41.0 54.4 79.4 30.0 71.9 32.8 46.5 32.0 34.2 51.1 47.9 40.5 26.9 27.4 28.4 75.3 62.5 30.1 41.6 10.4 11.7 12.9 12.9 10.0 11.0 12.2 11.2 12.8 13.0 10.9 14.9 23.8 25.6 34.5 3.3 24.5 29.8 49.3 57.9 15.9 18.8 28.8 32.5 43.8 20.0 36.0 33.1 14.6 62.4 26.6 3.8 107.6 30.4 111.1 24.9 24.6 20.8 8.3 26.9 4.3 21.3 74.0 25.4 8.2 21.5 31.0 18.6 18.2 38.1 94.7 21.9 5.6 9.1 40.7 19.1 17.7 22.6 19.9 33.2 16.0 14.0 39.6 25.7 19.6 3.5 6.4 22.4 11.0 23.7 20.9 55.5 5.3 72.1 34.2 33.0 26.3 31.0 35.3 187.2 77.6 20.8 25.4 46.7 19.2 22.1 13.7 40.2 GPR84 EX33 ENSG00000139572 "G protein-coupled receptor 84" Q9NQS5 12 54362445-54364487 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.8;urinary bladder: 15.8" "Group enriched" "Detected in some" 5 "Hofbauer cells: 21.9;Langerhans cells: 17.7;Macrophages: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 23 "basophil: 9.0;classical monocyte: 9.9;myeloid DC: 14.8;neutrophil: 6.0" "Group enriched" "Detected in many" 62 "dendritic cells: 14.8;granulocytes: 9.0;monocytes: 9.9" "Group enriched" "Detected in some" 5 "HL-60: 13.0;NB-4: 40.0" HPA027603 Enhanced NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" "HPA027603: AB_10612115" "unprognostic (5.40e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (3.92e-2)" "unprognostic (2.36e-2)" "unprognostic (4.54e-2)" "unprognostic (6.16e-3)" "unprognostic (7.43e-2)" "unprognostic (9.29e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (2.92e-1)" "unprognostic (1.36e-9)" "unprognostic (1.27e-1)" "unprognostic (4.42e-2)" "unprognostic (1.40e-1)" "unprognostic (9.44e-2)" 4.5 1.1 1.0 8.3 1.1 22.8 0.3 1.0 1.8 0.4 1.4 0.4 0.3 0.3 0.3 0.5 0.7 1.0 0.6 1.0 1.7 0.9 0.4 2.4 0.3 2.6 1.6 0.3 0.4 0.1 0.8 3.1 1.7 0.6 0.6 2.7 0.6 0.2 0.0 0.7 0.4 1.9 1.7 3.6 0.6 0.3 1.8 0.5 0.6 0.2 0.8 15.8 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.0 2.2 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.1 0.0 9.0 9.9 0.0 0.0 0.4 0.0 0.0 0.0 0.1 14.8 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 2.1 1.0 1.1 1.0 1.8 1.0 1.7 2.6 1.6 1.7 1.7 1.8 3.1 0.2 0.0 0.5 2.0 0.3 0.9 0.1 4.6 0.0 2.6 0.2 0.3 0.1 0.0 1.2 0.0 4.2 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 1.6 0.0 0.0 0.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 1.1 0.0 0.0 2.8 17.7 0.2 0.0 31.8 0.0 0.0 1.2 0.1 0.0 1.5 0.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.5 0.0 0.1 0.4 0.3 0.1 0.1 0.4 0.8 0.1 0.0 0.0 0.1 GRPEL1 "FLJ25609, GrpE, hMGE" ENSG00000109519 "GrpE like 1, mitochondrial" Q9HAV7 4 7058895-7068064 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036647 Supported Supported Mitochondria NA NA 23000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA036647: AB_10672359" "unprognostic (6.13e-3)" "unprognostic (3.66e-2)" "unprognostic (1.92e-2)" "unprognostic (6.31e-2)" "unprognostic (9.77e-2)" "unprognostic (2.12e-3)" "unprognostic (2.17e-1)" "unprognostic (2.21e-3)" "unprognostic (1.51e-1)" "unprognostic (5.53e-2)" "unprognostic (4.99e-2)" "unprognostic (3.86e-2)" "prognostic favorable (2.00e-6)" "unprognostic (9.61e-2)" "unprognostic (7.18e-2)" "unprognostic (2.81e-1)" "unprognostic (7.30e-2)" 15.4 35.9 12.7 7.7 13.2 24.9 11.2 14.2 16.4 7.2 14.2 10.1 9.0 7.0 8.4 10.9 8.4 7.5 23.1 13.1 13.6 20.7 32.4 7.7 10.2 14.0 13.5 10.4 10.1 13.1 6.9 7.8 14.4 7.9 9.7 12.4 8.6 7.9 26.8 10.7 7.8 8.3 13.8 10.4 11.1 12.8 13.7 7.6 8.9 29.7 11.3 15.2 7.6 14.1 21.7 20.0 11.3 22.3 21.3 17.9 13.9 27.9 22.2 30.8 22.6 35.5 27.5 46.4 18.3 21.4 47.7 21.5 45.0 32.0 35.9 11.2 28.2 49.8 17.6 38.7 24.9 50.7 24.2 17.8 41.4 27.3 32.8 15.7 27.4 30.8 29.7 18.9 36.7 21.9 40.3 62.5 16.9 38.8 65.7 26.6 42.1 19.5 31.0 22.4 31.6 15.3 21.9 21.5 24.3 11.4 19.3 29.2 23.8 20.5 12.7 29.5 49.3 20.3 31.1 31.0 27.9 32.6 16.5 12.0 25.2 41.1 22.8 27.6 31.9 27.3 24.4 25.9 36.3 21.6 30.8 23.9 8.4 26.2 22.7 22.0 26.6 27.2 12.7 13.2 14.2 16.4 13.1 13.6 14.0 13.5 14.4 13.8 13.7 14.1 52.5 25.6 32.1 1.6 40.7 133.4 134.8 68.5 60.9 27.8 44.0 43.6 96.1 34.3 43.1 38.6 10.4 69.3 52.9 35.3 133.1 75.0 60.3 35.0 41.7 51.5 18.5 34.5 4.5 47.7 80.3 46.5 26.0 38.0 58.2 23.2 25.0 109.4 60.3 28.6 5.1 34.1 52.9 29.0 74.7 84.9 28.0 41.7 64.0 2.8 54.0 26.4 17.5 3.0 6.5 91.4 27.6 29.0 27.0 116.5 49.2 203.1 36.2 28.0 0.0 38.1 56.3 51.7 55.0 58.1 125.2 86.1 61.6 92.0 47.0 120.3 GTF2IRD2B ENSG00000174428 "GTF2I repeat domain containing 2B" Q6EKJ0 7 75092573-75149817 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 14.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA056679, HPA056680" Supported Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA056679: AB_2683205, HPA056680: AB_2683206" "prognostic favorable (3.27e-4)" "unprognostic (1.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-1)" "unprognostic (1.53e-2)" "unprognostic (2.19e-2)" "unprognostic (6.28e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-1)" "unprognostic (8.90e-4)" "unprognostic (1.54e-2)" "unprognostic (7.21e-3)" "unprognostic (2.31e-1)" "unprognostic (3.61e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-5)" 11.5 9.5 6.2 5.7 10.8 14.0 13.6 7.8 8.8 13.6 10.7 15.1 5.1 16.0 5.5 8.1 17.3 9.4 15.1 6.3 7.1 13.8 15.6 10.7 5.3 9.7 9.5 32.8 17.0 13.8 7.5 7.3 9.1 12.9 9.2 10.8 13.3 12.9 36.0 5.9 7.9 13.5 7.9 8.0 15.4 4.6 11.2 17.2 12.3 28.6 7.9 13.8 8.5 19.8 19.0 7.4 12.4 12.9 9.8 13.4 9.4 9.7 14.5 4.4 11.5 3.5 14.2 11.4 9.4 9.7 17.3 6.3 6.1 6.3 5.3 14.7 5.5 8.4 9.5 7.9 19.0 13.5 12.5 12.4 12.7 3.7 15.5 15.9 6.1 4.1 11.7 24.4 14.4 12.4 9.1 31.6 12.6 16.3 11.5 18.0 3.8 17.6 13.2 13.8 11.5 21.6 20.4 20.9 22.7 3.4 20.8 13.0 10.8 11.4 7.7 10.4 12.8 10.1 6.3 31.4 5.3 12.9 25.6 0.5 1.3 5.0 1.0 1.8 1.5 14.8 1.7 2.2 1.0 6.6 2.9 1.3 1.3 1.1 1.1 1.4 2.6 0.7 6.2 10.8 7.8 8.8 6.3 7.1 9.7 9.5 9.1 7.9 11.2 19.8 4.6 0.0 10.8 20.5 22.1 4.5 4.5 10.3 27.3 7.2 11.9 9.5 21.1 14.3 5.5 7.3 12.5 2.4 8.1 9.1 0.0 12.9 13.5 9.9 7.8 6.1 19.2 8.6 4.1 12.9 2.7 13.2 35.2 5.6 3.8 13.3 11.0 12.0 2.6 13.5 7.2 15.1 10.2 8.1 5.4 4.4 27.4 4.0 21.4 5.6 6.0 6.5 9.2 15.6 27.0 14.8 14.6 17.0 23.4 4.6 10.2 3.4 13.8 13.4 13.1 11.3 10.7 2.5 1.5 22.2 4.3 3.0 13.0 6.0 14.3 3.6 GTF3A "AP2, TFIIIA" ENSG00000122034 "General transcription factor IIIA" Q92664 13 27424619-27435823 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007990 Supported Supported Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 52: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA007990: AB_1857960" "unprognostic (9.88e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-1)" "unprognostic (1.36e-1)" "unprognostic (2.87e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-2)" "unprognostic (8.64e-2)" "unprognostic (7.53e-2)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (3.41e-1)" "prognostic unfavorable (3.43e-6)" "unprognostic (1.98e-1)" "unprognostic (1.33e-1)" "unprognostic (3.26e-1)" "unprognostic (1.41e-1)" 63.5 40.3 51.0 50.3 53.0 85.3 59.3 53.1 63.0 31.9 50.4 41.8 30.3 26.6 57.4 38.3 32.8 33.4 126.7 52.8 51.9 52.5 129.8 33.2 81.2 53.2 53.3 16.0 116.4 34.5 26.9 28.4 52.7 30.7 40.4 10.4 70.4 34.8 89.3 25.0 32.3 38.0 53.0 54.6 46.9 17.4 52.9 111.6 31.2 132.6 89.8 46.0 23.7 56.2 91.2 78.8 65.4 136.8 90.4 98.8 93.3 95.1 86.0 118.3 75.4 118.5 139.4 275.3 65.9 112.6 73.9 64.9 136.6 131.0 165.8 289.2 93.1 229.9 71.6 135.4 102.5 432.3 150.9 81.5 137.9 109.2 142.4 81.8 107.2 246.9 184.2 88.6 140.5 178.3 311.3 467.9 115.8 299.6 210.7 154.8 169.3 254.0 142.5 39.2 158.9 81.5 67.6 101.6 141.7 83.7 73.7 223.6 66.0 62.5 67.1 49.3 99.1 57.0 104.9 275.1 67.1 264.9 117.4 116.8 173.8 162.5 250.2 180.1 335.2 290.5 251.6 271.7 218.4 250.3 192.5 219.6 38.3 243.7 169.5 298.3 345.1 484.4 51.0 53.0 53.1 63.0 52.8 51.9 53.2 53.3 52.7 53.0 52.9 56.2 96.9 44.8 33.0 15.0 183.3 63.2 62.4 109.1 56.3 41.7 107.2 117.6 207.8 91.5 58.3 27.6 29.2 76.3 207.1 20.0 150.6 195.7 33.9 60.1 68.1 76.3 34.8 126.4 28.7 190.6 187.4 75.0 63.2 49.1 75.5 93.0 40.0 146.7 215.5 35.3 25.8 60.6 77.3 156.1 119.3 85.6 63.6 133.9 97.8 15.9 185.3 73.1 236.9 7.1 24.3 153.3 28.9 58.3 248.4 122.7 35.6 207.7 37.9 35.7 85.5 58.3 76.1 34.8 145.1 83.4 64.4 42.1 187.1 89.0 69.8 70.3 H1-3 "H1.3, H1d, H1F3, H1s-2, HIST1H1D" ENSG00000124575 "H1.3 linker histone, cluster member" P16402 6 26234212-26234987 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 21.1;brain: 24.1" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.4;dendritic cells: 23.3;Extravillous trophoblasts: 18.3;Hofbauer cells: 7.5;Plasma cells: 7.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 24.1" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 5.8;MOLT-4: 9.9;NB-4: 4.3;REH: 4.0;SiHa: 3.8;U-266/70: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA055907 Supported NA NA 4000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA055907: AB_2682966" "unprognostic (8.78e-2)" "unprognostic (1.01e-4)" "unprognostic (8.69e-2)" "unprognostic (5.67e-2)" "unprognostic (2.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.11e-2)" "unprognostic (2.13e-1)" "unprognostic (3.06e-2)" "unprognostic (1.99e-1)" "unprognostic (1.14e-2)" "unprognostic (8.96e-2)" "unprognostic (3.61e-8)" "unprognostic (8.78e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-3)" "unprognostic (1.33e-2)" 1.2 0.1 1.3 0.2 0.5 21.1 1.1 24.1 4.6 1.7 3.4 1.5 0.0 0.1 0.1 0.7 0.4 0.0 0.4 0.5 1.4 0.6 0.3 1.3 1.9 2.5 1.8 0.3 0.0 0.0 0.1 0.5 4.5 1.4 0.7 0.0 0.5 0.0 0.0 2.4 2.5 0.1 3.8 1.3 0.6 0.3 2.6 5.5 0.5 0.0 0.4 0.2 3.8 7.0 0.7 0.5 0.1 0.0 0.2 0.0 5.8 0.3 0.2 0.7 0.5 0.1 0.6 0.0 0.1 0.1 0.3 0.7 0.2 0.0 0.3 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.2 0.8 1.7 1.7 0.1 0.0 9.9 4.3 0.5 0.0 1.7 4.0 0.1 2.2 0.0 0.0 1.9 0.3 3.8 1.6 0.0 0.5 0.7 0.9 0.0 0.2 0.0 0.1 0.6 4.8 2.5 0.3 0.6 1.2 0.5 22.3 7.5 6.5 31.4 4.4 21.9 32.1 28.7 21.7 18.2 46.7 37.1 30.6 2.6 25.8 6.9 32.8 23.4 14.1 1.3 0.5 24.1 4.6 0.5 1.4 2.5 1.8 4.5 3.8 2.6 7.0 3.5 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.4 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 18.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.6 3.6 0.0 0.0 0.0 H2AC12 "dJ86C11.1, H2A/S, H2AFALii, HIST1H2AH" ENSG00000274997 "H2A clustered histone 12" Q96KK5 6 27147106-27147562 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.8;brain: 2.8" "Cell type enhanced" "Detected in some" "dendritic cells: 1.6;Extravillous trophoblasts: 2.3;Hofbauer cells: 1.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive B-cell: 11.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 5.4;MOLT-4: 6.2;NB-4: 6.9" "CAB004030, HPA041189" Supported Approved Nucleoplasm NA Yes "Cluster 21: B-cells - Adaptive immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB004030: AB_2118804, HPA041189: AB_2677357" "unprognostic (4.07e-1)" "unprognostic (2.73e-3)" "unprognostic (4.04e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.35e-3)" "unprognostic (3.90e-2)" "unprognostic (3.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.38e-3)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (9.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.26e-4)" 0.2 0.1 0.5 0.0 0.9 8.8 0.3 0.7 0.5 0.2 0.8 0.7 0.2 0.0 0.0 0.2 0.2 0.1 0.1 0.3 0.9 0.0 0.1 0.2 1.1 1.6 1.3 0.1 0.1 0.1 0.0 0.3 1.8 0.1 0.1 0.0 0.1 0.0 0.0 0.2 2.1 0.1 1.8 0.6 0.2 1.6 2.0 1.5 0.1 0.0 0.2 0.2 0.2 2.8 1.7 2.0 0.7 3.0 0.0 0.0 0.4 0.2 0.3 0.3 0.0 2.0 0.6 2.7 0.6 0.0 0.3 0.2 0.6 0.0 0.0 1.4 5.4 3.0 2.5 0.0 0.0 2.1 1.1 0.0 0.0 0.7 0.0 0.0 0.5 1.1 3.1 1.7 0.5 0.3 6.2 6.9 2.1 0.6 0.7 2.2 1.9 3.2 0.0 0.2 1.5 0.4 0.9 0.3 0.2 0.0 0.6 1.0 0.0 0.6 1.7 0.1 1.8 1.8 2.0 4.0 0.8 2.8 0.6 0.0 0.8 0.0 2.2 2.3 1.0 3.3 4.1 3.8 2.0 11.9 2.1 1.5 0.0 5.1 1.4 1.4 0.7 2.0 0.5 0.9 0.7 0.5 0.3 0.9 1.6 1.3 1.8 1.8 2.0 2.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 H2AC16 "dJ193B12.9, H2A/i, H2AFI, HIST1H2AL" ENSG00000276903 "H2A clustered histone 16" P0C0S8 6 27865317-27865798 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 7.6;brain: 2.5" "Cell type enhanced" "Detected in single" "Extravillous trophoblasts: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 4.8;MOLT-4: 5.2" "Low region specificity" "Detected in single" HPA041189 Supported Approved Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041189: AB_2677357" "unprognostic (2.45e-2)" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.46e-3)" "unprognostic (3.17e-1)" "unprognostic (1.82e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-2)" "unprognostic (4.18e-1)" "unprognostic (2.38e-1)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (2.41e-2)" "unprognostic (2.12e-1)" "unprognostic (6.21e-2)" 0.1 0.1 0.5 0.1 0.3 7.6 0.2 0.6 0.4 0.0 1.0 0.2 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.3 1.0 0.1 0.1 0.4 0.4 1.5 1.3 0.0 0.0 0.3 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 1.2 0.7 0.2 0.3 1.7 0.5 0.0 0.1 0.1 0.0 0.2 2.5 2.8 1.2 0.8 0.0 0.0 0.0 0.5 0.9 0.5 1.5 1.4 0.0 0.7 2.0 0.8 0.2 0.8 0.8 0.0 0.2 1.0 1.9 4.8 0.6 0.2 0.5 0.0 0.4 1.1 0.0 0.0 0.4 0.2 0.0 0.0 1.1 4.5 3.3 0.2 3.0 5.2 3.9 1.6 1.5 0.6 2.6 0.0 0.2 0.3 2.0 1.6 1.4 1.0 0.1 0.4 0.1 0.7 1.1 0.0 0.1 0.0 1.0 1.7 3.7 0.0 4.0 0.8 3.1 0.7 2.0 1.4 1.1 0.1 1.3 0.0 2.4 1.2 1.3 3.6 5.9 0.4 0.7 6.1 0.0 2.9 2.6 1.1 0.7 0.5 0.3 0.6 0.4 0.3 1.0 1.5 1.3 1.5 1.2 1.7 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 H2AC21 HIST2H2AB ENSG00000184270 "H2A clustered histone 21" Q8IUE6 1 149887469-149887965 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 15.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 15.3" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "MOLT-4: 3.3;NB-4: 1.9;U-266/70: 1.6;U-266/84: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011483, HPA041189" Supported Supported Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 24: NB-4 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB011483: AB_732909, HPA041189: AB_2677357" "unprognostic (6.31e-2)" "unprognostic (6.63e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.09e-1)" "unprognostic (3.34e-1)" "unprognostic (2.42e-3)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (9.97e-3)" "unprognostic (5.33e-2)" "unprognostic (2.00e-2)" "unprognostic (4.36e-2)" 0.2 0.1 3.3 0.0 4.6 3.4 0.3 15.3 3.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 3.0 0.1 0.1 0.2 0.0 0.5 1.3 0.3 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.2 0.6 0.5 0.0 1.5 0.3 0.1 0.1 2.3 0.3 0.1 0.0 0.0 0.1 0.2 3.7 0.5 0.0 0.2 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.3 0.4 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.7 0.2 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.3 0.2 0.0 3.3 1.9 0.4 0.3 0.5 0.7 0.2 0.7 0.0 0.1 0.6 0.4 0.8 0.0 0.1 0.0 0.2 1.4 0.0 0.3 1.2 0.0 0.3 1.6 1.9 0.5 0.6 0.1 0.2 1.5 1.9 0.8 2.2 1.7 2.0 3.7 3.7 3.3 2.1 6.6 2.3 2.5 9.8 3.6 2.0 4.0 2.0 0.5 3.3 4.6 15.3 3.0 1.7 3.0 0.5 1.3 1.0 1.5 2.3 3.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 H2AZ2 "H2AFV, H2AV, MGC10170, MGC10831, MGC1947" ENSG00000105968 "H2A.Z variant histone 2" Q71UI9 7 44826791-44848087 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 238.5;Cytotrophoblasts: 174.1;dendritic cells: 85.4;Extravillous trophoblasts: 435.9;Hofbauer cells: 242.8;Syncytiotrophoblasts: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057236 Supported NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 24: NB-4 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA057236: AB_2683377" "unprognostic (2.16e-2)" "prognostic favorable (4.66e-4)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (3.51e-3)" "unprognostic (9.87e-2)" "unprognostic (1.77e-2)" "unprognostic (3.48e-1)" "unprognostic (1.32e-2)" "unprognostic (2.61e-2)" "unprognostic (8.17e-2)" "unprognostic (2.68e-1)" "prognostic favorable (8.04e-4)" "unprognostic (4.86e-2)" "unprognostic (8.74e-3)" "unprognostic (1.96e-1)" "unprognostic (1.25e-1)" 67.9 82.0 98.4 95.7 106.3 316.8 68.2 115.2 106.2 65.9 75.2 106.5 78.2 71.8 69.7 85.5 64.3 57.3 142.7 91.1 100.5 92.8 90.1 77.1 145.2 94.0 104.7 61.7 72.3 83.3 59.0 65.4 97.6 70.3 103.9 141.7 65.9 66.4 139.3 60.2 96.1 78.0 104.0 90.5 87.3 92.8 110.0 288.1 79.4 134.9 170.7 69.2 64.3 103.9 278.2 280.7 368.9 313.8 147.1 115.0 154.2 184.0 202.9 202.4 245.3 234.7 356.1 349.7 195.1 234.4 393.3 308.2 286.9 237.9 319.6 335.1 175.4 221.8 461.0 298.4 103.6 566.6 296.1 92.3 103.0 236.6 209.2 165.6 248.5 379.1 402.8 383.2 306.3 575.2 536.8 919.1 282.0 342.3 266.2 433.4 411.5 331.0 219.7 244.9 233.7 318.9 330.8 369.3 142.3 363.1 328.6 558.4 220.1 181.9 533.3 168.3 459.5 354.6 401.1 619.7 188.6 448.7 589.5 104.7 62.0 229.9 62.2 54.1 80.5 77.7 86.7 83.4 96.4 76.1 63.2 61.2 74.6 77.0 50.3 147.0 169.1 48.2 98.4 106.3 115.2 106.2 91.1 100.5 94.0 104.7 97.6 104.0 110.0 103.9 34.6 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 238.5 0.0 0.0 0.0 0.0 174.1 85.4 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 435.9 37.0 0.0 0.0 0.0 0.0 0.0 0.0 242.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 106.9 17.1 0.0 0.0 0.0 H2BC3 "H2B/f, H2BFF, HIST1H2BB" ENSG00000276410 "H2B clustered histone 3" P33778 6 26043227-26043713 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.1;brain: 2.6;lymphoid tissue: 1.1;testis: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 1.3;Karpas-707: 1.3;MOLT-4: 1.6;NB-4: 1.7;THP-1: 2.0;U-266/84: 2.2" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.92e-2)" "unprognostic (9.15e-2)" "unprognostic (3.29e-1)" "unprognostic (2.18e-1)" "unprognostic (2.36e-1)" "unprognostic (1.26e-1)" "unprognostic (6.10e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (2.58e-1)" 0.0 0.0 0.5 0.0 0.5 1.1 0.0 2.1 0.6 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.2 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.0 1.3 2.6 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.4 0.2 1.3 1.3 0.0 0.0 1.6 1.7 0.7 0.2 0.6 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 2.0 0.0 0.1 0.1 0.1 0.3 0.3 2.2 0.0 0.2 0.5 0.4 2.6 0.5 0.5 0.8 0.1 2.2 1.4 2.4 0.9 1.9 0.9 1.2 0.5 2.0 0.1 0.2 6.4 1.9 0.3 0.5 0.5 2.1 0.6 0.2 1.3 0.9 1.2 0.9 0.6 2.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 H2BC6 "H2B.h, H2B/h, H2BFH, HIST1H2BE" ENSG00000274290 "H2B clustered histone 6" P62807 6 26172059-26184655 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 1.8;Cytotrophoblasts: 1.0;dendritic cells: 1.8;Extravillous trophoblasts: 1.1;Hofbauer cells: 1.0;Plasma cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 5.3;REH: 5.1" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-1)" "unprognostic (7.06e-3)" "unprognostic (8.28e-2)" "unprognostic (1.31e-1)" "unprognostic (7.98e-2)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (1.69e-2)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.55e-6)" "unprognostic (3.03e-2)" "unprognostic (4.86e-2)" "unprognostic (2.30e-1)" "unprognostic (3.11e-2)" 0.8 0.4 1.6 0.5 2.0 2.7 0.6 3.0 1.5 3.6 3.6 0.7 0.4 0.4 0.4 0.7 0.6 0.4 0.6 1.6 0.3 1.0 0.6 1.3 0.9 1.9 0.8 0.9 0.2 0.1 0.7 0.3 0.4 2.6 0.5 1.1 1.3 0.2 0.8 1.7 0.3 0.2 1.8 0.9 0.8 0.5 0.6 2.9 0.5 0.6 0.6 0.4 2.1 1.5 0.3 2.1 1.9 0.5 1.6 0.2 0.2 1.9 0.6 0.3 0.1 0.5 1.3 0.4 0.8 0.3 0.9 2.7 0.3 0.7 0.3 0.9 0.5 0.2 1.0 0.1 0.1 0.1 1.6 0.4 0.1 0.4 0.1 0.6 0.2 0.5 1.4 1.0 0.0 1.0 3.0 5.3 1.5 1.0 0.5 5.1 0.1 1.5 0.8 1.1 1.5 2.2 2.3 0.8 0.5 0.8 1.6 1.0 0.5 0.8 1.5 0.6 1.2 1.3 2.7 0.3 0.4 0.8 0.3 2.9 0.6 1.0 0.7 0.5 0.5 1.0 0.7 0.9 0.2 1.2 0.6 0.6 2.1 0.6 0.6 1.2 1.1 0.3 1.6 2.0 3.0 1.5 1.6 0.3 1.9 0.8 0.4 1.8 0.6 1.5 1.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 HDAC8 "HDACL1, KDAC8, MRXS6, RPD3, WTS" ENSG00000147099 "Histone deacetylase 8" Q9BY41 X 72329516-72573101 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Disease variant, FDA approved drug targets, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 120.8;Excitatory neurons: 186.8;Inhibitory neurons: 191.3;Microglial cells: 134.9;Oligodendrocyte precursor cells: 146.8;Oligodendrocytes: 141.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA048560 Supported NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA048560: AB_2680442" "unprognostic (1.42e-1)" "unprognostic (6.62e-3)" "unprognostic (3.20e-2)" "unprognostic (9.24e-3)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (6.03e-2)" "unprognostic (1.58e-1)" "unprognostic (2.81e-2)" "unprognostic (3.17e-2)" "unprognostic (9.68e-2)" "unprognostic (8.42e-2)" "unprognostic (2.33e-3)" "unprognostic (9.10e-2)" "unprognostic (7.15e-3)" "unprognostic (2.12e-3)" 9.2 21.2 16.1 9.8 16.2 17.5 10.3 23.2 19.1 10.3 14.4 9.8 8.5 9.5 22.8 10.2 8.8 9.7 11.9 15.8 19.4 15.1 16.3 9.0 10.9 14.4 13.2 11.2 11.0 11.5 13.4 9.5 15.1 11.2 11.8 16.5 11.4 8.1 10.7 11.5 8.1 10.6 9.7 8.4 10.2 4.2 16.2 8.6 13.0 10.4 10.9 9.7 9.6 20.8 21.0 27.2 20.5 29.9 26.9 24.4 13.5 14.0 21.3 15.9 19.1 20.8 23.3 15.2 38.6 17.2 27.5 14.5 37.0 23.1 21.7 25.9 25.5 21.5 32.7 22.4 14.2 29.9 30.4 22.3 15.4 20.2 15.1 27.6 27.1 20.3 22.4 38.4 24.4 24.8 15.9 53.8 25.9 31.2 38.1 19.7 24.0 26.7 32.8 21.0 16.5 33.0 26.7 19.7 26.9 25.9 12.0 26.9 21.8 15.0 21.3 19.4 13.5 13.5 28.1 18.1 18.5 34.7 20.3 13.8 16.5 28.1 10.5 13.8 8.7 11.9 11.2 9.6 17.2 12.2 8.4 7.5 1.7 10.9 14.5 6.0 15.6 9.8 16.1 16.2 23.2 19.1 15.8 19.4 14.4 13.2 15.1 9.7 16.2 20.8 13.0 3.2 25.7 120.8 14.5 6.1 12.7 15.3 17.1 15.4 9.5 9.7 11.3 12.8 15.7 7.3 43.8 16.4 8.0 7.2 9.8 13.9 0.9 8.8 11.3 12.5 9.1 17.1 186.8 12.4 13.2 14.0 10.7 8.4 12.0 19.2 12.5 10.3 15.8 23.5 191.3 9.3 16.2 8.2 9.0 1.2 11.8 13.3 7.2 134.9 10.9 10.3 8.2 146.8 141.1 11.2 4.7 10.5 19.9 10.6 9.3 22.6 17.4 17.3 26.3 10.1 16.0 4.7 0.8 12.6 6.3 13.5 11.8 15.1 9.7 12.6 HES6 bHLHb41 ENSG00000144485 "Hes family bHLH transcription factor 6" Q96HZ4 2 238238267-238240662 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;pituitary gland: 62.6" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 86.0;Enteroendocrine cells: 109.9;Erythroid cells: 120.0;Intestinal goblet cells: 176.0;Ionocytes: 93.6" "Cancer enhanced" "Detected in all" "glioma: 62.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "eosinophil: 5.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.1" "Cell line enhanced" "Detected in many" "NB-4: 196.8;SCLC-21H: 123.5;SK-MEL-30: 192.4;THP-1: 85.1;U-937: 100.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073997 Approved "Nuclear bodies,Cytosol" NA No "Cluster 52: Eosinophils - Transcription" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 24: NB-4 - Immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "Nuclear bodies" Cytosol "HPA073997: " "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (2.40e-3)" "unprognostic (7.46e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.79e-4)" "prognostic favorable (9.18e-5)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-2)" "unprognostic (4.35e-1)" "unprognostic (6.30e-2)" "unprognostic (5.13e-2)" "unprognostic (8.50e-2)" "unprognostic (6.66e-2)" "unprognostic (3.49e-2)" 3.4 10.2 44.8 2.8 53.1 12.5 2.6 55.1 57.6 13.8 32.4 22.3 18.4 16.9 0.5 3.0 14.0 1.6 4.7 43.8 37.8 10.0 8.3 5.5 3.1 49.6 43.3 2.6 23.5 4.1 62.6 1.1 44.8 3.9 9.0 1.0 5.1 1.0 25.8 2.6 19.8 2.7 56.2 9.1 11.1 25.5 43.9 3.6 5.1 1.6 2.2 4.6 2.8 58.2 4.9 5.6 23.5 26.9 1.6 0.8 15.1 1.7 1.8 2.3 3.5 4.8 3.0 0.3 3.9 0.4 9.8 3.1 24.1 1.8 0.7 11.5 30.4 5.9 4.5 50.7 3.8 42.7 33.0 2.3 14.6 3.4 4.7 1.3 1.5 25.1 53.4 0.5 1.5 12.3 6.3 196.8 38.5 4.8 4.3 28.1 62.5 11.7 3.1 2.3 123.5 54.6 7.7 10.7 192.4 2.8 9.4 85.1 1.9 2.3 4.9 13.2 14.7 11.6 2.1 8.9 8.2 100.2 4.2 0.1 0.1 5.1 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.1 44.8 53.1 55.1 57.6 43.8 37.8 49.6 43.3 44.8 56.2 43.9 58.2 3.3 0.0 1.1 63.0 5.7 3.3 6.4 3.0 1.8 9.2 8.8 5.2 6.5 1.5 4.7 3.7 22.9 2.2 30.5 37.1 7.9 9.2 32.2 86.0 7.8 3.8 109.9 120.0 9.6 31.8 3.9 3.5 13.7 6.7 0.0 39.0 2.2 5.2 5.5 3.3 10.3 176.0 93.6 4.8 5.8 9.3 1.5 7.4 35.6 8.4 8.3 6.2 23.7 17.6 19.6 14.9 22.2 1.5 7.1 5.2 13.1 4.9 9.5 4.9 0.0 26.9 12.5 35.3 36.5 2.9 2.0 0.3 9.4 30.0 41.8 2.2 HMGN3 TRIP7 ENSG00000118418 "High mobility group nucleosomal binding domain 3" Q15651 6 79201245-79234738 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018370, HPA027971, HPA063572" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Cytosol "CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703" "unprognostic (1.02e-1)" "unprognostic (2.04e-2)" "unprognostic (5.92e-2)" "unprognostic (5.26e-2)" "unprognostic (3.48e-1)" "unprognostic (3.88e-2)" "unprognostic (5.24e-2)" "prognostic favorable (2.76e-4)" "unprognostic (8.78e-2)" "unprognostic (5.31e-3)" "unprognostic (1.47e-3)" "unprognostic (5.81e-2)" "prognostic unfavorable (1.02e-7)" "unprognostic (1.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.69e-1)" "unprognostic (6.43e-3)" 92.4 174.4 132.9 69.5 136.2 72.8 116.1 141.8 190.4 82.2 153.6 100.6 90.4 93.6 168.6 95.1 209.3 82.8 227.2 132.9 135.8 168.4 147.5 111.5 127.1 139.5 135.2 105.5 90.3 116.7 152.0 114.6 140.8 84.7 73.4 164.6 154.3 68.0 151.4 81.1 74.1 76.1 136.6 91.5 106.9 83.2 133.7 112.7 113.2 130.1 109.9 77.1 81.9 145.6 101.7 90.3 309.7 135.0 121.9 99.6 70.1 69.0 73.7 75.6 110.3 508.3 83.9 1.2 124.2 56.5 101.0 63.4 203.6 78.3 74.2 298.7 170.9 355.9 292.3 268.9 78.0 294.9 52.3 121.5 85.4 50.3 27.7 72.9 170.9 74.3 212.3 275.0 123.8 92.9 136.3 564.7 227.8 87.7 224.5 229.7 472.6 103.8 525.3 145.3 126.0 168.5 131.3 149.4 102.4 271.1 85.1 488.6 75.0 20.9 91.7 73.5 155.3 235.3 375.2 1.9 11.8 1.1 103.0 38.3 147.3 13.6 107.8 148.0 95.9 112.9 75.7 92.8 179.2 99.8 88.7 106.8 7.2 142.3 143.9 208.6 90.4 169.3 132.9 136.2 141.8 190.4 132.9 135.8 139.5 135.2 140.8 136.6 133.7 145.6 140.6 96.1 167.9 129.9 110.1 171.1 193.7 516.8 234.5 261.8 301.4 376.3 424.5 231.6 373.7 242.8 75.0 940.6 169.9 35.3 602.6 229.3 72.5 775.8 108.1 166.0 272.9 95.4 115.8 198.6 823.7 165.3 116.2 199.2 109.6 80.9 261.3 256.3 309.7 195.2 105.3 131.1 435.4 186.0 206.5 60.9 187.0 148.4 257.9 58.1 403.3 320.2 198.8 66.9 159.7 107.2 52.4 167.0 211.3 85.3 36.5 852.5 900.3 134.3 144.7 102.4 233.9 26.8 52.0 260.0 149.9 555.3 109.9 232.4 121.5 173.2 HNRNPA1L2 LOC144983 ENSG00000139675 "Heterogeneous nuclear ribonucleoprotein A1 like 2" Q32P51 13 52642425-52643796 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 97.8;Extravillous trophoblasts: 72.0;Suprabasal keratinocytes: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" "prognostic favorable (2.58e-4)" "unprognostic (1.37e-1)" "unprognostic (8.39e-2)" "unprognostic (2.05e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (2.30e-1)" "unprognostic (1.66e-2)" "unprognostic (3.68e-2)" "unprognostic (5.48e-2)" "prognostic favorable (4.26e-4)" "unprognostic (3.27e-3)" "unprognostic (1.88e-2)" "unprognostic (2.89e-1)" "unprognostic (7.38e-2)" "unprognostic (9.49e-3)" "unprognostic (1.92e-2)" 4.8 5.0 11.3 6.4 11.0 18.8 6.5 13.2 12.7 6.5 11.5 4.5 3.9 7.7 7.9 4.1 6.2 3.4 5.5 10.6 12.9 6.3 4.1 5.6 9.6 11.2 11.1 11.0 5.3 4.3 6.5 4.6 11.5 6.6 5.4 11.1 4.7 5.9 5.6 6.2 5.1 5.4 10.4 8.5 3.7 3.8 11.8 12.5 6.9 3.7 8.3 5.1 5.3 11.8 8.6 6.5 14.6 17.5 6.5 7.3 7.3 10.6 9.4 6.3 5.0 9.0 9.2 15.8 3.7 6.1 5.2 13.3 11.0 12.2 10.5 16.2 8.5 16.2 17.4 14.0 11.6 27.9 4.3 9.3 10.3 6.8 15.6 13.5 13.3 14.8 9.0 7.5 6.9 10.3 20.3 30.9 12.3 3.6 7.7 16.9 10.4 9.6 10.0 14.7 7.3 13.5 5.0 6.9 11.5 9.4 7.0 18.3 10.1 7.9 9.2 7.5 11.3 8.5 10.0 19.4 4.1 13.8 8.3 2.2 1.9 7.2 6.3 1.7 7.0 7.0 5.7 6.4 3.2 9.5 7.1 5.4 0.2 8.9 1.3 9.1 5.7 8.1 11.3 11.0 13.2 12.7 10.6 12.9 11.2 11.1 11.5 10.4 11.8 11.8 2.7 3.2 3.6 13.7 13.7 97.8 5.9 39.8 0.0 3.4 1.9 2.5 12.0 27.1 12.0 0.0 2.1 44.9 15.3 4.6 0.0 5.8 15.2 0.6 1.9 15.7 28.9 4.0 12.4 6.9 72.0 10.6 1.1 0.8 10.2 1.4 20.3 2.4 21.4 1.7 13.8 22.9 14.2 20.4 58.7 7.9 40.4 4.5 33.8 13.1 18.3 3.9 30.9 22.1 16.9 5.4 18.8 23.7 1.0 3.0 14.1 2.2 5.5 2.8 6.6 4.9 12.2 15.9 22.2 1.5 87.9 48.7 16.0 0.8 34.0 2.4 HNRNPA2B1 HNRPA2B1 ENSG00000122566 "Heterogeneous nuclear ribonucleoprotein A2/B1" P22626 7 26171151-26201529 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, CAB012403, HPA065537" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 11000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507" "unprognostic (1.19e-1)" "unprognostic (4.45e-1)" "unprognostic (2.33e-1)" "unprognostic (6.39e-2)" "unprognostic (5.64e-2)" "unprognostic (8.04e-3)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.25e-2)" "unprognostic (9.12e-3)" "unprognostic (4.35e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.12e-4)" "prognostic unfavorable (8.01e-5)" "unprognostic (6.74e-2)" "unprognostic (3.36e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" 367.0 421.3 101.3 151.4 105.4 77.6 314.1 110.9 140.3 403.5 106.4 381.8 124.8 404.3 116.1 417.6 376.3 62.4 463.6 99.7 106.4 530.8 388.5 364.9 184.1 106.4 105.0 527.8 350.2 80.8 337.6 118.9 108.2 300.8 127.5 131.1 325.1 79.2 764.9 280.5 419.0 84.2 102.3 447.5 353.4 370.5 105.4 174.8 367.2 92.0 172.5 339.9 360.8 111.7 202.5 101.8 491.6 312.7 110.7 117.5 249.6 255.8 110.7 149.6 183.6 159.8 338.5 210.2 104.2 180.1 218.8 300.0 196.3 268.7 288.5 74.9 191.2 232.6 309.9 212.1 72.9 374.6 359.4 123.6 192.4 156.3 253.3 194.6 161.1 273.9 210.9 250.4 280.4 229.1 216.5 817.2 320.7 81.7 117.7 239.5 122.1 159.3 287.0 335.8 190.7 245.6 203.5 291.8 127.7 393.6 326.3 359.7 222.0 193.2 265.6 184.6 253.7 367.0 296.0 308.7 149.9 453.8 316.5 0.0 1.7 1.3 4.8 1.0 4.0 2.7 3.0 0.8 0.8 0.8 2.7 2.6 0.6 3.3 0.8 1.6 1.0 0.5 101.3 105.4 110.9 140.3 99.7 106.4 106.4 105.0 108.2 102.3 105.4 111.7 717.8 487.2 591.0 194.6 667.5 738.5 797.7 793.2 560.5 469.4 361.0 361.3 702.1 316.0 665.8 343.9 298.2 971.6 707.7 435.1 461.8 568.0 128.2 465.8 640.8 600.5 491.4 683.2 123.3 452.2 939.9 602.7 449.6 591.1 644.7 680.5 333.4 382.8 613.1 312.9 147.2 533.1 496.4 388.5 681.9 150.0 411.0 640.3 393.1 157.4 572.0 545.4 484.1 198.0 320.6 438.2 438.7 390.0 751.0 520.4 428.4 506.8 608.0 547.0 440.4 599.4 726.5 596.9 490.6 573.8 600.5 1082.8 701.7 652.2 541.4 632.1 HSD17B13 "SCDR9, SDR16C3" ENSG00000170509 "Hydroxysteroid 17-beta dehydrogenase 13" Q7Z5P4 4 87303789-87322886 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "liver: 573.7" "Cell type enhanced" "Detected in many" "Adipocytes: 100.0;Club cells: 42.9;Hepatocytes: 131.3;Respiratory ciliated cells: 34.0;Urothelial cells: 57.0" "Cancer enriched" "Detected in some" 26 "liver cancer: 52.9" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "NB-4: 1.4" "Not detected" "Not detected" HPA029125 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 24: NB-4 - Immune response" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Golgi apparatus" "HPA029125: AB_10601580" "unprognostic (2.49e-1)" "unprognostic (7.46e-2)" "unprognostic (7.02e-2)" "unprognostic (1.86e-4)" "unprognostic (4.74e-2)" "unprognostic (8.44e-2)" "prognostic favorable (2.94e-4)" "prognostic favorable (7.80e-4)" "unprognostic (4.97e-1)" "unprognostic (2.22e-2)" "unprognostic (1.00e-1)" "unprognostic (2.46e-1)" "unprognostic (7.18e-4)" "unprognostic (3.62e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-3)" 9.4 0.3 0.6 0.2 0.6 1.4 6.4 2.4 1.0 2.7 0.1 0.7 0.4 2.7 0.2 0.2 1.0 0.2 0.4 0.6 0.5 0.4 573.7 3.6 0.2 0.8 0.5 0.5 1.8 0.1 0.2 0.8 0.9 4.5 0.4 0.8 0.2 0.2 0.3 6.5 0.7 4.2 0.4 0.7 0.3 0.4 0.5 0.3 0.2 0.1 0.1 1.2 7.8 0.9 0.0 0.1 0.2 0.2 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.4 0.2 0.7 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.1 0.0 0.1 1.4 0.1 0.4 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.4 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.2 1.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.2 0.1 0.6 0.1 0.0 0.1 0.1 0.0 0.6 0.6 2.4 1.0 0.6 0.5 0.8 0.5 0.9 0.4 0.5 0.9 100.0 3.2 6.4 1.6 0.0 2.5 22.6 0.3 0.0 0.2 0.2 0.3 0.3 4.3 42.9 1.8 0.0 0.1 0.4 1.0 0.0 0.1 2.7 0.4 0.5 2.4 1.8 5.3 3.7 0.4 0.3 0.8 0.0 0.1 0.0 0.2 1.8 131.3 0.2 0.0 3.0 0.5 0.0 2.4 0.4 2.7 0.0 0.7 0.0 0.0 0.3 0.3 0.0 1.5 2.8 0.1 1.4 0.4 0.1 4.7 0.2 0.5 34.0 0.1 0.0 0.7 0.4 0.0 0.9 0.2 0.4 0.0 0.7 0.2 0.7 57.0 HVCN1 "Hv1, MGC15619, VSOP" ENSG00000122986 "Hydrogen voltage gated channel 1" Q96D96 12 110627841-110704950 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 162.1;lymphoid tissue: 72.9" "Cell type enhanced" "Detected in many" "B-cells: 178.4;Early spermatids: 87.3;Hofbauer cells: 57.0;Late spermatids: 76.4;Spermatocytes: 117.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NB-4: 286.4;U-698: 90.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039329 Enhanced NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 57: B-cells - Immune response" "HPA039329: AB_10674284" "unprognostic (3.43e-2)" "unprognostic (6.32e-3)" "unprognostic (7.05e-2)" "unprognostic (1.54e-2)" "unprognostic (4.62e-3)" "unprognostic (3.89e-2)" "unprognostic (1.96e-1)" "unprognostic (5.85e-3)" "unprognostic (2.40e-1)" "unprognostic (3.09e-2)" "unprognostic (1.54e-2)" "unprognostic (5.67e-2)" "unprognostic (3.35e-3)" "unprognostic (4.82e-2)" "unprognostic (1.33e-1)" "unprognostic (1.79e-1)" "unprognostic (1.68e-1)" 8.2 5.1 23.4 32.0 34.7 6.9 5.2 24.3 21.1 9.3 162.1 6.5 4.8 10.1 11.5 4.6 9.2 8.3 17.5 26.2 29.5 3.3 4.4 13.7 65.0 25.7 32.8 13.5 1.7 2.2 3.0 8.1 27.8 6.4 6.7 2.7 3.9 8.7 7.9 3.0 17.8 10.3 20.2 42.7 7.6 44.7 27.6 16.2 3.9 9.8 72.9 9.7 5.2 25.0 0.1 0.5 2.8 0.2 4.5 4.7 1.4 0.9 1.1 2.6 1.4 0.5 0.0 2.9 2.4 5.1 0.0 0.4 3.3 0.2 3.7 0.2 0.6 0.1 0.3 0.7 4.0 44.1 3.1 6.2 0.4 2.4 0.0 0.4 6.4 13.4 1.9 2.4 4.7 0.2 6.4 286.4 3.2 0.0 2.7 5.4 0.2 0.3 0.0 0.1 0.3 0.4 0.1 0.0 0.2 2.9 0.0 42.8 1.9 0.0 0.2 0.4 0.1 27.4 3.7 90.5 0.3 2.2 0.2 378.0 208.3 675.7 14.0 197.8 7.7 550.4 13.2 22.7 88.7 799.8 25.2 17.2 327.4 182.6 185.0 131.7 31.0 193.2 23.4 34.7 24.3 21.1 26.2 29.5 25.7 32.8 27.8 20.2 27.6 25.0 18.4 3.2 5.3 9.4 178.4 0.8 1.9 2.0 1.2 0.5 1.2 2.8 6.6 0.0 3.6 1.8 0.0 0.4 25.8 0.0 0.0 0.5 87.3 0.5 5.8 13.1 0.0 0.8 0.6 0.2 1.4 5.4 1.5 0.3 8.2 3.9 12.1 0.3 57.0 0.0 0.5 0.2 0.0 41.7 17.2 76.4 13.4 42.2 12.4 15.0 31.6 15.2 23.7 2.0 0.1 0.5 0.1 13.9 9.9 0.6 0.0 0.5 1.7 1.8 13.1 4.7 15.1 117.5 2.8 0.7 0.4 1.2 7.6 0.5 0.2 1.2 IGHD2-2 IGHD22 ENSG00000211931 "Immunoglobulin heavy diversity 2-2" 14 105916826-105916856 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "bone marrow: 2.9;intestine: 2.5;lymphoid tissue: 2.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 3.0" "Lineage enriched" "Detected in single" 31 "B-cells: 3.0" "Cell line enriched" "Detected in single" 23 "NB-4: 2.3" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "unprognostic (3.23e-3)" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.9 0.0 2.9 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-10 "DXP'1, IGHD310" ENSG00000211923 "Immunoglobulin heavy diversity 3-10" 14 105904497-105904527 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "bone marrow: 1.3;intestine: 3.7;lymphoid tissue: 4.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "cervical cancer: 5.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 7 "naive B-cell: 5.4" "Lineage enriched" "Detected in single" 55 "B-cells: 5.4" "Cell line enriched" "Detected in single" 12 "NB-4: 1.1" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-3 "DXP4, IGHD33" ENSG00000211930 "Immunoglobulin heavy diversity 3-3" 14 105914359-105914389 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;lymphoid tissue: 2.6;salivary gland: 3.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "naive B-cell: 62.6" "Lineage enriched" "Detected in single" 626 "B-cells: 62.6" "Group enriched" "Detected in some" 48 "NB-4: 6.9;SH-SY5Y: 2.6" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "unprognostic (1.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.13e-1)" "unprognostic (1.75e-1)" 0.0 0.0 0.0 0.9 0.1 4.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.0 0.0 0.0 1.9 1.6 0.1 0.0 0.1 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 62.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1-18 ENSG00000211945 "Immunoglobulin heavy variable 1-18" A0A0C4DH31 14 106184901-106185394 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 223.2;lymphoid tissue: 486.7;salivary gland: 234.3" "Cell type enriched" "Detected in some" 259 "Plasma cells: 13773.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 21 "memory B-cell: 73.2" "Lineage enriched" "Detected in many" 21 "B-cells: 73.2" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HL-60: 3.0;RPMI-8226: 2.9;TIME: 1.6" "Immunoglobulin genes" NA NA 4700000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (3.47e-4)" "unprognostic (2.53e-2)" "unprognostic (8.73e-3)" "unprognostic (2.56e-2)" "unprognostic (9.67e-3)" "prognostic favorable (8.27e-4)" "unprognostic (5.47e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-1)" "unprognostic (3.50e-2)" "unprognostic (3.60e-1)" "unprognostic (4.26e-1)" "prognostic unfavorable (5.84e-7)" "unprognostic (3.22e-1)" "unprognostic (2.62e-1)" "unprognostic (2.87e-1)" "unprognostic (2.44e-2)" 22.0 3.5 0.0 0.0 0.3 0.0 22.9 0.0 0.6 54.6 0.0 223.2 0.0 8.9 4.5 162.5 24.3 7.7 2.3 0.0 0.0 16.2 14.3 58.3 0.0 0.6 0.1 8.5 3.2 1.9 1.3 0.2 0.4 10.8 0.0 0.0 234.3 0.0 0.4 1.3 103.2 2.6 0.0 486.7 84.0 0.5 0.1 0.0 33.9 0.2 0.0 156.1 12.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.6 0.5 0.8 0.0 0.0 1.1 1.2 2.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.4 1.0 0.5 0.0 0.3 0.0 1.4 0.0 3.4 0.0 0.1 0.0 0.0 0.1 73.2 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 53.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 13773.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 3.2 0.0 0.1 0.0 IGHV1-46 ENSG00000211962 "Immunoglobulin heavy variable 1-46" P01743 14 106511117-106511856 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 67.9;lymphoid tissue: 125.7;salivary gland: 67.4" "Cell type enriched" "Detected in some" 201 "Plasma cells: 8432.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;RPMI-8226: 1.2;SH-SY5Y: 1.2;TIME: 2.3;U-266/70: 1.1;U-266/84: 1.2" "Immunoglobulin genes" NA NA 2900000000 "Cluster 24: B-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (6.28e-4)" "unprognostic (2.49e-2)" "prognostic favorable (7.34e-4)" "unprognostic (1.10e-2)" "unprognostic (3.53e-2)" "unprognostic (1.80e-3)" "unprognostic (1.87e-1)" "unprognostic (6.76e-2)" "unprognostic (8.11e-2)" "unprognostic (2.57e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-1)" "prognostic unfavorable (1.56e-6)" "unprognostic (6.19e-2)" "unprognostic (2.52e-1)" "unprognostic (2.27e-1)" "unprognostic (5.13e-1)" 5.1 1.3 0.0 0.0 0.0 0.0 7.2 0.0 0.1 6.2 0.0 67.9 0.0 2.5 1.0 4.9 3.5 0.7 5.0 0.0 0.0 3.2 4.2 15.3 0.0 0.1 0.0 3.0 5.3 0.1 0.3 0.3 0.1 1.9 45.1 0.0 67.4 0.0 0.1 0.7 34.2 0.0 0.0 125.7 25.1 0.2 0.0 0.0 10.5 0.2 0.0 5.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.0 0.5 1.2 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.3 0.0 0.1 1.1 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 1.9 41.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8432.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 IGHV3-11 ENSG00000211941 "Immunoglobulin heavy variable 3-11" P01762 14 106116635-106117204 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 220.1;lymphoid tissue: 613.1;stomach 1: 206.7" "Cell type enriched" "Detected in some" 142 "Plasma cells: 1655.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 445 "memory B-cell: 43.1;naive B-cell: 45.7" "Lineage enriched" "Detected in single" 458 "B-cells: 45.7" "Cell line enhanced" "Detected in some" "Daudi: 1.1;SH-SY5Y: 1.2" "Immunoglobulin genes" NA NA 18000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (2.07e-3)" "unprognostic (4.84e-2)" "unprognostic (5.81e-3)" "unprognostic (1.07e-2)" "unprognostic (1.04e-2)" "prognostic favorable (3.42e-5)" "unprognostic (4.12e-1)" "unprognostic (6.50e-2)" "unprognostic (2.37e-1)" "unprognostic (3.44e-2)" "unprognostic (3.51e-1)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (1.86e-1)" "unprognostic (1.30e-1)" 9.3 25.9 0.0 175.0 0.0 38.0 66.0 0.0 0.5 34.7 0.2 220.1 193.4 6.8 12.3 38.6 6.6 43.7 8.6 0.0 0.0 6.8 10.5 29.1 123.7 0.8 0.0 7.8 2.0 0.2 0.8 0.0 0.1 4.0 167.9 0.0 119.7 3.7 0.3 0.7 116.8 11.2 0.1 219.2 206.7 1.3 0.4 44.9 17.0 0.0 613.1 109.4 8.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1655.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 IGHV3-15 ENSG00000211943 "Immunoglobulin heavy variable 3-15" A0A0B4J1V0 14 106153624-106154163 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 183.3;lymphoid tissue: 380.2;salivary gland: 177.7;stomach 1: 112.8;urinary bladder: 172.6" "Cell type enriched" "Detected in some" 112 "Plasma cells: 6281.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "MAIT T-cell: 21.6;memory B-cell: 24.4" "Group enriched" "Detected in many" 9 "B-cells: 24.4;T-cells: 21.6" "Cell line enhanced" "Detected in some" "BEWO: 2.2;Daudi: 1.9;HL-60: 2.1;K-562: 2.0;NB-4: 2.4;RH-30: 1.9;RPMI-8226: 4.1;SH-SY5Y: 3.7" "Immunoglobulin genes" NA NA 20000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (8.85e-5)" "unprognostic (2.07e-1)" "unprognostic (1.94e-2)" "unprognostic (1.41e-2)" "unprognostic (1.62e-2)" "prognostic favorable (3.34e-5)" "unprognostic (5.20e-2)" "unprognostic (2.44e-1)" "unprognostic (9.67e-2)" "unprognostic (3.24e-2)" "unprognostic (2.53e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (6.85e-2)" "unprognostic (6.92e-2)" "unprognostic (7.12e-2)" "unprognostic (3.63e-1)" 12.2 36.8 0.0 24.7 0.5 1.8 23.2 0.0 1.2 13.0 0.1 183.3 4.5 5.0 0.9 11.7 16.3 29.6 1.4 0.0 0.2 9.1 10.6 40.0 0.0 1.0 0.0 5.8 19.1 0.4 1.3 0.4 0.3 9.5 14.6 0.0 177.7 23.0 0.8 4.2 107.2 0.3 0.0 380.2 112.8 0.5 0.0 0.0 14.9 0.0 10.4 172.6 9.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.8 2.4 0.7 0.0 0.0 0.0 1.9 4.1 0.0 0.0 0.0 3.7 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.1 0.4 1.6 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.1 0.1 0.0 21.6 24.4 0.1 0.2 0.2 0.0 0.2 0.1 2.5 0.0 0.0 0.2 0.1 1.8 0.0 0.5 0.0 1.2 0.0 0.2 1.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 1.1 8.2 0.0 0.0 0.1 1.1 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6281.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 IGHV3-23 ENSG00000211949 "Immunoglobulin heavy variable 3-23" P01764 14 106268606-106269140 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1683.1;lymphoid tissue: 2989.8" "Cell type enriched" "Detected in some" 139 "Plasma cells: 15979.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 406 "memory B-cell: 548.5;naive B-cell: 336.7" "Lineage enriched" "Detected in many" 503 "B-cells: 548.5" "Cell line enhanced" "Detected in some" "BEWO: 4.4;HL-60: 3.3;NB-4: 4.1;RH-30: 3.0;RPMI-8226: 9.0;SH-SY5Y: 5.8" "Immunoglobulin genes" NA NA 42000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.17e-3)" "unprognostic (5.43e-2)" "unprognostic (9.68e-3)" "unprognostic (3.31e-3)" "unprognostic (1.34e-2)" "prognostic favorable (3.85e-4)" "unprognostic (3.26e-1)" "unprognostic (4.79e-1)" "unprognostic (7.26e-2)" "unprognostic (6.52e-3)" "unprognostic (1.72e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.79e-7)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.36e-1)" "unprognostic (6.42e-2)" 66.5 189.3 0.4 912.2 0.4 185.5 343.1 0.1 2.1 80.1 1.5 1683.1 1640.8 37.0 9.8 342.6 30.1 231.2 46.4 0.1 0.3 27.3 56.4 248.7 859.5 0.8 0.1 42.6 31.0 1.5 2.7 0.9 0.4 35.3 1087.1 0.1 697.8 53.4 0.9 15.0 886.8 40.0 0.8 802.7 1058.8 35.0 0.2 197.5 52.3 0.1 2989.8 993.6 27.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 4.1 0.7 0.0 0.0 0.6 3.0 9.0 0.0 0.0 2.7 5.8 0.8 0.1 0.0 0.0 0.0 0.0 1.8 0.0 1.3 1.3 1.1 1.5 0.0 0.3 0.0 0.9 0.0 0.4 0.4 0.1 0.2 0.0 0.1 548.5 0.2 0.3 0.3 336.7 0.1 0.2 1.0 0.2 0.2 0.2 0.8 62.4 0.4 0.4 0.1 2.1 0.1 0.3 0.8 0.1 0.4 0.8 0.2 1.4 0.1 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 12.0 0.0 0.0 0.0 1.6 19.4 0.0 1.3 0.0 1.8 2.0 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15979.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.1 0.0 IGHV3-30 ENSG00000270550 "Immunoglobulin heavy variable 3-30" "P01768, P0DP03" 14 106335082-106335613 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 534.0;lymphoid tissue: 1294.8;salivary gland: 459.9;stomach 1: 572.6;urinary bladder: 378.9" "Cell type enriched" "Detected in some" 184 "Plasma cells: 14426.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 409 "memory B-cell: 164.0;naive B-cell: 136.6" "Lineage enriched" "Detected in single" 446 "B-cells: 164.0" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Daudi: 1.7;NB-4: 2.3;RPMI-8226: 1.7;SCLC-21H: 1.7;SH-SY5Y: 3.0;U-266/70: 1.3" "Immunoglobulin genes" NA NA 8500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (2.12e-3)" "unprognostic (5.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "unprognostic (1.72e-2)" "prognostic favorable (3.23e-5)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.94e-2)" "unprognostic (2.94e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (1.65e-7)" "unprognostic (1.32e-1)" "unprognostic (2.16e-1)" "unprognostic (2.01e-1)" "unprognostic (6.96e-2)" 25.3 38.5 0.1 320.5 0.2 119.7 143.9 0.0 0.4 49.3 0.5 534.0 265.5 13.3 0.0 134.6 44.8 146.5 30.3 0.4 0.2 29.2 25.1 128.2 374.9 0.6 0.2 23.0 12.3 0.7 3.3 0.7 0.2 18.6 254.9 0.0 459.9 20.4 0.9 3.5 296.1 23.6 0.1 797.4 572.6 5.9 0.1 158.2 76.6 0.1 1294.8 378.9 34.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.0 1.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 164.0 0.2 0.0 0.1 136.6 0.3 0.1 0.3 0.0 0.0 0.2 0.0 24.4 0.1 0.2 0.0 0.4 0.4 0.2 0.6 0.2 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 78.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 5.4 16.3 0.0 1.3 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14426.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.0 IGHV3-48 ENSG00000211964 "Immunoglobulin heavy variable 3-48" P01763 14 106537810-106538344 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 516.4;lymphoid tissue: 858.8;stomach 1: 404.9" "Cell type enriched" "Detected in some" 100 "Plasma cells: 5878.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Group enriched" "Detected in some" 527 "memory B-cell: 187.1;naive B-cell: 97.5" "Lineage enriched" "Detected in single" 693 "B-cells: 187.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.6" "Immunoglobulin genes" NA NA 49000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (9.19e-3)" "unprognostic (1.87e-2)" "unprognostic (5.12e-2)" "unprognostic (9.07e-3)" "unprognostic (1.77e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.23e-1)" "unprognostic (9.59e-2)" "unprognostic (2.65e-1)" "unprognostic (4.02e-2)" "unprognostic (2.64e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (4.88e-8)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" 8.7 22.9 0.0 232.6 0.0 81.2 56.4 0.0 1.3 25.9 0.2 434.1 516.4 8.1 0.1 33.4 12.1 38.6 6.9 0.0 0.0 10.8 18.6 32.3 125.3 0.3 0.0 12.2 8.8 0.9 0.9 0.1 0.7 6.8 253.2 0.0 164.6 16.0 0.6 1.6 134.4 17.7 0.1 271.1 404.9 27.9 0.0 36.3 16.0 0.0 858.8 248.6 7.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.9 0.4 0.0 0.0 0.0 0.8 0.9 0.0 0.0 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 187.1 0.0 0.0 0.1 97.5 0.0 0.1 0.1 0.0 0.0 0.0 0.2 22.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.7 17.9 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5878.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 IGHV3-49 ENSG00000211965 "Immunoglobulin heavy variable 3-49" A0A0A0MS15 14 106556936-106557477 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 210.7;lymphoid tissue: 373.5;stomach 1: 182.3" "Cell type enriched" "Detected in some" 46 "Plasma cells: 717.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 187 "memory B-cell: 59.4;naive B-cell: 42.2" "Lineage enriched" "Detected in single" 219 "B-cells: 59.4" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "Immunoglobulin genes" NA NA 1600000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (7.16e-4)" "unprognostic (7.91e-3)" "unprognostic (2.50e-2)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "prognostic favorable (2.34e-6)" "unprognostic (4.47e-2)" "unprognostic (4.30e-2)" "unprognostic (7.00e-3)" "unprognostic (9.17e-2)" "unprognostic (2.18e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.43e-6)" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (8.96e-2)" "unprognostic (3.00e-1)" 20.8 7.1 0.0 112.3 0.0 45.7 42.5 0.0 0.5 11.5 0.3 210.7 184.4 4.6 3.9 20.0 5.1 10.9 9.4 0.0 0.2 5.0 12.8 43.2 108.6 0.7 0.0 26.5 1.7 0.2 0.4 0.0 0.3 3.0 139.3 0.0 88.5 12.1 0.2 0.4 88.2 11.5 0.1 183.1 182.3 1.8 0.1 21.4 9.7 0.0 373.5 100.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 0.0 0.0 0.0 42.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 717.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 IGHV3-7 ENSG00000211938 "Immunoglobulin heavy variable 3-7" P01780 14 106062151-106062683 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 461.3;lymphoid tissue: 971.3" "Cell type enriched" "Detected in some" 255 "Plasma cells: 20463.1" "Cancer enhanced" "Detected in many" "stomach cancer: 18.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 147 "memory B-cell: 134.0;naive B-cell: 107.0" "Lineage enriched" "Detected in single" 163 "B-cells: 134.0" "Cell line enhanced" "Detected in some" "Daudi: 7.6;HL-60: 3.1;K-562: 3.0;NB-4: 3.0;RPMI-8226: 5.8;SH-SY5Y: 4.8;TIME: 2.9" "Immunoglobulin genes" NA NA 39000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.29e-2)" "unprognostic (5.57e-3)" "unprognostic (1.37e-2)" "prognostic favorable (1.47e-6)" "unprognostic (1.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (5.46e-2)" "unprognostic (1.37e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (4.35e-5)" "unprognostic (5.18e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (7.70e-2)" 47.8 10.1 0.7 50.1 1.0 71.1 202.7 0.3 0.8 87.4 0.6 461.3 154.1 37.7 8.2 17.8 13.4 37.0 2.2 0.2 0.4 17.6 20.3 56.4 102.5 1.6 2.8 24.7 4.8 2.9 1.8 0.3 2.3 9.2 303.5 0.0 265.5 22.9 1.3 9.6 206.0 3.6 3.9 610.4 230.4 13.2 0.4 0.0 21.1 0.1 971.3 42.9 14.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.4 2.6 5.8 0.0 0.0 2.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.7 0.0 1.2 1.6 0.0 0.1 0.0 0.6 0.0 0.4 0.8 0.2 0.1 0.0 0.2 134.0 0.2 0.2 0.3 107.0 0.1 0.1 0.1 0.1 0.2 0.6 0.2 12.6 0.7 1.0 0.3 0.8 0.2 0.4 1.6 2.8 2.3 3.9 0.4 1.3 0.0 0.0 0.0 0.0 80.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.5 0.0 5.3 0.0 0.0 0.0 4.4 31.1 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20463.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 7.4 0.0 0.5 0.0 IGHV4-39 ENSG00000211959 "Immunoglobulin heavy variable 4-39" P01824 14 106421711-106422218 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 251.6;lymphoid tissue: 474.9;salivary gland: 247.1;urinary bladder: 541.3" "Cell type enriched" "Detected in some" 432 "Plasma cells: 48104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.6;naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.3;Daudi: 1.8;HL-60: 2.4;NB-4: 2.2;RH-30: 2.1;RPMI-8226: 1.4;U-266/70: 2.1;U-698: 2.0" "Immunoglobulin genes" NA NA 5000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.95e-3)" "unprognostic (1.46e-2)" "unprognostic (5.65e-2)" "unprognostic (2.38e-3)" "unprognostic (4.48e-2)" "unprognostic (2.63e-1)" "unprognostic (1.77e-1)" "unprognostic (2.23e-2)" "unprognostic (2.35e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (2.04e-2)" "unprognostic (2.77e-1)" "unprognostic (7.68e-2)" "unprognostic (8.33e-2)" 17.8 6.5 0.5 378.0 0.5 14.5 33.2 0.1 0.8 24.0 1.5 251.6 4.4 12.5 2.5 19.1 17.7 0.0 11.4 0.1 0.2 13.8 13.8 54.9 0.0 0.8 1.2 17.6 3.7 1.2 1.4 0.0 0.6 7.1 5.0 0.0 247.1 9.5 0.5 12.1 143.6 2.0 0.1 474.9 108.1 1.3 0.4 2.8 37.2 0.0 5.3 541.3 13.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 1.1 2.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.2 0.2 0.0 2.1 0.0 2.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.2 1.6 0.1 0.1 0.1 1.7 0.5 0.1 1.1 0.1 0.1 0.2 0.1 0.0 0.5 0.5 0.1 0.8 0.1 0.2 0.8 1.2 0.6 0.1 0.4 0.3 0.0 0.0 0.0 0.0 89.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 111.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48104.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.3 0.0 IGHV5-51 ENSG00000211966 "Immunoglobulin heavy variable 5-51" A0A0C4DH38 14 106578744-106579236 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 245.7;lymphoid tissue: 547.1;salivary gland: 224.5;urinary bladder: 353.3" "Cell type enriched" "Detected in some" 87 "Plasma cells: 5993.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.7;K-562: 2.4;NB-4: 1.7;TIME: 3.3" HPA006014 Approved "Immunoglobulin genes" NA NA 2700000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA006014: " "unprognostic (2.03e-3)" "unprognostic (1.00e-1)" "unprognostic (3.21e-2)" "unprognostic (7.65e-3)" "unprognostic (1.80e-2)" "prognostic favorable (5.47e-4)" "unprognostic (2.40e-2)" "unprognostic (1.15e-1)" "unprognostic (3.92e-2)" "unprognostic (6.47e-2)" "unprognostic (2.49e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.31e-7)" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.70e-1)" "unprognostic (1.17e-1)" 20.0 4.8 0.3 0.0 0.0 0.0 25.9 0.1 1.7 17.8 0.7 245.7 0.0 8.6 6.3 19.1 15.2 27.1 2.1 0.1 0.7 15.4 15.0 56.2 0.0 0.9 0.0 8.8 17.1 1.0 2.2 0.6 0.2 11.2 0.0 0.0 224.5 0.0 0.7 3.2 144.8 1.7 0.6 547.1 99.9 4.8 0.1 0.0 25.6 0.0 0.0 353.3 14.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 1.3 1.2 0.8 0.0 0.1 0.0 0.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 1.7 0.1 0.7 0.9 0.0 0.2 0.6 0.1 1.3 0.0 0.0 0.0 0.0 68.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.8 44.9 0.0 0.0 0.0 0.7 1.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5993.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 IGKV1-12 "IGKV112, L19" ENSG00000243290 "Immunoglobulin kappa variable 1-12" A0A0C4DH73 2 89040224-89040745 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 395.8;lymphoid tissue: 788.8" "Cell type enriched" "Detected in some" 92 "Plasma cells: 12442.9" "Cancer enhanced" "Detected in many" "stomach cancer: 17.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 820 "memory B-cell: 259.8;naive B-cell: 164.2" "Lineage enriched" "Detected in single" 1005 "B-cells: 259.8" "Cell line enhanced" "Detected in some" "BEWO: 1.5;Daudi: 2.1;RPMI-8226: 1.9;SH-SY5Y: 1.9" HPA048721 Approved "Immunoglobulin genes" NA NA 13000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (6.09e-4)" "prognostic favorable (1.59e-4)" "unprognostic (7.33e-2)" "unprognostic (3.74e-2)" "prognostic favorable (3.85e-5)" "unprognostic (5.89e-2)" "unprognostic (5.74e-1)" "unprognostic (7.13e-2)" "unprognostic (6.15e-2)" "unprognostic (3.90e-1)" "prognostic unfavorable (6.59e-8)" "unprognostic (1.18e-1)" "unprognostic (1.84e-1)" "unprognostic (2.68e-1)" "unprognostic (1.71e-1)" 13.6 144.8 0.0 201.7 0.2 73.1 116.8 0.0 0.4 50.8 0.2 395.8 240.6 7.3 0.0 57.1 16.2 69.6 9.9 0.1 0.1 13.7 17.8 65.3 238.6 0.6 0.0 18.1 7.2 0.2 1.4 0.0 1.1 7.2 278.6 0.0 219.0 5.4 0.4 2.8 231.2 11.2 1.2 360.5 254.9 6.7 0.0 69.5 32.7 0.0 788.8 243.3 9.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.0 259.8 0.0 0.1 0.1 164.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 24.3 0.0 0.2 0.0 0.4 0.1 0.1 0.6 0.0 1.1 1.2 0.0 0.3 0.0 0.0 0.0 0.0 134.3 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 20.4 0.0 0.0 0.0 1.8 1.6 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12442.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.3 0.0 0.3 5.0 0.0 0.0 0.0 IGKV1-16 "IGKV116, L1" ENSG00000240864 "Immunoglobulin kappa variable 1-16" P04430 2 89099859-89100361 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 279.7;lymphoid tissue: 597.8;urinary bladder: 260.3" "Cell type enriched" "Detected in some" 559 "Plasma cells: 18463.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 523 "memory B-cell: 164.7;naive B-cell: 112.8" "Lineage enriched" "Detected in single" 621 "B-cells: 164.7" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" HPA048721 Approved "Immunoglobulin genes" NA NA 10000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (2.63e-4)" "unprognostic (7.81e-2)" "unprognostic (1.43e-3)" "unprognostic (2.61e-2)" "unprognostic (3.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.69e-2)" "unprognostic (1.87e-1)" "unprognostic (8.35e-2)" "unprognostic (3.24e-2)" "unprognostic (1.30e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (2.84e-1)" "unprognostic (1.17e-1)" "unprognostic (3.84e-2)" "unprognostic (5.82e-2)" 11.8 4.7 0.1 159.1 0.1 40.0 75.9 0.0 0.8 76.0 0.6 279.7 199.4 6.3 0.5 34.3 6.6 99.0 11.4 0.0 0.1 9.2 14.9 40.5 155.0 0.2 0.0 17.7 2.0 0.1 3.6 0.1 0.1 5.6 235.6 0.0 126.9 30.9 0.8 0.7 143.6 11.8 0.1 315.4 158.9 2.0 0.1 45.7 18.4 0.0 597.8 260.3 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 164.7 0.0 0.0 0.1 112.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 16.9 0.1 0.1 0.0 0.8 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.6 21.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18463.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 IGKV1-17 "A30, IGKV117" ENSG00000240382 "Immunoglobulin kappa variable 1-17" P01599 2 89117342-89117844 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 375.0;lymphoid tissue: 454.4" "Cell type enriched" "Detected in some" 113 "Plasma cells: 4510.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 425 "memory B-cell: 105.7;naive B-cell: 82.2" "Lineage enriched" "Detected in single" 478 "B-cells: 105.7" "Cell line enhanced" "Detected in some" "Daudi: 1.9;K-562: 1.2;RPMI-8226: 2.0;SH-SY5Y: 1.4" HPA048721 Approved "Immunoglobulin genes" NA NA 8400000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "unprognostic (7.72e-3)" "unprognostic (1.60e-1)" "unprognostic (7.37e-3)" "unprognostic (1.78e-2)" "unprognostic (5.08e-3)" "prognostic favorable (4.11e-4)" "unprognostic (8.04e-2)" "unprognostic (1.00e-1)" "unprognostic (9.59e-2)" "unprognostic (1.76e-2)" "unprognostic (5.06e-2)" "unprognostic (2.54e-1)" "prognostic unfavorable (3.44e-7)" "unprognostic (3.12e-3)" "unprognostic (8.83e-2)" "unprognostic (3.80e-1)" "unprognostic (7.28e-2)" 12.8 26.5 0.1 183.7 0.2 27.7 87.1 0.0 0.7 11.9 0.4 358.5 294.8 6.6 4.1 54.7 12.4 55.7 10.9 0.0 0.1 10.3 14.2 36.5 95.7 0.6 0.0 12.4 3.3 1.1 1.0 0.1 0.2 5.5 375.0 0.0 134.3 31.0 1.3 1.2 152.7 4.7 0.1 306.1 159.7 2.4 0.3 45.6 25.8 0.0 454.4 182.6 6.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.8 2.0 0.0 0.0 0.5 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 105.7 0.0 0.0 0.1 82.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 12.6 0.1 0.2 0.0 0.7 0.0 0.1 0.6 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4510.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 IGKV1-5 ENSG00000243466 "Immunoglobulin kappa variable 1-5" P01602 2 88947301-88947957 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 777.1;lymphoid tissue: 1459.2;urinary bladder: 945.2" "Cell type enriched" "Detected in some" 240 "Plasma cells: 39194.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 364 "memory B-cell: 859.0;naive B-cell: 860.5" "Lineage enriched" "Detected in many" 364 "B-cells: 860.5" "Cell line enhanced" "Detected in some" "Daudi: 4.0;HL-60: 2.4;RPMI-8226: 5.0;SCLC-21H: 2.9;SH-SY5Y: 4.5" HPA048721 Approved "Immunoglobulin genes" NA NA 8400000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (1.19e-4)" "unprognostic (1.26e-2)" "unprognostic (3.12e-3)" "unprognostic (5.00e-3)" "unprognostic (1.59e-2)" "prognostic favorable (3.47e-4)" "unprognostic (7.60e-2)" "unprognostic (2.84e-1)" "unprognostic (1.68e-1)" "unprognostic (3.32e-2)" "unprognostic (2.28e-1)" "unprognostic (3.58e-1)" "prognostic unfavorable (4.36e-8)" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (8.27e-2)" "unprognostic (3.17e-2)" 35.8 82.0 0.2 639.7 0.2 115.4 233.9 0.1 1.6 115.8 0.6 777.1 528.7 17.1 2.0 146.2 86.9 124.8 18.7 0.1 0.5 36.2 32.0 125.3 387.2 1.0 0.2 60.8 10.8 0.5 3.0 0.4 0.3 16.7 745.0 0.0 392.2 34.8 0.9 3.2 429.7 24.4 1.3 915.4 456.3 11.5 0.2 155.3 58.4 0.0 1459.2 945.2 28.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 1.6 0.5 0.0 0.0 0.3 1.0 5.0 0.0 0.0 2.9 4.5 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.4 0.7 0.4 0.6 0.1 0.4 0.0 0.6 0.0 0.7 1.2 1.3 0.5 0.2 0.4 859.0 2.3 0.3 1.0 860.5 0.2 0.3 1.4 0.4 0.6 0.7 0.6 113.5 0.2 0.2 0.1 1.6 0.1 0.5 1.0 0.2 0.3 1.3 0.2 0.5 0.0 0.0 0.6 0.0 163.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 7.0 89.7 0.0 0.0 0.0 0.7 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39194.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 11.8 0.0 0.2 0.0 IGKV1-9 "IGKV19, L8" ENSG00000241755 "Immunoglobulin kappa variable 1-9" A0A0C4DH69 2 89009982-89010515 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 428.1;lymphoid tissue: 671.3;stomach 1: 283.7" "Cell type enriched" "Detected in some" 116 "Plasma cells: 7178.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Group enriched" "Detected in some" 705 "memory B-cell: 300.5;naive B-cell: 296.8" "Lineage enriched" "Detected in single" 709 "B-cells: 300.5" "Cell line enhanced" "Detected in some" "HL-60: 1.2;NB-4: 1.0;RPMI-8226: 2.9;TIME: 1.2" HPA048721 Approved "Immunoglobulin genes" NA NA 4500000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "prognostic favorable (2.10e-7)" "unprognostic (1.30e-2)" "unprognostic (1.95e-2)" "unprognostic (2.55e-3)" "unprognostic (4.70e-2)" "prognostic favorable (4.91e-4)" "unprognostic (3.30e-2)" "unprognostic (1.57e-1)" "unprognostic (1.09e-2)" "unprognostic (6.80e-2)" "unprognostic (1.95e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (6.04e-8)" "unprognostic (4.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (3.40e-1)" 12.6 12.6 0.2 184.3 0.4 53.6 202.8 0.0 1.3 15.8 0.4 428.1 267.0 8.3 0.8 52.9 78.3 30.0 13.9 0.1 0.1 15.4 17.9 40.1 201.8 0.3 0.1 20.7 2.5 0.5 1.3 0.1 0.2 12.8 348.6 0.0 221.3 13.3 0.5 1.6 182.8 13.3 0.4 313.1 283.7 35.1 0.1 85.1 34.2 0.0 671.3 187.5 8.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 1.0 0.3 0.0 0.0 0.0 0.9 2.9 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.2 0.4 0.1 0.2 0.0 0.1 300.5 0.1 0.0 0.3 296.8 0.0 0.1 0.3 0.2 0.2 0.1 0.3 34.5 0.2 0.4 0.0 1.3 0.1 0.1 0.3 0.1 0.2 0.4 0.1 0.3 0.0 0.0 0.0 0.0 61.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.7 0.0 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7178.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 IGKV2-24 ENSG00000241294 "Immunoglobulin kappa variable 2-24" A0A0C4DH68 2 89176328-89177160 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 272.7;lymphoid tissue: 474.9;urinary bladder: 935.2" "Cell type enriched" "Detected in some" 252 "Plasma cells: 5620.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 4 "memory B-cell: 48.1" "Lineage enriched" "Detected in single" 482 "B-cells: 48.1" "Cell line enhanced" "Detected in single" "NB-4: 1.3" "Immunoglobulin genes" NA NA 840000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (5.74e-6)" "unprognostic (4.92e-3)" "unprognostic (1.04e-2)" "unprognostic (2.38e-2)" "unprognostic (3.79e-3)" "prognostic favorable (1.59e-4)" "unprognostic (5.02e-2)" "unprognostic (1.65e-1)" "unprognostic (2.71e-2)" "unprognostic (1.31e-1)" "unprognostic (4.10e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.82e-5)" "unprognostic (1.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" 13.7 14.6 0.1 65.8 0.1 27.4 91.8 0.0 0.6 11.5 0.4 272.7 250.8 3.2 1.1 82.0 6.6 24.1 14.7 0.2 1.0 7.8 8.6 30.0 131.7 0.6 0.1 6.3 5.6 0.2 0.9 0.2 0.9 5.4 180.6 0.0 219.3 3.3 0.3 3.3 98.5 7.9 1.1 474.9 106.8 1.2 0.2 23.7 11.1 0.0 235.6 935.2 14.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.1 0.0 0.6 0.2 1.0 0.6 0.1 0.9 1.1 0.2 0.3 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5620.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 IGKV2-28 ENSG00000244116 "Immunoglobulin kappa variable 2-28" A0A075B6P5 2 89221698-89222461 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1044.6;lymphoid tissue: 1735.3" "Cell type enriched" "Detected in some" 92 "Plasma cells: 1868.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 13 "naive B-cell: 11.1" "Lineage enriched" "Detected in single" 13 "B-cells: 11.1" "Cell line enhanced" "Detected in some" "BEWO: 2.4;Daudi: 2.8;HL-60: 3.6;K-562: 2.0;NB-4: 2.7;RPMI-8226: 4.5;SCLC-21H: 2.1;SH-SY5Y: 1.7" "Immunoglobulin genes" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.03e-2)" "unprognostic (1.73e-2)" "unprognostic (1.34e-1)" "prognostic favorable (3.32e-4)" "unprognostic (2.12e-2)" "unprognostic (6.32e-3)" "unprognostic (3.14e-1)" "unprognostic (3.71e-2)" "unprognostic (5.21e-2)" "unprognostic (2.64e-2)" 36.2 40.2 0.2 402.4 0.2 180.2 425.2 0.1 1.1 56.6 0.9 1044.6 756.7 38.2 4.9 662.7 29.0 130.8 22.3 0.1 0.3 46.2 40.2 157.6 584.6 0.6 0.9 87.9 19.5 3.8 3.3 0.5 0.3 21.1 709.6 0.1 732.4 95.0 1.8 7.1 425.6 23.9 0.8 1207.7 530.0 161.9 0.2 167.6 84.8 0.0 1735.3 494.1 30.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 1.1 4.5 0.0 0.4 2.1 1.7 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.4 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 11.1 0.2 0.1 0.8 0.1 0.0 0.4 0.1 0.0 0.2 0.2 0.1 1.1 0.1 0.3 0.6 0.9 0.3 0.8 0.2 0.9 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1868.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 IGKV3-11 ENSG00000241351 "Immunoglobulin kappa variable 3-11" P04433 2 89027171-89027731 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1373.3;lymphoid tissue: 2812.9;urinary bladder: 1822.6" "Cell type enriched" "Detected in some" 129 "Plasma cells: 27475.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 9 "spinal cord: 19.8" "Group enriched" "Detected in many" 292 "memory B-cell: 1729.8;naive B-cell: 1401.2" "Lineage enriched" "Detected in many" 323 "B-cells: 1729.8" "Cell line enhanced" "Detected in some" "BEWO: 3.0;Daudi: 2.0;SCLC-21H: 3.7;SH-SY5Y: 4.6" HPA047702 Approved "Immunoglobulin genes" NA NA 18000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "unprognostic (3.97e-3)" "unprognostic (1.17e-2)" "unprognostic (3.51e-2)" "unprognostic (1.91e-2)" "unprognostic (2.70e-2)" "prognostic favorable (1.36e-5)" "unprognostic (2.02e-1)" "unprognostic (3.20e-1)" "unprognostic (5.73e-2)" "unprognostic (2.86e-2)" "unprognostic (1.70e-1)" "unprognostic (2.34e-1)" "prognostic unfavorable (2.26e-8)" "unprognostic (5.93e-2)" "unprognostic (2.48e-1)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" 45.8 60.5 0.4 733.2 0.3 189.1 385.3 0.2 2.1 136.2 0.6 1373.3 701.6 32.1 11.5 143.5 34.0 253.5 18.9 0.2 0.6 44.4 55.2 227.4 575.7 0.6 0.7 120.8 13.7 1.9 3.2 0.9 0.9 30.1 1090.9 0.1 496.0 60.9 1.2 14.2 536.0 59.5 19.8 1100.0 788.6 22.2 0.3 261.9 88.8 0.9 2812.9 1822.6 33.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.4 1.8 1.5 0.0 0.0 3.7 4.6 0.4 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.7 0.7 0.6 1.8 0.3 0.1 0.0 1.4 0.0 1.9 1.3 1.2 2.0 0.2 0.7 1729.8 0.8 0.6 1.6 1401.2 0.8 0.8 5.3 0.9 1.1 1.2 1.3 186.7 0.4 0.3 0.2 2.1 0.2 0.6 0.6 0.7 0.9 19.8 0.3 1.0 0.0 0.0 0.5 0.0 211.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 82.6 0.0 0.0 0.0 2.5 1.9 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.7 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27475.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 62.0 0.0 0.3 0.0 IGKV3-15 ENSG00000244437 "Immunoglobulin kappa variable 3-15" P01624 2 89085177-89085787 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 785.8;lymphoid tissue: 1996.3;urinary bladder: 784.8" "Cell type enriched" "Detected in some" 85 "Plasma cells: 22923.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 561 "memory B-cell: 2243.8;naive B-cell: 1651.4" "Lineage enriched" "Detected in all" 646 "B-cells: 2243.8" "Cell line enhanced" "Detected in some" "Daudi: 1.7;K-562: 1.3;NB-4: 1.9;RH-30: 1.2;RPMI-8226: 2.2;SCLC-21H: 1.4;SH-SY5Y: 2.5" HPA047702 Approved "Immunoglobulin genes" NA NA 7200000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA047702: " "prognostic favorable (1.57e-4)" "unprognostic (1.29e-2)" "unprognostic (7.02e-3)" "unprognostic (3.89e-3)" "unprognostic (9.06e-3)" "unprognostic (2.06e-3)" "unprognostic (5.36e-2)" "unprognostic (3.55e-1)" "unprognostic (1.45e-1)" "unprognostic (5.82e-3)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.15e-7)" "unprognostic (2.00e-1)" "unprognostic (2.54e-1)" "unprognostic (2.07e-1)" "unprognostic (1.17e-1)" 47.9 114.5 0.0 603.8 0.1 131.0 174.3 0.0 1.5 141.8 0.3 785.8 431.4 19.4 34.7 120.0 30.0 144.4 14.8 0.1 0.3 35.2 36.7 184.8 500.9 0.7 0.3 55.4 9.3 2.5 3.0 0.5 0.3 18.3 649.4 0.0 399.3 114.2 1.0 2.7 335.8 29.5 1.5 1020.7 629.8 64.8 0.2 250.2 77.7 0.0 1996.3 784.8 28.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.4 1.9 0.6 0.0 0.0 0.0 1.2 2.2 0.0 0.0 1.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.4 0.7 0.5 0.0 0.0 0.0 1.0 0.0 1.8 3.4 0.8 1.0 0.4 0.8 2243.8 1.0 1.1 1.8 1651.4 1.0 1.1 1.9 1.0 1.3 1.7 1.5 193.1 0.0 0.1 0.0 1.5 0.1 0.3 0.7 0.3 0.3 1.5 0.2 1.0 0.0 0.0 0.0 0.0 269.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.6 73.4 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22923.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 252.5 0.0 0.0 0.2 0.0 0.0 28.2 0.0 0.0 0.0 IGKV4-1 "B3, IGKV41" ENSG00000211598 "Immunoglobulin kappa variable 4-1" P06312 2 88885397-88886153 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1805.7;lymphoid tissue: 3169.0" "Cell type enriched" "Detected in some" 219 "Plasma cells: 46306.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 588 "memory B-cell: 3036.3;naive B-cell: 3070.9" "Lineage enriched" "Detected in all" 591 "B-cells: 3070.9" "Cell line enhanced" "Detected in some" "Daudi: 14.9;RPMI-8226: 10.4;SH-SY5Y: 6.9;U-266/70: 7.5" "Immunoglobulin genes" NA NA 8500000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (6.41e-5)" "unprognostic (9.19e-2)" "unprognostic (4.29e-3)" "unprognostic (5.42e-3)" "unprognostic (2.08e-2)" "prognostic favorable (8.25e-4)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (3.32e-1)" "unprognostic (3.71e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-1)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (6.29e-2)" "unprognostic (1.19e-1)" 55.9 296.3 0.4 1054.1 0.9 342.1 665.2 0.4 3.4 145.2 2.4 1805.7 1769.7 46.8 19.4 195.7 41.3 188.2 51.9 0.4 1.2 35.0 76.1 302.3 816.8 1.9 0.8 86.5 28.3 2.5 2.8 1.0 3.5 43.9 1318.2 0.1 701.8 89.6 1.0 8.6 1023.0 66.4 3.6 972.3 1125.7 125.7 0.7 405.1 51.0 0.1 3169.0 758.2 19.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.0 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.6 3.6 0.3 0.0 0.0 1.4 2.2 10.4 0.0 0.0 4.0 6.9 2.3 0.0 0.0 0.0 0.0 0.7 2.6 0.0 0.8 1.1 1.0 7.5 0.2 0.8 0.0 1.2 0.0 3.9 3.2 5.1 1.6 0.9 1.7 3036.3 1.9 1.1 2.8 3070.9 2.1 1.3 2.4 1.6 2.4 2.3 1.7 344.9 0.4 0.9 0.4 3.4 0.4 1.2 1.9 0.8 3.5 3.6 0.7 1.5 0.0 0.0 0.0 0.0 210.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.0 0.0 0.0 0.0 17.0 40.2 0.0 0.0 0.0 2.2 2.8 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46306.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 15.7 0.0 0.1 0.0 IGLV1-40 ENSG00000211653 "Immunoglobulin lambda variable 1-40" P01703 22 22409766-22410282 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1291.5;stomach 1: 1287.4" "Cell type enriched" "Detected in some" 358 "Plasma cells: 43406.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 3.0" "Group enriched" "Detected in some" 496 "memory B-cell: 666.4;naive B-cell: 576.7" "Lineage enriched" "Detected in many" 532 "B-cells: 666.4" "Cell line enhanced" "Detected in some" "Daudi: 3.5;RPMI-8226: 2.2;SH-SY5Y: 3.4;TIME: 2.3" "Immunoglobulin genes" NA NA 2300000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.64e-3)" "unprognostic (4.68e-3)" "unprognostic (3.88e-2)" "unprognostic (3.37e-3)" "unprognostic (9.60e-3)" "prognostic favorable (5.74e-6)" "unprognostic (2.39e-2)" "unprognostic (1.53e-1)" "unprognostic (8.43e-2)" "unprognostic (5.51e-2)" "unprognostic (1.06e-1)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.44e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (4.57e-2)" 43.4 13.0 0.8 203.5 0.5 114.3 138.5 0.1 3.0 68.1 1.1 553.8 551.6 14.8 0.6 125.4 21.5 236.0 15.2 0.2 0.2 28.8 28.3 115.4 282.5 0.3 0.2 56.6 10.0 1.1 3.4 0.6 0.6 46.1 336.7 4.2 413.8 19.7 1.2 3.1 287.2 14.3 0.2 1029.8 1287.4 7.2 0.3 179.2 61.2 0.0 1291.5 464.8 19.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 1.0 1.1 0.0 0.0 0.2 0.8 2.2 0.0 0.0 1.3 3.4 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.4 0.7 0.7 1.1 1.1 0.8 0.0 0.3 0.0 0.4 0.7 0.2 0.3 0.1 0.6 666.4 0.3 0.3 0.6 576.7 0.1 0.2 1.2 0.3 0.3 0.6 0.4 53.7 0.8 0.5 0.1 3.0 0.2 0.2 0.3 0.2 0.6 0.2 0.3 1.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.2 8.0 0.0 0.0 0.0 28.6 64.2 0.0 0.0 0.0 1.8 0.9 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 43406.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 7.4 0.0 0.1 0.0 IGLV3-1 ENSG00000211673 "Immunoglobulin lambda variable 3-1" P01715 22 22880706-22881396 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1234.9;lymphoid tissue: 3325.7;stomach 1: 1460.4" "Cell type enriched" "Detected in some" 321 "Plasma cells: 56277.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 725 "memory B-cell: 779.5;naive B-cell: 1038.5" "Lineage enriched" "Detected in many" 828 "B-cells: 1038.5" "Cell line enhanced" "Detected in some" "Daudi: 14.4;RPMI-8226: 4.5;SCLC-21H: 9.1;SH-SY5Y: 9.9" HPA003285 Approved "Immunoglobulin genes" NA NA 4300000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA003285: AB_1079122" "prognostic favorable (9.70e-5)" "unprognostic (9.06e-2)" "unprognostic (5.39e-3)" "unprognostic (2.37e-2)" "unprognostic (8.13e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.30e-2)" "unprognostic (1.21e-1)" "unprognostic (1.92e-2)" "unprognostic (1.63e-2)" "unprognostic (2.86e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (9.06e-9)" "unprognostic (2.70e-2)" "unprognostic (4.35e-1)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" 44.5 70.9 0.3 485.2 0.2 332.4 317.1 0.2 2.0 192.0 0.9 1234.9 643.4 39.2 0.0 217.7 19.2 310.4 28.1 0.1 0.4 26.3 70.1 176.2 1117.0 1.0 0.3 34.1 7.6 2.7 2.0 0.7 1.5 21.9 684.4 0.2 627.3 19.6 1.2 4.1 481.7 37.2 0.4 654.2 1460.4 56.0 0.3 335.5 35.9 0.0 3325.7 679.7 30.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.1 0.0 0.0 1.1 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.0 0.0 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.2 2.4 0.8 0.0 0.0 0.5 3.0 4.5 0.0 0.0 9.1 9.9 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.6 1.7 1.8 1.2 2.8 0.0 0.3 0.0 0.7 1.1 0.5 0.3 0.4 0.4 779.5 0.6 0.2 1.2 1038.5 0.2 0.3 0.6 0.4 0.8 0.5 0.5 52.3 0.3 0.2 0.2 2.0 0.1 0.4 1.0 0.3 1.5 0.4 0.3 0.9 0.0 3.2 0.0 0.0 111.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 122.5 0.0 0.0 0.0 0.0 0.0 10.7 174.8 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56277.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 11.7 0.0 0.2 0.0 IGLV3-25 ENSG00000211659 "Immunoglobulin lambda variable 3-25" P01717 22 22686726-22687271 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 2440.7;stomach 1: 1015.7" "Cell type enriched" "Detected in some" 41 "Plasma cells: 17441.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 45 "memory B-cell: 545.0;naive B-cell: 794.2" "Lineage enriched" "Detected in many" 53 "B-cells: 794.2" "Cell line enhanced" "Detected in some" "HL-60: 2.6;RPMI-8226: 2.7;SCLC-21H: 4.6;SH-SY5Y: 5.1" HPA003285 Approved "Immunoglobulin genes" NA NA 3200000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA003285: AB_1079122" "prognostic favorable (5.55e-4)" "unprognostic (8.28e-2)" "unprognostic (4.28e-3)" "unprognostic (2.89e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.43e-4)" "unprognostic (1.92e-2)" "unprognostic (1.05e-1)" "unprognostic (1.87e-1)" "unprognostic (1.98e-2)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.78e-7)" "unprognostic (1.25e-1)" "unprognostic (4.78e-1)" "unprognostic (2.16e-1)" "unprognostic (1.72e-1)" 56.8 163.2 0.2 293.2 0.2 243.2 430.9 0.1 1.7 151.9 1.3 847.4 338.9 20.8 2.1 161.5 49.8 177.1 29.8 0.2 0.3 17.1 45.7 870.5 1024.7 1.8 0.2 21.8 14.5 1.7 1.7 0.5 0.6 18.9 467.5 0.0 532.3 116.5 0.7 2.4 228.9 34.1 0.4 543.5 1015.7 59.8 0.5 155.9 23.1 0.0 2440.7 779.6 20.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 1.7 0.4 1.7 0.0 0.0 1.6 1.5 2.7 0.0 0.0 4.6 5.1 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.0 0.1 0.8 1.8 0.2 0.7 0.0 1.3 0.0 0.8 0.4 0.3 0.7 0.1 0.2 545.0 0.4 0.1 0.5 794.2 0.2 0.1 14.9 0.3 0.6 0.3 0.3 76.5 0.2 0.2 0.1 1.7 0.2 0.3 1.8 0.2 0.6 0.4 0.5 0.6 0.0 0.0 0.0 0.0 84.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 1.9 40.8 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17441.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 417.4 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 IKBKE "IKK-i, IKKE, KIAA0151" ENSG00000263528 "Inhibitor of nuclear factor kappa B kinase subunit epsilon" Q14164 1 206470476-206496889 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 47.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015788, CAB025983" Approved Supported Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 24: NB-4 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "CAB025983: , HPA015788: AB_1851566" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (1.48e-1)" "unprognostic (5.76e-2)" "unprognostic (7.78e-3)" "unprognostic (7.37e-3)" "unprognostic (1.99e-3)" "unprognostic (2.82e-1)" "unprognostic (5.09e-3)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.34e-7)" "unprognostic (1.48e-2)" "unprognostic (5.77e-2)" "unprognostic (2.84e-3)" "unprognostic (2.84e-2)" 2.4 3.7 2.6 16.7 4.6 8.7 3.1 2.0 3.2 4.1 1.9 7.8 7.4 1.7 3.9 14.6 2.8 5.1 1.4 2.7 3.3 3.4 1.6 4.1 24.3 4.1 3.6 1.2 3.4 1.0 1.9 2.6 3.9 3.6 7.7 0.1 6.9 2.1 0.5 15.0 8.0 2.5 2.7 14.2 7.2 0.7 4.4 16.5 4.5 0.3 20.4 8.4 6.8 4.6 17.8 13.9 3.7 0.4 6.7 9.2 3.9 7.1 22.3 9.4 10.4 11.5 26.9 35.3 18.6 14.5 11.5 23.0 0.1 18.1 2.2 5.5 3.5 4.7 8.8 7.6 8.4 29.5 14.8 12.2 3.2 7.7 1.7 10.9 14.2 9.4 2.3 10.0 10.5 3.6 19.2 47.7 5.2 4.3 10.9 9.7 4.3 27.7 10.7 29.4 0.0 0.0 2.9 22.9 4.2 4.5 13.8 20.3 26.5 9.0 5.5 6.9 8.5 3.5 1.8 23.3 17.1 24.2 3.7 12.2 32.8 0.6 21.2 23.3 14.8 26.4 32.4 30.1 9.5 14.0 25.7 27.3 2.2 23.9 13.4 3.2 52.8 28.6 2.6 4.6 2.0 3.2 2.7 3.3 4.1 3.6 3.9 2.7 4.4 4.6 0.4 0.0 4.5 0.7 13.7 1.9 3.6 37.8 1.8 0.0 4.3 3.7 0.9 4.3 16.3 0.0 0.0 4.2 7.9 11.7 0.0 12.1 3.3 1.5 0.9 0.7 3.6 4.4 1.5 12.6 5.2 3.4 17.3 2.4 5.1 3.7 2.2 0.8 13.8 0.0 1.5 6.4 8.2 12.9 0.7 7.0 0.9 16.0 7.2 1.9 9.0 0.0 14.4 1.0 0.2 15.9 21.5 0.7 6.4 3.2 10.7 3.5 14.5 0.0 0.0 0.7 3.1 0.3 0.9 11.1 4.8 1.5 15.8 3.9 10.2 11.6 IL27RA "CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1" ENSG00000104998 "Interleukin 27 receptor subunit alpha" Q6UWB1 19 14031762-14053218 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.5" "Cell type enhanced" "Detected in many" "B-cells: 49.1;dendritic cells: 56.6;Kupffer cells: 41.1;Langerhans cells: 44.2;NK-cells: 69.0;T-cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA073441 Approved Vesicles NA NA 4900000 "Cluster 32: T-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA073441: " "prognostic favorable (1.74e-6)" "unprognostic (1.99e-1)" "unprognostic (1.55e-1)" "unprognostic (6.09e-2)" "unprognostic (2.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.05e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.40e-3)" "unprognostic (9.92e-2)" "unprognostic (3.35e-2)" "prognostic unfavorable (2.58e-10)" "unprognostic (5.45e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.87e-3)" 7.8 1.7 2.4 8.7 2.3 2.7 6.5 2.2 2.7 2.7 2.2 3.1 2.3 2.4 0.7 2.6 3.3 2.3 7.7 2.8 2.9 6.1 1.5 8.0 12.6 2.5 2.5 1.0 2.8 5.6 0.8 1.3 2.7 3.6 2.1 0.2 3.0 1.2 2.0 2.2 8.1 1.9 2.5 14.7 2.8 2.0 3.1 11.1 4.0 2.4 16.5 3.9 2.8 2.4 7.7 3.3 3.2 4.4 0.2 1.6 1.3 3.5 7.3 6.3 9.0 1.6 6.1 0.1 3.6 3.1 2.9 1.4 5.1 2.1 4.8 14.8 3.5 18.6 0.7 2.7 0.5 9.0 0.2 1.6 0.8 3.0 0.6 5.1 2.5 4.6 13.1 13.5 0.3 10.7 6.8 19.5 4.2 4.5 2.2 5.8 1.9 7.1 3.9 1.8 2.8 1.5 4.5 0.3 5.2 1.7 5.6 5.4 4.0 0.6 7.7 6.4 3.8 13.9 7.2 6.7 0.6 18.2 4.2 7.9 22.5 0.6 24.3 18.4 21.4 15.6 24.0 20.2 20.7 12.8 26.1 20.6 1.6 22.9 9.5 7.6 23.1 21.4 2.4 2.3 2.2 2.7 2.8 2.9 2.5 2.5 2.7 2.5 3.1 2.4 30.4 0.0 10.0 0.0 49.1 1.9 13.3 8.5 3.4 0.3 14.0 11.9 5.4 5.7 5.7 3.7 0.0 0.6 56.6 0.7 0.0 10.7 0.4 1.9 1.2 22.8 2.4 7.2 2.4 2.7 1.4 4.0 3.6 1.5 17.7 1.4 22.9 0.7 21.4 1.7 2.1 0.9 4.1 41.1 44.2 0.5 3.4 32.8 5.4 1.0 22.8 0.3 69.0 1.0 0.6 3.8 0.8 3.4 26.0 12.4 0.0 0.9 2.0 0.0 0.0 1.9 2.2 0.1 11.5 2.6 1.3 0.1 63.5 0.4 2.4 3.5 INAFM1 PRR24 ENSG00000257704 "InaF motif containing 1" C9JVW0 19 47274885-47275723 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 100.3;Smooth muscle cells: 73.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 58.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064015 Uncertain NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 36: Stromal cells - Cell proliferation" "HPA064015: AB_2685177" "unprognostic (3.88e-2)" "unprognostic (8.88e-3)" "prognostic unfavorable (3.20e-5)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.15e-2)" "unprognostic (3.60e-1)" "unprognostic (2.32e-1)" "unprognostic (3.57e-2)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (9.99e-2)" "prognostic unfavorable (3.04e-4)" "unprognostic (3.52e-2)" "unprognostic (2.02e-1)" "unprognostic (4.03e-1)" "unprognostic (4.36e-3)" 24.1 65.4 26.3 9.0 25.3 9.0 22.8 23.5 30.3 39.6 29.2 34.5 6.4 32.3 4.8 14.7 31.4 9.8 23.8 27.2 34.7 22.6 18.1 26.0 5.5 31.8 31.6 33.9 27.7 4.6 21.0 6.6 27.8 32.4 3.4 16.1 15.2 9.0 17.0 25.3 15.9 9.3 23.8 18.5 23.0 12.9 31.6 4.9 21.6 4.9 3.3 31.2 26.9 22.1 11.1 10.1 8.8 14.4 2.6 7.7 5.2 12.6 4.2 5.7 7.4 4.9 4.9 5.8 3.9 7.8 4.5 8.0 2.2 5.0 1.4 11.6 13.6 9.3 6.3 7.7 13.1 6.7 13.6 10.9 8.9 5.4 4.8 4.2 2.3 6.4 15.1 12.4 2.3 22.5 5.1 43.1 2.6 11.2 10.1 9.0 3.5 4.8 4.5 6.5 6.6 8.4 13.8 4.3 6.2 2.3 6.1 6.5 5.4 6.5 9.6 3.7 6.7 5.9 5.0 5.5 13.4 4.7 5.8 11.0 15.4 36.3 3.1 11.0 2.5 11.3 3.6 4.3 13.6 8.6 6.6 4.7 58.6 2.9 14.4 16.0 5.0 7.1 26.3 25.3 23.5 30.3 27.2 34.7 31.8 31.6 27.8 23.8 31.6 22.1 23.8 9.6 7.0 7.5 6.3 0.0 43.5 0.0 15.9 16.5 20.7 20.8 9.4 8.6 3.7 11.0 10.4 20.1 3.1 12.6 19.6 11.4 13.5 16.4 100.3 18.3 7.3 18.9 5.0 12.4 15.3 30.5 11.7 16.5 1.3 10.2 11.4 14.8 10.0 3.3 11.6 13.0 0.0 15.9 0.0 22.9 61.8 12.3 0.0 4.7 8.0 5.9 8.2 3.5 2.7 9.6 17.7 25.9 9.0 31.3 28.4 15.4 0.7 48.6 46.0 12.9 73.4 10.3 13.0 10.6 0.0 27.6 6.5 16.2 13.2 49.0 INO80D FLJ20309 ENSG00000114933 "INO80 complex subunit D" Q53TQ3 2 205993721-206086303 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.9" "Cell type enhanced" "Detected in all" "Astrocytes: 158.7;Excitatory neurons: 127.7;Inhibitory neurons: 129.0;Oligodendrocytes: 188.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043976 Approved NA NA "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 44: Endometrium - Transcription" "HPA043976: AB_10960835" "unprognostic (6.79e-2)" "unprognostic (9.77e-2)" "unprognostic (1.34e-1)" "unprognostic (2.43e-1)" "unprognostic (4.81e-2)" "prognostic favorable (5.53e-4)" "unprognostic (4.83e-3)" "unprognostic (3.00e-1)" "unprognostic (8.10e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" "unprognostic (1.39e-2)" "unprognostic (4.05e-3)" "unprognostic (1.30e-1)" "unprognostic (1.91e-1)" "unprognostic (1.19e-1)" "unprognostic (3.03e-2)" 4.6 3.0 0.7 2.3 1.1 17.9 4.3 5.3 1.4 4.3 1.0 3.9 3.4 4.0 1.4 4.4 3.9 3.0 3.6 0.5 0.6 3.0 3.7 4.1 4.4 1.4 0.5 5.1 4.1 1.4 4.0 2.5 0.8 3.4 1.4 5.1 4.2 0.9 5.7 6.1 4.7 1.0 0.0 3.9 3.8 5.6 1.1 1.7 5.2 1.7 1.7 3.6 4.5 3.0 2.4 1.8 4.5 3.6 1.3 1.6 3.3 1.8 0.9 1.3 1.0 3.6 4.7 2.4 2.9 1.1 4.5 3.2 1.7 1.2 1.5 2.1 3.3 5.2 4.2 4.4 0.8 4.5 3.3 1.0 1.6 1.6 2.1 3.5 1.7 2.9 5.1 5.6 1.4 3.2 2.5 14.8 6.0 1.4 2.6 3.1 2.8 2.6 1.3 4.1 4.1 3.9 3.3 2.1 3.5 3.6 2.9 4.4 4.7 3.7 3.6 1.6 2.2 7.0 5.7 6.1 2.9 3.9 2.8 4.1 2.2 2.0 3.0 1.2 2.5 4.1 2.2 1.4 1.6 5.2 2.5 1.9 5.1 2.0 3.4 4.5 2.6 0.9 0.7 1.1 5.3 1.4 0.5 0.6 1.4 0.5 0.8 0.0 1.1 3.0 31.5 22.4 34.7 158.7 35.5 30.8 18.2 9.8 25.6 39.5 19.9 13.8 17.5 31.5 18.6 18.4 39.6 8.4 43.0 27.3 5.9 13.5 3.7 25.3 31.4 27.8 25.2 29.9 127.7 13.1 5.9 29.4 26.5 41.2 32.4 24.1 17.2 16.3 11.7 11.8 129.0 20.3 4.1 21.7 28.9 5.4 20.2 23.1 17.8 117.1 25.9 16.8 26.8 126.2 188.3 17.8 19.9 15.4 33.2 26.1 24.3 12.8 16.2 39.9 13.1 55.6 29.3 11.3 5.7 31.2 29.1 15.5 33.6 16.4 17.8 25.7 INTS13 "ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30" ENSG00000064102 "Integrator complex subunit 13" Q9NVM9 12 26905181-26938326 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Endometrial stromal cells: 16.7;Extravillous trophoblasts: 16.1;Theca cells: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039543, HPA040109, HPA073020" Uncertain Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Vesicles" "HPA039543: AB_10795150, HPA040109: , HPA073020: " "unprognostic (2.09e-1)" "unprognostic (8.48e-3)" "unprognostic (2.75e-2)" "unprognostic (1.40e-3)" "unprognostic (3.94e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (1.17e-10)" "unprognostic (5.22e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.78e-3)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.16e-6)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (4.37e-2)" "unprognostic (4.78e-2)" 9.9 21.4 9.3 11.3 13.4 17.2 11.7 13.2 14.3 10.4 8.1 9.7 9.9 10.0 10.3 14.6 8.5 8.2 12.2 9.5 11.6 13.2 15.1 7.9 16.7 15.4 12.0 8.0 11.5 8.0 8.1 10.0 14.8 8.5 10.7 21.8 9.0 7.0 19.0 11.8 8.5 11.9 13.9 12.9 15.4 12.1 12.2 18.6 9.9 18.1 16.8 12.8 10.6 20.0 33.4 38.1 21.5 46.4 30.5 48.9 30.9 44.9 27.4 43.3 48.1 58.4 43.1 82.7 45.0 25.1 40.6 46.2 56.1 43.6 72.8 39.5 37.4 66.7 44.5 44.9 53.9 110.6 38.4 26.3 32.2 69.5 147.0 53.5 56.8 35.6 71.5 31.9 46.7 40.9 57.9 197.8 94.6 45.6 68.9 40.8 62.3 114.0 36.4 31.0 17.8 16.7 39.1 30.6 47.4 72.8 42.6 23.4 36.5 50.1 36.2 85.6 55.1 15.6 19.6 119.4 33.1 75.8 36.2 7.8 8.1 7.8 14.6 5.7 22.1 9.7 18.2 18.2 9.9 11.3 12.7 15.7 2.5 25.9 5.2 6.7 28.1 10.5 9.3 13.4 13.2 14.3 9.5 11.6 15.4 12.0 14.8 13.9 12.2 20.0 7.2 22.4 7.8 0.0 2.7 0.0 0.0 0.0 0.0 0.0 7.9 8.3 0.0 0.0 2.5 5.5 0.0 11.8 8.8 0.0 3.9 13.7 0.0 8.7 16.7 3.9 0.0 0.0 0.0 11.9 16.1 8.3 0.0 8.2 7.6 13.9 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 5.7 0.0 0.0 0.0 0.0 13.7 0.0 0.0 1.6 0.0 0.0 11.6 2.9 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 13.1 6.5 18.5 0.0 0.0 INTS6L "DDX26B, FLJ41215" ENSG00000165359 "Integrator complex subunit 6 like" Q5JSJ4 X 135520659-135582510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Breast myoepithelial cells: 14.0;dendritic cells: 15.9;Endometrial ciliated cells: 16.0;Glandular and luminal cells: 11.1;granulocytes: 25.2;Theca cells: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 20.7;U-937: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001552, HPA013200, HPA013335, HPA030747" Uncertain Approved "Nuclear bodies,Centrosome,Mitochondria" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Centrosome "Nuclear bodies, Mitochondria" "HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589" "unprognostic (2.03e-1)" "prognostic favorable (5.39e-4)" "unprognostic (1.96e-1)" "unprognostic (7.42e-2)" "unprognostic (2.89e-2)" "unprognostic (1.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.33e-3)" "prognostic favorable (5.54e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (2.87e-1)" "unprognostic (1.81e-1)" "unprognostic (5.37e-2)" "prognostic favorable (2.94e-4)" 3.4 7.5 3.3 6.3 2.9 13.1 3.8 8.7 3.7 6.7 2.6 7.7 2.6 4.6 2.8 4.7 6.5 3.8 4.4 3.0 3.0 3.8 1.1 4.4 12.6 3.5 3.6 8.2 2.1 1.8 6.7 3.3 3.4 5.0 7.1 5.1 12.0 3.6 1.1 6.1 7.3 3.7 3.3 10.2 3.4 6.3 3.4 8.4 3.3 0.8 11.3 5.7 5.1 3.7 0.1 0.0 7.5 8.9 2.2 2.5 0.0 1.9 4.0 2.2 6.6 0.7 3.2 7.5 6.3 1.6 5.4 5.6 8.4 2.5 1.5 5.8 3.0 6.5 0.7 0.0 1.9 6.8 0.5 3.3 2.4 2.5 2.5 3.8 2.8 4.9 4.3 11.8 1.6 5.5 6.5 20.7 3.5 8.0 3.1 5.3 2.4 6.4 1.8 3.0 1.2 2.7 2.6 2.6 0.2 3.2 2.8 12.5 1.6 5.6 3.2 0.0 2.2 13.5 11.2 11.3 1.9 19.0 1.1 0.0 1.6 1.4 2.9 1.4 3.8 3.3 3.4 3.5 2.3 3.5 5.2 3.4 0.8 1.9 1.8 2.2 2.0 2.5 3.3 2.9 8.7 3.7 3.0 3.0 3.5 3.6 3.4 3.3 3.4 3.7 6.8 12.8 5.8 0.0 7.3 0.0 0.0 0.0 0.0 0.0 7.2 14.0 0.0 0.0 3.7 3.7 0.0 2.1 15.9 0.0 0.0 1.3 0.0 16.0 5.3 3.3 0.0 0.0 0.0 1.6 0.3 3.3 0.0 11.1 25.2 7.3 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.3 0.0 0.0 1.0 6.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.8 6.9 11.1 0.0 0.0 IRF2BP1 "DKFZP434M154, IRF-2BP1" ENSG00000170604 "Interferon regulatory factor 2 binding protein 1" Q8IU81 19 45883608-45886141 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "NB-4: 82.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042164, HPA049480" Approved Supported Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA042164: AB_2677882, HPA049480: AB_2680785" "unprognostic (5.90e-2)" "unprognostic (1.34e-1)" "unprognostic (8.86e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (2.61e-2)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (3.03e-1)" "unprognostic (1.01e-1)" "prognostic favorable (2.32e-4)" "unprognostic (2.60e-1)" "prognostic favorable (3.85e-5)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (2.66e-1)" "unprognostic (5.07e-3)" 11.1 15.8 12.2 4.6 11.9 3.6 12.3 13.8 15.8 17.8 3.8 17.6 7.3 20.0 3.6 11.8 16.9 3.2 16.6 12.7 10.8 14.2 21.0 8.3 5.2 15.2 11.9 21.7 15.7 7.1 20.6 3.1 11.8 15.3 2.0 4.3 13.7 6.9 22.0 14.4 13.8 3.0 10.3 13.6 16.4 9.3 11.8 6.1 12.3 7.9 2.8 15.9 12.0 14.8 18.1 27.1 6.5 14.6 5.5 3.4 10.8 13.0 7.4 10.2 8.9 10.1 8.4 14.5 9.6 6.7 6.1 16.7 4.7 4.9 3.0 18.4 46.4 14.6 7.6 13.1 11.1 15.2 13.1 4.8 6.6 5.3 3.8 6.4 6.3 17.8 23.4 11.2 4.0 14.1 31.0 82.8 12.3 6.7 23.8 35.2 7.7 12.6 7.4 9.9 19.4 33.3 13.8 17.8 17.3 2.5 14.8 27.8 9.2 8.8 17.7 6.8 18.6 30.4 36.2 8.6 11.9 14.3 13.0 0.0 0.3 0.1 0.7 0.4 0.7 0.7 0.6 0.6 0.3 0.6 0.9 0.5 0.4 0.7 0.2 0.5 0.6 0.4 12.2 11.9 13.8 15.8 12.7 10.8 15.2 11.9 11.8 10.3 11.8 14.8 6.0 0.0 1.1 2.6 8.4 10.7 5.8 4.1 14.2 15.2 13.5 11.4 1.3 11.5 2.4 11.0 0.0 10.9 8.4 8.9 13.7 7.8 2.0 6.0 6.7 6.3 9.6 10.1 2.2 9.5 6.6 8.2 7.1 6.9 0.0 8.3 7.9 9.3 5.0 10.1 3.2 11.2 0.0 2.2 8.6 1.5 18.6 5.1 8.8 3.7 4.5 10.2 5.2 2.0 3.7 7.5 11.9 10.9 2.5 7.4 9.3 13.5 3.0 7.0 19.7 10.7 11.7 3.8 2.2 8.9 11.2 8.8 7.3 9.9 8.7 3.0 IRX3 IRX-1 ENSG00000177508 "Iroquois homeobox 3" P78415 16 54283304-54286787 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 89.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 66.7;Breast glandular cells: 133.8;Breast myoepithelial cells: 84.6;Endometrial ciliated cells: 73.0;Glandular and luminal cells: 88.2;Respiratory ciliated cells: 67.3;Squamous epithelial cells: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 119.4;NB-4: 204.4;RPTEC TERT1: 236.4;T-47d: 122.9;THP-1: 201.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA066576 Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Skin - Epidermis development" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm Cytosol "HPA066576: " "unprognostic (4.21e-3)" "unprognostic (4.50e-2)" "unprognostic (2.34e-2)" "unprognostic (1.04e-1)" "unprognostic (3.34e-2)" "unprognostic (2.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.35e-2)" "unprognostic (1.52e-1)" "unprognostic (9.75e-2)" "unprognostic (2.92e-1)" "unprognostic (1.07e-1)" "unprognostic (3.15e-2)" "unprognostic (5.40e-2)" "unprognostic (2.39e-1)" "unprognostic (8.20e-2)" "unprognostic (1.25e-1)" 8.2 6.8 3.4 0.4 3.0 0.1 75.6 6.3 1.2 29.7 2.7 0.3 0.4 2.2 36.5 33.0 10.9 0.3 63.1 1.2 5.1 42.6 2.2 36.5 2.0 7.5 8.1 0.9 4.0 27.2 7.2 1.9 6.2 23.2 0.0 1.2 43.2 31.3 22.7 89.3 0.6 1.2 6.2 0.1 22.5 0.5 7.5 1.0 9.3 8.8 4.5 4.8 17.5 5.0 1.1 1.1 15.6 15.1 8.4 3.3 1.7 6.6 14.5 13.9 3.4 4.2 6.8 0.0 2.2 10.0 5.5 29.0 12.6 3.6 18.5 14.3 9.8 0.0 22.2 14.6 0.6 16.7 4.1 2.5 59.7 26.5 12.0 9.8 0.0 19.1 0.0 0.0 119.4 7.7 30.9 204.4 1.1 0.0 0.0 23.2 19.2 0.0 236.4 6.2 10.6 1.9 20.4 51.3 2.6 1.7 122.9 201.8 3.4 57.9 6.4 10.6 5.3 0.0 0.0 0.1 38.0 53.7 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.0 6.3 1.2 1.2 5.1 7.5 8.1 6.2 6.2 7.5 5.0 2.6 19.2 66.7 0.0 0.4 25.0 47.4 25.3 45.5 1.3 133.8 84.6 14.1 0.0 43.2 5.5 0.0 0.1 1.3 0.1 1.9 5.2 0.0 73.0 8.1 5.8 0.0 0.0 0.0 0.2 0.1 18.3 2.0 88.2 0.0 5.5 8.2 7.1 0.3 0.0 0.0 0.0 36.7 1.2 2.7 0.0 0.0 9.0 10.6 0.0 0.2 10.4 0.0 0.0 0.0 0.1 0.0 0.0 1.7 25.8 0.0 6.5 67.3 1.2 0.0 32.1 6.4 0.4 1.0 72.8 41.3 0.0 1.1 0.1 0.0 34.0 JRKL HHMJG ENSG00000183340 "JRK like" Q9Y4A0 11 96389989-96507574 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 171.1;Late spermatids: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046184, HPA060341" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 10: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Cytokinetic bridge" "HPA046184: AB_10963576, HPA060341: AB_2732646" "unprognostic (4.59e-3)" "unprognostic (9.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.80e-2)" "unprognostic (6.90e-2)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" "unprognostic (4.94e-2)" "unprognostic (7.55e-3)" "unprognostic (6.12e-2)" "unprognostic (3.99e-3)" "unprognostic (1.31e-1)" "unprognostic (3.20e-3)" "unprognostic (6.21e-2)" "unprognostic (1.21e-1)" "unprognostic (2.97e-1)" "unprognostic (9.57e-3)" 7.4 6.2 4.2 7.6 4.4 1.7 8.8 4.5 4.9 9.8 4.3 7.1 7.2 8.4 7.4 5.9 10.1 6.6 6.1 4.0 5.3 6.7 4.2 6.2 9.3 4.7 4.7 13.2 5.1 6.9 4.1 8.4 4.8 8.4 9.0 11.1 8.8 6.9 4.1 7.8 8.4 6.9 4.4 7.5 8.6 11.7 4.7 9.6 9.6 4.4 9.2 6.8 6.0 5.3 9.4 5.8 11.8 8.9 23.1 25.7 8.6 15.6 10.5 10.9 14.2 9.8 22.2 12.8 22.3 14.4 13.9 14.5 5.9 10.6 12.6 13.9 5.5 11.9 17.0 7.5 18.7 6.8 7.4 12.2 16.3 15.8 19.6 20.3 10.0 14.5 6.4 5.5 17.9 1.9 8.8 19.8 1.8 16.7 7.9 8.9 11.5 10.5 13.5 9.7 4.7 8.6 9.1 6.2 7.1 11.0 7.6 9.1 12.4 21.1 9.4 18.6 6.4 4.7 10.9 7.5 9.8 10.9 9.2 3.3 2.6 2.6 1.6 2.1 2.3 2.2 2.6 2.0 2.6 1.6 3.2 2.9 0.9 1.8 2.5 4.1 1.3 1.6 4.2 4.4 4.5 4.9 4.0 5.3 4.7 4.7 4.8 4.4 4.7 5.3 6.2 9.6 5.8 4.2 5.0 4.7 10.3 6.6 2.8 7.4 7.6 8.9 6.8 15.7 12.0 0.0 4.2 6.0 11.7 9.0 1.9 11.5 171.1 9.9 13.6 5.8 6.0 4.8 3.4 5.1 5.0 9.9 7.1 6.8 3.8 5.0 6.4 2.2 5.0 8.4 3.0 10.5 4.1 7.2 5.2 49.3 8.4 6.0 1.8 1.0 6.9 5.2 6.2 3.5 8.2 8.2 4.5 9.4 2.4 8.4 7.6 6.1 25.3 12.3 0.0 6.0 9.6 9.9 4.9 5.3 6.0 4.0 4.8 7.5 9.7 8.4 KCNJ14 "IRK4, Kir2.4" ENSG00000182324 "Potassium inwardly rectifying channel subfamily J member 14" Q9UNX9 19 48455574-48466980 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "retina: 58.7" "Cell type enriched" "Detected in many" 7 "Rod photoreceptor cells: 326.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA071765 Approved Nucleoli NA NA "Cluster 17: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 24: NB-4 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoli "HPA071765: AB_2686444" "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (1.33e-5)" "unprognostic (5.77e-2)" "unprognostic (9.41e-2)" "unprognostic (5.26e-2)" "unprognostic (7.05e-4)" "unprognostic (7.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.48e-2)" "unprognostic (4.43e-3)" "unprognostic (4.92e-2)" "unprognostic (5.02e-6)" "unprognostic (1.47e-1)" "unprognostic (4.98e-2)" "unprognostic (6.82e-3)" "unprognostic (4.41e-2)" 0.9 0.3 1.9 0.3 2.7 2.0 0.7 3.1 2.1 0.8 1.7 0.5 0.3 0.6 0.6 1.3 0.9 0.4 0.4 2.1 1.8 0.8 0.9 0.7 0.5 2.8 2.8 1.0 0.6 0.2 0.9 0.3 3.5 1.4 0.3 58.7 0.6 0.2 1.6 2.2 0.6 0.3 1.8 0.6 0.5 1.2 2.9 0.3 1.2 0.2 0.3 0.6 1.0 2.5 0.9 2.3 0.4 1.5 0.9 0.9 1.5 0.3 0.2 0.5 0.7 2.2 1.2 1.1 0.4 0.3 1.1 3.2 0.7 0.4 1.2 0.8 1.2 0.6 1.5 0.6 0.5 0.9 1.8 0.9 1.6 1.1 1.3 0.6 0.3 1.0 1.0 1.1 0.3 1.4 0.4 7.6 0.8 1.2 1.1 1.5 0.9 0.2 0.3 2.7 0.8 1.0 1.0 1.5 0.9 0.8 1.0 0.8 0.5 1.5 2.0 1.6 1.8 1.2 1.9 0.7 0.4 2.4 1.6 1.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.3 0.1 0.2 0.6 0.1 0.0 0.1 0.1 0.0 1.9 2.7 3.1 2.1 2.1 1.8 2.8 2.8 3.5 1.8 2.9 2.5 3.7 0.0 3.4 5.2 1.2 4.5 3.6 1.0 1.8 17.0 4.9 2.4 0.6 2.8 0.7 1.8 41.7 1.4 0.3 1.3 0.0 1.1 4.7 4.1 2.8 2.3 0.0 0.8 2.3 1.1 2.4 1.3 0.5 5.6 0.0 2.4 0.7 0.5 0.6 15.2 3.1 1.4 0.0 0.0 0.7 0.6 1.2 1.0 0.0 1.9 0.6 24.5 0.0 0.0 0.9 3.1 0.3 0.4 0.7 4.4 0.5 0.1 1.8 326.4 0.0 6.5 1.5 3.9 3.3 2.6 5.4 1.0 0.9 1.2 1.7 2.9 KDELR1 "ERD2, ERD2.1, HDEL" ENSG00000105438 "KDEL endoplasmic reticulum protein retention receptor 1" P24390 19 48382575-48391551 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 605.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 856.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017455 Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Vesicles, Cytosol" "CAB017455: AB_10615208" "unprognostic (3.10e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.49e-4)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.35e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.51e-1)" "unprognostic (7.55e-2)" "unprognostic (4.97e-2)" "unprognostic (3.81e-1)" "unprognostic (2.74e-1)" "unprognostic (3.06e-1)" "unprognostic (1.68e-2)" 109.3 124.4 58.0 61.7 56.5 45.8 106.6 54.5 59.7 132.5 78.1 120.3 132.5 110.0 117.3 107.3 112.2 100.9 96.6 56.1 62.5 119.5 127.2 101.4 53.3 61.1 59.1 165.8 138.9 191.7 116.2 128.7 59.0 102.5 128.5 39.0 137.7 105.0 76.8 103.8 114.5 100.6 56.2 79.5 120.1 93.7 62.9 51.6 121.8 58.4 73.2 102.5 102.4 58.0 216.2 305.3 173.1 184.7 379.7 440.6 126.5 207.4 363.9 247.0 281.0 202.3 238.7 89.1 132.6 456.4 154.4 187.6 211.1 222.2 234.0 72.7 224.5 74.4 99.4 382.2 329.6 84.1 133.4 419.6 268.0 168.5 178.5 387.4 233.0 75.3 131.7 160.9 333.1 173.6 79.4 856.7 126.3 426.8 122.5 112.1 103.4 141.0 316.2 176.3 172.9 134.5 182.1 160.6 113.1 196.7 126.6 102.1 182.6 173.4 142.6 145.3 179.3 451.1 382.0 60.2 110.1 112.4 181.1 10.8 41.0 12.6 18.1 34.7 20.8 17.0 17.6 19.7 30.6 14.3 14.3 16.1 9.9 20.2 30.2 45.4 20.4 18.2 58.0 56.5 54.5 59.7 56.1 62.5 61.1 59.1 59.0 56.2 62.9 58.0 150.8 35.3 54.2 8.5 82.2 75.3 130.6 147.1 124.7 39.4 141.0 154.4 28.8 98.7 110.9 93.8 6.2 231.7 59.5 153.0 56.7 224.1 6.2 72.0 188.8 111.4 145.0 56.8 8.7 169.0 605.5 161.0 120.3 166.3 62.7 149.2 102.8 79.6 180.0 40.4 12.7 379.6 93.6 107.6 73.5 14.2 163.5 103.1 92.5 8.4 102.3 89.8 35.0 10.6 10.6 190.3 199.8 132.0 365.9 161.2 213.8 149.6 49.2 28.1 85.5 87.9 131.6 41.8 69.1 127.7 70.2 387.7 55.4 191.3 202.9 157.6 KEAP1 "INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454" ENSG00000079999 "Kelch like ECH associated protein 1" Q14145 19 10486125-10503558 "Cancer-related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 178.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005558, CAB025337" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Centriolar satellite" Cytosol "CAB025337: , HPA005558: AB_1079175" "unprognostic (1.98e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-2)" "unprognostic (2.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (5.22e-3)" "unprognostic (2.04e-1)" "unprognostic (9.99e-2)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.06e-1)" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" 31.3 41.2 54.8 20.5 61.6 20.4 30.3 61.8 60.9 32.7 49.7 37.6 26.5 31.3 22.2 55.4 28.9 24.3 60.7 53.2 59.4 32.5 60.9 25.3 23.2 61.4 60.5 25.3 32.8 24.3 30.0 17.0 60.3 36.8 16.5 16.4 34.7 24.9 178.2 38.7 27.5 18.7 58.8 32.2 33.2 20.5 59.6 23.0 35.6 75.7 18.5 41.4 36.3 68.4 58.0 102.8 27.2 35.1 55.8 45.4 30.3 48.1 35.9 46.6 41.6 73.7 54.2 82.9 122.9 53.3 34.8 49.7 55.6 36.9 23.7 78.3 61.7 126.3 29.9 87.9 54.5 65.4 63.9 50.0 51.0 53.5 25.1 39.1 46.3 23.7 79.1 135.4 41.6 79.9 46.1 177.8 80.8 54.2 88.6 84.6 34.8 95.1 30.4 67.4 75.3 40.4 66.8 42.4 42.1 23.9 37.8 82.3 56.5 72.9 41.0 86.0 57.0 86.8 113.0 81.1 58.0 78.5 56.0 36.4 37.9 41.4 55.3 33.8 53.1 26.3 38.5 52.0 45.4 11.7 23.6 33.7 20.9 42.5 34.6 31.4 50.2 41.8 54.8 61.6 61.8 60.9 53.2 59.4 61.4 60.5 60.3 58.8 59.6 68.4 18.3 28.9 20.8 5.5 13.8 21.9 24.4 40.3 27.9 21.5 15.7 11.4 24.0 21.5 25.4 11.0 8.4 27.3 11.6 33.2 13.7 32.8 27.5 13.4 17.1 27.8 26.9 45.2 5.3 36.3 25.2 23.5 18.8 13.3 12.0 22.8 35.3 34.4 29.0 26.9 5.9 21.4 40.7 15.1 13.4 43.9 29.2 16.1 10.6 3.7 41.8 43.0 7.2 11.6 18.3 29.8 27.1 25.9 26.6 33.3 36.8 24.9 17.2 13.9 13.1 17.7 22.4 21.2 16.6 34.7 22.0 26.8 20.1 29.6 31.5 24.8 KLK2 ENSG00000167751 "Kallikrein related peptidase 2" P20151 19 50861568-50880567 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 87 "prostate: 566.2" "Cell type enriched" "Detected in some" 40 "Prostatic glandular cells: 777.2" "Cancer enriched" "Detected in some" 1666 "prostate cancer: 989.9" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 3.5;NB-4: 5.6" HPA000764 Supported "Secreted in male reproductive system" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" "HPA000764: AB_1079700" "unprognostic (3.05e-2)" "unprognostic (2.40e-1)" "unprognostic (1.69e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (3.22e-1)" "unprognostic (6.44e-2)" "unprognostic (8.06e-2)" "unprognostic (3.61e-1)" "unprognostic (2.11e-3)" "unprognostic (7.56e-2)" "unprognostic (8.10e-2)" "unprognostic (1.68e-1)" "unprognostic (2.04e-1)" 0.7 1.1 3.2 1.2 2.3 6.4 0.5 5.2 4.3 0.2 2.2 0.4 1.5 0.6 1.1 0.5 0.3 0.2 0.3 2.6 2.2 0.4 0.8 0.5 1.0 2.2 3.1 0.4 0.0 0.8 0.0 0.2 2.9 566.2 0.3 1.7 1.9 0.4 1.0 0.8 1.0 0.1 0.6 0.7 0.5 3.0 2.4 0.0 1.9 0.0 0.2 0.2 0.0 6.3 0.9 0.6 0.3 0.7 0.0 0.4 3.5 0.2 0.1 0.1 0.1 0.3 0.4 1.0 0.1 0.0 0.3 0.9 0.1 0.0 0.1 0.9 0.6 0.0 0.7 0.0 0.0 0.1 1.7 0.2 0.1 0.1 0.2 0.2 0.0 0.6 0.7 0.9 0.2 1.0 0.6 5.6 0.5 0.9 0.0 0.4 0.0 1.6 0.0 1.1 0.5 0.5 0.1 0.7 0.6 0.1 0.5 0.2 0.4 0.6 1.0 2.6 0.9 0.8 1.8 0.4 1.0 0.6 0.7 0.4 0.6 0.5 0.3 0.3 0.2 0.3 0.2 0.3 0.1 0.6 0.2 0.4 1.7 0.4 0.2 0.5 0.1 0.2 3.2 2.3 5.2 4.3 2.6 2.2 2.2 3.1 2.9 0.6 2.4 6.3 0.0 0.0 0.6 0.0 0.2 0.3 10.2 0.0 0.0 0.0 16.1 2.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.8 1.5 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 5.2 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 777.2 0.0 0.1 0.0 0.0 0.0 0.0 1.8 19.3 7.2 0.0 0.9 0.0 0.6 1.7 0.0 12.0 KLK3 "APS, PSA" ENSG00000142515 "Kallikrein related peptidase 3" P07288 19 50854915-50860764 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 320 "prostate: 8011.8" "Cell type enriched" "Detected in some" 77 "Prostatic glandular cells: 3438.6" "Cancer enriched" "Detected in some" 3905 "prostate cancer: 4241.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 173 "BEWO: 31.7;NB-4: 27.8;RPMI-8226: 19.3;SH-SY5Y: 10.5;U-2197: 10.7" "CAB000070, HPA000764" Enhanced "Secreted in male reproductive system" NA NA 7000000 "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" "CAB000070: , HPA000764: AB_1079700" "unprognostic (5.06e-3)" "unprognostic (5.60e-2)" "unprognostic (9.93e-2)" "unprognostic (3.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.54e-1)" "unprognostic (5.13e-3)" "unprognostic (1.94e-1)" "unprognostic (4.64e-1)" "unprognostic (3.15e-1)" 4.3 7.6 0.0 5.6 0.0 0.0 9.0 0.0 0.0 0.5 0.0 2.6 4.8 1.6 14.4 0.2 4.0 0.0 0.5 0.0 0.0 1.4 1.5 1.2 1.7 0.0 0.0 0.3 0.9 0.6 0.2 0.3 0.0 8011.8 1.1 0.0 4.5 25.0 0.3 0.5 3.7 0.0 0.0 0.2 1.0 6.9 0.0 0.0 0.8 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 19.3 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 12.4 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.4 2.6 0.0 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 1.8 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3438.6 0.1 0.1 0.0 0.0 0.0 0.0 6.9 0.1 0.0 0.0 0.0 0.0 4.2 0.2 0.4 44.6 KNTC1 "KIAA0166, ROD" ENSG00000184445 "Kinetochore associated 1" P50748 12 122527246-122626396 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 42.3" "Cell type enhanced" "Detected in many" "Early spermatids: 30.4;Erythroid cells: 29.5;Plasma cells: 28.7;Spermatocytes: 40.7;Spermatogonia: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025241 Approved Supported "Plasma membrane,Cytosol" NA Yes "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Plasma membrane" "HPA025241: AB_1852629" "unprognostic (1.17e-1)" "unprognostic (2.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.53e-2)" "unprognostic (9.34e-2)" "prognostic favorable (8.69e-4)" "prognostic unfavorable (4.79e-6)" "unprognostic (4.04e-2)" "unprognostic (7.20e-3)" "unprognostic (1.59e-2)" "unprognostic (4.78e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.89e-8)" "unprognostic (2.17e-2)" "unprognostic (3.08e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" 7.1 7.6 3.7 11.7 3.6 42.3 7.6 4.9 5.3 9.1 3.5 9.8 9.0 5.3 5.2 12.2 6.8 3.4 4.1 3.6 3.4 6.7 6.4 8.0 16.4 3.8 3.4 8.2 6.6 2.9 5.7 5.8 3.9 7.3 11.9 5.5 7.7 2.9 2.5 15.1 14.5 4.6 3.1 18.2 7.2 28.2 4.0 17.8 5.4 1.4 17.4 6.2 8.9 5.0 33.8 27.6 77.8 17.9 5.9 10.8 35.0 30.6 19.8 29.7 27.9 26.2 27.6 40.2 15.6 14.9 19.5 45.4 34.1 19.1 39.1 28.8 23.7 49.7 57.1 27.1 2.0 49.3 32.8 5.8 4.3 30.7 20.2 15.5 20.5 50.5 50.4 29.4 22.6 25.0 40.9 113.0 39.4 16.3 34.5 55.4 37.8 44.8 17.8 35.6 24.1 31.0 55.7 11.7 16.7 46.2 44.4 28.1 15.1 33.7 32.3 33.3 36.3 39.3 42.3 61.0 20.1 31.3 39.6 2.5 0.5 1.8 0.7 0.7 0.6 1.6 1.1 1.3 0.5 0.9 0.8 1.0 1.6 0.9 1.0 0.8 0.5 0.3 3.7 3.6 4.9 5.3 3.6 3.4 3.8 3.4 3.9 3.1 4.0 5.0 4.3 0.0 2.6 3.3 8.1 4.2 1.9 1.9 2.2 2.2 3.1 3.4 1.8 0.0 1.9 5.5 4.2 7.0 3.8 3.0 0.0 1.5 30.4 3.3 3.9 2.9 0.0 29.5 6.2 0.4 5.9 2.9 10.2 5.2 1.3 14.7 2.2 1.3 4.8 0.0 4.5 2.3 0.0 2.2 4.7 17.7 4.7 4.0 1.8 4.7 1.6 1.1 2.1 2.5 4.4 0.8 1.0 3.0 28.7 1.0 1.5 0.5 5.0 5.0 6.6 3.1 2.9 40.7 39.9 4.9 2.3 2.9 5.3 2.1 5.8 1.6 KPTN 2E4 ENSG00000118162 "Kaptin, actin binding protein" Q9Y664 19 47475150-47484265 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 23.9" "Lineage enriched" "Detected in all" 4 "dendritic cells: 23.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041710, HPA041796" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Plasma membrane" "Nucleoplasm, Vesicles" "HPA041710: AB_10961904, HPA041796: AB_10962832" "unprognostic (4.80e-3)" "unprognostic (2.22e-1)" "unprognostic (7.24e-2)" "unprognostic (1.53e-1)" "unprognostic (5.54e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (9.30e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-2)" "unprognostic (5.51e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (7.82e-4)" "unprognostic (1.40e-1)" "unprognostic (8.72e-2)" "unprognostic (2.04e-1)" "unprognostic (2.34e-1)" 5.2 6.6 5.1 3.0 5.5 5.6 4.7 5.9 8.4 7.2 3.6 6.2 3.4 5.3 1.4 7.7 4.4 2.4 5.8 5.6 5.1 6.3 8.6 4.5 3.4 5.6 5.1 3.2 5.5 4.0 10.0 2.8 5.0 8.0 2.2 1.6 10.1 2.0 6.9 4.8 4.5 2.6 4.6 6.1 4.7 5.4 5.1 8.2 4.8 6.7 2.1 5.1 5.8 5.4 9.7 16.8 12.9 8.6 12.9 10.0 9.3 5.4 9.9 28.4 17.5 12.6 11.3 12.3 4.1 9.5 10.1 11.1 11.0 19.1 7.9 11.4 17.2 5.2 12.2 11.4 11.5 10.1 13.8 11.5 12.3 9.5 8.7 7.2 11.0 15.2 10.1 10.9 8.3 7.8 17.7 44.8 11.6 10.5 10.3 12.6 6.3 4.8 8.8 15.0 27.8 21.1 9.1 10.3 6.8 6.4 8.5 14.5 6.6 6.9 7.6 3.7 12.2 2.8 4.8 5.3 6.1 6.4 10.4 0.0 3.9 1.7 1.4 3.4 0.4 1.5 1.0 1.2 4.6 1.6 1.3 1.1 3.2 1.2 5.3 23.9 1.7 2.2 5.1 5.5 5.9 8.4 5.6 5.1 5.6 5.1 5.0 4.6 5.1 5.4 2.6 3.2 2.7 4.6 4.8 2.8 8.5 13.8 2.8 5.8 5.8 3.9 3.7 4.3 8.9 5.5 6.2 14.5 12.1 3.4 9.8 9.6 0.8 3.1 3.3 3.0 3.0 0.8 4.7 4.2 13.3 5.0 5.1 3.4 2.5 4.9 3.3 6.2 8.5 10.1 3.5 2.5 8.2 5.6 2.8 2.5 1.2 5.8 1.8 1.9 2.5 6.9 5.2 3.0 4.3 5.0 1.8 0.7 6.5 4.4 4.3 8.3 2.9 4.0 0.0 3.5 3.5 4.9 18.9 4.5 3.1 15.3 1.7 8.2 4.0 5.8 KRT20 "CK20, K20, MGC35423" ENSG00000171431 "Keratin 20" P35900 17 40875889-40885242 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 646.9" "Group enriched" "Detected in some" 6 "Distal enterocytes: 1328.5;Intestinal goblet cells: 421.7;Paneth cells: 1606.6;Proximal enterocytes: 1107.3" "Group enriched" "Detected in many" 6 "colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000032, HPA024309, HPA024684, HPA027236" Enhanced Supported Cytosol NA NA 30000000 "Cluster 9: Intestine - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224" "unprognostic (3.49e-1)" "unprognostic (3.13e-1)" "unprognostic (1.71e-1)" "unprognostic (6.38e-3)" "unprognostic (5.12e-2)" "unprognostic (2.66e-3)" "prognostic unfavorable (7.05e-4)" "unprognostic (2.63e-2)" "unprognostic (4.87e-3)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.71e-2)" "unprognostic (6.30e-2)" "unprognostic (7.27e-2)" 1.3 0.0 0.0 49.9 0.0 0.0 1.6 0.0 0.0 0.1 0.0 597.7 295.9 2.1 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 480.1 0.0 0.0 1.2 0.0 0.1 646.9 27.0 0.0 0.0 124.9 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.4 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1328.5 0.0 0.1 0.0 0.0 0.0 0.0 43.9 0.0 0.1 0.0 0.0 0.0 115.7 0.1 13.4 0.0 0.0 0.0 0.1 0.0 0.0 421.7 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1606.6 0.0 0.6 1.9 1107.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.6 0.0 160.4 1.4 LCORL "FLJ30696, MLR1" ENSG00000178177 "Ligand dependent nuclear receptor corepressor like" Q8N3X6 4 17841199-18021876 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 133.6;Microglial cells: 135.9;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 164.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028794, HPA028795, HPA060033" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear membrane" "HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192" "unprognostic (1.06e-1)" "unprognostic (4.95e-2)" "prognostic favorable (9.65e-4)" "unprognostic (3.22e-3)" "unprognostic (3.62e-2)" "unprognostic (2.54e-4)" "unprognostic (8.90e-4)" "unprognostic (3.46e-1)" "unprognostic (3.52e-2)" "unprognostic (7.59e-2)" "unprognostic (2.10e-1)" "unprognostic (1.22e-1)" "unprognostic (7.39e-2)" "unprognostic (1.70e-2)" "unprognostic (6.06e-2)" "unprognostic (1.32e-1)" "unprognostic (7.27e-4)" 2.6 3.7 2.8 3.0 3.6 3.7 2.8 6.4 3.4 2.6 2.1 3.2 5.8 3.0 2.8 2.5 2.0 3.4 1.6 2.3 6.9 4.0 3.4 2.8 3.6 3.4 5.0 4.1 3.3 4.6 1.6 3.9 3.6 2.7 3.6 6.5 2.3 2.1 2.8 4.9 7.0 2.7 3.4 3.4 4.5 5.8 6.3 3.9 3.7 2.9 2.7 2.7 1.9 5.5 5.3 3.4 11.5 5.1 7.1 10.5 2.8 5.9 6.3 5.0 6.7 2.1 7.0 11.4 2.7 3.5 8.8 2.2 4.9 2.2 5.4 1.6 3.7 9.7 5.6 2.4 4.6 7.5 6.7 6.0 2.9 3.3 8.1 7.9 7.1 6.9 5.6 12.1 6.3 1.7 7.3 13.0 5.3 4.1 5.3 7.8 9.1 6.1 7.1 3.0 8.7 10.2 4.8 2.7 3.3 5.2 5.0 4.3 5.8 7.9 4.6 6.7 11.5 12.0 6.2 9.6 6.5 7.9 7.1 7.6 3.3 3.3 2.2 3.5 1.7 2.8 1.3 1.3 2.8 3.5 1.5 2.2 2.5 2.3 3.0 2.3 2.2 1.3 2.8 3.6 6.4 3.4 2.3 6.9 3.4 5.0 3.6 3.4 6.3 5.5 16.9 12.8 15.6 65.6 18.2 23.8 4.4 7.9 17.1 18.4 13.0 9.0 9.4 34.3 9.5 7.3 41.7 8.8 20.9 16.1 9.8 12.3 33.2 14.0 13.1 23.4 35.4 10.1 69.2 10.9 9.0 10.2 14.8 11.8 19.6 26.5 12.8 13.6 16.4 20.2 133.6 23.5 8.2 18.9 29.2 20.1 14.6 23.5 3.6 135.9 21.0 10.4 13.4 117.1 164.2 12.4 16.1 7.5 40.7 10.1 34.1 14.6 15.9 22.5 19.7 13.6 12.8 52.2 16.3 13.6 19.0 9.9 11.6 19.8 16.5 6.3 LGALS12 GRIP1 ENSG00000133317 "Galectin 12" Q96DT0 11 63506052-63516774 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 78.3;breast: 41.3" "Cell type enhanced" "Detected in some" "granulocytes: 17.8;Macrophages: 13.3;monocytes: 2.5;Muller glia cells: 3.9" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 20 "eosinophil: 554.9" "Lineage enriched" "Detected in many" 20 "granulocytes: 554.9" "Group enriched" "Detected in some" 14 "ASC diff: 28.9;HL-60: 53.0;NB-4: 109.4;U-937: 112.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA021124 Approved Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "HPA021124: " "unprognostic (3.89e-2)" "unprognostic (4.40e-2)" "unprognostic (5.17e-2)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.31e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-3)" "unprognostic (4.69e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (4.60e-7)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (6.22e-2)" "unprognostic (8.60e-2)" 78.3 0.8 0.1 2.7 0.2 18.4 41.3 0.1 0.2 0.1 0.4 0.9 0.5 0.2 0.0 0.2 1.0 1.7 2.1 0.1 0.2 0.3 0.3 1.0 0.1 0.2 0.2 0.2 0.6 0.0 0.0 0.1 0.2 0.4 0.6 1.9 4.5 0.7 0.5 1.0 2.0 1.0 0.2 1.1 0.9 0.0 0.1 0.3 0.7 1.4 0.0 1.0 0.3 0.2 0.0 0.0 0.0 0.0 28.9 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.8 53.0 3.3 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 109.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 5.3 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 112.2 0.0 15.5 28.1 554.9 0.2 3.3 0.2 0.0 0.0 0.0 7.5 0.1 0.1 0.1 5.7 0.2 0.5 0.7 0.3 17.3 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 17.8 0.0 1.1 0.1 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 13.3 0.0 0.0 2.5 3.9 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 LIG1 ENSG00000105486 "DNA ligase 1" P18858 19 48115445-48170603 "Enzymes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 34.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037015, HPA041431, HPA048071" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus, Vesicles" "CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248" "unprognostic (1.83e-1)" "unprognostic (1.48e-3)" "unprognostic (6.45e-2)" "unprognostic (9.76e-2)" "unprognostic (9.47e-2)" "unprognostic (9.24e-3)" "unprognostic (1.17e-3)" "unprognostic (2.28e-1)" "unprognostic (6.03e-3)" "unprognostic (4.26e-1)" "unprognostic (1.78e-2)" "unprognostic (1.10e-3)" "prognostic unfavorable (5.75e-5)" "unprognostic (3.59e-2)" "unprognostic (4.09e-2)" "unprognostic (1.59e-2)" "unprognostic (1.55e-2)" 2.8 3.2 3.3 9.0 3.2 34.5 3.6 3.6 3.5 5.5 2.3 6.8 8.6 4.0 2.5 7.4 5.9 2.3 1.6 2.9 3.2 2.9 4.0 3.4 15.6 4.4 2.9 6.0 7.0 4.2 4.8 5.1 4.5 4.0 4.2 2.7 4.8 3.0 3.8 10.4 9.6 2.2 2.6 6.0 5.2 8.2 3.1 20.7 5.1 1.0 9.7 3.5 5.0 3.9 43.4 64.1 57.1 37.6 2.6 4.2 41.7 27.0 19.1 44.1 47.2 35.0 42.9 83.7 15.3 11.2 11.9 30.1 24.7 26.7 16.9 45.2 48.8 56.4 38.7 47.5 1.0 63.0 43.7 5.7 2.5 23.0 3.4 5.0 24.0 51.0 46.3 29.8 23.3 44.0 107.3 123.7 33.6 46.7 15.9 84.1 48.4 43.6 12.3 64.8 36.3 36.5 32.3 33.6 10.1 12.5 22.7 44.5 22.6 31.7 54.3 23.9 40.3 29.3 49.0 83.1 12.7 38.0 33.3 0.0 1.6 2.6 7.8 6.8 7.7 10.9 8.8 8.3 1.6 10.0 11.5 8.2 1.3 12.1 3.3 1.5 10.9 5.7 3.3 3.2 3.6 3.5 2.9 3.2 4.4 2.9 4.5 2.6 3.1 3.9 3.9 3.2 13.6 5.9 16.1 8.3 9.5 8.7 24.5 21.5 7.8 12.3 3.9 7.2 10.3 3.7 10.4 31.1 9.6 10.2 7.9 5.8 19.3 12.0 5.1 8.3 0.0 36.2 4.2 5.2 35.8 6.8 5.1 8.3 6.3 23.1 5.0 5.3 16.4 8.4 5.6 10.0 6.1 3.5 6.8 8.5 2.1 6.6 3.6 3.7 7.2 10.9 11.3 3.5 8.4 3.0 4.4 1.9 23.0 2.8 7.6 4.7 19.5 11.3 13.1 4.5 6.5 13.5 26.1 15.9 9.1 10.0 13.9 6.0 15.3 8.7 LRCH4 "LRN, LRRN1" ENSG00000077454 "Leucine rich repeats and calponin homology domain containing 4" O75427 7 100574011-100586129 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 205.8;Syncytiotrophoblasts: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 79.6;NB-4: 174.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037667, HPA037668" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA037667: AB_10671882, HPA037668: AB_10672910" "unprognostic (2.41e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (8.32e-3)" "unprognostic (2.76e-2)" "unprognostic (3.96e-3)" "unprognostic (8.98e-3)" "unprognostic (3.72e-2)" "unprognostic (2.52e-1)" "unprognostic (5.51e-2)" "unprognostic (2.63e-3)" "unprognostic (7.81e-2)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (7.96e-2)" "unprognostic (1.26e-2)" 29.0 37.5 15.8 25.3 18.3 49.2 26.8 16.8 26.1 32.5 17.0 32.7 19.1 28.3 5.1 35.8 33.7 8.5 28.0 15.5 17.7 35.5 30.9 52.0 33.6 21.4 17.1 55.3 33.5 12.7 51.2 10.9 20.5 36.1 5.5 21.4 36.3 8.8 41.4 30.3 71.6 5.3 16.0 130.1 31.2 112.3 20.3 27.1 47.8 7.2 14.7 24.3 29.9 23.1 15.2 9.8 8.5 9.2 6.5 4.3 17.3 14.5 7.3 9.0 7.1 16.6 24.7 9.9 17.0 3.6 10.7 15.9 5.5 7.0 3.0 10.5 12.2 9.8 12.0 8.1 18.4 18.0 79.6 8.0 7.5 7.6 5.5 7.6 10.3 27.6 18.5 18.7 6.6 32.2 21.2 174.5 11.5 20.5 11.2 25.6 7.1 13.9 10.3 4.2 12.5 18.6 7.8 25.6 20.2 16.2 13.6 40.5 14.4 12.2 23.6 15.2 9.1 23.3 9.9 9.9 9.1 51.6 22.3 22.5 10.6 14.6 5.8 8.4 5.5 6.1 5.9 6.8 7.0 6.6 7.9 6.9 30.6 1.6 5.9 7.7 6.3 3.7 15.8 18.3 16.8 26.1 15.5 17.7 21.4 17.1 20.5 16.0 20.3 23.1 7.5 9.6 12.7 7.5 29.4 12.0 15.4 13.0 5.7 15.9 14.8 8.4 0.8 27.1 15.1 22.0 41.7 39.4 42.9 27.2 15.6 32.7 205.8 11.9 7.7 9.9 6.1 12.2 7.3 24.7 13.9 9.1 14.8 13.5 19.6 12.7 15.4 13.8 32.8 13.5 7.9 11.8 20.3 65.9 33.6 32.3 24.8 40.5 14.2 3.7 66.1 13.6 46.4 4.5 5.2 28.9 13.1 10.1 15.7 12.8 41.9 6.9 12.1 33.5 19.7 9.8 13.3 58.3 33.9 9.0 11.5 103.3 33.7 12.0 10.0 16.4 LRRC37B ENSG00000185158 "Leucine rich repeat containing 37B" Q96QE4 17 32007872-32053504 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.1" "Cell type enhanced" "Detected in many" "Early spermatids: 101.9;Excitatory neurons: 45.4;Spermatocytes: 66.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 3.8" "Group enriched" "Detected in many" 4 "granulocytes: 1.5;NK-cells: 3.8;T-cells: 2.6" "Low cell line specificity" "Detected in all" HPA015135 Approved Approved Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA015135: AB_1853309" "unprognostic (5.46e-3)" "unprognostic (2.56e-2)" "unprognostic (5.08e-2)" "unprognostic (5.30e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-1)" "unprognostic (3.60e-2)" "unprognostic (9.65e-3)" "unprognostic (5.06e-2)" "unprognostic (3.19e-2)" "unprognostic (1.72e-4)" "unprognostic (6.99e-2)" "unprognostic (5.72e-3)" "unprognostic (6.94e-2)" "unprognostic (3.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.36e-3)" 4.7 3.7 7.5 3.7 6.6 25.1 5.2 13.7 10.3 6.9 0.9 4.9 3.4 6.2 4.7 4.2 6.8 3.6 2.6 8.0 4.2 3.6 2.1 5.6 4.6 4.8 3.4 9.1 3.2 5.7 8.3 3.5 5.2 4.7 4.6 6.9 4.7 2.8 3.5 10.5 5.0 5.2 2.2 6.2 5.0 17.9 5.1 10.9 4.1 1.4 4.5 4.6 5.9 7.1 2.7 5.0 15.6 8.9 3.9 4.7 4.8 2.4 9.0 6.9 8.7 6.8 2.6 7.1 5.0 5.5 8.5 3.6 9.3 1.9 5.4 2.2 7.6 3.4 8.1 2.6 5.8 13.3 5.8 5.1 5.9 6.3 15.9 6.6 5.9 12.1 8.2 6.8 2.6 2.5 23.4 20.5 4.8 2.5 3.3 16.2 3.7 5.9 3.9 6.6 2.9 5.0 6.1 3.8 8.8 5.2 10.4 20.9 5.0 4.8 3.2 10.8 6.1 6.8 10.4 7.5 3.4 13.2 3.4 0.0 0.2 1.5 0.5 0.2 1.0 0.1 1.0 1.4 0.4 0.4 1.4 0.4 0.5 3.8 0.1 0.6 2.6 0.3 7.5 6.6 13.7 10.3 8.0 4.2 4.8 3.4 5.2 2.2 5.1 7.1 7.4 6.4 9.1 39.2 5.1 4.1 6.9 3.8 2.8 10.0 7.3 5.6 4.7 7.2 7.1 1.8 0.0 2.3 10.0 2.9 9.8 8.9 101.9 7.9 6.3 6.0 1.8 7.4 45.4 10.5 2.3 6.0 1.5 4.7 3.8 7.0 8.2 2.9 9.7 3.3 33.4 5.7 4.1 8.7 6.9 22.9 6.8 7.9 8.8 14.0 9.3 14.5 20.6 39.7 28.3 9.2 1.8 7.2 3.8 9.1 6.8 8.3 7.8 9.7 0.0 8.9 7.8 66.7 13.0 1.6 5.1 2.2 9.0 4.6 4.8 7.7 LSM5 YER146W ENSG00000106355 "LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y4Y9 7 32485338-32495283 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019054 Uncertain NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" "HPA019054: AB_10960217" "unprognostic (1.92e-1)" "unprognostic (5.36e-2)" "unprognostic (3.23e-2)" "unprognostic (1.51e-1)" "unprognostic (8.92e-2)" "unprognostic (3.51e-2)" "prognostic unfavorable (7.53e-5)" "unprognostic (2.22e-1)" "unprognostic (1.77e-2)" "unprognostic (1.01e-2)" "unprognostic (8.06e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (1.84e-4)" "unprognostic (3.08e-1)" "unprognostic (3.89e-2)" "unprognostic (2.53e-2)" "unprognostic (1.18e-1)" 35.8 41.9 26.2 35.8 27.0 77.6 62.6 27.0 40.3 33.7 25.4 58.1 42.4 34.0 35.5 46.6 34.5 28.1 50.1 26.2 26.9 46.8 76.0 28.1 61.7 26.0 26.6 36.4 54.7 30.0 29.1 28.8 26.5 34.3 60.0 28.8 31.4 27.8 57.6 33.8 39.4 36.5 26.7 41.0 47.0 22.5 26.3 67.9 44.4 51.1 72.2 37.6 34.4 27.0 204.6 121.9 162.8 229.4 56.0 62.2 80.9 94.9 79.9 119.3 125.6 168.9 170.0 118.8 49.0 67.7 290.9 119.1 121.1 118.7 161.2 84.6 132.7 124.6 193.5 233.7 49.6 267.4 123.3 52.4 85.1 116.7 137.4 79.2 132.9 203.4 261.0 90.5 169.2 246.3 140.3 598.9 267.9 296.7 139.4 122.3 128.4 200.9 107.3 97.8 140.5 206.4 84.9 237.0 114.6 243.5 148.4 331.6 63.9 102.5 252.6 95.8 246.2 149.2 339.9 354.5 96.9 314.9 296.6 17.9 35.0 34.2 38.6 57.4 58.2 69.2 62.9 50.7 50.7 60.2 89.3 68.9 6.0 44.9 49.5 100.1 57.4 45.2 26.2 27.0 27.0 40.3 26.2 26.9 26.0 26.6 26.5 26.7 26.3 27.0 68.9 32.1 50.6 13.7 135.3 146.4 152.0 254.1 109.8 52.5 201.8 262.4 109.7 94.4 116.7 114.0 22.9 211.9 93.4 95.6 277.8 137.0 16.1 91.1 68.2 81.0 50.5 184.5 15.9 216.6 286.2 98.8 98.8 74.6 72.2 148.2 79.6 285.6 189.8 43.7 20.4 164.9 175.0 117.9 158.2 21.2 75.8 100.1 122.7 13.1 163.9 94.3 78.2 10.1 13.9 146.3 118.2 82.4 187.0 146.9 107.6 343.4 137.5 59.7 65.7 81.9 141.9 88.5 133.2 167.7 177.6 100.6 111.8 123.2 233.2 152.8 LSM8 YJR022W ENSG00000128534 "LSM8 homolog, U6 small nuclear RNA associated" O95777 7 118184144-118204035 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020116 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" "Nucleoplasm, Vesicles" "HPA020116: AB_1853385" "unprognostic (1.02e-2)" "unprognostic (6.58e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (9.85e-4)" "unprognostic (3.33e-2)" "unprognostic (7.34e-2)" "unprognostic (1.13e-3)" "unprognostic (1.87e-2)" "unprognostic (1.79e-2)" "unprognostic (9.90e-2)" "unprognostic (5.14e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.46e-6)" "unprognostic (4.82e-2)" "unprognostic (1.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.00e-3)" 26.8 19.1 6.2 22.3 8.3 44.8 25.6 16.5 7.7 20.5 6.2 22.0 15.5 19.9 16.5 24.4 18.7 9.2 19.2 6.3 7.5 23.7 18.5 21.2 28.9 7.5 7.4 19.8 24.9 8.4 16.3 10.1 7.7 20.8 14.2 16.7 22.7 7.8 21.7 21.6 26.0 8.3 6.8 30.9 21.3 17.3 7.2 18.2 22.1 7.8 27.5 20.0 20.6 10.5 37.2 21.2 53.7 43.6 11.3 19.4 25.3 36.1 26.4 19.2 21.5 16.8 35.6 70.0 78.9 13.4 51.5 28.2 23.1 16.3 18.6 35.9 27.7 49.5 63.3 48.6 29.2 63.9 59.1 20.8 19.6 24.6 25.8 17.7 19.6 55.8 45.8 71.2 26.1 13.2 142.9 155.6 43.6 28.9 26.0 40.8 32.0 53.3 20.3 27.8 28.2 41.6 29.2 83.0 89.1 36.9 17.3 72.7 17.4 36.9 27.7 56.3 51.2 69.9 52.0 101.1 29.1 66.9 61.5 65.3 46.5 45.5 61.8 66.7 59.8 68.0 67.8 75.6 51.5 58.0 64.6 67.5 15.4 43.9 65.7 93.2 74.2 39.5 6.2 8.3 16.5 7.7 6.3 7.5 7.5 7.4 7.7 6.8 7.2 10.5 108.5 25.6 58.6 15.0 130.3 0.0 93.6 0.0 82.6 41.5 71.8 92.1 43.5 74.4 35.3 62.5 47.9 133.2 141.2 76.8 90.1 101.2 54.6 76.1 92.8 79.6 86.4 83.1 19.5 172.0 193.6 69.0 66.3 76.4 101.4 87.1 88.5 75.3 139.8 42.1 22.4 99.1 0.0 148.9 0.0 19.1 97.3 102.2 0.0 36.5 184.9 52.6 158.6 23.6 39.1 144.8 109.0 76.0 95.6 108.6 83.6 106.8 36.5 42.0 85.5 65.3 66.2 135.3 117.8 106.7 0.0 120.8 121.1 76.1 100.7 121.2 MAD2L2 "FANCV, MAD2B, POLZ2, REV7" ENSG00000116670 "Mitotic arrest deficient 2 like 2" Q9UI95 1 11674480-11691650 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 148.1;Late spermatids: 522.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008110, HPA024176, HPA024612" Approved Supported Nucleoli,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" Cytosol Nucleoli "CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: " "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (2.43e-1)" "unprognostic (3.27e-1)" "unprognostic (2.41e-1)" "unprognostic (6.84e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.60e-2)" "unprognostic (1.24e-1)" "unprognostic (9.09e-3)" "unprognostic (1.54e-1)" "unprognostic (9.27e-2)" "unprognostic (8.43e-2)" "unprognostic (2.36e-1)" 25.6 19.5 30.3 22.2 32.0 59.8 25.2 33.2 35.9 23.5 27.6 24.6 11.6 19.3 15.0 14.6 20.4 13.4 26.5 30.2 33.1 37.7 49.8 29.6 27.7 34.9 30.2 21.7 39.9 13.3 22.7 10.6 31.7 22.3 7.5 5.0 28.6 11.2 49.3 23.5 17.1 15.5 31.6 25.2 28.8 64.3 35.3 55.1 15.4 31.5 26.1 23.1 17.8 35.9 62.8 57.2 90.8 106.8 28.6 55.1 37.3 56.5 64.8 110.4 97.8 75.2 59.2 87.6 67.6 58.1 64.4 27.4 115.1 60.1 60.5 133.3 129.6 40.1 87.5 93.4 50.2 80.5 62.7 36.1 60.7 81.0 68.9 41.6 51.4 116.7 165.6 138.3 55.5 94.6 365.6 381.3 235.1 25.9 91.2 245.6 100.2 109.6 40.8 13.5 167.8 118.1 93.6 36.5 168.1 61.2 52.6 172.1 26.8 90.7 114.1 85.6 81.8 109.5 82.0 233.7 67.2 281.5 71.8 45.3 85.2 42.8 82.1 97.3 66.8 58.5 55.4 64.8 100.8 43.8 37.0 54.9 36.7 43.3 86.8 139.1 69.9 92.0 30.3 32.0 33.2 35.9 30.2 33.1 34.9 30.2 31.7 31.6 35.3 35.9 24.8 0.0 5.0 4.2 26.1 38.6 26.5 35.7 18.8 5.7 26.9 26.9 15.9 11.5 14.1 14.7 4.2 18.2 49.6 3.7 50.9 40.8 148.1 8.4 21.6 28.2 34.0 69.5 1.7 76.6 50.7 30.6 12.2 11.4 14.0 17.3 29.6 59.1 41.7 11.8 2.3 10.6 54.9 36.4 88.1 522.5 31.1 32.5 48.0 1.9 82.6 10.8 53.5 4.0 5.5 40.7 4.5 17.0 42.9 35.8 4.5 29.6 6.0 3.5 39.5 25.1 26.5 76.0 40.6 14.3 34.7 8.3 37.7 18.8 8.6 17.6 MAEA "EMP, GID9, HLC-10, p44EMLP" ENSG00000090316 "Macrophage erythroblast attacher, E3 ubiquitin ligase" Q7L5Y9 4 1289887-1340147 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway" "Actin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036886, HPA058185" Approved Enhanced Nucleoplasm Yes No "Cluster 5: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA036886: , HPA058185: AB_2683633" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.11e-1)" "unprognostic (2.03e-2)" "prognostic favorable (5.34e-4)" "unprognostic (3.10e-3)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (6.94e-3)" "unprognostic (4.65e-3)" "prognostic favorable (1.90e-4)" "unprognostic (1.17e-2)" "unprognostic (2.49e-1)" "unprognostic (1.97e-1)" "unprognostic (4.51e-2)" 28.5 44.2 21.9 23.5 21.3 18.3 28.8 19.8 24.0 32.6 25.9 39.7 33.5 34.4 10.9 46.7 29.2 17.5 38.6 21.1 27.2 40.9 32.3 24.0 24.3 25.7 23.0 34.9 35.4 30.7 38.9 17.2 26.3 29.2 14.2 8.8 35.7 21.5 37.1 41.2 35.7 14.9 18.1 40.0 37.1 26.8 23.2 20.7 33.9 19.2 15.7 30.7 33.5 20.0 58.1 66.9 47.6 47.7 31.5 31.1 61.4 57.4 30.6 47.1 42.2 70.5 73.5 52.5 43.6 42.4 85.5 42.0 46.1 72.2 19.1 42.4 52.2 49.2 74.1 68.1 37.1 55.8 50.9 38.8 38.6 37.8 23.6 31.8 38.0 50.4 70.4 41.6 41.3 61.5 84.2 86.5 62.2 63.4 72.9 81.0 38.1 47.8 50.3 68.2 84.7 57.8 51.1 39.3 41.5 26.3 71.5 48.4 52.8 85.9 36.0 39.0 96.1 50.5 83.4 58.1 59.0 51.3 48.2 74.9 49.9 70.9 59.2 52.6 83.5 47.6 47.1 56.4 47.1 38.1 41.4 42.5 117.9 45.5 77.3 33.0 59.8 59.1 21.9 21.3 19.8 24.0 21.1 27.2 25.7 23.0 26.3 18.1 23.2 20.0 22.0 19.2 25.0 28.4 21.6 18.7 15.7 33.9 8.0 28.1 22.5 25.3 35.5 14.3 24.3 16.5 20.9 48.2 29.7 41.2 46.9 43.4 8.0 21.9 25.2 24.4 20.4 26.3 19.6 30.3 46.4 25.0 25.5 25.0 10.8 30.4 19.6 15.0 39.6 21.9 23.2 33.1 30.5 29.2 15.9 9.8 35.4 23.2 28.4 14.0 46.3 22.3 28.8 22.6 20.0 40.3 31.3 37.2 23.5 22.7 30.4 36.4 17.9 19.1 13.1 24.9 27.9 36.6 44.0 19.3 19.9 95.2 29.7 59.6 38.1 21.8 MAT2A "MATA2, MATII, SAMS2" ENSG00000168906 "Methionine adenosyltransferase 2A" P31153 2 85539168-85545281 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 874.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009968, HPA043028" Approved Approved Nucleoplasm,Cytosol NA NA 1800000 "Cluster 39: Non-specific - mRNA processing" "Cluster 22: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm Cytosol "CAB009968: AB_675710, HPA043028: AB_10960707" "unprognostic (1.38e-3)" "unprognostic (2.58e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (5.29e-5)" "unprognostic (9.89e-3)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.87e-4)" "prognostic favorable (8.94e-4)" "prognostic unfavorable (5.94e-5)" "unprognostic (4.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.59e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (1.77e-2)" 270.4 277.5 184.1 153.2 226.7 98.3 136.1 199.3 235.9 173.0 152.6 193.2 141.4 165.5 236.0 166.2 200.1 209.5 189.6 191.5 207.3 203.6 115.7 168.5 121.8 226.8 219.3 211.0 874.7 165.8 284.1 122.3 208.0 196.2 146.5 248.7 137.7 120.0 278.9 141.1 155.6 127.2 194.4 116.7 225.5 132.3 219.2 102.1 388.8 112.0 127.7 262.9 168.2 289.7 175.3 253.0 290.4 181.6 195.3 236.7 171.1 213.5 195.6 219.3 232.4 208.4 569.9 404.5 137.0 261.0 178.9 264.3 369.6 318.6 279.8 207.0 271.0 242.5 408.7 181.9 355.6 364.3 259.7 215.9 315.8 237.4 164.1 278.1 211.5 230.7 277.9 309.0 505.1 149.5 334.4 398.2 193.5 148.7 320.8 350.3 275.0 264.2 328.9 271.2 227.9 209.6 193.2 183.4 354.6 145.9 156.0 192.3 207.7 267.4 160.9 149.3 260.5 189.0 161.4 290.6 175.0 447.3 143.8 9.1 24.7 8.2 22.3 26.9 32.7 19.8 25.2 23.7 23.6 18.9 23.1 20.5 2.5 27.3 22.3 16.6 24.2 24.9 184.1 226.7 199.3 235.9 191.5 207.3 226.8 219.3 208.0 194.4 219.2 289.7 150.5 48.1 83.6 122.4 104.2 143.5 217.1 47.1 206.1 73.5 116.3 134.6 6.5 82.9 57.6 71.7 68.8 36.2 126.3 60.6 19.6 59.2 75.2 28.8 49.2 83.6 83.3 87.1 56.1 58.5 40.6 121.9 106.0 47.4 84.4 83.3 45.0 44.6 67.4 26.9 60.4 65.1 26.4 118.8 141.9 25.8 72.1 165.7 67.6 26.2 64.6 58.8 27.8 28.6 95.5 53.6 48.0 83.8 78.4 66.7 73.8 138.7 35.2 89.0 111.7 298.5 231.0 54.1 56.2 168.2 118.3 38.2 102.0 51.1 70.6 88.4 MATN4 ENSG00000124159 "Matrilin 4" O95460 20 45293445-45308529 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "pancreas: 24.8" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 6.4;Fibroblasts: 8.5;Langerhans cells: 6.3;Spermatogonia: 4.9;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;NB-4: 2.5;U-937: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 14000 "Cluster 25: Pancreas - Digestion" "Cluster 24: NB-4 - Immune response" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (1.54e-1)" "unprognostic (2.39e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-2)" "unprognostic (8.38e-2)" "unprognostic (9.67e-2)" "unprognostic (1.84e-1)" "unprognostic (6.79e-2)" "unprognostic (6.27e-2)" "unprognostic (6.74e-3)" "unprognostic (5.53e-1)" "unprognostic (6.19e-3)" "unprognostic (3.63e-6)" "unprognostic (2.38e-1)" "unprognostic (4.69e-2)" "unprognostic (4.27e-1)" "unprognostic (5.38e-2)" 0.7 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 24.8 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.0 3.2 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.1 0.1 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 2.5 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 6.4 0.7 1.0 0.0 0.0 1.6 1.9 1.1 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.1 0.7 0.2 0.4 0.0 0.0 1.0 2.5 0.0 8.5 1.1 0.8 0.0 0.3 0.4 0.2 0.1 0.0 0.4 0.1 0.0 0.0 6.3 0.5 0.0 0.1 1.8 1.0 0.0 0.0 0.0 3.0 0.4 0.9 0.1 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.4 0.4 1.6 4.9 0.3 4.3 0.3 0.3 0.1 0.2 1.0 MED28 "DKFZP434N185, EG1, magicin" ENSG00000118579 "Mediator complex subunit 28" Q9H204 4 17614641-17634105 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Activator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035900, HPA035901" Uncertain Supported Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA035900: AB_10673223, HPA035901: AB_2674853" "unprognostic (1.14e-3)" "unprognostic (6.97e-2)" "unprognostic (1.95e-1)" "unprognostic (6.08e-3)" "unprognostic (8.22e-3)" "unprognostic (3.90e-1)" "unprognostic (1.55e-2)" "unprognostic (5.47e-2)" "unprognostic (5.71e-2)" "unprognostic (2.43e-1)" "unprognostic (2.27e-2)" "unprognostic (7.00e-2)" "unprognostic (1.16e-2)" "unprognostic (6.30e-2)" "unprognostic (8.46e-2)" "unprognostic (1.14e-1)" "unprognostic (5.07e-3)" 6.9 5.6 8.8 7.5 9.3 12.2 9.2 9.4 8.8 12.2 8.8 9.8 5.9 11.5 9.7 7.9 10.6 5.2 6.4 8.4 9.4 7.7 6.2 9.7 10.8 9.4 8.8 14.8 7.3 6.6 10.3 8.5 8.4 9.1 6.9 11.7 9.2 7.3 12.6 10.2 9.6 7.2 8.6 10.2 8.7 6.0 9.6 11.2 9.8 5.9 11.1 9.1 9.9 11.9 4.6 2.9 23.2 11.7 10.0 7.8 9.4 6.5 7.7 8.6 7.8 8.1 10.9 12.6 4.5 6.0 7.6 4.5 14.1 7.0 8.6 5.0 7.0 22.2 10.1 12.3 7.0 15.7 10.7 7.6 9.6 5.4 4.5 9.0 7.5 18.0 20.0 11.3 7.7 4.5 23.3 27.0 16.1 9.1 4.8 17.8 8.5 5.9 8.2 6.8 16.6 8.3 5.7 4.9 5.7 13.6 9.3 16.0 9.4 5.6 3.9 4.0 6.2 8.4 4.0 16.1 5.1 14.9 6.1 5.2 6.6 6.5 4.5 5.2 4.4 5.5 4.9 4.2 6.4 5.6 6.4 5.0 9.0 5.5 4.4 4.4 4.2 7.5 8.8 9.3 9.4 8.8 8.4 9.4 9.4 8.8 8.4 8.6 9.6 11.9 45.7 19.2 27.6 4.9 67.6 92.2 114.0 86.2 46.1 42.6 54.9 65.8 19.5 38.6 55.2 22.0 16.7 114.5 69.9 25.9 84.1 61.6 11.6 31.2 47.3 63.9 44.3 93.2 5.1 53.8 167.8 57.9 19.4 35.5 59.1 78.4 52.5 31.5 93.9 33.7 5.8 41.2 65.1 74.1 103.0 20.4 56.5 61.7 60.5 5.6 115.4 58.9 94.7 9.5 8.9 57.2 47.4 47.0 33.0 110.2 33.6 58.8 40.6 35.1 32.9 50.5 74.7 76.0 100.5 46.0 93.5 134.6 61.3 62.7 47.5 104.6 MED30 "THRAP6, TRAP25" ENSG00000164758 "Mediator complex subunit 30" Q96HR3 8 117520713-117540262 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 169.9;Suprabasal keratinocytes: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045767 Approved Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 28: Keratinocytes - Keratinization" Nucleoplasm "HPA045767: AB_2679446" "unprognostic (1.15e-1)" "unprognostic (1.90e-1)" "unprognostic (3.86e-2)" "unprognostic (1.57e-2)" "unprognostic (1.46e-1)" "unprognostic (3.20e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-2)" "unprognostic (8.41e-2)" "unprognostic (4.02e-2)" "unprognostic (1.51e-2)" "unprognostic (7.73e-2)" "prognostic unfavorable (1.70e-6)" "unprognostic (5.38e-3)" "unprognostic (2.80e-1)" "unprognostic (1.05e-1)" "unprognostic (4.62e-2)" 18.4 9.4 10.7 11.6 11.4 44.6 17.6 11.4 14.4 15.5 10.1 14.6 9.3 15.7 8.3 12.6 18.4 6.6 11.0 10.4 10.6 8.2 15.2 13.0 17.3 11.1 10.8 20.1 9.1 7.3 10.0 11.4 11.1 11.4 11.6 5.0 9.7 10.3 10.4 17.0 12.4 9.3 11.5 14.0 11.2 11.4 10.9 25.1 12.1 10.4 15.3 13.3 14.9 12.7 54.0 5.6 20.8 13.9 14.2 13.3 22.9 15.9 16.9 23.8 29.4 10.2 26.2 42.7 24.7 8.7 18.3 23.7 18.6 12.4 30.4 57.4 23.0 34.7 3.2 13.2 15.6 27.7 28.9 12.3 13.8 12.3 27.5 8.8 14.9 60.7 19.7 25.2 11.4 12.7 85.9 70.9 11.6 50.6 38.7 31.5 26.1 19.1 12.2 9.3 29.2 24.7 18.8 42.6 25.6 18.8 10.3 35.1 7.1 11.5 30.2 21.2 28.0 22.0 16.1 50.1 10.7 31.2 19.7 64.0 37.9 111.3 46.7 46.2 49.7 56.3 46.8 46.7 42.8 63.6 51.8 49.4 90.7 44.5 69.9 82.5 55.6 43.4 10.7 11.4 11.4 14.4 10.4 10.6 11.1 10.8 11.1 11.5 10.9 12.7 47.6 9.6 21.7 9.1 71.4 169.9 81.2 65.2 52.9 6.0 33.7 46.6 5.5 25.8 32.2 9.2 6.2 45.3 62.8 27.9 11.7 22.6 32.7 49.5 38.0 33.2 37.7 35.7 10.0 22.7 69.4 46.9 15.8 42.0 21.5 15.7 30.0 21.9 30.4 0.0 12.7 43.4 42.7 28.8 65.4 11.9 59.7 37.7 40.9 6.5 23.5 10.4 43.3 9.0 18.4 20.5 34.4 37.2 37.5 76.5 24.2 16.9 64.8 5.3 32.9 68.4 44.6 47.8 37.1 46.4 152.3 61.6 60.4 13.5 35.5 72.1 MEMO1 "C2orf4, CGI-27, MEMO" ENSG00000162959 "Mediator of cell motility 1" Q9Y316 2 31865060-32011230 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 115.0;Inhibitory neurons: 111.2;Microglial cells: 100.2;Oligodendrocyte precursor cells: 106.1;Oligodendrocytes: 134.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042603, HPA057952" Approved Approved Vesicles NA NA 9100 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 24: NB-4 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "HPA042603: AB_10806243, HPA057952: AB_2683562" "unprognostic (1.33e-1)" "unprognostic (1.28e-3)" "unprognostic (1.81e-1)" "unprognostic (2.94e-5)" "unprognostic (1.02e-2)" "unprognostic (3.96e-2)" "unprognostic (2.24e-4)" "unprognostic (1.70e-2)" "unprognostic (6.73e-2)" "unprognostic (8.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (5.95e-9)" "unprognostic (6.57e-2)" "unprognostic (2.26e-1)" "unprognostic (3.77e-2)" "unprognostic (4.23e-2)" 17.2 23.7 15.0 23.2 13.7 45.7 14.7 14.0 14.1 15.1 9.9 17.5 16.7 14.4 16.7 33.6 13.1 13.4 36.3 13.4 13.7 16.4 35.9 13.9 31.9 14.2 14.2 10.7 17.3 14.6 11.9 20.6 13.9 14.2 20.7 11.7 16.8 13.6 58.8 19.2 16.7 19.5 13.4 20.3 17.3 62.2 14.4 31.5 12.5 36.5 34.2 26.3 19.3 16.8 87.7 37.4 40.5 37.8 34.8 49.4 73.0 73.6 45.7 41.1 31.5 51.0 48.2 92.4 23.2 50.6 54.2 43.4 48.4 63.9 54.0 61.8 26.4 67.0 22.8 62.7 48.6 67.7 53.7 37.2 40.7 40.6 40.7 46.7 65.1 21.8 49.0 41.4 72.2 38.3 81.5 137.8 60.0 74.9 46.2 54.4 46.0 71.4 81.8 83.6 34.2 63.3 38.0 90.7 59.2 33.9 38.2 80.4 61.0 57.0 63.4 45.8 82.1 42.8 69.8 79.7 51.7 96.1 45.7 1.8 16.6 17.1 7.5 23.4 5.7 9.6 9.2 9.0 24.4 7.5 6.6 6.5 13.4 12.6 27.9 9.1 17.1 10.1 15.0 13.7 14.0 14.1 13.4 13.7 14.2 14.2 13.9 13.4 14.4 16.8 6.7 6.4 13.3 70.8 19.1 27.8 17.2 10.3 17.6 15.3 10.6 6.3 4.7 12.8 9.3 11.0 16.7 13.3 9.0 8.3 1.9 4.9 3.6 5.2 9.1 11.3 13.1 18.3 115.0 2.6 10.5 9.6 11.2 8.7 10.1 10.2 14.3 14.0 10.1 11.8 111.2 7.0 8.2 19.2 18.4 3.0 13.1 15.2 12.4 100.2 21.8 4.6 14.4 106.1 134.4 7.5 8.3 8.6 11.2 19.7 8.5 2.4 8.8 10.5 6.6 12.5 6.0 12.2 6.4 26.9 16.6 16.6 12.8 7.9 10.4 16.8 MFSD10 "IT10C3, TETRAN" ENSG00000109736 "Major facilitator superfamily domain containing 10" Q14728 4 2930561-2934834 "Predicted membrane proteins" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 251.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 275.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043209 Uncertain Approved "Nucleoplasm,Nuclear membrane" No No "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear membrane" Nucleoplasm "HPA043209: AB_2678364" "unprognostic (1.44e-1)" "unprognostic (2.26e-2)" "unprognostic (7.06e-2)" "unprognostic (2.11e-3)" "unprognostic (7.76e-2)" "unprognostic (9.43e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.82e-3)" "unprognostic (4.70e-3)" "unprognostic (3.21e-1)" "unprognostic (1.91e-2)" "unprognostic (5.42e-3)" "prognostic unfavorable (5.68e-5)" "unprognostic (8.32e-2)" "unprognostic (2.30e-1)" "unprognostic (8.03e-2)" "unprognostic (1.00e-2)" 35.2 20.2 15.8 9.9 16.4 66.1 30.5 13.6 24.1 43.1 19.3 30.3 12.3 34.7 3.3 27.6 36.9 12.5 26.5 16.1 14.4 33.6 10.8 36.9 13.2 16.9 14.7 41.6 29.0 3.6 28.7 11.5 14.7 34.3 3.8 1.1 30.4 11.3 14.0 22.0 31.0 7.6 13.2 36.1 31.6 15.6 17.6 6.3 37.6 3.4 6.3 34.6 32.8 14.3 50.4 46.2 13.3 33.7 21.7 15.5 36.0 45.1 21.9 21.5 24.6 24.7 117.3 8.8 23.7 28.4 40.0 45.9 12.1 65.6 5.8 56.9 40.7 19.1 39.2 25.9 36.5 59.9 27.1 23.5 37.5 24.5 15.4 33.4 24.7 20.0 26.4 18.0 16.5 53.8 16.9 275.6 43.0 38.9 54.5 20.7 6.4 41.8 32.9 30.6 34.2 40.7 10.8 31.5 49.1 13.5 82.9 112.9 37.1 17.7 30.4 22.2 36.6 12.2 5.8 13.8 50.0 153.3 27.8 64.7 55.0 117.4 73.0 71.2 62.6 45.1 46.8 82.1 57.4 35.2 23.3 41.1 44.2 45.9 95.8 45.7 34.4 42.6 15.8 16.4 13.6 24.1 16.1 14.4 16.9 14.7 14.7 13.2 17.6 14.3 64.6 38.5 29.1 17.6 41.3 31.4 78.8 251.5 28.5 9.2 56.3 68.1 5.0 28.6 123.2 46.0 8.4 67.4 71.0 37.8 3.9 96.0 11.7 41.5 33.4 41.1 28.2 13.3 21.5 45.9 93.0 42.9 33.6 44.3 32.4 50.7 45.7 3.1 69.6 15.2 14.8 37.2 93.6 49.3 36.7 18.8 36.4 45.6 42.7 9.4 62.1 11.0 64.9 9.5 8.8 86.0 51.5 22.6 28.1 92.1 60.0 17.9 104.9 10.0 92.1 27.0 56.6 15.5 16.1 26.9 26.9 83.7 62.4 44.7 49.4 100.5 MITD1 LOC129531 ENSG00000158411 "Microtubule interacting and trafficking domain containing 1" Q8WV92 2 99161427-99181058 "Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036162, HPA036163" Approved Enhanced Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA036162: AB_10672236, HPA036163: AB_2674978" "prognostic favorable (5.96e-4)" "unprognostic (1.67e-2)" "unprognostic (3.09e-1)" "unprognostic (2.79e-1)" "unprognostic (2.02e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (1.39e-1)" "unprognostic (5.35e-2)" "unprognostic (1.01e-2)" "unprognostic (1.09e-1)" "unprognostic (6.31e-3)" "prognostic unfavorable (1.32e-11)" "unprognostic (2.38e-1)" "unprognostic (2.40e-1)" "unprognostic (6.91e-2)" "prognostic favorable (5.46e-8)" 17.9 16.8 12.3 25.1 12.9 13.2 17.1 12.3 15.5 17.2 11.8 17.5 15.4 16.8 14.3 17.9 15.8 12.7 13.6 11.9 12.9 18.7 17.3 14.2 36.5 13.0 12.7 17.0 11.7 9.1 11.0 16.6 12.9 13.5 20.0 22.1 13.5 11.9 10.7 15.8 19.1 17.0 12.4 22.3 17.4 7.0 12.7 27.0 15.1 11.2 29.1 16.8 16.2 13.7 58.0 15.3 30.5 11.8 35.1 45.2 41.9 27.1 37.8 37.2 50.3 18.8 47.6 40.0 30.4 22.2 84.9 43.0 30.0 29.9 61.7 57.2 20.6 35.4 22.3 40.4 52.2 60.2 20.1 35.9 25.4 32.6 31.2 34.3 42.4 37.8 29.6 24.1 34.0 13.8 57.8 88.5 25.8 37.1 30.0 32.4 43.8 34.7 47.2 32.1 10.0 14.7 26.5 24.3 35.0 52.8 12.9 47.1 32.1 23.0 30.2 24.3 34.1 28.2 23.6 55.5 41.7 50.2 23.4 19.2 24.7 18.2 17.5 22.8 19.7 30.6 24.8 20.8 22.0 28.4 23.6 19.3 28.0 26.0 21.8 29.8 23.1 12.8 12.3 12.9 12.3 15.5 11.9 12.9 13.0 12.7 12.9 12.4 12.7 13.7 31.0 25.6 19.9 22.9 51.2 18.9 30.3 78.2 22.2 13.4 19.5 22.9 12.3 31.5 41.6 35.0 14.6 48.2 39.1 28.1 45.0 46.9 18.8 28.2 34.8 33.1 15.7 27.3 18.3 61.2 34.9 27.6 19.9 24.7 30.4 20.2 30.0 31.2 51.0 11.8 16.9 25.5 40.7 24.5 22.3 6.2 51.0 31.0 23.2 11.2 50.5 26.2 40.2 15.6 38.4 57.3 33.5 39.5 23.3 20.2 32.9 63.4 34.5 55.4 39.5 22.4 24.4 14.4 15.5 20.0 17.5 22.6 42.4 26.4 27.5 19.6 MMP9 CLG4B ENSG00000100985 "Matrix metallopeptidase 9" P14780 20 46008908-46016561 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "bone marrow: 376.0;lymphoid tissue: 105.3" "Group enriched" "Detected in many" 5 "Hofbauer cells: 260.1;Langerhans cells: 606.0;Macrophages: 230.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 4 "cerebral cortex: 3.1;thalamus: 4.8" "Immune cell enriched" "Detected in some" 127 "neutrophil: 272.2" "Lineage enriched" "Detected in single" 341 "granulocytes: 272.2" "Cell line enriched" "Detected in some" 13 "NB-4: 360.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201" Enhanced Approved Cytosol "Secreted to blood" NA NA 43300000 61000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" Cytosol "CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150" "unprognostic (4.62e-2)" "unprognostic (1.64e-1)" "unprognostic (2.85e-2)" "prognostic favorable (2.55e-4)" "unprognostic (6.65e-3)" "unprognostic (2.82e-1)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.54e-1)" "unprognostic (8.57e-2)" "unprognostic (3.21e-2)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.05e-5)" "unprognostic (4.65e-1)" "unprognostic (9.85e-3)" "unprognostic (2.48e-2)" "unprognostic (2.17e-3)" 19.5 0.6 0.5 61.9 0.8 376.0 8.2 0.4 3.1 2.9 0.8 5.7 11.6 1.0 0.0 2.2 2.2 3.0 3.2 0.3 0.9 2.6 3.8 21.1 103.2 0.8 0.5 0.8 1.6 0.1 1.1 2.0 0.7 1.9 3.4 0.6 3.6 0.4 0.7 3.2 12.4 1.9 0.4 105.3 11.3 1.3 4.8 17.0 2.1 0.9 36.5 12.0 1.1 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.3 0.3 28.8 0.0 0.3 0.4 0.0 1.4 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 4.0 0.0 360.6 0.8 0.0 0.2 0.4 0.3 0.1 0.0 0.0 0.6 0.6 0.0 0.6 0.0 3.7 0.3 1.2 0.3 10.3 10.9 0.1 0.3 0.3 0.2 0.2 0.1 0.8 0.2 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 272.2 0.0 0.3 0.0 0.0 0.5 0.5 0.8 0.4 3.1 0.3 0.9 0.8 0.5 0.7 0.4 4.8 0.2 0.7 0.0 5.5 0.0 3.9 34.3 0.1 61.5 0.0 3.8 0.5 2.0 0.4 1.5 0.9 0.0 8.4 1.5 2.0 0.0 0.0 0.8 0.9 0.0 0.1 7.2 0.0 0.0 0.1 1.8 2.4 2.5 0.0 0.1 1.3 0.2 0.0 0.0 260.1 3.3 0.2 0.5 0.0 1.3 606.0 0.3 0.0 230.6 56.9 0.0 2.3 1.2 0.0 0.0 0.0 1.8 0.0 0.0 0.9 0.1 0.0 0.3 6.9 5.3 0.0 0.2 45.5 6.7 11.2 0.2 28.1 1.9 3.4 0.3 0.0 0.1 MND1 GAJ ENSG00000121211 "Meiotic nuclear divisions 1" Q9BWT6 4 153344649-153415118 "Predicted intracellular proteins" "DNA recombination, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.3;lymphoid tissue: 26.7;testis: 15.9" "Cell type enhanced" "Detected in many" "Early spermatids: 25.9;Erythroid cells: 30.9;Spermatocytes: 55.5;Spermatogonia: 96.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 1.3;T-reg: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA043499 Supported NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" "HPA043499: AB_2732506" "unprognostic (2.21e-2)" "unprognostic (6.46e-3)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (7.98e-2)" "unprognostic (2.97e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (6.21e-3)" "prognostic unfavorable (3.40e-4)" "unprognostic (5.28e-2)" "unprognostic (1.28e-2)" "unprognostic (9.43e-2)" "unprognostic (2.71e-8)" "unprognostic (7.65e-2)" "unprognostic (5.70e-2)" "unprognostic (9.84e-2)" "unprognostic (7.64e-2)" 0.5 0.5 1.1 4.7 1.2 13.3 2.5 1.0 2.0 0.7 0.7 4.4 3.0 0.7 1.2 3.3 0.5 1.0 0.4 1.1 1.3 0.6 1.3 0.8 12.0 1.4 1.1 0.3 0.3 0.0 0.3 2.4 1.2 0.5 5.1 0.0 0.9 0.9 1.3 2.1 2.6 1.5 1.1 1.8 1.6 15.9 1.3 26.7 0.4 0.5 14.0 1.3 1.3 1.7 38.6 17.7 52.7 30.6 0.7 7.2 20.9 35.1 15.4 31.4 25.6 32.8 26.1 74.4 5.8 8.5 29.5 15.7 52.3 15.8 39.9 47.7 19.9 39.1 17.3 42.9 1.1 88.2 17.9 1.9 3.3 24.4 21.1 7.8 10.7 86.0 71.0 91.9 26.8 21.5 124.1 116.0 39.1 17.9 17.8 74.1 18.2 35.8 19.3 9.7 26.5 23.3 15.7 17.7 30.0 26.5 14.7 72.1 2.6 24.1 34.8 28.1 32.6 79.0 96.0 58.8 24.1 69.6 28.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.0 0.3 0.0 0.0 0.4 0.0 0.1 1.7 0.1 1.1 1.2 1.0 2.0 1.1 1.3 1.4 1.1 1.2 1.1 1.3 1.7 0.2 0.0 0.5 2.6 1.9 2.8 1.8 5.1 0.0 0.0 2.2 4.6 0.6 2.8 0.7 0.0 0.0 14.5 1.0 4.1 1.9 0.3 25.9 3.5 1.6 1.3 0.0 30.9 1.6 0.5 20.6 3.6 2.0 5.7 0.0 11.8 1.4 1.0 12.5 0.0 2.6 4.3 4.1 2.5 5.0 20.5 0.9 2.4 3.6 1.9 0.1 0.0 1.0 2.0 23.3 0.6 1.6 2.2 7.7 1.2 0.7 0.1 1.0 0.0 6.6 0.9 8.6 55.5 96.3 10.2 1.4 2.5 2.5 1.5 10.3 2.7 MOK "RAGE, RAGE1, STK30" ENSG00000080823 "MOK protein kinase" Q9UQ07 14 102224500-102305190 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 125.8;testis: 54.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 185.6;Early spermatids: 212.8;Late spermatids: 185.8;Respiratory ciliated cells: 156.9;Rod photoreceptor cells: 465.7" "Cancer enriched" "Detected in many" 4 "melanoma: 7.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 149.0;hTEC/SVTERT24-B: 383.5;NB-4: 499.1;U-138 MG: 200.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027292 Supported "Endoplasmic reticulum" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 24: NB-4 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Endoplasmic reticulum" "HPA027292: AB_10600989" "unprognostic (8.16e-2)" "unprognostic (1.82e-1)" "unprognostic (6.68e-2)" "unprognostic (6.05e-3)" "unprognostic (1.34e-2)" "unprognostic (1.81e-2)" "unprognostic (4.43e-2)" "unprognostic (3.49e-4)" "unprognostic (2.19e-1)" "unprognostic (2.03e-2)" "unprognostic (2.93e-1)" "unprognostic (3.01e-3)" "unprognostic (5.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.48e-1)" 9.2 11.2 15.7 1.8 16.0 3.0 6.8 14.8 18.6 8.9 26.9 5.3 3.4 7.8 7.3 4.3 21.2 4.6 13.0 17.2 16.9 12.6 5.8 5.3 1.7 16.2 17.2 12.9 9.7 7.1 18.6 2.4 15.9 7.6 1.8 125.8 6.3 3.5 2.2 6.8 3.0 3.9 15.0 4.7 9.3 54.0 17.1 1.7 14.8 0.7 1.3 8.4 5.5 15.6 18.9 16.5 2.2 9.5 3.8 13.1 4.2 37.7 11.0 53.4 63.7 1.5 45.4 14.5 3.1 7.2 11.5 4.1 3.3 19.4 149.0 16.2 14.1 3.4 2.3 12.7 15.9 1.6 17.9 11.1 4.9 383.5 35.3 41.3 2.0 2.9 3.4 1.0 35.3 12.5 1.2 499.1 0.7 8.3 39.4 2.2 1.0 0.3 21.9 0.8 6.0 3.9 6.8 2.6 109.4 0.8 11.2 1.5 1.4 200.4 10.4 7.7 12.1 1.3 2.4 1.2 40.2 1.2 93.1 0.0 0.7 0.0 0.5 0.6 0.8 0.0 0.4 1.4 3.0 0.5 0.7 1.7 0.5 8.0 0.1 0.0 0.0 0.9 15.7 16.0 14.8 18.6 17.2 16.9 16.2 17.2 15.9 15.0 17.1 15.6 5.8 19.2 17.5 68.6 1.0 10.7 6.3 12.0 7.4 40.9 19.1 17.3 12.3 10.0 27.5 12.9 185.6 1.4 2.4 6.1 5.9 8.3 212.8 122.1 16.9 7.2 4.8 3.6 54.7 16.0 2.6 17.6 12.2 10.7 3.8 12.2 8.6 2.0 2.1 16.8 37.5 2.4 6.1 1.3 5.3 185.8 30.4 2.5 80.0 7.5 0.5 59.5 1.0 16.1 6.8 6.5 1.2 16.1 1.1 2.7 3.5 11.1 156.9 465.7 26.3 22.4 13.4 121.4 32.0 5.4 5.8 1.2 4.2 13.4 4.2 3.8 MORN5 "C9orf113, C9orf18, FLJ46909" ENSG00000185681 "MORN repeat containing 5" Q5VZ52 9 122159908-122200088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 111.0;testis: 81.7" "Cell type enhanced" "Detected in many" "Early spermatids: 490.3;Endometrial ciliated cells: 240.0;Late spermatids: 692.9;Respiratory ciliated cells: 454.7;Spermatocytes: 142.1" "Group enriched" "Detected in many" 4 "endometrial cancer: 9.2;glioma: 4.0;ovarian cancer: 2.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.6;U-87 MG: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (5.24e-3)" "unprognostic (7.30e-3)" "unprognostic (1.12e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (7.80e-3)" "unprognostic (1.91e-3)" "unprognostic (3.25e-3)" "unprognostic (2.64e-2)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (2.95e-1)" 0.0 0.1 8.1 0.6 8.4 0.0 0.2 7.3 8.7 3.5 16.2 24.8 0.9 6.2 2.2 2.2 111.0 0.6 0.0 8.3 9.2 1.3 0.0 5.8 0.0 13.0 14.8 0.5 0.3 2.8 3.9 0.0 11.8 0.8 5.4 10.0 0.9 3.7 0.0 0.0 2.3 17.1 10.3 0.0 3.8 81.7 8.7 0.1 0.0 0.0 0.0 2.2 0.5 9.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 8.4 7.3 8.7 8.3 9.2 13.0 14.8 11.8 10.3 8.7 9.6 0.1 0.0 3.6 0.3 0.0 0.0 0.2 30.3 0.0 1.1 0.1 0.5 0.1 0.0 36.9 3.7 2.1 0.0 0.0 0.0 0.0 0.1 490.3 240.0 1.6 0.7 0.0 0.0 1.8 0.0 0.0 0.7 0.0 3.0 0.0 0.2 0.0 0.0 0.1 1.7 1.5 0.0 63.1 0.0 0.0 692.9 6.5 0.7 0.0 0.0 0.0 5.6 0.0 1.0 0.3 0.0 0.0 4.1 0.0 1.2 0.0 4.9 454.7 8.1 0.0 0.0 8.4 142.1 6.4 0.0 0.0 0.0 0.3 0.1 0.0 0.1 MPHOSPH9 MPP9 ENSG00000051825 "M-phase phosphoprotein 9" Q99550 12 123152320-123244014 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 114.7;Excitatory neurons: 87.7;Inhibitory neurons: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037485 Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus, Centrosome" "HPA037485: AB_10672792" "unprognostic (2.98e-2)" "unprognostic (5.00e-1)" "unprognostic (4.36e-3)" "unprognostic (1.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.81e-1)" "unprognostic (5.81e-3)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.53e-3)" "unprognostic (1.31e-2)" "unprognostic (2.75e-1)" "unprognostic (5.14e-3)" "unprognostic (1.17e-1)" 4.6 5.4 13.7 8.0 15.2 26.2 5.0 21.6 19.8 4.7 18.9 6.1 6.8 5.3 11.1 3.1 5.3 3.6 5.6 14.3 13.2 6.2 9.6 3.9 12.1 13.8 13.7 4.5 4.0 8.9 4.4 5.2 13.9 4.6 6.8 21.3 5.5 4.4 6.8 5.0 5.2 5.2 13.4 8.1 5.1 12.4 14.4 32.8 5.2 7.8 10.3 4.2 1.9 16.0 15.0 15.9 23.9 28.0 10.7 10.1 9.1 15.7 7.8 18.7 15.2 15.1 7.2 29.6 10.6 10.1 15.7 10.2 30.3 11.1 26.0 17.6 20.7 30.5 17.9 15.0 6.6 27.0 24.6 10.5 4.7 18.2 16.1 15.6 19.5 40.1 21.4 12.7 17.3 12.9 32.6 44.6 17.1 9.4 17.2 27.6 24.9 19.1 14.7 14.8 31.4 15.0 23.7 9.3 15.4 22.4 17.5 21.2 11.1 15.3 21.5 17.5 22.1 19.0 33.8 24.4 12.2 26.4 32.4 11.5 3.7 5.4 10.1 3.7 7.2 6.5 8.4 9.5 3.7 6.0 11.6 12.0 0.8 10.1 3.3 5.3 7.8 2.8 13.7 15.2 21.6 19.8 14.3 13.2 13.8 13.7 13.9 13.4 14.4 16.0 7.3 9.6 9.5 50.3 15.6 4.5 4.5 5.7 8.6 43.5 5.8 5.2 16.3 10.0 7.2 7.3 114.7 12.2 25.3 2.8 5.9 4.8 57.9 21.2 12.4 8.5 14.3 33.6 87.7 1.8 7.1 10.6 5.1 6.5 2.5 23.6 7.9 31.1 8.6 53.8 84.7 5.6 6.1 15.3 7.4 73.3 7.2 10.4 3.6 24.4 17.0 14.7 32.0 46.3 48.1 1.8 1.6 11.3 21.4 3.0 4.3 11.0 14.9 65.9 0.0 11.6 7.2 31.7 20.4 8.4 2.3 1.6 26.8 17.2 9.8 2.7 MPLKIP "C7orf11, ORF20, TTDN1" ENSG00000168303 "M-phase specific PLK1 interacting protein" Q8TAP9 7 40126027-40134622 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058457, HPA065463" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Golgi apparatus, Vesicles" "HPA058457: AB_2683724, HPA065463: AB_2685493" "unprognostic (5.59e-2)" "unprognostic (1.74e-1)" "unprognostic (9.40e-2)" "unprognostic (2.39e-2)" "unprognostic (5.55e-2)" "unprognostic (1.34e-3)" "unprognostic (2.73e-1)" "unprognostic (3.40e-2)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (3.16e-3)" "unprognostic (8.89e-2)" "unprognostic (1.61e-2)" "unprognostic (8.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-2)" "unprognostic (6.08e-2)" 2.9 3.8 2.6 2.0 2.6 2.4 2.8 4.7 3.0 2.8 3.0 2.8 2.2 2.6 2.0 3.1 2.5 1.2 2.1 2.6 2.3 4.2 8.0 2.1 2.6 2.4 2.3 2.8 2.9 2.5 3.0 1.8 2.6 2.5 1.8 3.1 2.7 1.5 2.4 3.0 2.6 1.1 2.0 3.1 2.4 2.3 2.5 3.3 3.0 1.4 2.0 2.5 2.7 4.0 8.2 2.5 4.8 6.6 4.3 4.9 4.9 3.1 3.3 4.4 4.3 3.1 4.0 6.8 4.2 3.0 8.7 10.3 3.0 5.3 5.6 5.2 9.2 5.4 3.7 6.9 4.9 6.7 5.2 4.8 6.7 3.4 4.1 4.5 5.1 7.5 13.1 5.5 4.4 4.1 6.8 20.4 6.7 6.7 7.4 9.6 3.3 8.9 5.0 2.1 7.1 8.4 5.0 4.8 7.7 6.2 6.1 9.3 5.5 2.8 7.5 3.6 4.7 8.6 9.6 10.9 4.4 10.5 7.6 20.6 11.2 16.8 8.0 10.8 9.0 16.9 10.1 9.4 11.8 15.3 11.3 9.9 9.2 10.6 10.4 13.1 14.2 13.1 2.6 2.6 4.7 3.0 2.6 2.3 2.4 2.3 2.6 2.0 2.5 4.0 49.8 51.3 34.5 6.5 53.3 110.1 96.2 151.8 58.6 43.5 53.8 66.2 18.0 67.2 79.6 58.8 25.0 110.8 41.3 60.3 117.4 66.6 118.4 73.6 62.3 58.0 48.6 52.2 7.4 54.6 79.7 51.1 35.7 56.6 51.3 63.6 47.2 133.4 69.0 53.8 8.1 63.4 85.5 59.3 62.6 38.6 75.8 50.4 58.7 7.5 74.6 52.9 66.9 12.1 12.5 59.9 97.2 55.3 36.3 76.2 61.6 190.5 91.1 50.1 52.6 57.1 58.4 66.6 53.9 67.1 134.1 95.6 46.8 125.7 82.3 105.7 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269855-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "bone marrow: 4023.1" "Cell type enriched" "Detected in some" 30 "Erythroid cells: 87.4" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "classical monocyte: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 94 "HL-60: 3517.4;NB-4: 4589.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" No NA 576000000 24000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.5 0.4 0.8 0.6 0.6 4023.1 0.3 0.6 1.1 0.0 0.3 0.2 0.0 0.2 1.1 0.1 0.1 0.3 1.1 0.8 0.7 0.2 1.8 8.4 1.7 0.9 1.0 0.1 0.1 0.0 1.5 1.4 0.9 0.2 0.2 0.4 66.3 0.1 1.1 4.3 0.2 0.3 0.8 21.7 0.1 0.4 0.8 10.9 0.3 0.3 0.2 0.5 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3517.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4589.9 0.0 0.0 0.0 5.3 3.2 0.6 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 4.0 0.0 0.0 6.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.1 7.5 0.8 0.6 0.6 1.1 0.8 0.7 0.9 1.0 0.9 0.8 0.8 0.7 0.0 0.0 0.5 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.9 0.0 0.5 0.1 0.0 0.1 0.0 87.4 0.3 0.2 0.9 0.7 0.0 0.0 0.0 0.0 0.7 0.3 0.9 0.0 0.2 0.0 0.0 1.2 0.0 1.3 0.0 2.9 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.3 0.1 0.0 0.1 0.6 0.0 0.0 0.0 MRPL4 CGI-28 ENSG00000105364 "Mitochondrial ribosomal protein L4" Q9BYD3 19 10251901-10260055 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 1034.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051261 Approved NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "HPA051261: AB_2681413" "unprognostic (3.33e-1)" "unprognostic (2.49e-2)" "unprognostic (8.92e-2)" "unprognostic (1.22e-2)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (2.48e-2)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" "unprognostic (2.39e-2)" "unprognostic (4.06e-2)" "unprognostic (1.01e-3)" "unprognostic (1.15e-3)" "unprognostic (7.60e-3)" "unprognostic (2.87e-1)" "unprognostic (3.03e-1)" "unprognostic (1.11e-1)" 42.5 65.9 35.6 27.6 36.4 37.5 40.2 37.2 51.2 36.3 33.4 49.3 33.1 41.0 8.7 73.2 37.3 12.2 83.6 35.4 35.4 54.6 90.9 31.0 30.8 39.4 35.1 49.9 31.8 25.9 35.7 21.8 39.3 38.9 13.4 8.7 38.3 21.1 79.1 62.0 40.5 14.9 33.1 46.5 45.1 31.4 37.2 19.5 40.4 49.3 19.4 45.4 42.8 37.2 146.6 81.9 34.4 95.2 26.9 35.6 76.0 66.3 41.4 86.7 70.6 138.1 55.2 215.6 148.5 36.5 51.3 128.0 71.6 93.2 26.6 80.4 302.6 181.0 62.6 136.4 80.9 136.1 96.7 46.5 63.1 58.7 54.2 27.2 53.4 97.8 155.7 100.8 33.7 213.0 189.6 1034.0 98.3 91.4 300.4 140.3 51.1 219.8 53.2 89.1 85.6 75.4 56.6 124.2 104.6 16.5 67.3 90.4 71.2 83.7 75.3 182.3 134.8 148.5 189.7 218.2 72.7 189.2 74.0 6.4 53.7 17.5 35.1 74.0 38.2 36.9 34.4 39.5 83.2 41.1 31.1 31.4 4.9 47.4 60.1 71.7 43.2 36.8 35.6 36.4 37.2 51.2 35.4 35.4 39.4 35.1 39.3 33.1 37.2 37.2 46.9 16.0 27.4 11.4 53.0 86.2 60.4 115.9 76.8 50.4 58.5 85.0 12.9 44.3 49.8 40.5 8.4 187.6 43.0 57.8 144.8 74.0 25.4 44.0 52.2 39.7 44.9 37.0 17.5 77.7 76.6 46.8 63.7 45.3 26.0 81.6 25.7 80.5 95.0 32.0 17.6 70.1 52.9 36.1 38.7 10.8 51.0 42.4 46.2 8.4 58.0 45.0 45.3 10.6 12.3 84.8 39.7 50.4 79.4 79.7 59.6 133.5 27.6 35.8 13.1 39.8 61.4 38.7 42.2 120.4 98.7 149.4 42.5 141.3 104.9 78.0 MSH5 G7 ENSG00000204410 "MutS homolog 5" O43196 6 31739677-31762676 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Meiosis" DNA-binding "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 18.8;Erythroid cells: 8.0;Gastric mucus-secreting cells: 10.7;Plasma cells: 10.7;Spermatocytes: 10.9;Spermatogonia: 8.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 3.1;NB-4: 5.2" HPA062688 Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Vesicles "Endoplasmic reticulum" "HPA062688: AB_2684835" "unprognostic (3.21e-3)" "unprognostic (2.32e-2)" "unprognostic (2.05e-1)" "unprognostic (4.37e-2)" "unprognostic (4.51e-1)" "unprognostic (9.20e-4)" "unprognostic (7.67e-3)" "unprognostic (2.57e-2)" "unprognostic (1.45e-2)" "unprognostic (2.05e-3)" "unprognostic (4.59e-3)" "unprognostic (2.28e-2)" "unprognostic (5.19e-5)" "unprognostic (3.75e-2)" "unprognostic (8.83e-2)" "unprognostic (9.21e-2)" "unprognostic (9.34e-4)" 1.3 1.2 0.1 0.5 0.1 0.7 1.5 0.1 0.4 1.7 0.2 1.6 0.0 1.4 0.0 2.2 1.9 0.0 1.0 0.1 0.1 5.6 2.0 1.4 0.6 0.1 0.2 2.3 1.6 0.0 2.2 0.0 0.1 2.9 0.0 0.1 1.6 0.0 0.6 1.8 1.8 0.0 0.1 2.4 1.6 14.0 0.1 0.0 1.5 0.0 0.0 1.6 1.7 0.2 0.3 1.1 0.4 0.9 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.1 1.0 3.1 0.4 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.7 1.1 0.1 0.6 0.0 0.3 1.3 0.0 0.0 0.1 0.3 0.5 0.9 1.2 1.9 1.6 0.0 2.1 0.5 5.2 0.9 0.9 0.0 2.1 0.1 2.4 0.3 0.5 0.2 0.8 0.3 0.2 0.0 0.0 0.3 1.8 0.0 0.3 1.6 0.1 0.6 0.3 2.1 1.7 0.0 0.5 0.8 2.5 0.4 0.0 0.4 0.3 0.0 1.4 0.4 0.1 0.1 0.6 0.1 0.1 0.6 0.1 0.6 0.8 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.4 0.0 2.3 0.0 3.6 0.5 0.5 0.3 3.4 0.7 0.5 0.5 0.3 2.8 0.8 3.7 18.8 0.6 0.5 1.0 0.0 0.2 0.1 1.6 1.3 0.6 1.2 8.0 0.0 0.2 0.4 0.9 10.7 2.8 3.8 3.1 0.4 0.3 0.5 0.0 0.0 1.2 0.0 0.8 1.3 0.5 1.2 1.5 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.5 0.7 10.7 0.5 2.0 0.8 0.9 7.3 0.0 1.0 1.4 10.9 8.3 6.2 0.4 0.5 2.5 0.9 1.9 0.4 MSMB "IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94" ENSG00000263639 "Microseminoprotein beta" P08118 10 46033307-46048180 "Cancer-related genes, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "prostate: 9384.0" "Cell type enriched" "Detected in many" 4 "Prostatic glandular cells: 10715.4" "Cancer enriched" "Detected in many" 42 "prostate cancer: 3435.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 25.6;NB-4: 21.6;RPMI-8226: 11.3;SH-SY5Y: 6.1;SK-BR-3: 5.9;U-2197: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB026357, HPA051257" Enhanced "Secreted in male reproductive system" NA NA 6000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" "CAB026357: , HPA051257: AB_2681410" "unprognostic (6.47e-2)" "unprognostic (7.21e-3)" "unprognostic (1.37e-2)" "unprognostic (8.18e-3)" "unprognostic (4.28e-3)" "unprognostic (9.24e-3)" "unprognostic (1.66e-1)" "unprognostic (8.66e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (2.01e-1)" "unprognostic (7.04e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.19e-4)" 5.1 4.5 0.0 3.0 0.0 0.1 20.5 0.0 0.0 3.2 0.0 2.8 10.3 0.3 45.1 12.3 4.6 3.0 0.5 0.0 0.0 1.8 1.8 29.9 0.2 0.0 0.0 0.3 2.3 0.2 0.5 0.6 0.0 9384.0 0.1 0.0 31.9 0.6 0.4 39.7 2.3 0.0 0.0 0.7 552.3 10.1 0.0 1.0 0.7 0.0 10.0 7.2 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 25.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 21.6 0.2 0.0 0.0 0.0 0.0 11.3 0.0 1.6 1.0 6.1 0.0 5.9 0.0 0.2 0.4 0.0 0.0 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.3 0.0 195.9 586.4 0.0 0.0 6.4 1.3 0.0 4.3 2203.2 0.0 0.0 2.1 0.1 0.3 0.0 0.1 48.9 0.6 0.0 10.7 0.0 0.0 0.1 0.2 0.4 9.5 404.2 0.2 1.3 0.0 0.0 1.2 0.2 0.0 0.0 0.8 419.1 0.0 0.0 78.8 0.3 30.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 29.6 0.0 0.8 10715.4 0.3 0.0 570.6 0.0 0.0 0.0 271.0 0.5 1.4 0.0 0.4 1.5 14.3 0.0 0.1 192.4 MTR cblG ENSG00000116984 "5-methyltetrahydrofolate-homocysteine methyltransferase" Q99707 1 236795260-236921278 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Methyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 100.0;Glandular and luminal cells: 130.9;Inhibitory neurons: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044474, HPA054915" Approved Supported Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 44: Endometrium - Transcription" Cytosol "HPA044474: AB_10966696, HPA054915: AB_2732589" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (6.96e-2)" "unprognostic (1.99e-1)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (4.87e-1)" "unprognostic (1.02e-1)" "unprognostic (2.48e-2)" "unprognostic (3.34e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-1)" "unprognostic (1.67e-2)" "unprognostic (8.84e-3)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (8.10e-2)" 9.1 6.6 4.3 6.9 5.4 4.6 8.0 5.2 5.4 10.1 6.5 11.1 4.8 10.2 10.5 5.0 11.9 8.9 15.0 4.9 4.6 12.7 6.0 7.1 8.1 6.7 5.3 14.6 13.0 20.2 6.4 11.6 6.9 7.6 5.0 5.6 6.4 9.1 16.6 9.3 7.1 8.7 4.8 9.4 9.0 9.0 4.8 10.0 13.4 18.1 7.0 10.3 7.6 6.5 17.6 11.0 13.0 8.8 22.6 20.3 15.3 14.9 14.8 18.8 19.0 12.6 12.5 40.0 13.2 16.6 8.7 10.6 18.4 13.1 20.4 19.8 13.7 23.7 14.2 18.3 15.1 37.2 13.3 28.9 7.0 22.9 17.9 11.5 22.3 19.8 33.1 16.4 13.1 10.1 19.6 10.3 16.2 12.9 5.4 20.9 24.8 24.2 11.2 21.3 11.1 27.8 17.7 11.9 14.8 9.3 16.7 13.0 28.8 24.1 9.1 19.6 18.8 34.4 12.3 22.7 17.2 21.1 26.2 0.6 0.5 1.5 1.1 0.8 2.3 0.7 1.4 1.4 0.7 0.8 1.4 1.5 0.0 0.9 0.5 0.5 0.9 0.9 4.3 5.4 5.2 5.4 4.9 4.6 6.7 5.3 6.9 4.8 4.8 6.5 23.0 57.7 35.0 53.8 25.8 8.2 8.3 8.3 17.1 0.0 10.7 11.9 100.0 20.0 10.9 40.5 0.0 24.2 25.9 3.4 1.9 13.8 9.8 57.5 80.1 21.4 8.4 23.5 87.7 14.8 9.2 22.8 15.8 130.9 30.4 35.0 15.4 10.8 14.4 0.0 106.8 7.7 4.1 16.6 6.8 6.2 23.9 17.1 10.6 47.8 15.3 0.0 19.6 62.8 73.6 12.3 8.0 33.1 20.3 14.9 9.7 9.1 13.3 0.0 6.6 39.4 23.2 17.2 22.0 11.5 5.1 22.6 26.1 40.2 12.0 6.4 MYO1F ENSG00000142347 "Myosin IF" O00160 19 8520778-8577577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 96.0;lung: 24.4;lymphoid tissue: 78.1" "Cell type enhanced" "Detected in many" "dendritic cells: 110.2;Kupffer cells: 235.4;Macrophages: 122.7;monocytes: 195.5;NK-cells: 616.9;T-cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 263.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 52.4;HL-60: 52.3;HMC-1: 87.9;NB-4: 210.2;THP-1: 154.3;U-937: 84.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055242, HPA056036" Enhanced Enhanced Cytosol NA NA 46000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "HPA055242: AB_2682754, HPA056036: " "unprognostic (4.86e-2)" "unprognostic (5.86e-3)" "unprognostic (1.39e-2)" "unprognostic (1.04e-3)" "unprognostic (1.76e-2)" "unprognostic (2.12e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (7.47e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.57e-1)" "unprognostic (9.35e-2)" 9.6 4.5 5.1 38.9 5.2 96.0 3.5 5.7 7.2 2.7 6.3 5.0 7.4 2.0 0.7 3.3 6.5 10.5 4.6 4.7 5.9 3.8 7.8 24.4 20.7 9.2 7.6 1.2 2.4 1.2 2.2 7.1 8.7 3.7 3.4 0.2 3.7 1.8 1.5 2.7 12.2 6.4 7.5 78.1 6.5 1.4 8.6 5.4 3.0 4.2 8.5 10.2 2.8 10.1 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.2 6.1 0.4 0.0 0.4 0.0 0.0 0.0 52.4 0.2 38.1 0.0 0.0 0.1 52.3 87.9 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.5 23.8 0.1 0.3 0.1 210.2 0.0 0.1 0.3 1.0 0.0 5.6 0.1 0.0 0.1 0.3 0.0 0.1 0.3 0.1 0.8 154.3 12.3 0.1 0.2 0.2 0.1 0.1 1.9 0.3 0.3 84.3 0.0 64.5 107.6 105.7 56.6 78.7 44.5 5.9 22.3 39.7 62.8 2.8 1.6 17.0 263.2 32.3 98.8 8.1 34.0 101.3 5.1 5.2 5.7 7.2 4.7 5.9 9.2 7.6 8.7 7.5 8.6 10.1 1.9 3.2 12.3 2.0 26.5 3.3 2.4 0.8 1.2 0.7 3.1 4.3 2.6 5.7 2.9 1.8 2.1 5.0 110.2 2.0 1.9 1.7 6.0 0.6 2.9 4.1 1.2 14.3 2.3 0.9 8.2 2.7 3.6 1.2 31.6 2.2 10.8 6.7 75.8 6.7 1.5 2.1 0.0 235.4 49.3 6.8 2.5 122.7 7.2 64.6 195.5 1.5 616.9 1.5 3.4 1.3 3.2 1.2 30.0 1.8 3.0 2.9 0.2 0.8 0.0 3.4 2.2 6.0 3.4 3.6 5.4 5.1 100.1 3.9 2.7 1.9 MYPOP P42pop ENSG00000176182 "Myb related transcription factor, partner of profilin" Q86VE0 19 45890023-45902613 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HDLM-2: 27.7;NB-4: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065307 Approved Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 47: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA065307: AB_2685460" "unprognostic (5.13e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.87e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.94e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (8.67e-5)" "unprognostic (1.28e-3)" "unprognostic (1.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.19e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-3)" 5.8 7.8 15.5 3.0 14.6 1.4 5.7 10.0 23.2 8.6 3.6 8.5 4.4 7.5 2.3 8.5 8.8 1.5 12.0 17.0 9.8 10.0 8.4 5.4 3.4 13.5 10.2 6.5 7.9 2.9 12.9 2.1 13.0 9.0 1.9 5.3 7.3 2.7 17.3 7.5 7.2 2.1 8.2 10.7 7.3 7.6 12.4 4.1 6.2 7.8 2.5 7.7 8.2 15.9 6.2 9.7 3.6 7.4 4.5 2.9 7.2 4.4 4.5 4.8 6.2 3.9 3.8 5.9 4.2 2.2 4.7 5.1 2.7 2.0 3.4 27.7 15.5 2.8 5.8 6.3 5.0 2.8 8.5 2.8 5.6 2.7 2.5 5.1 4.0 9.7 3.8 5.1 3.1 2.6 14.7 37.8 4.0 7.9 9.6 11.6 1.5 3.4 2.8 3.4 7.4 5.6 4.3 4.7 5.0 2.6 3.2 10.2 5.1 4.4 7.4 4.2 7.1 15.0 11.6 3.8 6.5 7.4 5.4 0.0 0.2 0.5 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 15.5 14.6 10.0 23.2 17.0 9.8 13.5 10.2 13.0 8.2 12.4 15.9 4.6 3.2 2.0 3.3 5.8 11.5 5.2 7.5 9.6 10.9 4.4 5.5 16.0 4.3 3.3 5.5 8.4 5.4 3.5 8.1 23.5 8.2 7.3 2.6 5.4 4.9 9.0 5.2 9.4 8.9 19.4 6.6 3.1 3.6 0.0 4.8 4.2 3.4 5.6 6.7 10.2 5.1 4.1 5.7 9.8 2.3 7.2 5.5 3.6 7.5 7.6 4.9 8.2 6.0 7.7 6.1 5.5 7.5 10.5 4.2 15.8 8.5 2.1 11.7 19.7 4.2 5.5 7.0 5.1 6.6 9.8 5.3 4.8 4.8 5.2 3.1 N4BP2L1 CG018 ENSG00000139597 "NEDD4 binding protein 2 like 1" Q5TBK1 13 32400723-32428311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 23.8;JURKAT: 22.2;NB-4: 61.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038971, HPA057219" Approved Approved Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 15: Liver - Metabolism" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA038971: AB_10673408, HPA057219: " "unprognostic (2.66e-3)" "unprognostic (2.38e-3)" "unprognostic (3.63e-2)" "unprognostic (5.32e-2)" "unprognostic (5.09e-2)" "unprognostic (3.40e-2)" "prognostic favorable (3.11e-4)" "unprognostic (6.91e-3)" "unprognostic (2.30e-1)" "unprognostic (9.37e-2)" "unprognostic (2.30e-2)" "unprognostic (1.20e-3)" "unprognostic (4.56e-2)" "unprognostic (1.04e-1)" "unprognostic (2.30e-1)" "unprognostic (3.29e-2)" "unprognostic (2.57e-3)" 24.8 11.9 34.0 14.9 33.8 49.5 26.9 32.9 41.1 23.7 32.3 20.3 15.6 19.5 16.1 11.2 26.3 12.6 12.4 34.2 36.2 15.4 85.6 30.2 26.6 29.0 31.1 45.2 20.3 8.6 37.1 13.5 28.4 21.7 14.6 7.9 12.4 11.6 13.8 27.5 21.1 13.0 28.9 30.1 13.8 4.4 37.2 32.0 17.0 9.7 17.9 16.6 20.5 32.7 0.9 0.3 1.3 0.5 5.0 4.0 0.4 0.6 2.2 1.2 2.0 3.8 5.1 10.3 1.4 1.1 3.7 0.1 3.7 0.3 1.6 15.5 2.3 23.8 1.4 11.4 7.8 9.0 1.4 2.8 0.8 1.0 1.0 9.0 0.8 22.2 0.0 18.3 1.0 0.8 18.6 61.4 1.9 0.0 0.5 17.5 0.6 8.8 4.9 1.8 3.4 4.2 3.7 0.1 1.7 2.4 0.5 16.8 0.4 0.5 0.3 0.3 0.1 10.4 6.6 0.5 0.6 3.4 0.7 59.0 49.3 13.9 18.0 47.2 15.9 28.6 17.5 22.4 43.7 33.0 23.9 20.8 12.5 32.1 34.4 56.0 27.9 36.7 34.0 33.8 32.9 41.1 34.2 36.2 29.0 31.1 28.4 28.9 37.2 32.7 46.1 44.8 27.6 53.2 51.4 30.1 29.6 8.7 23.9 10.6 26.6 22.6 4.3 17.2 16.5 5.5 0.0 22.3 74.8 5.5 9.8 15.0 22.5 23.0 5.7 36.1 37.9 25.5 71.7 8.5 1.1 26.2 6.1 4.8 8.8 16.0 21.0 67.2 22.5 0.0 60.4 9.2 24.4 46.6 102.7 22.7 27.4 54.6 30.2 40.3 110.2 7.2 47.4 72.9 43.4 4.4 12.5 22.2 38.4 24.5 25.8 9.8 8.1 2.2 78.9 48.9 40.4 1.4 2.8 15.2 35.4 10.4 44.0 2.5 12.9 16.5 NACA2 "MGC71999, NACAL" ENSG00000253506 "Nascent polypeptide associated complex subunit alpha 2" Q9H009 17 61590421-61591219 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 33 "testis: 64.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 143.4;Early spermatids: 418.0;Late spermatids: 155.3;Spermatocytes: 233.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 3.2;SK-MEL-30: 2.0" "HPA073152, HPA073648" Approved Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 83: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" Cytosol "HPA073152: AB_2686575, HPA073648: AB_2686621" "unprognostic (2.37e-1)" "unprognostic (1.50e-2)" "unprognostic (9.59e-2)" "unprognostic (5.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.45e-1)" "unprognostic (8.14e-3)" "unprognostic (4.91e-2)" "unprognostic (3.51e-2)" "unprognostic (1.18e-2)" "unprognostic (7.80e-2)" "unprognostic (2.08e-1)" "unprognostic (1.80e-2)" "unprognostic (6.88e-2)" "unprognostic (7.53e-3)" "unprognostic (5.45e-3)" "unprognostic (3.09e-3)" 1.0 0.9 0.0 0.5 0.0 0.2 1.0 0.0 0.0 1.1 0.0 0.9 0.1 0.7 0.0 1.1 0.7 0.0 0.9 0.0 0.0 1.1 0.8 0.7 0.4 0.0 0.0 1.9 1.1 0.0 0.7 0.1 0.0 1.0 0.1 0.0 0.8 0.0 1.0 1.4 0.7 0.1 0.0 0.7 0.8 64.1 0.0 0.0 0.8 0.0 0.2 0.7 1.0 0.0 0.3 0.0 0.3 0.3 0.1 0.2 0.9 0.0 0.3 0.1 0.2 0.2 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.3 0.3 0.1 0.1 0.3 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 1.0 0.0 0.1 0.4 3.2 0.7 0.0 0.1 0.4 0.2 1.1 0.1 0.0 0.3 0.7 0.2 0.4 2.0 0.0 0.8 1.1 0.0 0.1 0.4 0.6 0.3 0.3 0.3 0.3 0.4 0.2 0.2 0.1 0.3 0.1 0.2 0.7 0.3 0.4 0.3 0.3 0.4 0.4 0.4 0.4 0.0 0.3 0.7 0.4 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.0 11.2 69.3 60.6 15.0 0.0 0.7 2.2 3.2 143.4 35.8 5.2 1.8 0.0 17.5 11.7 2.9 86.1 0.3 418.0 0.5 1.1 17.6 3.6 2.7 3.4 0.8 24.1 18.5 0.0 0.6 0.0 0.7 26.4 15.1 14.5 0.0 4.0 9.1 10.2 50.7 66.3 155.3 33.8 8.2 46.2 1.0 23.7 1.5 23.7 1.5 3.5 0.6 11.1 11.3 0.0 48.1 8.1 62.1 2.9 0.9 13.1 63.8 107.3 233.8 11.4 0.0 79.3 24.1 16.3 1.1 11.8 42.9 NAPA ENSG00000105402 "NSF attachment protein alpha" P54920 19 47487637-47515091 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010100, HPA046149, HPA050196" Approved Uncertain Cytosol NA NA 2200000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "CAB010100: AB_628263, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (9.83e-2)" "unprognostic (9.43e-3)" "unprognostic (1.12e-2)" "unprognostic (1.76e-3)" "unprognostic (9.72e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (5.61e-2)" "unprognostic (2.42e-3)" "unprognostic (1.09e-3)" "prognostic favorable (4.26e-9)" "unprognostic (4.04e-2)" "unprognostic (4.17e-2)" "unprognostic (8.55e-2)" "unprognostic (2.90e-2)" 83.0 147.5 104.8 56.8 112.1 115.2 83.6 112.4 146.1 87.2 89.8 79.5 61.9 102.0 54.5 122.7 86.0 63.7 112.9 125.1 102.5 98.6 153.2 79.8 57.0 120.9 99.8 66.4 92.0 101.1 96.5 56.9 119.3 105.1 50.8 83.7 124.3 94.6 180.2 131.9 62.4 72.6 97.3 66.4 83.6 79.3 111.2 85.2 74.6 116.8 53.1 76.7 85.7 112.8 73.1 99.3 48.1 85.3 100.4 80.9 36.7 78.1 98.7 189.3 229.1 76.1 44.3 55.8 41.5 110.4 119.1 56.3 77.7 98.1 72.8 89.2 84.6 70.1 88.5 93.6 256.9 80.6 124.5 122.0 70.2 77.0 47.6 38.1 92.1 74.9 67.0 150.0 123.7 66.2 115.7 284.6 40.5 110.7 75.7 79.8 42.2 82.6 149.6 133.5 174.9 67.6 101.0 126.4 76.6 43.8 98.9 136.9 91.0 97.4 51.3 83.9 93.6 94.5 143.7 76.9 176.3 89.5 102.5 196.4 165.0 313.1 96.1 189.8 81.3 68.7 82.9 94.3 132.3 70.3 84.8 85.3 187.9 111.1 201.1 209.9 112.2 209.4 104.8 112.1 112.4 146.1 125.1 102.5 120.9 99.8 119.3 97.3 111.2 112.8 59.1 12.8 41.5 19.9 48.6 63.3 91.1 73.5 92.2 55.1 69.5 63.5 3.8 72.9 44.5 51.5 27.1 106.4 73.3 89.1 178.1 110.9 44.2 40.8 37.5 49.3 83.6 89.9 30.5 99.8 69.0 48.0 94.8 70.0 64.7 23.8 39.7 89.6 131.1 35.3 21.7 62.6 99.7 58.4 69.1 37.4 42.9 87.7 97.8 14.0 79.1 76.7 66.9 11.1 21.8 100.2 69.8 46.3 92.9 50.5 80.3 99.0 20.1 47.3 92.1 44.3 63.0 119.0 73.7 97.4 68.6 228.9 58.0 61.7 50.7 75.5 NCR3 "1C7, CD337, LY117, NKp30" ENSG00000204475 "Natural cytotoxicity triggering receptor 3" O14931 6 31588895-31593006 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 4.0;intestine: 5.6;lymphoid tissue: 16.1" "Group enriched" "Detected in some" 10 "B-cells: 43.6;dendritic cells: 110.4;NK-cells: 166.9;T-cells: 55.5" "Cancer enhanced" "Detected in many" "testis cancer: 2.6" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 274.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 2.0;HEL: 2.7;NB-4: 10.9;U-698: 1.7" "Low region specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (3.99e-3)" "unprognostic (9.23e-4)" "unprognostic (1.23e-3)" "unprognostic (2.49e-4)" "unprognostic (2.15e-1)" "unprognostic (2.57e-4)" "unprognostic (5.99e-2)" "unprognostic (1.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-1)" "unprognostic (1.81e-1)" "unprognostic (2.21e-4)" "unprognostic (1.72e-1)" "unprognostic (1.83e-1)" "unprognostic (8.17e-2)" "unprognostic (1.43e-1)" 0.5 0.0 0.0 2.9 0.0 4.0 0.2 0.0 0.1 0.1 0.0 0.4 0.3 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 1.0 1.8 5.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.2 5.6 0.0 0.0 16.1 0.4 0.7 0.1 2.0 0.3 0.0 4.9 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.2 0.5 0.0 98.8 0.1 274.3 65.2 12.1 53.9 0.3 51.8 5.7 30.1 0.9 76.6 0.6 0.6 20.3 31.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.7 0.0 1.9 0.0 43.6 3.4 0.0 0.0 0.6 0.0 0.3 0.4 0.1 0.0 1.3 0.0 0.0 0.1 110.4 0.1 0.0 0.0 0.5 0.1 0.2 0.5 0.0 2.7 0.0 0.0 0.2 0.3 0.5 0.1 8.9 0.0 1.4 0.4 0.4 0.0 0.0 0.0 0.0 2.5 2.9 0.2 0.3 1.2 3.6 0.0 1.6 0.0 166.9 0.0 0.1 0.0 0.1 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.6 0.7 0.1 1.7 0.1 55.5 0.0 0.1 0.0 NDUFB6 "B17, CI" ENSG00000165264 "NADH:ubiquinone oxidoreductase subunit B6" O95139 9 32553001-32573184 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 583.9;Distal tubular cells: 534.1;Early spermatids: 889.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044001, HPA053334" Supported Enhanced Mitochondria No No "Cluster 50: Neutrophils - Cellular senescence" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Mitochondria "HPA044001: AB_10959448, HPA053334: AB_2682116" "unprognostic (4.09e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.81e-2)" "unprognostic (1.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-3)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "prognostic favorable (7.47e-10)" "unprognostic (2.70e-1)" "unprognostic (1.82e-1)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" 38.6 50.8 42.7 30.7 45.3 31.0 35.9 47.1 48.1 34.1 42.8 41.8 44.6 38.1 26.8 43.8 36.0 17.6 144.9 44.5 46.5 73.6 66.7 30.5 26.9 44.5 42.9 29.7 31.0 41.8 40.3 22.5 44.6 28.5 29.1 30.7 37.0 22.0 168.0 28.2 43.6 26.7 45.9 28.8 43.5 53.5 44.3 28.7 33.2 101.8 24.5 34.1 33.4 47.1 106.4 63.7 69.6 80.1 46.7 43.0 44.5 69.5 56.5 62.8 68.8 62.8 46.5 78.4 70.5 48.2 65.1 58.8 66.5 76.8 47.0 108.6 106.0 187.2 88.8 65.9 45.2 94.4 46.3 44.8 36.7 56.8 42.9 47.5 57.6 118.4 61.0 86.1 71.9 61.2 128.1 221.2 73.6 90.7 140.1 86.7 58.4 73.1 72.0 39.3 69.7 78.4 80.2 91.1 50.7 52.0 86.3 72.0 51.4 67.9 103.8 75.7 103.8 38.0 77.0 131.5 113.7 65.6 32.7 126.3 97.6 136.1 76.9 94.3 74.5 106.0 81.4 80.0 108.8 89.0 82.3 87.4 302.1 91.9 116.3 152.7 112.4 110.2 42.7 45.3 47.1 48.1 44.5 46.5 44.5 42.9 44.6 45.9 44.3 47.1 69.5 125.0 111.6 15.3 76.2 94.2 106.2 222.9 90.0 44.1 64.6 72.6 583.9 101.5 141.4 108.5 6.2 191.8 69.4 115.8 534.1 172.5 889.5 106.9 86.1 101.0 64.6 196.7 21.8 166.7 143.0 109.5 83.6 86.4 90.5 64.3 74.3 182.2 160.8 18.5 23.8 152.5 209.5 55.0 96.4 146.9 91.6 78.4 160.1 3.7 108.6 115.3 90.6 18.1 21.3 144.4 124.9 89.9 165.7 80.0 201.0 520.3 152.3 56.5 105.2 94.8 151.3 182.0 125.9 139.7 96.7 104.1 81.0 95.6 167.3 103.8 NELFA "NELF-A, WHSC2" ENSG00000185049 "Negative elongation factor complex member A" Q9H3P2 4 1982717-2041903 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009960, HPA039858, HPA043931" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Nuclear bodies" "CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737" "unprognostic (1.66e-1)" "unprognostic (2.23e-1)" "unprognostic (3.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.32e-1)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (2.40e-1)" "unprognostic (1.12e-1)" "unprognostic (9.38e-2)" "unprognostic (2.74e-2)" "unprognostic (1.88e-3)" "unprognostic (1.58e-1)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (2.43e-1)" "unprognostic (3.05e-2)" 9.3 7.8 7.5 10.8 8.6 14.2 6.0 8.0 11.5 7.1 6.1 9.4 13.4 11.3 6.3 9.5 12.4 5.7 6.3 8.0 6.9 6.8 5.8 6.6 10.8 8.7 8.9 15.5 16.7 10.1 3.0 10.3 6.8 8.9 4.7 7.0 18.2 8.4 12.0 12.8 13.4 5.7 8.1 12.1 12.7 16.5 7.4 9.4 7.4 4.6 7.4 6.8 1.8 9.5 27.2 24.6 21.0 38.8 8.5 8.9 41.6 14.3 10.1 16.9 13.4 41.1 45.7 47.8 20.1 9.3 21.0 25.2 21.3 17.9 8.2 24.5 33.2 31.5 18.0 39.4 12.4 33.1 30.9 7.6 15.6 11.3 12.0 12.5 13.0 26.6 60.5 22.3 7.4 31.7 63.8 94.4 60.8 23.2 36.5 57.6 18.3 30.2 12.1 22.5 57.1 35.7 16.4 19.3 24.4 13.0 37.1 24.5 14.7 17.0 19.2 19.8 31.9 47.2 52.7 53.6 19.4 34.5 21.4 7.0 14.4 14.9 15.4 16.9 18.5 16.3 17.9 13.9 13.9 24.0 15.0 12.0 5.3 15.4 14.0 17.3 22.1 13.1 7.5 8.6 8.0 11.5 8.0 6.9 8.7 8.9 6.8 8.1 7.4 9.5 11.1 12.8 17.9 30.7 18.5 32.6 18.6 20.3 17.6 19.2 17.6 19.3 4.6 14.3 19.1 12.9 39.6 27.9 16.2 14.6 9.8 18.7 24.0 25.2 17.7 13.2 16.2 17.2 55.9 13.6 28.1 14.7 13.3 28.5 9.5 23.3 11.4 8.3 16.4 37.0 40.9 17.8 14.2 10.1 12.1 7.4 15.5 11.3 14.2 13.1 19.6 18.1 19.6 31.7 30.2 16.2 18.7 13.2 14.0 23.6 17.5 8.9 17.3 21.9 0.0 15.4 15.2 32.9 39.4 29.8 38.2 28.5 18.8 15.8 20.1 27.0 NFKBIE IKBE ENSG00000146232 "NFKB inhibitor epsilon" O00221 6 44258166-44265788 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002692, HPA005941, CAB010272" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478" "prognostic favorable (1.72e-5)" "unprognostic (1.43e-1)" "unprognostic (1.39e-2)" "unprognostic (2.37e-2)" "unprognostic (6.32e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (4.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-2)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (1.37e-6)" "unprognostic (2.61e-2)" "unprognostic (8.83e-2)" "unprognostic (1.37e-2)" "prognostic favorable (8.07e-4)" 6.8 5.8 10.9 19.1 10.8 31.5 5.9 12.1 17.6 4.1 10.7 7.2 7.4 3.7 4.7 5.9 3.3 8.3 5.3 11.3 10.6 16.1 10.5 13.6 19.9 11.5 11.4 2.7 8.3 5.3 4.5 5.5 11.2 8.3 5.9 3.7 7.4 3.3 3.5 9.9 12.1 3.6 11.7 35.0 7.0 10.7 11.8 9.9 5.3 3.9 25.1 16.3 5.0 12.3 28.4 7.9 9.5 15.1 3.7 2.8 5.3 4.9 23.8 14.9 15.4 15.0 12.9 15.7 17.0 5.1 39.7 6.2 10.3 15.4 16.6 26.1 6.0 7.9 3.0 17.0 11.4 26.1 23.0 7.1 6.7 13.8 8.8 12.5 10.7 7.2 7.7 39.2 3.9 14.4 5.2 52.7 5.0 44.1 4.0 9.9 8.5 14.0 34.7 30.3 6.1 7.8 3.4 12.5 20.9 8.0 8.6 29.9 18.1 8.4 9.8 5.3 15.4 25.0 11.4 28.7 7.4 28.4 16.1 8.8 7.5 4.0 1.6 9.4 3.2 8.6 2.2 1.5 6.6 6.5 1.0 1.6 3.0 0.8 11.1 8.1 3.1 1.7 10.9 10.8 12.1 17.6 11.3 10.6 11.5 11.4 11.2 11.7 11.8 12.3 7.5 0.0 9.7 1.0 26.0 38.2 28.7 11.6 14.8 3.4 15.3 9.9 5.4 22.8 9.2 3.7 2.1 5.2 12.5 12.2 17.6 49.5 17.3 10.0 6.2 15.9 14.9 1.7 1.1 21.0 8.0 17.3 10.7 12.8 32.5 2.5 6.1 2.0 57.2 3.3 2.0 11.9 6.1 22.6 151.2 34.1 1.8 48.6 48.0 3.7 55.2 3.3 1.0 0.5 0.9 58.9 33.3 2.6 18.7 32.6 14.3 14.4 6.1 4.1 6.6 11.8 11.0 25.9 12.3 11.6 39.2 5.3 13.8 7.0 8.5 34.7 NKD2 Naked2 ENSG00000145506 "NKD inhibitor of WNT signaling pathway 2" Q969F2 5 1008802-1038943 "Predicted intracellular proteins" "Exocytosis, Transport, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 42.1" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 6.8;Fibroblasts: 11.6;Langerhans cells: 7.1;Melanocytes: 7.2;Microglial cells: 7.5;Muller glia cells: 7.1;Spermatogonia: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 24.4;HEK 293: 14.4;MOLT-4: 7.3;NB-4: 13.4;REH: 8.8;RPMI-8226: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049463 Uncertain NA NA "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" "HPA049463: AB_2680777" "unprognostic (6.23e-3)" "unprognostic (2.82e-1)" "unprognostic (4.38e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (6.24e-3)" "unprognostic (5.87e-3)" "unprognostic (4.43e-1)" "prognostic unfavorable (9.97e-4)" "unprognostic (3.35e-2)" "unprognostic (6.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (2.66e-5)" "unprognostic (2.36e-1)" "unprognostic (1.48e-1)" "unprognostic (2.81e-2)" "unprognostic (1.52e-1)" 4.7 5.1 0.7 0.2 1.3 0.0 3.8 0.0 2.4 1.6 0.0 4.0 0.1 1.1 0.0 8.5 3.1 0.1 5.5 2.4 0.0 6.9 3.1 42.1 0.0 0.6 0.0 1.3 4.2 0.1 2.0 0.4 0.0 6.1 0.0 0.1 4.9 0.0 0.3 9.6 3.5 0.0 0.0 15.3 2.4 8.0 0.0 0.9 2.3 0.0 0.1 3.8 2.5 0.1 0.0 0.2 0.5 0.2 0.0 0.0 24.4 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 1.2 7.3 13.4 0.2 1.9 0.0 8.8 0.0 22.1 0.0 1.7 0.2 0.0 0.2 0.0 1.2 0.1 0.0 2.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 2.4 2.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 6.1 2.8 0.5 4.6 0.2 0.8 1.9 3.3 2.8 0.1 0.0 2.1 0.1 0.2 0.0 0.0 2.9 0.6 2.1 6.8 2.0 0.0 0.0 1.5 0.0 0.1 11.6 0.0 0.5 0.0 0.0 0.7 0.0 0.3 1.7 1.4 0.0 0.0 0.0 7.1 1.3 0.3 0.5 7.2 7.5 0.0 7.1 0.0 0.0 0.2 0.1 0.0 0.4 0.1 2.7 0.0 2.0 0.0 0.1 0.0 0.1 1.9 1.0 11.3 0.5 5.7 0.0 1.3 0.0 0.0 1.2 NKG7 "GIG1, GMP-17" ENSG00000105374 "Natural killer cell granule protein 7" Q16617 19 51371606-51372701 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 602.6;lymphoid tissue: 154.6" "Group enriched" "Detected in many" 4 "dendritic cells: 3163.4;NK-cells: 7721.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "gdT-cell: 6827.0;MAIT T-cell: 2871.2;memory CD8 T-cell: 4295.0;naive CD8 T-cell: 3114.2;NK-cell: 4796.8" "Group enriched" "Detected in all" 44 "NK-cells: 4796.8;T-cells: 6827.0" "Group enriched" "Detected in some" 5 "NB-4: 180.8;THP-1: 54.5;U-937: 46.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071454 Approved Vesicles NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA071454: AB_2686399" "unprognostic (1.56e-2)" "unprognostic (1.05e-2)" "unprognostic (6.54e-2)" "prognostic favorable (7.42e-6)" "unprognostic (1.27e-2)" "unprognostic (3.25e-3)" "unprognostic (2.96e-3)" "unprognostic (2.14e-1)" "unprognostic (3.22e-3)" "unprognostic (3.89e-3)" "unprognostic (3.39e-1)" "unprognostic (9.93e-2)" "prognostic unfavorable (3.32e-6)" "unprognostic (7.62e-3)" "unprognostic (2.61e-1)" "unprognostic (1.30e-2)" "unprognostic (6.44e-3)" 12.5 7.9 3.7 23.2 3.6 602.6 7.7 3.6 6.3 5.9 4.2 9.5 11.0 12.5 6.1 7.2 7.9 21.4 6.7 3.5 3.6 6.5 23.5 49.2 136.4 4.9 3.9 4.2 2.2 2.2 3.2 7.9 4.2 4.9 7.3 0.4 9.6 4.5 6.5 2.7 14.6 7.7 4.1 154.6 10.6 3.3 4.3 9.4 6.6 3.3 21.9 16.7 4.4 4.2 0.1 0.3 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.9 7.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.6 2.0 0.8 0.2 0.0 20.1 3.6 0.0 0.0 0.3 0.0 0.2 0.0 2.5 0.5 0.8 0.0 0.0 2.4 180.8 0.0 0.2 0.3 4.4 9.4 0.4 0.0 0.0 0.1 0.2 0.4 0.1 0.1 0.3 0.0 54.5 0.4 0.1 0.2 0.6 0.1 2.6 0.9 0.9 0.1 46.6 0.0 76.9 34.1 15.2 6827.0 131.7 2871.2 37.9 811.1 4295.0 87.1 15.4 261.0 3114.2 111.7 4796.8 104.8 67.1 17.5 4929.2 3.7 3.6 3.6 6.3 3.5 3.6 4.9 3.9 4.2 4.1 4.3 4.2 17.2 3.2 8.0 0.0 24.5 5.0 0.1 0.0 0.0 0.0 5.7 3.7 0.7 28.6 1.3 5.5 0.0 1.0 3163.4 1.9 3.9 1.0 0.2 2.7 3.6 7.1 0.0 186.5 0.0 0.0 0.8 5.2 17.3 4.2 24.1 0.2 55.3 9.9 15.0 0.0 0.0 0.5 0.0 132.9 10.2 0.3 0.0 55.5 17.8 1.0 49.4 0.0 7721.0 0.0 0.2 0.0 1.2 0.0 120.4 0.0 0.6 9.2 0.7 0.0 0.0 6.4 4.7 0.0 0.5 1.1 6.5 1.1 1321.5 0.0 1.1 0.1 NKX3-2 "BAPX1, NKX3.2, NKX3B" ENSG00000109705 "NK3 homeobox 2" P78367 4 13540830-13544508 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 18.7" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.2;Cardiomyocytes: 4.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.3;NB-4: 11.3;NTERA-2: 6.2;THP-1: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA027564 Approved Approved Nucleoplasm NA NA "Cluster 37: Intestine - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm "HPA027564: AB_10601973" "unprognostic (3.26e-2)" "unprognostic (1.26e-1)" "unprognostic (7.42e-3)" "unprognostic (5.97e-2)" "unprognostic (9.15e-3)" "unprognostic (5.72e-2)" "unprognostic (2.24e-5)" "unprognostic (3.49e-2)" "unprognostic (1.12e-1)" "unprognostic (4.06e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.93e-8)" "unprognostic (5.81e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" 1.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.9 0.0 18.7 0.6 0.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.1 0.6 0.0 0.0 0.4 1.0 0.0 0.1 0.2 0.0 0.1 1.8 1.4 0.0 2.3 1.8 0.7 0.0 0.0 0.2 0.4 0.0 0.0 1.4 0.0 0.0 0.4 2.0 1.8 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.9 0.0 4.3 0.0 0.0 0.0 2.2 0.6 1.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.5 1.4 0.0 0.6 0.0 0.3 11.3 6.2 0.0 0.5 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.9 6.6 0.0 0.5 2.5 0.1 0.4 1.7 0.0 0.0 0.4 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 NLRC3 "CLR16.2, FLJ00348, NOD3" ENSG00000167984 "NLR family CARD domain containing 3" Q7RTR2 16 3539033-3577403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 6.5;lymphoid tissue: 13.6" "Cell type enhanced" "Detected in many" "B-cells: 10.3;dendritic cells: 18.8;NK-cells: 37.0;T-cells: 23.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 8.8;HEL: 8.7;HL-60: 18.6;HMC-1: 9.0;JURKAT: 9.2;NB-4: 19.7;U-698: 28.9;U-937: 13.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA048062 Supported "Vesicles,Centriolar satellite,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "Vesicles, Centriolar satellite" "HPA048062: AB_2680242" "unprognostic (4.93e-3)" "unprognostic (3.84e-4)" "unprognostic (7.61e-4)" "unprognostic (4.94e-7)" "unprognostic (9.56e-2)" "unprognostic (3.76e-5)" "unprognostic (1.86e-3)" "unprognostic (6.70e-3)" "unprognostic (2.66e-2)" "unprognostic (7.02e-2)" "unprognostic (3.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.40e-2)" "unprognostic (5.13e-2)" "unprognostic (7.15e-3)" "unprognostic (4.54e-2)" "unprognostic (2.08e-2)" 1.0 0.8 0.3 7.8 0.4 4.1 0.7 0.8 0.7 0.9 1.0 1.5 1.7 0.9 0.4 0.8 1.2 1.4 1.5 0.3 0.0 1.3 1.1 2.4 13.6 0.3 0.3 0.7 0.5 0.2 0.9 0.9 0.1 1.1 1.2 1.1 1.1 0.3 1.1 0.5 6.5 0.5 0.0 11.8 2.1 0.9 0.3 11.3 1.5 0.9 11.1 1.5 0.8 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 8.8 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.2 8.7 0.1 0.0 0.0 18.6 9.0 0.0 0.0 0.0 0.0 0.5 0.2 9.2 0.2 0.0 0.0 0.4 7.7 19.7 0.0 0.0 0.1 5.1 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.1 4.9 0.5 0.3 0.1 0.2 0.1 0.4 0.2 28.9 0.2 13.6 0.1 2.9 0.0 0.0 2.3 0.0 2.1 0.8 1.7 2.2 0.0 0.6 1.4 1.5 0.0 2.6 0.0 0.0 2.0 2.1 0.3 0.4 0.8 0.7 0.3 0.0 0.3 0.3 0.1 0.0 0.3 0.1 1.7 3.2 0.0 1.0 10.3 0.0 0.3 0.0 0.0 1.6 0.4 0.3 4.6 1.5 0.6 1.8 4.2 0.0 18.8 0.0 0.0 0.0 4.0 1.3 0.8 2.3 0.0 6.5 3.8 0.0 0.0 0.5 1.5 0.7 2.5 0.2 3.9 0.1 0.1 0.0 3.7 0.0 0.0 1.0 0.0 1.3 0.0 1.1 0.0 1.9 1.3 0.3 37.0 1.0 0.6 0.0 0.0 0.0 6.2 0.1 0.0 0.1 0.7 5.1 0.0 0.9 0.7 0.5 0.3 0.0 0.0 0.0 23.8 0.1 0.0 0.3 NOP53 "GLTSCR2, PICT-1, PICT1" ENSG00000105373 "NOP53 ribosome biogenesis factor" Q9NZM5 19 47745546-47757058 "Predicted intracellular proteins" "Host-virus interaction, Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 605.5;Breast myoepithelial cells: 415.5;Cytotrophoblasts: 454.3;Exocrine glandular cells: 989.2;Extravillous trophoblasts: 570.3;Syncytiotrophoblasts: 506.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "B-cells: 311.8;NK-cells: 96.7;T-cells: 244.1" "Cell line enhanced" "Detected in all" "NB-4: 1305.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018999, HPA049600" Approved Supported Nucleoli NA NA "Cluster 37: B-cells - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoli "HPA018999: AB_1849733, HPA049600: AB_2680831" "unprognostic (2.08e-3)" "unprognostic (1.84e-1)" "unprognostic (4.02e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (1.56e-2)" "unprognostic (3.62e-3)" "unprognostic (1.89e-1)" "unprognostic (9.27e-2)" "unprognostic (2.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" 400.7 245.3 101.7 175.2 105.0 242.1 420.4 97.4 125.9 589.9 106.6 440.5 185.0 405.7 77.3 320.0 424.5 39.4 273.8 93.6 99.7 259.3 224.7 219.1 213.6 114.7 103.5 790.1 1016.5 123.0 201.7 78.4 105.4 386.3 64.1 70.2 397.0 104.5 308.6 635.8 333.6 60.1 108.4 358.9 445.3 116.5 107.3 225.3 302.8 110.0 128.3 411.8 422.5 105.6 99.7 103.0 90.7 214.6 110.6 184.2 176.8 60.6 110.5 57.8 85.3 95.5 194.8 440.3 87.0 71.2 44.2 139.8 52.9 88.8 30.2 133.0 177.8 142.6 85.1 113.5 163.0 207.4 271.6 162.5 198.9 50.8 136.1 188.0 92.3 183.1 176.8 206.5 52.3 86.9 577.2 1305.4 209.4 173.4 60.0 380.4 160.8 209.8 112.6 151.9 96.8 340.9 50.6 330.7 330.0 65.8 156.2 493.7 114.4 56.4 150.2 49.2 125.8 306.3 290.6 120.9 71.2 145.4 92.4 21.5 23.3 26.3 55.3 35.3 74.5 311.8 108.2 96.0 33.1 238.5 244.1 108.6 3.3 96.7 25.1 41.6 120.0 15.8 101.7 105.0 97.4 125.9 93.6 99.7 114.7 103.5 105.4 108.4 107.3 105.6 229.4 41.7 120.7 0.0 210.4 0.0 0.0 0.0 0.0 0.0 605.5 415.5 0.0 0.0 69.3 104.8 0.0 454.3 224.1 0.0 266.1 266.5 0.0 100.6 156.9 94.5 0.0 0.0 0.0 989.2 570.3 107.2 0.0 115.5 68.1 268.3 0.0 0.0 259.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.1 0.0 0.0 269.8 0.0 0.0 0.0 0.0 348.1 0.0 0.0 61.8 0.0 0.0 369.7 18.2 0.0 0.0 0.0 108.6 0.0 0.0 0.0 0.0 506.8 131.3 226.3 0.0 0.0 NPAS1 "bHLHe11, MOP5, PASD5" ENSG00000130751 "Neuronal PAS domain protein 1" Q99742 19 47019837-47045775 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3;skin 1: 7.7" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 16.7;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 28.3" "Cancer enhanced" "Detected in many" "testis cancer: 5.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 9.9;Daudi: 10.2;HEK 293: 11.1;HMC-1: 9.0;NB-4: 18.1;U-266/84: 11.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043364, HPA072259" Approved Approved Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA043364: , HPA072259: AB_2686500" "unprognostic (2.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.32e-4)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-3)" "unprognostic (2.21e-2)" "unprognostic (1.09e-1)" "unprognostic (3.75e-1)" "unprognostic (5.91e-2)" "unprognostic (2.64e-1)" "unprognostic (2.14e-8)" "unprognostic (8.82e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (4.20e-2)" 0.9 0.4 3.1 0.3 1.8 0.2 0.7 0.3 6.3 0.4 1.9 0.4 0.0 0.1 0.0 1.0 0.6 0.0 1.1 5.4 2.8 1.7 0.6 0.4 0.5 2.9 2.5 0.2 0.6 0.0 1.3 0.1 4.3 0.4 0.0 0.5 0.4 0.0 0.1 7.7 0.4 0.1 0.7 2.8 2.7 0.6 1.5 0.1 0.5 0.0 0.3 0.4 0.7 2.0 0.2 2.4 0.3 0.5 0.2 0.2 0.0 9.9 0.3 0.1 0.4 0.7 0.5 10.2 2.2 8.1 0.4 0.2 2.1 0.2 0.1 0.7 11.1 0.8 1.2 2.5 0.0 5.5 9.0 0.9 0.4 0.0 0.1 0.6 0.2 1.3 3.5 0.8 1.3 0.9 0.4 18.1 2.4 0.4 1.7 0.9 0.4 0.8 0.6 0.6 0.7 0.6 0.8 0.3 2.4 0.8 2.1 1.7 0.1 0.2 0.9 0.1 0.2 5.4 11.5 2.2 1.2 1.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.8 0.3 6.3 5.4 2.8 2.9 2.5 4.3 0.7 1.5 2.0 0.1 0.0 0.6 1.6 1.1 0.8 1.4 1.1 1.8 0.7 2.2 2.5 1.1 0.0 1.1 0.0 16.7 0.0 0.1 0.3 0.0 0.6 0.1 0.4 0.2 0.2 1.2 2.7 5.7 0.4 0.1 0.5 27.0 0.4 0.0 0.7 0.0 0.1 0.3 0.0 28.3 1.4 2.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 5.4 0.0 2.0 1.2 1.0 0.2 0.0 2.6 1.5 0.0 0.9 2.0 5.4 0.0 0.1 1.1 0.4 2.1 2.2 2.3 0.0 1.2 0.1 0.6 1.2 NPIPB11 ENSG00000254206 "Nuclear pore complex interacting protein family member B11" E5RHQ5 16 29381354-29404029 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Early spermatids: 17.5;Intestinal goblet cells: 9.4;Undifferentiated cells: 9.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (6.82e-2)" "unprognostic (2.99e-1)" "unprognostic (1.93e-3)" "unprognostic (1.42e-1)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "unprognostic (3.06e-1)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (5.57e-4)" "unprognostic (7.41e-2)" "unprognostic (2.94e-6)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "unprognostic (5.96e-3)" "unprognostic (4.79e-5)" 2.8 1.6 6.0 2.8 5.4 4.7 2.5 7.2 8.4 2.9 6.3 2.7 2.0 2.1 3.2 2.1 3.1 1.8 2.3 5.6 6.7 3.3 4.2 2.5 6.0 5.5 4.6 3.3 2.0 0.9 2.6 1.2 5.4 2.8 1.7 5.8 2.2 0.6 4.4 6.7 3.7 0.9 3.4 4.4 2.7 4.9 5.8 2.0 3.2 0.9 1.1 2.3 2.5 6.6 1.5 1.2 2.2 3.2 1.6 1.2 2.9 1.4 0.6 1.2 0.5 1.7 2.9 9.0 2.1 0.7 0.5 2.6 1.8 2.1 1.2 2.2 2.4 2.1 4.4 2.8 0.8 2.6 4.9 0.7 1.6 1.3 1.8 2.5 0.6 2.4 2.7 2.6 1.1 3.5 2.2 8.3 3.8 0.9 2.7 3.3 0.9 3.0 1.3 1.1 2.9 1.4 0.4 2.0 1.1 6.8 1.1 3.3 3.0 3.0 1.3 2.1 1.9 2.5 1.7 7.3 1.7 3.3 2.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.5 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.0 6.0 5.4 7.2 8.4 5.6 6.7 5.5 4.6 5.4 3.4 5.8 6.6 1.4 9.6 5.6 3.6 4.2 0.0 0.1 0.3 0.6 0.2 1.5 0.9 2.5 1.5 2.6 0.0 0.0 0.3 3.7 8.8 0.0 1.2 17.5 0.6 0.5 2.6 7.2 1.3 4.6 0.8 0.2 1.8 3.6 0.6 5.1 0.4 0.4 0.2 0.3 5.0 5.4 9.4 0.0 0.0 0.0 5.9 0.3 1.6 0.0 1.0 1.5 0.1 5.2 2.5 4.2 1.9 5.9 0.7 2.7 0.1 3.7 0.3 2.3 0.3 0.0 0.5 1.0 0.8 0.1 0.5 0.0 0.4 4.4 0.3 9.8 0.0 NPIPB12 ENSG00000169203 "Nuclear pore complex interacting protein family member B12" F8W0I5 16 29483642-29505999 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 198.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.5;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 29.3" "Group enriched" "Detected in all" 4 "B-cells: 8.4;granulocytes: 29.3;NK-cells: 14.2" "Cell line enhanced" "Detected in all" "NB-4: 166.4" HPA053611 Approved Approved Nucleoplasm NA NA "Cluster 11: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.83e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "unprognostic (7.92e-2)" "unprognostic (1.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.20e-2)" "unprognostic (2.42e-1)" "unprognostic (6.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.28e-7)" "unprognostic (3.32e-2)" "unprognostic (4.11e-2)" "unprognostic (2.33e-1)" "unprognostic (2.14e-4)" 25.4 21.7 135.6 40.5 135.5 63.7 21.9 136.7 198.1 30.8 109.8 27.5 24.0 24.0 38.5 24.8 27.5 24.8 29.2 127.2 143.6 31.8 58.2 27.5 57.0 128.7 140.4 26.9 24.2 15.1 26.3 20.4 128.8 33.3 25.6 32.2 34.5 20.0 44.3 108.9 33.6 19.7 105.7 51.2 23.5 29.1 137.3 28.1 28.8 15.5 29.8 26.7 24.2 131.2 26.2 26.7 20.6 52.8 24.7 14.7 40.0 15.7 4.4 7.8 6.7 23.1 52.5 43.8 27.4 13.1 15.4 34.5 35.2 25.3 10.7 28.1 25.6 33.3 36.0 46.5 22.2 36.1 61.5 23.0 19.5 17.6 18.5 19.9 9.0 24.3 34.5 37.2 12.7 42.6 26.6 166.4 31.5 17.6 19.3 61.6 9.1 42.7 19.1 18.6 21.9 15.4 8.9 36.5 22.5 9.2 18.7 43.4 22.4 49.9 19.2 34.9 30.2 19.5 21.3 42.7 20.3 63.9 23.9 29.3 3.5 1.4 3.9 1.2 1.0 3.7 2.3 2.7 2.4 8.4 3.1 2.1 9.5 14.2 3.0 2.6 1.8 1.3 135.6 135.5 136.7 198.1 127.2 143.6 128.7 140.4 128.8 105.7 137.3 131.2 0.0 3.2 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 NPIPB5 ENSG00000243716 "Nuclear pore complex interacting protein family member B5" A8MRT5 16 22479121-22536521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 57.1;Club cells: 50.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.52e-4)" "unprognostic (2.08e-1)" "unprognostic (2.32e-2)" "unprognostic (9.43e-3)" "unprognostic (3.96e-1)" "unprognostic (2.64e-3)" "unprognostic (2.40e-3)" "unprognostic (4.20e-2)" "unprognostic (1.65e-1)" "unprognostic (4.19e-2)" "unprognostic (1.09e-1)" "unprognostic (3.87e-2)" "unprognostic (1.90e-10)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (3.86e-2)" "unprognostic (3.76e-5)" 58.6 36.5 63.2 66.8 37.2 136.4 58.0 69.0 90.4 67.1 6.8 61.8 36.5 41.8 124.9 41.2 54.9 27.7 50.9 24.8 27.4 49.0 38.4 77.0 82.6 22.1 37.3 57.1 49.4 14.7 50.4 29.3 22.9 58.9 47.3 115.7 56.7 22.8 78.4 212.1 90.9 25.3 2.6 84.6 50.9 41.0 57.1 43.1 75.5 17.7 61.0 45.9 58.8 33.2 31.3 25.7 16.3 23.3 27.8 24.9 35.4 18.9 6.3 11.5 13.9 35.4 53.3 43.9 34.7 17.4 11.3 24.5 41.2 21.3 19.0 53.8 17.2 16.1 85.6 66.1 27.5 83.5 29.1 30.1 20.9 23.0 41.1 20.6 18.3 45.0 43.5 52.8 10.3 57.6 26.6 101.3 46.4 4.9 11.7 44.7 12.1 51.1 18.2 18.9 21.0 14.9 23.3 36.6 19.7 32.9 19.9 30.8 71.4 39.4 17.4 31.2 30.6 35.7 18.9 54.4 15.7 63.6 14.3 6.2 2.7 2.1 3.9 1.2 1.6 6.8 3.8 2.6 1.4 7.7 4.0 3.5 6.0 2.8 2.5 5.2 2.0 1.3 63.2 37.2 69.0 90.4 24.8 27.4 22.1 37.3 22.9 2.6 57.1 33.2 30.0 28.9 57.1 1.0 20.3 14.4 11.2 3.0 17.1 16.5 10.5 7.1 34.8 4.3 50.6 5.5 10.4 5.1 22.8 3.3 0.0 3.8 7.1 19.3 20.5 23.6 1.2 17.2 0.3 1.4 2.8 20.4 22.4 32.7 10.1 21.0 8.2 2.0 4.4 6.7 0.2 3.8 0.0 8.1 16.7 2.8 10.2 25.5 5.4 1.0 14.2 5.5 12.3 0.5 0.3 5.0 4.0 6.4 21.7 13.0 4.3 1.6 31.6 23.8 0.0 32.7 22.7 3.6 2.3 14.0 11.5 5.9 29.7 9.3 3.3 10.3 NRROS "ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030" ENSG00000174004 "Negative regulator of reactive oxygen species" Q86YC3 3 196639694-196662004 "Disease related genes, Predicted membrane proteins" "Growth factor binding" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.7" "Cell type enhanced" "Detected in many" "B-cells: 40.2;Erythroid cells: 27.5;Hofbauer cells: 76.9;Kupffer cells: 35.5;Langerhans cells: 59.9;Macrophages: 33.3;Microglial cells: 31.9;NK-cells: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 4.2" "Group enriched" "Detected in many" 6 "dendritic cells: 1.3;granulocytes: 4.2;monocytes: 1.1" "Cell line enhanced" "Detected in many" "HEL: 53.1;HMC-1: 106.4;Karpas-707: 66.7;MOLT-4: 59.8;NB-4: 138.5;RPMI-8226: 68.9;THP-1: 60.5;U-937: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031586 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 57: B-cells - Immune response" "HPA031586: AB_10601543" "unprognostic (5.28e-2)" "unprognostic (8.92e-3)" "unprognostic (1.02e-1)" "unprognostic (3.05e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-3)" "unprognostic (1.05e-1)" "unprognostic (9.67e-2)" "unprognostic (3.20e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (6.73e-3)" "unprognostic (1.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" 7.8 2.6 1.9 8.6 1.5 32.7 5.1 1.5 1.6 2.5 1.6 2.7 2.4 2.9 0.5 2.0 2.8 4.2 2.9 1.8 3.0 2.8 2.5 7.7 10.5 2.7 1.9 1.2 1.1 0.9 1.2 9.9 2.7 2.0 1.6 0.3 2.4 1.6 1.3 2.0 5.1 4.1 2.7 15.7 2.3 1.3 3.4 7.7 2.2 2.5 3.6 4.5 2.1 4.4 0.1 0.0 0.3 0.0 0.4 1.0 0.1 0.4 2.1 0.4 0.3 0.1 0.2 0.0 6.7 0.4 0.3 0.1 1.1 0.0 0.1 4.0 0.1 53.1 0.0 0.0 0.5 43.7 106.4 0.4 0.0 1.7 0.7 2.1 4.3 48.6 5.5 66.7 1.2 0.1 59.8 138.5 4.4 0.0 0.1 15.7 0.1 68.9 0.1 0.4 0.3 0.0 0.1 0.1 28.0 0.9 0.1 60.5 0.5 0.5 0.2 1.9 0.1 26.5 43.1 12.1 3.4 76.1 0.7 4.2 1.0 1.8 0.3 1.0 0.1 0.3 0.2 0.2 1.3 0.2 0.1 0.2 0.0 0.3 1.1 0.2 0.3 0.7 1.9 1.5 1.5 1.6 1.8 3.0 2.7 1.9 2.7 2.7 3.4 4.4 5.6 0.0 0.5 0.0 40.2 1.5 0.1 0.0 2.2 0.4 0.4 0.3 0.3 0.0 0.6 0.0 4.2 0.3 15.5 0.0 0.0 0.0 1.4 0.0 0.4 10.1 0.0 27.5 1.8 0.0 0.7 0.7 0.5 0.1 14.5 0.1 15.4 0.2 76.9 0.0 2.7 0.0 0.0 35.5 59.9 0.4 0.6 33.3 8.8 31.9 24.1 0.1 33.0 1.0 0.3 0.0 0.0 0.7 25.7 0.0 0.0 0.1 0.0 0.4 6.6 0.3 0.3 2.7 0.4 0.2 0.9 0.5 10.8 0.5 0.0 0.0 NTAN1 ENSG00000157045 "N-terminal asparagine amidase" Q96AB6 16 15037854-15056079 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 17.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 18.5;REH: 9.2;U-266/84: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051418 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Golgi apparatus" "HPA051418: " "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (6.69e-4)" "unprognostic (1.87e-2)" "unprognostic (9.16e-2)" "unprognostic (8.11e-3)" "unprognostic (2.79e-1)" "unprognostic (1.75e-1)" "unprognostic (5.05e-2)" "unprognostic (1.65e-1)" "unprognostic (9.30e-3)" "prognostic unfavorable (9.07e-4)" "unprognostic (4.35e-1)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" 38.6 10.2 3.6 0.5 3.9 2.2 28.1 3.8 8.9 25.3 2.1 30.3 0.1 20.7 1.4 19.4 18.8 1.2 19.3 3.4 3.7 15.9 15.2 21.6 0.7 3.8 4.1 19.7 11.0 0.5 6.5 0.4 4.1 20.2 0.3 1.3 15.8 0.4 24.5 21.6 15.6 0.8 2.9 20.5 17.9 20.3 3.7 0.8 13.5 0.6 0.4 27.8 21.8 3.5 3.6 0.0 1.8 0.7 1.2 0.6 0.6 6.2 2.6 1.0 2.8 0.0 0.0 3.2 2.5 4.7 1.7 0.1 0.9 0.7 0.9 5.0 5.9 0.3 0.0 0.0 1.1 1.7 4.3 0.8 0.4 3.4 1.5 1.5 1.3 2.6 0.5 3.2 0.9 0.3 5.3 18.5 1.1 0.0 0.2 9.2 0.1 1.3 1.2 0.0 0.7 2.1 0.0 0.1 1.5 0.4 0.0 0.6 4.1 1.1 3.8 1.1 1.1 4.2 10.1 2.5 1.5 1.3 2.2 4.9 1.3 17.5 2.8 1.7 3.0 4.2 3.4 2.6 1.9 3.8 3.9 1.3 1.6 3.8 2.0 5.7 5.9 3.1 3.6 3.9 3.8 8.9 3.4 3.7 3.8 4.1 4.1 2.9 3.7 3.5 79.7 3.2 3.9 7.8 24.7 33.6 16.4 24.1 7.4 6.1 20.2 33.4 3.2 12.8 13.8 18.4 10.4 77.4 30.4 25.1 45.0 49.3 48.9 8.8 29.3 55.0 6.7 25.3 12.6 23.6 23.8 51.3 8.2 12.7 8.8 22.0 62.8 23.0 116.6 25.2 15.6 7.2 30.5 75.0 48.3 32.4 83.0 53.9 58.7 12.2 46.0 15.2 37.0 3.0 6.6 56.9 14.6 75.2 37.6 21.2 9.6 38.6 6.0 9.4 39.5 20.8 52.3 33.3 30.7 16.0 21.7 56.9 25.6 23.5 13.5 23.9 NTNG2 "KIAA1857, Lmnt2, NTNG1" ENSG00000196358 "Netrin G2" Q96CW9 9 132161676-132244526 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 40.4;brain: 74.6;retina: 26.7" "Cell type enhanced" "Detected in many" "Astrocytes: 34.9;Bipolar cells: 69.6;Cone photoreceptor cells: 171.0;Rod photoreceptor cells: 108.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "basal ganglia: 74.6" "Immune cell enriched" "Detected in single" 5 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "HL-60: 6.8;HMC-1: 16.2;NB-4: 39.0;U-937: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071290 Approved "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA071290: AB_2686381" "unprognostic (5.01e-2)" "unprognostic (2.95e-2)" "unprognostic (4.12e-2)" "unprognostic (1.01e-1)" "unprognostic (3.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.73e-2)" "unprognostic (2.87e-1)" "unprognostic (4.86e-2)" "unprognostic (1.47e-1)" "unprognostic (2.62e-2)" "prognostic favorable (6.06e-4)" "unprognostic (9.30e-12)" "unprognostic (1.66e-1)" "unprognostic (3.23e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" 0.6 1.9 18.6 1.1 74.6 40.4 0.2 13.3 25.6 0.8 0.0 0.5 1.2 0.5 0.3 0.3 0.5 0.8 5.5 17.6 6.5 0.7 0.3 2.9 1.4 11.5 5.4 0.2 1.0 4.4 1.7 0.5 14.7 6.2 0.2 26.7 0.8 1.1 0.4 0.4 0.8 0.3 5.0 3.9 0.6 2.1 11.4 0.5 0.4 1.4 0.4 0.8 0.6 11.5 0.0 0.5 0.2 0.6 0.6 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.9 0.0 0.2 0.0 0.0 1.1 0.2 0.1 0.1 0.0 0.9 6.8 16.2 0.1 0.0 0.2 0.1 1.4 0.0 1.3 0.0 0.0 0.5 0.2 0.3 39.0 1.4 0.0 0.2 0.4 0.4 0.2 0.0 0.0 4.6 4.2 0.2 0.0 0.1 0.0 0.0 0.6 0.1 0.9 2.8 3.6 0.1 0.1 0.0 0.0 1.3 10.0 1.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 18.6 74.6 13.3 25.6 17.6 6.5 11.5 5.4 14.7 5.0 11.4 11.5 0.8 0.0 0.6 34.9 0.5 0.3 0.6 0.0 0.6 69.6 0.1 1.0 3.0 0.0 0.6 0.0 171.0 0.1 5.0 0.0 0.0 0.3 1.4 0.6 2.4 1.3 0.0 0.4 8.1 0.0 0.0 1.9 0.0 1.1 1.3 0.9 0.7 0.1 0.7 1.7 3.6 0.2 0.0 0.3 0.3 1.3 0.6 1.2 1.8 8.4 0.9 20.3 3.1 11.1 21.5 0.1 0.0 1.2 2.0 2.3 0.0 0.1 0.0 108.3 6.6 2.4 1.8 0.5 0.2 0.2 0.3 0.1 1.2 4.3 0.1 0.3 OLIG1 "BHLHB6, bHLHe21" ENSG00000184221 "Oligodendrocyte transcription factor 1" Q8TAK6 21 33070141-33072413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 178.0" "Cell type enhanced" "Detected in some" "Distal tubular cells: 64.6;Oligodendrocyte precursor cells: 371.5;Oligodendrocytes: 134.7" "Cancer enriched" "Detected in some" 18 "glioma: 116.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 12.1;eosinophil: 37.6" "Lineage enriched" "Detected in many" 15 "granulocytes: 37.6" "Group enriched" "Detected in some" 6 "NB-4: 39.2;RPMI-8226: 20.8;THP-1: 25.5;U-937: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 24: NB-4 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "unprognostic (4.13e-2)" "unprognostic (6.46e-2)" "unprognostic (4.06e-1)" "unprognostic (3.58e-1)" "unprognostic (9.01e-3)" "unprognostic (2.40e-1)" "unprognostic (7.93e-2)" "unprognostic (1.50e-1)" "unprognostic (3.82e-3)" "unprognostic (5.19e-2)" "unprognostic (8.17e-2)" "unprognostic (2.51e-1)" "unprognostic (4.05e-2)" "unprognostic (5.96e-3)" "unprognostic (3.20e-2)" "unprognostic (1.17e-1)" 0.0 0.0 126.5 0.1 168.1 0.8 0.0 132.7 127.3 0.0 34.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 103.6 121.3 2.8 0.1 0.7 0.0 154.2 156.5 0.0 0.1 0.0 0.5 0.0 128.1 0.0 0.0 0.0 0.2 0.0 1.3 0.8 0.1 0.0 118.4 0.6 0.2 2.0 144.5 0.0 0.0 0.6 0.0 0.1 0.0 178.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 2.6 0.7 0.0 0.0 0.0 0.0 1.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 39.2 0.2 0.0 0.0 0.0 0.1 20.8 0.0 0.0 1.3 0.0 0.0 0.0 4.7 0.0 0.2 25.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 29.1 1.6 12.1 2.4 37.6 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 2.5 0.1 0.0 0.6 126.5 168.1 132.7 127.3 103.6 121.3 154.2 156.5 128.1 118.4 144.5 178.0 0.0 0.0 0.0 13.7 0.3 0.0 0.1 0.0 0.0 0.0 0.9 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.6 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 1.8 0.0 0.0 3.2 0.0 0.5 0.0 2.4 5.4 1.0 24.1 0.0 1.0 371.5 134.7 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.4 0.0 2.7 3.3 0.0 0.1 0.1 0.1 0.0 0.0 0.1 ORAI1 "CRACM1, FLJ14466, TMEM142A" ENSG00000276045 "ORAI calcium release-activated calcium modulator 1" Q96D31 12 121626550-121642677 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 60.1" "Cell type enhanced" "Detected in many" "dendritic cells: 92.3;NK-cells: 88.6;Theca cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 81.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016583 Approved NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA016583: AB_1848720" "unprognostic (2.22e-2)" "unprognostic (3.78e-3)" "unprognostic (7.82e-3)" "unprognostic (8.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.99e-3)" "unprognostic (4.25e-3)" "unprognostic (1.92e-1)" "unprognostic (2.00e-2)" "prognostic favorable (4.30e-4)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "unprognostic (6.84e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" 10.8 5.4 4.4 9.6 4.6 8.8 10.9 5.2 6.8 7.3 22.1 10.6 20.8 7.6 0.0 8.7 7.7 3.3 9.3 3.8 4.9 11.2 12.3 15.5 12.0 5.5 4.9 6.7 8.1 8.7 2.6 4.5 5.5 6.4 0.3 0.0 15.6 2.6 60.1 46.6 13.8 2.2 5.4 23.1 12.5 11.5 5.1 6.1 10.4 14.0 2.8 11.1 7.8 5.1 18.3 42.0 3.4 16.9 4.0 4.9 18.4 20.5 2.9 8.8 4.7 33.1 16.2 13.3 31.4 3.1 11.8 30.2 3.4 13.7 0.0 41.9 7.8 23.9 6.8 16.6 10.1 18.5 43.7 2.0 5.1 14.4 0.9 4.9 12.9 30.0 16.8 6.9 2.3 41.4 46.1 81.7 19.6 10.3 35.7 16.8 7.9 20.5 5.0 13.4 16.4 3.3 10.7 11.7 17.5 0.2 29.3 11.6 23.5 21.0 8.4 28.6 15.9 9.4 8.7 5.6 15.7 25.9 19.1 9.4 6.3 8.2 18.6 5.4 13.9 6.3 15.4 18.8 7.5 9.0 14.3 12.5 6.9 7.5 5.2 1.9 13.7 7.6 4.4 4.6 5.2 6.8 3.8 4.9 5.5 4.9 5.5 5.4 5.1 5.1 32.0 28.9 16.4 1.0 41.0 22.6 10.1 3.4 6.8 2.1 48.4 22.9 4.2 18.6 10.3 1.8 4.2 3.7 92.3 8.4 1.9 13.3 3.4 14.1 11.1 40.6 2.4 23.8 0.3 19.5 15.2 9.5 8.6 17.4 7.0 24.0 43.2 17.9 38.6 0.0 0.5 9.3 2.0 28.2 65.0 11.8 13.4 42.8 21.4 4.7 27.2 5.8 88.6 3.0 1.5 29.5 6.3 9.4 30.5 14.8 17.2 12.1 6.3 6.9 0.0 6.3 10.8 1.7 6.0 6.9 37.4 7.8 70.3 86.0 20.1 10.7 OSBPL5 "KIAA1534, OBPH1, ORP5" ENSG00000021762 "Oxysterol binding protein like 5" Q9H0X9 11 3087107-3166739 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 34.6;Horizontal cells: 62.2;NK-cells: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.6;gdT-cell: 9.0;intermediate monocyte: 4.7;memory CD8 T-cell: 3.3;myeloid DC: 3.0;naive CD8 T-cell: 3.4;NK-cell: 11.0;non-classical monocyte: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038335, HPA038712, HPA058727" Approved Enhanced Vesicles NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (3.69e-2)" "unprognostic (8.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (4.03e-3)" "unprognostic (1.29e-1)" "unprognostic (3.49e-3)" "unprognostic (2.16e-3)" "unprognostic (9.44e-2)" "unprognostic (2.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.50e-2)" "unprognostic (7.67e-2)" "unprognostic (2.60e-1)" 22.0 8.0 7.1 7.2 7.7 13.6 19.2 7.8 11.5 42.2 2.1 28.2 5.9 26.6 2.9 12.5 22.3 5.0 14.9 5.2 6.4 13.5 3.1 17.5 2.4 50.3 13.3 14.5 10.4 2.3 10.3 5.0 56.0 25.6 3.2 1.8 16.4 9.9 9.9 25.9 16.6 7.6 5.4 24.9 15.5 3.3 19.8 22.0 14.9 5.9 1.4 24.6 28.3 10.5 3.7 5.6 6.6 7.6 18.9 8.8 0.1 17.9 8.8 7.1 5.0 0.0 10.4 0.0 5.3 10.1 4.9 13.3 1.3 5.0 1.1 3.5 6.0 15.1 19.2 0.0 15.9 13.6 2.3 13.9 5.7 2.5 2.6 5.2 4.8 26.7 5.5 0.0 3.5 10.3 30.7 75.5 4.8 2.4 11.5 15.9 9.0 2.2 3.0 3.3 10.8 1.3 7.6 26.1 7.0 3.7 10.8 35.9 16.4 8.8 12.1 21.2 3.1 3.8 0.0 0.5 9.5 25.3 11.5 0.2 3.6 1.2 9.0 4.7 1.2 0.0 0.9 3.3 3.0 0.0 0.6 3.4 0.4 11.0 11.5 1.3 0.1 5.2 7.1 7.7 7.8 11.5 5.2 6.4 50.3 13.3 56.0 5.4 19.8 10.5 19.5 0.0 5.5 8.1 0.5 4.8 2.6 4.2 5.2 11.5 7.7 5.2 6.9 2.8 4.8 3.7 8.4 0.4 34.6 8.3 1.9 3.0 0.1 2.2 22.1 12.1 0.0 5.7 25.6 2.0 0.6 12.3 5.1 2.5 1.3 3.5 3.9 0.5 1.7 62.2 20.6 8.0 2.0 8.7 3.1 1.2 9.0 3.9 3.6 17.8 2.3 4.1 56.7 20.1 28.2 2.2 8.5 17.0 4.9 3.2 6.1 3.2 5.5 1.2 13.1 7.4 11.4 0.1 0.6 3.8 6.8 0.0 9.1 2.5 8.2 2.5 PATE1 PATE ENSG00000171053 "Prostate and testis expressed 1" Q8WXA2 11 125746279-125749867 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "epididymis: 1868.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;NB-4: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA076587 Approved "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" "HPA076587: AB_2732316" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1868.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 209.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCGF3 "DONG1, FLJ36550, MGC40413, RNF3, RNF3A" ENSG00000185619 "Polycomb group ring finger 3" Q3KNV8 4 705748-770640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061879 Approved Supported Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA061879: AB_2684631" "unprognostic (1.24e-1)" "unprognostic (2.77e-1)" "unprognostic (2.62e-1)" "unprognostic (1.06e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.73e-4)" "unprognostic (2.76e-2)" "unprognostic (4.21e-2)" "unprognostic (9.52e-2)" "unprognostic (1.47e-2)" "prognostic favorable (1.44e-4)" "unprognostic (2.36e-2)" "unprognostic (6.84e-3)" "unprognostic (2.53e-1)" "unprognostic (2.20e-1)" "unprognostic (1.96e-1)" "prognostic favorable (5.25e-4)" 32.7 45.1 17.9 15.5 18.5 30.1 34.7 30.6 19.5 41.9 16.7 31.7 22.6 35.3 8.7 35.5 33.6 14.0 27.2 18.9 17.0 31.7 29.7 34.7 18.3 18.1 17.2 50.4 27.8 7.8 31.4 19.8 17.5 38.3 10.3 13.3 37.4 9.7 18.4 53.3 36.2 10.7 16.2 51.0 32.1 23.3 17.9 18.6 34.6 11.4 11.8 27.2 39.4 24.1 22.1 19.6 35.3 40.4 15.8 16.2 43.3 29.2 15.9 23.5 23.7 21.5 23.8 15.7 19.1 28.3 23.8 14.9 16.5 23.7 17.8 20.8 17.9 22.6 24.2 38.4 19.3 15.5 28.9 20.5 31.0 20.5 9.3 15.4 30.5 28.2 31.5 12.6 23.3 24.6 41.8 54.6 23.4 14.9 35.0 41.0 22.4 10.1 14.1 35.6 50.2 37.9 15.2 16.1 16.1 22.7 31.5 21.8 36.9 22.8 18.4 19.2 38.1 30.1 27.6 24.6 18.0 24.5 43.0 3.4 7.1 3.1 3.3 5.1 2.8 4.2 2.0 2.1 3.2 5.0 2.5 1.7 4.5 4.7 2.2 4.6 3.3 2.3 17.9 18.5 30.6 19.5 18.9 17.0 18.1 17.2 17.5 16.2 17.9 24.1 29.5 12.8 28.8 19.6 12.5 25.4 17.3 17.2 25.0 12.3 28.3 21.3 21.7 17.2 21.8 9.2 12.5 13.4 13.5 21.4 3.9 20.6 52.0 17.7 28.7 27.8 19.2 9.1 18.1 19.8 30.0 17.8 35.2 21.2 16.5 22.4 25.4 15.3 12.2 6.7 18.6 21.7 20.3 15.1 21.0 54.4 16.4 20.1 23.2 23.4 14.3 9.1 16.5 27.2 22.8 32.7 19.3 15.4 22.9 24.0 19.1 9.4 14.0 8.5 6.6 18.8 18.8 19.0 25.6 22.5 28.7 23.7 13.3 20.8 20.2 38.2 PCLAF "KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15" ENSG00000166803 "PCNA clamp associated factor" Q15004 15 64364304-64387687 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 128.6;lymphoid tissue: 73.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 82.2;Extravillous trophoblasts: 160.2;Granulosa cells: 48.8;Hofbauer cells: 110.2;Syncytiotrophoblasts: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 4 "T-reg: 23.6" "Lineage enriched" "Detected in many" 4 "T-cells: 23.6" "Low cell line specificity" "Detected in all" HPA047929 Supported Centrosome NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Centrosome "HPA047929: AB_2680215" "unprognostic (5.34e-2)" "unprognostic (1.36e-3)" "unprognostic (9.39e-2)" "unprognostic (1.28e-1)" "unprognostic (4.16e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (4.38e-3)" "unprognostic (1.91e-3)" "unprognostic (7.26e-2)" "unprognostic (2.56e-3)" "unprognostic (9.65e-2)" "prognostic unfavorable (9.77e-15)" "unprognostic (5.59e-2)" "unprognostic (2.05e-1)" "unprognostic (8.65e-2)" "unprognostic (3.22e-1)" 2.1 1.4 0.9 22.9 1.0 128.6 3.9 1.4 1.1 1.7 0.8 19.0 14.7 4.5 1.2 15.2 1.3 2.5 0.4 0.9 0.6 1.2 3.6 2.5 49.5 1.0 0.8 0.4 1.9 0.8 0.5 8.7 0.9 2.0 22.6 0.3 2.3 0.3 0.4 6.7 15.8 5.0 0.5 7.4 8.1 1.1 1.0 73.8 2.2 0.1 47.1 7.9 4.9 1.9 212.6 165.8 154.4 140.8 15.9 60.9 134.4 146.2 84.8 185.4 276.4 198.4 202.1 343.7 46.4 57.4 64.8 153.6 340.7 83.1 235.3 192.5 124.8 352.5 202.5 209.8 1.5 285.3 153.8 20.0 7.9 156.4 31.9 52.3 168.9 175.9 201.3 104.4 248.1 187.8 268.0 605.5 73.9 179.9 73.4 416.6 353.8 247.1 115.9 200.2 19.1 86.7 112.8 105.2 69.3 78.9 153.8 365.3 36.3 158.4 308.6 177.8 386.7 65.5 223.4 229.0 67.7 512.9 108.5 2.4 0.3 0.9 1.4 0.2 0.2 2.0 4.4 4.2 2.8 0.6 0.5 1.0 2.7 5.7 0.4 0.3 23.6 2.3 0.9 1.0 1.4 1.1 0.9 0.6 1.0 0.8 0.9 0.5 1.0 1.9 0.5 9.6 11.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 27.5 25.5 0.0 0.0 5.0 1.8 0.0 82.2 8.3 0.0 1.9 6.5 0.0 18.6 10.4 8.5 0.0 0.0 0.0 3.0 160.2 25.4 0.0 13.8 3.8 48.8 0.0 0.0 110.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 4.3 0.0 0.0 3.0 3.6 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 42.1 5.8 7.6 0.0 0.0 PCMTD2 "C20orf36, FLJ10883" ENSG00000203880 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2" Q9NV79 20 64255695-64287821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 180.5" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 138.2;Rod photoreceptor cells: 181.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057849 Approved Approved Nucleoplasm,Mitochondria No No "Cluster 20: T-cells - T-cell receptor" "Cluster 77: Retina - Visual perception" "Cluster 24: NB-4 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" Mitochondria Nucleoplasm "HPA057849: AB_2683544" "unprognostic (2.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (2.88e-2)" "unprognostic (2.23e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.07e-1)" "unprognostic (4.07e-2)" "unprognostic (1.90e-2)" "unprognostic (1.40e-2)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-1)" "unprognostic (3.46e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-3)" 31.4 33.6 27.2 22.9 31.0 17.8 37.5 40.2 40.7 36.7 28.3 25.3 23.3 39.2 49.2 22.8 29.0 32.5 42.5 27.1 30.5 34.2 32.1 24.0 41.6 27.1 25.9 57.0 27.0 27.7 31.8 41.2 25.3 29.5 20.3 180.5 32.3 18.3 44.6 66.0 25.0 19.0 24.9 36.3 21.7 24.7 28.4 39.5 27.1 32.9 29.6 20.6 28.1 38.9 22.9 8.5 32.0 25.0 30.1 37.1 30.1 13.6 15.1 19.7 12.0 19.4 35.9 33.8 23.5 16.6 15.6 27.6 17.6 22.4 26.5 7.4 23.0 16.4 42.1 32.9 25.3 16.9 24.0 52.7 30.5 10.4 17.9 35.1 29.1 34.0 30.4 29.8 16.3 14.8 39.8 56.7 23.5 31.6 31.7 32.6 12.6 41.1 30.0 26.1 50.0 58.9 26.1 30.1 37.2 49.4 32.2 34.1 21.2 29.4 10.3 18.9 11.3 35.8 31.3 32.9 19.5 17.9 16.1 10.1 7.9 9.4 9.4 5.4 11.2 10.2 14.0 10.7 9.0 10.7 19.2 14.2 10.2 17.4 5.3 5.4 22.6 9.8 27.2 31.0 40.2 40.7 27.1 30.5 27.1 25.9 25.3 24.9 28.4 38.9 40.8 22.4 26.9 25.8 21.0 20.4 15.6 10.2 31.3 118.5 27.5 18.0 67.4 28.6 17.5 29.5 93.8 33.7 21.9 6.7 23.5 8.4 13.2 21.3 23.2 36.6 22.8 35.3 34.8 9.1 7.0 34.8 17.9 26.4 12.7 33.5 45.0 36.7 14.4 37.0 29.5 15.9 14.2 28.8 10.7 9.5 42.9 17.3 48.0 21.5 19.2 61.3 20.6 138.2 64.6 9.9 15.7 30.9 20.2 14.6 12.0 23.3 24.3 181.9 26.3 25.0 27.7 51.7 37.7 24.9 21.3 21.9 21.6 63.1 15.2 11.3 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 53.4;retina: 33.3;testis: 112.4" "Cell type enriched" "Detected in many" 4 "Late spermatids: 4139.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 53.4;white matter: 16.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 8.4;Karpas-707: 4.2;NB-4: 17.7" "Region enriched" "Detected in many" 44 "cerebellum: 2160.4" "Region enriched" "Detected in all" 28 "cerebellum: 552.9" HPA057428 Approved "Nuclear speckles,Vesicles" Yes NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 21: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear speckles" Vesicles "HPA057428: AB_2683436" "prognostic favorable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favorable (2.76e-5)" 0.4 1.6 0.4 1.1 0.6 3.7 5.5 53.4 2.3 2.1 0.0 0.6 1.4 0.9 3.3 2.0 2.4 2.3 2.2 0.5 0.0 8.0 3.7 2.2 3.0 0.1 3.5 0.1 5.4 1.1 1.4 0.4 5.5 5.9 0.3 33.3 16.3 1.9 0.2 7.0 1.6 0.0 0.1 3.0 3.1 112.4 0.0 3.1 5.7 0.0 1.4 0.9 1.6 16.8 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.6 0.7 1.1 0.0 0.0 1.3 0.0 0.2 0.0 0.8 0.6 2.6 2.8 0.1 0.0 0.3 8.4 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.2 4.2 0.0 0.3 0.3 17.7 0.4 0.3 0.0 0.8 0.2 0.7 0.8 0.1 0.1 0.0 1.4 1.4 0.0 0.4 3.7 3.4 0.2 0.0 0.5 0.4 0.0 1.4 0.7 0.2 0.0 2.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.1 0.1 0.1 0.2 0.3 0.2 0.3 0.8 0.2 0.0 0.6 0.0 1.7 0.4 0.6 53.4 2.3 0.5 0.0 0.1 3.5 5.5 0.1 0.0 16.8 0.1 0.0 2.3 0.0 0.2 0.8 1.1 1.4 0.0 734.7 7.7 5.8 0.0 2.8 1.8 5.5 22.9 0.2 2.7 0.7 9.8 0.8 836.5 1.0 0.1 2.6 0.0 0.0 0.0 0.2 0.1 0.1 0.0 1.5 1.3 1.3 0.0 0.5 0.4 23.5 0.0 0.4 0.0 0.8 1.3 4139.3 10.5 7.1 1.8 1.0 1.5 40.7 2.1 0.0 0.0 0.4 0.1 13.2 0.3 1.0 1.3 0.5 0.4 100.3 19.7 0.0 0.1 14.5 9.0 0.0 1.1 0.0 1.0 0.0 0.6 0.6 PHKG1 PHKG ENSG00000164776 "Phosphorylase kinase catalytic subunit gamma 1" Q16816 7 56080283-56092996 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "skeletal muscle: 264.6;tongue: 172.3" "Cell type enhanced" "Detected in many" "Cholangiocytes: 48.6;Hepatocytes: 46.5" "Cancer enriched" "Detected in many" 18 "glioma: 23.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012057 Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "HPA012057: AB_1855305" "unprognostic (2.00e-3)" "unprognostic (1.09e-1)" "unprognostic (7.09e-3)" "unprognostic (5.87e-3)" "unprognostic (2.19e-1)" "unprognostic (1.54e-2)" "unprognostic (1.31e-1)" "unprognostic (6.69e-3)" "unprognostic (2.10e-1)" "unprognostic (1.99e-1)" "unprognostic (9.14e-4)" "unprognostic (1.92e-1)" "unprognostic (7.97e-9)" "unprognostic (6.61e-3)" "unprognostic (2.34e-1)" "unprognostic (1.12e-2)" "unprognostic (3.85e-2)" 4.0 4.1 11.4 0.7 15.0 1.7 2.8 14.8 11.6 1.8 8.8 8.5 1.1 1.3 0.7 5.2 1.9 1.6 18.7 11.8 15.6 1.1 1.6 1.7 0.8 17.6 17.5 1.8 1.2 0.9 2.4 0.3 15.3 2.3 0.7 0.9 5.2 0.5 264.6 3.3 2.5 1.1 16.6 1.5 1.6 1.0 16.9 0.7 2.0 172.3 0.9 4.1 1.2 15.4 1.1 0.8 0.2 0.7 1.1 2.0 0.6 0.1 0.2 0.4 0.3 0.3 0.5 0.3 0.2 0.3 0.5 0.6 0.5 0.1 0.3 0.3 0.9 0.3 1.5 0.3 0.2 0.6 1.2 1.2 0.8 0.5 0.2 0.3 0.0 0.8 0.9 1.5 0.0 0.5 0.9 2.4 0.3 0.3 0.5 0.5 0.0 0.3 0.2 0.8 0.6 0.6 0.1 0.8 0.0 0.1 0.4 0.8 0.3 0.2 0.6 1.7 0.5 0.6 0.3 0.9 0.4 0.6 0.4 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.7 0.0 0.1 0.1 0.1 0.0 11.4 15.0 14.8 11.6 11.8 15.6 17.6 17.5 15.3 16.6 16.9 15.4 12.6 12.8 4.2 16.0 10.4 1.3 7.7 0.2 0.6 3.9 25.6 6.7 1.7 48.6 3.7 27.6 0.0 7.5 17.7 9.0 1.9 14.6 2.7 20.8 11.3 8.2 16.7 6.6 3.1 12.3 14.5 10.4 2.6 16.4 8.2 4.6 23.6 46.5 12.1 11.8 3.8 12.6 0.0 36.8 1.2 5.9 18.0 8.9 1.8 3.7 10.7 5.0 8.2 3.5 5.2 11.0 10.1 16.1 5.2 11.6 17.8 16.8 2.2 5.4 13.1 34.0 7.2 11.1 9.1 1.2 1.0 7.3 8.2 3.7 24.1 8.4 PIN1 dod ENSG00000127445 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 1" Q13526 19 9835257-9849689 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 782.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004528, CAB009326, HPA068650, HPA070887" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 120000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: " "unprognostic (2.54e-1)" "unprognostic (6.14e-3)" "unprognostic (6.50e-2)" "unprognostic (4.36e-2)" "unprognostic (1.71e-2)" "unprognostic (6.50e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (2.67e-1)" "unprognostic (7.23e-3)" "prognostic favorable (3.25e-4)" "unprognostic (9.43e-2)" "prognostic favorable (7.80e-5)" "unprognostic (2.20e-2)" "unprognostic (2.56e-1)" "unprognostic (3.13e-2)" "unprognostic (1.21e-2)" 55.3 90.1 130.7 31.2 140.6 48.1 52.3 132.5 201.4 59.4 99.9 83.2 36.4 61.7 7.2 59.5 63.7 13.0 105.5 149.6 141.4 70.1 63.2 49.0 26.4 152.6 134.4 54.6 43.5 28.2 69.2 20.5 156.7 74.7 9.3 20.6 39.6 22.0 90.4 54.3 49.0 16.7 113.9 53.8 61.1 98.4 133.8 42.3 44.8 33.4 12.4 67.4 52.4 132.7 116.8 104.5 75.4 70.8 25.8 22.9 45.1 85.3 35.7 60.9 58.3 97.5 36.1 72.0 132.0 31.7 63.8 58.4 52.2 49.6 19.3 153.9 223.5 187.0 137.2 85.5 41.9 88.0 105.0 31.5 33.5 39.5 18.7 45.7 49.9 124.1 86.1 105.4 37.3 81.0 133.7 338.6 72.8 47.8 156.8 120.6 79.4 121.2 44.5 56.4 95.1 112.4 82.0 40.5 96.6 30.8 51.9 104.3 87.3 85.6 68.3 133.6 139.1 135.0 137.0 97.1 90.9 111.3 107.2 280.9 181.0 397.6 170.1 202.0 159.8 165.5 165.5 171.8 171.4 176.5 130.5 146.0 114.0 192.2 195.8 316.9 245.5 214.7 130.7 140.6 132.5 201.4 149.6 141.4 152.6 134.4 156.7 113.9 133.8 132.7 73.8 28.9 20.5 11.1 48.8 48.3 65.7 153.9 23.3 77.3 56.1 62.0 79.6 44.3 67.4 62.5 12.5 119.4 81.3 82.3 164.4 101.5 270.5 75.9 57.6 65.6 99.9 78.9 41.3 108.6 98.1 66.5 38.7 40.6 63.5 83.6 56.4 45.8 140.7 60.6 39.2 70.6 160.7 54.7 75.2 782.4 90.1 60.6 124.5 20.6 131.6 87.9 138.0 11.6 24.3 113.7 81.2 129.8 74.3 68.9 97.0 143.8 104.5 76.0 65.7 52.3 98.6 186.7 94.7 54.0 65.9 55.0 77.8 81.8 69.2 58.5 PIWIL4 "FLJ36156, HIWI2, Miwi2" ENSG00000134627 "Piwi like RNA-mediated gene silencing 4" Q7Z3Z4 11 94543840-94621421 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.3" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 8.7;Spermatogonia: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NB-4: 93.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036587, HPA036588, HPA057508" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Mitochondria" "HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452" "unprognostic (1.43e-1)" "unprognostic (9.46e-2)" "unprognostic (2.59e-3)" "unprognostic (2.22e-3)" "unprognostic (3.16e-2)" "unprognostic (1.07e-3)" "unprognostic (1.96e-2)" "unprognostic (5.18e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (6.17e-2)" "unprognostic (2.68e-1)" "unprognostic (1.21e-4)" "unprognostic (6.89e-2)" "unprognostic (1.68e-1)" "unprognostic (2.50e-1)" "unprognostic (2.80e-2)" 3.3 1.1 5.5 2.8 5.3 24.3 3.6 4.9 5.0 4.4 3.4 5.8 5.8 3.7 2.3 1.6 3.6 4.6 2.8 5.6 4.7 3.2 1.3 2.7 3.9 4.5 4.4 3.4 11.3 0.4 2.2 2.0 4.5 2.5 6.0 6.7 8.8 2.6 1.0 1.7 6.3 2.0 4.5 3.7 5.1 13.3 4.9 3.0 2.0 1.0 2.7 3.3 3.0 5.4 0.2 0.1 0.4 0.0 6.6 4.3 0.5 0.5 0.3 0.2 0.9 0.7 0.6 0.0 0.4 2.8 0.2 0.0 0.9 0.0 0.2 2.7 0.3 0.2 0.6 0.0 2.5 6.5 0.1 1.5 0.0 0.5 0.0 0.1 0.1 0.5 0.3 0.0 1.1 0.4 0.3 93.2 0.1 9.2 0.6 0.4 0.0 0.0 2.1 0.0 0.4 0.3 0.4 0.9 0.4 0.3 0.0 20.7 1.2 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.1 9.9 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 5.5 5.3 4.9 5.0 5.6 4.7 4.5 4.4 4.5 4.5 4.9 5.4 1.1 0.0 0.5 3.3 0.2 1.3 0.2 0.4 0.0 0.6 1.3 1.3 3.5 7.2 1.4 0.0 0.0 4.0 0.2 4.1 1.9 6.2 4.7 0.7 0.7 0.6 0.0 0.4 5.4 2.0 0.5 1.6 7.7 1.3 0.0 0.9 0.7 0.0 1.7 0.0 4.9 8.7 0.0 3.0 1.7 2.1 0.3 1.7 0.0 3.7 2.0 0.7 1.0 5.0 6.0 3.0 4.9 1.2 0.1 0.5 4.4 0.6 1.7 3.3 0.0 2.2 1.3 1.2 12.0 0.6 0.1 1.0 0.3 0.3 5.3 0.1 PKN1 "DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1" ENSG00000123143 "Protein kinase N1" Q16512 19 14433053-14471867 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003982, CAB010278" Approved Approved "Plasma membrane,Cytokinetic bridge" Yes NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane" "Cytokinetic bridge" "CAB010278: AB_2163965, HPA003982: AB_1855440" "unprognostic (3.83e-2)" "unprognostic (2.14e-1)" "unprognostic (4.13e-2)" "unprognostic (1.13e-2)" "unprognostic (1.94e-1)" "unprognostic (4.58e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (8.55e-3)" "unprognostic (4.08e-3)" "unprognostic (2.11e-1)" "unprognostic (1.45e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (4.08e-1)" "unprognostic (2.24e-2)" 59.2 45.1 47.1 40.4 50.3 66.8 49.0 44.6 52.4 46.6 44.2 72.4 14.5 61.0 13.6 16.2 48.7 23.9 89.0 40.9 46.3 43.1 25.0 71.1 49.4 53.6 48.4 38.7 52.5 32.8 44.9 33.3 49.8 43.8 9.3 11.5 41.3 30.6 81.7 20.1 45.2 33.0 49.8 90.4 51.4 50.2 49.2 35.6 39.6 53.8 25.8 60.3 32.8 48.5 152.8 88.9 32.3 67.8 51.3 59.8 53.0 53.5 63.5 55.2 52.5 34.9 84.2 144.4 135.0 92.2 68.9 34.4 52.1 23.8 21.2 117.6 67.7 172.8 55.4 75.2 169.1 68.2 103.9 43.3 17.0 33.5 52.2 62.5 129.8 74.9 78.0 96.7 41.4 62.5 104.1 63.2 59.2 54.7 100.0 138.5 43.9 104.7 27.3 24.2 117.3 166.0 33.2 41.7 88.9 15.5 37.8 117.7 196.6 108.8 46.1 133.2 82.8 126.5 123.6 78.9 71.5 135.7 87.4 27.6 27.9 40.6 30.4 38.5 23.3 15.9 20.5 21.1 26.8 16.9 18.6 21.0 32.6 22.1 52.3 17.0 25.7 29.0 47.1 50.3 44.6 52.4 40.9 46.3 53.6 48.4 49.8 49.8 49.2 48.5 78.1 3.2 2.2 17.3 35.3 3.7 6.4 1.9 1.8 37.2 17.6 14.7 4.0 27.1 3.1 35.0 16.7 2.8 77.9 4.9 1.9 28.2 4.9 27.0 25.4 49.4 40.2 17.7 3.6 30.1 14.5 20.8 30.1 20.7 2.5 80.9 53.2 11.3 59.8 48.8 8.6 10.9 8.2 69.0 17.0 8.4 19.9 56.2 17.8 17.8 48.2 61.2 102.0 7.5 11.9 64.2 10.6 23.0 27.1 12.7 1.1 15.2 12.4 29.2 26.3 21.7 29.2 9.3 42.2 1.3 2.7 3.7 55.5 34.3 4.8 4.9 PLGLB1 "PLGL, PRP-B" ENSG00000183281 "Plasminogen like B1" Q02325 2 87002559-87021852 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in all" 6 "liver: 234.9" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 95.9" "Cancer enriched" "Detected in single" 7 "liver cancer: 0.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Secreted to blood" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 15: Liver - Metabolism" "Cluster 24: NB-4 - Immune response" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (7.25e-2)" "unprognostic (7.25e-2)" "unprognostic (2.35e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-5)" "unprognostic (7.04e-3)" "unprognostic (1.15e-1)" "unprognostic (8.53e-4)" "unprognostic (1.60e-1)" "unprognostic (4.56e-4)" "unprognostic (9.90e-3)" "unprognostic (2.96e-5)" "unprognostic (1.02e-1)" "unprognostic (1.16e-1)" "unprognostic (4.32e-2)" "unprognostic (3.98e-5)" 3.6 5.5 19.9 4.5 19.9 8.5 3.6 33.4 26.5 6.9 21.3 4.9 3.9 5.9 8.2 4.0 4.3 4.7 5.9 20.0 20.3 8.5 234.9 3.3 7.9 16.7 17.4 6.7 4.1 2.2 9.5 2.3 16.0 6.6 2.7 42.5 4.8 3.2 8.8 14.2 5.3 2.4 15.0 9.5 4.0 4.3 20.0 7.2 5.6 4.4 4.3 4.9 4.9 19.6 2.7 3.7 4.6 2.6 3.6 5.2 4.5 3.2 2.3 1.7 2.6 2.9 6.9 7.3 3.3 1.3 1.3 2.4 1.2 0.5 1.8 8.2 3.1 5.8 6.6 3.1 2.5 3.5 1.5 4.0 4.2 4.7 4.8 7.9 0.8 8.0 3.0 5.9 2.2 3.9 13.3 11.5 5.9 2.4 2.4 3.1 1.7 3.9 4.5 2.9 3.6 4.0 2.9 2.5 2.7 4.6 1.3 7.6 5.0 3.3 2.3 2.3 2.0 6.7 5.1 2.9 1.9 4.7 1.9 1.9 0.3 0.4 0.7 0.1 0.6 1.2 0.7 0.5 0.1 0.8 0.9 0.5 1.0 0.4 0.3 0.6 1.1 0.1 19.9 19.9 33.4 26.5 20.0 20.3 16.7 17.4 16.0 15.0 20.0 19.6 1.3 0.0 3.4 0.7 1.0 1.1 0.3 0.4 1.2 10.3 1.1 1.0 2.6 1.5 1.5 0.0 6.2 0.2 1.5 0.7 0.0 1.1 0.8 1.0 1.0 1.6 1.2 4.0 0.9 0.2 0.2 1.6 0.5 0.9 0.0 1.0 1.8 95.9 0.2 5.0 1.1 2.5 0.0 1.3 0.4 0.3 1.2 1.1 3.6 0.0 1.6 2.7 1.0 0.0 0.8 0.3 0.3 1.9 0.9 0.5 0.7 1.8 2.3 18.2 0.0 2.5 1.0 0.7 0.5 1.5 1.3 0.0 1.4 0.9 0.9 0.3 PNMT PENT ENSG00000141744 "Phenylethanolamine N-methyltransferase" P11086 17 39667981-39670475 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "adrenal gland: 158.3" "Cell type enhanced" "Detected in many" "Breast glandular cells: 20.1;Breast myoepithelial cells: 15.1;Cardiomyocytes: 13.4;Endometrial ciliated cells: 24.0;Erythroid cells: 16.6;Hepatic stellate cells: 27.5;Skeletal myocytes: 48.0" "Group enriched" "Detected in many" 5 "breast cancer: 7.7;cervical cancer: 27.0;urothelial cancer: 9.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 5.3;K-562: 12.8;NB-4: 24.1;NTERA-2: 4.5;SCLC-21H: 6.4;SH-SY5Y: 5.8" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "CAB017029, HPA043412, HPA051005" Enhanced NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306" "unprognostic (1.50e-1)" "unprognostic (3.74e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (3.95e-5)" "unprognostic (4.27e-2)" "unprognostic (3.02e-1)" "unprognostic (2.98e-2)" "unprognostic (5.75e-2)" "unprognostic (5.29e-2)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (1.33e-1)" "unprognostic (1.52e-4)" "unprognostic (1.58e-1)" "unprognostic (1.97e-1)" "unprognostic (4.72e-2)" "unprognostic (1.87e-2)" 5.3 158.3 15.9 0.2 28.9 2.1 8.4 17.3 16.3 7.6 7.4 4.2 0.5 4.4 1.4 3.0 9.0 0.3 22.6 9.9 17.0 3.7 0.5 8.9 0.3 17.3 22.7 3.0 1.7 7.4 30.7 3.2 20.0 8.5 0.0 0.1 3.2 21.3 21.1 3.1 7.2 0.2 10.8 2.1 6.9 4.5 25.7 0.1 1.8 17.5 0.0 6.5 5.9 11.7 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.9 5.3 0.2 0.4 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 24.1 4.5 0.5 0.1 0.1 0.0 0.3 0.0 0.0 6.4 5.8 0.1 2.3 0.2 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.9 28.9 17.3 16.3 9.9 17.0 17.3 22.7 20.0 10.8 25.7 11.7 3.1 0.0 0.0 1.0 0.5 0.5 0.7 0.0 0.0 0.3 20.1 15.1 13.4 1.5 0.0 5.5 0.0 0.1 1.1 0.1 1.9 0.0 0.7 24.0 2.6 5.0 3.0 16.6 0.5 0.0 0.9 1.1 0.0 9.0 0.0 0.7 27.5 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.5 2.1 0.2 0.0 1.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.2 0.1 0.1 0.0 0.5 0.0 48.0 0.8 1.0 2.3 0.0 0.4 0.0 11.0 0.0 0.3 1.8 POLE POLE1 ENSG00000177084 "DNA polymerase epsilon, catalytic subunit" Q07864 12 132623753-132687376 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 46.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 4 "cerebellum: 4.1;cerebral cortex: 1.1;hippocampal formation: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA058210, HPA067385" Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Plasma membrane" "HPA058210: AB_2683639, HPA067385: AB_2685830" "unprognostic (1.60e-1)" "unprognostic (1.77e-3)" "unprognostic (2.00e-1)" "unprognostic (9.17e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-2)" "unprognostic (3.96e-3)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (7.12e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.19e-8)" "unprognostic (8.60e-2)" "unprognostic (3.18e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" 6.0 2.9 0.2 6.1 0.2 24.7 6.0 4.1 1.1 6.4 0.3 7.3 6.5 5.4 2.1 7.0 6.2 3.1 4.3 1.6 0.0 3.0 8.6 5.0 7.2 0.3 0.1 7.8 6.5 2.6 2.7 5.3 0.3 6.4 6.3 2.4 6.1 3.3 7.5 13.2 8.5 3.7 0.1 16.2 8.0 16.2 0.5 15.7 4.7 3.0 7.1 6.1 6.2 0.3 25.3 33.3 48.7 22.0 10.2 7.6 39.9 26.0 11.7 30.3 21.8 38.3 14.5 28.7 10.2 14.1 11.6 33.6 35.4 16.7 18.8 13.3 41.2 45.4 45.7 15.2 1.9 37.2 24.9 5.5 6.0 31.8 10.5 8.1 10.8 35.1 53.4 15.7 14.9 33.3 61.8 46.8 36.9 9.3 18.5 48.0 27.6 13.0 6.9 40.8 40.6 22.0 30.0 22.7 4.7 23.4 35.0 19.1 9.9 26.5 24.7 20.6 25.9 20.3 14.5 44.8 14.7 26.3 19.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 4.1 1.1 1.6 0.0 0.3 0.1 0.3 0.1 0.5 0.3 3.2 0.0 6.7 7.5 4.0 5.7 3.8 3.0 4.0 8.7 7.8 6.7 6.9 1.5 1.6 1.8 0.0 8.8 5.6 18.8 0.0 2.3 8.2 3.2 3.8 4.9 7.2 14.9 13.6 3.3 10.8 5.1 11.2 6.8 2.5 16.2 8.9 10.5 13.2 0.0 7.6 9.1 2.0 6.9 5.4 9.7 6.8 2.9 5.4 4.7 1.6 2.6 2.1 3.5 2.9 2.6 6.0 3.4 6.3 4.0 4.1 1.0 1.9 6.1 26.3 7.0 6.1 46.6 18.2 5.8 7.7 4.0 5.8 2.9 10.9 2.8 POLE4 p12 ENSG00000115350 "DNA polymerase epsilon 4, accessory subunit" Q9NR33 2 74958643-74970128 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 110.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054979, HPA071815" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 47: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA054979: AB_2682661, HPA071815: AB_2686453" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.19e-2)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (3.09e-1)" "unprognostic (1.99e-1)" "unprognostic (2.95e-1)" "unprognostic (1.39e-2)" "unprognostic (4.44e-2)" "unprognostic (8.64e-3)" "unprognostic (6.61e-2)" "unprognostic (3.73e-1)" "unprognostic (3.47e-2)" "unprognostic (1.95e-1)" 19.7 17.1 16.0 5.4 16.1 23.3 19.9 14.5 25.3 14.7 13.9 16.4 5.9 12.0 2.7 11.4 11.9 7.7 15.0 15.8 14.9 14.5 15.2 12.1 12.5 15.4 15.2 13.6 8.6 3.0 3.1 6.5 15.8 10.7 6.0 7.1 12.2 6.7 29.0 10.5 13.2 7.3 15.1 12.1 14.6 6.8 15.5 5.3 10.3 16.9 7.3 15.0 12.0 17.2 37.4 33.5 3.3 3.3 11.2 23.4 0.0 24.3 29.1 36.6 30.7 43.1 16.2 33.3 19.9 26.6 10.1 16.0 15.6 19.5 39.6 15.5 42.2 28.0 20.3 46.7 38.8 40.4 41.5 23.8 37.0 15.3 33.3 12.6 16.1 4.8 33.9 21.2 28.1 35.6 12.0 110.1 24.2 23.0 59.1 14.1 28.8 29.4 30.3 1.0 10.8 15.9 33.5 13.9 19.1 1.9 10.4 13.6 18.4 8.7 9.6 6.0 24.7 7.3 5.0 12.8 31.2 58.8 43.4 7.0 53.6 19.1 13.3 32.7 14.5 35.2 19.2 16.1 29.7 33.3 20.5 14.7 3.5 10.6 30.2 33.8 20.4 31.8 16.0 16.1 14.5 25.3 15.8 14.9 15.4 15.2 15.8 15.1 15.5 17.2 156.9 25.6 40.4 3.9 83.9 84.5 96.6 82.4 62.0 33.9 89.9 80.4 40.3 48.6 52.6 73.5 43.8 156.3 69.5 116.4 148.7 53.6 12.1 37.3 34.2 96.0 12.2 50.9 6.2 80.7 154.7 66.4 30.5 33.4 61.6 53.9 94.2 147.1 115.6 18.5 6.6 100.8 44.7 113.7 111.5 24.0 67.1 91.9 97.8 9.4 134.1 174.9 87.6 4.0 11.1 83.5 157.5 54.5 55.8 100.3 190.7 182.3 49.2 126.8 78.9 99.4 68.8 45.9 91.5 57.8 97.7 94.0 70.3 108.1 88.3 95.4 PPAN "BXDC3, SSF, SSF1, SSF2" ENSG00000130810 "Peter pan homolog" Q9NQ55 19 10106362-10112012 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 243.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043265 Approved NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "HPA043265: AB_10793943" "unprognostic (1.91e-2)" "unprognostic (1.27e-1)" "unprognostic (7.97e-2)" "unprognostic (1.30e-1)" "unprognostic (4.93e-2)" "unprognostic (4.23e-2)" "unprognostic (9.47e-3)" "unprognostic (2.13e-1)" "unprognostic (3.80e-1)" "unprognostic (5.51e-2)" "unprognostic (3.10e-2)" "unprognostic (1.94e-2)" "unprognostic (2.01e-3)" "unprognostic (8.75e-3)" "unprognostic (7.52e-2)" "unprognostic (4.27e-2)" "unprognostic (2.92e-3)" 23.3 20.5 4.9 15.8 5.3 12.3 20.2 6.6 7.7 18.3 2.5 18.8 12.3 19.3 4.0 27.8 18.9 6.9 17.6 5.1 4.0 18.9 24.5 14.8 18.1 4.1 4.2 19.6 23.2 8.4 13.8 7.5 4.3 19.5 5.8 4.8 16.6 6.8 32.8 28.2 20.0 6.9 1.9 26.5 18.4 18.9 5.5 10.0 16.0 11.1 12.0 20.4 20.5 8.8 51.0 42.0 16.0 35.9 10.8 11.4 34.2 26.7 12.8 33.7 26.3 56.0 19.5 59.0 48.0 17.2 24.4 42.6 42.0 47.7 14.5 31.8 104.6 104.1 47.6 55.2 27.5 66.4 62.5 17.9 36.0 37.0 46.0 22.0 17.2 45.6 76.1 54.9 17.7 72.2 82.5 243.5 75.1 26.8 103.2 60.2 20.5 80.4 19.0 44.8 33.7 41.7 23.9 42.9 40.8 10.6 23.8 37.2 21.1 45.8 24.3 50.6 70.9 111.0 59.3 61.2 31.8 60.2 41.4 2.4 7.1 4.0 6.7 5.0 8.6 17.0 9.2 10.7 6.6 20.6 12.9 5.9 4.7 5.6 3.7 5.0 9.7 3.2 4.9 5.3 6.6 7.7 5.1 4.0 4.1 4.2 4.3 1.9 5.5 8.8 12.2 3.2 6.4 0.0 20.2 57.4 50.3 15.4 4.0 11.3 12.8 14.1 3.9 10.0 12.1 5.5 6.2 26.4 24.0 20.0 3.9 33.2 9.0 4.6 10.5 13.0 6.7 10.3 0.0 30.6 32.0 14.1 6.1 5.1 7.0 13.8 10.4 11.4 32.4 18.5 0.0 17.7 16.2 7.6 17.0 9.1 18.6 10.5 12.4 0.0 15.7 5.0 18.6 0.0 0.0 31.7 12.6 10.5 9.9 33.2 10.3 18.9 5.8 9.9 0.0 18.8 16.7 22.7 42.1 6.8 52.8 17.8 18.9 19.9 24.9 27.9 PPP5C "PP5, PPP5" ENSG00000011485 "Protein phosphatase 5 catalytic subunit" P53041 19 46347087-46392981 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022641, HPA029065, HPA056933" Approved Supported Vesicles,Cytosol NA NA 120000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" "Vesicles, Cytosol" "CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278" "unprognostic (8.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.44e-1)" "unprognostic (6.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.29e-1)" "unprognostic (1.04e-2)" "unprognostic (8.25e-2)" "unprognostic (5.56e-2)" "unprognostic (2.20e-2)" "unprognostic (3.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.37e-1)" 27.4 37.5 27.7 17.7 29.3 14.2 26.3 28.4 36.5 28.0 27.7 31.3 16.8 34.9 9.8 30.4 31.7 13.3 56.4 29.8 28.6 29.1 32.7 28.0 19.7 32.3 28.2 24.7 23.7 32.5 36.6 15.8 33.3 23.7 15.4 14.4 23.0 18.2 58.9 27.5 25.9 20.8 26.2 33.5 33.6 16.9 30.3 20.5 26.2 45.7 15.0 27.7 26.3 28.5 61.9 114.9 66.0 50.1 48.3 50.9 30.6 75.4 59.6 88.2 78.2 82.4 47.9 94.3 39.9 54.0 48.4 49.9 86.2 88.5 24.7 65.9 120.5 76.4 80.9 59.4 54.5 106.6 52.8 47.8 40.9 62.1 45.9 34.2 77.2 79.3 76.0 47.3 49.4 67.5 59.5 203.4 50.2 109.6 61.7 89.0 56.6 76.5 52.8 81.8 93.1 69.7 62.6 78.8 26.9 28.6 49.7 67.8 65.5 38.3 64.3 29.1 79.1 38.0 93.0 111.5 41.7 89.4 65.9 0.0 10.3 3.0 27.8 18.0 17.8 15.1 12.8 22.0 16.8 11.7 12.2 16.8 0.2 22.0 23.4 11.7 14.3 15.4 27.7 29.3 28.4 36.5 29.8 28.6 32.3 28.2 33.3 26.2 30.3 28.5 28.1 6.4 12.5 22.9 16.5 9.4 16.6 20.9 19.9 19.7 13.1 13.5 5.6 44.3 14.2 16.5 16.7 26.4 12.3 25.2 33.2 29.9 1.2 31.3 25.2 19.6 14.9 11.6 18.5 19.5 36.2 17.6 26.0 19.6 4.5 18.6 24.3 24.9 21.6 16.8 23.2 17.0 22.4 12.3 8.2 3.2 17.4 11.9 16.0 11.2 12.1 21.0 17.5 17.6 14.5 26.4 17.0 18.4 25.5 12.1 16.3 21.4 14.6 17.9 39.5 14.6 19.9 26.6 32.0 20.8 13.2 25.7 20.4 23.1 25.0 11.7 PRG2 "BMPG, MBP, proMBP" ENSG00000186652 "Proteoglycan 2, pro eosinophil major basic protein" P13727 11 57386780-57390650 "FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Immunity "Antibiotic, Antimicrobial, Heparin-binding" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "placenta: 2616.3" "Group enriched" "Detected in some" 10 "Erythroid cells: 44.3;Extravillous trophoblasts: 107.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 36 "basophil: 7.2" "Lineage enriched" "Detected in single" 73 "granulocytes: 7.2" "Group enriched" "Detected in some" 62 "HL-60: 3328.5;HMC-1: 5009.7;NB-4: 10560.9" "Not detected" "Not detected" HPA038515 Supported "Secreted in female reproductive system" NA NA 100000000 "Cluster 38: Basophils - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 24: NB-4 - Immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" "HPA038515: AB_10675800" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (3.39e-2)" "unprognostic (3.49e-1)" "unprognostic (8.62e-4)" "unprognostic (4.77e-3)" "unprognostic (3.20e-2)" "unprognostic (4.17e-2)" "unprognostic (2.26e-2)" "unprognostic (5.19e-3)" "unprognostic (2.17e-1)" "unprognostic (1.40e-11)" "unprognostic (4.26e-2)" "unprognostic (4.52e-3)" "unprognostic (6.47e-2)" "unprognostic (2.32e-1)" 0.7 0.0 0.0 0.1 0.0 215.8 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.1 2.5 1.1 1.4 0.0 0.0 0.3 3.8 0.0 0.2 2616.3 0.0 0.0 0.4 0.0 0.9 0.0 0.2 2.1 0.4 0.5 0.0 3.0 0.3 0.0 0.0 8.7 0.2 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 101.3 0.0 0.0 0.2 3328.5 5009.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 9.0 0.6 0.0 0.0 0.8 10560.9 0.0 0.0 0.0 0.3 0.8 1.0 0.0 0.0 1.6 4.2 0.4 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.3 0.8 0.0 0.5 0.0 0.4 0.2 0.4 0.3 7.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 44.3 0.0 0.0 107.2 0.5 0.0 0.0 6.3 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.7 0.0 0.0 0.0 0.0 PRM1 CT94.1 ENSG00000175646 "Protamine 1" P04553 16 11280841-11281330 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1099 "testis: 14115.0" "Cell type enriched" "Detected in some" 6 "Late spermatids: 776887.9" "Cancer enriched" "Detected in single" 161 "testis cancer: 11.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.4;U-2197: 1.7" "Not detected" "Not detected" "HPA055150, HPA059371" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA055150: AB_2682718, HPA059371: " "unprognostic (2.10e-2)" 2.3 2.2 0.0 0.5 0.0 0.0 9.9 0.0 0.0 2.1 0.0 2.1 1.5 1.0 0.0 1.9 1.2 0.0 2.2 0.0 0.2 2.7 4.4 1.3 0.4 0.1 0.0 1.6 3.0 0.0 1.9 0.0 0.1 12.8 0.0 0.0 2.1 1.3 5.8 3.7 4.0 0.0 0.0 1.4 2.4 14115.0 0.0 0.0 4.3 0.0 0.1 1.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 126844.3 0.0 0.0 80.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 776887.9 1855.9 161.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1689.6 0.0 0.0 0.0 0.0 0.0 0.0 1157.0 0.0 0.0 2054.0 1211.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS57 "PRSSL1, UNQ782" ENSG00000185198 "Serine protease 57" Q6UWY2 19 685546-695498 "Enzymes, Predicted secreted proteins" "Heparin-binding, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "bone marrow: 165.3" "Cell type enriched" "Detected in some" 9 "Erythroid cells: 77.8" "Cancer enriched" "Detected in single" 10 "pancreatic cancer: 2.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "NB-4: 377.2;THP-1: 184.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" "unprognostic (2.89e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (3.99e-4)" "unprognostic (3.07e-1)" "unprognostic (1.33e-2)" "unprognostic (3.50e-2)" "unprognostic (4.04e-2)" "unprognostic (7.70e-2)" "unprognostic (3.80e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (8.16e-2)" "unprognostic (2.56e-2)" 0.1 0.0 0.0 0.0 0.0 165.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.1 7.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 377.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 184.4 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 3.2 0.0 5.9 1.1 0.0 0.4 0.2 0.0 0.0 0.0 3.1 1.5 0.0 0.0 0.5 0.7 2.5 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 77.8 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.0 2.5 1.0 8.2 0.0 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 PTEN "BZS, MHAM, MMAC1, PTEN1, TEP1" ENSG00000171862 "Phosphatase and tensin homolog" P60484 10 87863625-87971930 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Lipid metabolism, Neurogenesis" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 60.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004076, HPA031335" Approved Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm Cytosol "CAB004076: AB_390810, HPA031335: AB_2797221" "unprognostic (8.72e-2)" "unprognostic (2.45e-1)" "unprognostic (5.43e-1)" "unprognostic (1.50e-2)" "unprognostic (3.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.18e-1)" "unprognostic (2.08e-1)" "unprognostic (2.07e-1)" "unprognostic (6.87e-2)" "unprognostic (9.77e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (7.35e-4)" "unprognostic (1.57e-1)" "unprognostic (2.73e-1)" "unprognostic (6.54e-3)" "unprognostic (2.41e-1)" 64.0 25.4 17.8 18.6 19.3 12.9 47.6 34.5 23.4 54.8 15.6 28.1 12.9 27.4 18.6 28.3 35.2 15.6 29.7 20.4 18.4 22.6 39.2 39.5 21.4 16.6 17.8 28.0 33.2 11.9 17.3 30.5 16.4 26.3 14.6 30.0 19.6 16.5 23.7 25.9 24.5 22.2 14.5 40.0 25.6 28.2 19.7 31.8 26.1 14.0 16.5 28.1 38.4 17.6 23.5 10.8 12.3 11.2 28.5 19.7 10.9 12.5 28.0 14.5 20.4 10.9 28.0 28.1 8.0 20.9 8.3 14.1 16.6 14.3 22.8 14.1 4.7 9.3 28.5 13.8 30.1 31.9 15.3 13.5 38.7 18.0 23.7 60.3 20.8 17.7 7.0 72.6 13.5 18.1 17.8 56.3 4.6 19.9 0.0 27.6 6.4 20.8 22.9 13.4 4.5 19.9 16.6 7.9 23.0 9.7 21.9 45.2 17.9 44.6 10.8 18.3 10.1 23.9 32.9 30.7 14.6 29.2 2.9 21.3 14.2 25.8 6.8 21.8 7.2 7.9 7.2 6.6 10.3 6.8 8.3 8.3 60.5 8.9 15.6 8.2 7.0 4.5 17.8 19.3 34.5 23.4 20.4 18.4 16.6 17.8 16.4 14.5 19.7 17.6 67.2 35.3 63.3 83.6 48.3 56.1 57.4 31.5 47.3 113.0 49.4 41.9 46.5 57.2 31.2 29.5 39.6 25.8 64.4 57.7 33.2 24.7 70.1 40.0 114.5 56.0 31.2 52.0 141.0 30.0 62.2 79.3 39.8 33.6 25.4 39.6 53.9 64.1 35.0 45.4 132.4 44.7 12.2 206.1 97.2 92.1 56.8 105.2 62.2 196.8 101.5 61.6 44.3 139.2 95.7 30.6 39.7 54.5 39.3 45.1 50.1 38.0 31.2 61.2 92.1 66.4 170.7 33.5 25.4 45.2 60.1 57.3 46.3 44.7 46.1 64.0 PTMA TMSA ENSG00000187514 "Prothymosin alpha" P06454 2 231706895-231713551 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047183 Approved Enhanced Nucleoplasm,Cytosol No No 1200000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" Nucleoplasm Cytosol "HPA047183: AB_2679972" "unprognostic (1.49e-3)" "prognostic favorable (6.56e-4)" "unprognostic (3.73e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (5.99e-2)" "unprognostic (1.56e-2)" "unprognostic (3.72e-3)" "unprognostic (2.35e-3)" "unprognostic (9.24e-2)" "prognostic unfavorable (1.99e-7)" "unprognostic (5.54e-2)" "unprognostic (6.07e-2)" "unprognostic (3.81e-3)" "unprognostic (8.64e-3)" 1203.7 522.8 832.1 1028.5 1020.8 2322.6 1026.6 865.2 1035.4 1185.1 644.5 1045.1 703.0 1110.9 698.4 1186.1 1022.9 565.9 541.0 779.9 898.4 1203.7 652.1 933.2 1396.2 952.9 933.7 1078.5 1090.3 481.3 398.6 688.1 919.2 722.6 985.0 437.1 765.6 604.7 305.9 1425.4 935.1 699.4 875.4 896.2 873.2 237.1 929.1 2059.3 1002.8 246.4 1523.2 896.5 999.1 1137.2 2436.8 1416.4 1990.8 1788.7 592.5 783.4 2037.5 1614.2 1346.2 1379.8 1436.6 1380.8 2759.6 3811.5 1795.4 1271.0 948.1 1252.2 2830.6 1992.5 1738.6 3027.0 2228.9 4906.7 1096.2 2266.8 732.6 5621.1 2018.0 1143.7 733.1 1226.2 1002.6 1307.0 2286.8 3049.7 2910.9 1573.5 1222.0 3433.7 7998.5 7671.0 3004.9 2381.4 1180.4 5426.1 1408.4 2601.9 1719.2 2116.3 4041.8 2483.3 1851.0 1833.5 1507.1 1552.9 1383.9 4430.2 1704.1 1154.2 2052.5 1429.4 1769.7 1887.9 999.3 7614.4 790.8 3401.9 1897.3 2067.1 1713.8 1146.7 1346.2 1695.8 1945.2 2776.6 1928.5 1640.8 1828.0 2438.2 2109.4 1808.0 321.7 1782.3 1957.1 1944.4 2506.6 4661.6 832.1 1020.8 865.2 1035.4 779.9 898.4 952.9 933.7 919.2 875.4 929.1 1137.2 3907.5 971.2 1529.2 49.6 4518.0 7745.0 3851.3 5347.3 5459.5 703.1 3534.0 3673.7 259.7 1974.5 2483.8 2273.2 294.0 2599.4 4054.7 1741.3 3785.9 3474.2 103.3 2713.9 3364.3 4186.4 1695.3 3942.3 37.4 4190.1 5153.9 2404.0 2340.5 3092.6 2928.1 2349.3 1940.1 1347.6 3134.5 812.6 40.9 3178.6 3733.2 3492.4 8474.1 201.4 1306.3 3470.5 3689.1 78.7 3334.5 2195.9 2988.7 40.7 282.0 3669.3 2492.8 1404.5 3523.3 4524.2 1624.2 3136.2 1925.7 934.2 1926.2 2766.5 4571.8 1157.6 2467.8 5778.6 7944.4 2734.1 4276.7 1312.4 3381.3 4052.2 PTPRCAP "CD45-AP, LPAP" ENSG00000213402 "Protein tyrosine phosphatase receptor type C associated protein" Q14761 11 67435510-67437682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 79.7;lymphoid tissue: 174.1" "Group enriched" "Detected in some" 6 "B-cells: 203.3;Plasma cells: 283.5;T-cells: 233.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 351.1;HDLM-2: 242.3;HL-60: 140.6;MOLT-4: 206.8;NB-4: 996.9;U-698: 248.9" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Low region specificity" "Detected in many" HPA043734 Enhanced Approved "Plasma membrane" "Intracellular and membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "Plasma membrane" "HPA043734: AB_10962214" 7.1 2.9 3.0 73.0 2.9 27.0 5.3 2.6 4.9 7.0 3.1 14.3 14.0 4.6 0.0 7.9 7.9 3.0 3.5 2.5 2.5 9.9 8.9 14.4 126.5 3.9 2.8 5.0 3.8 0.3 4.2 0.6 3.4 10.6 2.4 0.0 10.2 0.6 2.2 4.2 79.7 0.9 3.4 174.1 24.7 1.5 3.0 109.2 13.0 0.2 51.3 7.5 7.0 3.5 0.4 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.2 351.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 242.3 0.5 0.2 0.9 0.0 0.0 140.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 95.5 1.1 33.3 0.1 3.7 206.8 996.9 0.0 0.0 0.3 65.8 0.2 0.6 0.0 1.1 0.2 0.4 0.2 0.0 1.1 0.0 0.6 0.3 1.4 0.0 1.5 0.0 0.3 0.3 0.3 248.9 0.0 0.3 0.1 23.6 6.7 75.0 1559.9 5.6 1322.2 1334.4 955.3 1380.5 12.7 1714.2 688.5 1083.9 33.4 826.7 8.0 848.7 1374.2 1237.9 3.0 2.9 2.6 4.9 2.5 2.5 3.9 2.8 3.4 3.4 3.0 3.5 0.0 0.0 0.0 7.2 203.3 12.7 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 15.1 0.2 0.0 0.0 4.4 17.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.3 20.6 0.0 0.0 5.0 39.2 7.5 0.5 0.0 1.0 0.5 3.1 0.0 0.0 0.0 283.5 0.0 0.0 0.1 1.4 0.0 0.0 0.0 3.5 0.0 0.0 1.6 9.7 0.0 233.3 0.0 0.0 0.0 PTPRN2 "IA-2beta, ICAAR, KIAA0387, phogrin" ENSG00000155093 "Protein tyrosine phosphatase receptor type N2" Q92932 7 157539056-158587823 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Protein phosphatase, Receptor" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9;pancreas: 98.1" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 131.1;Excitatory neurons: 439.6;Inhibitory neurons: 433.4;Oligodendrocyte precursor cells: 138.2" "Cancer enhanced" "Detected in all" "prostate cancer: 40.8" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 23.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 23.6" "Cell line enhanced" "Detected in many" "AF22: 45.5;HDLM-2: 42.0;MOLT-4: 22.1;NB-4: 43.0;SCLC-21H: 23.8;SH-SY5Y: 25.4;U-87 MG: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006900, HPA007255, HPA026656" Enhanced Approved Vesicles NA NA 1600000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 22: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912" "unprognostic (2.42e-1)" "unprognostic (4.17e-2)" "unprognostic (7.82e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (9.37e-5)" "unprognostic (7.12e-3)" "unprognostic (1.04e-1)" "unprognostic (4.55e-2)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.68e-4)" "unprognostic (2.60e-2)" "unprognostic (1.48e-1)" "unprognostic (1.43e-3)" "unprognostic (6.16e-2)" 3.8 16.5 29.4 2.7 34.3 1.3 2.9 0.0 49.9 2.1 0.0 7.7 8.3 3.0 4.2 1.9 10.8 7.6 3.1 35.2 22.7 3.9 1.6 4.8 3.4 7.9 3.1 8.7 98.1 1.0 41.0 2.1 3.4 17.3 6.1 9.2 12.9 3.6 1.2 0.8 6.7 2.1 0.1 13.4 40.2 6.2 14.1 1.6 8.7 1.9 2.5 4.2 2.1 20.5 0.1 0.4 45.5 3.6 0.1 0.2 0.1 0.4 0.3 0.0 0.1 0.0 4.0 0.0 1.2 0.5 9.4 0.3 1.0 0.0 0.0 42.0 0.8 0.0 0.0 7.3 1.1 0.0 0.1 2.0 0.8 0.1 0.5 0.3 0.0 3.4 0.1 0.3 0.0 0.7 22.1 43.0 5.7 13.7 3.2 0.0 2.7 0.2 0.2 0.0 23.8 25.4 0.0 0.1 0.0 0.0 0.0 20.9 6.2 9.2 4.3 0.1 1.5 0.3 0.1 0.0 27.7 17.4 6.8 14.1 1.5 2.8 1.3 0.2 0.5 3.5 2.1 1.4 2.1 4.2 2.4 1.4 23.6 2.4 0.0 0.6 5.3 1.3 29.4 34.3 0.0 49.9 35.2 22.7 7.9 3.1 3.4 0.1 14.1 20.5 40.7 3.2 12.9 16.3 18.4 2.3 12.7 1.3 4.0 30.2 1.9 2.2 3.1 10.0 9.1 40.5 10.4 0.4 8.7 5.9 35.2 22.9 51.9 8.7 2.5 26.3 131.1 6.6 439.6 13.1 0.4 13.0 41.8 0.8 19.0 14.1 44.3 0.8 44.5 11.8 433.4 43.3 6.1 7.0 11.3 19.3 12.5 7.9 12.4 27.2 5.7 67.3 15.5 138.2 11.0 7.3 7.0 19.5 5.4 15.0 6.5 3.8 52.6 8.0 26.3 1.4 7.0 62.8 16.3 4.8 1.4 0.7 14.8 32.7 9.7 24.8 PTX4 C16orf38 ENSG00000251692 "Pentraxin 4" Q96A99 16 1485886-1488981 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HL-60: 21.2;NB-4: 15.7" "Region enhanced" "Detected in single" "hypothalamus: 1.0" "Low region specificity" "Detected in all" HPA073694 Supported "Secreted - unknown location" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 24: NB-4 - Immune response" "HPA073694: AB_2732237" "unprognostic (1.04e-1)" "unprognostic (2.66e-1)" "unprognostic (1.54e-2)" "unprognostic (1.55e-2)" "unprognostic (1.12e-1)" "unprognostic (1.84e-4)" "unprognostic (3.98e-2)" "unprognostic (5.66e-2)" "unprognostic (1.10e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-2)" "unprognostic (3.54e-1)" "unprognostic (1.52e-4)" "unprognostic (2.23e-3)" "unprognostic (4.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.03e-1)" 0.1 0.2 0.6 0.0 0.2 0.7 0.0 0.2 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 1.5 3.1 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 21.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 15.7 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.2 0.2 0.3 0.4 0.8 1.5 3.1 2.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201486-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 84.7;skin 1: 90.5" "Cell type enhanced" "Detected in many" "Hofbauer cells: 425.8;Kupffer cells: 555.8;Macrophages: 344.2;Paneth cells: 360.0;Proximal enterocytes: 504.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 585.7;classical monocyte: 1098.3;eosinophil: 948.1;intermediate monocyte: 1138.3;myeloid DC: 829.2;neutrophil: 1638.4;non-classical monocyte: 1152.8;plasmacytoid DC: 769.2" "Group enriched" "Detected in all" 6 "dendritic cells: 829.2;granulocytes: 1638.4;monocytes: 1152.8" "Cell line enhanced" "Detected in many" "MCF7: 148.9;NB-4: 237.0;THP-1: 186.9;U-937: 112.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA 640000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 31: Skin - Epidermis development" "Cluster 24: NB-4 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 25.6 11.4 4.1 32.9 4.0 43.4 20.4 4.6 8.6 22.1 5.0 48.1 63.9 10.7 0.0 56.1 17.4 4.9 9.7 3.7 5.2 10.9 10.4 32.8 19.1 7.8 5.1 14.9 11.3 1.7 7.7 6.1 6.7 19.9 9.5 0.1 24.6 8.7 3.4 90.5 48.5 5.8 7.6 84.7 22.1 2.3 6.7 9.5 9.1 1.2 12.7 19.8 33.1 11.3 23.9 54.8 0.5 0.2 9.2 18.9 0.6 12.6 22.6 8.8 6.5 0.1 31.7 10.6 0.1 17.6 0.0 69.7 2.9 57.4 0.3 73.0 0.0 9.3 7.9 18.3 25.6 86.9 65.7 24.7 30.3 4.0 1.2 0.2 18.4 0.1 42.9 17.5 2.9 148.9 0.2 237.0 15.7 13.2 0.1 75.5 0.0 35.2 1.3 22.3 0.7 0.2 10.4 0.0 12.4 0.3 15.5 186.9 11.8 0.4 0.7 9.9 0.3 0.6 0.1 0.2 6.4 112.1 0.1 585.7 1098.3 948.1 178.4 1138.3 112.2 213.7 146.5 183.3 829.2 210.7 102.1 139.6 1638.4 219.2 1152.8 769.2 206.4 814.2 4.1 4.0 4.6 8.6 3.7 5.2 7.8 5.1 6.7 7.6 6.7 11.3 35.7 22.4 28.9 0.0 58.5 74.1 66.3 237.0 100.7 0.2 92.2 131.7 2.5 41.5 84.3 25.8 0.0 62.5 158.8 184.5 5.9 90.5 0.8 18.6 16.8 39.2 58.9 42.9 0.1 56.5 11.3 39.3 50.4 7.3 110.9 60.2 48.9 3.3 425.8 0.0 0.1 144.6 75.3 555.8 280.2 2.9 47.2 344.2 97.8 13.1 277.8 0.0 132.8 0.0 0.1 60.4 360.0 22.6 54.1 22.6 504.8 3.6 88.2 0.7 26.3 10.5 28.5 0.3 1.4 83.9 163.7 17.8 70.8 119.9 287.1 70.6 RAB11B H-YPT3 ENSG00000185236 "RAB11B, member RAS oncogene family" Q15907 19 8389981-8404434 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 334.5" "Low region specificity" "Detected in all" HPA054396 Approved "Vesicles,Centriolar satellite" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" "Vesicles, Centriolar satellite" "HPA054396: AB_2682474" "unprognostic (5.81e-3)" "prognostic favorable (2.08e-4)" "unprognostic (1.13e-2)" "unprognostic (1.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-3)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-1)" "unprognostic (4.78e-2)" "prognostic favorable (7.58e-5)" "unprognostic (1.23e-1)" "prognostic favorable (2.06e-4)" "unprognostic (3.66e-1)" "unprognostic (3.87e-1)" "unprognostic (8.85e-2)" "unprognostic (3.29e-3)" 102.1 96.7 97.6 59.2 113.2 68.7 113.8 118.5 131.4 105.3 67.4 99.1 76.5 101.3 23.0 95.2 97.3 51.2 167.9 91.7 102.0 129.3 133.8 98.2 58.8 130.9 121.8 107.6 129.7 49.0 115.7 53.9 127.7 111.7 23.4 38.2 104.3 49.3 119.6 101.8 97.2 27.8 108.1 118.7 118.0 64.5 120.4 44.1 210.0 36.6 28.2 99.5 94.2 127.3 93.1 115.3 83.1 75.9 43.7 39.9 64.8 54.6 36.8 39.5 42.0 79.4 74.3 54.1 147.7 47.3 53.1 70.8 29.4 78.7 13.1 109.3 142.4 57.5 97.8 98.0 42.4 67.6 102.6 59.5 49.1 44.6 29.6 51.2 50.1 71.7 62.4 137.2 42.2 92.8 116.7 334.5 117.9 44.6 111.3 75.2 56.2 91.0 43.6 130.1 91.4 118.7 67.7 53.8 71.5 33.8 67.9 75.0 98.0 146.2 85.4 114.0 86.2 145.3 101.7 64.1 109.4 75.3 100.6 47.6 44.4 100.7 44.7 45.5 30.6 39.6 40.3 46.8 45.4 41.3 38.1 36.6 65.7 53.7 55.2 59.1 43.0 39.6 97.6 113.2 118.5 131.4 91.7 102.0 130.9 121.8 127.7 108.1 120.4 127.3 74.0 19.2 25.7 21.2 68.3 62.1 86.2 115.1 75.7 60.1 85.0 79.8 18.1 71.4 59.5 95.6 14.6 152.2 52.4 148.4 127.2 93.8 44.3 58.2 43.2 70.7 114.7 63.1 15.1 94.9 166.7 71.3 99.4 51.0 29.9 56.5 76.1 62.2 109.6 67.3 18.7 112.4 118.0 62.8 52.7 38.0 86.3 62.6 71.2 15.9 76.9 104.1 59.8 8.5 41.3 82.3 154.7 76.3 78.0 81.1 135.5 113.9 59.3 36.0 92.1 50.1 121.0 64.5 38.7 69.8 69.3 209.9 63.3 46.4 92.8 104.6 RASGRP2 CALDAG-GEFI ENSG00000068831 "RAS guanyl releasing protein 2" Q7LDG7 11 64726911-64745456 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 147.3;lymphoid tissue: 140.5" "Cell type enhanced" "Detected in many" "B-cells: 125.5;dendritic cells: 86.1;Kupffer cells: 77.3;Macrophages: 72.2;NK-cells: 98.9;Sertoli cells: 131.5" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 103.4;HL-60: 192.8;NB-4: 347.1;REH: 105.0;THP-1: 108.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015635, HPA015667" Approved Supported "Plasma membrane" NA NA 1900000 "Cluster 37: B-cells - Transcription" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" "HPA015635: , HPA015667: AB_1856090" "unprognostic (5.96e-2)" "unprognostic (3.24e-3)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (3.52e-2)" "unprognostic (4.74e-5)" "unprognostic (1.11e-2)" "unprognostic (7.36e-3)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.91e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.08e-1)" "unprognostic (5.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.23e-1)" 23.8 10.1 16.1 52.9 35.5 147.3 16.8 9.6 22.4 20.1 7.1 37.5 6.6 28.3 4.6 9.1 29.2 8.7 51.7 13.4 13.4 15.8 10.1 29.5 106.0 12.4 16.3 9.1 4.1 1.0 5.5 10.9 11.9 23.2 5.3 1.3 4.6 18.6 12.2 6.1 86.4 15.0 9.5 140.5 17.5 11.9 20.7 34.6 10.6 10.2 62.0 26.7 15.5 9.8 0.1 0.1 3.0 0.1 0.0 0.3 8.7 1.3 0.2 1.2 0.8 1.5 0.2 62.8 2.7 0.2 0.8 0.7 5.4 0.9 0.3 0.3 1.7 103.4 0.0 0.4 0.3 192.8 35.9 0.0 0.0 0.5 0.0 0.0 0.1 25.9 4.1 1.1 0.0 1.4 45.4 347.1 2.5 0.4 0.0 105.0 0.2 4.4 0.0 0.0 0.5 2.3 0.1 0.1 0.0 2.2 0.6 108.5 0.6 0.0 2.0 1.5 0.1 0.5 0.1 58.9 0.0 58.2 0.0 64.4 34.1 59.9 70.4 88.0 37.3 170.7 72.9 57.2 34.5 100.2 92.7 83.1 70.9 55.3 105.8 85.9 93.8 67.5 16.1 35.5 9.6 22.4 13.4 13.4 12.4 16.3 11.9 9.5 20.7 9.8 27.4 3.2 1.8 2.6 125.5 2.3 0.1 0.0 0.0 2.6 1.6 3.7 53.1 2.8 0.0 0.0 0.0 1.7 86.1 0.1 0.0 0.0 6.6 1.9 27.1 13.5 0.0 24.2 6.0 0.0 1.3 6.6 2.6 1.2 3.8 5.7 31.4 1.7 6.1 0.0 12.2 0.1 0.0 77.3 19.7 19.5 18.0 72.2 0.0 6.5 55.8 0.7 98.9 2.5 0.9 0.0 0.0 47.8 28.6 0.1 0.4 0.9 0.7 2.5 131.5 5.4 56.8 18.0 43.9 0.9 1.3 11.8 61.0 0.8 0.3 0.2 RASL10A RRP22 ENSG00000100276 "RAS like family 10 member A" Q92737 22 29312933-29319679 "Enzymes, Predicted intracellular proteins" Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 28.7" "Cell type enhanced" "Detected in many" "Astrocytes: 17.9;Breast glandular cells: 35.9;Breast myoepithelial cells: 58.3;Excitatory neurons: 35.1;Rod photoreceptor cells: 19.6" "Group enriched" "Detected in some" 4 "glioma: 2.5;testis cancer: 3.4;urothelial cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.6;NB-4: 2.5;U-2 OS: 1.1;U-266/70: 2.7;U-266/84: 1.0" "Group enriched" "Detected in many" 6 "amygdala: 33.7;basal ganglia: 16.7;cerebral cortex: 36.0;hippocampal formation: 26.3;white matter: 15.3" "Group enriched" "Detected in many" 4 "cerebral cortex: 35.6;hippocampal formation: 27.8" HPA056169 Approved NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" "HPA056169: AB_2683053" "unprognostic (1.94e-1)" "unprognostic (2.51e-4)" "unprognostic (3.78e-2)" "unprognostic (1.75e-1)" "unprognostic (2.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.16e-1)" "unprognostic (7.99e-2)" "unprognostic (9.42e-2)" "unprognostic (1.61e-2)" "unprognostic (5.00e-4)" "unprognostic (2.44e-1)" "unprognostic (7.00e-4)" "unprognostic (3.12e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-2)" "unprognostic (3.61e-3)" 0.9 1.4 26.6 0.3 23.2 0.1 2.0 6.3 28.7 0.4 5.3 0.7 0.3 0.6 0.1 0.4 0.6 0.1 3.8 24.5 13.4 1.2 0.9 1.2 0.1 9.3 11.6 0.2 0.4 0.1 5.0 0.2 10.4 2.0 0.0 2.6 1.0 0.1 0.7 0.7 1.1 0.0 9.0 1.2 0.5 1.8 13.3 0.1 1.1 0.1 0.1 0.5 0.3 16.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.4 0.0 2.5 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.5 0.5 0.2 0.1 0.0 1.1 0.0 0.1 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 23.2 6.3 28.7 24.5 13.4 9.3 11.6 10.4 9.0 13.3 16.2 3.9 0.0 0.0 17.9 0.4 0.4 0.6 0.0 0.0 6.8 35.9 58.3 1.1 1.5 0.0 0.0 6.2 0.2 1.0 0.7 0.0 0.0 1.3 0.8 0.3 3.1 0.0 0.0 35.1 0.0 4.7 0.5 1.5 1.4 0.0 0.5 7.9 0.5 1.1 0.0 4.4 1.1 0.0 2.6 5.8 0.5 0.3 2.7 0.0 4.7 0.2 3.3 0.0 3.0 3.9 0.1 0.1 0.0 0.3 1.7 0.2 0.1 0.2 19.6 0.0 13.4 0.5 1.5 3.9 0.3 0.6 0.5 0.5 0.6 0.4 0.2 RASSF1 "123F2, NORE2A, RDA32, REH3P21" ENSG00000068028 "Ras association domain family member 1" Q9NS23 3 50329782-50340980 "Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 116.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 252.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040735 Approved NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 82: Adipose tissue - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA040735: AB_10671692" "unprognostic (5.02e-2)" "prognostic favorable (2.64e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.00e-3)" "prognostic favorable (2.60e-4)" "prognostic unfavorable (9.77e-4)" "unprognostic (3.80e-2)" "unprognostic (2.11e-1)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (8.58e-5)" "unprognostic (4.27e-2)" "unprognostic (2.29e-1)" "unprognostic (1.11e-1)" "unprognostic (9.71e-2)" 50.1 18.9 19.2 23.2 19.5 84.3 46.0 19.6 20.1 44.1 18.1 28.4 15.6 29.7 11.1 26.2 35.4 21.5 47.7 18.4 19.2 39.0 24.7 61.2 39.5 20.8 20.0 31.2 35.3 7.5 22.2 25.8 20.4 31.6 11.6 6.1 30.2 11.8 28.5 38.9 39.6 18.1 20.7 72.3 31.7 38.5 20.4 16.3 29.7 14.3 25.5 32.3 37.4 22.1 37.4 15.1 11.1 18.5 25.0 33.8 16.2 62.5 40.9 52.6 41.8 34.7 27.3 18.0 9.4 67.3 23.6 19.6 23.3 26.1 28.3 44.6 15.2 61.8 51.9 18.4 28.6 61.2 65.2 26.1 18.1 52.0 18.4 15.4 23.7 21.8 26.2 40.7 24.1 13.1 23.3 81.9 14.7 31.2 44.9 19.0 11.4 41.4 15.7 10.8 13.0 23.9 55.6 37.2 41.5 11.2 22.3 59.2 22.9 36.1 27.2 52.0 31.3 16.5 11.7 39.4 20.3 75.6 66.1 252.6 23.3 79.5 77.0 41.5 48.3 44.3 24.6 55.3 24.9 33.6 15.7 37.7 18.4 64.6 59.1 18.5 27.5 42.0 19.2 19.5 19.6 20.1 18.4 19.2 20.8 20.0 20.4 20.7 20.4 22.1 76.6 16.0 8.1 4.6 50.7 73.8 36.3 22.6 34.1 11.6 32.7 22.9 14.3 12.8 14.4 1.8 14.6 27.5 116.1 12.2 5.9 23.1 2.4 16.5 16.3 47.4 16.7 33.2 3.8 26.5 28.1 29.1 27.0 17.6 57.1 9.0 26.0 4.3 38.6 3.3 3.8 19.4 22.4 27.7 43.8 10.4 19.0 28.7 90.7 9.4 23.2 6.1 93.7 2.0 6.0 40.9 17.4 14.7 63.8 24.7 12.1 10.2 7.7 10.1 26.3 19.3 50.4 33.1 11.0 19.2 50.2 16.6 67.2 9.0 15.2 21.3 RAVER1 KIAA1978 ENSG00000161847 "Ribonucleoprotein, PTB binding 1" Q8IY67 19 10316212-10333638 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 15.2;Enteroendocrine cells: 16.3;Plasma cells: 15.3;Proximal enterocytes: 14.0;Undifferentiated cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 255.5" "Low region specificity" "Detected in all" "HPA043575, HPA049457" Enhanced Supported Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA043575: AB_2678562, HPA049457: AB_2680774" "unprognostic (2.04e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-1)" "unprognostic (2.34e-2)" "unprognostic (2.36e-1)" "unprognostic (1.80e-2)" "unprognostic (1.59e-1)" "unprognostic (4.22e-2)" "unprognostic (2.01e-2)" "unprognostic (7.20e-2)" "unprognostic (2.64e-2)" "unprognostic (3.22e-2)" "unprognostic (3.40e-2)" "unprognostic (1.14e-2)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (2.97e-1)" 12.4 12.9 4.1 11.8 4.9 19.0 12.6 3.9 5.5 17.9 6.2 20.4 17.7 22.8 0.7 15.1 19.8 3.3 9.7 3.7 4.4 12.0 8.3 13.1 11.1 6.9 5.0 19.3 11.7 4.4 17.5 6.0 4.4 15.2 3.2 1.1 13.1 7.5 8.5 11.8 22.6 4.0 3.8 21.7 13.9 11.5 5.0 11.4 14.3 2.2 5.2 16.8 14.0 4.5 62.0 38.9 14.1 21.6 5.6 7.0 31.0 31.9 14.0 24.7 21.8 42.7 17.3 65.0 43.7 10.4 19.9 31.5 15.8 21.1 4.9 55.2 93.5 100.3 25.7 48.6 12.6 63.5 62.4 8.2 7.2 16.6 6.2 8.2 16.2 48.6 80.9 56.2 7.6 57.8 85.6 255.5 55.1 13.1 73.9 78.3 20.5 57.2 6.9 24.4 40.3 46.7 34.7 22.3 18.3 4.8 32.0 30.5 22.5 63.7 32.4 56.7 54.5 122.1 109.0 54.9 42.1 44.2 42.5 0.2 1.3 1.8 3.3 1.5 1.7 1.4 2.8 4.6 2.1 2.0 1.9 1.7 1.2 1.9 3.3 0.9 1.1 2.2 4.1 4.9 3.9 5.5 3.7 4.4 6.9 5.0 4.4 3.8 5.0 4.5 1.2 0.0 1.1 6.5 7.8 0.8 0.3 0.5 10.2 0.8 2.0 1.1 0.7 0.0 0.4 0.0 0.0 2.0 2.3 15.2 0.0 4.5 0.4 1.6 2.2 1.1 16.3 12.0 4.8 4.3 1.9 1.6 6.1 1.2 4.5 0.6 0.4 0.3 1.3 0.0 4.5 9.3 0.0 0.0 0.8 0.0 0.0 2.0 0.0 6.5 6.8 0.3 0.0 4.0 4.2 5.4 10.2 0.7 15.3 0.3 14.0 0.6 1.1 1.0 0.0 0.8 2.4 0.7 0.3 6.1 0.1 1.5 5.5 0.6 14.3 0.2 RBM14-RBM4 ENSG00000248643 "RBM14-RBM4 readthrough" 11 66616626-66646469 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 5.5;Club cells: 5.0;Excitatory neurons: 8.7;Inhibitory neurons: 8.7;Microglial cells: 5.6;Oligodendrocytes: 10.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 10.0" HPA047849 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA047849: AB_2680180" "unprognostic (2.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" "unprognostic (2.52e-2)" "unprognostic (2.01e-2)" "unprognostic (1.37e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-4)" "unprognostic (3.92e-2)" "unprognostic (2.52e-1)" "unprognostic (3.77e-4)" "unprognostic (5.74e-7)" "unprognostic (1.43e-1)" "unprognostic (2.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.10e-2)" 0.6 0.8 3.5 0.4 2.5 3.0 0.5 3.4 3.4 0.6 2.9 1.3 0.1 0.8 0.8 1.0 0.7 0.6 2.7 2.6 3.6 1.0 3.0 0.7 0.6 2.9 1.9 0.6 1.1 0.3 1.0 0.4 1.8 1.1 0.4 0.7 0.9 0.5 1.0 0.6 1.0 0.5 1.3 1.1 1.0 0.5 2.6 0.8 1.0 0.4 0.4 1.1 0.7 3.4 1.6 0.9 0.7 1.3 1.0 0.1 0.8 0.9 0.5 1.6 0.3 2.6 0.5 0.9 1.3 0.7 1.2 2.5 1.8 0.6 0.6 0.8 0.7 2.7 1.8 2.0 0.5 1.7 1.5 0.4 0.5 0.8 0.2 0.6 0.0 1.4 3.8 1.4 1.0 3.2 2.5 10.0 1.7 1.9 4.4 2.8 3.4 1.5 0.7 1.8 2.2 1.0 0.7 2.3 5.9 0.5 1.4 1.2 0.7 2.1 1.5 1.7 1.1 1.1 1.0 1.7 1.8 1.2 1.8 4.8 4.3 5.9 4.6 4.8 2.7 5.9 2.9 3.1 4.3 5.9 1.9 2.5 2.8 3.5 5.0 8.4 2.1 3.6 3.5 2.5 3.4 3.4 2.6 3.6 2.9 1.9 1.8 1.3 2.6 3.4 0.5 0.0 1.1 5.5 1.1 0.0 0.5 0.1 1.2 1.1 0.4 0.4 0.0 1.5 5.0 0.0 4.2 0.5 2.0 0.3 0.0 0.5 1.7 1.4 0.9 0.6 0.0 0.4 8.7 0.2 0.4 0.8 1.1 1.1 0.0 0.7 0.0 0.5 0.2 0.0 8.7 0.5 0.0 0.3 0.3 0.9 0.0 1.2 0.0 5.6 0.0 0.1 0.0 4.0 10.3 0.4 0.1 0.0 1.0 0.5 0.0 0.4 3.6 0.8 0.0 0.8 0.4 1.0 0.9 1.0 0.1 1.1 1.0 0.5 0.2 0.8 RBPJL "RBP-L, RBPSUHL, SUH, SUHL" ENSG00000124232 "Recombination signal binding protein for immunoglobulin kappa J region like" Q9UBG7 20 45306840-45317824 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 270 "pancreas: 975.5" "Cell type enhanced" "Detected in some" "Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.0;Spermatogonia: 1.4" "Cancer enriched" "Detected in some" 4 "pancreatic cancer: 4.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" CAB006846 Enhanced NA NA "Cluster 25: Pancreas - Digestion" "Cluster 24: NB-4 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "CAB006846: " "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.34e-2)" "unprognostic (6.09e-1)" "unprognostic (3.07e-2)" "unprognostic (2.08e-1)" "unprognostic (9.60e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.65e-1)" "unprognostic (3.92e-3)" "unprognostic (2.48e-7)" "unprognostic (5.08e-1)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (3.49e-5)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 975.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 REG3A "HIP, PAP, PAP1, PBCGF, REG-III, REG3" ENSG00000172016 "Regenerating family member 3 alpha" Q06141 2 79157003-79159753 "Plasma proteins, Predicted secreted proteins, Transporters" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 61 "intestine: 6743.6;pancreas: 12212.2" "Group enriched" "Detected in some" 11 "Exocrine glandular cells: 1988.6;Pancreatic endocrine cells: 5382.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 710.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 17.6;EFO-21: 15.8;HDLM-2: 15.4;NB-4: 17.7;RPMI-8226: 24.6;SH-SY5Y: 14.6;U-2 OS: 28.5;U-251 MG: 11.0;U-266/84: 15.1" "HPA047894, HPA048334, HPA060705" Supported Approved Cytosol "Secreted to digestive system" NA NA 23000000 "Cluster 25: Pancreas - Digestion" "Cluster 24: NB-4 - Immune response" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (2.43e-2)" "unprognostic (2.12e-1)" "unprognostic (3.62e-2)" "unprognostic (1.42e-1)" 18.5 10.0 0.0 13.3 0.0 0.2 0.6 0.0 0.0 0.3 0.0 19.2 5180.0 2.9 0.0 1.4 0.2 24.9 1.0 0.0 0.0 2.6 2.0 0.5 4.9 0.0 0.0 0.9 12212.2 0.0 2.1 0.1 0.0 0.5 0.0 0.0 2.1 0.0 0.6 0.4 6743.6 0.2 0.0 1.3 156.5 0.9 0.0 0.0 0.6 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.1 0.4 0.0 0.0 0.0 24.6 0.0 0.0 1.8 14.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.5 5.4 11.0 0.0 15.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 152.8 7.7 0.0 0.0 3.0 0.0 0.0 0.0 1988.6 0.0 0.0 189.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 130.2 0.0 0.0 0.0 6.8 0.0 1.4 0.0 0.0 55.8 0.0 0.0 0.0 0.0 5382.1 32.5 0.0 0.2 0.0 215.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 315.9 0.0 RETN "ADSF, FIZZ3, RETN1" ENSG00000104918 Resistin Q9HD89 19 7669049-7670455 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Hormone "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 247.2" "Group enriched" "Detected in some" 6 "Hofbauer cells: 118.2;Kupffer cells: 47.0;Macrophages: 90.4;monocytes: 58.2" "Group enriched" "Detected in many" 4 "lung cancer: 2.6;pancreatic cancer: 4.8;thyroid cancer: 1.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "classical monocyte: 170.4;intermediate monocyte: 91.7;myeloid DC: 118.7;non-classical monocyte: 47.4" "Group enriched" "Detected in many" 11 "dendritic cells: 118.7;monocytes: 170.4" "Group enriched" "Detected in some" 11 "NB-4: 524.3;U-937: 243.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted to blood" NA NA 5120000 1200000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "unprognostic (5.61e-2)" "unprognostic (6.20e-3)" "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (5.19e-4)" "unprognostic (1.53e-4)" "unprognostic (7.34e-2)" "unprognostic (3.35e-2)" "unprognostic (9.30e-2)" "unprognostic (1.35e-2)" "unprognostic (1.20e-1)" "unprognostic (4.02e-1)" "unprognostic (7.16e-5)" "unprognostic (4.23e-2)" "unprognostic (2.26e-1)" "unprognostic (8.91e-2)" "unprognostic (1.20e-1)" 3.4 1.0 0.1 5.2 0.1 247.2 1.4 0.0 0.9 0.6 0.0 0.8 6.1 0.7 0.0 0.5 2.4 0.3 2.3 0.4 0.1 1.7 3.3 34.0 0.1 0.1 0.1 0.4 0.9 0.1 0.5 1.1 0.1 1.0 0.2 0.0 1.1 0.0 0.6 0.7 0.7 4.3 0.0 53.3 1.0 0.2 0.0 4.0 0.8 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.9 524.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 243.2 0.0 0.1 170.4 0.1 0.4 91.7 1.2 0.0 1.9 1.5 118.7 0.1 4.4 9.0 13.6 0.3 47.4 4.5 0.0 64.3 0.1 0.1 0.0 0.9 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 12.8 9.9 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.5 0.0 0.0 1.1 0.6 0.0 0.0 3.8 0.0 0.4 0.1 118.2 0.0 0.0 0.0 0.0 47.0 8.7 0.2 0.0 90.4 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.5 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.1 2.2 0.0 0.0 0.1 RFPL3 RNF120 ENSG00000128276 "Ret finger protein like 3" O75679 22 32354885-32361161 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 24.8" "Cell type enhanced" "Detected in some" "Early spermatids: 2.6;Spermatocytes: 2.0;Spermatogonia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;NB-4: 2.2;U-266/70: 2.5;U-266/84: 2.6" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (1.63e-1)" "unprognostic (9.90e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.97e-1)" "unprognostic (3.25e-2)" "unprognostic (4.31e-2)" "unprognostic (1.90e-1)" "unprognostic (6.32e-2)" 0.1 0.1 0.0 0.2 0.1 1.4 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.6 0.1 0.1 0.5 0.7 0.0 0.1 0.1 0.1 0.3 0.0 2.4 0.5 0.0 0.5 1.3 0.3 0.0 0.0 0.7 0.1 24.8 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 1.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.8 0.0 0.4 0.6 2.2 0.1 0.1 0.0 1.1 0.2 0.3 0.0 0.2 0.8 0.1 0.0 0.2 0.6 0.2 0.0 0.2 0.0 0.0 0.4 0.1 0.0 2.5 2.6 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 142.0;Inhibitory neurons: 170.1;Suprabasal keratinocytes: 110.0;Urothelial cells: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" Cytosol "HPA054646: AB_2682555, HPA067421: AB_2685836" "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 8.4 6.5 13.6 2.9 46.6 2.3 8.7 10.2 20.5 16.1 10.5 8.3 4.8 8.6 4.7 30.4 9.9 3.9 6.7 12.9 8.5 11.1 17.3 10.6 3.5 9.5 8.5 12.5 4.9 3.3 13.8 3.7 8.2 16.6 1.9 3.8 9.4 4.7 12.3 20.7 6.2 2.6 7.8 6.0 6.7 10.3 8.7 3.6 8.0 4.6 3.3 10.4 20.2 10.5 4.8 6.0 11.9 8.6 3.9 3.1 4.9 5.1 4.1 5.2 3.8 4.9 2.8 1.1 3.1 4.5 7.6 4.6 2.3 16.3 1.7 0.1 1.9 0.5 3.6 12.0 3.5 0.3 6.5 2.6 10.9 2.7 3.6 4.6 11.5 4.2 5.6 0.2 4.8 4.1 0.8 13.1 5.6 2.7 5.7 12.3 4.6 4.0 2.7 14.1 13.3 13.8 3.2 2.2 11.4 2.9 5.4 8.2 8.7 10.0 6.5 2.0 5.5 5.9 4.9 2.7 5.9 7.2 7.3 0.4 0.3 0.0 0.2 1.1 0.0 0.0 0.2 0.1 0.4 0.2 0.3 0.1 0.4 0.0 1.1 0.2 0.2 0.2 13.6 46.6 10.2 20.5 12.9 8.5 9.5 8.5 8.2 7.8 8.7 10.5 16.1 6.4 6.4 66.9 2.6 84.4 142.0 69.3 71.2 17.3 11.0 14.9 8.6 8.6 28.6 5.5 29.2 6.2 1.3 6.4 3.9 10.4 5.0 22.8 13.3 26.6 14.9 4.8 44.3 10.4 1.3 14.6 7.7 11.8 14.0 57.7 27.8 28.8 20.8 10.1 170.1 10.8 8.2 12.4 11.3 5.5 14.9 21.7 17.8 47.8 7.8 29.3 2.1 71.4 25.5 14.7 2.7 7.9 0.8 53.9 6.0 23.9 34.6 18.9 0.0 12.5 12.7 24.0 15.3 84.4 110.0 6.7 4.3 11.8 9.0 153.8 RILPL2 "FLJ30380, FLJ32372, MGC7036" ENSG00000150977 "Rab interacting lysosomal protein like 2" Q969X0 12 123415039-123436684 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 116.2" "Cell type enhanced" "Detected in many" "B-cells: 149.8;Macrophages: 288.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 103.8;NB-4: 235.2;THP-1: 149.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028958 Approved Supported Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" Cytosol "HPA028958: AB_10602124" "unprognostic (1.94e-3)" "unprognostic (3.29e-3)" "unprognostic (1.02e-1)" "prognostic favorable (5.24e-7)" "unprognostic (2.62e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.69e-2)" "unprognostic (4.08e-2)" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (1.11e-1)" "unprognostic (8.57e-2)" "unprognostic (2.10e-1)" "unprognostic (4.74e-2)" 21.4 7.5 9.3 27.4 9.7 116.2 15.8 8.2 11.1 26.3 14.2 6.3 5.4 19.3 11.2 7.6 18.4 15.7 8.2 9.5 10.2 18.6 11.9 24.1 23.8 9.7 9.7 13.1 8.0 11.4 3.5 14.4 9.2 18.6 5.8 1.4 23.2 23.7 4.6 5.5 6.5 13.8 9.1 26.7 10.3 3.2 10.3 15.2 27.8 5.9 17.7 20.5 7.0 8.6 14.2 12.7 4.6 21.8 29.8 23.6 13.3 16.1 41.0 15.3 12.7 16.2 5.5 7.6 15.2 25.1 8.4 9.2 10.3 12.3 14.2 29.1 9.8 103.8 9.9 24.2 33.2 81.2 50.6 18.3 9.3 16.0 11.6 19.8 15.7 20.4 11.1 3.8 12.4 9.4 28.0 235.2 2.9 4.5 13.9 19.8 14.1 15.4 16.0 26.1 1.0 6.7 21.9 0.7 16.9 9.2 19.5 149.0 17.0 12.5 9.2 22.8 9.9 6.2 8.0 18.2 12.3 55.1 5.3 98.6 133.3 159.3 24.0 106.0 22.4 55.8 51.1 42.7 98.7 41.9 19.7 22.5 176.8 22.4 121.5 46.7 67.7 63.8 9.3 9.7 8.2 11.1 9.5 10.2 9.7 9.7 9.2 9.1 10.3 8.6 75.7 35.3 75.2 7.2 149.8 24.5 68.4 67.8 32.5 1.4 45.3 35.9 5.1 17.2 43.3 22.0 2.1 10.1 75.0 2.4 25.4 20.1 2.1 51.9 24.8 73.2 4.2 24.2 7.5 21.0 5.4 28.2 9.2 27.0 62.6 8.4 84.3 13.3 72.9 1.7 2.6 8.1 0.0 112.5 129.7 2.7 50.4 288.7 37.4 10.3 117.8 18.7 42.2 5.5 2.3 22.7 6.4 66.2 25.7 82.6 1.5 63.5 47.1 2.1 6.6 13.1 30.1 1.4 13.0 12.5 15.3 8.1 92.5 10.1 4.8 69.2 RNASEH1 ENSG00000171865 "Ribonuclease H1" O60930 2 3541430-3558333 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA034817, HPA043037" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm Cytosol "HPA034817: , HPA043037: AB_2678280" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "unprognostic (8.81e-3)" "unprognostic (4.32e-3)" "unprognostic (1.79e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.83e-6)" "unprognostic (9.43e-2)" "unprognostic (8.46e-3)" "unprognostic (6.38e-2)" "unprognostic (2.29e-3)" "unprognostic (2.67e-1)" "unprognostic (4.06e-2)" "unprognostic (2.34e-2)" "unprognostic (2.11e-1)" "unprognostic (3.06e-2)" "unprognostic (2.23e-3)" 10.6 8.7 9.7 9.5 10.6 11.4 9.7 8.2 12.3 8.5 6.8 7.8 7.2 11.7 11.3 9.6 7.8 7.5 13.0 11.1 11.2 7.1 8.1 7.9 10.2 10.1 9.1 8.2 8.7 9.1 3.3 7.9 10.1 9.3 9.5 8.7 7.7 11.8 15.3 9.9 7.8 13.3 9.2 9.0 6.9 7.0 11.7 10.3 9.5 15.0 10.9 8.5 4.7 10.5 11.9 21.4 22.1 22.5 24.9 23.2 17.2 29.0 30.6 24.8 16.5 19.4 13.0 33.6 13.7 31.5 18.8 14.7 32.6 23.2 30.9 12.4 17.5 33.1 18.9 27.5 35.5 42.0 23.3 23.5 24.9 24.2 29.3 18.5 21.5 54.8 33.0 19.4 31.1 9.3 32.7 27.3 34.7 20.6 17.0 26.9 32.0 34.3 21.0 19.7 33.3 48.9 17.8 15.9 27.5 16.7 10.3 22.9 24.8 24.1 11.5 24.7 40.7 36.1 37.5 43.9 43.2 35.1 37.5 0.1 0.6 1.3 1.3 1.2 2.2 1.1 1.0 1.7 0.7 0.6 1.0 2.1 0.5 0.4 1.2 1.5 0.4 0.7 9.7 10.6 8.2 12.3 11.1 11.2 10.1 9.1 10.1 9.2 11.7 10.5 15.6 22.4 6.9 9.1 30.7 7.5 26.1 21.0 13.6 25.7 14.9 12.6 25.9 11.5 14.7 3.7 20.9 32.7 25.4 14.4 37.2 44.3 5.1 9.6 20.8 20.1 15.0 13.5 11.8 48.7 44.3 20.2 17.9 11.0 27.3 17.9 16.8 18.0 30.8 35.3 10.7 16.4 14.2 18.8 8.9 3.4 13.7 16.2 10.6 10.3 32.3 17.5 30.9 7.5 9.8 48.3 9.9 26.4 41.7 50.2 16.6 28.6 14.1 18.8 19.7 23.6 23.4 21.0 27.5 17.8 12.1 36.5 18.9 27.7 15.9 37.9 RNF166 "MGC14381, MGC2647" ENSG00000158717 "Ring finger protein 166" Q96A37 16 88696499-88706408 "Enzymes, Predicted intracellular proteins" "Autophagy, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 91.2;lymphoid tissue: 101.6" "Cell type enhanced" "Detected in all" "dendritic cells: 132.3;NK-cells: 111.2;T-cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 108.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042970 Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Plasma membrane, Cytosol" "HPA042970: AB_10796682" "unprognostic (3.01e-2)" "unprognostic (6.98e-3)" "unprognostic (3.96e-2)" "unprognostic (5.36e-3)" "unprognostic (1.23e-1)" "unprognostic (2.71e-2)" "unprognostic (6.52e-2)" "unprognostic (5.86e-2)" "unprognostic (4.88e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.04e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.54e-1)" "unprognostic (3.91e-2)" "unprognostic (1.28e-1)" "unprognostic (2.69e-2)" 22.7 18.4 16.1 28.8 16.2 91.2 16.0 14.4 24.5 18.3 13.9 18.3 14.1 16.6 3.2 11.8 20.0 14.0 21.3 15.5 15.0 20.7 23.4 48.3 40.4 19.4 16.8 17.8 19.5 5.4 17.6 8.2 17.6 19.7 4.9 3.4 14.8 5.8 21.3 11.8 37.2 6.3 16.9 101.6 17.8 12.8 20.9 18.0 18.8 8.2 21.1 18.1 14.4 20.0 10.3 15.9 12.5 18.4 5.8 5.0 23.3 10.3 6.5 11.8 5.3 11.1 6.4 12.4 13.0 6.0 6.8 11.1 7.2 6.8 4.7 6.4 21.7 16.7 12.4 18.7 15.9 16.7 20.4 6.0 6.4 9.4 8.2 6.9 12.4 20.6 28.6 8.8 5.0 20.3 38.9 108.0 20.3 4.4 21.5 36.3 7.8 32.2 5.3 4.5 11.8 12.3 23.9 4.8 12.1 5.9 13.4 53.3 18.6 8.7 13.4 13.5 12.5 19.9 13.5 31.6 7.8 62.8 12.4 7.0 25.6 61.3 31.6 19.1 27.7 4.2 19.3 27.6 23.8 3.9 15.7 22.9 40.4 11.3 22.7 14.8 21.8 21.6 16.1 16.2 14.4 24.5 15.5 15.0 19.4 16.8 17.6 16.9 20.9 20.0 15.2 9.6 3.6 7.8 23.5 4.8 4.6 2.4 6.2 10.1 6.0 7.1 2.8 4.3 3.1 7.3 6.2 8.8 132.3 2.3 9.8 6.5 1.4 5.2 7.4 11.0 4.9 13.7 6.5 9.2 9.6 8.8 8.2 4.9 21.0 12.3 8.6 4.8 38.8 8.4 4.8 3.1 2.0 46.7 32.4 2.5 9.3 52.4 10.6 15.0 41.5 11.7 111.2 3.5 4.5 5.5 1.0 7.9 55.1 4.5 1.8 7.0 4.7 9.6 6.6 8.9 10.0 9.1 9.9 4.8 5.8 3.7 73.1 12.2 3.7 1.9 ROPN1L "ASP, FLJ25776, RSPH11" ENSG00000145491 "Rhophilin associated tail protein 1 like" Q96C74 5 10441524-10472029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 323.0" "Group enriched" "Detected in many" 5 "Early spermatids: 3125.2;Late spermatids: 3173.9;Spermatocytes: 987.8" "Group enriched" "Detected in many" 5 "endometrial cancer: 9.6;ovarian cancer: 3.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "basophil: 45.1;eosinophil: 55.0;neutrophil: 105.3" "Lineage enriched" "Detected in many" 18 "granulocytes: 105.3" "Cell line enriched" "Detected in some" 5 "NB-4: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039193, HPA041830" Enhanced NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" "HPA039193: AB_10673415, HPA041830: AB_2677695" "unprognostic (2.39e-4)" "unprognostic (1.21e-1)" "unprognostic (3.78e-3)" "unprognostic (6.84e-3)" "unprognostic (3.59e-2)" "unprognostic (2.82e-1)" "unprognostic (5.88e-2)" "unprognostic (1.04e-2)" "unprognostic (2.53e-1)" "unprognostic (8.81e-2)" "unprognostic (2.07e-3)" "unprognostic (3.13e-1)" "unprognostic (1.32e-3)" "unprognostic (7.54e-3)" "unprognostic (1.58e-2)" "unprognostic (1.73e-2)" "unprognostic (3.22e-2)" 0.7 0.2 1.3 0.3 1.3 4.3 0.8 0.7 0.8 2.0 6.5 0.2 0.0 0.8 0.0 0.1 27.4 0.3 0.6 1.8 1.5 0.8 0.3 5.3 0.4 5.0 8.4 0.2 1.1 0.0 1.2 0.2 4.9 0.6 0.0 1.0 0.1 0.1 0.2 0.3 0.3 0.0 4.2 4.5 0.3 323.0 1.3 0.2 0.8 0.3 0.0 0.2 0.1 2.1 0.1 0.4 0.0 0.0 0.4 0.0 0.5 0.0 0.6 0.5 0.5 0.1 0.1 0.0 1.5 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 2.7 0.0 0.0 0.1 0.2 0.2 0.5 0.0 0.0 0.1 0.0 0.1 0.0 13.4 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.2 0.4 0.0 0.0 0.9 1.5 0.1 0.1 0.4 0.0 1.5 1.6 0.3 45.1 0.8 55.0 4.0 0.3 2.7 0.0 3.5 4.7 0.1 0.0 2.3 2.7 105.3 0.4 1.4 0.0 5.8 2.1 1.3 1.3 0.7 0.8 1.8 1.5 5.0 8.4 4.9 4.2 1.3 2.1 2.0 3.2 2.0 1.6 0.1 0.3 0.0 38.0 0.0 0.2 0.4 0.4 0.4 0.0 45.3 0.0 0.0 0.0 2.2 0.0 0.0 1.0 3125.2 311.3 2.0 4.0 0.0 0.0 5.4 0.0 0.1 0.9 0.0 3.4 1.3 0.0 7.5 0.2 0.1 3.3 4.0 0.0 38.7 0.6 0.3 3173.9 36.1 2.2 0.0 0.0 0.2 0.2 0.0 1.0 0.3 0.1 0.0 18.4 0.1 0.3 0.0 1.3 482.3 3.3 13.1 0.4 14.1 987.8 35.8 0.0 0.1 0.1 0.8 2.9 0.0 0.1 RPL18 L18 ENSG00000063177 "Ribosomal protein L18" Q07020 19 48615328-48619184 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "NB-4: 16079.5" "Low region specificity" "Detected in all" HPA046572 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 290000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA046572: AB_2679705" "unprognostic (2.12e-2)" "unprognostic (1.86e-2)" "unprognostic (7.30e-2)" "unprognostic (2.57e-2)" "unprognostic (3.48e-3)" "unprognostic (4.76e-2)" "unprognostic (3.21e-3)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (9.15e-2)" "unprognostic (6.15e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.40e-1)" "unprognostic (3.04e-2)" "unprognostic (6.36e-2)" "unprognostic (1.27e-2)" 1000.7 1074.9 985.7 753.7 981.5 1976.6 1333.2 932.2 1170.2 1491.2 910.5 995.0 912.2 1051.5 782.6 1786.5 1415.0 719.4 754.8 924.1 955.5 756.7 974.7 730.6 1740.2 980.7 953.9 3084.6 2343.7 580.6 905.7 746.8 972.6 1262.1 814.4 139.0 1779.2 702.0 1056.9 1944.3 956.6 709.9 999.1 1151.6 1122.4 332.2 993.5 1091.5 880.0 643.0 1399.0 1017.9 1356.0 989.5 1874.4 2697.1 1148.7 1520.6 1267.0 2299.6 1455.1 1042.7 1489.0 1754.3 1471.6 2497.8 1407.6 3436.1 874.1 1007.2 803.9 1400.0 1211.2 2056.9 844.3 1349.6 3380.2 1286.3 1234.0 2438.1 2166.6 1793.6 1309.6 2633.8 3015.8 1031.9 1603.7 1760.0 1836.8 2149.2 1629.3 2043.5 1297.6 2236.5 1926.2 16079.5 1421.6 3171.4 1469.5 2058.1 1073.4 2438.4 1527.9 2370.7 1410.8 1739.1 850.4 2306.0 2082.3 641.1 1241.4 2618.1 1220.9 1032.3 1275.0 727.4 2119.8 1970.9 2939.2 1934.2 649.6 2246.7 1257.7 381.1 1022.8 217.6 1066.6 890.3 1889.0 2384.8 1921.2 1461.0 1380.1 2368.0 2373.9 1981.4 140.7 1357.8 681.2 1451.1 1707.2 3192.5 985.7 981.5 932.2 1170.2 924.1 955.5 980.7 953.9 972.6 999.1 993.5 989.5 1729.2 593.0 983.1 22.9 4066.2 4468.5 4767.6 3561.4 4933.7 393.5 3680.3 5354.2 264.0 1637.1 1809.1 708.1 143.9 3891.0 2534.2 1344.7 1387.2 1853.2 80.5 1067.0 2619.6 1812.4 1673.5 1713.1 21.7 4530.2 5344.1 1765.9 1597.9 1584.8 1021.6 2791.1 1810.1 1426.6 2225.3 134.6 28.2 3186.8 1253.2 2491.6 3341.9 221.3 3248.9 2059.4 2278.5 16.9 2958.8 1413.2 2345.1 22.6 51.3 3022.6 2516.1 1459.7 2801.6 4727.0 2534.3 1832.5 697.3 433.7 1032.1 2596.1 2246.5 283.4 558.4 5421.3 5559.5 4138.0 2961.3 3084.2 3163.6 5183.8 RPS6 S6 ENSG00000137154 "Ribosomal protein S6" P62753 9 19375715-19380236 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 16920.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004027, HPA031153" Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 320000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "CAB004027: AB_2238583, HPA031153: AB_10602245" "unprognostic (3.95e-3)" "unprognostic (2.08e-1)" "unprognostic (6.34e-2)" "prognostic favorable (4.12e-4)" "unprognostic (1.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (8.16e-2)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" "unprognostic (2.76e-1)" "unprognostic (1.90e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (8.36e-3)" "unprognostic (2.06e-3)" 2449.1 1527.7 1230.0 1483.1 1315.9 3988.9 3070.3 1218.7 1877.5 2746.3 1206.5 2056.1 1485.0 2008.1 1857.3 2788.4 2192.6 927.2 1419.4 1155.2 1268.7 1807.1 1330.8 1520.1 2961.1 1299.0 1255.9 4555.2 3817.4 1069.3 1427.4 1008.9 1322.1 2250.4 1643.0 716.4 2066.9 969.4 1747.9 3577.8 1929.2 1124.2 1314.7 2032.4 2122.9 697.6 1262.2 2341.4 1663.3 1250.8 2493.5 2378.2 2538.4 1357.3 3146.0 2013.7 2004.4 2363.6 3318.8 5075.0 2399.4 2066.1 2675.8 2423.3 2011.5 1686.4 1409.3 7139.0 1986.4 1988.0 859.3 1500.9 2274.1 3180.3 2611.8 3750.0 2173.6 4721.4 2328.7 3106.0 4041.3 2533.2 2256.0 4248.4 5692.5 1620.0 4727.2 3469.1 2964.4 3160.6 2022.8 2830.1 2653.9 1886.9 5406.2 16920.1 3772.8 2466.3 1354.6 4159.9 2025.5 3447.5 3412.7 2646.9 1993.2 2674.3 781.7 3280.0 4564.1 1597.1 2139.0 9080.4 2194.5 1386.6 1486.6 1453.3 3293.5 1324.9 2750.6 4935.9 939.6 3747.0 829.8 1125.0 2374.7 735.3 3116.0 2085.1 5427.4 7104.3 5693.8 4240.7 4059.2 6035.0 7515.6 6032.8 374.2 4153.1 1946.8 3766.4 4744.0 14744.9 1230.0 1315.9 1218.7 1877.5 1155.2 1268.7 1299.0 1255.9 1322.1 1314.7 1262.2 1357.3 1666.2 1653.8 3379.0 28.7 5653.1 9735.5 13864.1 9387.7 4797.6 270.6 10286.6 10100.4 820.4 2965.4 5237.5 1276.3 127.2 5414.0 3535.8 1396.0 5791.2 3073.2 2516.7 1356.0 3150.4 3882.7 2052.9 3987.8 23.0 6777.1 9231.6 2652.7 1988.8 1730.0 3234.5 2265.7 4298.1 2248.6 4065.7 75.7 23.7 4887.3 2541.0 4150.7 6491.3 7208.8 4631.0 3029.8 4605.0 37.5 5131.6 1404.2 4136.0 25.1 42.9 4532.4 4207.9 2423.4 2549.8 11104.9 2807.8 6997.6 2168.7 461.5 1485.7 4699.9 4234.9 1260.7 962.3 6520.0 12082.7 5409.2 4876.4 2935.1 6434.2 12610.3 RTL6 "dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3" ENSG00000188636 "Retrotransposon Gag like 6" Q6ICC9 22 44492583-44498233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 11.1;Collecting duct cells: 12.9;Ductal cells: 8.4;Endometrial stromal cells: 12.9;Granulosa cells: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005697 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" Cytosol "HPA005697: AB_1079244" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (1.57e-1)" "unprognostic (9.64e-3)" "unprognostic (5.40e-2)" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.57e-2)" "unprognostic (1.65e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" 10.6 12.1 21.3 7.2 19.2 3.2 8.9 15.1 18.9 11.2 8.3 12.5 8.8 15.7 12.1 8.2 16.6 11.0 15.3 20.1 17.4 9.3 3.2 9.4 6.3 18.8 20.0 19.2 11.0 17.8 8.7 5.1 17.1 9.8 9.1 9.6 7.2 13.6 15.5 3.4 8.4 16.9 18.8 7.5 9.7 11.2 21.9 14.2 10.2 18.0 4.8 10.4 5.4 17.2 13.8 18.9 23.9 31.9 18.3 14.8 6.3 17.9 21.1 24.6 19.2 6.3 8.0 0.0 10.9 33.5 18.5 11.8 16.3 17.7 15.1 6.5 31.8 0.0 35.8 0.0 22.6 1.8 8.7 16.2 16.8 22.5 17.3 33.4 22.3 21.6 7.8 0.1 16.9 24.3 44.4 4.1 14.7 15.1 20.0 12.1 12.7 0.0 21.1 15.8 25.6 30.0 29.2 14.0 18.1 11.5 14.0 19.3 23.1 19.2 25.7 25.7 14.5 8.3 3.5 0.0 28.5 4.5 29.2 0.0 0.7 0.0 1.8 0.3 1.9 0.0 1.0 1.5 0.5 0.0 0.4 1.0 0.0 0.4 0.4 0.0 0.2 1.1 21.3 19.2 15.1 18.9 20.1 17.4 18.8 20.0 17.1 18.8 21.9 17.2 5.8 0.0 5.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.1 6.5 0.0 0.0 2.5 12.9 0.0 2.9 4.8 0.0 0.0 8.4 0.0 7.4 12.9 4.0 0.0 0.0 0.0 6.5 2.7 3.5 0.0 8.1 0.0 13.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.0 0.0 0.0 1.7 0.0 0.0 5.7 7.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.2 1.8 5.2 0.0 0.0 SAE1 "AOS1, FLJ3091, Sua1" ENSG00000142230 "SUMO1 activating enzyme subunit 1" Q9UBE0 19 47113274-47210636 "Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041906, HPA043552" Supported Enhanced Nucleoplasm,Cytosol NA NA 37000 "Cluster 32: T-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Cytosol" "HPA041906: AB_2677735, HPA043552: AB_2678548" "unprognostic (9.69e-3)" "unprognostic (1.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.68e-1)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.49e-8)" "unprognostic (9.86e-2)" "unprognostic (1.62e-2)" "unprognostic (1.58e-1)" "unprognostic (1.93e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.15e-5)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.27e-1)" 43.9 34.7 33.1 18.7 33.9 21.5 38.9 30.2 39.9 47.8 29.7 115.7 9.9 58.5 4.9 53.0 44.5 14.7 44.3 34.2 34.3 29.4 32.4 39.5 23.1 33.4 33.5 36.4 29.3 22.1 27.2 21.6 33.4 38.5 15.8 11.0 31.0 22.3 53.6 41.3 43.2 27.6 30.5 51.8 59.1 76.6 35.6 36.5 50.8 17.7 24.9 68.1 42.3 34.4 126.7 71.6 189.2 81.8 57.9 68.8 51.3 180.7 130.3 154.7 192.7 76.0 61.6 131.4 72.6 112.0 89.6 49.4 179.6 93.2 141.0 138.4 172.0 117.4 45.2 62.7 68.4 142.3 81.7 64.0 42.2 75.4 72.0 58.9 142.2 141.3 138.7 51.3 135.9 68.0 127.1 396.8 87.3 116.0 68.5 171.7 110.2 47.9 56.2 77.1 59.9 79.3 126.8 87.9 79.3 84.3 70.8 75.9 72.7 71.0 103.8 47.0 161.9 97.0 352.1 206.5 44.7 108.7 98.5 55.3 37.6 21.7 41.6 34.7 45.2 37.2 50.4 43.2 45.2 29.6 69.9 54.6 18.9 63.8 23.6 30.1 69.4 65.3 33.1 33.9 30.2 39.9 34.2 34.3 33.4 33.5 33.4 30.5 35.6 34.4 29.2 9.6 18.7 11.4 24.1 25.6 32.6 33.2 16.5 20.1 19.2 16.3 21.9 15.7 18.6 12.9 6.2 77.7 20.5 18.5 11.7 41.6 13.1 13.3 34.4 39.4 19.2 36.6 20.9 34.9 107.2 30.8 17.3 22.0 15.2 40.2 22.1 21.0 57.6 20.2 21.8 25.2 42.7 17.2 25.0 19.1 15.5 19.2 46.2 10.3 48.5 25.8 41.2 10.6 16.3 38.1 20.1 18.8 26.3 32.6 11.4 15.6 7.2 16.6 52.6 16.5 39.0 151.3 113.7 22.4 24.6 57.5 33.5 35.4 32.5 30.5 SAP18 "2HOR0202, MGC27131, SAP18p" ENSG00000150459 "Sin3A associated protein 18" O00422 13 21140514-21149084 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011352, CAB012273" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" Cytosol "CAB012273: , HPA011352: AB_1856563" "unprognostic (5.08e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-3)" "unprognostic (2.84e-1)" "unprognostic (5.21e-2)" "unprognostic (3.02e-1)" "unprognostic (3.18e-1)" "unprognostic (8.15e-2)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (4.14e-2)" "unprognostic (2.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.70e-2)" "unprognostic (3.70e-3)" "unprognostic (2.78e-2)" 125.7 164.3 140.9 122.9 152.2 242.3 121.6 149.6 198.9 120.4 137.8 141.8 137.4 123.8 97.5 159.2 112.9 82.4 195.8 147.4 160.7 190.4 171.1 106.5 118.0 154.7 153.8 109.5 134.6 114.2 129.6 111.7 157.7 109.7 58.5 89.5 126.3 73.0 297.9 119.5 127.5 51.7 164.1 107.6 119.5 194.3 155.7 115.5 110.7 156.3 64.8 131.7 118.5 170.7 182.1 99.3 159.5 173.1 169.0 140.5 246.9 227.1 167.2 205.5 151.3 181.1 342.4 187.3 272.0 189.1 223.4 186.5 198.1 142.4 231.5 288.0 100.4 267.6 121.2 305.9 191.8 367.1 207.5 143.0 159.7 157.5 187.1 158.4 157.3 223.1 128.8 103.6 188.2 231.0 417.0 599.0 200.7 501.5 109.7 261.1 251.4 187.1 295.7 160.7 185.0 161.1 145.7 213.8 296.5 176.5 206.8 528.0 192.6 126.0 141.9 230.1 268.9 159.6 243.6 536.7 122.5 214.9 236.4 433.0 431.5 540.0 344.1 485.0 349.3 493.7 418.2 410.9 427.8 443.6 405.9 402.9 430.5 395.3 547.4 568.8 517.5 909.3 140.9 152.2 149.6 198.9 147.4 160.7 154.7 153.8 157.7 164.1 155.7 170.7 638.0 134.6 143.5 15.0 291.7 458.6 336.3 640.9 310.7 101.5 298.9 594.9 592.9 194.5 383.8 233.6 41.7 566.2 397.4 353.6 759.2 396.5 1259.5 334.1 231.1 273.1 234.5 214.4 20.8 365.6 528.0 374.0 170.2 256.2 258.6 176.6 180.2 242.0 396.0 119.5 23.4 364.5 468.0 189.5 440.9 206.0 342.3 260.4 407.4 17.8 385.0 370.8 233.8 19.6 26.2 401.9 417.6 303.6 182.3 325.9 475.0 1100.6 446.8 132.3 203.8 362.5 438.3 547.7 319.9 271.7 422.2 908.3 338.8 254.2 344.7 419.9 SAPCD1 "C6orf26, NG23" ENSG00000228727 "Suppressor APC domain containing 1" Q5SSQ6 6 31762996-31764851 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 28.3" "Cell type enriched" "Detected in single" 15 "Respiratory ciliated cells: 1.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.4;U-2 OS: 1.1;U-937: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071699 Approved "Vesicles,Cell Junctions" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "Cell Junctions" "HPA071699: AB_2686433" "unprognostic (9.25e-4)" "unprognostic (1.32e-1)" "unprognostic (3.41e-2)" "unprognostic (3.28e-1)" "unprognostic (9.34e-2)" "unprognostic (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (8.16e-3)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "unprognostic (8.15e-10)" "unprognostic (2.65e-2)" "unprognostic (4.45e-1)" "unprognostic (3.57e-1)" "unprognostic (7.98e-5)" 2.7 1.1 0.4 0.0 0.4 0.2 2.5 0.5 0.9 2.4 0.4 3.7 0.0 2.5 0.1 2.5 3.9 0.0 1.2 0.4 0.3 7.4 3.1 2.0 0.6 0.4 0.5 3.8 2.1 0.0 6.1 0.1 0.4 6.0 0.2 1.2 2.3 0.1 1.0 28.3 3.9 0.1 0.4 4.8 2.6 3.6 0.4 0.2 2.2 0.0 0.1 2.5 2.2 0.4 0.4 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.5 0.0 0.3 0.2 0.0 0.1 0.5 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.3 0.7 0.4 0.2 0.2 0.2 0.5 0.0 0.1 0.7 1.4 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.2 0.1 0.0 0.3 0.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.7 0.1 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.9 0.4 0.3 0.4 0.5 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCGB3A1 "HIN-1, HIN1, LU105, PnSP-2, UGRP2" ENSG00000161055 "Secretoglobin family 3A member 1" Q96QR1 5 180590105-180591499 "Plasma proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 270.0;lung: 508.1;salivary gland: 746.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 2883.9;Breast myoepithelial cells: 4199.8;Club cells: 13674.8;Respiratory ciliated cells: 3325.6;Urothelial cells: 3139.7" "Group enriched" "Detected in many" 7 "endometrial cancer: 114.2;lung cancer: 288.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 51.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 2.3;T-47d: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 10000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 24: NB-4 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (7.70e-3)" "unprognostic (4.90e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-2)" "unprognostic (3.03e-1)" "unprognostic (1.36e-2)" "unprognostic (7.87e-3)" "unprognostic (2.00e-2)" "unprognostic (3.20e-1)" "unprognostic (4.88e-2)" "unprognostic (3.55e-2)" "unprognostic (7.19e-2)" "unprognostic (8.74e-3)" "unprognostic (5.43e-2)" "unprognostic (4.62e-1)" "unprognostic (4.50e-1)" "unprognostic (1.50e-2)" 1.8 1.5 1.1 0.2 1.2 0.5 122.4 0.7 1.2 270.0 11.7 0.5 0.6 1.5 1.2 74.8 29.9 2.9 0.7 1.1 5.9 1.5 7.0 508.1 0.4 1.4 1.6 2.0 18.2 0.0 12.6 0.1 1.0 37.9 0.0 0.0 746.5 2.4 0.3 4.9 1.0 0.0 1.2 9.4 50.7 3.0 3.0 0.8 3.1 0.0 0.8 14.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 20.3 2.4 17.2 13.3 1.8 3.3 4.5 10.1 0.0 5.9 5.0 0.0 0.0 51.8 0.2 4.3 2.6 1.1 1.2 0.7 1.2 1.1 5.9 1.4 1.6 1.0 1.2 3.0 1.5 36.4 173.1 1441.5 0.0 5.9 0.5 51.2 2883.9 0.6 0.0 1831.7 4199.8 0.4 1554.2 13674.8 0.0 0.0 0.0 30.4 0.1 0.0 20.5 0.1 1.6 0.1 40.5 0.0 10.7 0.2 1.6 0.3 15.2 3.6 1.7 35.3 1.0 68.9 1.1 0.4 0.0 0.0 0.1 1566.5 1.2 0.6 0.2 0.6 14.8 5.4 0.0 0.6 0.0 0.0 0.0 0.1 146.1 0.5 0.0 0.0 214.9 0.0 0.0 3325.6 0.0 0.0 1.6 305.2 0.3 4.4 140.8 0.4 0.0 20.2 0.1 0.2 3139.7 SETD1B "KIAA1076, KMT2G, Set1B" ENSG00000139718 "SET domain containing 1B, histone lysine methyltransferase" Q9UPS6 12 121804009-121832656 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021667, HPA059412" Approved Enhanced Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA021667: AB_1856753, HPA059412: AB_2684006" "unprognostic (1.69e-1)" "unprognostic (2.38e-2)" "unprognostic (6.32e-2)" "unprognostic (3.51e-1)" "unprognostic (2.06e-1)" "unprognostic (2.75e-2)" "unprognostic (5.32e-2)" "unprognostic (1.35e-1)" "unprognostic (1.28e-2)" "unprognostic (5.65e-2)" "unprognostic (1.59e-2)" "unprognostic (1.75e-1)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 14.3 8.9 2.8 8.6 2.5 15.1 12.1 7.6 4.4 19.4 1.3 28.5 7.5 26.0 4.7 14.0 19.6 4.5 8.0 2.7 0.7 8.4 11.3 9.2 6.9 1.7 1.4 15.8 12.5 5.5 9.2 5.5 0.7 15.6 3.7 3.4 11.4 10.0 9.0 11.6 15.6 7.1 0.5 13.1 16.7 9.4 1.6 8.4 13.9 4.2 4.8 22.0 14.1 1.5 7.4 14.8 7.4 12.5 6.9 4.7 11.2 6.8 5.4 5.1 2.9 8.1 4.4 5.4 6.1 7.6 3.2 11.3 8.6 5.3 3.0 9.7 10.5 16.3 20.3 7.1 5.9 15.3 14.0 5.7 6.4 7.0 5.6 6.2 5.6 10.6 17.1 3.7 3.9 17.1 22.5 21.5 10.6 3.6 8.5 17.3 4.8 7.9 5.0 15.1 9.0 6.9 15.0 10.5 5.7 5.5 12.8 13.8 9.5 7.6 9.4 10.8 7.7 7.3 4.0 3.2 6.3 9.7 8.8 1.4 0.2 0.6 0.4 0.5 0.3 0.3 0.3 0.4 0.2 0.3 0.5 0.3 1.0 0.3 0.2 0.5 0.3 0.2 2.8 2.5 7.6 4.4 2.7 0.7 1.7 1.4 0.7 0.5 1.6 1.5 10.1 3.2 7.3 9.8 11.2 11.7 3.2 5.7 26.2 13.8 12.7 9.5 9.7 10.0 6.7 5.5 8.4 7.9 17.6 8.5 0.0 5.1 9.8 13.9 14.5 9.5 7.3 7.8 10.6 7.2 7.0 8.5 8.6 20.3 3.8 10.1 12.1 13.8 6.5 11.8 11.7 7.8 4.1 17.7 14.8 21.4 11.5 10.8 1.8 5.6 13.9 5.0 9.2 5.0 6.8 6.5 10.5 10.1 11.2 9.1 6.8 3.2 5.4 10.0 6.6 10.6 12.9 11.3 3.5 29.4 12.9 13.1 13.3 8.1 6.6 9.1 SHLD1 "C20orf196, FLJ25067, RINN3" ENSG00000171984 "Shieldin complex subunit 1" Q8IYI0 20 5750393-5864395 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;dendritic cells: 13.1;Distal tubular cells: 19.6;Exocrine glandular cells: 14.2;Hofbauer cells: 17.0;Pancreatic endocrine cells: 11.7;Proximal tubular cells: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 55.7;U-698: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040749 Approved Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum, Golgi apparatus, Vesicles" "HPA040749: AB_10673093" "unprognostic (2.03e-1)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "unprognostic (4.20e-3)" "unprognostic (6.15e-2)" "unprognostic (1.66e-1)" "unprognostic (1.72e-3)" "unprognostic (6.66e-2)" "unprognostic (9.04e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-2)" "unprognostic (7.59e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "prognostic favorable (4.05e-5)" 4.0 9.7 5.0 6.2 5.8 16.7 5.3 7.2 6.1 5.1 4.6 5.1 9.1 3.8 5.3 5.4 3.9 4.4 8.6 4.9 5.8 6.7 3.0 4.8 14.3 5.6 5.3 5.1 5.2 2.4 6.0 3.0 6.3 6.3 4.9 4.0 8.4 3.7 12.0 4.1 7.1 2.6 4.6 9.9 4.7 3.1 5.4 13.3 6.6 7.7 12.1 4.5 4.7 6.4 9.2 9.6 4.6 2.3 2.8 2.8 2.3 2.5 4.5 3.1 4.3 4.5 9.4 33.3 6.3 2.5 2.5 4.1 2.8 6.1 3.6 10.3 3.4 12.9 1.4 18.2 6.2 16.2 5.7 3.3 7.2 4.7 3.1 3.0 6.4 8.7 17.8 13.9 5.9 3.5 20.4 55.7 6.3 10.3 5.2 16.5 7.1 15.1 5.0 4.5 8.2 7.4 4.6 4.7 10.0 2.6 3.9 13.2 4.3 3.6 5.4 3.5 5.4 8.7 16.6 45.8 1.8 13.9 6.4 21.7 12.4 22.5 21.3 14.8 16.4 27.7 25.2 21.5 12.7 33.1 22.9 17.2 4.9 23.5 16.9 15.1 31.5 13.0 5.0 5.8 7.2 6.1 4.9 5.8 5.6 5.3 6.3 4.6 5.4 6.4 9.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 6.4 8.6 0.0 0.0 0.0 12.9 0.0 7.5 13.1 0.0 19.6 7.9 0.0 6.4 4.4 2.8 0.0 0.0 0.0 14.2 7.5 1.7 0.0 5.2 0.0 7.3 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 11.7 0.0 0.0 2.3 0.0 0.0 11.7 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 5.9 6.4 5.0 0.0 0.0 SI ENSG00000090402 Sucrase-isomaltase P14410 3 164978898-165078496 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 150 "intestine: 545.1" "Cell type enriched" "Detected in some" 8 "Proximal enterocytes: 1083.9" "Cancer enhanced" "Detected in some" "stomach cancer: 6.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;CACO-2: 1.5;HeLa: 1.2;NB-4: 1.3;RPMI-8226: 2.0;SH-SY5Y: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA011897 Enhanced NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" "HPA011897: AB_1856840" "unprognostic (2.71e-2)" "unprognostic (1.62e-2)" "unprognostic (2.68e-1)" "unprognostic (2.05e-1)" "unprognostic (4.41e-2)" 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 545.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 31.0 0.0 0.0 0.0 0.0 0.0 448.2 0.8 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 9.7 0.0 0.0 0.1 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 123.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 124.7 0.0 0.0 0.3 1083.9 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 77.8 0.0 SIRPB1 "CD172b, SIRP-BETA-1" ENSG00000101307 "Signal regulatory protein beta 1" "O00241, Q5TFQ8" 20 1561385-1620061 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.2;lung: 19.4;lymphoid tissue: 28.6" "Cell type enhanced" "Detected in some" "dendritic cells: 10.9;Hofbauer cells: 14.7;Kupffer cells: 29.4;Macrophages: 30.9;monocytes: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "neutrophil: 1594.8" "Group enriched" "Detected in all" 6 "granulocytes: 1594.8;monocytes: 502.2" "Group enriched" "Detected in some" 4 "HMC-1: 54.0;NB-4: 76.2;THP-1: 58.9" HPA047463 Uncertain Uncertain Vesicles,Centrosome NA NA 44000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles Centrosome "HPA047463: AB_2680057" "unprognostic (1.88e-2)" "unprognostic (6.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (5.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (7.18e-2)" "unprognostic (4.11e-3)" "unprognostic (9.12e-2)" "unprognostic (6.31e-2)" "unprognostic (4.57e-2)" "unprognostic (2.65e-3)" "unprognostic (5.76e-2)" "unprognostic (2.39e-3)" "unprognostic (5.00e-3)" "unprognostic (1.19e-2)" 5.4 1.6 1.3 28.6 1.3 52.2 1.9 1.2 4.2 1.2 0.1 2.1 1.5 0.8 0.8 1.3 2.2 11.2 1.6 1.4 0.8 1.2 3.1 19.4 11.0 0.7 0.8 0.7 1.3 0.3 0.6 2.8 1.3 0.8 1.8 1.2 1.7 0.9 0.8 0.8 2.8 3.2 0.9 24.5 1.5 0.6 2.1 4.5 0.9 1.5 4.3 8.1 0.8 1.9 0.2 0.0 0.2 0.1 0.3 0.5 0.2 0.4 0.1 0.2 0.0 0.2 0.1 0.1 0.8 0.4 7.1 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.2 14.9 54.0 0.1 0.2 0.3 0.0 8.0 0.5 1.1 0.0 0.2 0.4 0.1 0.0 76.2 0.2 0.0 3.3 0.2 0.0 0.1 10.8 0.3 0.1 0.2 0.2 0.0 0.5 0.0 0.0 58.9 1.6 0.7 0.1 0.4 0.3 0.1 0.1 0.1 1.1 13.4 0.2 6.1 502.2 868.9 7.3 419.7 10.3 2.8 6.5 5.7 175.2 3.4 8.8 5.5 1594.8 8.2 357.6 165.7 11.8 287.0 1.3 1.3 1.2 4.2 1.4 0.8 0.7 0.8 1.3 0.9 2.1 1.9 0.6 3.2 5.2 0.3 1.2 0.0 0.1 0.2 0.6 0.2 0.1 0.0 0.5 0.0 1.6 0.0 0.0 0.2 10.9 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.3 0.0 0.1 0.7 0.0 0.2 7.0 0.0 1.8 0.2 14.7 0.0 0.1 0.0 0.0 29.4 0.0 0.0 0.0 30.9 0.0 0.0 26.7 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.8 0.0 0.0 0.0 SIRPG "bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma" ENSG00000089012 "Signal regulatory protein gamma" Q9P1W8 20 1629152-1657779 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 39.1" "Group enriched" "Detected in some" 8 "Early spermatids: 48.9;Late spermatids: 14.1;T-cells: 41.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 369.4" "Lineage enriched" "Detected in many" 6 "T-cells: 369.4" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 4.8;JURKAT: 10.7;NB-4: 13.8;RT4: 3.6;THP-1: 2.3" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (3.35e-3)" "unprognostic (4.09e-3)" "unprognostic (7.32e-3)" "prognostic favorable (1.05e-6)" "unprognostic (4.23e-3)" "prognostic favorable (2.24e-4)" "unprognostic (4.49e-2)" "unprognostic (1.30e-2)" "prognostic favorable (7.36e-7)" "unprognostic (1.62e-2)" "unprognostic (6.90e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (1.47e-6)" "unprognostic (1.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.40e-2)" "unprognostic (2.95e-3)" 0.4 0.7 0.0 12.9 0.0 2.9 0.9 0.0 0.2 1.0 0.0 2.5 1.8 0.4 0.2 1.1 0.4 2.3 0.6 0.0 0.0 0.3 1.0 1.5 34.3 0.2 0.0 0.3 0.2 0.0 0.1 0.2 0.1 0.7 3.0 0.0 1.2 0.6 0.0 0.3 5.8 0.7 0.1 9.4 3.0 0.3 0.0 39.1 0.7 0.1 28.1 3.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 4.8 0.0 10.7 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.9 1.5 1.2 67.6 0.7 186.4 0.7 207.6 157.7 0.9 0.7 215.8 176.2 6.0 59.1 1.1 6.7 369.4 101.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.0 1.3 1.4 0.3 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 48.9 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 0.2 0.5 0.1 1.3 0.0 0.4 0.2 0.0 0.0 0.4 0.2 0.0 1.0 0.4 14.1 0.3 0.7 0.0 1.0 1.4 0.0 2.1 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 41.3 0.0 0.0 0.0 SLC30A5 "FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1" ENSG00000145740 "Solute carrier family 30 member 5" Q8TAD4 5 69093949-69131069 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035373 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" "Golgi apparatus" Nucleoplasm "HPA035373: AB_10794630" "unprognostic (9.81e-3)" "unprognostic (3.33e-1)" "unprognostic (2.82e-2)" "unprognostic (8.16e-2)" "unprognostic (1.65e-1)" "unprognostic (3.88e-2)" "unprognostic (1.16e-3)" "unprognostic (2.47e-2)" "unprognostic (4.65e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (2.92e-1)" "unprognostic (1.49e-1)" "unprognostic (2.53e-2)" "unprognostic (2.07e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" 25.8 25.6 9.8 21.0 10.3 19.6 30.3 11.7 15.9 29.7 17.4 26.9 24.7 25.6 38.2 19.3 24.3 24.0 24.1 9.7 10.6 29.1 29.0 21.1 24.7 10.1 11.4 22.3 33.0 35.9 24.0 27.4 10.2 29.4 24.7 18.5 30.8 24.0 16.4 27.1 23.6 22.8 9.7 21.9 26.3 16.4 10.9 20.8 37.5 16.5 23.7 23.6 19.7 12.1 37.4 29.9 26.3 46.2 69.1 53.2 82.5 58.8 53.6 36.4 55.1 26.0 45.7 50.2 70.6 41.4 63.7 38.8 38.6 46.1 61.5 60.2 43.5 55.7 35.0 43.2 55.0 34.8 58.3 35.7 57.1 38.3 46.5 50.1 36.6 34.2 34.9 57.0 46.1 46.9 46.4 71.6 29.4 25.3 33.3 35.5 33.2 89.9 53.6 34.5 46.0 36.8 47.4 45.0 84.5 36.0 43.7 76.2 33.3 23.2 29.5 58.7 58.2 49.5 67.5 37.9 46.6 62.3 58.9 11.9 5.1 8.5 4.1 5.3 4.4 6.9 6.4 6.2 6.3 4.3 5.9 4.8 4.1 4.0 5.5 9.6 4.9 2.8 9.8 10.3 11.7 15.9 9.7 10.6 10.1 11.4 10.2 9.7 10.9 12.1 17.3 19.2 21.5 14.7 26.9 18.7 27.9 27.5 19.9 15.3 28.5 20.6 29.2 18.6 23.2 25.8 22.9 42.0 35.3 19.9 29.4 22.0 6.9 28.8 35.8 19.3 13.2 29.9 29.6 27.1 80.4 24.8 34.7 23.7 41.3 15.4 21.8 19.8 22.3 8.4 30.6 27.9 32.6 17.2 18.4 9.9 24.2 16.8 14.2 19.7 21.2 14.9 15.5 22.1 23.3 19.0 16.7 22.2 51.8 34.7 16.9 21.3 27.7 24.7 26.3 17.5 21.4 11.0 14.9 26.6 21.5 51.6 23.4 20.9 23.2 28.6 SMIM10 CXorf69 ENSG00000184785 "Small integral membrane protein 10" Q96HG1 X 134990991-134992473 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 25.5;Endothelial cells: 24.6;Erythroid cells: 39.1;Smooth muscle cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.0;NK-cell: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 39.0" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" "unprognostic (2.66e-2)" "unprognostic (1.91e-2)" "unprognostic (3.07e-2)" "unprognostic (1.79e-3)" "unprognostic (3.23e-2)" "unprognostic (2.22e-4)" "unprognostic (3.63e-2)" "unprognostic (5.03e-2)" "unprognostic (2.26e-1)" "unprognostic (1.09e-3)" "unprognostic (1.25e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (3.69e-6)" "unprognostic (1.59e-2)" "unprognostic (2.25e-1)" "unprognostic (2.13e-1)" "unprognostic (9.28e-2)" 16.5 13.9 10.3 3.8 10.3 12.2 11.2 11.6 13.3 14.6 10.0 15.5 2.5 14.3 4.5 5.8 15.6 6.5 12.1 9.7 12.1 7.4 2.1 8.2 2.8 13.8 12.8 11.2 3.6 24.8 6.0 3.4 13.5 12.5 4.1 3.3 5.2 11.1 3.7 4.1 7.0 9.2 13.6 10.8 7.2 27.7 11.4 1.6 8.1 6.2 1.7 15.7 11.1 14.1 0.0 0.0 0.1 0.0 17.3 20.8 6.3 9.0 29.5 5.3 7.9 7.6 0.1 0.0 23.4 9.2 26.5 0.0 16.6 0.1 7.7 25.4 15.9 26.8 35.2 0.0 15.2 24.3 5.4 27.8 0.0 15.8 0.0 7.1 4.2 0.0 13.5 0.0 18.8 0.0 0.0 39.0 0.0 0.0 0.0 0.0 2.2 0.0 1.4 4.8 4.6 0.0 11.1 0.0 17.3 0.4 0.0 17.7 0.8 13.2 8.7 28.2 12.9 0.0 0.0 0.0 10.3 26.7 4.9 1.5 0.3 2.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 3.4 0.2 0.0 0.0 0.1 10.3 10.3 11.6 13.3 9.7 12.1 13.8 12.8 13.5 13.6 11.4 14.1 25.5 3.2 3.6 2.0 0.6 1.8 6.4 0.6 0.0 3.3 3.0 3.9 14.3 1.5 3.8 1.8 0.0 0.9 0.6 0.0 3.9 5.7 4.2 9.3 12.1 24.6 0.0 39.1 0.2 1.2 1.2 13.9 0.5 1.2 9.5 9.5 20.0 0.1 5.5 1.7 0.3 0.2 2.0 2.5 2.4 9.4 18.6 1.3 19.6 2.8 0.5 19.3 1.0 0.5 0.4 0.9 0.2 18.0 0.2 1.0 0.0 1.4 2.2 1.3 6.6 17.6 31.9 3.1 2.9 1.2 1.0 0.5 1.7 8.7 0.5 2.7 SMIM27 "C9orf133, TOPORS-AS1" ENSG00000235453 "Small integral membrane protein 27" A0A1B0GUW7 9 32551144-32568621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 48.6;Distal tubular cells: 119.3;Proximal tubular cells: 112.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 680.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 680.4" "Low cell line specificity" "Detected in all" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "prognostic favorable (4.18e-5)" "prognostic favorable (6.11e-4)" "unprognostic (1.47e-1)" "unprognostic (5.30e-2)" "unprognostic (4.88e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-1)" "unprognostic (4.74e-3)" "unprognostic (8.58e-2)" "prognostic favorable (8.39e-4)" "prognostic favorable (7.33e-5)" "unprognostic (1.30e-1)" "prognostic favorable (3.46e-4)" "unprognostic (7.64e-2)" "unprognostic (3.14e-1)" "unprognostic (2.38e-2)" "unprognostic (2.14e-3)" 10.0 19.0 22.4 9.3 23.3 17.4 10.4 25.9 28.0 9.1 21.5 11.5 9.6 8.4 13.8 8.6 8.4 3.0 17.5 22.4 24.8 18.6 9.0 9.8 12.2 23.4 22.6 8.5 19.8 13.0 24.0 4.8 23.2 10.2 4.0 18.9 11.9 6.0 28.5 11.0 10.7 4.0 23.1 16.6 12.8 41.7 22.6 17.1 11.7 13.7 8.7 9.4 8.1 26.2 13.8 7.2 13.7 12.4 5.9 17.8 7.5 6.4 10.2 5.3 10.8 1.9 3.5 10.3 10.0 10.2 9.7 5.3 9.4 6.2 7.7 20.0 21.1 50.5 22.5 17.5 13.5 13.0 8.2 13.1 9.6 5.2 12.2 15.1 12.3 33.6 7.4 25.6 9.7 10.3 22.6 52.5 17.0 13.9 14.5 11.1 6.1 18.8 12.8 7.1 10.2 12.4 16.5 6.3 8.8 16.5 5.0 11.0 6.3 3.6 9.5 4.9 6.9 28.5 23.8 38.0 22.7 7.6 3.0 116.8 47.3 332.4 79.5 51.3 107.8 122.1 114.0 93.7 41.8 129.3 135.6 117.4 680.4 93.3 54.9 56.9 129.0 62.9 22.4 23.3 25.9 28.0 22.4 24.8 23.4 22.6 23.2 23.1 22.6 26.2 22.2 28.9 30.1 0.0 13.4 0.0 0.0 0.0 0.0 0.0 38.6 48.6 0.0 0.0 9.3 29.5 0.0 26.4 27.3 0.0 119.3 20.4 0.0 43.9 18.1 8.1 0.0 0.0 0.0 32.2 12.6 6.4 0.0 29.2 25.2 15.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 6.2 0.0 0.0 0.0 0.0 22.9 0.0 0.0 5.3 0.0 0.0 112.9 29.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 20.0 16.7 11.2 0.0 0.0 SMN2 "BCD541, GEMIN1, SMNC, TDRD16B" ENSG00000205571 "Survival of motor neuron 2, centromeric" Q16637 5 70049638-70078522 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 41.8;Club cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 122.7;MOLT-4: 125.1;NB-4: 106.2" "CAB009344, HPA045271, HPA073601" Supported Supported "Nuclear bodies,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear bodies, Cytosol" "CAB009344: AB_2193083, HPA045271: AB_2679280, HPA073601: " "unprognostic (2.07e-2)" "unprognostic (5.70e-3)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.77e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.21e-1)" "unprognostic (5.19e-2)" "unprognostic (2.98e-5)" "unprognostic (2.36e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (1.19e-1)" 19.7 15.6 1.6 4.5 1.8 13.8 19.4 1.0 2.3 20.3 1.0 19.2 0.5 20.0 16.9 17.1 15.2 13.6 16.0 1.1 7.2 14.4 23.2 16.4 13.8 1.7 2.0 25.9 18.3 8.4 20.5 3.8 2.0 18.8 5.6 3.0 15.1 5.8 26.0 17.0 13.6 14.0 1.3 14.7 14.5 16.5 1.6 0.1 17.3 0.0 0.1 16.0 20.9 2.3 61.3 0.6 0.6 0.4 16.1 20.9 122.7 31.7 21.1 42.0 44.0 0.4 0.4 1.2 86.6 31.8 1.1 28.8 0.9 0.0 50.1 0.8 1.2 68.6 0.0 2.1 0.0 1.1 0.0 0.3 36.0 0.0 1.1 14.3 0.7 0.0 0.0 0.6 0.0 0.6 125.1 106.2 0.5 0.0 0.5 0.0 45.8 55.3 31.5 0.3 30.5 70.7 60.2 6.7 89.7 0.0 41.4 25.2 53.4 27.2 1.3 0.4 0.7 0.6 1.1 72.4 0.4 0.0 76.2 8.0 9.9 5.2 12.1 16.5 14.6 16.8 14.4 10.1 16.6 20.0 17.0 14.8 1.8 10.9 11.4 16.3 12.7 13.4 1.6 1.8 1.0 2.3 1.1 7.2 1.7 2.0 2.0 1.3 1.6 2.3 2.0 6.4 7.8 0.0 2.7 13.6 3.4 9.7 1.8 0.3 2.7 2.8 41.8 0.0 20.2 1.8 0.0 6.9 4.0 1.1 5.9 2.7 14.1 3.3 4.0 6.6 1.8 3.4 0.0 1.0 3.3 10.1 2.6 3.2 8.2 1.2 2.5 3.1 2.6 1.7 0.0 3.1 6.1 2.6 6.8 8.9 7.2 3.3 1.8 0.0 2.9 0.6 2.1 0.0 0.0 2.3 1.6 5.3 2.5 1.7 2.7 3.8 14.0 1.1 0.0 5.3 6.4 12.0 11.4 3.1 12.6 7.1 5.0 1.0 2.5 2.8 SMU1 "BWD, FLJ10805, fSAP57, SMU-1" ENSG00000122692 "SMU1 DNA replication regulator and spliceosomal factor" Q2TAY7 9 33041765-33076674 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019708 Supported Approved Vesicles NA NA 25000 "Cluster 51: Monocytes - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" Vesicles "HPA019708: AB_1857300" "unprognostic (2.20e-2)" "prognostic favorable (2.66e-4)" "unprognostic (1.17e-1)" "unprognostic (1.58e-1)" "unprognostic (1.80e-2)" "unprognostic (8.44e-2)" "unprognostic (2.59e-3)" "unprognostic (5.06e-2)" "unprognostic (3.04e-2)" "prognostic favorable (1.25e-4)" "unprognostic (4.98e-3)" "unprognostic (3.15e-1)" "prognostic favorable (1.67e-5)" "unprognostic (1.09e-2)" "unprognostic (7.04e-2)" "unprognostic (8.71e-2)" "unprognostic (5.96e-2)" 11.5 11.3 11.2 10.6 13.0 16.0 11.9 13.9 12.1 11.4 8.6 10.9 8.6 13.1 11.8 10.6 11.4 8.6 10.3 10.7 11.5 11.2 12.9 10.0 12.8 12.4 11.9 14.7 8.2 15.8 8.1 8.4 12.4 11.9 10.9 12.6 9.3 11.5 14.4 12.8 9.4 13.2 12.6 12.1 9.1 8.5 11.7 14.1 11.2 13.0 15.2 11.5 9.9 16.6 26.3 20.4 24.0 20.9 25.4 19.3 18.7 20.1 18.1 26.9 26.5 20.8 10.7 33.0 14.4 25.1 14.6 15.7 31.1 24.1 29.7 38.1 14.9 24.8 33.4 24.5 22.1 43.5 22.4 20.4 27.0 24.9 17.6 20.1 22.9 22.7 23.4 20.5 22.7 12.1 34.2 46.3 33.1 19.6 21.4 28.8 19.9 17.9 20.5 19.4 20.3 17.7 27.2 19.4 13.1 18.6 18.7 15.7 24.6 17.2 19.1 25.2 23.8 9.1 18.1 38.0 19.2 20.2 12.5 23.4 13.9 11.5 12.4 15.4 13.3 12.9 14.0 11.6 15.8 11.7 13.9 14.3 8.1 12.4 17.9 20.0 12.6 10.8 11.2 13.0 13.9 12.1 10.7 11.5 12.4 11.9 12.4 12.6 11.7 16.6 45.5 25.6 31.4 17.9 48.0 53.7 45.7 41.0 43.3 29.5 23.8 22.4 30.6 30.0 39.9 20.2 37.5 34.9 72.7 19.1 21.5 32.3 29.6 41.6 42.8 38.2 28.1 24.4 23.4 24.3 36.3 37.7 17.9 47.3 39.2 32.1 21.4 29.4 30.8 23.5 25.3 19.5 44.7 29.2 40.8 8.7 32.3 40.2 23.2 14.0 39.7 34.8 32.0 21.6 28.3 27.9 20.1 25.9 28.3 33.3 18.1 31.7 44.1 39.3 19.7 53.9 44.7 41.4 30.5 36.3 57.5 57.7 43.7 37.0 23.5 35.5 SNRPF Sm-F ENSG00000139343 "Small nuclear ribonucleoprotein polypeptide F" P62306 12 95858928-95903828 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 486.5" NA NA 47000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" "unprognostic (6.86e-2)" "unprognostic (1.70e-3)" "unprognostic (3.08e-1)" "unprognostic (5.63e-2)" "unprognostic (3.12e-2)" "unprognostic (3.32e-2)" "unprognostic (1.23e-2)" "unprognostic (1.18e-1)" "unprognostic (2.74e-2)" "unprognostic (6.81e-2)" "unprognostic (2.22e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (8.06e-2)" "unprognostic (3.81e-2)" "unprognostic (1.80e-1)" "unprognostic (1.52e-2)" 22.5 21.5 19.2 27.4 19.6 47.7 21.9 21.3 28.4 19.7 18.8 26.2 21.7 21.2 15.8 38.2 17.9 8.0 22.8 19.2 21.0 28.4 32.3 19.6 28.2 19.3 20.5 22.7 17.2 16.4 24.5 16.0 19.6 17.4 18.7 18.4 18.3 11.8 24.0 22.3 21.3 14.7 19.7 23.0 19.9 18.6 20.6 36.5 17.5 18.2 24.9 20.1 23.1 19.5 146.0 116.9 129.9 88.7 35.2 34.7 107.2 72.7 50.7 95.9 67.7 169.1 46.9 160.3 68.2 48.8 83.8 97.7 116.9 103.4 78.5 107.3 184.7 154.7 116.1 171.7 43.9 243.4 68.3 35.7 50.1 87.3 83.9 64.2 67.3 176.7 138.7 31.5 52.2 155.3 212.2 486.5 178.1 109.9 258.0 166.4 103.4 118.3 71.9 150.7 129.0 76.2 107.6 102.5 74.2 87.6 105.6 187.4 58.8 52.2 90.0 68.6 144.3 46.2 87.0 232.1 26.0 125.9 66.7 8.4 42.6 20.0 51.4 43.4 69.8 80.2 72.0 63.2 97.8 75.1 77.3 70.7 4.1 65.9 35.8 92.9 68.2 60.7 19.2 19.6 21.3 28.4 19.2 21.0 19.3 20.5 19.6 19.7 20.6 19.5 129.3 51.3 103.2 5.5 150.7 265.2 231.1 272.4 139.5 53.7 188.1 286.3 58.4 124.4 146.5 136.1 31.3 350.9 132.8 142.8 272.0 217.4 76.2 166.0 189.1 151.0 172.8 165.7 6.1 285.9 457.3 128.1 95.3 186.8 106.5 172.1 128.2 338.6 241.1 32.0 6.8 282.2 140.4 128.7 197.9 36.8 134.2 126.9 120.9 3.7 197.1 119.9 146.2 7.1 7.0 236.7 152.5 119.6 98.1 280.1 119.7 272.1 98.2 60.6 92.1 210.5 213.9 200.9 276.0 217.6 265.2 207.8 158.2 152.9 346.3 253.1 SOX18 ENSG00000203883 "SRY-box transcription factor 18" P35713 20 64047582-64049639 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 78.4" "Group enriched" "Detected in many" 9 "Adipocytes: 370.9;Endothelial cells: 212.4;Hepatic stellate cells: 306.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 20.8;NB-4: 35.8;REH: 8.5;TIME: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073703 Approved Nucleoplasm NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "HPA073703: AB_2686628" "unprognostic (2.51e-1)" "unprognostic (3.23e-1)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.07e-1)" "unprognostic (2.88e-2)" "unprognostic (2.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.62e-1)" "unprognostic (3.45e-2)" "unprognostic (1.33e-3)" "unprognostic (1.76e-1)" "unprognostic (1.13e-3)" "unprognostic (9.63e-3)" "unprognostic (1.41e-1)" "unprognostic (2.46e-1)" "unprognostic (5.40e-2)" 51.8 14.3 8.9 3.1 6.4 0.0 43.1 6.5 6.3 19.5 1.7 16.3 3.1 38.4 0.3 12.0 29.2 3.7 78.4 4.4 5.5 21.4 5.2 29.1 3.1 10.1 8.0 8.0 8.2 1.3 6.6 5.5 9.5 17.6 0.4 0.0 12.6 1.3 13.9 12.2 17.0 1.5 6.7 22.5 15.6 5.6 9.9 0.8 29.0 3.8 0.5 19.7 21.9 5.4 0.0 0.3 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.0 0.0 0.0 0.2 0.3 0.0 0.0 0.5 1.0 0.0 3.0 5.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 20.8 0.0 3.7 0.0 0.0 0.7 0.0 35.8 0.1 0.0 0.3 8.5 0.0 0.6 0.0 1.4 0.6 0.6 0.3 0.0 0.5 0.0 0.5 1.8 9.6 0.1 2.6 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 6.4 6.5 6.3 4.4 5.5 10.1 8.0 9.5 6.7 9.9 5.4 370.9 0.0 0.6 0.3 3.7 1.0 0.2 0.0 2.2 0.9 1.9 3.0 8.8 1.5 0.0 1.8 0.0 0.0 1.6 0.1 0.0 0.3 22.1 1.0 11.9 212.4 0.0 2.7 0.0 0.0 0.0 2.5 0.0 0.7 4.5 0.0 306.6 0.6 0.1 0.0 0.0 0.0 0.0 6.0 2.2 4.8 1.2 1.3 1.8 15.9 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.2 0.0 3.6 6.5 32.4 2.5 0.9 1.1 0.3 0.7 2.3 0.0 0.3 SPAG11A "EDDM2A, HE2" ENSG00000178287 "Sperm associated antigen 11A" Q6PDA7 8 7847876-7868867 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11461 "epididymis: 4564.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;NB-4: 5.7;RPMI-8226: 1.7" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4564.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAST "ADPSP, FSP2, KIAA1083, SPG4" ENSG00000021574 Spastin Q9UBP0 2 32063556-32157637 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Differentiation, Neurogenesis" "Allosteric enzyme, Developmental protein, Isomerase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 55.2;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017311 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA017311: AB_1857415" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (5.33e-2)" "unprognostic (3.90e-2)" "unprognostic (3.75e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.26e-2)" "unprognostic (2.35e-2)" "unprognostic (7.39e-2)" "unprognostic (5.98e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (5.71e-2)" "unprognostic (3.04e-1)" "unprognostic (1.53e-2)" "unprognostic (1.13e-1)" 5.8 5.9 9.0 7.2 12.7 9.9 6.2 10.8 12.9 8.6 1.6 7.1 7.4 7.7 5.0 6.9 6.5 6.5 3.9 9.0 10.6 5.9 9.6 6.3 9.7 10.8 11.2 9.1 5.3 6.2 4.4 6.8 10.5 6.3 7.5 6.9 4.2 5.3 7.8 7.4 8.0 7.3 11.6 7.0 6.3 9.8 10.7 14.1 8.5 10.0 9.2 7.3 4.4 13.9 17.5 12.2 19.7 19.5 12.0 14.2 17.8 9.4 13.7 9.7 8.6 16.9 14.8 30.2 8.5 13.1 14.2 12.0 19.5 9.6 11.9 20.7 11.8 33.3 6.0 20.5 11.0 23.2 22.4 7.9 12.3 12.4 11.6 11.7 21.5 9.6 27.6 10.0 10.7 7.4 37.8 19.4 20.5 19.2 7.1 19.8 27.9 19.5 13.0 10.7 27.9 29.9 16.0 13.2 15.9 16.0 8.7 15.8 18.8 10.6 16.2 9.5 11.1 14.7 29.7 23.8 11.6 19.9 13.0 1.8 3.5 3.8 1.8 4.9 2.5 2.4 2.8 2.9 3.9 1.9 2.9 3.0 5.3 3.9 3.8 1.7 4.2 2.5 9.0 12.7 10.8 12.9 9.0 10.6 10.8 11.2 10.5 11.6 10.7 13.9 15.0 9.6 4.4 26.4 12.2 9.6 5.9 7.9 11.4 15.4 11.7 6.9 8.0 8.6 7.9 5.5 22.9 9.6 21.4 11.4 0.0 6.6 4.4 16.9 11.8 11.3 10.8 10.3 38.9 8.0 7.4 8.1 9.7 13.7 10.1 16.7 7.9 12.0 9.7 10.1 55.2 10.8 10.2 17.5 9.9 8.5 8.7 17.6 1.8 36.5 21.1 7.9 18.6 59.3 62.7 10.4 9.8 10.1 12.5 8.7 10.9 7.0 13.0 14.1 0.0 11.9 11.9 16.7 21.2 11.7 13.1 8.1 13.3 10.9 10.4 7.2 SPATA5L1 "FLJ12286, MGC5347" ENSG00000171763 "Spermatogenesis associated 5 like 1" Q9BVQ7 15 45402336-45421415 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043679 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm Nucleoli "HPA043679: AB_10964179" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (7.03e-2)" "unprognostic (1.57e-2)" "unprognostic (9.67e-2)" "unprognostic (6.85e-2)" "unprognostic (2.46e-2)" "unprognostic (3.13e-2)" "unprognostic (3.69e-2)" "unprognostic (3.69e-1)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.40e-2)" "unprognostic (2.98e-2)" "unprognostic (2.55e-2)" "unprognostic (2.72e-2)" "unprognostic (4.80e-2)" 4.5 4.9 4.7 4.6 5.1 6.3 4.5 5.5 6.2 5.5 4.4 5.2 5.9 4.4 3.9 10.0 5.0 2.7 5.7 4.9 5.0 6.0 7.5 3.3 4.6 4.9 4.8 6.1 5.8 4.3 3.1 5.2 5.0 4.2 4.8 4.6 4.4 3.9 8.9 7.4 5.5 4.4 5.0 4.5 4.5 3.4 5.2 4.9 5.3 5.4 5.0 5.4 6.0 5.6 10.0 6.3 9.9 7.3 8.0 7.8 12.0 8.7 7.9 9.3 9.0 17.3 6.3 7.3 9.5 5.8 16.9 22.5 14.8 10.9 10.3 10.0 8.4 9.5 11.2 13.6 9.0 12.8 4.0 6.2 12.2 7.7 10.1 10.6 7.4 9.4 15.6 11.4 10.5 6.7 8.9 24.5 7.1 24.8 9.7 9.8 13.9 6.8 11.7 9.8 13.5 6.9 7.2 15.5 8.4 11.7 13.7 23.1 4.7 4.5 6.9 27.8 18.8 9.7 20.8 11.3 11.6 20.8 8.3 0.0 0.9 1.2 1.1 0.7 0.4 0.6 0.7 1.5 0.9 0.7 0.6 0.9 1.1 1.1 1.9 1.0 0.8 0.2 4.7 5.1 5.5 6.2 4.9 5.0 4.9 4.8 5.0 5.0 5.2 5.6 4.7 0.0 1.1 7.2 8.9 5.0 8.9 4.6 5.2 7.9 3.7 2.4 6.9 7.2 5.2 3.7 16.7 12.2 7.3 5.4 3.9 6.2 20.6 6.2 5.4 6.3 3.6 2.5 11.0 7.3 11.9 5.2 9.2 8.4 4.5 8.6 1.1 5.7 8.0 6.7 10.1 6.3 0.0 3.7 7.6 7.1 7.8 7.7 3.6 6.5 7.7 5.0 2.1 16.6 14.6 5.5 3.1 3.8 8.5 6.2 9.2 5.7 2.4 6.5 0.0 4.1 4.1 6.2 5.6 10.4 6.8 6.7 5.8 6.1 7.3 8.2 SPDYA "Ringo3, SPDY1, SPY1" ENSG00000163806 "Speedy/RINGO cell cycle regulator family member A" Q5MJ70 2 28782517-28850611 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "testis: 32.5" "Group enriched" "Detected in many" 4 "Early spermatids: 58.8;Spermatocytes: 225.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.6;THP-1: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035162, HPA066214" Enhanced Supported Nucleoplasm NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA035162: AB_2674501, HPA066214: AB_2685636" "unprognostic (3.41e-2)" "unprognostic (3.20e-3)" "unprognostic (2.45e-1)" "unprognostic (3.53e-2)" "unprognostic (4.21e-2)" "unprognostic (4.04e-3)" "unprognostic (1.10e-4)" "unprognostic (3.04e-3)" "unprognostic (1.95e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.99e-2)" "unprognostic (1.66e-13)" "unprognostic (8.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.85e-1)" "unprognostic (5.55e-5)" 0.8 0.9 0.2 0.2 0.2 0.6 0.7 0.2 0.3 1.8 0.0 0.8 0.5 0.7 0.0 0.9 0.9 0.5 0.8 0.3 0.0 1.7 1.4 0.7 0.5 0.0 0.0 1.4 0.8 0.0 1.4 0.2 0.0 1.7 0.0 1.0 0.7 0.0 0.3 1.6 0.9 0.0 0.0 1.8 0.8 32.5 0.1 0.0 1.2 0.0 0.0 0.7 1.0 0.1 0.4 0.2 0.7 1.6 0.0 0.0 0.8 0.4 0.0 0.1 0.0 0.4 0.3 0.3 0.5 0.0 0.4 1.0 0.1 0.0 0.1 0.2 0.4 0.3 1.0 1.3 0.0 0.5 0.7 0.1 0.0 0.1 0.2 0.3 0.0 0.3 0.2 0.6 0.3 0.2 0.1 2.6 0.2 0.1 0.1 0.3 1.2 0.4 0.5 0.3 0.5 0.3 0.8 1.0 0.3 0.7 0.3 2.5 0.1 1.2 1.0 0.6 0.6 0.3 0.7 0.7 0.3 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.5 3.2 0.5 6.5 2.6 0.3 1.0 0.4 0.6 0.8 3.7 3.8 0.6 0.0 1.4 1.8 6.2 0.1 2.1 2.1 0.0 0.7 58.8 9.9 2.7 1.4 0.0 0.4 9.0 0.5 0.2 1.9 4.1 12.2 2.5 0.8 1.8 0.1 0.4 0.0 6.0 0.0 0.0 0.3 3.1 29.1 2.5 6.7 0.0 1.9 0.8 0.1 0.0 9.0 6.0 0.8 0.3 2.2 2.9 1.2 0.5 0.1 1.6 1.4 6.6 9.0 1.7 225.0 9.6 1.8 0.1 0.5 3.8 0.5 0.5 2.1 SPHK2 ENSG00000063176 "Sphingosine kinase 2" Q9NRA0 19 48619291-48630717 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 68.5;Cone photoreceptor cells: 77.2;Rod photoreceptor cells: 79.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049062 Supported Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 24: NB-4 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA049062: " "unprognostic (5.33e-2)" "unprognostic (4.11e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (5.19e-4)" "unprognostic (2.10e-1)" "unprognostic (7.19e-3)" "unprognostic (3.04e-1)" "unprognostic (4.45e-3)" "unprognostic (7.28e-2)" "unprognostic (2.80e-1)" "prognostic favorable (9.30e-4)" "unprognostic (1.25e-1)" "prognostic favorable (2.59e-5)" "unprognostic (1.18e-2)" "unprognostic (9.97e-2)" "unprognostic (4.21e-2)" "unprognostic (7.06e-2)" 9.4 10.5 18.9 6.8 20.6 3.4 9.6 23.5 29.3 9.4 9.1 16.5 22.1 12.0 2.1 9.2 11.6 3.1 7.3 25.9 19.4 23.1 31.8 8.5 5.9 36.0 30.5 15.5 8.9 7.4 16.5 2.2 37.2 13.3 3.6 3.2 7.6 4.4 7.8 4.8 18.9 2.6 21.2 11.4 14.8 24.1 30.6 5.3 16.0 3.1 3.1 10.7 7.3 26.1 8.4 22.3 8.2 15.3 8.5 3.6 16.3 8.5 6.8 9.3 11.1 39.8 10.4 15.0 5.9 5.3 5.6 6.4 7.5 6.9 1.3 17.5 19.4 16.9 11.5 13.7 13.5 11.1 17.3 6.5 3.6 6.5 4.4 4.4 5.2 20.9 11.7 12.5 4.7 8.3 27.2 64.7 11.2 6.0 10.7 23.3 6.5 10.0 4.3 5.3 29.3 23.1 8.3 12.7 8.3 4.5 7.1 6.9 8.5 13.6 7.7 10.9 17.1 24.5 31.0 16.4 7.9 12.2 12.6 11.7 6.2 2.9 4.3 7.1 4.0 5.0 3.4 4.2 5.5 8.6 4.8 4.8 2.4 5.6 6.2 5.4 3.7 3.5 18.9 20.6 23.5 29.3 25.9 19.4 36.0 30.5 37.2 21.2 30.6 26.1 3.7 6.4 7.7 8.5 13.3 3.3 5.7 5.6 4.6 68.5 6.8 6.5 1.5 12.8 6.2 11.0 77.2 6.8 13.6 20.6 1.9 6.2 11.0 6.2 6.1 6.5 16.2 2.1 9.1 5.0 6.3 5.3 15.3 6.9 4.5 14.5 6.4 19.8 8.3 45.4 11.2 11.3 4.1 12.3 7.3 18.4 16.4 6.5 3.6 6.5 11.4 20.8 33.0 6.0 11.9 6.8 16.7 12.8 7.1 6.2 44.2 18.6 4.9 79.9 6.6 6.3 5.4 18.1 6.3 7.3 2.8 4.5 12.3 8.9 17.3 4.3 SPINDOC "C11orf84, SPIN-DOC" ENSG00000168005 "Spindlin interactor and repressor of chromatin binding" Q9BUA3 11 63813456-63827716 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 7.2;Breast glandular cells: 6.7;Breast myoepithelial cells: 8.6;Cytotrophoblasts: 13.3;dendritic cells: 9.4;Endometrial stromal cells: 8.0;Granulosa cells: 9.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040128, HPA050313" Uncertain Approved "Nuclear speckles" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "HPA040128: AB_10673027, HPA050313: AB_2681083" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-2)" "unprognostic (2.82e-3)" "unprognostic (1.13e-1)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (2.20e-1)" "unprognostic (3.78e-3)" "unprognostic (1.44e-2)" "unprognostic (1.20e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (5.42e-5)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" 11.9 10.4 25.8 12.1 26.3 6.2 8.9 27.9 38.1 16.3 20.7 19.2 5.4 19.1 5.1 10.1 15.3 9.3 15.8 26.0 31.5 13.8 5.2 16.4 15.0 25.4 26.4 16.6 8.0 3.3 17.3 26.4 27.9 18.2 3.6 9.8 9.0 10.4 8.0 6.0 11.3 8.2 22.9 13.9 11.4 38.8 31.4 12.3 13.4 7.2 9.8 18.0 12.3 25.8 34.9 45.7 65.7 57.6 12.5 12.3 24.7 26.6 22.7 47.4 32.9 48.7 23.4 58.1 60.6 15.5 60.8 44.9 60.3 13.7 17.1 55.6 26.4 64.2 46.4 42.0 20.1 36.4 53.6 14.2 14.1 37.2 13.6 24.9 28.5 54.8 36.1 27.6 20.2 48.0 75.7 98.2 112.9 10.0 42.1 100.3 45.5 19.7 16.5 20.2 50.0 63.2 40.6 25.6 55.3 39.7 35.3 43.0 32.2 52.9 60.8 64.0 47.3 40.1 61.9 58.2 27.3 31.8 38.1 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 25.8 26.3 27.9 38.1 26.0 31.5 25.4 26.4 27.9 22.9 31.4 25.8 7.2 3.2 1.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 6.7 8.6 0.0 0.0 0.6 0.0 0.0 13.3 9.4 0.0 0.0 2.2 0.0 5.6 8.0 3.1 0.0 0.0 0.0 1.8 3.0 2.7 0.0 6.5 0.0 9.6 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.4 0.0 0.0 0.7 0.7 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 3.8 2.8 4.0 0.0 0.0 SPINT4 "C20orf137, dJ601O1.1" ENSG00000149651 "Serine peptidase inhibitor, Kunitz type 4" Q6UDR6 20 45722347-45725830 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 255 "epididymis: 278.8" "Cell type enriched" "Detected in single" 9 "Rod photoreceptor cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" HPA046703 Enhanced "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA046703: AB_2732530" "unprognostic (3.61e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 278.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.4 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPNS1 "HSpin1, LAT, nrs, PP2030, SLC62A1, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 26.8 30.8 17.0 19.3 17.4 37.0 24.8 17.1 26.3 27.7 18.6 32.5 22.4 30.9 6.6 25.9 23.0 18.0 27.5 16.9 15.7 32.1 33.9 31.5 20.1 19.1 16.6 22.0 24.4 20.8 21.1 19.8 17.2 26.5 10.0 6.5 24.4 14.9 25.0 35.7 27.8 15.1 15.8 33.9 28.2 20.3 19.8 20.8 27.8 14.9 10.5 30.5 25.2 18.3 25.9 59.6 22.2 51.9 41.5 22.8 62.9 28.2 28.9 46.1 40.9 55.0 60.4 16.4 67.8 25.5 38.2 53.3 36.4 31.2 16.4 19.0 61.6 23.8 57.1 69.3 70.4 26.7 49.2 38.4 40.9 49.7 21.0 26.8 42.9 30.0 54.4 28.7 23.4 68.8 29.3 75.8 52.6 20.8 39.1 36.7 26.7 73.6 24.9 24.8 39.5 51.3 20.1 59.3 44.9 18.5 59.2 31.9 36.6 37.3 28.2 52.7 22.0 43.2 36.7 15.6 47.7 40.4 30.8 13.4 32.8 13.5 9.9 42.1 8.3 5.7 9.8 13.0 27.6 4.3 10.0 6.8 5.6 7.7 28.8 11.5 12.1 18.1 17.0 17.4 17.1 26.3 16.9 15.7 19.1 16.6 17.2 15.8 19.8 18.3 24.4 6.4 7.2 8.8 14.9 21.3 21.3 29.8 14.8 31.0 17.2 15.7 0.3 20.0 20.1 20.2 29.2 63.3 26.5 10.5 13.7 58.1 2.1 15.3 19.2 24.1 12.2 21.8 10.2 45.7 72.3 24.6 16.8 18.9 22.7 40.9 19.2 14.3 98.7 26.9 10.3 13.8 46.8 45.6 28.4 3.7 22.7 61.8 33.8 15.0 32.7 28.5 24.7 7.1 8.6 37.3 16.0 16.6 18.6 14.4 41.5 18.2 26.2 38.6 6.6 17.4 23.8 24.8 33.5 16.4 22.7 87.3 20.7 37.8 20.0 19.4 SPNS3 "MGC29671, SLC62A3" ENSG00000182557 "Sphingolipid transporter 3 (putative)" Q6ZMD2 17 4433940-4488208 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "bone marrow: 31.2" "Cell type enhanced" "Detected in many" "dendritic cells: 30.9;Langerhans cells: 16.4;Proximal tubular cells: 51.8;T-cells: 23.7" "Cancer enhanced" "Detected in many" "renal cancer: 2.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "eosinophil: 354.8;plasmacytoid DC: 127.7" "Group enriched" "Detected in many" 37 "dendritic cells: 127.7;granulocytes: 354.8" "Group enriched" "Detected in some" 4 "JURKAT: 29.5;NB-4: 46.8;THP-1: 35.5;U-937: 22.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023928 Uncertain NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA023928: AB_1844393" "unprognostic (4.39e-2)" "unprognostic (8.10e-5)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.94e-4)" "unprognostic (2.86e-2)" "unprognostic (1.96e-2)" "unprognostic (1.81e-2)" "unprognostic (6.46e-2)" "unprognostic (1.37e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.09e-4)" "unprognostic (6.18e-2)" "unprognostic (6.57e-2)" "unprognostic (4.13e-2)" "unprognostic (9.69e-2)" 0.1 0.1 0.3 1.4 0.2 31.2 0.3 0.4 0.4 0.2 0.0 0.2 0.4 0.0 0.0 0.1 0.7 0.7 0.2 0.2 0.7 0.2 0.1 0.2 2.0 0.8 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.9 0.3 0.0 0.3 0.7 0.1 0.6 2.1 0.3 0.0 0.5 3.6 0.0 0.0 1.1 0.3 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 2.4 0.0 0.0 8.1 46.8 0.0 0.2 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 6.6 0.0 22.1 0.0 0.3 6.5 354.8 1.1 1.3 0.7 0.2 0.0 1.5 47.6 0.3 0.4 1.7 1.0 0.2 0.1 127.7 0.0 6.2 0.3 0.2 0.4 0.4 0.2 0.7 0.8 0.4 0.5 0.6 0.5 0.7 0.5 3.2 1.1 0.0 4.3 1.3 0.1 0.4 0.0 0.0 1.0 0.8 0.8 1.5 1.6 0.0 0.0 0.3 30.9 0.5 3.9 2.0 1.1 0.8 0.0 0.6 0.0 4.8 0.9 0.0 6.1 0.3 2.0 0.1 0.0 0.0 0.7 0.3 1.4 0.0 0.8 2.1 6.1 5.5 16.4 2.6 0.0 9.8 1.8 3.7 6.7 0.0 11.3 0.0 0.1 1.1 1.4 0.0 0.6 0.5 10.9 51.8 5.0 0.0 0.0 0.3 0.6 0.0 0.3 0.2 0.4 0.3 23.7 0.0 2.5 2.1 SRSF9 "SFRS9, SRp30c" ENSG00000111786 "Serine and arginine rich splicing factor 9" Q13242 12 120461672-120469748 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049849 Supported Supported Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Nucleoli "HPA049849: AB_2680911" "unprognostic (3.80e-1)" "unprognostic (3.84e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (2.50e-3)" "prognostic unfavorable (9.85e-7)" "unprognostic (9.65e-3)" "prognostic unfavorable (7.80e-4)" "unprognostic (2.31e-2)" "unprognostic (4.35e-1)" "unprognostic (1.19e-2)" "unprognostic (1.19e-3)" "unprognostic (9.57e-2)" "unprognostic (3.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" 68.2 112.1 71.2 75.5 74.3 95.0 72.0 73.9 75.2 70.3 81.0 88.7 73.0 57.5 85.5 126.6 76.1 48.7 38.8 70.6 75.1 94.7 92.0 62.1 99.3 72.7 77.2 71.2 113.8 94.2 78.2 85.2 74.0 76.9 84.2 21.8 77.1 57.4 30.0 80.6 63.5 58.9 74.4 86.7 82.6 93.3 77.6 110.2 80.6 27.5 129.1 82.9 75.6 72.1 334.7 229.2 344.3 222.7 153.6 153.7 365.3 224.3 200.7 281.5 240.2 276.9 153.1 323.6 254.7 189.4 152.7 194.9 312.0 318.9 308.5 244.7 321.9 276.3 152.8 273.5 197.7 344.7 241.8 163.4 201.8 244.6 211.0 301.2 260.4 207.0 353.6 95.3 245.9 466.8 339.7 668.7 429.6 224.8 198.2 374.2 144.1 312.9 246.4 420.4 303.9 217.3 262.5 137.3 276.2 222.4 415.9 299.4 229.1 207.8 247.0 157.8 246.3 288.6 234.5 404.9 218.8 255.7 221.5 28.7 16.9 49.3 22.5 19.8 17.5 41.2 17.4 19.9 22.5 36.7 17.3 19.1 19.7 26.5 27.7 30.7 20.1 8.7 71.2 74.3 73.9 75.2 70.6 75.1 72.7 77.2 74.0 74.4 77.6 72.1 172.6 25.6 37.2 17.3 190.1 264.9 269.7 81.2 140.0 74.5 235.6 174.4 1.7 157.3 60.4 161.8 29.2 339.2 204.5 119.5 489.1 200.6 68.5 179.1 149.9 143.8 144.7 141.9 24.1 155.1 469.4 148.9 105.5 143.9 33.7 321.3 132.8 150.0 202.9 72.3 23.6 160.5 63.1 136.3 322.0 28.5 124.5 171.3 200.9 11.2 192.7 134.4 129.8 14.1 24.1 152.4 102.2 155.0 317.8 336.8 89.8 404.3 63.6 55.3 52.6 128.1 165.5 288.5 248.8 218.2 313.4 475.4 158.1 433.1 160.6 392.2 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42596934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Cluster 13: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: AB_2680020" "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favorable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 21.0 17.1 27.6 18.5 28.6 33.9 21.9 28.8 37.1 19.8 26.7 17.5 19.0 12.6 17.8 21.2 15.7 10.4 18.7 28.2 28.4 24.5 32.4 19.6 35.4 28.2 27.8 19.1 21.6 13.5 25.1 9.9 28.3 35.9 13.6 13.7 19.1 8.6 16.2 24.9 25.6 7.4 28.4 31.6 22.7 10.1 27.8 23.6 20.4 11.0 30.2 19.4 18.5 31.5 32.3 14.0 29.0 26.4 34.9 27.8 17.3 20.6 22.4 28.7 32.2 27.1 29.1 43.3 18.2 13.6 31.6 17.9 33.9 28.0 30.9 21.7 40.5 46.9 28.9 45.3 25.4 62.5 36.2 22.1 17.7 23.7 21.9 20.6 31.4 39.1 43.2 65.4 23.1 29.3 44.8 76.4 45.9 42.7 34.2 23.6 20.6 61.2 32.3 38.2 16.2 23.0 17.6 27.2 29.8 30.2 35.8 57.4 19.5 18.0 29.0 42.8 38.0 46.5 76.3 73.5 26.3 66.1 17.0 60.4 56.4 84.9 88.4 66.0 121.0 120.3 116.3 106.2 62.1 104.3 99.5 101.1 75.8 83.0 50.9 74.5 139.2 90.4 27.6 28.6 28.8 37.1 28.2 28.4 28.2 27.8 28.3 28.4 27.8 31.5 39.3 12.8 16.7 5.5 96.3 107.1 70.1 101.5 91.0 16.2 78.6 77.8 19.3 42.9 46.1 27.6 8.4 57.1 102.9 39.2 56.7 43.4 4.3 47.0 37.9 37.0 55.1 67.3 13.6 49.2 75.8 39.0 39.8 71.9 45.7 39.6 32.5 61.0 66.8 23.5 11.2 51.1 79.3 38.6 51.2 3.7 34.5 43.0 51.6 6.5 69.3 38.1 88.6 3.0 25.8 50.6 58.9 15.8 72.4 75.6 121.4 85.2 28.2 26.8 13.1 26.4 32.5 19.4 24.7 84.5 138.1 37.4 103.2 34.5 53.7 99.2 STRN4 "PPP2R6C, ZIN" ENSG00000090372 "Striatin 4" Q9NRL3 19 46719511-46746994 "Predicted intracellular proteins, Predicted membrane proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043051, HPA043527, HPA056706" Supported Approved Cytosol NA NA 32000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA043051: AB_2678290, HPA043527: AB_10959664, HPA056706: AB_2683214" "unprognostic (3.57e-2)" "unprognostic (7.96e-2)" "unprognostic (2.13e-2)" "unprognostic (7.39e-2)" "unprognostic (1.81e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (6.06e-8)" "unprognostic (8.31e-3)" "unprognostic (5.34e-2)" "prognostic unfavorable (2.98e-4)" "unprognostic (1.56e-1)" "unprognostic (9.41e-3)" "unprognostic (4.86e-3)" "unprognostic (6.74e-2)" "unprognostic (4.06e-2)" "unprognostic (6.04e-2)" "unprognostic (1.84e-1)" 34.2 25.3 25.5 19.5 25.3 37.6 32.8 15.5 31.1 33.5 19.7 38.0 22.6 37.0 7.9 48.1 32.8 19.6 37.1 32.5 21.4 29.2 23.0 33.8 21.2 19.1 18.8 30.9 36.5 21.3 22.8 20.4 17.6 33.2 12.8 9.7 31.0 19.8 36.1 42.5 30.5 17.7 17.8 42.8 33.8 85.3 24.9 19.4 27.7 15.5 11.6 35.2 34.2 23.5 60.8 79.2 67.5 50.2 19.1 21.1 47.7 51.2 27.4 52.0 45.3 59.7 52.5 30.1 30.2 42.0 42.5 42.2 31.9 49.8 20.3 43.7 66.9 66.3 52.4 51.4 60.8 54.1 69.5 33.8 49.1 33.5 45.5 26.2 46.8 34.9 59.2 38.2 22.1 41.4 60.6 143.4 51.8 63.5 37.1 55.1 41.2 23.3 34.9 107.0 83.5 89.8 71.7 66.1 34.5 29.0 49.7 60.5 64.3 38.8 58.4 26.9 76.4 48.5 74.1 45.0 33.9 33.8 81.9 4.2 6.0 2.8 1.0 9.1 0.3 1.4 0.8 0.7 3.1 2.5 0.4 0.9 9.3 1.4 5.7 2.7 0.3 5.8 25.5 25.3 15.5 31.1 32.5 21.4 19.1 18.8 17.6 17.8 24.9 23.5 28.4 3.2 7.5 6.2 7.7 17.2 10.7 11.6 6.2 14.7 17.7 15.0 12.1 14.3 8.9 7.3 12.5 14.6 10.4 28.3 1.9 12.6 11.4 15.7 17.9 23.9 17.5 11.6 13.7 15.4 18.1 11.4 15.3 18.2 0.0 22.5 20.3 12.3 14.8 30.3 11.1 23.0 10.2 24.1 14.6 19.6 17.7 22.9 10.6 13.1 16.9 7.9 2.1 5.5 12.1 19.8 17.7 19.9 8.0 18.3 15.4 7.4 9.0 7.9 6.6 13.4 14.3 19.8 44.9 16.8 17.3 20.0 8.5 18.6 18.9 17.8 SYTL1 "exophilin-7, FLJ14996, JFC1, SLP1" ENSG00000142765 "Synaptotagmin like 1" Q8IYJ3 1 27342020-27353937 "Plasma proteins, Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;pancreas: 106.3;skin 1: 87.2" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 158.8;NK-cells: 208.1;Squamous epithelial cells: 179.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 4.3;cerebellum: 8.8" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 47.8;CAPAN-2: 55.8;NB-4: 81.8;U-266/70: 44.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA037825 Enhanced NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 24: NB-4 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA037825: AB_10671635" "unprognostic (4.23e-2)" "unprognostic (8.23e-2)" "unprognostic (2.40e-1)" "prognostic favorable (6.83e-7)" "unprognostic (7.81e-3)" "unprognostic (5.81e-2)" "unprognostic (1.05e-1)" "unprognostic (7.18e-3)" "unprognostic (4.41e-1)" "unprognostic (1.14e-2)" "unprognostic (2.07e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (1.45e-1)" "unprognostic (3.02e-1)" "unprognostic (1.72e-2)" "unprognostic (5.88e-3)" 2.0 0.6 4.3 19.1 0.7 46.7 7.7 8.8 1.4 22.6 6.1 6.7 7.8 1.3 1.2 103.9 15.5 8.6 0.9 1.0 1.0 2.8 2.1 13.1 32.9 0.7 0.8 0.6 106.3 4.2 15.6 2.9 0.8 63.6 3.3 0.0 47.6 12.7 0.5 87.2 17.6 0.4 0.5 42.0 41.8 0.9 1.2 21.4 9.8 0.5 20.0 21.6 50.9 0.6 11.3 0.2 0.0 0.4 0.0 0.0 47.8 0.0 0.0 0.0 0.0 1.2 55.8 8.5 10.9 0.0 0.3 34.7 0.0 21.0 0.0 0.0 2.1 1.0 0.9 15.3 0.8 21.9 0.0 0.0 37.8 0.0 7.8 0.2 0.0 28.2 0.7 9.5 0.0 15.5 12.9 81.8 0.5 19.1 5.7 14.9 0.1 40.2 8.6 9.6 15.9 0.9 0.0 15.9 0.6 0.5 40.4 23.3 0.2 0.1 5.1 0.0 0.0 44.3 11.7 8.0 1.6 27.7 0.0 47.0 18.9 176.5 65.0 49.1 58.4 42.8 51.5 53.2 51.0 32.3 30.6 37.3 34.1 49.0 100.8 3.0 63.4 40.0 4.3 0.7 8.8 1.4 1.0 1.0 0.7 0.8 0.8 0.5 1.2 0.6 1.9 22.4 13.6 0.0 68.6 41.2 78.2 84.4 158.8 0.6 33.6 49.8 3.9 8.6 69.2 0.0 0.0 37.4 92.3 4.8 7.9 3.7 0.8 67.8 2.4 2.3 11.4 15.8 0.3 25.5 10.1 3.1 100.9 18.3 1.3 0.2 2.2 1.1 3.2 0.0 0.3 47.6 32.6 6.7 12.7 0.7 0.3 15.7 10.6 0.0 18.8 2.0 208.1 0.0 0.1 12.1 3.7 0.7 52.3 46.8 3.1 6.4 62.8 0.8 0.0 1.3 5.6 30.3 23.1 179.1 55.3 14.1 74.9 0.2 9.4 95.3 TAF1D "JOSD3, MGC5306, TAF(I)41" ENSG00000166012 "TATA-box binding protein associated factor, RNA polymerase I subunit D" Q9H5J8 11 93729948-93784391 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030703, HPA055935, HPA060385" Uncertain Supported "Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite" Yes No "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli, Mitotic spindle, Centriolar satellite" "HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271" "unprognostic (9.91e-3)" "unprognostic (4.38e-2)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "unprognostic (5.40e-3)" "unprognostic (6.46e-2)" "unprognostic (3.68e-3)" "unprognostic (9.70e-2)" "unprognostic (5.24e-3)" "unprognostic (3.55e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (3.17e-7)" "unprognostic (1.95e-1)" "unprognostic (2.51e-1)" "unprognostic (2.34e-1)" "unprognostic (6.37e-2)" 10.0 9.3 2.5 18.2 3.0 16.4 12.6 5.0 6.7 7.7 1.2 9.5 13.7 14.1 9.0 9.5 7.7 15.4 7.1 2.9 3.5 6.8 6.9 8.1 20.6 2.3 0.6 13.8 20.9 5.3 4.9 18.0 2.3 9.9 12.5 8.2 10.1 7.3 8.0 11.4 13.3 9.1 0.5 11.9 11.9 5.5 1.7 10.9 10.1 7.1 13.1 13.8 7.2 7.8 18.2 8.6 17.5 17.9 14.0 47.8 29.2 27.0 11.5 18.4 13.8 28.6 38.8 32.6 34.0 15.6 12.6 44.3 21.5 25.9 21.2 10.6 7.8 34.8 55.6 20.2 16.4 31.9 25.1 19.5 25.8 16.0 35.7 35.0 23.7 22.7 24.2 50.4 22.8 5.0 25.8 66.4 12.1 16.7 9.6 23.3 19.1 30.9 22.7 17.4 10.7 19.5 10.8 38.2 16.5 19.3 32.7 12.4 28.7 26.9 30.5 44.2 28.7 22.9 26.2 32.5 11.2 36.9 10.3 44.2 16.7 28.8 17.3 12.5 17.7 39.1 24.9 19.8 12.0 39.8 28.4 24.1 42.7 18.1 10.8 26.1 18.2 5.2 2.5 3.0 5.0 6.7 2.9 3.5 2.3 0.6 2.3 0.5 1.7 7.8 106.7 89.8 95.5 20.9 246.1 244.2 252.4 66.6 255.0 86.6 129.4 130.9 26.2 134.4 105.3 29.5 39.6 176.0 162.5 94.5 45.0 95.2 19.9 144.9 184.9 121.3 110.2 98.4 41.6 146.3 170.2 147.1 125.4 245.6 104.4 257.2 63.1 54.2 69.3 69.0 38.2 148.0 24.4 103.7 153.6 16.5 128.6 112.0 80.0 24.4 102.1 34.8 89.6 35.2 44.0 110.4 87.5 67.7 162.2 269.2 71.1 101.5 67.7 78.2 72.3 187.4 123.1 49.0 71.5 251.4 203.0 160.9 182.3 119.7 174.1 356.8 TAS2R14 "T2R14, TRB1" ENSG00000212127 "Taste 2 receptor member 14" Q9NYV8 12 10937408-11171573 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 7.1;Cone photoreceptor cells: 10.4;Rod photoreceptor cells: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.2" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (4.26e-2)" "unprognostic (1.41e-1)" "unprognostic (6.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.46e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-3)" "unprognostic (1.18e-1)" "unprognostic (1.12e-3)" "unprognostic (1.93e-2)" "unprognostic (1.22e-4)" "unprognostic (2.45e-2)" "unprognostic (1.07e-1)" "unprognostic (9.29e-3)" "unprognostic (4.71e-3)" 1.2 2.1 1.0 0.4 0.5 0.7 1.3 0.5 1.4 2.4 0.6 2.1 0.5 2.1 2.4 1.1 2.1 0.3 1.3 0.9 0.5 1.4 1.7 1.5 0.4 1.1 0.8 3.3 1.7 0.4 3.0 0.4 0.7 1.9 0.5 1.8 1.7 0.4 1.0 1.0 2.0 0.5 0.5 2.0 1.5 0.9 0.6 0.1 2.5 0.2 0.5 1.7 1.8 0.5 0.3 0.2 0.6 0.1 0.1 0.4 0.1 0.3 0.0 0.0 0.1 0.6 0.4 1.0 0.1 0.2 0.3 0.4 0.0 0.3 0.2 0.5 0.5 0.2 0.6 0.3 0.0 0.3 0.1 0.4 0.2 0.8 0.1 0.5 0.4 0.3 0.5 0.0 0.4 0.1 0.2 2.2 0.6 0.1 0.3 0.3 0.3 0.3 0.5 0.6 0.1 0.6 0.5 0.0 0.0 0.5 0.1 0.3 0.5 0.4 0.3 0.2 0.5 0.1 0.1 0.4 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.5 1.4 0.9 0.5 1.1 0.8 0.7 0.5 0.6 0.5 1.4 3.2 1.5 0.0 1.7 0.6 0.7 1.0 0.6 7.1 1.3 1.8 0.5 1.5 0.5 0.0 10.4 2.1 1.3 0.3 3.9 0.6 0.1 1.7 2.6 0.9 3.5 0.8 0.0 0.4 0.6 1.5 0.0 1.0 0.0 4.8 2.2 1.4 1.3 1.7 0.0 0.9 0.0 1.0 0.3 0.0 2.1 1.6 0.0 0.0 1.3 1.4 1.0 0.0 0.0 0.7 0.2 2.6 0.8 1.0 0.4 0.7 0.8 7.7 0.0 2.2 1.8 0.9 0.5 0.4 0.1 0.5 1.2 4.4 1.0 0.4 TBC1D10C "Carabin, EPI64C, FLJ00332" ENSG00000175463 "TBC1 domain family member 10C" Q8IV04 11 67403915-67410089 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6" "Group enriched" "Detected in many" 4 "B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA069743 Enhanced Approved "Nuclear bodies" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" "HPA069743: AB_2686186" "prognostic favorable (3.83e-4)" "prognostic favorable (4.20e-4)" "unprognostic (9.23e-2)" "unprognostic (3.84e-2)" "unprognostic (1.28e-3)" "prognostic favorable (1.86e-5)" "unprognostic (6.22e-3)" "unprognostic (1.17e-2)" "unprognostic (3.65e-2)" "unprognostic (3.55e-2)" "unprognostic (3.28e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (7.18e-2)" "unprognostic (3.81e-2)" 2.3 0.7 0.7 25.8 1.2 40.4 1.1 0.4 1.2 1.4 0.8 4.1 5.5 0.9 0.1 2.3 1.9 3.2 0.9 0.6 0.6 2.5 2.6 8.9 56.7 0.9 0.5 0.5 0.8 0.2 0.5 0.8 0.6 1.9 1.5 0.0 3.8 0.7 0.9 1.4 25.6 0.5 0.5 58.6 7.6 0.5 0.7 46.0 7.6 0.6 21.8 3.2 1.7 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.7 0.1 1.2 0.0 6.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.1 0.0 0.0 0.3 47.1 64.7 0.0 0.0 0.0 6.6 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 4.5 0.0 0.0 0.1 0.2 0.0 0.4 0.5 12.2 0.0 24.6 0.0 191.0 46.0 270.4 237.7 120.4 169.7 177.3 201.5 208.3 65.6 184.2 206.7 192.0 237.6 148.0 167.0 55.8 286.6 261.6 0.7 1.2 0.4 1.2 0.6 0.6 0.9 0.5 0.6 0.5 0.7 1.1 2.5 6.4 19.5 0.0 109.6 1.1 0.1 0.1 0.6 1.0 1.4 1.9 1.5 2.8 2.5 0.0 0.0 0.2 144.4 0.2 0.0 0.2 0.2 2.4 0.4 1.9 1.2 12.6 0.2 0.0 0.3 2.0 2.0 1.1 23.4 0.1 5.0 1.4 23.7 0.0 0.1 0.0 0.0 16.0 6.9 0.6 0.0 23.1 3.6 1.0 24.5 0.3 284.2 0.0 0.5 0.0 0.0 0.0 40.2 0.1 0.1 1.1 1.3 0.5 0.0 1.3 1.1 0.1 0.2 0.0 1.0 0.4 147.7 0.1 0.1 0.1 TBXAS1 "CYP5, CYP5A1, THAS, TS, TXAS, TXS" ENSG00000059377 "Thromboxane A synthase 1" P24557 7 139777051-140020325 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Lyase, Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.8" "Group enriched" "Detected in many" 4 "granulocytes: 71.0;Hofbauer cells: 88.8;Kupffer cells: 193.6;Macrophages: 132.9;Microglial cells: 191.1;monocytes: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 14 "basophil: 324.3;classical monocyte: 322.4;eosinophil: 333.6;intermediate monocyte: 466.0;myeloid DC: 129.0;neutrophil: 271.1;non-classical monocyte: 423.1" "Group enriched" "Detected in all" 22 "dendritic cells: 129.0;granulocytes: 333.6;monocytes: 466.0" "Cell line enhanced" "Detected in many" "NB-4: 76.7;PC-3: 23.7;RPTEC TERT1: 21.0;U-937: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA031257, HPA031258, HPA031259" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 890000 "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" "Endoplasmic reticulum, Cytosol" "HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814" "unprognostic (4.46e-2)" "unprognostic (3.07e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (2.72e-1)" "unprognostic (9.41e-2)" "unprognostic (5.10e-2)" "unprognostic (3.12e-1)" "unprognostic (2.38e-1)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.52e-1)" "unprognostic (5.00e-3)" "unprognostic (8.53e-2)" "unprognostic (5.34e-2)" 13.2 10.8 5.3 28.1 5.1 24.8 8.2 5.4 5.9 5.4 5.8 10.1 10.3 3.2 2.0 5.4 4.9 21.2 3.3 4.5 6.8 5.8 12.8 23.9 12.4 10.0 6.6 2.9 3.6 2.9 2.3 14.2 8.8 6.4 13.0 1.6 9.0 4.0 1.0 1.3 11.9 12.6 8.9 57.8 11.2 1.4 9.7 15.1 1.8 3.3 8.3 13.9 2.1 14.7 0.2 5.4 0.3 0.1 1.2 3.9 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 12.1 0.0 0.3 0.0 0.0 0.0 0.0 9.4 0.7 17.8 0.0 0.0 1.6 6.2 15.3 2.1 0.0 0.0 0.9 1.1 2.3 0.1 0.6 2.2 0.6 0.2 2.4 76.7 0.2 18.0 23.7 2.6 0.0 1.2 21.0 0.0 0.2 1.1 0.2 0.0 0.8 0.0 0.0 14.4 2.0 0.6 0.2 1.4 1.0 4.6 0.9 0.3 0.4 60.8 1.7 324.3 322.4 333.6 7.3 466.0 11.9 8.3 13.5 3.7 129.0 4.5 2.3 1.3 271.1 11.9 423.1 22.6 13.9 216.7 5.3 5.1 5.4 5.9 4.5 6.8 10.0 6.6 8.8 8.9 9.7 14.7 3.9 3.2 10.8 8.1 9.9 0.4 1.2 0.5 2.8 1.0 3.0 3.0 1.1 5.7 1.7 1.8 6.2 0.6 16.4 0.8 9.8 5.2 0.4 1.0 0.6 5.0 1.8 12.8 1.2 9.5 0.5 2.9 7.1 3.8 71.0 0.5 16.8 8.6 88.8 3.3 1.8 1.9 12.2 193.6 19.5 0.7 0.3 132.9 3.6 191.1 63.7 4.9 26.8 3.0 5.9 4.4 7.9 0.0 16.4 5.8 0.2 6.3 1.0 4.1 19.7 1.3 1.7 0.5 0.7 26.2 0.6 0.5 13.4 0.3 2.7 1.2 TEKT2 TEKTB1 ENSG00000092850 "Tektin 2" Q9UIF3 1 36084094-36088275 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 62.8;testis: 71.2" "Group enriched" "Detected in some" 4 "Early spermatids: 523.7;Late spermatids: 306.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enriched" "Detected in some" 8 "NB-4: 37.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA027248, HPA027461" Approved Approved Microtubules NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" Microtubules "HPA027248: AB_1857884, HPA027461: AB_10600912" "unprognostic (1.02e-3)" "unprognostic (1.21e-2)" "unprognostic (2.96e-2)" "unprognostic (2.12e-3)" "unprognostic (2.64e-1)" "unprognostic (1.78e-2)" "unprognostic (1.98e-2)" "unprognostic (3.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-3)" "unprognostic (5.28e-4)" "unprognostic (6.11e-2)" "prognostic favorable (1.98e-4)" "unprognostic (9.78e-2)" "unprognostic (8.35e-2)" "unprognostic (5.29e-2)" "unprognostic (7.68e-2)" 0.2 0.5 2.2 0.1 2.4 1.5 0.9 1.9 2.6 3.5 12.2 0.6 0.1 1.5 0.1 0.2 62.8 0.1 0.1 2.3 3.0 3.1 0.1 6.3 0.1 4.6 6.3 0.5 2.4 0.7 4.3 0.0 3.7 0.7 0.0 0.1 0.4 0.5 0.0 0.2 0.2 0.3 4.4 0.0 0.4 71.2 3.1 1.1 2.7 0.0 0.0 0.1 0.3 3.3 0.0 0.0 4.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 37.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.2 2.4 1.9 2.6 2.3 3.0 4.6 6.3 3.7 4.4 3.1 3.3 0.2 0.0 0.0 0.0 0.2 0.1 0.6 9.4 0.0 0.0 0.8 0.6 0.6 0.0 8.0 1.8 0.0 0.2 0.0 0.0 0.0 0.9 523.7 81.2 0.8 0.4 1.8 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.1 12.2 0.0 0.0 306.1 5.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.1 0.0 3.8 0.0 0.4 0.0 2.5 84.7 0.1 0.0 0.0 2.6 27.6 4.0 0.0 0.0 0.0 0.2 0.4 0.1 0.5 TESC "CHP3, FLJ20607, TSC" ENSG00000088992 Tescalcin Q96BS2 12 117038923-117099479 "Predicted intracellular proteins" "Differentiation, Protein transport, Transport" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 329.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 183.0;Erythroid cells: 222.9;Exocrine glandular cells: 481.2;Gastric mucus-secreting cells: 316.0;Late spermatids: 319.3;Pancreatic endocrine cells: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 261.1" "Lineage enriched" "Detected in all" 5 "monocytes: 261.1" "Cell line enhanced" "Detected in many" "HMC-1: 398.5;NB-4: 675.1;OE19: 288.1;U-937: 221.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053200 Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 24: NB-4 - Immune response" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm Cytosol "HPA053200: AB_2682079" "unprognostic (4.53e-3)" "unprognostic (5.98e-2)" "unprognostic (6.50e-2)" "unprognostic (2.23e-3)" "unprognostic (6.31e-2)" "unprognostic (2.05e-3)" "unprognostic (4.98e-3)" "unprognostic (3.35e-1)" "unprognostic (4.35e-1)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.69e-2)" "unprognostic (8.65e-2)" "unprognostic (2.57e-1)" "unprognostic (1.56e-2)" "unprognostic (5.67e-3)" 8.1 46.5 17.4 10.3 36.8 118.8 8.9 16.4 25.4 4.3 15.7 3.8 7.2 3.9 121.9 3.3 4.0 36.1 71.5 26.5 15.0 26.5 4.9 10.2 8.0 17.8 15.0 5.3 102.4 9.4 26.7 10.2 18.2 9.8 2.8 0.5 329.9 19.7 5.1 9.7 7.3 2.8 14.8 11.9 138.4 31.1 15.5 7.4 10.7 8.1 10.3 29.3 5.3 18.9 0.2 97.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 4.3 13.8 4.7 0.0 0.2 0.6 8.1 0.0 0.0 37.5 19.2 115.5 9.8 78.1 0.0 49.2 398.5 0.1 0.0 0.0 0.0 0.0 0.0 18.5 54.0 0.9 0.0 2.2 95.5 675.1 9.0 288.1 0.0 0.4 0.0 52.4 56.5 15.0 17.0 6.1 0.1 0.1 3.6 0.9 0.0 53.9 0.0 0.0 1.7 0.2 0.4 17.0 38.2 0.0 0.1 221.8 0.5 0.0 51.0 51.5 7.0 67.9 0.4 5.5 2.4 9.1 35.8 13.1 0.3 3.8 12.6 11.6 261.1 2.6 3.5 19.0 17.4 36.8 16.4 25.4 26.5 15.0 17.8 15.0 18.2 14.8 15.5 18.9 35.6 0.0 0.0 5.9 16.2 2.7 0.3 0.4 1.8 0.8 5.5 67.1 58.3 183.0 0.9 12.9 0.0 0.4 21.1 0.2 74.3 159.5 106.5 1.3 0.7 43.6 1.8 222.9 26.1 481.2 0.6 7.9 316.0 3.2 71.1 1.2 1.8 0.5 48.0 0.0 2.0 1.5 0.0 17.9 6.1 319.3 3.1 30.6 72.9 8.4 41.0 0.2 25.7 2.5 1.5 215.6 0.9 3.4 25.8 3.5 0.2 6.1 0.0 1.5 144.7 1.9 68.4 63.0 20.3 0.5 2.0 1.2 28.3 66.7 2.3 1.3 TEX30 C13orf27 ENSG00000151287 "Testis expressed 30" Q5JUR7 13 102765888-102773811 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "epididymis: 71.3;liver: 40.1;testis: 122.8" "Cell type enhanced" "Detected in many" "Early spermatids: 384.7;Spermatocytes: 958.6;Spermatogonia: 283.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 364.5" "Lineage enriched" "Detected in all" 13 "granulocytes: 364.5" "Cell line enhanced" "Detected in many" "NB-4: 295.3;THP-1: 188.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053545 Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA053545: AB_2682181" "unprognostic (5.26e-2)" "prognostic favorable (2.09e-5)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" "unprognostic (7.48e-2)" "unprognostic (1.54e-2)" "unprognostic (7.49e-2)" "unprognostic (9.86e-3)" "unprognostic (1.22e-1)" "unprognostic (1.25e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.10e-6)" "unprognostic (1.89e-2)" "unprognostic (1.79e-1)" "unprognostic (8.66e-3)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" 8.4 6.0 8.5 6.7 7.8 14.4 7.7 8.6 12.3 7.3 8.0 5.6 5.5 10.4 71.3 8.4 6.1 4.9 9.1 7.7 7.9 19.2 40.1 5.9 11.8 7.7 8.2 7.2 5.6 4.3 7.2 14.9 7.7 4.6 4.5 7.5 5.2 13.1 9.7 7.5 5.4 7.3 7.8 6.5 5.7 122.8 9.1 16.1 5.5 9.3 7.4 6.8 6.4 8.5 44.0 16.1 39.0 30.8 23.3 16.8 0.4 59.0 14.9 39.9 35.6 41.2 43.0 25.6 25.0 22.4 52.5 23.8 35.3 21.0 53.9 53.8 21.3 44.2 34.9 0.4 15.7 92.5 86.0 8.9 13.6 33.2 20.8 14.4 30.8 64.9 27.6 0.0 47.6 24.5 61.0 295.3 14.1 63.4 38.3 37.8 18.0 18.4 61.7 18.5 51.2 22.1 33.3 42.9 37.8 23.0 30.0 188.3 12.0 27.3 21.2 44.0 63.7 23.9 30.3 0.1 46.9 54.0 45.9 364.5 7.6 79.4 10.6 9.4 15.2 12.9 11.6 13.6 8.8 11.8 13.1 11.2 3.9 28.5 9.7 17.8 18.8 8.8 8.5 7.8 8.6 12.3 7.7 7.9 7.7 8.2 7.7 7.8 9.1 8.5 12.4 0.0 3.7 1.6 15.0 23.7 16.2 35.3 12.0 7.4 12.1 21.5 12.2 7.2 14.3 12.9 4.2 110.9 10.9 3.4 37.2 16.0 384.7 11.1 10.2 15.5 3.0 34.1 5.1 9.7 113.9 15.7 5.1 6.7 27.3 11.3 13.6 39.5 46.6 6.7 6.3 4.9 22.4 5.3 18.9 79.2 30.4 11.7 28.4 4.7 17.7 8.0 14.4 5.0 4.6 9.7 2.2 18.8 15.8 16.0 8.1 100.8 11.2 5.9 92.1 15.4 29.7 958.6 283.2 16.9 19.9 142.3 20.2 5.0 8.3 10.9 TFAP2E AP2E ENSG00000116819 "Transcription factor AP-2 epsilon" Q6VUC0 1 35573314-35595328 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 9.8;Excitatory neurons: 9.0;Inhibitory neurons: 9.8;Oligodendrocytes: 11.3;Rod photoreceptor cells: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 4.6;SK-MEL-30: 1.7;U-937: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 24: NB-4 - Immune response" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (7.06e-4)" "unprognostic (1.96e-2)" "unprognostic (9.05e-2)" "unprognostic (2.29e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-2)" "unprognostic (3.27e-2)" "unprognostic (9.39e-2)" "unprognostic (4.02e-1)" "unprognostic (7.45e-2)" "unprognostic (1.67e-15)" "unprognostic (2.03e-1)" "unprognostic (4.83e-1)" "unprognostic (3.48e-2)" "unprognostic (7.40e-2)" 1.0 0.6 3.0 0.9 2.8 1.5 1.0 9.2 4.0 3.5 0.2 1.1 0.1 1.3 0.3 1.2 2.5 0.2 0.9 2.6 2.2 1.1 0.3 1.3 0.9 2.8 2.3 2.5 0.6 0.0 3.2 0.2 3.0 1.7 0.1 4.4 1.0 0.1 0.4 5.2 1.2 0.0 2.4 1.9 1.0 2.2 2.4 0.3 0.5 0.0 0.3 0.8 3.1 5.1 0.2 0.2 0.2 0.1 0.1 0.1 0.8 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.2 0.5 0.4 0.3 0.0 0.0 0.6 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.3 4.6 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.1 1.7 0.1 0.4 1.4 0.1 0.1 0.7 0.4 0.1 0.8 0.4 0.0 0.1 3.6 0.5 0.5 0.8 0.5 0.9 0.3 0.3 0.4 0.5 0.8 0.4 0.4 0.2 0.8 0.0 0.9 0.4 0.3 0.8 0.5 3.0 2.8 9.2 4.0 2.6 2.2 2.8 2.3 3.0 2.4 2.4 5.1 0.2 0.0 1.3 4.9 0.2 3.7 0.1 0.3 0.0 9.8 0.5 0.5 0.4 0.0 0.8 0.0 2.1 0.4 0.9 0.1 0.0 0.2 0.5 0.3 0.4 0.3 0.0 0.0 9.0 0.0 0.0 0.4 2.6 0.5 0.0 0.1 0.4 0.2 1.0 0.0 9.8 0.0 0.0 1.0 0.0 1.0 2.1 0.6 1.8 1.9 0.5 0.3 3.1 3.5 11.3 0.2 0.3 0.7 0.3 0.1 0.1 0.0 0.2 5.6 0.0 0.2 0.4 2.4 0.4 0.0 4.4 0.1 0.9 0.1 0.4 0.2 TFAP4 "AP-4, bHLHc41" ENSG00000090447 "Transcription factor AP-4" Q01664 16 4257186-4273075 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 30.1;Proximal enterocytes: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001912 Supported Supported Nucleoplasm,Mitochondria NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" "Nucleoplasm, Mitochondria" "HPA001912: AB_1080251" "unprognostic (1.61e-2)" "unprognostic (1.36e-1)" "unprognostic (5.10e-2)" "unprognostic (4.42e-3)" "unprognostic (8.61e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (8.05e-2)" "unprognostic (8.97e-2)" "unprognostic (4.60e-1)" "unprognostic (5.75e-2)" "unprognostic (7.68e-2)" "prognostic unfavorable (4.31e-6)" "unprognostic (1.08e-2)" "unprognostic (3.25e-1)" "unprognostic (2.39e-2)" "unprognostic (1.30e-1)" 6.2 4.2 3.7 6.9 3.8 1.9 5.8 5.3 5.4 9.0 1.7 5.4 6.4 7.8 1.0 8.1 6.9 3.8 3.2 3.5 3.2 3.6 5.3 3.9 6.8 3.9 3.7 10.0 12.0 3.3 4.3 3.7 3.9 5.7 1.9 0.7 7.6 3.1 7.5 10.5 6.8 2.5 3.5 7.3 5.0 1.7 3.7 8.3 4.6 3.1 3.9 6.4 8.4 5.1 14.9 15.4 12.9 19.2 5.4 14.1 21.7 5.7 14.6 9.6 10.5 8.1 23.0 51.0 14.5 5.5 4.5 22.0 23.6 19.4 3.0 29.8 17.4 15.6 13.0 21.1 7.5 27.8 8.8 13.3 12.2 10.4 29.0 4.5 6.4 16.7 29.1 13.1 3.8 23.9 39.2 46.4 29.8 14.7 20.2 34.3 28.8 53.7 3.7 11.2 27.0 20.0 19.2 19.7 18.9 2.0 10.0 21.9 4.2 13.1 10.4 46.2 15.1 21.3 19.3 43.6 8.8 27.2 9.5 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.7 3.8 5.3 5.4 3.5 3.2 3.9 3.7 3.9 3.5 3.7 5.1 7.0 3.2 0.0 2.3 11.6 21.5 9.8 5.7 30.1 4.2 8.1 6.6 2.2 7.2 2.1 27.6 0.0 7.7 5.3 5.3 7.9 4.1 0.1 2.4 9.6 5.4 7.8 22.7 3.0 5.7 11.7 7.6 10.7 3.1 0.0 6.9 3.6 3.4 4.2 0.0 3.9 12.4 8.2 4.0 7.4 0.1 11.8 3.7 3.6 1.0 4.7 2.2 5.2 1.5 3.6 2.9 5.3 5.3 7.2 11.1 40.0 5.7 1.4 3.4 6.6 6.9 7.1 0.9 0.9 22.1 22.3 2.2 7.3 7.5 20.2 4.3 TGM4 TGP ENSG00000163810 "Transglutaminase 4" P49221 3 44874608-44914990 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 377 "prostate: 434.4" "Cell type enriched" "Detected in some" 20 "Prostatic glandular cells: 226.6" "Cancer enriched" "Detected in single" 312 "prostate cancer: 75.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.9;hTERT-HME1: 1.3;NB-4: 2.7;RPMI-8226: 2.0;SH-SY5Y: 1.4" "Not detected" "Not detected" "CAB033571, HPA073290" Enhanced NA NA "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" "CAB033571: AB_2287329, HPA073290: " "unprognostic (4.40e-2)" "unprognostic (4.68e-2)" "unprognostic (1.92e-1)" "unprognostic (2.17e-3)" "unprognostic (2.84e-1)" "unprognostic (2.19e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-1)" "unprognostic (2.41e-2)" "unprognostic (1.65e-1)" "unprognostic (8.56e-3)" "unprognostic (5.08e-2)" "unprognostic (1.44e-8)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.68e-1)" "unprognostic (6.41e-2)" 0.0 1.1 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 434.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.3 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.5 4.2 0.7 0.0 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 0.5 0.2 0.1 0.0 0.0 5.7 0.8 0.6 0.4 0.0 0.0 0.2 0.0 0.3 1.3 0.0 1.5 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 11.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.4 0.0 226.6 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.1 0.3 0.0 0.4 1.0 0.2 0.1 0.2 2.4 THYN1 THY28 ENSG00000151500 "Thymocyte nuclear protein 1" Q9P016 11 134248279-134253370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038732, HPA038733" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA038732: AB_10697397, HPA038733: AB_2676183" "unprognostic (5.91e-2)" "unprognostic (6.22e-3)" "unprognostic (4.54e-2)" "unprognostic (3.48e-3)" "unprognostic (2.32e-2)" "unprognostic (8.99e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.01e-5)" "unprognostic (3.32e-2)" "unprognostic (1.99e-2)" "unprognostic (1.02e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" "unprognostic (1.71e-1)" "unprognostic (6.92e-2)" "unprognostic (1.66e-2)" "unprognostic (2.61e-2)" 42.3 40.5 74.2 22.0 75.4 43.3 45.1 74.4 104.9 39.8 68.5 53.9 30.2 43.1 75.8 28.1 47.6 31.1 51.7 75.9 76.2 40.1 57.5 28.3 40.5 72.2 71.3 62.9 32.8 27.9 50.8 22.2 73.2 50.1 44.9 41.3 29.6 54.2 32.3 28.1 36.3 42.3 72.5 36.6 39.4 42.6 74.9 77.1 52.1 38.0 44.5 44.3 33.1 76.6 32.0 19.5 69.8 56.0 65.9 74.7 41.0 26.9 59.2 62.0 58.1 106.8 76.3 60.0 88.6 37.8 66.6 48.9 106.8 82.0 60.5 61.5 30.3 165.5 25.7 97.6 94.3 133.0 52.4 56.9 43.2 73.9 48.2 80.6 98.9 199.0 78.1 28.0 56.5 17.7 155.1 242.8 81.0 127.0 71.0 72.3 51.8 50.6 86.4 55.4 66.4 53.7 55.8 13.6 33.1 50.3 78.2 66.5 52.7 26.6 41.3 24.4 41.7 31.4 35.0 126.9 39.5 170.6 31.5 185.4 89.8 330.3 145.2 108.4 175.6 122.1 152.3 146.8 99.1 96.4 175.4 200.0 47.2 139.1 104.4 131.3 199.8 160.0 74.2 75.4 74.4 104.9 75.9 76.2 72.2 71.3 73.2 72.5 74.9 76.6 41.9 32.1 28.8 8.1 31.1 23.8 42.2 107.4 28.5 28.6 37.5 65.4 52.1 47.1 57.7 36.8 14.6 52.7 33.5 25.5 86.1 48.2 28.2 44.7 33.8 36.9 57.6 40.8 15.3 55.6 52.9 42.3 20.4 23.4 40.5 65.5 37.1 47.9 53.0 28.6 12.0 47.9 75.3 22.2 23.7 16.0 50.4 32.7 40.9 8.4 43.1 65.7 44.3 11.1 11.1 53.2 33.0 48.5 29.8 13.4 49.3 93.3 73.1 23.9 46.0 34.0 51.3 79.1 94.9 31.4 20.6 13.8 44.1 72.7 52.7 31.6 TIGD1 EEYORE ENSG00000221944 "Tigger transposable element derived 1" Q96MW7 2 232543883-232550557 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041717 Approved Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Cluster 32: T-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies" "HPA041717: AB_2677636" "unprognostic (2.48e-1)" "unprognostic (1.77e-2)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (2.58e-2)" "unprognostic (2.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-2)" "unprognostic (1.20e-2)" "unprognostic (4.40e-2)" "unprognostic (6.86e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (3.77e-2)" "unprognostic (1.85e-2)" "unprognostic (2.77e-1)" "unprognostic (3.21e-3)" 1.8 2.3 6.3 2.3 5.3 6.5 2.7 13.4 7.8 3.2 5.4 2.8 1.9 2.6 2.9 2.8 3.8 1.9 2.4 5.0 4.5 7.4 2.7 2.5 3.4 3.2 2.4 5.7 2.9 1.6 5.0 2.0 4.1 4.4 2.1 10.4 2.7 1.7 4.0 4.2 3.6 1.3 1.5 6.1 3.3 5.2 4.5 3.3 4.7 1.4 2.2 2.8 3.0 9.7 3.1 2.3 4.7 7.5 1.7 2.3 3.6 2.1 1.2 2.6 2.9 2.8 3.6 5.0 1.5 1.6 2.8 3.2 4.1 1.3 3.8 3.0 3.9 4.5 7.7 3.5 1.1 3.6 2.9 2.6 1.2 2.6 1.6 2.5 1.5 6.5 3.6 5.0 2.1 5.3 4.9 8.3 2.8 1.9 2.7 4.7 6.3 2.3 1.5 3.5 6.1 6.0 2.2 2.1 2.3 3.3 3.1 3.9 2.5 4.3 4.5 2.7 2.1 4.8 3.4 4.5 2.5 3.6 2.6 1.6 1.7 1.8 1.9 1.4 1.9 1.7 2.0 1.5 1.1 2.1 3.1 2.5 2.3 1.8 1.5 1.2 1.6 0.7 6.3 5.3 13.4 7.8 5.0 4.5 3.2 2.4 4.1 1.5 4.5 9.7 2.4 9.6 3.9 4.2 5.3 1.3 4.5 2.3 1.8 4.9 2.5 2.2 2.0 1.5 2.9 3.7 8.4 2.2 3.1 1.7 0.0 3.6 4.2 1.0 3.6 1.7 1.2 6.5 4.5 1.5 1.3 3.1 7.7 1.5 0.0 6.4 1.4 0.7 1.4 6.7 5.7 1.5 2.0 1.6 1.7 0.7 4.7 2.4 1.8 1.0 2.8 7.5 5.2 5.0 8.1 2.0 2.4 1.9 5.6 2.6 3.5 1.4 1.7 7.0 6.6 3.7 2.0 3.9 5.7 3.7 2.0 1.4 4.1 4.0 3.0 2.9 TIGD7 Sancho ENSG00000140993 "Tigger transposable element derived 7" Q6NT04 16 3298808-3305729 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041357, HPA041474" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA041357: AB_10794992, HPA041474: AB_10795696" "unprognostic (7.69e-2)" "unprognostic (3.04e-4)" "unprognostic (6.56e-3)" "unprognostic (1.18e-3)" "unprognostic (1.79e-1)" "unprognostic (4.04e-2)" "unprognostic (6.50e-3)" "unprognostic (2.44e-1)" "unprognostic (2.78e-2)" "unprognostic (9.81e-2)" "unprognostic (8.56e-3)" "unprognostic (2.09e-1)" "unprognostic (2.25e-2)" "unprognostic (8.87e-2)" "unprognostic (4.04e-1)" "unprognostic (5.90e-3)" "unprognostic (3.12e-2)" 2.9 3.3 5.1 1.8 5.1 0.6 4.7 6.0 6.1 5.1 7.0 4.9 1.8 5.5 4.5 1.9 5.1 2.6 5.3 4.9 5.6 6.0 3.1 2.8 3.4 5.2 5.6 10.6 2.8 6.5 8.2 3.2 5.5 5.6 1.9 5.1 2.7 5.0 4.2 2.1 2.8 3.5 5.0 4.8 2.7 8.5 5.2 3.7 6.7 5.3 3.0 4.1 3.4 5.7 0.9 1.9 5.5 3.0 2.4 3.6 4.2 2.7 1.6 4.0 3.7 0.2 1.7 2.0 4.5 2.0 3.3 0.5 1.8 0.7 5.0 0.2 2.7 5.9 1.7 0.1 2.8 1.0 7.5 3.9 1.3 3.7 1.1 4.7 3.1 1.4 2.9 3.5 3.4 1.2 1.9 9.0 6.3 0.6 5.1 10.2 1.3 8.3 2.2 0.5 7.1 2.6 6.8 0.9 2.7 4.8 3.2 3.3 1.2 2.6 6.2 2.7 1.6 7.5 8.3 6.5 1.5 3.4 2.9 0.5 0.6 3.4 1.5 0.5 2.7 0.6 1.2 2.3 0.5 2.5 2.4 1.7 2.1 2.0 1.7 0.5 1.4 0.7 5.1 5.1 6.0 6.1 4.9 5.6 5.2 5.6 5.5 5.0 5.2 5.7 1.7 9.6 4.5 11.4 4.9 0.8 3.2 2.1 4.0 6.1 2.4 2.4 9.9 4.3 4.4 0.0 4.2 1.5 1.6 0.6 3.9 2.8 4.7 2.3 3.8 2.3 1.2 2.5 14.6 1.4 1.1 2.6 4.6 1.7 1.3 5.9 0.4 0.6 0.9 5.0 12.7 1.0 4.1 0.6 0.8 2.0 2.8 1.1 5.4 2.8 0.9 3.4 4.1 20.6 12.1 1.1 0.1 4.5 2.0 2.3 1.0 0.9 2.9 2.2 6.6 3.1 3.6 11.6 10.5 2.1 0.6 1.4 2.9 3.8 0.6 1.5 TIMM23B-AGAP6 LINC00843 ENSG00000178440 "TIMM23B-AGAP6 readthrough (NMD candidate)" 10 49942056-50011654 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" NA NA "Cluster 24: NB-4 - Immune response" "unprognostic (1.42e-1)" "unprognostic (6.27e-3)" "unprognostic (3.47e-2)" "unprognostic (2.15e-1)" "unprognostic (4.82e-2)" "unprognostic (1.69e-2)" "unprognostic (3.65e-1)" "unprognostic (1.33e-1)" "unprognostic (7.28e-2)" "unprognostic (2.86e-2)" "unprognostic (1.41e-1)" "unprognostic (5.84e-4)" "unprognostic (6.36e-4)" "unprognostic (6.62e-2)" "unprognostic (1.46e-1)" "unprognostic (4.84e-2)" "unprognostic (1.60e-2)" 0.4 0.2 0.9 0.6 0.9 1.1 0.2 1.3 1.1 0.2 1.3 0.1 0.6 0.3 0.2 0.2 0.1 0.1 0.3 0.9 0.9 0.1 0.3 0.2 0.8 1.0 0.9 0.3 0.3 0.1 0.0 0.9 0.4 0.3 0.5 0.4 0.3 0.8 0.4 0.1 0.3 0.8 0.5 0.2 0.9 1.0 0.7 0.1 0.8 0.5 0.2 1.1 1.0 0.5 1.4 2.6 0.5 0.3 1.8 0.9 0.6 1.0 1.0 1.9 0.5 1.3 1.5 0.9 0.8 1.9 1.4 0.5 0.9 0.6 1.2 0.6 1.7 1.7 0.7 0.8 2.4 0.8 1.1 2.4 1.1 0.8 1.1 2.9 2.5 1.4 0.0 2.0 4.1 5.6 1.7 1.0 3.8 1.5 0.7 1.9 0.4 0.4 1.6 1.7 0.4 1.4 0.9 1.6 0.9 2.3 0.7 0.9 2.2 0.3 2.0 1.6 2.3 1.9 1.1 2.2 0.8 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.9 0.9 1.3 1.1 0.9 0.9 1.0 0.9 0.9 0.8 1.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favorable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 252.5 276.8 498.7 220.7 507.8 434.6 241.9 504.6 588.9 236.5 500.2 253.3 192.8 179.4 344.5 310.5 181.7 117.9 355.4 502.2 514.7 317.6 273.2 208.0 279.3 511.7 510.0 259.6 230.3 309.8 302.0 146.6 505.9 239.6 229.3 295.4 215.9 142.7 511.6 215.1 220.4 132.7 513.0 272.9 235.5 216.0 511.9 388.3 232.4 287.4 297.7 213.3 239.3 514.5 565.0 398.8 634.2 456.6 514.0 497.1 435.6 454.1 355.7 425.1 419.3 326.3 395.9 365.2 315.3 397.8 553.6 215.5 559.8 512.5 471.6 452.6 475.5 689.4 910.3 845.8 399.0 792.2 443.0 459.7 538.2 402.6 388.8 414.2 546.0 641.1 376.6 379.0 615.3 581.2 929.4 1071.2 847.1 607.0 637.3 262.2 397.0 620.4 746.0 748.7 207.8 526.1 511.0 369.3 736.1 583.6 356.7 1156.3 412.1 358.0 650.8 560.5 902.6 626.1 1001.6 902.8 459.1 754.2 379.9 1923.2 1058.7 2195.0 1127.1 1022.5 1237.6 1412.6 1486.0 1377.1 1150.8 1172.2 1464.7 1408.1 2036.5 943.8 1028.9 1521.6 1652.1 2663.7 498.7 507.8 504.6 588.9 502.2 514.7 511.7 510.0 505.9 513.0 511.9 514.5 518.8 240.4 370.4 20.9 615.0 716.3 534.0 1308.9 618.6 219.6 866.8 1111.2 633.4 513.3 616.2 901.2 106.3 785.4 797.4 948.2 1717.8 566.9 653.6 524.8 511.4 474.5 635.3 609.1 25.8 1032.9 830.9 443.7 356.3 646.1 454.4 376.5 574.7 1098.6 854.5 119.5 25.4 985.5 695.8 652.4 790.5 1123.9 646.8 544.3 777.3 18.7 850.3 522.8 1080.3 10.1 28.3 872.9 980.3 464.6 593.9 584.6 1211.0 1438.8 466.4 321.9 355.0 393.6 448.4 547.4 689.4 805.5 898.4 440.1 757.1 351.9 937.2 572.2 TMEM216 "CORS2, HSPC244, JBTS2, MGC13379, MKS2" ENSG00000187049 "Transmembrane protein 216" Q9P0N5 11 61392360-61398863 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 192.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 84.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (7.75e-2)" "unprognostic (1.54e-1)" "unprognostic (6.20e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-2)" "unprognostic (1.58e-1)" "unprognostic (9.02e-3)" "unprognostic (4.44e-2)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" "unprognostic (1.90e-2)" "unprognostic (9.66e-2)" "unprognostic (2.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.54e-1)" "unprognostic (1.47e-2)" "unprognostic (8.03e-3)" 12.5 12.5 22.2 8.0 22.0 16.5 18.8 22.0 23.8 16.4 22.2 10.4 8.5 11.6 18.0 10.7 20.4 10.0 8.4 21.6 22.4 15.1 6.4 8.3 13.7 22.2 22.7 28.3 15.6 11.4 20.8 13.3 21.7 13.2 11.7 11.8 15.9 12.9 4.3 9.6 11.3 10.7 22.1 14.7 11.3 14.8 22.9 12.7 12.7 6.9 16.5 13.9 12.2 21.5 13.9 15.1 23.2 18.6 37.6 18.2 5.6 7.8 11.9 16.9 12.1 24.3 24.4 5.1 25.6 13.0 0.1 18.1 26.1 14.7 19.6 41.2 16.8 9.7 9.3 32.2 21.7 51.8 14.6 16.0 22.7 10.2 20.2 6.1 16.4 1.7 21.7 11.1 10.9 57.9 3.7 84.1 24.8 44.9 34.2 0.6 18.8 16.2 14.5 32.8 10.6 16.9 19.6 11.3 14.4 17.3 12.8 26.4 7.5 0.1 0.6 8.5 0.1 9.1 6.9 7.9 0.2 20.6 8.0 87.2 28.1 192.7 32.5 31.0 30.7 50.5 34.1 32.3 33.9 49.9 36.0 30.5 44.3 68.6 26.1 12.3 42.0 23.6 22.2 22.0 22.0 23.8 21.6 22.4 22.2 22.7 21.7 22.1 22.9 21.5 11.7 6.4 9.7 11.1 17.8 4.7 17.5 30.8 23.3 4.2 18.8 29.8 2.9 11.5 14.5 1.8 2.1 19.6 11.9 5.1 19.6 14.0 5.7 8.5 15.7 11.3 9.6 12.6 4.0 16.9 20.6 18.5 5.1 5.6 8.8 14.1 12.5 2.0 14.1 5.0 4.1 11.6 14.2 6.2 5.2 2.4 21.1 8.6 7.2 4.7 7.9 25.4 24.7 4.5 2.2 12.5 8.6 13.5 13.9 23.6 8.1 9.2 19.1 5.4 13.1 11.7 9.3 36.5 20.8 19.3 3.4 8.6 16.7 14.5 11.5 14.1 TMOD4 Sk-Tmod ENSG00000163157 "Tropomodulin 4" Q9NZQ9 1 151169986-151176284 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 68 "skeletal muscle: 1225.0;tongue: 534.1" "Cell type enhanced" "Detected in single" "Astrocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 8.6;U-266/84: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA028203 Enhanced NA NA "Cluster 24: B-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 24: NB-4 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "HPA028203: AB_10600830" 0.9 0.9 1.6 2.9 1.6 2.3 1.6 1.5 2.5 0.8 2.2 2.0 1.0 2.0 2.5 12.9 1.8 2.2 0.7 1.7 1.4 0.8 0.2 2.4 5.8 1.5 1.7 1.7 0.4 0.6 0.1 1.3 1.5 10.1 2.4 1.0 8.1 1.8 1225.0 4.1 2.0 1.5 1.4 3.5 1.7 1.4 1.5 2.7 0.5 534.1 7.1 1.2 0.2 1.4 0.9 1.5 2.1 0.5 1.3 0.2 1.8 0.8 0.3 0.8 0.1 0.7 0.8 1.2 0.9 1.2 0.4 0.7 1.5 0.4 0.3 2.9 4.4 2.1 3.4 0.0 0.6 1.9 5.0 0.2 0.6 0.9 2.5 2.4 0.6 4.5 1.2 2.8 0.4 2.4 0.8 8.6 1.3 0.6 2.3 3.6 0.8 0.4 0.3 1.2 1.7 1.4 0.4 0.0 0.2 0.5 0.7 4.0 0.5 0.1 1.0 1.7 1.0 3.4 6.4 1.0 0.6 4.3 0.6 0.0 0.1 0.1 0.5 0.0 0.2 0.4 0.5 0.1 0.0 0.4 0.4 0.9 0.0 0.0 0.1 0.3 0.4 0.2 1.6 1.6 1.5 2.5 1.7 1.4 1.5 1.7 1.5 1.4 1.5 1.4 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 TNF "DIF, TNF-alpha, TNFA, TNFSF2" ENSG00000232810 "Tumor necrosis factor" P01375 6 31575565-31578336 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 12.7;lymphoid tissue: 6.5" "Cell type enhanced" "Detected in many" "B-cells: 90.7;dendritic cells: 60.8;Langerhans cells: 72.7;Macrophages: 108.3;T-cells: 100.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 68.0" "Group enriched" "Detected in all" 5 "granulocytes: 20.8;monocytes: 68.0;T-cells: 36.6" "Group enriched" "Detected in some" 8 "HDLM-2: 103.7;NB-4: 214.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB078469 Supported "Secreted to blood" NA NA 10100 "Cluster 51: Monocytes - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 57: B-cells - Immune response" "CAB078469: AB_908070" "unprognostic (1.93e-1)" "unprognostic (1.07e-2)" "unprognostic (3.85e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-2)" "unprognostic (1.67e-1)" "unprognostic (3.46e-1)" "unprognostic (1.19e-2)" "unprognostic (1.94e-1)" "unprognostic (3.07e-2)" "unprognostic (1.38e-1)" "unprognostic (1.46e-2)" "unprognostic (1.82e-1)" "unprognostic (9.85e-3)" "unprognostic (1.09e-1)" "unprognostic (2.04e-1)" 1.4 0.5 0.0 3.3 0.0 12.7 0.5 0.0 0.1 0.1 0.0 0.9 0.0 1.5 0.0 0.7 0.3 0.6 2.6 0.1 0.0 1.2 0.6 3.6 1.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 1.5 2.4 0.2 0.1 6.5 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.8 0.0 0.0 0.0 0.0 103.7 0.0 19.4 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 214.4 0.0 0.0 0.0 9.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 10.1 0.0 23.2 39.5 36.6 7.2 17.2 13.9 7.6 7.0 5.0 5.2 20.8 2.0 68.0 4.3 13.6 14.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 3.0 0.0 90.7 8.4 1.2 12.1 4.6 0.2 17.4 20.4 2.0 2.8 4.0 0.0 2.1 0.9 60.8 0.5 0.0 7.4 0.1 15.5 5.9 10.7 0.0 0.0 0.0 3.3 1.7 2.0 1.5 30.5 12.6 0.0 1.8 0.1 36.5 0.0 0.0 0.4 10.2 14.1 72.7 0.0 0.3 108.3 5.4 1.9 3.4 0.1 2.1 0.0 0.1 14.3 0.0 0.0 10.4 1.7 0.0 0.1 3.0 0.2 0.0 0.6 4.0 0.0 0.0 1.3 4.1 1.1 100.0 0.0 0.4 0.3 TNFRSF4 "ACT35, CD134, OX40, TXGP1L" ENSG00000186827 "TNF receptor superfamily member 4" P43489 1 1211340-1214153 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 10.3;lymphoid tissue: 13.3" "Cell type enhanced" "Detected in many" "Adipocytes: 112.3;Endothelial cells: 58.0;granulocytes: 67.4;Ionocytes: 40.7;Langerhans cells: 128.1;T-cells: 43.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 9.7;memory CD4 T-cell: 26.6;NK-cell: 14.7;T-reg: 35.3" "Group enriched" "Detected in many" 17 "granulocytes: 9.7;NK-cells: 14.7;T-cells: 35.3" "Group enriched" "Detected in some" 10 "MOLT-4: 6.2;NB-4: 12.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" CAB016128 Enhanced NA NA "Cluster 35: T-regs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "CAB016128: AB_626897" "unprognostic (2.24e-1)" "unprognostic (8.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.55e-3)" "unprognostic (1.02e-1)" "prognostic favorable (3.50e-6)" "prognostic unfavorable (6.03e-4)" "unprognostic (3.30e-1)" "unprognostic (1.48e-2)" "unprognostic (7.04e-3)" "unprognostic (1.04e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.52e-6)" "unprognostic (1.61e-1)" "unprognostic (5.46e-2)" "unprognostic (2.42e-1)" "unprognostic (5.91e-2)" 10.2 0.5 0.5 6.2 0.1 0.6 6.7 0.6 0.9 1.9 0.2 3.3 1.7 1.1 0.0 1.0 1.2 0.5 10.3 0.5 0.2 4.1 0.7 6.3 6.5 0.3 0.2 0.8 1.2 0.2 1.6 1.8 0.3 3.7 0.2 0.0 1.8 0.7 2.1 1.1 5.2 0.2 0.3 13.3 2.6 0.3 0.5 1.8 4.6 0.4 1.5 1.7 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 12.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.3 0.4 0.0 3.0 0.0 26.6 2.8 0.0 0.0 2.3 0.1 0.3 14.7 0.0 1.1 35.3 2.8 0.5 0.1 0.6 0.9 0.5 0.2 0.3 0.2 0.3 0.3 0.5 0.4 112.3 0.0 0.0 0.3 11.1 9.1 0.3 0.9 0.0 0.3 1.0 2.4 1.7 0.0 0.1 0.0 0.0 0.0 25.6 0.0 0.0 0.9 0.0 0.6 3.8 58.0 0.0 2.7 0.7 0.2 0.4 7.7 0.0 0.6 67.4 0.0 13.9 0.4 1.9 0.0 0.1 0.3 40.7 1.9 128.1 0.0 0.3 9.6 10.6 1.0 18.4 0.0 8.2 1.5 0.1 0.0 0.0 0.4 26.2 0.4 0.0 0.2 0.1 0.2 0.0 17.8 2.0 0.0 0.2 0.1 8.4 0.1 43.6 2.5 0.1 0.2 TRAJ17 ENSG00000211872 "T cell receptor alpha joining 17" 14 22526844-22526906 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.3;retina: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 148.3" "Lineage enriched" "Detected in many" 31 "T-cells: 148.3" "Cell line enhanced" "Detected in some" "MOLT-4: 3.8;NB-4: 7.0;U-266/84: 2.4;U-698: 1.3" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" 0.0 0.0 1.7 5.0 2.8 2.5 1.2 1.3 1.6 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.3 0.0 0.0 0.3 3.2 1.7 1.7 0.0 0.0 0.0 0.0 0.0 2.3 0.9 2.5 15.9 3.4 0.0 0.0 0.6 2.1 1.2 1.1 6.0 1.1 0.5 1.5 7.3 0.0 0.0 3.6 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 26.5 0.0 97.2 71.2 0.7 0.3 86.6 57.5 4.7 0.0 0.5 0.0 148.3 29.9 1.7 2.8 1.3 1.6 0.6 0.3 1.7 1.7 2.3 1.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ23 ENSG00000211866 "T cell receptor alpha joining 23" 14 22520416-22520478 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.7;retina: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 181.7" "Lineage enriched" "Detected in many" 65 "T-cells: 181.7" "Group enriched" "Detected in some" 4 "NB-4: 7.0;U-266/84: 3.6" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "unprognostic (2.03e-1)" 0.0 1.9 1.0 7.7 3.5 0.0 0.6 1.7 2.4 0.0 1.2 1.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.3 0.0 0.0 5.1 3.2 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.8 12.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.4 0.0 0.4 0.9 6.8 0.0 0.0 3.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.3 0.0 0.0 0.0 2.8 0.3 0.0 4.2 0.4 32.6 0.1 105.8 96.9 0.0 0.3 110.9 98.5 1.9 0.5 0.1 0.1 181.7 35.0 1.0 3.5 1.7 2.4 0.9 1.7 3.2 1.2 2.9 1.0 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ4 ENSG00000211885 "T cell receptor alpha joining 4" 14 22542199-22542261 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 18.0;retina: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 36 "MAIT T-cell: 78.6;memory CD4 T-cell: 222.6;memory CD8 T-cell: 164.4;naive CD4 T-cell: 175.6;naive CD8 T-cell: 107.2;T-reg: 273.2" "Lineage enriched" "Detected in many" 91 "T-cells: 273.2" "Group enriched" "Detected in some" 70 "MOLT-4: 7.7;NB-4: 6.2" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "unprognostic (7.36e-2)" 0.0 0.0 2.3 7.7 2.7 5.0 3.5 1.6 2.6 0.0 0.7 1.8 5.4 0.0 0.0 0.0 0.7 3.5 0.0 0.9 0.5 1.3 1.0 5.9 15.0 2.5 2.2 0.0 0.0 0.0 0.0 0.6 1.2 0.3 5.8 56.0 1.9 0.0 0.0 2.2 1.6 0.0 1.5 11.3 3.4 0.1 0.9 18.0 0.2 0.0 10.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 4.7 0.7 78.6 0.2 222.6 164.4 0.3 0.9 175.6 107.2 2.9 0.3 0.2 0.4 273.2 46.2 2.3 2.7 1.6 2.6 0.9 0.5 2.5 2.2 1.2 1.5 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ41 ENSG00000211848 "T cell receptor alpha joining 41" 14 22497657-22497718 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.2;retina: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 95.0;memory CD8 T-cell: 77.7;naive CD4 T-cell: 96.3;naive CD8 T-cell: 304.6;T-reg: 90.4" "Lineage enriched" "Detected in many" 139 "T-cells: 304.6" "Cell line enriched" "Detected in single" 32 "NB-4: 3.1" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" 0.0 0.0 0.6 2.4 0.4 1.0 0.0 0.9 0.9 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.3 0.0 0.0 2.3 2.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.6 11.6 0.0 0.0 0.0 0.7 2.5 0.0 0.4 1.1 1.1 0.0 0.9 3.2 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 1.1 24.0 0.4 5.1 0.1 95.0 77.7 0.0 0.6 96.3 304.6 2.1 1.6 1.4 0.4 90.4 96.7 0.6 0.4 0.9 0.9 0.1 0.3 1.0 1.0 1.5 0.4 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ56 ENSG00000211835 "T cell receptor alpha joining 56" 14 22479521-22479582 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 4.5;intestine: 3.2;lymphoid tissue: 4.9;stomach 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 4.5" "Group enriched" "Detected in many" 40 "memory CD4 T-cell: 49.8;memory CD8 T-cell: 52.1;naive CD4 T-cell: 47.3;naive CD8 T-cell: 20.4;T-reg: 49.2" "Lineage enriched" "Detected in single" 59 "T-cells: 52.1" "Cell line enhanced" "Detected in some" "NB-4: 3.1;U-266/84: 2.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 4.5 1.2 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.5 4.9 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.3 0.0 0.0 0.0 0.7 3.2 0.0 0.8 4.0 1.2 0.4 1.0 1.1 0.0 0.0 2.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.1 1.0 0.0 49.8 52.1 0.0 0.0 47.3 20.4 0.0 0.1 0.2 0.0 49.2 13.5 0.4 0.3 4.5 1.2 0.5 0.9 1.1 0.4 0.8 0.8 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ6 ENSG00000211883 "T cell receptor alpha joining 6" 14 22539073-22539134 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 15.2;retina: 56.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 28 "MAIT T-cell: 137.1;memory CD4 T-cell: 135.0;memory CD8 T-cell: 142.8;naive CD4 T-cell: 138.2;naive CD8 T-cell: 76.2;T-reg: 264.4" "Lineage enriched" "Detected in many" 192 "T-cells: 264.4" "Cell line enhanced" "Detected in some" "HL-60: 3.3;MOLT-4: 8.6;NB-4: 13.3" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "unprognostic (8.83e-2)" 0.0 0.0 2.5 12.3 2.8 2.1 0.0 1.4 1.0 0.0 1.4 1.4 0.0 0.9 0.0 0.0 0.7 1.9 1.6 0.6 0.6 0.0 0.0 3.8 15.2 1.6 1.2 0.0 0.0 0.0 0.0 0.0 1.9 0.4 2.5 56.6 0.0 0.0 0.0 4.9 3.7 0.0 2.0 14.8 6.8 0.5 0.8 12.3 0.0 0.0 5.8 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 5.3 0.1 137.1 0.1 135.0 142.8 0.5 0.2 138.2 76.2 1.3 0.4 0.2 0.5 264.4 54.6 2.5 2.8 1.4 1.0 0.6 0.6 1.6 1.2 1.9 2.0 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDC ENSG00000211829 "T cell receptor delta constant" 14 22462932-22465787 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "lymphoid tissue: 404.4" "Cell type enriched" "Detected in some" 4 "NK-cells: 746.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 19.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 87 "gdT-cell: 5873.4;NK-cell: 2243.9" "Group enriched" "Detected in all" 150 "NK-cells: 2243.9;T-cells: 5873.4" "Cell line enriched" "Detected in some" 38 "NB-4: 356.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 63: T-cells - Adaptive immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (1.21e-3)" "unprognostic (8.15e-3)" "unprognostic (7.03e-2)" "prognostic favorable (8.25e-4)" "unprognostic (2.53e-1)" "unprognostic (2.42e-3)" "unprognostic (2.19e-1)" "prognostic favorable (6.13e-4)" "unprognostic (2.76e-2)" "unprognostic (2.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.67e-5)" "unprognostic (1.25e-1)" "unprognostic (2.38e-1)" "unprognostic (1.22e-2)" "unprognostic (1.99e-2)" 13.4 0.4 1.3 7.8 1.0 26.2 3.8 1.4 1.4 2.9 0.6 8.9 3.9 7.6 2.1 2.0 4.1 7.9 2.7 2.0 0.9 1.1 11.1 11.6 22.7 0.9 1.2 1.9 0.2 0.4 0.7 2.8 0.8 1.0 7.5 0.0 4.6 1.2 1.6 1.3 5.6 2.2 0.7 54.2 2.0 2.7 0.9 404.4 1.8 1.3 18.3 4.6 0.9 1.3 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 356.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 3.1 0.9 1.4 0.0 0.0 0.1 3.2 4.8 2.3 5873.4 7.9 3.8 5.7 16.7 31.7 9.2 1.9 16.2 46.6 27.0 2243.9 5.5 7.1 27.5 1292.0 1.3 1.0 1.4 1.4 2.0 0.9 0.9 1.2 0.8 0.7 0.9 1.3 1.1 3.2 5.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.6 0.0 0.0 0.0 165.7 0.3 0.0 0.5 0.0 0.9 0.8 0.7 0.0 1.3 0.0 0.0 0.0 1.3 0.0 1.0 0.0 0.0 4.2 0.5 0.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.9 0.0 0.0 5.7 0.0 746.6 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 123.5 0.0 0.0 0.0 TRDJ1 ENSG00000211825 "T cell receptor delta joining 1" A0A075B706 14 22450089-22450139 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 54.0;lymphoid tissue: 78.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 77 "gdT-cell: 13481.1;NK-cell: 5148.7" "Group enriched" "Detected in all" 101 "NK-cells: 5148.7;T-cells: 13481.1" "Cell line enriched" "Detected in some" 15 "NB-4: 522.3" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" 21.1 0.0 2.0 10.6 1.5 54.0 3.7 0.6 2.5 3.7 0.5 6.3 9.9 22.4 0.0 2.3 4.6 4.5 4.6 3.5 1.1 1.0 15.8 24.9 18.8 1.5 0.7 2.2 0.0 2.4 0.0 3.2 0.9 2.4 13.2 0.0 2.8 0.0 0.0 0.0 5.8 1.3 0.4 56.1 2.0 3.4 1.0 78.4 2.0 7.6 21.2 3.1 0.0 2.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 522.3 3.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 2.6 13.6 6.1 13481.1 20.3 9.7 15.9 27.1 86.2 20.6 4.7 30.5 120.9 92.1 5148.7 11.2 16.9 62.4 2899.6 2.0 1.5 0.6 2.5 3.5 1.1 1.5 0.7 0.9 0.4 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDJ2 ENSG00000211827 "T cell receptor delta joining 2" 14 22456689-22456742 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 37.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 89 "gdT-cell: 953.4;NK-cell: 2991.2" "Group enriched" "Detected in all" 279 "NK-cells: 2991.2;T-cells: 953.4" "Cell line enriched" "Detected in some" 17 "NB-4: 104.6" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 24: NB-4 - Immune response" 3.0 0.0 0.5 3.7 0.3 4.8 0.8 0.2 0.9 0.0 0.0 3.3 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.8 0.4 1.2 0.0 7.6 6.4 0.7 0.2 1.7 0.0 0.0 0.0 1.8 0.4 0.0 2.9 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 26.2 1.4 0.7 0.8 37.0 0.0 0.0 2.9 0.5 0.0 1.9 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 6.3 0.4 0.0 953.4 2.0 3.3 0.8 22.0 14.7 3.9 1.7 17.6 14.4 7.0 2991.2 2.2 1.4 19.2 206.2 0.5 0.3 0.2 0.9 0.8 0.4 0.7 0.2 0.4 0.0 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDJ3 ENSG00000211828 "T cell receptor delta joining 3" 14 22459098-22459156 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "lymphoid tissue: 99.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 4 "gdT-cell: 2218.4" "Lineage enriched" "Detected in all" 4 "T-cells: 2218.4" "Cell line enriched" "Detected in some" 49 "NB-4: 148.4" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 63: T-cells - Adaptive immune response" "Cluster 24: NB-4 - Immune response" 1.5 0.0 0.8 4.7 0.3 3.3 0.0 0.6 0.8 0.0 0.3 1.6 5.1 2.0 0.0 0.0 0.0 0.5 0.0 1.7 0.3 0.0 0.0 1.6 4.1 1.2 0.6 0.0 0.0 0.0 0.0 2.6 0.9 0.0 2.6 0.0 1.6 0.0 4.0 0.0 1.9 0.0 0.1 22.0 0.0 0.1 0.6 99.4 0.0 0.0 3.8 0.0 0.0 1.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 2218.4 1.1 1.1 1.0 4.4 15.1 5.5 0.3 8.2 8.0 6.7 525.7 0.8 2.8 12.9 120.0 0.8 0.3 0.6 0.8 1.7 0.3 1.2 0.6 0.9 0.1 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDJ4 ENSG00000211826 "T cell receptor delta joining 4" 14 22455249-22455296 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 5.9;lymphoid tissue: 13.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "ovarian cancer: 2.9" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 45 "gdT-cell: 123.0;NK-cell: 281.9" "Group enriched" "Detected in many" 362 "NK-cells: 281.9;T-cells: 123.0" "Cell line enriched" "Detected in some" 16 "NB-4: 38.7" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" 0.9 0.0 0.2 0.0 0.3 0.9 1.7 0.5 2.3 0.0 2.5 1.4 5.9 2.4 0.0 0.0 0.3 0.0 0.0 0.3 0.2 0.0 0.0 1.2 1.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.1 0.4 13.2 1.3 0.1 0.7 4.4 0.0 0.0 2.0 0.0 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 123.0 0.0 0.3 0.2 1.9 0.6 0.3 0.0 1.5 4.5 0.0 281.9 0.5 0.0 3.0 13.1 0.2 0.3 0.5 2.3 0.3 0.2 0.4 0.2 0.6 0.4 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRGV10 "TCRGV10, V3P" ENSG00000211694 "T cell receptor gamma variable 10 (non-functional)" 7 38299811-38300322 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.1;lymphoid tissue: 13.9" "Cell type enhanced" "Detected in some" "dendritic cells: 7.5;Plasma cells: 7.1;T-cells: 29.9" "Cancer enriched" "Detected in many" 8 "prostate cancer: 7.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "gdT-cell: 196.5" "Lineage enriched" "Detected in many" 8 "T-cells: 196.5" "Group enriched" "Detected in some" 24 "NB-4: 79.7;U-937: 20.5" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.59e-2)" "unprognostic (4.53e-3)" "unprognostic (5.13e-2)" "unprognostic (2.94e-3)" "unprognostic (1.54e-2)" "unprognostic (1.22e-4)" "unprognostic (2.47e-3)" "unprognostic (2.24e-1)" "unprognostic (2.50e-2)" "unprognostic (2.53e-2)" "unprognostic (1.94e-1)" "unprognostic (2.56e-1)" "unprognostic (1.24e-4)" "unprognostic (2.68e-1)" "unprognostic (9.00e-2)" "unprognostic (5.10e-2)" "unprognostic (2.07e-2)" 1.7 0.6 0.1 2.7 0.3 14.1 1.8 0.1 0.4 1.2 0.6 2.0 2.1 0.8 0.7 1.1 1.3 3.3 0.4 0.0 0.1 0.6 1.8 4.1 11.0 0.4 0.1 0.3 0.2 0.1 0.2 0.4 0.3 6.1 2.7 0.0 1.1 0.7 0.2 0.6 4.1 0.6 0.2 13.9 2.6 0.3 0.2 12.5 1.1 0.0 5.0 3.8 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 79.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.5 0.0 0.7 0.4 1.0 196.5 0.1 156.1 0.5 47.2 137.6 0.2 0.1 11.3 159.7 2.9 26.0 0.3 0.8 0.1 33.3 0.1 0.3 0.1 0.4 0.0 0.1 0.4 0.1 0.3 0.2 0.2 0.3 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 29.9 0.0 0.0 0.0 TRGV11 "TCRGV11, V4P" ENSG00000211693 "T cell receptor gamma variable 11 (non-functional)" 7 38291616-38292078 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 7 "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 30 "T-cells: 2.9" "Cell line enriched" "Detected in single" 10 "NB-4: 1.0" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.55e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TRIM65 ENSG00000141569 "Tripartite motif containing 65" Q6PJ69 17 75880335-75896951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021575, HPA021578, HPA064820" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Vesicles, Cytosol" "HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359" "unprognostic (1.82e-1)" "unprognostic (1.47e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-1)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (4.74e-6)" "unprognostic (5.36e-2)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-2)" "unprognostic (6.00e-3)" "prognostic unfavorable (1.82e-5)" "unprognostic (2.86e-3)" "unprognostic (7.18e-2)" "unprognostic (4.24e-3)" "unprognostic (7.50e-3)" 13.0 7.8 12.5 8.5 15.2 7.4 10.7 15.3 13.5 15.5 11.0 14.1 8.8 14.7 6.8 14.2 13.1 7.1 10.3 11.5 13.2 11.2 8.4 12.9 10.5 15.0 14.6 14.1 15.7 7.4 11.8 5.4 14.8 11.7 7.9 7.2 12.6 8.1 13.2 14.6 13.5 8.3 13.8 16.6 11.3 3.9 14.5 6.5 12.2 6.9 8.2 14.6 14.0 17.0 19.8 20.2 7.8 22.2 13.5 19.2 4.0 8.3 8.9 11.1 9.4 9.1 17.0 21.4 6.5 7.2 15.6 13.7 16.8 18.6 6.8 11.1 28.9 16.9 20.4 12.5 13.4 17.2 18.9 12.0 14.4 8.9 16.0 9.3 29.2 27.2 29.3 19.5 8.7 20.6 38.0 33.7 17.7 20.0 19.5 31.3 11.2 30.9 11.2 8.2 16.1 14.9 11.4 21.3 22.7 9.7 21.2 24.2 14.5 26.6 13.5 13.3 16.9 17.9 7.4 6.2 16.2 32.2 11.8 1.4 1.1 1.8 1.9 1.0 2.2 1.4 1.4 1.9 0.9 2.0 1.5 1.5 1.1 1.9 0.6 1.3 1.3 0.6 12.5 15.2 15.3 13.5 11.5 13.2 15.0 14.6 14.8 13.8 14.5 17.0 8.4 6.4 4.8 13.1 7.5 2.9 5.7 2.4 3.4 19.0 3.7 3.0 4.3 5.7 3.4 9.2 12.5 0.9 9.0 3.6 1.9 3.2 0.4 2.8 9.2 8.2 0.0 9.5 4.5 3.4 3.6 6.6 7.1 4.0 7.0 8.6 5.7 3.8 8.9 5.0 5.9 6.6 6.1 5.4 9.3 0.5 13.7 6.9 8.8 3.7 4.9 6.3 3.1 6.6 9.3 5.3 2.9 9.4 5.8 5.1 4.8 5.9 1.8 12.9 0.0 9.3 5.2 0.8 2.9 6.7 3.7 0.5 8.5 6.4 5.9 2.8 TSC22D4 "THG-1, TILZ2" ENSG00000166925 "TSC22 domain family member 4" Q9Y3Q8 7 100463359-100479232 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 601.0;choroid plexus: 224.0" "Cell type enriched" "Detected in all" 4 "Muller glia cells: 778.8" "Cancer enhanced" "Detected in all" "glioma: 118.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 198.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006757 Uncertain Approved Cytosol NA NA 160000 "Cluster 52: Eosinophils - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 24: NB-4 - Immune response" "Cluster 5: Muller glia cells - Visual perception" Cytosol "HPA006757: AB_1080403" "unprognostic (2.34e-2)" "unprognostic (3.06e-2)" "prognostic unfavorable (2.66e-4)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (9.45e-4)" "unprognostic (9.96e-2)" "unprognostic (1.27e-1)" "unprognostic (1.62e-2)" "unprognostic (2.31e-2)" "unprognostic (3.36e-1)" "unprognostic (1.09e-1)" "unprognostic (1.54e-2)" "unprognostic (3.84e-2)" "unprognostic (7.36e-2)" "unprognostic (3.81e-3)" 37.1 52.7 437.1 33.6 601.0 72.0 36.1 524.6 456.9 43.4 224.0 47.5 23.5 40.5 10.1 73.0 36.8 14.4 59.7 384.9 457.3 64.1 30.0 42.6 40.6 527.5 563.9 44.1 37.3 18.5 52.1 22.7 484.3 55.7 10.7 21.9 97.6 22.2 26.2 58.8 44.4 14.0 485.2 95.2 38.6 36.7 538.9 31.2 34.5 28.7 23.2 37.8 46.8 565.4 42.0 30.8 10.3 33.7 34.2 40.5 19.9 30.5 49.6 28.3 25.8 16.9 25.0 36.8 36.1 24.4 66.0 31.2 12.2 26.7 9.9 65.6 25.2 34.2 34.5 14.6 54.4 44.1 86.3 45.7 24.0 32.4 32.2 33.0 58.3 29.0 75.2 64.2 22.9 74.3 55.6 198.4 14.0 35.7 42.6 89.7 8.1 51.6 23.2 22.3 8.8 25.1 41.4 78.8 65.5 16.7 22.5 63.1 50.2 38.4 39.1 95.0 22.8 40.9 42.6 27.1 35.7 66.4 47.8 9.7 18.7 30.0 19.0 20.2 14.9 11.9 16.3 17.9 12.7 11.8 15.2 16.2 56.1 18.8 20.5 13.3 25.0 18.2 437.1 601.0 524.6 456.9 384.9 457.3 527.5 563.9 484.3 485.2 538.9 565.4 16.7 12.8 8.9 123.4 50.8 32.8 35.9 50.7 37.5 15.4 47.3 61.3 17.7 44.3 32.5 40.5 6.2 30.7 69.3 60.3 137.0 63.5 1.7 14.0 25.5 26.1 33.6 60.6 3.8 33.9 35.3 29.8 21.4 19.9 15.9 36.1 42.1 11.1 79.9 18.5 4.6 32.1 38.7 57.7 67.1 5.2 45.7 56.7 55.2 14.0 77.2 778.8 116.4 50.8 162.6 60.6 52.7 39.9 31.8 59.2 62.8 21.0 13.7 18.2 46.0 16.1 34.5 1.7 5.4 32.8 33.8 79.1 78.2 28.9 31.7 80.3 TSKS "PPP1R161, TSSKS" ENSG00000126467 "Testis specific serine kinase substrate" Q9UJT2 19 49739753-49763306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "testis: 120.0" "Group enriched" "Detected in some" 46 "Early spermatids: 887.3;Late spermatids: 1022.9" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.1;testis cancer: 2.2" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "NB-4: 11.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA045729 Enhanced NA NA "Cluster 35: T-regs - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" "HPA045729: AB_10963430" "unprognostic (3.56e-1)" "unprognostic (3.75e-3)" "unprognostic (8.33e-2)" "unprognostic (1.67e-1)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (1.93e-1)" "unprognostic (3.55e-1)" "unprognostic (1.54e-1)" "unprognostic (3.04e-2)" "unprognostic (2.44e-1)" "unprognostic (1.51e-8)" "unprognostic (7.89e-3)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-2)" 1.1 0.1 0.2 0.1 0.2 0.5 0.9 0.8 0.3 0.8 0.1 0.2 0.0 0.9 0.0 0.3 1.0 0.3 1.5 0.2 0.2 0.1 0.2 0.4 0.4 0.1 0.2 0.3 0.2 0.0 0.0 0.9 0.2 0.4 0.0 0.1 0.3 0.1 0.3 1.8 0.2 0.1 0.1 0.5 0.2 120.0 0.2 0.3 0.7 0.0 0.1 0.9 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 11.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.8 0.0 0.4 0.0 0.0 0.0 1.0 0.7 0.7 0.2 0.2 0.2 0.8 0.3 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.1 2.0 0.0 0.0 3.4 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 887.3 1.0 0.5 0.7 0.0 0.8 0.4 0.0 8.6 1.9 0.0 0.1 0.0 0.2 0.4 0.0 2.5 0.0 0.3 0.0 0.0 1.3 0.4 1022.9 9.6 1.5 0.0 1.0 0.2 1.2 1.0 0.5 0.5 0.0 0.0 7.5 0.1 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.3 20.5 8.4 0.7 1.4 6.7 0.5 0.2 0.0 0.1 TUBA8 TUBAL2 ENSG00000183785 "Tubulin alpha 8" Q9NY65 22 18110100-18146683 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 128.9;skeletal muscle: 332.2;tongue: 154.7" "Cell type enhanced" "Detected in some" "Early spermatids: 16.4;Excitatory neurons: 8.1;Inhibitory neurons: 5.6;Late spermatids: 22.9;Sertoli cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basophil: 2.8;eosinophil: 2.7;neutrophil: 5.0;NK-cell: 10.4" "Group enriched" "Detected in many" 7 "granulocytes: 5.0;NK-cells: 10.4" "Group enriched" "Detected in many" 5 "NB-4: 30.2;SCLC-21H: 10.9;TIME: 36.3" "Group enriched" "Detected in all" 4 "cerebellum: 54.7;olfactory bulb: 53.9" "Low region specificity" "Detected in all" "HPA043684, CAB046031, HPA063394" Approved Supported Microtubules NA NA 80000000 "Cluster 48: NK-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" Microtubules "CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (1.07e-1)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (1.52e-2)" "unprognostic (2.74e-1)" "unprognostic (8.92e-2)" "unprognostic (6.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-2)" "unprognostic (3.36e-1)" "unprognostic (2.90e-5)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.61e-4)" 7.3 1.9 9.0 1.0 11.8 4.7 7.2 24.3 16.3 2.5 0.8 2.0 0.8 2.7 6.3 4.3 4.8 1.0 128.9 15.0 2.8 2.3 4.3 2.4 3.5 0.6 9.0 2.3 4.4 2.7 14.5 0.6 0.8 2.5 0.5 2.8 4.4 0.6 332.2 4.4 2.6 0.7 1.5 4.2 4.7 52.3 11.5 0.8 6.5 154.7 1.0 2.0 2.2 12.5 0.6 1.1 1.2 1.4 1.8 0.5 0.4 0.6 0.3 1.4 0.8 0.9 1.1 0.9 2.2 0.7 0.4 0.6 2.2 0.4 0.3 0.8 1.6 2.2 1.7 0.9 1.0 1.0 1.0 0.7 0.8 0.8 0.6 0.5 2.0 0.9 0.6 0.9 0.6 3.4 1.0 30.2 1.0 0.5 0.5 0.9 0.5 0.2 0.7 1.1 10.9 1.1 0.6 1.9 1.0 0.5 0.6 4.8 36.3 0.9 1.0 1.0 0.4 2.2 1.3 0.7 0.9 1.4 0.6 2.8 0.7 2.7 0.5 0.6 0.7 0.4 0.4 0.3 0.4 0.6 0.7 0.4 5.0 10.4 0.4 1.0 0.8 17.1 9.0 11.8 24.3 16.3 15.0 2.8 0.6 9.0 0.8 1.5 11.5 12.5 0.2 0.0 1.7 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 4.7 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.3 16.4 0.2 0.1 0.4 0.0 0.0 8.1 1.1 0.0 0.3 0.0 0.2 2.5 0.1 0.7 0.0 0.1 3.3 5.6 0.0 0.0 0.3 0.0 22.9 0.3 0.1 0.0 0.0 0.2 0.1 1.0 3.5 1.7 0.6 0.1 0.4 0.0 0.0 0.4 0.1 0.0 0.2 6.6 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 TYK2 JTK1 ENSG00000105397 "Tyrosine kinase 2" P29597 19 10350529-10380572 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 206.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005157 Uncertain Approved Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "HPA005157: AB_1858480" "unprognostic (1.60e-2)" "unprognostic (6.12e-3)" "unprognostic (3.67e-2)" "prognostic favorable (9.62e-4)" "unprognostic (7.61e-2)" "prognostic favorable (1.05e-5)" "unprognostic (1.20e-2)" "unprognostic (6.16e-3)" "unprognostic (4.93e-2)" "unprognostic (1.90e-2)" "prognostic favorable (1.02e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.10e-3)" "unprognostic (1.78e-1)" "unprognostic (4.19e-1)" "prognostic favorable (4.16e-4)" 53.0 60.5 69.9 37.0 71.9 82.6 52.5 70.7 82.3 55.8 72.2 51.5 29.4 44.8 22.6 46.2 49.0 26.2 65.0 69.6 68.8 77.3 111.2 72.6 51.5 75.1 71.4 56.4 65.1 28.6 66.2 20.1 71.5 64.5 25.7 25.2 50.8 20.6 41.3 51.1 73.9 23.5 70.2 140.8 54.6 16.6 71.8 54.4 60.2 33.7 51.8 49.3 46.0 76.4 29.1 41.1 24.1 38.0 31.9 44.2 23.5 38.9 39.1 48.1 52.2 31.5 18.7 44.5 44.5 43.4 32.8 28.4 29.4 45.5 24.2 78.0 45.5 81.4 90.5 80.2 49.4 34.4 89.4 43.2 31.3 54.5 32.2 29.9 46.5 56.6 35.0 116.1 42.3 90.1 50.7 206.9 7.7 28.4 71.8 49.9 21.1 45.1 40.0 90.1 22.4 28.0 37.6 38.6 28.1 18.4 21.5 57.2 41.1 61.7 22.7 74.1 45.9 97.2 81.4 40.2 32.4 70.8 36.6 9.8 20.8 27.2 12.8 15.2 7.9 7.5 7.6 11.6 23.5 8.0 5.0 7.1 33.0 8.6 15.7 13.0 10.1 13.0 69.9 71.9 70.7 82.3 69.6 68.8 75.1 71.4 71.5 70.2 71.8 76.4 18.6 12.8 17.9 13.1 17.5 6.6 5.4 7.6 13.1 9.2 10.3 11.0 25.7 11.5 11.1 9.2 4.2 7.0 23.2 14.6 52.8 7.6 2.1 10.2 12.6 12.8 4.8 8.6 10.4 11.1 9.7 11.1 27.0 12.0 19.6 17.1 15.4 27.1 14.6 0.0 9.2 8.7 8.2 28.2 14.6 8.8 7.5 30.8 16.0 12.2 25.3 8.7 17.5 11.1 11.1 11.8 12.9 9.8 19.5 5.9 12.1 29.0 11.2 11.0 0.0 10.5 12.6 1.5 4.5 8.8 7.2 6.7 19.4 13.6 11.1 6.3 UBAP2 "bA176F3.5, FLJ22435, KIAA1491" ENSG00000137073 "Ubiquitin associated protein 2" Q5T6F2 9 33921693-34048949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021684 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Cytosol "HPA021684: AB_2211887" "unprognostic (2.71e-1)" "unprognostic (1.99e-1)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "prognostic favorable (8.59e-4)" "unprognostic (1.75e-1)" "unprognostic (9.76e-3)" "prognostic favorable (1.95e-4)" "unprognostic (8.06e-2)" "unprognostic (2.39e-1)" "unprognostic (2.95e-1)" "unprognostic (8.77e-2)" 12.2 25.7 12.5 8.2 12.9 17.2 12.8 17.3 13.4 15.5 5.3 13.8 8.7 13.0 8.8 19.1 11.4 6.6 15.3 9.5 13.7 14.9 11.1 13.2 10.4 9.4 9.5 15.2 15.4 9.3 11.0 11.8 9.7 14.3 12.1 9.9 13.1 6.7 37.8 22.2 10.8 10.3 6.8 10.9 14.0 32.5 13.6 13.9 15.8 20.5 12.1 12.5 15.2 12.9 40.5 36.5 25.9 32.9 25.2 22.0 31.2 31.8 19.6 32.1 31.0 49.9 21.0 46.8 9.8 26.7 24.7 23.1 43.9 34.9 35.5 34.8 21.5 26.2 47.2 55.0 20.5 59.6 40.3 20.4 28.8 40.8 28.2 16.7 26.3 28.3 36.5 37.6 29.4 26.9 44.6 100.4 27.7 22.6 28.5 34.1 16.0 29.9 31.2 30.1 26.5 18.4 37.6 30.3 9.4 25.8 26.9 26.3 30.9 19.0 25.5 22.8 35.7 14.5 32.3 49.3 20.9 22.5 48.3 1.6 2.7 3.0 2.2 3.1 4.7 2.7 2.7 3.2 3.1 1.4 2.4 3.3 1.6 4.5 7.2 4.1 3.3 2.3 12.5 12.9 17.3 13.4 9.5 13.7 9.4 9.5 9.7 6.8 13.6 12.9 23.8 54.5 23.1 56.8 15.0 28.2 23.8 21.0 27.3 28.7 25.3 26.2 59.9 8.6 32.4 12.9 60.5 44.4 24.7 28.1 3.9 20.0 102.8 52.5 30.3 28.6 25.1 20.8 46.8 19.8 36.3 23.7 32.6 68.8 14.5 36.2 11.7 14.0 16.6 16.8 48.3 30.4 14.2 17.0 21.4 85.0 30.4 17.1 26.6 33.7 19.0 12.5 16.5 50.8 46.3 27.0 26.8 24.5 28.4 24.9 12.3 15.9 24.1 27.0 26.3 27.4 22.6 81.0 70.4 25.9 31.1 72.9 22.3 68.4 29.6 23.7 UBL5 ENSG00000198258 "Ubiquitin like 5" Q9BZL1 19 9827892-9830115 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 3183.1" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (2.53e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (4.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.96e-1)" "unprognostic (7.30e-2)" "unprognostic (7.85e-2)" "unprognostic (8.51e-2)" "unprognostic (3.14e-3)" "unprognostic (2.04e-2)" "unprognostic (4.79e-2)" "unprognostic (1.05e-2)" "unprognostic (3.64e-1)" "unprognostic (1.07e-2)" "unprognostic (3.19e-2)" "unprognostic (2.23e-3)" 303.2 450.0 486.9 202.3 501.8 323.7 287.0 503.9 613.4 291.0 537.1 331.2 218.5 263.8 513.6 375.8 261.5 213.8 648.9 493.9 514.4 476.6 401.6 263.1 280.8 495.3 488.5 269.5 227.0 486.4 439.5 215.7 497.7 300.7 264.1 274.7 278.8 284.9 533.4 261.1 259.7 248.4 515.9 303.6 303.5 275.3 492.8 427.3 304.3 567.0 322.2 297.8 278.2 534.1 609.5 633.1 536.4 508.8 755.8 589.0 320.0 434.9 519.8 557.0 687.0 800.0 338.5 374.8 745.6 651.7 475.1 380.9 562.1 634.2 532.7 629.4 1032.4 1110.5 783.3 1328.0 508.8 1105.1 471.2 612.2 658.5 406.4 437.8 569.2 630.0 798.3 697.9 888.0 669.8 1016.8 758.8 3183.1 534.7 758.8 1046.3 444.4 435.8 972.4 1054.9 1138.9 474.9 616.1 380.3 358.4 568.1 612.2 397.3 1029.3 517.3 608.9 277.1 787.5 579.1 1046.1 1812.3 800.4 540.0 713.6 370.6 865.4 497.7 1271.3 424.7 488.1 410.8 445.4 468.2 464.3 466.7 352.4 395.3 430.8 818.7 395.9 529.2 780.2 618.9 756.0 486.9 501.8 503.9 613.4 493.9 514.4 495.3 488.5 497.7 515.9 492.8 534.1 387.5 256.4 330.2 8.1 329.4 397.7 342.1 779.0 236.2 177.4 479.0 535.4 763.9 446.1 491.5 662.1 62.6 549.6 422.1 970.8 1486.9 574.3 168.8 613.3 370.8 335.4 433.4 400.4 6.8 519.7 598.4 336.7 284.4 523.3 400.8 305.2 327.7 932.9 705.0 126.2 6.7 693.1 571.7 447.8 548.4 130.6 472.5 423.9 499.8 8.4 729.1 591.6 503.6 6.6 11.9 645.8 1081.0 495.0 427.5 460.5 1117.0 1610.2 642.1 230.1 355.0 284.4 417.4 622.6 596.8 420.5 519.0 585.7 395.1 235.8 555.7 495.3 UGT2B17 ENSG00000197888 "UDP glucuronosyltransferase family 2 member B17" O75795 4 68537184-68568527 "Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 460.0;liver: 136.2" "Group enriched" "Detected in some" 6 "Distal enterocytes: 130.1;Paneth cells: 35.1;Undifferentiated cells: 100.6" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.3;liver cancer: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "memory B-cell: 2.8;naive B-cell: 8.8" "Lineage enriched" "Detected in single" 61 "B-cells: 8.8" "Cell line enhanced" "Detected in some" "BEWO: 1.0;NB-4: 1.1;RPMI-8226: 1.7" HPA045108 Supported NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 9: Intestine - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA045108: AB_2679218" "unprognostic (1.66e-1)" "unprognostic (2.97e-2)" "unprognostic (2.96e-2)" "unprognostic (2.41e-1)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.36e-1)" "unprognostic (8.44e-3)" "unprognostic (9.67e-2)" "unprognostic (4.80e-3)" "unprognostic (8.52e-2)" "unprognostic (2.45e-1)" "unprognostic (6.44e-2)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" 0.3 0.0 0.0 38.8 0.0 0.0 0.7 0.0 0.0 1.5 0.0 365.7 364.3 1.4 1.5 0.1 0.2 0.6 0.0 0.0 0.0 0.2 136.2 0.2 1.5 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 125.8 0.0 0.2 0.7 0.0 0.0 460.0 9.1 0.1 0.6 0.8 0.0 0.1 0.4 0.0 0.0 2.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.0 1.3 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 130.1 0.0 0.0 0.0 11.1 0.1 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.4 2.8 0.0 0.0 0.1 13.8 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.3 0.1 35.1 0.0 1.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 100.6 0.2 UGT2B28 ENSG00000135226 "UDP glucuronosyltransferase family 2 member B28" Q9BY64 4 69280475-69295050 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "breast: 198.5" "Cell type enriched" "Detected in single" 16 "Cholangiocytes: 10.0" "Cancer enriched" "Detected in single" 8 "breast cancer: 1.9" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "eosinophil: 1.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.3" "Group enriched" "Detected in some" 10 "Daudi: 2.9;NB-4: 2.7" HPA045108 Uncertain "Intracellular and membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 5: Breast - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA045108: AB_2679218" "unprognostic (1.81e-1)" "unprognostic (1.40e-1)" "unprognostic (7.20e-3)" "unprognostic (1.51e-2)" "unprognostic (4.37e-5)" "unprognostic (9.79e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 198.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ULK1 "ATG1, ATG1A" ENSG00000177169 "Unc-51 like autophagy activating kinase 1" O75385 12 131894622-131923150 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Autophagy "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 84.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.0;plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;granulocytes: 4.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063990 Approved Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol "HPA063990: AB_2685167" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (2.52e-3)" "unprognostic (2.21e-3)" "unprognostic (8.01e-3)" "unprognostic (5.48e-2)" "unprognostic (2.74e-2)" "unprognostic (5.04e-3)" "unprognostic (3.94e-3)" "unprognostic (2.03e-2)" "unprognostic (9.09e-3)" "unprognostic (8.19e-2)" "unprognostic (6.25e-2)" "unprognostic (2.38e-1)" "unprognostic (2.75e-1)" "unprognostic (1.82e-2)" "unprognostic (3.16e-1)" 19.9 30.1 21.2 7.2 46.0 31.4 20.9 8.3 28.4 31.5 6.2 31.2 9.0 27.2 6.5 21.5 27.2 9.3 35.0 24.4 4.7 21.7 36.4 20.9 6.7 10.9 8.7 39.9 55.6 12.1 47.2 7.1 9.6 27.8 2.3 14.4 21.4 9.4 81.6 43.1 19.5 4.9 1.5 29.3 27.8 17.8 9.9 7.9 24.5 13.8 2.9 23.1 26.8 12.4 9.1 28.8 13.1 16.4 5.8 4.7 17.8 14.1 10.1 5.9 4.8 6.3 9.2 2.4 14.5 10.0 12.0 8.9 3.0 5.6 1.7 9.8 17.2 6.1 25.2 8.6 10.8 4.4 12.9 8.6 15.1 6.6 2.7 16.4 7.3 18.2 8.1 7.0 4.0 20.6 27.5 25.6 14.4 4.3 27.2 20.5 4.7 12.2 3.5 11.1 33.1 18.2 15.1 15.3 7.9 13.1 23.4 29.5 14.2 14.1 8.3 24.8 6.6 30.9 12.0 3.3 23.8 7.6 16.6 0.2 0.9 1.4 0.4 0.4 0.1 0.1 0.3 0.4 0.2 0.3 0.2 0.3 4.0 0.1 0.4 3.8 0.3 0.4 21.2 46.0 8.3 28.4 24.4 4.7 10.9 8.7 9.6 1.5 9.9 12.4 15.6 16.0 17.4 17.9 7.8 14.4 6.1 11.6 9.6 25.0 19.6 14.4 22.0 15.7 15.6 7.3 39.6 5.7 23.7 10.5 1.9 8.5 0.8 19.1 35.7 14.9 19.2 12.0 27.0 12.7 4.2 13.1 13.3 28.0 3.8 24.4 8.6 33.8 5.4 53.8 21.9 14.6 18.3 12.0 6.7 3.0 12.5 13.1 5.4 11.2 12.3 14.7 5.2 20.1 13.9 24.5 7.7 15.8 11.9 15.0 9.9 3.2 13.9 84.3 13.1 19.5 16.9 6.8 7.5 9.7 19.5 17.2 9.1 8.8 7.7 9.5 UNCX Uncx4.1 ENSG00000164853 "UNC homeobox" A6NJT0 7 1232872-1237326 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 17.5" "Cell type enriched" "Detected in single" 10 "Cardiomyocytes: 1.0" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "NB-4: 98.5" "Region enriched" "Detected in single" 5 "cerebellum: 3.2" "Region enriched" "Detected in single" 8 "cerebellum: 7.5" HPA063294 Approved Nucleoplasm NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 24: NB-4 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "HPA063294: AB_2684977" "unprognostic (1.15e-1)" "unprognostic (9.71e-2)" 0.0 0.0 0.7 0.0 0.1 0.0 0.0 17.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.4 0.0 0.0 0.0 2.2 3.0 0.0 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 17.5 0.5 0.0 2.8 2.2 3.0 3.2 0.6 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UROC1 "FLJ31300, HMFN0320" ENSG00000159650 "Urocanate hydratase 1" Q96N76 3 126481166-126517773 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 336 "liver: 116.6" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 62.2" "Cancer enriched" "Detected in single" 100 "liver cancer: 12.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NB-4: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069863 Enhanced NA NA 670000 "Cluster 62: Liver - Hemostasis" "Cluster 24: NB-4 - Immune response" "Cluster 15: Hepatocytes - Hemostasis" "HPA069863: AB_2732143" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (7.43e-2)" "unprognostic (6.43e-2)" "unprognostic (1.43e-1)" "unprognostic (2.23e-3)" "unprognostic (2.95e-1)" "unprognostic (2.57e-2)" "unprognostic (7.71e-2)" "unprognostic (9.97e-2)" "unprognostic (3.04e-1)" "unprognostic (3.65e-5)" "unprognostic (3.97e-2)" "unprognostic (2.66e-1)" "unprognostic (5.52e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 116.6 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.5 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.1 3.3 62.2 0.3 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 UTP14C "2700066J21Rik, KIAA0266" ENSG00000253797 "UTP14C small subunit processome component" Q5TAP6 13 52024691-52033600 "Predicted intracellular proteins" "Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;JURKAT: 2.2;MOLT-4: 1.3;NB-4: 5.7;RPTEC TERT1: 2.1;THP-1: 2.9" "HPA047217, HPA054023" Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (7.89e-2)" "unprognostic (5.98e-2)" "unprognostic (4.47e-1)" "unprognostic (1.25e-1)" "unprognostic (2.33e-3)" "unprognostic (2.51e-1)" "unprognostic (2.02e-1)" "unprognostic (3.30e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (7.35e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.46e-5)" "unprognostic (2.44e-2)" "unprognostic (3.43e-1)" "unprognostic (1.74e-1)" "unprognostic (3.04e-2)" 5.7 5.2 3.8 0.0 3.5 0.0 5.2 3.6 4.4 5.9 4.0 6.1 0.3 7.1 0.0 4.4 5.9 0.0 6.2 3.4 3.5 5.9 7.7 4.7 0.6 3.3 3.9 5.5 6.8 1.2 5.5 0.0 3.3 5.3 0.0 2.2 6.6 0.0 6.7 3.7 5.6 0.2 3.3 5.1 5.9 3.2 3.7 1.8 6.1 2.4 0.0 5.5 5.1 3.8 0.0 0.0 1.2 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.2 1.3 5.7 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 3.5 3.6 4.4 3.4 3.5 3.3 3.9 3.3 3.3 3.7 3.8 9.9 6.4 17.5 8.5 8.2 5.9 5.6 10.8 9.6 13.9 13.7 7.9 23.8 12.8 15.8 16.5 4.2 10.1 5.1 21.2 0.0 7.3 0.4 9.1 13.9 13.9 18.6 19.9 8.9 7.6 9.6 13.9 5.1 12.4 11.4 14.4 14.6 33.6 9.3 25.2 9.0 14.7 8.2 13.5 3.9 0.8 10.5 8.1 8.8 5.6 8.2 14.1 10.3 6.6 10.7 7.7 11.3 14.3 8.4 12.7 9.9 6.4 14.8 11.6 6.6 20.2 12.6 7.2 13.3 14.0 8.4 7.0 7.2 9.4 14.1 6.7 UTP6 "C17orf40, HCA66" ENSG00000108651 "UTP6 small subunit processome component" Q9NYH9 17 31860904-31901708 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 102.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025936, HPA055806" Supported Enhanced "Nucleoli,Mitotic chromosome" Yes No "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoli "Mitotic chromosome" "HPA025936: AB_1845588, HPA055806: AB_2682930" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (2.54e-1)" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (1.86e-5)" "unprognostic (5.68e-2)" "unprognostic (9.78e-3)" "unprognostic (5.50e-2)" "unprognostic (2.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.63e-1)" "unprognostic (2.87e-1)" "unprognostic (3.96e-2)" "unprognostic (4.76e-2)" 17.7 14.3 24.2 7.8 24.3 9.5 15.8 24.9 39.8 21.5 25.4 17.0 4.4 15.3 12.9 17.7 17.1 4.3 17.2 24.2 24.1 21.1 24.4 14.5 11.4 24.0 24.3 20.5 19.1 5.1 19.7 6.4 24.0 22.3 6.4 10.2 13.1 5.7 16.2 17.4 17.1 6.9 23.6 25.7 15.1 18.7 24.5 9.1 18.0 6.3 12.5 16.7 17.0 24.7 14.4 9.0 12.3 7.4 11.9 8.0 15.3 11.8 6.7 17.6 13.6 32.8 7.8 20.9 14.0 11.3 16.7 18.6 16.7 14.1 16.0 4.6 26.4 13.1 21.2 31.6 14.1 19.8 13.5 13.2 15.1 16.7 12.5 16.3 11.4 13.2 23.1 11.9 13.8 11.6 19.4 56.4 16.9 17.2 14.6 20.6 17.8 21.4 19.0 12.9 8.4 12.8 12.5 9.3 22.7 19.4 22.7 39.0 11.5 27.8 20.5 14.3 24.3 13.0 25.9 31.8 18.9 14.4 15.4 15.5 10.6 7.4 7.1 11.3 7.0 12.6 7.7 7.7 14.7 15.2 6.6 7.7 13.7 5.9 11.1 21.3 8.1 7.8 24.2 24.3 24.9 39.8 24.2 24.1 24.0 24.3 24.0 23.6 24.5 24.7 22.5 19.2 24.3 17.9 32.7 25.7 30.7 29.1 12.5 16.7 13.5 16.3 15.6 14.3 31.7 5.5 8.4 42.4 34.3 10.6 9.8 29.7 35.6 23.4 29.0 21.1 5.4 29.5 23.0 24.0 50.3 26.2 16.3 33.5 36.2 20.5 12.1 15.6 35.8 11.8 21.4 16.3 20.3 21.0 17.6 5.4 18.6 29.4 8.8 18.7 43.4 16.4 7.2 17.6 16.2 26.3 8.4 17.0 17.4 31.9 12.7 18.5 30.3 16.4 6.6 28.2 23.7 102.9 66.2 17.2 26.0 38.3 19.9 21.0 16.7 31.2 UXT "ART-27, STAP1" ENSG00000126756 "Ubiquitously expressed prefoldin like chaperone" Q9UBK9 X 47651796-47659180 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Chaperone, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050499, HPA058400" Approved Supported "Nucleoplasm,Centriolar satellite" Yes No "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" Nucleoplasm "Centriolar satellite" "HPA050499: AB_2681146, HPA058400: AB_2683706" "unprognostic (1.12e-1)" "unprognostic (3.85e-3)" "unprognostic (9.08e-2)" "unprognostic (2.09e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (2.31e-3)" "unprognostic (1.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (1.44e-1)" "unprognostic (8.11e-2)" "unprognostic (8.64e-2)" "unprognostic (4.09e-3)" 124.7 148.6 82.1 78.8 84.9 212.0 127.1 85.6 111.7 121.8 86.5 112.3 77.2 93.6 123.6 116.6 103.3 66.7 144.6 80.1 85.1 134.2 135.1 97.8 148.7 87.1 82.5 184.6 182.3 90.5 107.0 65.3 88.4 119.7 99.7 42.8 121.6 65.9 130.7 143.6 113.8 68.2 87.7 139.5 131.7 46.3 83.7 166.9 96.3 95.2 143.0 109.6 111.9 91.1 192.0 208.6 87.4 116.0 194.3 233.4 152.3 119.2 178.5 203.6 191.7 182.1 178.1 217.3 86.4 173.5 188.0 151.8 123.5 163.8 145.3 143.7 240.8 111.6 220.8 182.4 224.2 246.6 208.1 162.9 207.5 168.6 183.8 142.2 165.9 185.6 122.2 205.1 174.8 211.5 170.7 342.1 125.4 174.7 231.2 149.5 177.2 300.9 168.1 141.4 82.1 107.1 133.1 146.7 197.8 157.7 170.4 227.2 122.4 140.7 153.2 196.2 136.7 161.7 154.5 200.7 179.8 270.1 145.1 110.1 159.7 123.4 169.5 166.1 229.8 262.7 242.6 184.2 213.3 245.2 303.2 255.4 100.7 172.1 156.9 270.3 248.2 247.9 82.1 84.9 85.6 111.7 80.1 85.1 87.1 82.5 88.4 87.7 83.7 91.1 108.3 73.7 79.5 5.5 276.8 214.9 274.3 247.9 212.3 27.3 242.1 239.6 100.7 165.8 141.4 97.5 16.7 189.4 207.2 212.1 315.0 161.2 73.5 122.3 125.2 129.6 187.2 170.0 4.0 318.9 212.6 127.6 78.0 114.0 154.1 161.4 193.5 242.4 246.5 10.1 4.3 331.9 126.1 248.0 277.4 185.2 210.3 179.8 197.5 1.9 316.0 108.2 212.1 3.5 7.7 189.3 338.0 196.0 198.3 256.4 297.8 466.1 138.0 28.6 144.7 224.3 145.2 78.7 85.6 183.3 203.7 213.7 240.5 185.5 328.5 286.0 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 873.4;NB-4: 1362.5;U-937: 912.8" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 220000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus, Plasma membrane" Nucleoplasm "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favorable (8.07e-9)" "prognostic favorable (1.59e-6)" 74.0 34.7 26.9 148.4 28.2 299.7 225.1 28.7 53.8 121.8 51.6 250.6 229.9 30.6 144.5 303.1 166.1 119.2 24.6 26.5 29.9 280.1 247.4 266.5 212.4 35.6 31.6 10.4 182.5 270.3 33.7 265.7 34.3 107.7 300.9 4.4 322.5 90.4 24.3 210.2 252.1 71.4 31.9 175.9 228.4 23.4 35.5 173.5 126.0 27.3 311.7 198.0 150.0 36.5 255.0 33.2 2.6 2.3 2.4 1.4 241.6 0.7 0.3 0.2 0.3 191.2 225.2 56.8 174.4 1.2 17.9 175.2 2.4 451.6 0.6 232.3 173.7 290.3 104.4 220.7 3.3 873.4 287.1 2.3 317.5 0.3 72.3 1.2 58.2 1.2 214.9 11.6 103.8 363.9 0.8 1362.5 3.2 315.9 26.0 5.2 8.9 381.7 516.9 384.3 8.4 2.9 120.9 628.3 19.4 126.3 231.4 665.4 113.9 0.3 15.3 2.9 2.7 3.0 151.1 340.0 2.6 912.8 1.1 601.3 868.6 328.4 469.3 740.3 455.6 519.3 537.0 463.3 787.3 508.3 423.2 442.0 52.4 556.3 460.0 2135.6 665.3 1536.0 26.9 28.2 28.7 53.8 26.5 29.9 35.6 31.6 34.3 31.9 35.5 36.5 39.4 371.8 283.2 1.3 147.7 259.1 303.3 800.9 164.4 1.2 289.7 251.7 6.3 356.0 662.1 366.0 0.0 980.8 447.1 832.3 765.0 630.7 28.0 231.3 22.8 46.1 129.1 147.4 0.1 730.0 460.4 35.6 188.6 212.9 269.4 3.3 163.1 314.8 1191.1 0.0 0.1 391.8 545.3 1000.4 488.7 49.1 9.3 537.2 352.2 2.8 686.1 7.9 375.9 0.0 0.5 865.5 843.2 7.5 103.0 302.7 1184.0 1046.8 600.5 2.0 46.0 21.4 56.5 48.0 8.3 239.8 329.7 877.8 219.5 13.8 299.4 602.0 VENTX "HPX42B, VENTX2" ENSG00000151650 "VENT homeobox" O95231 10 133237855-133241928 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Kupffer cells: 6.2;Langerhans cells: 7.9;Macrophages: 7.8;monocytes: 5.0" "Cancer enriched" "Detected in some" 15 "testis cancer: 30.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 7 "dendritic cells: 1.8;granulocytes: 1.9;monocytes: 3.2" "Group enriched" "Detected in some" 10 "NB-4: 18.2;NTERA-2: 10.9" HPA050955 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" "Nucleoli fibrillar center" Cytosol "HPA050955: AB_2681288" "unprognostic (9.41e-2)" "unprognostic (8.89e-2)" "unprognostic (2.34e-1)" "unprognostic (4.26e-1)" "unprognostic (3.22e-2)" "unprognostic (2.01e-1)" "unprognostic (2.54e-1)" "unprognostic (9.62e-3)" "unprognostic (2.22e-1)" "unprognostic (3.00e-3)" "unprognostic (3.70e-4)" "unprognostic (4.22e-1)" "unprognostic (2.51e-3)" "unprognostic (3.43e-2)" "unprognostic (3.48e-1)" "unprognostic (7.54e-2)" "unprognostic (3.14e-1)" 4.8 2.3 1.6 3.6 1.1 2.8 1.9 1.6 1.5 1.5 1.9 1.9 0.4 1.6 0.5 0.5 1.8 1.5 1.5 1.5 1.5 1.7 0.5 3.8 0.5 1.9 1.7 1.5 1.2 0.5 1.4 0.5 1.5 1.3 0.4 0.2 1.3 0.8 0.9 1.2 1.0 1.2 0.9 5.7 0.9 1.0 2.5 0.2 0.8 0.1 0.4 1.4 1.0 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 18.2 10.9 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 1.9 2.6 0.3 0.1 3.2 0.0 0.3 0.1 0.0 1.8 0.2 0.1 0.1 0.9 0.3 2.4 0.1 0.0 0.7 1.6 1.1 1.6 1.5 1.5 1.5 1.9 1.7 1.5 0.9 2.5 1.8 0.0 0.0 1.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 7.9 0.2 0.0 7.8 0.0 0.0 5.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 VPS29 "DC15, DC7, PEP11" ENSG00000111237 "VPS29 retromer complex component" Q9UBQ0 12 110491083-110502111 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039748 Uncertain Supported Vesicles,Cytosol NA NA 110000 "Cluster 51: Monocytes - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" "Vesicles, Cytosol" "HPA039748: AB_10674426" "unprognostic (9.46e-2)" "unprognostic (3.46e-3)" "unprognostic (2.16e-2)" "unprognostic (2.58e-1)" "unprognostic (3.08e-1)" "unprognostic (2.26e-2)" "prognostic unfavorable (2.79e-5)" "unprognostic (1.52e-1)" "unprognostic (3.37e-2)" "prognostic favorable (7.70e-4)" "unprognostic (1.64e-1)" "unprognostic (2.10e-3)" "unprognostic (2.96e-1)" "unprognostic (2.04e-2)" "unprognostic (2.11e-1)" "unprognostic (5.57e-2)" "unprognostic (4.29e-3)" 61.1 62.7 45.6 57.0 47.0 96.2 59.2 46.2 61.8 50.3 47.0 76.4 64.1 52.9 89.5 71.1 50.3 51.1 73.8 48.7 48.3 79.2 77.6 54.9 69.7 47.2 46.3 47.1 56.6 54.8 53.7 47.3 47.4 62.7 79.0 99.6 58.5 71.3 127.3 46.8 65.7 67.1 48.0 76.5 62.8 32.6 46.1 63.2 54.1 100.8 72.0 65.1 50.6 51.1 103.5 98.6 91.9 65.6 100.4 98.7 72.6 94.9 98.1 93.9 84.2 100.0 87.0 94.0 97.1 94.3 87.7 95.5 123.1 88.0 97.0 112.2 98.9 115.4 122.6 83.0 87.4 139.5 97.1 66.0 73.3 79.3 87.4 114.1 166.0 116.6 112.1 85.5 170.0 51.9 110.3 196.4 52.6 90.9 124.8 72.2 93.5 131.8 157.0 149.7 98.1 51.8 107.9 94.0 122.8 78.5 128.6 106.0 94.0 80.6 53.4 112.9 113.0 58.0 87.5 112.1 93.9 130.8 87.8 246.2 262.7 259.4 139.1 356.8 155.3 195.9 175.5 164.9 318.3 158.7 159.8 156.8 178.7 202.9 405.4 214.0 224.8 385.1 45.6 47.0 46.2 61.8 48.7 48.3 47.2 46.3 47.4 48.0 46.1 51.1 138.8 76.9 96.2 21.2 93.7 143.5 172.6 395.9 70.6 39.0 93.4 109.2 282.4 90.1 209.7 101.2 27.1 192.8 116.5 156.3 289.5 231.0 56.8 94.7 79.8 125.0 83.2 147.5 30.2 179.8 187.6 120.2 60.1 104.1 153.9 78.1 94.9 158.7 409.9 42.1 26.7 149.8 248.2 158.0 296.1 82.6 92.2 178.7 177.9 30.9 295.2 107.9 101.0 22.6 30.4 217.9 182.2 105.7 94.8 157.4 142.2 404.7 131.1 111.8 157.8 81.9 212.1 256.4 148.4 108.3 173.0 178.8 111.2 105.8 164.5 187.7 WFDC9 "dJ688G8.2, WAP9" ENSG00000180205 "WAP four-disulfide core domain 9" Q8NEX5 20 45607939-45631284 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 464 "epididymis: 989.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 989.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XAGE1A "CT12.1a, GAGED2, XAGE-1, XAGE1" ENSG00000204379 "X antigen family member 1A" Q9HD64 X 52495808-52500812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 62 "testis: 94.5" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 1443.3;NB-4: 1484.7;THP-1: 1390.5;U-2 OS: 1014.9;U-266/70: 649.2;U-266/84: 1967.0;U-937: 1201.1" HPA046363 Approved Nucleoplasm NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA046363: " 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 94.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 5.7 235.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.0 6.5 2.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 1443.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 319.6 1.9 0.0 0.0 1.3 1484.7 0.2 0.0 0.0 0.7 0.0 5.3 0.0 0.0 0.6 156.7 0.0 2.6 3.7 0.0 96.1 1390.5 1.5 0.0 1014.9 0.3 187.7 649.2 1967.0 3.3 0.7 1201.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XAGE1B "CT12.1b, CT12.1c, CT12.1d, XAGE1C, XAGE1D, XAGE1E" ENSG00000204382 "X antigen family member 1B" Q9HD64 X 52512077-52520803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 37.8" "Cell type enhanced" "Detected in some" "Spermatocytes: 1.5;Spermatogonia: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 16 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.6" "Cell line enhanced" "Detected in some" "HMC-1: 81.1;NB-4: 95.0;THP-1: 89.4;U-2 OS: 70.5;U-266/84: 143.5;U-937: 69.5" HPA046363 Approved Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 83: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 37.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 23.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.2 0.0 95.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 9.3 0.0 0.7 0.4 0.0 6.2 89.4 0.0 0.0 70.5 0.0 13.3 38.3 143.5 0.0 0.0 69.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBTB17 "MIZ1, pHZ-67, ZNF151, ZNF60" ENSG00000116809 "Zinc finger and BTB domain containing 17" Q13105 1 15941869-15976132 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005789 Approved NA NA "Cluster 15: NK-cells - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "HPA005789: AB_1080633" "unprognostic (2.00e-2)" "unprognostic (1.21e-1)" "unprognostic (2.57e-2)" "unprognostic (4.19e-3)" "unprognostic (1.57e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.38e-6)" "unprognostic (2.28e-1)" "unprognostic (2.76e-1)" "unprognostic (5.08e-2)" "unprognostic (1.20e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.27e-5)" "unprognostic (2.08e-1)" "unprognostic (8.88e-2)" "unprognostic (8.42e-2)" "prognostic favorable (2.04e-4)" 17.1 21.7 21.2 11.9 22.1 28.4 17.3 20.5 24.8 20.3 18.7 19.5 9.1 18.7 3.0 19.8 15.6 7.3 24.2 20.5 20.1 20.2 17.6 20.2 12.8 21.9 21.7 19.9 23.8 6.8 16.8 6.3 20.8 20.6 3.7 6.2 16.3 7.2 27.2 17.6 19.6 5.4 19.4 28.6 20.8 31.8 21.5 10.6 20.7 10.9 7.1 17.6 18.0 23.9 10.7 11.6 13.3 24.7 10.0 6.9 11.1 14.5 16.5 14.5 12.5 11.8 16.3 10.9 12.9 12.7 11.3 11.1 6.6 14.6 4.5 22.6 11.6 17.6 18.6 15.5 13.3 13.0 21.4 9.4 11.7 20.9 12.8 10.8 12.6 22.2 17.4 17.9 10.2 16.0 23.7 26.0 11.8 9.5 16.7 23.8 12.9 11.6 8.9 8.5 16.5 21.9 11.4 11.2 19.8 5.5 11.9 21.0 14.2 16.0 16.9 14.5 11.7 22.5 11.2 11.6 21.1 15.4 22.3 1.3 6.4 6.6 7.5 6.0 5.6 8.6 5.7 8.0 5.5 6.4 5.2 4.7 10.9 9.7 5.1 5.1 6.6 4.6 21.2 22.1 20.5 24.8 20.5 20.1 21.9 21.7 20.8 19.4 21.5 23.9 10.6 9.6 2.7 8.5 15.7 13.9 8.5 8.9 10.8 10.4 8.5 6.1 7.1 10.0 7.5 9.2 6.2 7.8 9.0 14.9 5.9 12.9 29.9 6.2 6.2 10.8 6.6 8.6 6.9 9.8 9.5 7.9 13.7 7.6 8.8 12.9 6.8 6.9 10.0 16.8 7.2 7.5 22.4 9.1 9.4 7.8 12.5 8.8 8.8 6.5 29.3 9.1 9.2 7.1 17.9 11.7 14.2 13.2 9.5 8.2 12.2 7.0 4.3 11.0 13.1 9.0 10.6 34.6 14.8 10.1 10.7 10.7 12.1 8.4 9.1 9.6 ZBTB49 "FLJ38559, ZNF509" ENSG00000168826 "Zinc finger and BTB domain containing 49" Q6ZSB9 4 4290251-4321786 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024450 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Microtubules, Cytosol" "HPA024450: AB_1859311" "unprognostic (4.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.30e-1)" "unprognostic (2.49e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.56e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.11e-1)" "prognostic favorable (1.76e-4)" "unprognostic (5.54e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "prognostic favorable (2.88e-5)" 2.3 1.8 0.8 2.2 0.7 5.1 2.4 1.0 1.6 2.4 1.1 2.1 1.6 2.2 2.4 1.8 1.9 1.9 2.3 0.8 0.8 1.8 1.9 2.4 3.0 0.9 0.7 3.7 2.9 2.1 3.1 2.0 1.2 2.8 1.6 3.4 2.2 2.2 2.9 2.2 1.9 2.3 0.4 3.5 1.7 4.0 1.0 2.0 2.9 2.1 3.0 2.4 2.1 2.3 1.4 2.2 2.7 4.6 3.6 3.7 3.2 1.6 3.2 3.6 2.8 1.9 2.6 4.9 1.7 1.9 4.4 2.3 4.8 2.8 3.7 1.6 1.9 5.7 1.5 2.8 2.8 3.5 2.0 2.4 2.3 3.3 2.1 2.0 3.6 5.2 3.0 2.6 3.4 2.2 6.9 6.7 4.7 2.0 3.0 4.1 3.6 3.1 1.4 2.4 3.3 3.2 3.7 1.4 3.7 3.6 2.0 3.3 3.6 3.2 1.4 2.0 3.7 3.1 3.3 4.3 2.3 2.9 3.2 2.9 2.0 9.8 4.6 2.1 3.8 1.6 2.6 4.5 1.5 2.4 2.9 3.4 4.6 2.8 1.8 0.3 2.6 1.5 0.8 0.7 1.0 1.6 0.8 0.8 0.9 0.7 1.2 0.4 1.0 2.3 3.1 0.0 1.1 3.9 5.3 2.5 1.9 1.8 2.2 2.9 2.2 3.4 1.9 1.5 2.1 1.8 4.2 2.0 5.8 0.8 0.0 1.9 2.7 1.2 2.7 3.1 1.2 3.6 11.5 2.6 1.5 3.1 2.0 1.3 1.3 5.4 3.9 2.2 1.8 1.7 12.5 1.8 2.0 3.1 2.4 0.7 1.5 2.7 3.6 4.7 4.5 1.7 9.2 11.6 10.0 1.1 2.9 2.2 6.6 2.1 1.8 0.9 1.3 8.2 0.0 2.2 2.1 9.7 5.5 1.7 2.6 1.5 6.3 4.6 1.6 1.2 ZC3HAV1 "ARTD13, FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2" ENSG00000105939 "Zinc finger CCCH-type containing, antiviral 1" Q7Z2W4 7 139043515-139132122 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 85.9" "Cell type enhanced" "Detected in many" "dendritic cells: 194.8;Glandular and luminal cells: 359.9;T-cells: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047818, HPA059096" Approved Supported "Golgi apparatus,Cytosol" NA NA 24000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Golgi apparatus" "HPA047818: AB_10962642, HPA059096: AB_2683903" "unprognostic (1.68e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-1)" "unprognostic (1.51e-2)" "unprognostic (3.92e-1)" "unprognostic (2.61e-2)" "prognostic unfavorable (8.77e-7)" "unprognostic (5.40e-2)" "unprognostic (3.08e-1)" "unprognostic (2.55e-2)" "unprognostic (3.72e-1)" "unprognostic (5.41e-2)" "unprognostic (3.31e-3)" "prognostic favorable (6.86e-4)" "unprognostic (6.47e-2)" "unprognostic (1.99e-1)" "unprognostic (7.84e-2)" 13.5 12.7 8.7 19.1 8.9 85.9 11.1 8.1 15.2 8.6 12.2 12.9 9.7 8.6 10.3 12.9 9.7 11.4 6.4 8.1 13.6 11.1 11.0 16.1 24.0 12.3 11.5 10.9 7.3 9.2 6.2 9.3 12.3 9.5 13.7 2.5 14.3 9.1 3.2 13.1 13.9 13.8 12.7 21.0 10.4 6.5 14.9 24.0 10.6 5.6 23.8 11.9 8.7 12.4 25.1 29.5 4.1 24.7 37.4 35.9 17.6 27.5 21.2 46.9 47.7 21.6 31.4 21.9 25.2 43.9 40.6 27.6 33.2 32.6 26.3 37.2 12.2 43.8 29.7 26.9 21.8 51.1 38.6 37.0 20.3 53.3 11.8 17.4 35.3 32.1 37.6 23.5 20.1 23.3 41.9 59.0 16.6 18.6 17.6 48.5 14.6 21.0 32.0 31.0 7.5 15.4 43.1 29.2 37.8 9.3 17.4 30.9 45.3 9.9 14.3 27.6 23.1 17.9 20.2 49.9 22.4 47.0 24.0 78.7 19.6 30.8 43.0 26.0 56.0 32.2 61.9 53.1 15.2 35.3 59.0 58.6 52.5 38.7 30.6 17.7 58.8 30.6 8.7 8.9 8.1 15.2 8.1 13.6 12.3 11.5 12.3 12.7 14.9 12.4 150.3 25.6 41.1 8.1 119.4 28.7 21.7 17.5 62.6 2.8 70.8 44.8 6.2 21.5 21.1 53.3 4.2 12.6 194.8 57.0 9.8 20.2 2.8 185.9 77.7 74.5 53.2 64.4 0.8 21.2 23.1 68.1 60.6 359.9 32.3 41.6 49.2 36.1 35.1 0.0 3.0 42.2 8.2 43.9 150.0 1.9 18.6 84.4 39.2 33.7 57.1 13.9 88.6 27.6 1.0 23.8 33.8 26.7 104.2 41.5 28.0 36.4 29.9 1.3 13.1 79.5 53.6 1.0 1.1 61.7 22.3 2.3 222.3 41.3 35.8 28.0 ZFYVE27 "FLJ32919, SPG33" ENSG00000155256 "Zinc finger FYVE-type containing 27" Q5T4F4 10 97737121-97760907 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037523, HPA069876" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Vesicles" Cytosol "HPA037523: AB_10672351, HPA069876: AB_2686218" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.30e-2)" "unprognostic (2.48e-2)" "unprognostic (7.15e-2)" "unprognostic (2.05e-3)" "unprognostic (5.24e-2)" "unprognostic (3.38e-3)" "prognostic favorable (7.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.26e-2)" "prognostic favorable (7.80e-4)" 14.4 27.9 33.1 12.9 32.1 23.2 15.8 29.2 35.9 20.6 34.8 25.6 24.8 16.5 22.9 16.5 20.3 12.1 17.8 35.5 33.6 28.3 32.6 17.7 16.1 32.6 31.4 25.9 23.7 19.2 38.3 9.5 33.2 22.0 16.3 28.4 18.9 10.3 12.8 18.2 30.6 8.5 29.1 29.1 19.8 23.0 33.5 12.7 20.4 5.9 13.1 16.8 17.0 32.4 17.7 21.4 12.6 28.1 14.1 9.8 17.2 17.7 18.5 20.3 19.7 19.1 35.9 27.2 19.8 12.8 25.9 38.8 18.4 17.2 10.6 28.3 18.6 12.9 23.1 18.1 18.1 20.9 24.9 16.0 20.4 19.9 15.2 32.4 11.5 22.5 19.6 17.9 15.3 13.8 16.9 39.4 10.3 15.3 16.4 19.2 12.7 13.0 19.5 10.8 10.1 19.7 11.9 9.9 47.2 11.5 21.8 20.5 12.4 10.2 11.9 15.6 34.2 20.6 18.6 14.3 25.3 26.5 11.9 4.8 5.8 9.3 9.6 6.2 8.2 7.1 6.6 7.9 5.4 6.7 7.5 8.3 8.2 6.8 9.2 5.6 9.5 8.3 33.1 32.1 29.2 35.9 35.5 33.6 32.6 31.4 33.2 29.1 33.5 32.4 10.0 3.2 11.4 14.0 22.1 8.2 12.8 11.3 18.8 29.9 11.1 8.9 7.2 14.3 9.7 14.7 58.4 7.4 21.2 33.9 7.9 14.9 5.2 14.3 7.8 11.0 20.3 14.3 33.6 16.0 5.7 10.1 19.4 11.4 14.0 17.3 10.8 10.9 8.2 37.0 35.2 15.6 14.2 8.8 5.7 1.5 9.6 11.0 10.6 16.9 11.2 14.8 15.5 12.5 20.2 13.9 26.1 9.1 13.4 13.8 35.5 8.6 16.6 43.7 19.7 6.7 9.9 8.9 7.6 10.4 5.5 13.5 17.9 10.9 14.7 17.7 ZFYVE28 "KIAA1643, lst-2" ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418651 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 49.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 133.9;Inhibitory neurons: 93.2;NK-cells: 48.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 49.9" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.8;T-cells: 1.9" "Cell line enhanced" "Detected in many" "HMC-1: 12.6;NB-4: 14.2;U-266/70: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 24: NB-4 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: AB_2683477" "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favorable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 5.5 8.7 4.6 3.1 7.5 2.1 5.4 49.9 18.0 5.5 0.5 8.0 6.1 4.8 1.6 4.7 5.4 3.4 3.9 7.3 0.3 8.7 6.5 6.2 4.0 9.4 6.9 4.5 5.0 4.3 10.8 1.0 7.4 4.0 2.8 4.0 5.5 2.8 2.9 5.4 8.8 1.5 1.0 6.7 7.2 8.1 5.0 2.6 7.7 1.8 2.0 4.8 4.6 6.2 0.9 1.2 0.2 4.2 2.4 0.8 0.2 2.1 3.5 1.1 0.3 0.1 7.6 0.0 2.2 3.7 2.9 4.4 1.4 0.3 0.7 11.7 1.5 0.3 5.3 0.3 4.8 0.8 12.6 3.3 0.7 1.3 0.1 7.7 3.5 1.1 2.2 9.2 1.0 2.6 0.1 14.2 0.2 2.4 9.3 0.0 0.0 4.7 1.7 0.6 6.6 0.5 2.1 0.1 1.2 0.1 2.8 0.3 0.6 2.0 0.1 6.2 0.2 14.8 11.7 0.2 6.0 2.8 2.0 0.4 0.2 0.0 1.9 0.0 0.8 0.4 1.0 1.3 0.3 1.8 1.3 1.4 0.0 0.2 0.1 0.1 1.9 0.5 4.6 7.5 49.9 18.0 7.3 0.3 9.4 6.9 7.4 1.0 5.0 6.2 12.2 0.0 1.7 41.4 3.7 5.9 3.4 2.1 5.7 12.2 7.6 6.2 3.4 7.2 2.9 11.0 18.8 0.3 25.4 32.3 7.9 3.4 29.1 5.1 4.8 8.0 2.4 1.3 133.9 2.3 0.3 3.6 11.7 6.3 8.9 2.6 5.3 3.7 1.9 8.4 93.2 7.8 2.0 2.2 33.0 8.9 1.5 5.1 7.2 32.8 4.0 1.6 48.4 23.6 36.4 2.6 16.8 2.2 9.8 1.7 18.1 4.2 3.0 17.8 0.0 2.3 3.0 3.1 8.0 6.2 4.8 0.3 31.6 8.2 6.6 5.4 ZGLP1 "GATAD3, GLP-1, GLP1" ENSG00000220201 "Zinc finger GATA like protein 1" P0C6A0 19 10304803-10309880 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 9.5;Hofbauer cells: 12.7;Kupffer cells: 20.0;Macrophages: 12.6;Spermatogonia: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 32.8;U-937: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA049855 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Vesicles" "HPA049855: AB_2680916" "unprognostic (1.73e-2)" "unprognostic (3.43e-3)" "unprognostic (1.42e-3)" "unprognostic (1.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-4)" "unprognostic (1.18e-1)" "unprognostic (1.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-4)" "unprognostic (2.82e-2)" "unprognostic (6.57e-7)" "unprognostic (6.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.57e-1)" "unprognostic (2.57e-4)" 1.9 1.5 5.0 1.0 5.2 0.5 2.3 4.6 10.7 4.0 4.3 2.4 1.0 2.5 0.4 1.9 3.3 0.8 1.7 5.3 4.4 7.8 6.4 2.2 1.7 4.2 4.0 5.2 3.3 0.5 8.3 0.9 4.0 6.8 0.2 0.5 2.5 1.0 1.2 2.1 2.6 0.2 3.7 5.0 1.9 5.0 4.4 0.4 9.2 0.4 0.7 2.6 2.7 4.8 0.5 1.2 1.7 0.6 1.1 0.5 4.3 0.9 0.3 0.8 1.8 1.2 0.4 1.9 0.9 0.3 0.8 1.8 1.2 0.4 0.3 1.6 5.5 1.8 2.0 0.7 0.7 0.0 0.5 0.9 2.5 0.8 0.5 0.7 0.2 1.4 1.8 1.3 1.1 2.0 0.2 32.8 2.7 0.4 2.0 1.8 0.8 0.8 0.7 0.8 1.4 1.6 0.4 0.3 1.6 0.4 2.5 0.6 0.6 2.5 2.9 2.4 0.3 6.2 7.9 0.9 0.4 8.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 5.2 4.6 10.7 5.3 4.4 4.2 4.0 4.0 3.7 4.4 4.8 1.1 0.0 1.8 4.6 0.5 0.9 0.6 1.2 0.0 1.6 2.0 2.4 0.8 0.0 1.2 1.8 0.0 0.5 0.8 0.9 0.0 0.6 0.8 0.9 1.3 1.1 0.0 0.4 9.5 0.0 0.4 0.6 0.0 0.9 0.0 2.7 0.7 1.2 12.7 6.7 6.9 0.7 0.0 20.0 7.9 1.3 0.9 12.6 3.6 2.8 7.8 1.7 0.0 1.5 1.6 0.3 1.5 0.7 0.1 0.9 0.4 0.4 1.5 1.5 0.0 0.5 0.8 2.2 16.3 0.3 0.9 0.1 0.6 0.8 1.6 0.0 ZNF121 "D19S204, ZHC32, ZNF20" ENSG00000197961 "Zinc finger protein 121" P58317 19 9560329-9584504 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 68.2;RT4: 72.3" "Low region specificity" "Detected in all" HPA054961 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 24: NB-4 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Centrosome" Nucleoli "HPA054961: AB_2682651" "unprognostic (3.06e-1)" "unprognostic (9.38e-3)" "unprognostic (9.51e-2)" "unprognostic (7.49e-2)" "unprognostic (3.07e-2)" "unprognostic (3.91e-3)" "unprognostic (3.68e-2)" "unprognostic (1.76e-1)" "unprognostic (6.80e-3)" "prognostic favorable (6.59e-5)" "unprognostic (9.36e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (1.01e-4)" "unprognostic (8.75e-3)" "unprognostic (2.83e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.75e-5)" 7.0 4.8 5.5 5.2 5.9 14.3 7.2 8.8 6.4 5.3 8.2 5.5 3.6 4.7 5.6 9.3 5.4 4.0 6.1 5.7 6.7 8.0 8.5 7.5 6.2 6.0 5.1 4.6 6.3 8.7 6.7 4.2 6.3 7.1 5.8 7.2 6.7 3.5 4.4 10.8 6.4 4.8 5.3 7.4 5.7 3.6 6.3 6.0 5.6 3.2 6.8 5.3 7.0 9.5 14.9 8.7 10.3 23.7 4.6 5.4 16.4 5.3 5.3 7.3 10.0 17.7 6.6 16.1 13.3 4.6 4.1 13.6 18.8 15.0 9.2 8.4 32.4 43.2 29.2 15.7 6.1 26.0 25.6 7.2 11.2 7.2 16.3 6.1 5.4 17.4 16.9 27.7 5.4 11.8 17.9 68.2 27.1 5.2 13.9 10.9 13.0 11.8 8.0 72.3 19.6 10.2 7.6 10.6 6.2 20.7 7.8 8.2 6.1 21.7 12.0 7.6 12.1 26.6 17.6 18.4 6.0 14.4 9.1 1.6 1.5 0.9 2.1 1.9 2.8 1.5 2.0 1.9 1.6 2.3 2.3 2.6 1.2 3.1 2.0 2.0 2.0 0.9 5.5 5.9 8.8 6.4 5.7 6.7 6.0 5.1 6.3 5.3 6.3 9.5 16.0 6.4 10.5 3.9 14.7 22.6 36.9 15.6 10.8 7.3 12.7 11.7 11.2 5.7 15.7 9.2 12.5 12.3 25.8 5.6 7.9 11.4 1.5 12.3 16.9 11.8 13.7 11.6 6.2 5.3 11.3 11.7 11.7 18.3 15.2 16.7 10.8 9.9 5.3 6.7 5.3 10.2 8.2 10.4 13.8 0.6 6.2 9.7 8.8 1.0 6.9 3.1 12.3 7.5 6.7 11.4 5.6 8.2 12.6 26.2 4.1 5.3 11.0 7.8 6.6 17.0 10.3 11.0 12.5 21.3 31.7 10.5 14.5 11.9 14.6 35.9 ZNF141 "D4S90, pHZ-44" ENSG00000131127 "Zinc finger protein 141" Q15928 4 337814-384868 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 24: NB-4 - Immune response" "Cluster 57: B-cells - Immune response" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "unprognostic (6.88e-3)" "unprognostic (4.64e-2)" "unprognostic (2.60e-2)" "unprognostic (2.59e-2)" "unprognostic (1.44e-2)" "unprognostic (1.47e-1)" "unprognostic (3.09e-2)" "unprognostic (4.45e-3)" "unprognostic (1.11e-1)" "unprognostic (5.02e-2)" "unprognostic (1.47e-3)" "unprognostic (2.71e-1)" "unprognostic (1.66e-2)" "prognostic favorable (4.76e-4)" 4.7 13.9 8.6 3.3 9.1 1.3 4.8 12.5 12.1 8.8 9.1 5.3 2.4 5.1 4.2 4.2 6.9 1.5 5.1 8.9 8.6 6.1 6.1 6.5 5.1 8.1 8.2 15.6 5.5 3.2 8.5 2.3 8.3 7.6 2.5 13.7 5.9 2.5 2.5 4.8 6.2 1.2 7.6 7.1 4.4 5.6 8.5 3.3 7.5 1.1 4.3 5.5 6.7 9.2 0.1 1.3 5.0 2.0 1.4 1.9 1.3 1.5 0.9 2.1 3.0 4.4 2.6 0.3 1.2 1.2 2.5 2.1 0.0 1.2 2.8 0.0 1.2 0.1 2.3 0.2 1.0 0.1 4.8 2.2 1.3 2.1 0.9 1.1 0.5 1.0 0.1 0.2 2.1 1.4 4.3 6.3 5.4 0.5 2.3 0.1 0.0 0.5 1.5 2.7 5.0 2.5 1.8 0.7 1.3 2.6 2.2 4.8 0.4 0.3 1.6 1.2 1.5 0.1 0.2 0.2 0.0 0.0 0.9 0.5 0.5 1.0 1.3 0.6 1.3 1.2 1.1 1.1 1.0 1.8 1.6 1.3 0.9 1.4 0.9 0.7 0.9 0.5 8.6 9.1 12.5 12.1 8.9 8.6 8.1 8.2 8.3 7.6 8.5 9.2 9.5 6.4 7.7 14.7 28.3 3.7 3.3 2.0 6.2 24.0 5.2 5.8 5.3 8.6 4.2 14.7 14.6 3.5 11.2 2.6 5.9 3.5 7.9 4.5 9.3 9.6 6.0 8.4 9.9 2.9 3.0 9.7 4.6 5.6 5.7 22.8 3.9 2.0 2.3 33.7 11.6 2.7 2.0 2.2 6.0 6.1 11.1 12.2 3.6 15.0 5.5 7.9 16.5 15.1 16.3 2.9 1.0 6.0 7.2 2.8 3.3 1.7 4.8 18.1 26.3 9.8 21.3 10.6 9.7 3.3 4.1 4.1 13.5 15.3 4.5 2.2 ZNF177 ENSG00000188629 "Zinc finger protein 177" Q13360 19 9363020-9382617 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Early spermatids: 12.7;Late spermatids: 7.6;Spermatocytes: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 11.4" "Low region specificity" "Detected in all" HPA003141 Uncertain NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA003141: AB_1859102" "unprognostic (1.66e-1)" "unprognostic (2.88e-1)" "unprognostic (8.86e-3)" "unprognostic (1.74e-1)" "unprognostic (1.75e-2)" "unprognostic (2.71e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (3.80e-2)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (4.04e-2)" "unprognostic (1.97e-2)" 3.2 4.9 9.4 0.9 9.3 0.5 3.7 11.2 11.7 7.4 8.5 4.8 0.7 5.6 8.2 1.2 6.5 1.4 4.5 9.5 9.2 8.5 2.7 2.9 1.3 9.3 9.1 8.0 2.2 2.7 7.4 1.9 9.0 5.8 1.7 9.9 2.2 2.9 1.3 2.0 2.6 2.7 8.4 4.1 2.5 10.4 9.2 2.9 5.1 1.5 1.0 3.8 3.4 10.1 0.4 0.6 6.1 3.8 2.8 3.0 2.1 1.1 0.8 1.6 2.3 0.3 0.2 0.4 3.3 0.7 2.1 0.2 1.3 1.1 2.5 1.2 6.0 2.0 0.6 0.5 1.6 2.1 4.2 1.2 2.4 0.9 3.2 4.9 0.8 5.1 0.1 4.1 2.4 0.0 3.4 11.4 1.1 0.1 1.9 2.2 2.0 0.5 1.2 3.1 4.8 1.1 1.8 0.1 0.9 4.6 1.2 4.0 0.7 1.7 1.2 3.5 1.8 0.2 0.0 1.8 0.6 1.7 1.7 0.6 0.0 0.4 0.4 0.1 0.2 0.2 0.0 0.4 0.4 0.0 0.4 0.2 0.3 0.8 0.0 0.2 0.1 0.2 9.4 9.3 11.2 11.7 9.5 9.2 9.3 9.1 9.0 8.4 9.2 10.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 7.6 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 ZNF182 "HHZ150, KOX14, Zfp182, ZNF21" ENSG00000147118 "Zinc finger protein 182" P17025 X 47974851-48003989 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059574 Uncertain Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA059574: AB_2684068" "unprognostic (1.86e-1)" "unprognostic (9.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.88e-3)" "unprognostic (6.88e-2)" "unprognostic (8.81e-2)" "unprognostic (3.53e-3)" "unprognostic (2.42e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (1.01e-1)" "unprognostic (9.49e-2)" "unprognostic (8.59e-2)" "prognostic favorable (1.55e-7)" 4.5 4.2 4.3 4.0 4.5 5.0 4.5 6.0 5.8 6.5 4.6 4.8 2.9 4.6 4.6 3.0 5.4 3.2 3.6 4.0 4.4 6.3 5.3 4.5 6.6 4.6 4.3 6.3 6.5 4.4 7.7 3.4 4.7 5.7 3.4 6.7 4.2 3.6 3.0 3.7 5.7 2.9 4.1 8.4 4.6 2.8 4.7 7.6 8.8 3.6 6.2 4.6 4.4 5.3 3.6 4.8 5.8 5.6 3.2 3.6 2.2 4.5 5.3 6.4 7.7 3.7 4.7 9.2 3.2 2.9 6.1 4.3 9.7 2.6 7.7 6.6 5.6 4.6 6.3 4.7 4.0 8.6 7.2 3.2 5.5 5.5 6.5 7.7 3.9 8.9 4.0 6.7 6.0 2.7 6.7 15.2 9.2 2.4 5.4 5.7 11.0 10.2 5.6 2.4 5.4 7.3 7.3 2.3 4.3 12.6 5.9 7.5 3.9 5.1 5.5 7.6 3.8 8.7 7.6 7.1 3.5 7.2 3.4 1.8 1.9 4.2 3.3 1.9 3.8 4.4 3.0 3.1 2.4 2.9 4.6 3.9 4.2 3.0 5.5 1.8 3.2 2.5 4.3 4.5 6.0 5.8 4.0 4.4 4.6 4.3 4.7 4.1 4.7 5.3 3.5 12.8 7.0 6.2 5.8 0.3 1.0 1.3 3.4 6.7 2.3 2.0 4.4 5.7 2.4 1.8 2.1 2.1 4.7 0.6 0.0 2.8 0.2 3.6 4.1 3.5 7.7 7.8 6.6 1.8 1.4 2.5 1.1 2.5 0.0 10.3 4.2 2.5 1.7 1.7 7.4 4.1 2.0 3.7 0.7 0.4 2.5 4.0 3.6 4.7 4.9 3.8 6.2 5.0 8.0 2.7 3.0 1.9 6.0 1.1 0.9 2.1 4.4 2.9 0.0 4.0 4.5 2.8 3.2 1.7 1.1 0.8 3.8 6.5 2.5 1.1 ZNF212 C2H2-150 ENSG00000170260 "Zinc finger protein 212" Q9UDV6 7 149239651-149255606 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049807, HPA054178" Uncertain Supported Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA049807: AB_2680891, HPA054178: AB_2682406" "unprognostic (1.07e-2)" "unprognostic (6.31e-2)" "unprognostic (6.77e-3)" "unprognostic (3.66e-3)" "unprognostic (6.48e-2)" "unprognostic (2.79e-3)" "unprognostic (5.55e-3)" "unprognostic (8.75e-3)" "unprognostic (1.37e-3)" "unprognostic (1.15e-1)" "unprognostic (4.32e-3)" "unprognostic (2.46e-1)" "unprognostic (2.30e-1)" "unprognostic (4.75e-2)" "unprognostic (2.99e-1)" "unprognostic (1.60e-2)" "unprognostic (1.59e-1)" 5.4 8.3 6.7 4.8 6.9 12.2 6.7 7.2 6.9 9.9 6.7 7.1 9.2 8.1 6.2 14.7 7.4 4.1 5.9 6.4 6.5 7.4 10.2 4.8 8.0 7.1 6.8 9.1 7.9 6.4 6.4 6.2 6.9 8.7 4.8 4.5 8.6 6.2 6.2 10.9 9.7 5.1 6.7 10.7 7.0 12.5 6.8 9.5 7.7 4.7 8.0 6.9 9.6 7.2 10.7 10.4 12.5 15.9 8.7 7.0 13.8 6.3 9.5 11.2 11.2 8.9 13.3 14.0 9.7 6.4 9.0 9.6 9.3 10.4 9.2 10.8 16.7 7.7 8.1 7.5 6.6 12.8 9.2 8.0 11.7 7.7 8.1 7.0 6.7 16.9 14.3 10.5 6.5 15.2 23.2 26.0 16.6 8.4 12.5 15.6 8.6 15.3 7.0 8.9 12.5 20.5 9.7 9.4 9.6 7.5 5.6 13.5 5.7 11.3 3.1 14.5 11.7 24.1 11.3 12.6 14.8 11.5 10.4 0.0 3.5 7.6 5.0 2.9 5.0 4.1 3.7 4.2 4.4 3.9 6.4 5.5 1.9 8.2 3.7 3.9 5.9 2.1 6.7 6.9 7.2 6.9 6.4 6.5 7.1 6.8 6.9 6.7 6.8 7.2 3.7 6.4 3.3 5.9 5.4 9.7 3.1 3.2 4.0 7.3 5.4 4.7 3.0 5.7 2.2 0.0 4.2 9.6 2.9 5.5 3.9 5.9 1.8 5.9 3.5 4.2 6.7 5.2 6.8 4.0 10.0 4.0 2.6 5.7 2.5 7.1 4.2 5.8 4.2 10.1 6.5 5.5 8.2 5.6 2.3 0.8 6.2 2.9 1.8 5.6 6.1 6.0 6.2 6.0 7.7 4.6 1.2 6.0 4.0 3.8 11.1 3.8 4.5 8.3 13.1 4.2 3.1 13.8 22.1 4.4 8.7 15.1 5.4 5.8 5.3 4.0 ZNF266 HZF1 ENSG00000174652 "Zinc finger protein 266" Q14584 19 9412461-9435571 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 74.2" "Low region specificity" "Detected in all" "HPA026836, HPA054110" Uncertain Supported "Nucleoplasm,Vesicles,Rods & Rings" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Vesicles "Nucleoplasm, Rods & Rings" "HPA026836: AB_2672018, HPA054110: AB_2682383" "unprognostic (2.50e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (7.60e-2)" "prognostic favorable (3.94e-6)" "unprognostic (1.72e-2)" "prognostic favorable (4.47e-4)" "unprognostic (4.59e-2)" "unprognostic (9.00e-3)" "prognostic favorable (3.03e-5)" "unprognostic (2.92e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" "prognostic favorable (9.15e-5)" 21.0 17.6 8.7 12.7 9.1 17.5 22.8 10.5 10.7 26.3 10.1 22.8 10.2 20.6 53.3 17.5 21.7 9.7 15.3 8.4 8.9 16.3 15.4 21.8 23.8 8.9 8.9 24.2 15.1 15.7 20.1 15.0 9.0 31.5 15.9 12.6 19.0 14.6 11.4 25.1 29.4 14.0 8.8 44.1 19.4 16.7 9.1 27.6 26.3 8.6 27.9 20.0 20.3 9.9 21.5 5.4 13.0 26.6 10.8 15.3 10.3 19.4 18.9 19.1 27.5 10.1 7.1 22.5 12.6 10.7 7.4 6.3 19.3 10.8 22.1 6.8 29.6 27.1 21.8 13.9 9.2 16.9 17.3 16.4 16.0 9.6 14.3 15.5 14.2 25.7 18.0 0.0 16.7 2.1 25.8 74.2 16.6 9.9 16.5 9.6 16.4 16.9 13.6 22.2 13.0 19.5 10.5 11.0 14.0 14.0 8.8 14.2 13.7 16.6 6.9 23.1 11.8 32.1 55.6 28.0 4.5 14.8 11.3 4.0 3.5 4.9 9.6 4.1 6.8 4.8 5.7 7.4 2.9 5.3 7.5 8.1 2.0 11.1 5.4 2.7 7.5 4.8 8.7 9.1 10.5 10.7 8.4 8.9 8.9 8.9 9.0 8.8 9.1 9.9 8.8 0.0 14.3 10.4 15.3 4.0 5.9 5.3 11.4 8.0 9.0 8.8 5.5 4.3 8.7 3.7 12.5 4.8 22.4 7.2 3.9 5.5 0.7 5.0 5.4 7.5 9.5 14.3 12.5 3.7 3.3 6.6 11.2 6.5 12.0 12.9 10.8 3.1 4.8 8.4 12.0 7.1 6.1 11.4 7.2 1.4 6.2 9.1 5.4 14.0 11.3 4.2 20.6 14.1 15.1 4.7 5.2 4.5 10.5 5.6 7.6 1.4 6.6 9.5 6.6 7.2 6.2 5.5 8.7 6.4 4.7 4.7 17.1 6.5 7.4 6.4 ZNF317 ENSG00000130803 "Zinc finger protein 317" Q96PQ6 19 9140397-9163424 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042075, HPA048625" Approved Enhanced Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA042075: AB_10796471, HPA048625: AB_2680464" "unprognostic (3.81e-1)" "unprognostic (3.11e-2)" "unprognostic (3.90e-1)" "unprognostic (1.63e-1)" "unprognostic (2.98e-2)" "unprognostic (6.07e-3)" "unprognostic (7.70e-2)" "unprognostic (6.17e-2)" "unprognostic (3.89e-2)" "unprognostic (1.72e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.67e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (3.36e-1)" "unprognostic (2.42e-3)" 15.8 17.5 21.3 10.2 22.0 26.2 14.7 22.4 34.1 15.1 22.3 17.4 11.2 16.4 11.5 17.4 15.5 8.3 16.1 21.4 21.8 22.2 21.1 14.2 14.2 21.4 21.6 16.4 19.6 12.4 15.8 9.1 21.3 17.8 10.4 12.9 13.6 9.6 14.6 22.8 17.9 10.3 21.3 24.7 18.3 6.7 21.9 15.0 14.5 12.7 15.3 17.7 15.1 22.7 17.4 14.6 15.7 21.0 15.7 14.9 13.6 14.3 22.3 19.2 23.2 16.6 9.2 29.5 17.9 15.3 22.8 17.2 25.7 24.7 24.8 24.4 34.5 26.6 13.3 18.4 20.9 27.8 26.0 17.9 32.2 21.9 38.1 16.6 17.0 25.8 24.8 33.6 19.6 14.6 34.8 88.3 29.0 18.4 30.9 24.4 19.8 23.6 17.0 29.4 27.0 18.6 19.9 17.4 22.7 13.7 13.1 28.7 15.1 13.6 12.3 31.2 19.3 42.0 42.8 33.3 13.1 24.2 17.8 19.4 14.8 16.1 13.0 15.5 20.5 20.8 17.3 15.2 15.0 16.4 16.4 17.9 9.0 22.8 13.4 13.6 22.5 14.2 21.3 22.0 22.4 34.1 21.4 21.8 21.4 21.6 21.3 21.3 21.9 22.7 5.7 9.6 13.4 6.8 11.8 7.4 7.1 4.4 6.2 8.3 8.9 6.7 7.3 7.2 9.4 5.5 6.2 5.6 12.6 9.5 3.9 5.3 0.7 8.9 9.0 7.6 7.2 9.1 6.1 6.4 5.2 7.9 12.2 13.1 13.9 8.1 6.4 10.1 8.0 8.4 7.4 8.6 6.1 15.9 6.2 1.4 3.7 10.1 5.4 7.5 8.1 4.6 8.2 10.6 9.3 8.5 4.7 3.8 10.5 9.5 5.8 9.8 9.4 5.3 0.0 5.7 5.4 2.4 1.0 7.0 6.5 10.9 10.3 7.7 9.6 11.7 ZNF439 DKFZp571K0837 ENSG00000171291 "Zinc finger protein 439" Q8NDP4 19 11848726-11883750 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 52.1;Rod photoreceptor cells: 49.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 26.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 15.4;U-138 MG: 15.6" HPA047845 Approved Uncertain Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (4.83e-2)" "unprognostic (3.55e-3)" "unprognostic (2.93e-2)" "unprognostic (1.19e-3)" "unprognostic (8.26e-3)" "unprognostic (7.54e-2)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "unprognostic (9.66e-4)" "unprognostic (1.00e-1)" "unprognostic (8.68e-2)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.29e-2)" 2.6 3.5 3.8 3.5 4.7 4.2 5.7 8.2 5.2 4.2 4.3 5.0 1.1 5.2 5.0 3.2 4.0 2.4 3.5 4.0 4.0 6.3 1.3 5.1 7.3 4.5 4.1 8.1 4.1 16.5 10.1 5.2 5.0 6.2 3.8 14.7 5.3 4.4 0.8 8.0 8.0 2.6 4.0 9.4 3.9 5.7 4.1 10.0 7.3 1.1 7.6 5.6 4.8 6.7 0.1 0.0 4.2 12.2 0.4 0.3 0.0 5.2 1.8 6.2 4.2 3.0 0.2 4.5 2.2 2.9 1.8 0.1 0.0 0.4 7.2 0.0 0.1 4.4 0.0 1.8 1.2 0.0 4.2 1.2 0.3 1.3 0.0 2.7 0.0 4.2 0.8 0.0 0.4 0.4 6.2 15.4 5.1 0.0 1.2 7.3 1.2 0.0 4.6 2.6 7.5 8.0 0.0 0.1 5.6 4.3 3.2 10.0 0.0 15.6 1.4 1.3 3.1 6.0 10.1 10.1 0.2 0.0 4.3 26.1 0.6 5.7 1.7 1.6 2.3 8.9 3.0 1.7 2.8 8.6 5.4 3.1 1.6 2.2 3.5 2.7 1.4 1.9 3.8 4.7 8.2 5.2 4.0 4.0 4.5 4.1 5.0 4.0 4.1 6.7 3.1 3.2 10.4 15.0 23.9 0.5 2.5 1.6 3.4 26.2 3.9 4.6 3.5 11.5 6.8 0.0 52.1 32.8 8.3 9.2 3.9 8.2 4.5 6.5 5.1 4.6 6.1 3.0 19.2 1.8 22.2 3.8 4.1 4.4 29.8 11.2 6.1 0.2 4.2 16.8 8.7 2.3 2.0 1.9 3.1 3.8 4.4 2.7 5.4 14.0 2.4 10.4 25.7 31.7 28.3 3.0 6.0 7.9 4.1 2.1 6.5 2.1 5.8 49.9 13.1 1.8 5.9 21.7 5.8 1.1 1.8 13.5 7.4 2.8 3.1 1.3 ZNF558 FLJ30932 ENSG00000167785 "Zinc finger protein 558" Q96NG5 19 8806170-8832314 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003151 Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "HPA003151: AB_1859344" "unprognostic (2.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.90e-1)" "unprognostic (2.09e-2)" "unprognostic (1.84e-1)" "prognostic favorable (1.04e-4)" "unprognostic (1.61e-2)" "unprognostic (1.58e-2)" "unprognostic (1.69e-2)" "unprognostic (1.09e-2)" "unprognostic (3.20e-1)" "unprognostic (5.89e-3)" "prognostic unfavorable (1.23e-6)" "unprognostic (2.28e-2)" "unprognostic (6.92e-2)" "unprognostic (1.09e-1)" "prognostic favorable (9.30e-5)" 9.3 10.1 7.8 6.5 8.0 4.6 9.5 8.6 9.3 15.0 8.3 11.2 6.0 13.6 9.4 7.9 14.7 5.4 6.6 7.6 8.1 11.4 11.0 8.3 7.3 8.3 8.2 15.1 11.5 10.3 8.5 5.5 8.1 11.5 8.0 14.5 8.3 8.7 6.9 10.1 9.2 10.3 8.0 9.7 9.5 6.2 8.3 7.9 12.2 6.6 8.0 9.9 10.7 8.6 8.1 2.8 12.8 17.6 11.8 13.2 10.9 5.6 8.5 8.2 12.8 4.1 4.9 4.0 14.5 6.4 10.0 7.2 10.9 0.8 11.5 9.6 0.5 0.3 5.0 2.1 9.4 5.9 9.3 12.7 18.5 5.2 0.0 20.0 0.0 12.3 8.6 15.4 10.8 3.3 5.4 31.4 8.0 3.0 4.0 2.8 10.1 3.5 15.2 8.9 2.7 12.7 6.5 3.7 11.5 15.0 7.9 8.5 0.1 10.4 5.9 16.5 6.7 7.0 6.4 8.8 2.4 5.8 3.5 0.4 0.6 0.3 1.0 0.6 0.8 0.3 0.7 1.1 0.7 1.0 1.2 1.5 0.7 2.0 0.5 1.0 0.5 0.5 7.8 8.0 8.6 9.3 7.6 8.1 8.3 8.2 8.1 8.0 8.3 8.6 3.8 9.6 5.6 8.1 3.2 3.6 2.9 3.1 9.1 4.8 5.5 5.5 3.6 2.8 5.5 3.7 8.4 4.0 3.9 3.6 1.9 4.5 9.6 4.5 9.3 4.0 1.2 4.0 4.0 3.3 3.7 4.6 11.2 5.0 3.8 5.1 2.9 5.3 2.9 8.4 3.3 3.3 0.0 4.7 1.3 5.2 2.1 2.9 0.0 3.7 2.4 5.9 5.2 5.5 7.9 4.2 2.7 2.6 1.8 3.3 2.8 1.9 3.6 8.6 0.0 5.2 4.8 4.1 3.9 5.4 2.7 1.5 3.9 2.8 3.9 1.5 ZNF559 MGC13105 ENSG00000188321 "Zinc finger protein 559" Q9BR84 19 9323772-9351162 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA059632, HPA065485" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA059632: AB_2684089, HPA065485: AB_2685497" "unprognostic (1.35e-3)" "unprognostic (1.98e-1)" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.64e-3)" "prognostic favorable (6.99e-4)" "unprognostic (7.28e-3)" "unprognostic (4.04e-2)" "unprognostic (8.48e-2)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-3)" 14.8 14.2 12.5 9.2 13.7 4.0 16.8 19.7 14.0 23.5 17.8 16.7 6.4 22.4 21.5 7.4 23.1 9.9 19.7 12.4 12.9 19.1 11.1 12.4 16.0 12.7 12.3 32.7 10.6 22.2 25.9 12.1 12.4 20.5 11.0 20.4 12.3 12.9 4.7 10.7 14.8 19.1 11.8 22.1 12.9 16.3 13.7 22.7 19.7 10.6 13.1 17.0 15.6 19.4 15.4 8.3 15.6 19.3 9.2 8.3 4.2 9.3 18.6 13.3 11.4 3.8 1.8 12.4 10.8 13.7 18.4 5.4 9.5 8.8 16.9 19.9 13.5 16.2 14.0 5.7 16.0 15.0 18.3 17.3 15.6 14.7 18.7 11.4 11.3 18.8 12.7 42.8 8.7 0.0 20.4 46.8 25.4 2.6 13.4 10.0 18.8 16.7 8.1 21.5 17.8 14.7 17.9 2.9 22.6 22.9 12.7 11.5 9.6 24.6 5.6 20.1 14.2 3.5 0.1 12.6 4.6 9.4 16.0 40.7 4.8 11.4 12.1 4.7 16.4 17.4 13.0 13.3 7.7 17.0 21.0 17.2 2.7 20.9 6.5 6.4 12.6 9.0 12.5 13.7 19.7 14.0 12.4 12.9 12.7 12.3 12.4 11.8 13.7 19.4 9.8 3.2 3.3 0.0 12.9 3.8 6.7 6.2 5.7 30.2 7.0 7.1 8.8 10.0 5.1 3.7 27.1 7.0 12.4 2.2 1.9 7.3 9.1 6.1 8.3 11.0 3.0 3.0 0.0 3.2 5.3 9.8 1.5 3.8 2.5 17.8 12.8 2.7 4.9 26.9 0.0 4.0 2.0 7.0 3.7 2.9 12.8 4.7 3.6 0.0 7.7 17.3 29.9 0.0 0.0 3.2 3.0 13.5 1.8 4.6 2.2 3.4 5.7 27.2 6.6 14.1 10.1 27.0 40.4 2.9 3.0 2.9 10.0 8.5 4.1 2.8 ZNF692 "AREBP, FLJ20531, Zfp692" ENSG00000171163 "Zinc finger protein 692" Q9BU19 1 248850006-248859144 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059337, HPA062792" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA059337: AB_2683984, HPA062792: AB_2684869" "unprognostic (4.86e-2)" "unprognostic (9.51e-2)" "unprognostic (1.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.90e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-3)" "unprognostic (5.66e-3)" "unprognostic (1.25e-1)" "unprognostic (4.50e-2)" "prognostic favorable (4.09e-4)" "unprognostic (5.65e-3)" "prognostic unfavorable (7.72e-9)" "unprognostic (5.32e-2)" "unprognostic (2.07e-2)" "unprognostic (1.59e-1)" "prognostic favorable (8.35e-5)" 13.0 16.5 35.1 4.7 36.3 7.5 16.3 36.3 48.5 26.6 34.1 20.1 5.1 17.1 8.2 23.2 25.3 4.9 18.0 35.0 34.7 27.0 21.7 12.5 6.2 36.5 35.5 27.6 28.2 7.4 29.1 4.2 37.7 34.9 3.6 8.5 17.8 5.3 17.7 18.7 16.6 3.8 34.1 23.5 19.7 38.9 35.7 7.0 24.7 4.7 4.4 21.3 20.8 36.8 7.1 6.4 6.1 14.7 4.7 2.5 26.4 6.1 1.9 6.2 4.0 8.2 9.8 8.8 11.7 2.3 2.5 9.5 9.1 8.8 3.9 12.6 5.7 9.9 17.8 2.2 3.5 11.4 8.3 3.2 10.2 6.8 17.5 5.8 5.9 11.1 21.1 6.2 2.9 3.8 5.9 23.7 12.2 17.1 13.1 19.3 3.6 16.9 11.9 4.5 11.7 8.8 6.3 10.1 12.2 2.3 13.1 18.5 4.5 2.7 5.0 2.7 8.0 17.0 11.3 5.8 6.2 14.9 4.7 0.0 1.5 1.4 3.6 1.1 3.3 3.0 2.9 4.0 3.1 2.3 4.1 3.0 3.3 8.1 1.0 2.5 3.5 2.0 35.1 36.3 36.3 48.5 35.0 34.7 36.5 35.5 37.7 34.1 35.7 36.8 7.8 9.6 8.6 27.1 10.7 9.6 12.5 19.0 11.4 15.3 16.8 18.7 5.4 7.2 10.8 11.0 22.9 12.8 10.3 10.0 5.9 7.6 14.3 6.1 7.0 6.7 8.3 22.7 20.6 4.0 10.4 8.1 15.8 6.8 5.7 15.9 2.9 6.2 6.5 11.8 19.7 12.3 12.2 6.0 5.5 7.8 10.2 5.4 16.0 10.3 6.1 8.3 9.2 8.5 23.5 5.7 5.2 7.2 6.6 17.3 11.6 4.1 10.8 13.6 0.0 8.4 8.0 52.7 15.4 11.0 8.0 6.2 11.3 9.5 14.3 10.0 ZNF98 "F7175, ZNF739" ENSG00000197360 "Zinc finger protein 98" A6NK75 19 22391019-22532485 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 11.8;pancreas: 37.2" "Cell type enhanced" "Detected in many" "Astrocytes: 34.0;Distal tubular cells: 15.6;Early spermatids: 14.7;Granulosa cells: 12.9;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 15.7;Spermatogonia: 21.1" "Cancer enriched" "Detected in some" 4 "testis cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.8;GAMG: 5.4;NB-4: 4.8;RPMI-8226: 1.9;SuSa: 2.1;T-47d: 3.4;U-2197: 3.6" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 22: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "unprognostic (1.11e-1)" "unprognostic (1.31e-2)" "unprognostic (6.95e-3)" "unprognostic (1.36e-3)" "unprognostic (3.07e-3)" "unprognostic (1.56e-1)" "unprognostic (7.20e-2)" "unprognostic (1.63e-1)" "unprognostic (1.81e-1)" "unprognostic (3.81e-2)" "unprognostic (1.99e-2)" "unprognostic (2.14e-1)" "unprognostic (2.66e-1)" "unprognostic (7.56e-2)" 1.0 0.6 1.8 0.2 5.6 0.2 3.8 0.6 10.1 3.3 0.0 0.2 0.1 1.2 5.7 0.2 2.1 0.4 0.6 2.7 4.0 2.0 0.0 0.2 0.4 1.6 1.9 11.8 37.2 3.9 0.3 0.5 1.6 0.8 0.1 0.6 0.8 0.6 0.0 0.1 0.1 1.3 0.2 0.2 0.3 7.6 1.4 0.0 4.7 0.2 0.0 0.5 0.2 5.8 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 5.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 4.8 1.0 0.0 0.2 0.3 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 3.4 1.1 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 5.6 0.6 10.1 2.7 4.0 1.6 1.9 1.6 0.2 1.4 5.8 1.2 0.0 0.0 34.0 0.1 0.0 0.4 0.0 0.0 1.4 2.9 2.5 1.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 15.6 3.1 14.7 0.3 1.6 0.4 0.0 0.0 2.5 1.4 0.4 1.2 0.0 0.5 0.0 12.9 0.0 0.0 0.1 1.7 0.5 0.0 0.0 0.0 0.0 3.5 1.2 0.1 0.0 1.9 0.0 1.0 0.0 10.6 5.2 0.3 0.0 1.9 0.0 0.1 0.0 1.7 0.0 0.1 0.0 0.0 1.0 15.7 21.1 0.0 0.0 0.4 0.0 8.2 0.0 0.4 ZSWIM9 "C19orf68, LOC374920" ENSG00000185453 "Zinc finger SWIM-type containing 9" Q86XI8 19 48170680-48197620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2" "Cell type enhanced" "Detected in many" "Adipocytes: 6.1;Granulosa cells: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061028 Uncertain Approved Nucleoplasm NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA061028: AB_2684419" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (5.79e-3)" "unprognostic (1.65e-1)" "unprognostic (8.49e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.35e-5)" "unprognostic (1.26e-1)" "unprognostic (2.93e-1)" "unprognostic (6.96e-2)" "unprognostic (3.19e-3)" "unprognostic (2.20e-2)" "prognostic favorable (2.44e-4)" "unprognostic (3.59e-1)" "unprognostic (2.64e-1)" "unprognostic (7.07e-2)" "unprognostic (1.03e-1)" 3.8 2.4 17.0 2.2 15.6 2.4 3.2 10.1 14.4 5.3 7.4 6.9 2.2 6.1 0.8 4.1 4.9 1.2 5.3 13.6 13.3 2.9 2.6 3.0 2.5 18.2 14.8 5.6 4.6 2.6 3.6 1.7 13.3 4.2 1.3 1.6 3.5 2.5 9.1 5.4 4.0 2.2 12.5 3.6 3.9 4.0 13.8 1.9 4.3 2.8 1.4 6.1 4.7 14.2 9.5 10.4 6.1 4.5 3.9 2.2 5.5 7.2 3.8 3.3 3.8 1.7 3.0 7.6 3.4 3.3 4.1 7.8 2.0 4.4 3.6 11.5 7.6 4.8 7.0 4.4 4.2 4.4 3.9 2.3 3.5 4.8 5.7 5.9 3.4 6.0 1.2 4.0 2.1 5.1 4.8 18.5 3.8 8.9 6.6 8.9 5.5 2.1 2.3 7.7 4.2 5.2 10.0 3.1 5.0 3.7 4.3 6.6 8.6 3.9 7.1 3.3 7.9 6.5 7.0 4.5 2.3 6.2 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 15.6 10.1 14.4 13.6 13.3 18.2 14.8 13.3 12.5 13.8 14.2 6.1 3.2 3.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.3 5.5 0.0 0.0 0.6 3.7 0.0 5.6 2.2 0.0 3.9 4.1 0.0 3.2 5.6 2.4 0.0 0.0 0.0 5.8 2.8 2.4 0.0 5.5 2.5 11.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.7 0.0 0.0 2.4 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.7 1.7 5.8 0.0 0.0